PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Soda, M; Choi, YL; Enomoto, M; Takada, S; Yamashita, Y; Ishikawa, S; Fujiwara, SI; Watanabe, H; Kurashina, K; Hatanaka, H; Bando, M; Ohno, S; Ishikawa, Y; Aburatani, H; Niki, T; Sohara, Y; Sugiyama, Y; Mano, H				Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki			Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; TYROSINE KINASE; FACTOR-RECEPTOR; ALK; MUTATIONS; GEFITINIB; TRANSLOCATIONS; PROLIFERATION; INHIBITOR; COMMON	Improvement in the clinical outcome of lung cancer is likely to be achieved by identification of the molecular events that underlie its pathogenesis. Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells. Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and subcutaneous tumours in nude mice. The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examined; these individuals were distinct from those harbouring mutations in the epidermal growth factor receptor gene. Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic molecular marker in NSCLC.	Jichi Med Univ, Div Funct Genom, Tochigi 3290498, Japan; Jichi Med Univ, Div Pulm Med, Tochigi 3290498, Japan; Jichi Med Univ, Dept Pathol, Tochigi 3290498, Japan; Jichi Med Univ, Div Gen Thorac Surg, Tochigi 3290498, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University; Jichi Medical University; University of Tokyo; Japanese Foundation for Cancer Research; Japan Science & Technology Agency (JST)	Mano, H (corresponding author), Jichi Med Univ, Div Funct Genom, Tochigi 3290498, Japan.	hmano@jichi.ac.jp	Fujiwara, Shin-ichiro/ABH-2030-2020; niki, toshiro/K-8917-2012	Fujiwara, Shin-ichiro/0000-0002-4523-2994; Takada, Shuji/0000-0002-9406-4683				Choi YL, 2007, LEUKEMIA RES, V31, P203, DOI 10.1016/j.leukres.2006.05.006; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Eichenmuller B, 2002, J BIOL CHEM, V277, P1301, DOI 10.1074/jbc.M106628200; Fujiwara S, 2005, BIOCHEM BIOPH RES CO, V338, P1256, DOI 10.1016/j.bbrc.2005.10.080; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Hatanaka H, 2007, BIOCHEM BIOPH RES CO, V356, P723, DOI 10.1016/j.bbrc.2007.03.048; Hernandez L, 2002, AM J PATHOL, V160, P1487, DOI 10.1016/S0002-9440(10)62574-6; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kaul KL, 2001, CLIN CHEM, V47, P1553; Li RS, 2006, J MED CHEM, V49, P1006, DOI 10.1021/jm050824x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Onishi M, 1996, EXP HEMATOL, V24, P324; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pollmann M, 2006, EXP CELL RES, V312, P3241, DOI 10.1016/j.yexcr.2006.06.035; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SHIOTA M, 1994, ONCOGENE, V9, P1567; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; Yamashita Y, 2001, J BIOL CHEM, V276, P39012, DOI 10.1074/jbc.M106249200; Yoshizuka N, 2004, J BIOL CHEM, V279, P43998, DOI 10.1074/jbc.M406082200	27	3819	4155	13	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					561	U3		10.1038/nature05945	http://dx.doi.org/10.1038/nature05945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17625570				2022-12-24	WOS:000248446700036
J	Hamilton, GL; Kang, EJ; Mba, M; Toste, FD				Hamilton, Gregory L.; Kang, Eun Joo; Mba, Miriam; Toste, F. Dean			A powerful chiral counterion strategy for asymmetric transition metal catalysis	SCIENCE			English	Article							GOLD; HYDROGENATION; CYCLIZATION; COMPLEXES	Traditionally, transition metal-catalyzed enantioselective transformations rely on chiral ligands tightly bound to the metal to induce asymmetric product distributions. Here we report high enantioselectivities conferred by a chiral counterion in a metal-catalyzed reaction. Two different transformations catalyzed by cationic gold( I) complexes generated products in 90 to 99% enantiomeric excess with the use of chiral binaphthol-derived phosphate anions. Furthermore, we show that the chiral counterion can be combined additively with chiral ligands to enable an asymmetric transformation that cannot be achieved by either method alone. This concept of relaying chiral information via an ion pair should be applicable to a vast number of metal-mediated processes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Kang, Eun/AAK-7225-2020	Toste, F. Dean/0000-0001-8018-2198; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073932] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073932] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama T, 2006, ADV SYNTH CATAL, V348, P999, DOI 10.1002/adsc.200606074; Bates RW, 2002, CHEM SOC REV, V31, P12, DOI 10.1039/b103904k; Connon SJ, 2006, ANGEW CHEM INT EDIT, V45, P3909, DOI 10.1002/anie.200600529; Dorta R, 2004, J ORGANOMET CHEM, V689, P751, DOI 10.1016/j.jorganchem.2003.12.012; Gonzalez-Arellano C, 2005, CHEM COMMUN, P3451, DOI 10.1039/b505271h; Gorin DJ, 2007, NATURE, V446, P395, DOI 10.1038/nature05592; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; ITO Y, 1986, J AM CHEM SOC, V108, P6405, DOI 10.1021/ja00280a056; Jimenez-Nunez E, 2007, CHEM COMMUN, P333, DOI 10.1039/b612008c; Johansson MJ, 2005, J AM CHEM SOC, V127, P18002, DOI 10.1021/ja0552500; Lacour J, 2003, CHEM SOC REV, V32, P373, DOI 10.1039/b205251m; LaLonde RL, 2007, J AM CHEM SOC, V129, P2452, DOI 10.1021/ja068819l; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; Llewellyn DB, 2005, TETRAHEDRON-ASYMMETR, V16, P1789, DOI 10.1016/j.tetasy.2005.04.004; Llewellyn DB, 2000, ORG LETT, V2, P4165, DOI 10.1021/ol000303y; Martin NJA, 2006, J AM CHEM SOC, V128, P13368, DOI 10.1021/ja065708d; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Mulzer J., 1999, COMPREHENSIVE ASYMME, V1; Munoz MP, 2005, ORGANOMETALLICS, V24, P1293, DOI 10.1021/om0491645; O'Donnell M.J., 2000, CATALYTIC ASYMMETRIC, P727; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Zhang LM, 2006, ADV SYNTH CATAL, V348, P2271, DOI 10.1002/adsc.200600368; Zhang ZB, 2007, ANGEW CHEM INT EDIT, V46, P283, DOI 10.1002/anie.200603260	24	697	699	6	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					496	499		10.1126/science.1145229	http://dx.doi.org/10.1126/science.1145229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	194JD	17656720				2022-12-24	WOS:000248339800040
J	Gudbjartsson, DF; Arnar, DO; Helgadottir, A; Gretarsdottir, S; Holm, H; Sigurdsson, A; Jonasdottir, A; Baker, A; Thorleifsson, G; Kristjansson, K; Palsson, A; Blondal, T; Sulem, P; Backman, VM; Hardarson, GA; Palsdottir, E; Helgason, A; Sigurjonsdottir, R; Sverrisson, JT; Kostulas, K; Ng, MCY; Baum, L; So, WY; Wong, KS; Chan, JCN; Furie, KL; Greenberg, SM; Sale, M; Kelly, P; MacRae, CA; Smith, EE; Rosand, J; Hillert, J; Ma, RCW; Ellinor, PT; Thorgeirsson, G; Gulcher, JR; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Arnar, David O.; Helgadottir, Anna; Gretarsdottir, Solveig; Holm, Hilma; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Baker, Adam; Thorleifsson, Gudmar; Kristjansson, Kristleifur; Palsson, Arnar; Blondal, Thorarinn; Sulem, Patrick; Backman, Valgerdur M.; Hardarson, Gudmundur A.; Palsdottir, Ebba; Helgason, Agnar; Sigurjonsdottir, Runa; Sverrisson, Jon T.; Kostulas, Konstantinos; Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Furie, Karen L.; Greenberg, Steven M.; Sale, Michelle; Kelly, Peter; MacRae, Calum A.; Smith, Eric E.; Rosand, Jonathan; Hillert, Jan; Ma, Ronald C. W.; Ellinor, Patrick T.; Thorgeirsson, Gudmundur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Variants conferring risk of atrial fibrillation on chromosome 4q25	NATURE			English	Article							OF-FUNCTION MUTATION; FAMILIAL AGGREGATION; ISCHEMIC-STROKE; GENE; PREVALENCE; KCNQ1	Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is characterized by chaotic electrical activity of the atria(1). It affects one in ten individuals over the age of 80 years, causes significant morbidity and is an independent predictor of mortality(2). Recent studies have provided evidence of a genetic contribution to AF(3-5). Mutations in potassium-channel genes have been associated with familial AF(6-10) but account for only a small fraction of all cases of AF(11,12). We have performed a genome-wide association scan, followed by replication studies in three populations of European descent and a Chinese population from Hong Kong and find a strong association between two sequence variants on chromosome 4q25 and AF. Here we show that about 35% of individuals of European descent have at least one of the variants and that the risk of AF increases by 1.72 and 1.39 per copy. The association with the stronger variant is replicated in the Chinese population, where it is carried by 75% of individuals and the risk of AF is increased by 1.42 per copy. A stronger association was observed in individuals with typical atrial flutter. Both variants are adjacent to PITX2, which is known to have a critical function in left-right asymmetry of the heart(13-15).	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ, Div Cardiol, Dept Med, IS-101 Reykjavik, Iceland; Akureyri Reg Hosp, Dept Med, IS-600 Akureyri, Iceland; Karolinska Univ Hosp, Dept Neurol, S-14186 Huddinge, Sweden; Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Karolinska Institutet; Karolinska University Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gudbjartsson, DF (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Smith, Eric E/C-5443-2012; Helgason, Agnar/K-1522-2015; Palsson, Arnar/M-2742-2015; Wong, Ka Sing Lawrence/N-3434-2015; Stefansson, Kari/AAE-7187-2019; Baum, Lawrence/B-1005-2013; Demchuk, Andrew M/E-1103-2012; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016	Smith, Eric E/0000-0003-3956-1668; Palsson, Arnar/0000-0002-6525-8112; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Baum, Lawrence/0000-0002-5345-9355; Demchuk, Andrew M/0000-0002-4930-7789; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Ellinor, Patrick/0000-0002-2067-0533	NHLBI NIH HHS [R01 HL075431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Baum L, 2004, CLIN CHEM LAB MED, V42, P1370, DOI 10.1515/CCLM.2004.256; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Ellinor PT, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-70; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Ellinor PT, 2004, HEART, V90, P1487, DOI 10.1136/hrt.2003.027227; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Faucourt M, 2001, DEV BIOL, V229, P287, DOI 10.1006/dbio.2000.9950; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Frank B, 2003, TAPPI J, V2, P13; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Waldo AL, 2005, PROG CARDIOVASC DIS, V48, P41, DOI 10.1016/j.pcad.2005.06.015; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Yang RG, 2005, J COMPUT THEOR NANOS, V2, P75; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	24	659	685	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					353	357		10.1038/nature06007	http://dx.doi.org/10.1038/nature06007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17603472				2022-12-24	WOS:000248118300058
J	Fulweiler, RW; Nixon, SW; Buckley, BA; Granger, SL				Fulweiler, R. W.; Nixon, S. W.; Buckley, B. A.; Granger, S. L.			Reversal of the net dinitrogen gas flux in coastal marine sediments	NATURE			English	Article							SPRING PHYTOPLANKTON BLOOM; NARRAGANSETT-BAY; NITROGEN-FIXATION; CLIMATE-CHANGE; WATER; EUTROPHICATION; TEMPERATURE; ECOSYSTEMS; PHOSPHORUS; REDUCTION	The flux of nitrogen from land and atmosphere to estuaries and the coastal ocean has increased substantially in recent decades. The observed increase in nitrogen loading is caused by population growth, urbanization, expanding water and sewer infrastructure, fossil fuel combustion and synthetic fertilizer consumption(1,2). Most of the nitrogen is removed by denitrification in the sediments of estuaries and the continental shelf, leading to a reduction in both cultural eutrophication and nitrogen pollution of the open ocean(3,4). Nitrogen fixation, however, is thought to be a negligible process in sub-tidal heterotrophic marine systems(5). Here we report sediment core data from Narragansett Bay, USA, which demonstrate that heterotrophic marine sediments can switch from being a net sink to being a net source of nitrogen. Mesocosm and core incubation experiments, together with a historic data set of mean annual chlorophyll production(6,7), support the idea that a climate-induced decrease in primary production has led to a decrease in organic matter deposition to the benthos and the observed reversal of the net sediment nitrogen flux. Our results suggest that some estuaries may no longer remove nitrogen from the water column. Instead, nitrogen could be exported to the continental shelf and the open ocean and could shift the effect of anthropogenic nitrogen loading beyond the immediate coastal zone.	Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Fulweiler, RW (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	wally@gso.uri.edu	Fulweiler, Robinson W./A-3806-2010	Fulweiler, Robinson W./0000-0003-0871-4246				Borkman DG, 1998, ICES J MAR SCI, V55, P668, DOI 10.1006/jmsc.1998.0380; BORKMAN GD, 2002, THESIS U RHODE ISLAN; Brush MJ, 2002, MAR ECOL PROG SER, V238, P31, DOI 10.3354/meps238031; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Farnsworth EJ, 1995, J ECOL, V83, P967, DOI 10.2307/2261178; FULWEILER RW, IN PRESS HYDROBIOLOG; Furnas M.J., 1976, ESTUARINE PROCESSES, V1, P118; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gardner WS, 2006, LIMNOL OCEANOGR, V51, P558, DOI 10.4319/lo.2006.51.1_part_2.0558; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Keller AA, 1999, LIMNOL OCEANOGR, V44, P344, DOI 10.4319/lo.1999.44.2.0344; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Li YQ, 1998, ICES J MAR SCI, V55, P661, DOI 10.1006/jmsc.1998.0383; Nixon SW, 1996, BIOGEOCHEMISTRY, V35, P141, DOI 10.1007/BF02179826; Nixon SW, 1995, BIOGEOCHEMISTRY, V31, P15; NIXON SW, ECOSYSTEM BASED ESTU; Nixon SW, 1980, MARINE BENTHIC DYNAM, P219; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Nowicld B.L., 1991, THESIS U RHODE ISLAN; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; Pinckney JL, 2001, ORG GEOCHEM, V32, P585, DOI 10.1016/S0146-6380(00)00196-0; SEITZINGER S, 1982, THESIS U RHODE ISLAN; Seitzinger SP, 1996, BIOGEOCHEMISTRY, V35, P235, DOI 10.1007/BF02179829; SEITZINGER SP, 1987, MAR ECOL PROG SER, V37, P65, DOI 10.3354/meps037065; SISLER FD, 1951, SCIENCE, V113, P511, DOI 10.1126/science.113.2940.511; Townsend D.W., 1988, BIOL OCEANOGR, V5, P215, DOI DOI 10.1080/01965581.1987.10749514; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	31	151	154	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					180	182		10.1038/nature05963	http://dx.doi.org/10.1038/nature05963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625562				2022-12-24	WOS:000247934500039
J	Wicks, E				Wicks, Emma			A patient's journey - Cystic fibrosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England		Wicks, E (corresponding author), Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England.	ewicks@cftrust.org.uk							0	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1270	1271		10.1136/bmj.39188.741944.47	http://dx.doi.org/10.1136/bmj.39188.741944.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569935	Bronze, Green Published			2022-12-24	WOS:000247545100040
J	Kiriakidou, M; Tan, GS; Lamprinaki, S; De Planell-Saguer, M; Nelson, PT; Mourelatos, Z				Kiriakidou, Marianthi; Tan, Grace S.; Lamprinaki, Styliani; De Planell-Saguer, Mariangels; Nelson, Peter T.; Mourelatos, Zissimos			An mRNA m(7)G cap binding-like motif within human Ago2 represses translation	CELL			English	Article							HUMAN-CELLS; CRYSTAL-STRUCTURE; PROTEIN-SYNTHESIS; ANIMAL MICRORNAS; ARGONAUTE FAMILY; SLICER ACTIVITY; IN-VIVO; RECOGNITION; INITIATION; COMPLEX	microRNAs (miRNAs) bind to Argonaute (Ago) proteins and inhibit translation or promote degradation of mRNA targets. Human let-7 miRNA inhibits translation initiation of mRNA targets in an m(7)G cap-dependent manner and also appears to block protein production, but the molecular mechanism(s) involved is unknown and the role of Ago proteins in translational regulation remains elusive. Here we identify a motif (MC) within the Mid domain of Ago proteins, which bears significant similarity to the m(7)G cap-binding domain of elF4E, an essential translation initiation factor. We identify conserved aromatic residues within the MC motif of human Ago2 that are required for binding to the m(7)G cap and for translational repression but do not affect the assembly of Ago2 with miRNA or its catalytic activity. We propose that Ago2 represses the initiation of mRNA translation by binding to the m(7)G cap of mRNA targets, thus likely precluding the recruitment of elF4E.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kiriakidou, M (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kiriakim@uphs.upenn.edu; mourelaz@uphs.upenn.edu		Mourelatos, Zissimos/0000-0002-9852-1845	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050110] Funding Source: NIH RePORTER; NIAID NIH HHS [K08-AI63030] Funding Source: Medline; NICHD NIH HHS [PA30-HD026979] Funding Source: Medline; NIGMS NIH HHS [GM0720777] Funding Source: Medline; NINDS NIH HHS [K08-NS050110, NS053839] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMANN M, 1988, J BIOL CHEM, V263, P17229; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kiriakidou M, 2005, METH MOL B, V309, P295; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	74	305	338	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1141	1151		10.1016/j.cell.2007.05.016	http://dx.doi.org/10.1016/j.cell.2007.05.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17524464	Bronze			2022-12-24	WOS:000247390400017
J	Murray, F				Murray, Fiona			The stem-cell market - Patents and the pursuit of scientific progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Murray, F (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.							DASGUPTA P, 1994, RES POLICY, V23, P487; Thomson JA, 1998, SCIENCE, V282, P1827; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2341	2343		10.1056/NEJMp068256	http://dx.doi.org/10.1056/NEJMp068256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17554114				2022-12-24	WOS:000247029300001
J	Glickman, SW; Ou, FS; DeLong, ER; Roe, MT; Lytle, BL; Mulgund, J; Rumsfeld, JS; Gibler, WB; Ohman, EM; Schulman, KA; Peterson, ED				Glickman, Seth W.; Ou, Fang-Shu; DeLong, Elizabeth R.; Roe, Matthew T.; Lytle, Barbara L.; Mulgund, Jyotsna; Rumsfeld, John S.; Gibler, W. Brian; Ohman, E. Magnus; Schulman, Kevin A.; Peterson, Eric D.			Pay for performance, quality of care, and outcomes in acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; HEALTH-CARE; FINANCIAL INCENTIVES; IMPORTANT DIFFERENCE; FOR-PERFORMANCE; UNSTABLE ANGINA; IMPROVEMENT; MANAGEMENT; ASSOCIATION; STRATEGIES	of Context Pay for performance has been promoted as a tool for improving quality of care. In 2003, the Centers for Medicare & Medicaid Services ( CMS) launched the largest pay-for-performance pilot project to date in the United States, including indicators for acute myocardial infarction. Objective To determine if pay for performance was associated with either improved processes of care and outcomes or unintended consequences for acute myocardial infarction at hospitals participating in the CMS pilot project. Design, Setting, and Participants An observational, patient-level analysis of 105 383 patients with acute non-ST-segment elevation myocardial infarction enrolled in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association ( ACC/AHA) Guidelines ( CRUSADE) national quality-improvement initiative. Patients were treated between July 1, 2003, and June 30, 2006, at 54 hospitals in the CMS program and 446 control hospitals. Main Outcome Measures The differences in the use of ACC/AHA class I guideline recommended therapies and in-hospital mortality between pay for performance and control hospitals. Results Among treatments subject to financial incentives, there was a slightly higher rate of improvement for 2 of 6 targeted therapies at pay-for-performance vs control hospitals ( odds ratio [ OR] comparing adherence scores from 2003 through 2006 at half-year intervals for aspirin at discharge, 1.31; 95% confidence interval [ CI], 1.181.46 vs OR, 1.17; 95% CI, 1.12-1.21; P=. 04) and for smoking cessation counseling ( OR, 1.50; 95% CI, 1.29-1.73 vs OR, 1.28; 95% CI, 1.22-1.35; P=. 05). There was no significant difference in a composite measure of the 6 CMS rewarded therapies between the 2 hospital groups ( change in odds per half-year period of receiving CMS therapies: OR, 1.23; 95% CI, 1.15-1.30 vs OR, 1.17; 95% CI, 1.14-1.20; P=. 16). For composite measures of acute myocardial infarction treatments not subject to incentives, rates of improvement were not significantly different ( OR, 1.09; 95% CI, 1.051.14 vs OR, 1.08; 95% CI, 1.06- 1.09; P=. 49). Overall, there was no evidence that improvements in in-hospital mortality were incrementally greater at pay-for-performance sites ( change in odds of in-hospital death per half-year period, 0.91; 95% CI, 0.84-0.99 vs 0.97; 95% CI, 0.94-0.99; P=. 21). Conclusions Among hospitals participating in a voluntary quality-improvement initiative, the pay-for-performance program was not associated with a significant incremental improvement in quality of care or outcomes for acute myocardial infarction. Conversely, we did not find evidence that pay for performance had an adverse association with improvement in processes of care that were not subject to financial incentives. Additional studies of pay for performance are needed to determine its optimal role in quality-improvement initiatives.	Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC 27715 USA; Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC USA; Duke Univ, Med Ctr, Hlth Sector Management Program, Fuqua Sch Business, Durham, NC USA; Denver VA Med Ctr, Cardiol Sect, Denver, CO USA; Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University System of Ohio; University of Cincinnati	Peterson, ED (corresponding author), Duke Clin Res Inst, Outcomes Res & Assessment Grp, POB 17969, Durham, NC 27715 USA.	peter016@mc.duke.edu	Peterson, Eric David/ABF-5033-2021; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	NATIONAL INSTITUTE ON AGING [R01AG025312] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG025312 01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett B, 2005, MED DECIS MAKING, V25, P250, DOI 10.1177/0272989X05276863; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; *CMS QHID, IMPR CONT YEAR 2; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Conrad DA, 2004, MED CARE RES REV, V61, p37S, DOI 10.1177/1077558704266770; *CTR MED MED SERV, HOSP QUAL IN WEB PAG; Darr Kurt, 2003, Hosp Top, V81, P30; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; KOHN A, 1993, HARVARD BUS REV, V71, P54; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Porter M.E., 2006, REDEFINING HLTH CARE; *PREM INC CMS, PREM HOSP QUAL INC D; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Roe MT, 2003, AM HEART J, V146, P605, DOI 10.1016/S0002-8703(03)00388-0; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Staman Karen L, 2003, Crit Pathw Cardiol, V2, P34, DOI 10.1097/01.HPC.0000053684.59325.88	30	223	224	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2373	2380		10.1001/jama.297.21.2373	http://dx.doi.org/10.1001/jama.297.21.2373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551130	Bronze			2022-12-24	WOS:000247007200019
J	Reeves, MB; Davies, AA; McSharry, BP; Wilkinson, GW; Sinclair, JH				Reeves, Matthew B.; Davies, Andrew A.; McSharry, Brian P.; Wilkinson, Gavin W.; Sinclair, John H.			Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death	SCIENCE			English	Article							HUMAN CYTOMEGALOVIRUS; LOCALIZED INHIBITOR; GENE-EXPRESSION; APOPTOSIS; GRIM-19; PROTEIN; ACTIVATION; INFECTION; REVEALS; PRODUCT	Human cytomegalovirus infection perturbs multiple cellular processes that could promote the release of proapoptotic stimuli. Consequently, it encodes mechanisms to prevent cell death during infection. Using rotenone, a potent inhibitor of the mitochondrial enzyme complex I (reduced nicotinamide adenine dinucleotide-ubiquinone oxido-reductase), we found that human cytomegalovirus infection protected cells from rotenone-induced apoptosis, a protection mediated by a 2.7-kilobase virally encoded RNA (beta 2.7). During infection, beta 2.7 RNA interacted with complex I and prevented the relocalization of the essential subunit genes associated with retinoid/interferon-induced mortality-19, in response to apoptotic stimuli. This interaction, which is important for stabilizing the mitochondrial membrane potential, resulted in continued adenosine triphosphate production, which is critical for the successful completion of the virus' life cycle. Complex I targeting by a viral RNA represents a refined strategy to modulate the metabolic viability of the infected host cell.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Wales Coll Cardiff, Coll Med, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Sinclair, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk	McSharry, Brian/AAE-3351-2019; Wilkinson, Gavin WG/J-6388-2015	McSharry, Brian/0000-0003-0473-2789; Wilkinson, Gavin WG/0000-0002-5623-0126; Reeves, Matthew/0000-0002-4909-1076	Medical Research Council [G9202171, G0700142] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9202171, G0700142] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chernyak BV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P240, DOI 10.1007/s10541-005-0106-3; Crowe WE, 2004, AM J PHYSIOL-CELL PH, V287, pC1023, DOI 10.1152/ajpcell.00511.2003; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Fish KN, 1998, J VIROL, V72, P5661, DOI 10.1128/JVI.72.7.5661-5668.1998; Gawn JM, 2002, J VIROL, V76, P4441, DOI 10.1128/JVI.76.9.4441-4455.2002; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GREENAWAY PJ, 1987, VIRUS RES, V7, P17, DOI 10.1016/0168-1702(87)90055-4; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003; McSharry BP, 2003, J GEN VIROL, V84, P2511, DOI 10.1099/vir.0.19298-0; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Reboredo M, 2004, J GEN VIROL, V85, P3555, DOI 10.1099/vir.0.80379-0; Simon DK, 1999, ANNU REV MED, V50, P111; Singer T P, 1979, Methods Enzymol, V55, P454; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Spector DH, 1996, INTERVIROLOGY, V39, P361, DOI 10.1159/000150507; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06	27	196	212	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1345	1348		10.1126/science.1142984	http://dx.doi.org/10.1126/science.1142984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540903				2022-12-24	WOS:000246885600052
J	Feachem, RGA; Sabot, OJ				Feachem, Richard G. A.; Sabot, Oliver J.			Global malaria control in the 21st century - A historic but fleeting opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clinton Fdn, HIV AIDS Initiat, New York, NY 10024 USA; Univ Calif San Francisco, Global Fund Fight AIDS TB & Malaria, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Sabot, OJ (corresponding author), Clinton Fdn, HIV AIDS Initiat, 65 W 86th St, New York, NY 10024 USA.	osabot@clintonfoundation.org						Alilio MS, 2004, AM J TROP MED HYG, V71, P205, DOI 10.4269/ajtmh.2004.71.205; Alilio MS, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.268; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2005, GLOB STRAT PLAN ROLL; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; BATE R, 2006, STILL TAXED DEATH AN; Booman Marlize, 2003, Malar J, V2, P13, DOI 10.1186/1475-2875-2-13; *CDCP, 2005, MMWR-MORBID MORTAL W, V55, P913; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P994; CHIKANDI S, 2005, 4 YEARS ABUJA MORE A; *GLOB FUND FIGHT A, 2006, FUND GLOB FIGHT HIV; Levine Ruth, 2004, MILLIONS SAVED PROVE; Lomborg B., 2004, GLOBAL CRISES GLOBAL; Low-Beer D., 2007, PARTNERS IMPACT RESU; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; WHO UNICEF, 2005, WORLD MALARIA REPORT; Zambia Ministry of Health, 2006, ZAMB NAT MAL IND SUR; 2003, LANCET INFECT DIS, V3, P317; [No title captured]	21	17	17	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2281	2284		10.1001/jama.297.20.2281	http://dx.doi.org/10.1001/jama.297.20.2281			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519417				2022-12-24	WOS:000246659700028
J	Laurance, W; Luizao, R				Laurance, William; Luizao, Regina			Driving a wedge into the Amazon	NATURE			English	Editorial Material							FOREST FRAGMENTS; DEFORESTATION; DECAY		Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Natl Inst Amazonian Res, Dept Ecol, BR-69011970 Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia	Laurance, W (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.		Laurance, William F/B-2709-2012	Laurance, William F/0000-0003-4430-9408				AYRES JM, 1997, ABORDAGENS INOVADORA; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Lovejoy T.E., 1986, P257; Pimm SL, 1998, NATURE, V393, P23, DOI 10.1038/29892; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397	9	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					409	410		10.1038/448409a	http://dx.doi.org/10.1038/448409a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653170				2022-12-24	WOS:000248302700024
J	Stern-Ginossar, N; Elefant, N; Zimmermann, A; Wolf, DG; Saleh, N; Biton, M; Horwitz, E; Prokocimer, Z; Prichard, M; Hahn, G; Goldman-Wohl, D; Greenfield, C; Yagel, S; Hengel, H; Altuvia, Y; Margalit, H; Mandelboim, O				Stern-Ginossar, Noam; Elefant, Naama; Zimmermann, Albert; Wolf, Dana G.; Saleh, Nivin; Biton, Moshe; Horwitz, Elad; Prokocimer, Zafnat; Prichard, Mark; Hahn, Gabriele; Goldman-Wohl, Debra; Greenfield, Caryn; Yagel, Simcha; Hengel, Hartmut; Altuvia, Yael; Margalit, Hanah; Mandelboim, Ofer			Host immune system gene targeting by a viral miRNA	SCIENCE			English	Article							GLYCOPROTEIN UL16; T-CELLS; MICRORNAS; NKG2D; CYTOMEGALOVIRUSES; IDENTIFICATION; CYTOTOXICITY; STRATEGIES; RECEPTOR	Virally encoded microRNAs (miRNAs) have recently been discovered in herpesviruses. However, their biological roles are mostly unknown. We developed an algorithm for the prediction of miRNA targets and applied it to human cytomegalovirus miRNAs, resulting in the identification of the major histocompatibility complex class I-related chain B (MICB) gene as a top candidate target of hcmv-miR-UL112. MICB is a stress-induced ligand of the natural killer (NK) cell activating receptor NKG2D and is critical for the NK cell killing of virus-infected cells and tumor cells. We show that hcmv-miR-UL112 specifically down-regulates MICB expression during viral infection, leading to decreased binding of NKG2D and reduced killing by NK cells. Our results reveal a miRNA-based immunoevasion mechanism that appears to be exploited by human cytomegalovirus.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel; Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; Hadassah Univ Hosp, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel; Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Max Von Pettenkofer Inst, Dept Virol, D-80336 Munich, Germany; Hadassah Hebrew Univ, Hosp Mt Scopus, Dept Obstet & Gynecol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Heinrich Heine University Dusseldorf; Hebrew University of Jerusalem; University of Alabama System; University of Alabama Birmingham; University of Munich; Hebrew University of Jerusalem; Hadassah University Medical Center	Altuvia, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Genet & Biotechnol, Jerusalem, Israel.	yaelal@md.huji.ac.il; hanahm@ekmd.huji.ac.il; oferm@ekmd.huji.ac.il	Margalit, Hanah/H-1651-2013	Prichard, Mark/0000-0002-2720-6661; Mandelboim, Ofer/0000-0002-9354-1855; Biton, Moshe/0000-0001-8330-1674	NIAID NIH HHS [N01 AI30049] Funding Source: Medline; PHS HHS [N01-30049] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Mocarski ES, 2004, CELL MICROBIOL, V6, P707, DOI 10.1111/j.1462-5822.2004.00425.x; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012	18	503	582	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					376	381		10.1126/science.1140956	http://dx.doi.org/10.1126/science.1140956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641203	Green Accepted			2022-12-24	WOS:000248150200048
J	Einstein, AJ; Henzlova, MJ; Rajagopalan, S				Einstein, Andrew J.; Henzlova, Milena J.; Rajagopalan, Sanjay			Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATOMIC-BOMB SURVIVORS; BREAST-CANCER; HEART; COMMITTEE; CARDIOLOGY; MORTALITY; DISEASE; COHORT; CT	Context Computed tomography coronary angiography (CTCA) has become a common diagnostic test, yet there are little data on its associated cancer risk. The recent Biological Effects of Ionizing Radiation (BEIR) VII Phase 2 report provides a framework for estimating lifetime attributable risk (LAR) of cancer incidence associated with radiation exposure from a CTCA study, using the most current data available on health effects of radiation. Objectives To determine the LAR of cancer incidence associated with radiation exposure from a 64-slice CTCA study and to evaluate the influence of age, sex, and scan protocol on cancer risk. Design, Setting, and Patients Organ doses from 64-slice CTCA to standardized phantom (computational model) male and female patients were estimated using Monte Carlo simulation methods, using standard spiral CT protocols. Age- and sex-specific LARs of individual cancers were estimated using the approach of BEIR VII and summed to obtain whole-body LARs. Main Outcome Measures Whole-body and organ LARs of cancer incidence. Results Organ doses ranged from 42 to 91 mSv for the lungs and 50 to 80 mSv for the female breast. Lifetime cancer risk estimates for standard cardiac scans varied from 1 in 143 for a 20-year-old woman to 1 in 3261 for an 80-year-old man. Use of simulated electrocardiographically controlled tube current modulation (ECTCM) decreased these risk estimates to 1 in 219 and 1 in 5017, respectively. Estimated cancer risks using ECTCM for a 60-year-old woman and a 60-year-old man were 1 in 715 and 1 in 1911, respectively. A combined scan of the heart and aorta had higher LARs, up to 1 in 114 for a 20-year-old woman. The highest organ LARs were for lung cancer and, in younger women, breast cancer. Conclusions These estimates derived from our simulation models suggest that use of 64-slice CTCA is associated with a nonnegligible LAR of cancer. This risk varies markedly and is considerably greater for women, younger patients, and for combined cardiac and aortic scans.	Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Med,Div Cardiol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; Mt Sinai Med Ctr, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; Mt Sinai Med Ctr, Marie Josee & Henry R Kravis Ctr Cardiovasc Hlth, New York, NY 10029 USA; Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University	Einstein, AJ (corresponding author), Columbia Univ, Med Ctr, Coll Phys & Surg, Dept Med,Div Cardiol, 622 W 168th St,PH 10-408, New York, NY 10032 USA.	andrew.einstein@columbia.edu						ABRAMS HL, BEIR 7 VERY ERROR MO; American Nuclear Society, 2001, HLTH EFF LOW LEV RAD; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1995, Documents of the NRPB, V6, P1; Berman DS, 2006, J NUCL MED, V47, P74; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carr ZA, 2002, RADIAT RES, V157, P668, DOI 10.1667/0033-7587(2002)157[0668:MNARTF]2.0.CO;2; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; DAVIS FG, 1989, CANCER RES, V49, P6130; Elkind MM, 1999, RADIAT RES, V152, P567, DOI 10.2307/3580156; Gallagher MJ, 2007, ANN EMERG MED, V49, P125, DOI 10.1016/j.annemergmed.2006.06.043; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Health Physics Society, 1996, RAD RISK PERSP POS S RAD RISK PERSP POS S; HOWE GR, 1995, RADIAT RES, V142, P295, DOI 10.2307/3579139; *IMV MED INF DIV, 2005, 2004 CT CENS MARK SU; Jakobs TF, 2002, EUR RADIOL, V12, P1081, DOI 10.1007/s00330-001-1278-x; Kalender WA, 1999, EUR RADIOL, V9, P555, DOI 10.1007/s003300050709; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Mitka M, 2006, JAMA-J AM MED ASSOC, V295, P1989, DOI 10.1001/jama.295.17.1989; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; Stillman AE, 2007, INT J CARDIOVAS IMAG, V23, P415, DOI 10.1007/s10554-007-9226-8; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Tubiana M, 2005, DOSE EFFECT RELATION; United Nations, 2000, SOURC EFF ION RAD UN; Upton A. C., 2001, 136 NCRP; Valentin J., 2005, Annals of the ICRP, V35, pIII, DOI 10.1016/j.icrp.2005.01.001	29	1045	1115	1	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2007	298	3					317	323		10.1001/jama.298.3.317	http://dx.doi.org/10.1001/jama.298.3.317			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190US	17635892	Bronze			2022-12-24	WOS:000248086700026
J	Ziurys, LM; Milam, SN; Apponi, AJ; Woolf, NJ				Ziurys, L. M.; Milam, S. N.; Apponi, A. J.; Woolf, N. J.			Chemical complexity in the winds of the oxygen-rich supergiant star VY Canis Majoris	NATURE			English	Article							MASS-LOSS; BEARING MOLECULES; RED GIANTS; CIRCUMSTELLAR; ABUNDANCES; ENVELOPES; CHEMISTRY; EMISSION; HCN; CONVECTION	The interstellar medium is enriched primarily by matter ejected from old, evolved stars(1,2). The outflows from these stars create spherical envelopes, which foster gas-phase chemistry(3-5). The chemical complexity in circumstellar shells was originally thought to be dominated by the elemental carbon to oxygen ratio(6). Observations have suggested that envelopes with more carbon than oxygen have a significantly greater abundance of molecules than their oxygen-rich analogues(7). Here we report observations of molecules in the oxygen-rich shell of the red supergiant star VY Canis Majoris (VY CMa). A variety of unexpected chemical compounds have been identified, including NaCl, PN, HNC and HCO+. From the spectral line profiles, the molecules can be distinguished as arising from three distinct kinematic regions: a spherical outflow, a tightly collimated, blue-shifted expansion, and a directed, red-shifted flow. Certain species (SiO, PN and NaCl) exclusively trace the spherical flow, whereas HNC and sulphur-bearing molecules (amongst others) are selectively created in the two expansions, perhaps arising from shock waves. CO, HCN, CS and HCO+ exist in all three components. Despite the oxygen-rich environment, HCN seems to be as abundant as CO. These results suggest that oxygen-rich shells may be as chemically diverse as their carbon counterparts.	Univ Arizona, Astrobiol Inst, NASA, Tucson, AZ 85721 USA; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; Univ Arizona, Arizona Radio Observ, Tucson, AZ 85721 USA; Univ Arizona, Dept Astron, Steward Observ, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); University of Arizona; University of Arizona; National Radio Astronomy Observatory (NRAO); University of Arizona; University of Arizona	Ziurys, LM (corresponding author), Univ Arizona, Astrobiol Inst, NASA, 1306 E Univ Blvd, Tucson, AZ 85721 USA.	lziurys@as.arizona.edu	Milam, Stefanie/D-1092-2012	Milam, Stefanie/0000-0001-7694-4129				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BOWERS PF, 1983, ASTROPHYS J, V274, P733, DOI 10.1086/161485; BUJARRABAL V, 1994, ASTRON ASTROPHYS, V285, P247; Cernicharo J, 2000, ASTRON ASTROPHYS SUP, V142, P181, DOI 10.1051/aas:2000147; Cherchneff I, 2006, ASTRON ASTROPHYS, V456, P1001, DOI 10.1051/0004-6361:20064827; Duari D, 1999, ASTRON ASTROPHYS, V341, pL47; Glassgold AE, 1996, ANNU REV ASTRON ASTR, V34, P241, DOI 10.1146/annurev.astro.34.1.241; Highberger JL, 2003, ASTROPHYS J, V593, P393, DOI 10.1086/376446; Humphreys RM, 2005, ASTRON J, V129, P492, DOI 10.1086/426565; Kemper F, 2003, ASTRON ASTROPHYS, V407, P609, DOI 10.1051/0004-6361:20030701; LAURIA EF, 2006, 553 ALMA; Lim J, 1998, NATURE, V392, P575, DOI 10.1038/33352; Marvel KB, 2005, ASTRON J, V130, P261, DOI 10.1086/430746; MCCABE EM, 1979, NATURE, V281, P263, DOI 10.1038/281263a0; Monnier JD, 2000, ASTROPHYS J, V543, P868, DOI 10.1086/317127; Muller S, 2007, ASTROPHYS J, V656, P1109, DOI 10.1086/510513; NEJAD LAM, 1988, MON NOT R ASTRON SOC, V230, P79, DOI 10.1093/mnras/230.1.79; NERCESSIAN E, 1989, ASTRON ASTROPHYS, V210, P225; Olofsson H, 1997, ASTROPHYS SPACE SCI, V251, P31, DOI 10.1023/A:1000747630702; SAHAI R, 1992, ASTROPHYS J, V394, P320, DOI 10.1086/171585; SCHILKE P, 1992, ASTRON ASTROPHYS, V256, P595; SCHWARZSCHILD M, 1975, ASTROPHYS J, V195, P137, DOI 10.1086/153313; Smith N, 2004, MON NOT R ASTRON SOC, V349, pL31, DOI 10.1111/j.1365-2966.2004.07718.x; Smith N, 2001, ASTRON J, V121, P1111, DOI 10.1086/318748; Szczerba R, 2007, BALT ASTRON, V16, P134; Wallerstein G, 2001, PUBL ASTRON SOC PAC, V113, P954, DOI 10.1086/322920; Willson LA, 2000, ANNU REV ASTRON ASTR, V38, P573, DOI 10.1146/annurev.astro.38.1.573; Ziurys LM, 2006, P NATL ACAD SCI USA, V103, P12274, DOI 10.1073/pnas.0602277103; Zubko V, 2004, ASTROPHYS J, V610, P427, DOI 10.1086/421700	30	102	103	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1094	1097		10.1038/nature05905	http://dx.doi.org/10.1038/nature05905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597755				2022-12-24	WOS:000247564600033
J	Robertson, CMT; Watt, MJ; Yasui, Y				Robertson, Charlene M. T.; Watt, Man-Joe; Yasui, Yutaka			Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; GESTATIONAL-AGE; NEUROLOGIC DISABILITY; IMPROVED SURVIVAL; PRETERM INFANTS; TRENDS; GRAMS; MORTALITY; PROGNOSIS; PANORAMA	Context Although cerebral palsy (CP) among extremely premature infants has been reported as a major morbidity outcome, there are difficulties comparing published CP rates from many sites over various birth years. Objective To assess the changes in population-based, gestational age - specific prevalence rates of CP among extremely premature infants over 30 years. Design Prospective population-based longitudinal outcome study. Setting and Participants In Northern Alberta, 2318 infants 20 to 27 weeks' gestational age with birth weights of 500 to 1249 g were liveborn from 1974 through 2003. By 2 years of age, 1437 (62%) had died, 23 (1%) were lost to follow-up, and 858 (37%) had received multidisciplinary neurodevelopmental assessment. Main Outcome Measure Population-based prevalence rates of CP were determined. Logistic regression with linear spline was used to assess changes in CP prevalence over time. Results At age 2 years, 122 (14.2%) of 858 survivors had CP. This diagnosis was confirmed for each child by age 3 years or older. Among those whose gestational age was 20 to 25 weeks, population-based survival increased from 4% to 31% ( P <. 001), while CP prevalence per 1000 live births increased monotonically from 0 to 110 until the years 1992-1994 ( P <. 001) and decreased thereafter to 22 in the years 20012003 ( P <. 001). Among those whose gestational age was 26 to 27 weeks, population-based survival increased from 23% to between 75% and 80% ( P <. 001), while CP prevalence per 1000 live births increased monotonically from 15 to 155 until the years 1992-1994 ( P <. 001) and then decreased to 16 in the years 2001-2003 ( P <. 001). For all survivors born in the years 2001-2003, CP prevalence was 19 per 1000 live births. Conclusion Population-based CP prevalence rates for children whose gestational age was 20 to 27 weeks and whose birth weight ranged from 500 to 1249 g show steady reductions in the last decade with stable or reducing mortality, reversing trends prior to 1992-1994.	Glenrose Rehabil Hosp, Dept Pediat, Neonatal & Infant Follow Up Clin, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Fac Med & Dent, Dept Pediat, Sect Neurosci, Edmonton, AB, Canada; Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; Glenrose Rehabil Hosp, Dept Rehabil Med, Edmonton, AB T5G 0B7, Canada	University of Alberta; University of Alberta	Robertson, CMT (corresponding author), Glenrose Rehabil Hosp, Dept Pediat, Neonatal & Infant Follow Up Clin, Edmonton, AB T5G 0B7, Canada.	charlene.robertson@capitalhealth.ca	Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638				ALBERMAN E, 1984, EPIDEMIOLOGY CEREBRA, P172; ALLEN AC, 1994, CAN MED ASSOC J, V151, P547; Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; AZIZ K, 1995, PEDIATRICS, V95, P837; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BAX M C, 1964, Dev Med Child Neurol, V6, P295; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; BHUSHAN V, 1993, PEDIATRICS, V91, P1094; Blackmon LR, 2002, PEDIATRICS, V109, P330; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CASIRO O, 1995, J PEDIATR-US, V126, pS53, DOI 10.1016/S0022-3476(95)70008-0; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V80, pF115, DOI 10.1136/fn.80.2.F115; Dammann O, 2001, EARLY HUM DEV, V64, P79, DOI 10.1016/S0378-3782(01)00183-9; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; *GOV SERV, ALB VIT STAT ANN REV; Grether JK, 2000, J PEDIATR-US, V136, P133, DOI 10.1016/S0022-3476(00)90071-4; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Harrell Jr FE, 2001, REGRESSION MODELING, P16; HENDSON L, 2005, 57 PED AC SOC ANN M; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Jacobs SE, 2000, ACTA PAEDIATR, V89, P959; Lorenz JM, 2001, PEDIATRICS, V108, P1269, DOI 10.1542/peds.108.6.1269; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; PELIOWSKI A, 1998, PEDIATR RES, V43, P293; PHAROAH POD, 1990, ARCH DIS CHILD, V65, P602, DOI 10.1136/adc.65.6.602; PHAROAH POD, 1987, ARCH DIS CHILD, V62, P1035, DOI 10.1136/adc.62.10.1035; Pharoah POD, 1996, ARCH DIS CHILD-FETAL, V75, pF169, DOI 10.1136/fn.75.3.F169; Powell K, 2006, J MATERN-FETAL NEO M, V19, P43, DOI 10.1080/14767050500363519; R Development Core Team, 2005, LANG ENV STAT COMP; Robertson Charlene M T, 2002, J Obstet Gynaecol Can, V24, P138; ROBERTSON CMT, 1992, PEDIATRICS, V90, P750; Robertson CMT, 1998, CAN J NEUROL SCI, V25, P117, DOI 10.1017/S0317167100033710; Rosenbaum PL, 2002, JAMA-J AM MED ASSOC, V288, P1357, DOI 10.1001/jama.288.11.1357; ROSNER B, 2000, FUNDAMENTAL BIOSTATI, P296; Sauve RS, 1998, PEDIATRICS, V101, P438, DOI 10.1542/peds.101.3.438; SCHMIDT B, 2003, JAMA-J AM MED ASSOC, V289, P11142; STANLEY FJ, 1992, BRIT MED J, V304, P1658, DOI 10.1136/bmj.304.6843.1658; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; Tommiska V, 2003, ARCH DIS CHILD-FETAL, V88, P29; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; WATT JM, 1989, DEV MED CHILD NEUROL, V31, P766; Weber C, 2005, WIEN KLIN WOCHENSCHR, V117, P740, DOI 10.1007/s00508-005-0468-y; *WHO, 1997, INT CLASS DIS, P763; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	51	111	117	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2733	2740		10.1001/jama.297.24.2733	http://dx.doi.org/10.1001/jama.297.24.2733			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182UE	17595274	Bronze			2022-12-24	WOS:000247528700023
J	Batt, CA				Batt, Carl A.			Materials science - Food pathogen detection	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI O157-H7		Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Cornell University	Batt, CA (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	cab10@cornell.edu						Cady NC, 2005, SENSOR ACTUAT B-CHEM, V107, P332, DOI 10.1016/j.snb.2004.10.022; Dierksen KP, 2004, J APPL TOXICOL, V24, P363, DOI 10.1002/jat.1030; FSIS-USDA, 1995, FED REGISTER, V60, P49553; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Ochoa ML, 2005, ANAL CHEM, V77, P5258, DOI 10.1021/ac0502596; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Ramos D, 2006, J APPL PHYS, V100, DOI 10.1063/1.2370507; Yu CX, 2006, ANAL CHEM, V78, P2500, DOI 10.1021/ac051828c	8	97	99	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1579	1580		10.1126/science.1140729	http://dx.doi.org/10.1126/science.1140729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569853				2022-12-24	WOS:000247239900029
J	Kawaguchi, S; Ng, DTW				Kawaguchi, Shinichi; Ng, Davis T. W.			SnapShot: ER-associated protein degradation pathways	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; UBIQUITIN LIGASE		Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.							Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	13	13	13	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1230	+						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574032	Bronze			2022-12-24	WOS:000247390400026
J	Coombes, R				Coombes, Rebecca			Cold turkey	BRITISH MEDICAL JOURNAL			English	Article												rcoombes@bmjgroup.com						Advisory Council on the Misuse of Drugs, 2005, METH REV; Fulde GWO, 2007, MED J AUSTRALIA, V186, P334, DOI 10.5694/j.1326-5377.2007.tb00931.x; GLOSSOP M, 2006, BRIT MED J, V333, P272; Gray SD, 2007, MED J AUSTRALIA, V186, P336, DOI 10.5694/j.1326-5377.2007.tb00932.x; *HAMPSH CONST, 2007, NAT PROBL PROF METH; *PROPR ASS GREAT B, 2007, INF US COUNT PSEUD L	6	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1190	1192		10.1136/bmj.39223.422824.AD	http://dx.doi.org/10.1136/bmj.39223.422824.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556470	Green Published			2022-12-24	WOS:000247277000028
J	Edgren, G; Hjalgrim, H; Reilly, M; Tran, TN; Rostgaard, K; Shanwell, A; Titlestad, K; Adami, J; Wikman, A; Jersild, C; Gridley, G; Wideroff, L; Nyren, O; Melbye, M				Edgren, Gustaf; Hjalgrim, Henrik; Reilly, Marie; Tran, Trung Nam; Rostgaard, Klaus; Shanwell, Agneta; Titlestad, Kjell; Adami, Johanna; Wikman, Agneta; Jersild, Casper; Gridley, Gloria; Wideroff, Louise; Nyren, Olof; Melbye, Mads			Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; TRAUMA PATIENTS; OLDER WOMEN; RECIPIENTS; TRANSMISSION; MICROCHIMERISM; LEUKEMIA; HISTORY; MORBIDITY; REGISTRY	Background Although mechanisms for detection of short-term complications after blood transfusions are well developed, complications with delayed onset, notably transmission of chronic diseases such as cancer, have been difficult to assess. Our aim was to investigate the possible risk of cancer transmission from blood donors to recipients through blood transfusion. Methods We did a register-based retrospective cohort study of cancer incidence among patients who received blood from donors deemed to have a subclinical cancer at the time of donation. These precancerous donors were diagnosed with a cancer within 5 years of the donation. Data from all computerised blood bank registers in Sweden and Denmark gathered between 1968 and 2002 were merged into a common database. Demographic and medical data, including mortality and cancer incidence, were ascertained through linkages with nationwide, and essentially complete, population and health-care registers. The risk of cancer in exposed recipients relative to that in recipients who received blood from non-cancerous donors was estimated with multivariate Poisson regression, adjusting for potential confounding factors. Findings Of the 354094 transfusion recipients eligible for this analysis, 12012 (3%) were exposed to blood products from precancerous donors. There was no excess risk of cancer overall (adjusted relative risk 1.00, 95% CI 0.94-1.07) or in crude anatomical subsites among recipients of blood from precancerous donors compared with recipients of blood from non-cancerous donors. Interpretation Our data provide no evidence that blood transfusions from precancerous blood donors are associated with increased risk of cancer among recipients compared with transfusions from non-cancerous donors.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Immunol & Transfus Med, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Hjalgrim, Henrik/AAG-4973-2021; Adami, Johanna/AAA-3312-2021; Hernandez, Jessica/G-6527-2011; Edgren, Gustaf/F-4013-2014	Edgren, Gustaf/0000-0002-2198-4745; melbye, mads/0000-0001-8264-6785; Rostgaard, Klaus/0000-0001-6220-9414; Wikman, Agneta/0000-0002-8810-7974	NCI NIH HHS [N01-CP-21175] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami J, 1997, ANN INTERN MED, V127, P365, DOI 10.7326/0003-4819-127-5-199709010-00004; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Berg KD, 2001, NEW ENGL J MED, V345, P1458, DOI 10.1056/NEJMoa010041; BLOMBERG J, 1993, EUR J CANCER, V29A, P2101, DOI 10.1016/0959-8049(93)90042-E; Bodo I, 1999, NEW ENGL J MED, V341, P807, DOI 10.1056/NEJM199909093411105; Brandt L, 1996, BRIT J CANCER, V73, P1148, DOI 10.1038/bjc.1996.220; Buell Joseph F, 2004, Ann Transplant, V9, P53; Cerhan JR, 1997, J NATL CANCER I, V89, P314, DOI 10.1093/jnci/89.4.314; Cerhan JR, 2001, CANCER EPIDEM BIOMAR, V10, P361; CERHAN JR, 1993, ANN INTERN MED, V119, P8, DOI 10.7326/0003-4819-119-1-199307010-00002; Chow EJ, 2002, EPIDEMIOL REV, V24, P269, DOI 10.1093/epirev/mxf005; Chow EJ, 2002, AM J EPIDEMIOL, V155, P725, DOI 10.1093/aje/155.8.725; COMAN DR, 1951, CANCER RES, V11, P648; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; GRAMEN K, 1928, ACTA CHIR SCAND, V64, P369; GREENWALD P, 1976, CANCER, V38, P324, DOI 10.1002/1097-0142(197607)38:1<324::AID-CNCR2820380147>3.0.CO;2-Q; GUGEL EA, 1986, NEW ENGL J MED, V315, P1487; Haque T, 1996, J GEN VIROL, V77, P1169, DOI 10.1099/0022-1317-77-6-1169; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; LANMAN JT, 1950, BLOOD, V5, P1099, DOI 10.1182/blood.V5.12.1099.1099; Lee TH, 2005, TRANSFUSION, V45, P1280, DOI 10.1111/j.1537-2995.2005.00201.x; Lee TH, 1999, BLOOD, V93, P3127; Maguire-Boston EK, 1999, AM J EPIDEMIOL, V149, P1113; MEMON A, 1994, INT J CANCER, V58, P366, DOI 10.1002/ijc.2910580310; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; SCHIFFER CA, 1983, AM J HEMATOL, V15, P65, DOI 10.1002/ajh.2830150108; SOUTHAM C M, 1958, Bull N Y Acad Med, V34, P416; Storm HH, 1997, DAN MED BULL, V44, P535; THIERSCH JB, 1946, CANCER RES, V6, P695; THIERSCH JB, 1945, J LAB CLIN MED, V30, P866; Utter GH, 2004, J TRAUMA, V57, P702, DOI 10.1097/01.TA.0000140666.15972.37; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; WEISS L, 1992, CLIN EXP METASTAS, V10, P191, DOI 10.1007/BF00132751; Zhang YW, 2004, AM J EPIDEMIOL, V160, P325, DOI 10.1093/aje/kwh233	40	55	55	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1724	1730		10.1016/S0140-6736(07)60779-X	http://dx.doi.org/10.1016/S0140-6736(07)60779-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512857				2022-12-24	WOS:000246631300028
J	Ding, M; Chao, D; Wang, G; Shen, K				Ding, Mei; Chao, Dan; Wang, George; Shen, Kang			Spatial regulation of an E3 ubiquitin ligase directs selective synapse elimination	SCIENCE			English	Article							VENTRAL NERVE CORD; C-ELEGANS; PROTEASOME SYSTEM; CAENORHABDITIS-ELEGANS; GLUTAMATE RECEPTORS; DIFFERENTIATION; DEGRADATION; SCF; NEUROTRANSMITTER; SYNAPTOGENESIS	Stereotyped synaptic connectivity can arise both by precise recognition between appropriate partners during synaptogenesis and by selective synapse elimination. The molecular mechanisms that underlie selective synapse removal are largely unknown. We found that stereotyped developmental elimination of synapses in the Caenorhabditis elegans hermaphrodite-specific motor neuron (HSNL) was mediated by an E3 ubiquitin ligase, a Skp1-cullin-F-box (SCF) complex composed of SKR-1 and the F-box protein SEL-10. SYG-1, a synaptic adhesion molecule, bound to SKR-1 and inhibited assembly of the SCF complex, thereby protecting nearby synapses. Thus, subcellular regulation of ubiquitin-mediated protein degradation contributes to precise synaptic connectivity through selective synapse elimination.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	kangshen@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS048392] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jager S, 2004, P NATL ACAD SCI USA, V101, P12549, DOI 10.1073/pnas.0405087101; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	27	84	98	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					947	951		10.1126/science.1145727	http://dx.doi.org/10.1126/science.1145727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17626846				2022-12-24	WOS:000248780200040
J	Molina, DM; Wetterholm, A; Kohl, A; McCarthy, AA; Niegowski, D; Ohlson, E; Hammarberg, T; Eshaghi, S; Haeggstrom, J; Nordlund, PR				Molina, Daniel Martinez; Wetterholm, Anders; Kohl, Andreas; McCarthy, Andrew A.; Niegowski, Damian; Ohlson, Eva; Hammarberg, Tove; Eshaghi, Said; Haeggstroem, Jesper Z.; Nordlund, Paer			Structural basis for synthesis of inflammatory mediators by human leukotriene C-4 synthase	NATURE			English	Article							GLUTATHIONE; REFINEMENT; ASTHMA	Cysteinyl leukotrienes are key mediators in inflammation and have an important role in acute and chronic inflammatory diseases of the cardiovascular and respiratory systems, in particular bronchial asthma. In the biosynthesis of cysteinyl leukotrienes, conversion of arachidonic acid forms the unstable epoxide leukotriene A(4) (LTA(4)). This intermediate is conjugated with glutathione (GSH) to produce leukotriene C-4 (LTC4) in a reaction catalysed by LTC4 synthase(1): this reaction is the key step in cysteinyl leukotriene formation. Here we present the crystal structure of the human LTC4 synthase in its apo and GSH- complexed forms to 2.00 and 2.15 angstrom resolution, respectively. The structure reveals a homotrimer, where each monomer is composed of four transmembrane segments. The structure of the enzyme in complex with substrate reveals that the active site enforces a horseshoe- shaped conformation on GSH, and effectively positions the thiol group for activation by a nearby arginine at the membrane - enzyme interface. In addition, the structure provides a model for how the omega- end of the lipophilic co- substrate is pinned at one end of a hydrophobic cleft, providing a molecular 'ruler' to align the reactive epoxide at the thiol of glutathione. This provides newstructural insights into themechanismof LTC4 formation, and also suggests that the observed binding and activation of GSHmight be common for a family of homologous proteins important for inflammatory and detoxification responses.	Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Div Chem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University; European Molecular Biology Laboratory (EMBL)	Haeggstrom, J (corresponding author), Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	said.eshaghi@ki.se; jesper.haeggstrom@ki.se; par.nordlund@ki.se	McCarthy, Andrew A/A-5926-2013	McCarthy, Andrew A/0000-0003-4478-0136				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; COREY EJ, 1980, J AM CHEM SOC, V102, P1436, DOI 10.1021/ja00524a045; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; HANNA CJ, 1981, NATURE, V290, P343, DOI 10.1038/290343a0; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; IZUMI T, 1988, BIOCHIM BIOPHYS ACTA, V959, P305; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lam BK, 2002, PROSTAG OTH LIPID M, V68-9, P511, DOI 10.1016/S0090-6980(02)00052-7; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morgenstern R, 2001, BIOCHEMISTRY-US, V40, P3378, DOI 10.1021/bi0023394; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	28	155	159	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					613	U13		10.1038/nature06009	http://dx.doi.org/10.1038/nature06009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632546				2022-12-24	WOS:000248446700048
J	Goldacre, B				Goldacre, Ben			Medicine and the media - MMR: the scare stories are back	BRITISH MEDICAL JOURNAL			English	Editorial Material												ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728					0	13	13	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					126	127		10.1136/bmj.39280.447419.59	http://dx.doi.org/10.1136/bmj.39280.447419.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17634177	Green Published			2022-12-24	WOS:000248428100030
J	Martin, CR; Siwy, ZS				Martin, Charles R.; Siwy, Zuzanna S.			Learning nature's way: Biosensing with synthetic nanopores	SCIENCE			English	Editorial Material							SOLID-STATE NANOPORES; SINGLE; SELECTIVITY		Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res Bionano Interface, Gainesville, FL 32611 USA; Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Irvine	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	crmartin@chem.ufl.edu	Martin, Charles/AAA-1040-2019					Apel PY, 2001, NUCL INSTRUM METH B, V184, P337, DOI 10.1016/S0168-583X(01)00722-4; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fleischer R.L., 1975, NUCL TRACKS SOLIDS; Heins EA, 2005, NANO LETT, V5, P1824, DOI 10.1021/nl050925i; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; LINES RW, 1992, ROY SOC CH, V102, P350; Nilsson J, 2006, ADV MATER, V18, P427, DOI 10.1002/adma.200501991; Siwy Z, 2005, J AM CHEM SOC, V127, P5000, DOI 10.1021/ja043910f; Spohr R, 1983, U S Patent. No., Patent No. [4369370, US4369370A]; Spohr R, 1983, German Patent DE, Patent No. [2951376 C2, 2951376]; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Sutherland TC, 2004, NANO LETT, V4, P1273, DOI 10.1021/nl049413e	16	229	233	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					331	332		10.1126/science.1146126	http://dx.doi.org/10.1126/science.1146126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641190				2022-12-24	WOS:000248150200034
J	Lundqvist, T; Fisher, SL; Kern, G; Folmer, RHA; Xue, YF; Newton, DT; Keating, TA; Alm, RA; de Jonge, BLM				Lundqvist, Tomas; Fisher, Stewart L.; Kern, Gunther; Folmer, Rutger H. A.; Xue, Yafeng; Newton, D. Trevor; Keating, Thomas A.; Alm, Richard A.; de Jonge, Boudewijn L. M.			Exploitation of structural and regulatory diversity in glutamate racemases	NATURE			English	Article							AMINO-ACID TRANSAMINASE; ESCHERICHIA-COLI; ALLOSTERIC SITE; L-ALANINE; INHIBITION; MECHANISM; IDENTIFICATION; PHOSPHATASE; MUTAGENESIS; DISCOVERY	Glutamate racemase is an enzyme essential to the bacterial cell wall biosynthesis pathway, and has therefore been considered as a target for antibacterial drug discovery. We characterized the glutamate racemases of several pathogenic bacteria using structural and biochemical approaches. Here we describe three distinct mechanisms of regulation for the family of glutamate racemases: allosteric activation by metabolic precursors, kinetic regulation through substrate inhibition, and D-glutamate recycling using a D-amino acid transaminase. In a search for selective inhibitors, we identified a series of uncompetitive inhibitors specifically targeting Helicobacter pylori glutamate racemase that bind to a cryptic allosteric site, and used these inhibitors to probe the mechanistic and dynamic features of the enzyme. These structural, kinetic and mutational studies provide insight into the physiological regulation of these essential enzymes and provide a basis for designing narrow-spectrum antimicrobial agents.	AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA; AstraZeneca R&D, AstraZeneca Global Struct Chem, SE-43188 Molndal, Sweden	AstraZeneca; AstraZeneca	Fisher, SL (corresponding author), AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA.	stewart.fisher@astrazeneca.com	DeJonge, Boudewijn/AAR-6717-2020	Xue, Yafeng/0000-0002-7526-8672				ANDERSON M, 2005, Patent No. 20050037478; ASHIUCHI M, 1993, BIOSCI BIOTECH BIOCH, V57, P1978, DOI 10.1271/bbb.57.1978; de Dios A, 2002, J MED CHEM, V45, P4559, DOI 10.1021/jm020901d; DOUBLET P, 1994, BIOCHEMISTRY-US, V33, P5285, DOI 10.1021/bi00183a035; Doublet P, 1996, MICROB DRUG RESIST, V2, P43, DOI 10.1089/mdr.1996.2.43; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; Fotheringham IG, 1998, J BACTERIOL, V180, P4319, DOI 10.1128/JB.180.16.4319-4323.1998; GHOSH NK, 1966, J BIOL CHEM, V241, P2516; Glavas S, 1997, BIOORG MED CHEM LETT, V7, P2265, DOI 10.1016/S0960-894X(97)00413-7; Glavas S, 2001, BIOCHEMISTRY-US, V40, P6199, DOI 10.1021/bi002703z; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HO HT, 1995, BIOCHEMISTRY-US, V34, P2464, DOI 10.1021/bi00008a009; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Oikonomakos NG, 2000, STRUCTURE, V8, P575, DOI 10.1016/S0969-2126(00)00144-1; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; PUCCI MJ, 1995, J BACTERIOL, V177, P336, DOI 10.1128/jb.177.2.336-342.1995; Ruzheinikov SN, 2005, STRUCTURE, V13, P1707, DOI 10.1016/j.str.2005.07.024; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Song JH, 2005, MOL CELLS, V19, P365; TANNER ME, 1994, TETRAHEDRON LETT, V35, P4073, DOI 10.1016/S0040-4039(00)73115-7; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; WANG L, 2005, Patent No. 20050026189A1; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803	27	108	136	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					817	822		10.1038/nature05689	http://dx.doi.org/10.1038/nature05689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568739				2022-12-24	WOS:000247207500035
J	Sims, TN; Soos, TJ; Xenias, HS; Dubin-Thaler, B; Hofman, JM; Waite, JC; Cameron, TO; Thomas, VK; Varma, R; Wiggins, CH; Sheetz, MP; Littman, DR; Dustin, ML				Sims, Tasha N.; Soos, Timothy J.; Xenias, Harry S.; Dubin-Thaler, Benjamin; Hofman, Jake M.; Waite, Janelle C.; Cameron, Thomas O.; Thomas, V. Kaye; Varma, Rajat; Wiggins, Chris H.; Sheetz, Michael P.; Littman, Dan R.; Dustin, Michael L.			Opposing effects of PKC theta and WASp on symmetry breaking and relocation of the immunological synapse	CELL			English	Article							T-CELL-ACTIVATION; ALDRICH-SYNDROME PROTEIN; KINASE-C-THETA; IN-VIVO; DENDRITIC CELL; IMMUNE SYNAPSE; CUTTING EDGE; ACTIN; LYMPHOCYTES; POLARIZATION	The immunological synapse (IS) is a junction between the T cell and antigen-presenting cell and is composed of supramolecular activation clusters (SMACs). No studies have been published on naive T cell IS dynamics. Here, we find that IS formation during antigen recognition comprises cycles of stable IS formation and autonomous naive T cell migration. The migration phase is driven by PKC theta, which is localized to the F-actin-dependent peripheral (p)SMAC. PKC theta(-/-) T cells formed hyperstable, IS in vitro and in vivo and, like WT cells, displayed fast oscillations in the distal SMAC, but they showed reduced slow oscillations in pSMAC integrity. IS reformation is driven by the Wiscoft Aldrich Syndrome protein (WASp). WASp(-/-) T cells displayed normal IS formation but were unable to reform IS after migration unless PKC theta was inhibited. Thus, opposing effects of PKC theta and WASp control IS stability through pSMAC symmetry breaking and reformation.	NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	New York University; Howard Hughes Medical Institute; New York University; Columbia University; Columbia University; Columbia University	Dustin, ML (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; Varma, Rajat/I-1209-2012	Varma, Rajat/0000-0001-5131-0402; Dustin, Michael/0000-0003-4983-6389				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2003, DEV CELL, V4, P3, DOI 10.1016/S1534-5807(02)00407-0; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898	52	274	275	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					773	785		10.1016/j.cell.2007.03.037	http://dx.doi.org/10.1016/j.cell.2007.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512410	Bronze			2022-12-24	WOS:000246788300021
J	Marijon, E; Ou, P; Celermajer, DS; Ferreira, B; Mocumbi, AO; Jani, D; Paquet, C; Jacob, S; Sidi, D; Jouven, X				Marijon, Eloi; Ou, Phalla; Celermajer, David S.; Ferreira, Beatriz; Mocumbi, Ana Olga; Jani, Dinesh; Paquet, Christophe; Jacob, Sophie; Sidi, Daniel; Jouven, Xavier			Prevalence of rheumatic heart disease detected by echocardiographic screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; FEVER; DIAGNOSIS; CARDITIS; CHILDREN	Background: Epidemiologic studies of the prevalence of rheumatic heart disease have used clinical screening with echocardiographic confirmation of suspected cases. We hypothesized that echocardiographic screening of all surveyed children would show a significantly higher prevalence of rheumatic heart disease. Methods: Randomly selected schoolchildren from 6 through 17 years of age in Cambodia and Mozambique were screened for rheumatic heart disease according to standard clinical and echocardiographic criteria. Results: Clinical examination detected rheumatic heart disease that was confirmed by echocardiography in 8 of 3677 children in Cambodia and 5 of 2170 children in Mozambique; the corresponding prevalence rates and 95% confidence intervals (CIs) were 2.2 cases per 1000 (95% CI, 0.7 to 3.7) for Cambodia and 2.3 cases per 1000 (95% CI, 0.3 to 4.3) for Mozambique. In contrast, echocardiographic screening detected 79 cases of rheumatic heart disease in Cambodia and 66 cases in Mozambique, corresponding to prevalence rates of 21.5 cases per 1000 (95% CI, 16.8 to 26.2) and 30.4 cases per 1000 (95% CI, 23.2 to 37.6), respectively. The mitral valve was involved in the great majority of cases (87.3% in Cambodia and 98.4% in Mozambique). Conclusions: Systematic screening with echocardiography, as compared with clinical screening, reveals a much higher prevalence of rheumatic heart disease (approximately 10 times as great). Since rheumatic heart disease frequently has devastating clinical consequences and secondary prevention may be effective after accurate identification of early cases, these results have important public health implications. N Engl J Med 2007;357:470-6.	Hop Necker Enfants Malad, Dept Pediat Cardiol, Paris, France; Hop Necker Enfants Malad, Dept Pediat Radiol, Paris, France; Maputo Heart Inst, Maputo, Mozambique; Phnom Penh Heart Ctr, Phnom Penh, Cambodia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Natl Inst Publ Hlth Surveillance, St Maurice, France; INSERM, Unite Avenir 780, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sydney; Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm)	Marijon, E (corresponding author), Univ Paris 05, Georges Pompidou Europeen Hosp, Serv Cardiol 2, 20 Rue Leblanc, F-75908 Paris 15, France.	eloi_marijon@yahoo.fr		Mocumbi, Ana/0000-0002-9564-2860; Jacob, Sophie/0000-0003-1729-305X				Anabwani GM, 1996, E AFR MED J, V73, P215; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; McDonald M, 2005, HEART, V91, P1131, DOI 10.1136/hrt.2004.057570; Meira ZMA, 2005, HEART, V91, P1019, DOI 10.1136/hrt.2004.042762; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; *SPEC WRIT GROUP C, 1993, JAMA-J AM MED ASSOC, V269, P476; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2001, LANCET, V357, P1994, DOI 10.1016/S0140-6736(00)05134-5; WHO Expert Consultation Report, 2001, RHEUM FEV RHEUM HEAR; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q	15	478	491	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					470	476		10.1056/NEJMoa065085	http://dx.doi.org/10.1056/NEJMoa065085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671255				2022-12-24	WOS:000248436300008
J	Ploegh, HL				Ploegh, Hidde L.			A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum	NATURE			English	Article							I MEMBRANE-PROTEIN; CROSS-PRESENTATION; RETRO-TRANSLOCATION; DROPLETS; DEGRADATION; DISLOCATION; MECHANISMS; PROTEASOME; TRANSPORT; INITIATE	Lipids are not encoded by a DNA template and therefore cannot be mutated, knocked out or knocked down. This by no means renders them impotent from a cell biological perspective. Here I propose a model for the involvement of lipid rearrangements in the execution of crucial steps in ( glyco) protein quality control.	MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	45	217	221	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					435	438		10.1038/nature06004	http://dx.doi.org/10.1038/nature06004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653186				2022-12-24	WOS:000248302700039
J	[Anonymous]				[Anonymous]			Nuclear test	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					387	387		10.1038/448387a	http://dx.doi.org/10.1038/448387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653146	Bronze			2022-12-24	WOS:000248302700001
J	Irmis, RB; Nesbitt, SJ; Padian, K; Smith, ND; Turner, AH; Woody, D; Downs, A				Irmis, Randall B.; Nesbitt, Sterling J.; Padian, Kevin; Smith, Nathan D.; Turner, Alan H.; Woody, Daniel; Downs, Alex			A Late Triassic dinosauromorph assemblage from New Mexico and the rise of dinosaurs	SCIENCE			English	Article							ARGENTINA; ORIGIN	It has generally been thought that the first dinosaurs quickly replaced more archaic Late Triassic faunas, either by outcompeting them or when the more archaic faunas suddenly became extinct. Fossils from the Hayden Quarry, in the Upper Triassic Chinle Formation of New Mexico, and an analysis of other regional Upper Triassic assemblages instead imply that the transition was gradual. Some dinosaur relatives preserved in this Chinle assemblage belong to groups previously known only from the Middle and lowermost Upper Triassic outside North America. Thus, the transition may have extended for 15 to 20 million years and was probably diachronous at different paleolatitudes.	Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Ghost Ranch Conference Ctr, Ruth Hall Museum Paleontol, Abiquiu, NM 87510 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University; American Museum of Natural History (AMNH); University of Chicago; Field Museum of Natural History (Chicago); University of Colorado System; University of Colorado Boulder	Irmis, RB (corresponding author), Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA.	irmis@berkeley.edu; snesbitt@ldeo.columbia.edu		Nesbitt, Sterling/0000-0002-7017-1652				ARCUCCI A, 1987, Ameghiniana, V24, P89; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; BENTON MJ, 1993, SCIENCE, V260, P769, DOI 10.1126/science.260.5109.769; BENTON MJ, 1988, PHYLOGENY CLASSIFICA, V1, pCH8; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; FRASER N, 2006, DAWN DINOSAURS; HECKERT AB, 2003, NEW MEXICO MUSEUM NA, V24, P127; Heckert Andrew B., 2005, New Mexico Geological Society Field Conference Guidebook, V56, P302; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; LITWIN RJ, 1991, REV PALAEOBOT PALYNO, V68, P269, DOI 10.1016/0034-6667(91)90028-2; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; PADIANK, 1989, DAWN AGE DINOSAURS A, P401; Parker W.G., 2006, MUS NORTH ARIZ BULL, V62, P46; Parker WG, 2005, P ROY SOC B-BIOL SCI, V272, P963, DOI 10.1098/rspb.2004.3047; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Sidor CA, 2005, NATURE, V434, P886, DOI 10.1038/nature03393; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; ZEIGLER KE, 2003, NEW MEXICO MUSEUM NA, V24, P1	26	188	197	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					358	361		10.1126/science.1143325	http://dx.doi.org/10.1126/science.1143325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641198	Green Published			2022-12-24	WOS:000248150200043
J	Zhang, K; Guo, JZ; Peng, YQ; Xi, W; Guo, AK				Zhang, Ke; Guo, JianZeng; Peng, Yueqing; Xi, Wang; Guo, Aike			Dopamine-mushroom body circuit regulates saliency-based decision-making in Drosophila	SCIENCE			English	Article							EXPRESSION; NEURONS; BEHAVIOR; MEMORY; BRAIN; MELANOGASTER; VALUATION; BODIES; SYSTEM; REWARD	Drosophila melanogaster can make appropriate choices among alternative flight options on the basis of the relative salience of competing visual cues. We show that this choice behavior consists of early and late phases; the former requires activation of the dopaminergic system and mushroom bodies, whereas the latter is independent of these activities. Immunohistological analysis showed that mushroom bodies are densely innervated by dopaminergic axons. Thus, the circuit from the dopamine system to mushroom bodies is crucial for choice behavior in Drosophila.	Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	akguo@ion.ac.cn						Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Salzman CD, 2005, CURR OPIN NEUROBIOL, V15, P721, DOI 10.1016/j.conb.2005.10.016; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf R, 1998, LEARN MEMORY, V5, P166; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	28	147	159	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1901	1904		10.1126/science.1137357	http://dx.doi.org/10.1126/science.1137357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600217				2022-12-24	WOS:000247602700041
J	Foerster, K; Coulson, T; Sheldon, BC; Pemberton, JM; Clutton-Brock, TH; Kruuk, LEB				Foerster, Katharina; Coulson, Tim; Sheldon, Ben C.; Pemberton, Josephine M.; Clutton-Brock, Tim H.; Kruuk, Loeske E. B.			Sexually antagonistic genetic variation for fitness in red deer	NATURE			English	Article							NATURAL-POPULATIONS; ONTOGENIC CONFLICT; MATE CHOICE; SELECTION; HERITABILITY; DIMORPHISM; PLEIOTROPY; EVOLUTION; SEXES; WILD	Evolutionary theory predicts the depletion of genetic variation in natural populations as a result of the effects of selection, but genetic variation is nevertheless abundant for many traits that are under directional or stabilizing selection(1). Evolutionary geneticists commonly try to explain this paradox with mechanisms that lead to a balance between mutation and selection(2). However, theoretical predictions of equilibrium genetic variance under mutation-selection balance are usually lower than the observed values, and the reason for this is unknown(3). The potential role of sexually antagonistic selection in maintaining genetic variation has received little attention in this debate, surprisingly given its potential ubiquity in dioecious organisms. At fitness-related loci, a given genotype may be selected in opposite directions in the two sexes. Such sexually antagonistic selection will reduce the otherwise-expected positive genetic correlation between male and female fitness(4). Both theory(5-7) and experimental data(8-12) suggest that males and females of the same species may have divergent genetic optima, but supporting data from wild populations are still scarce(13-15). Here we present evidence for sexually antagonistic fitness variation in a natural population, using data from a long-term study of red deer (Cervus elaphus). We show that male red deer with relatively high fitness fathered, on average, daughters with relatively low fitness. This was due to a negative genetic correlation between estimates of fitness in males and females. In particular, we show that selection favours males that carry low breeding values for female fitness. Our results demonstrate that sexually antagonistic selection can lead to a trade-off between the optimal genotypes for males and females; this mechanism will have profound effects on the operation of selection and the maintenance of genetic variation in natural populations.	Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England	University of Edinburgh; University of Cambridge; University of Oxford; Imperial College London; Imperial College London	Foerster, K (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	foerster@orn.mpg.de; loeske.kruuk@ed.ac.uk	Kruuk, Loeske/AAB-8714-2019; Pemberton, Josephine M/F-3100-2010; Foerster, Katharina/AAX-3894-2020; Coulson, Tim/AAL-8148-2021; Sheldon, Ben C/A-8056-2010; Kruuk, Loeske E. B./J-3295-2012	Kruuk, Loeske/0000-0001-8588-1123; Coulson, Tim/0000-0001-9371-9003; Sheldon, Ben C/0000-0002-5240-7828; Kruuk, Loeske E. B./0000-0001-8588-1123	NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, NE/B504314/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; FORSMAN A, 1995, J EVOLUTION BIOL, V8, P53, DOI 10.1046/j.1420-9101.1995.8010053.x; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; GILMOUR AW, 2002, ASREML USER GUIDE 1; Hedrick PW, 1999, HEREDITY, V82, P126, DOI 10.1038/sj.hdy.6884400; HOULE D, 1992, GENETICS, V130, P195; Kokko H, 2001, ECOL LETT, V4, P322, DOI 10.1046/j.1461-0248.2001.00224.x; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall TC, 2002, P ROY SOC B-BIOL SCI, V269, P1533, DOI 10.1098/rspb.2002.2035; MEAGHER TR, 1992, EVOLUTION, V46, P445, DOI 10.1111/j.1558-5646.1992.tb02050.x; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Metcalf CJE, 2007, TRENDS ECOL EVOL, V22, P205, DOI 10.1016/j.tree.2006.12.001; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Sokal RR, 1995, BIOMETRY; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053	31	280	283	0	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1107	U9		10.1038/nature05912	http://dx.doi.org/10.1038/nature05912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597758				2022-12-24	WOS:000247564600036
J	Egli, D; Rosains, J; Birkhoff, G; Eggan, K				Egli, Dieter; Rosains, Jacqueline; Birkhoff, Garrett; Eggan, Kevin			Developmental reprogramming after chromosome transfer into mitotic mouse zygotes	NATURE			English	Article							EMBRYONIC STEM-CELLS; ADULT SOMATIC-CELLS; NUCLEAR TRANSFER; ENUCLEATED ZYGOTES; HUMAN OOCYTES; MICE; TRANSPLANTATION; CLONING; FETAL; DIFFERENTIATION	Until now, animal cloning and the production of embryonic stem cell lines by somatic cell nuclear transfer have relied on introducing nuclei into meiotic oocytes. In contrast, attempts at somatic cell nuclear transfer into fertilized interphase zygotes have failed. As a result, it has generally been assumed that unfertilized human oocytes will be required for the generation of tailored human embryonic stem cell lines from patients by somatic cell nuclear transfer. Here we report, however, that, unlike interphase zygotes, mouse zygotes temporarily arrested in mitosis can support somatic cell reprogramming, the production of embryonic stem cell lines and the full-term development of cloned animals. Thus, human zygotes and perhaps human embryonic blastomeres may be useful supplements to human oocytes for the creation of patient-derived human embryonic stem cells.	Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Stowers Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Stowers Institute for Medical Research	Eggan, K (corresponding author), Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018					Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHEONG HT, 1992, JPN J VET RES, V40, P149; CHEONG HT, 1993, THERIOGENOLOGY, V39, P451, DOI 10.1016/0093-691X(93)90388-L; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Damario MA, 1999, FERTIL STERIL, V72, P1049, DOI 10.1016/S0015-0282(99)00444-6; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Nagy A., 2003, MANIPULATING MOUSE E; Nikolettos N, 2000, MOL CELL ENDOCRINOL, V169, P55, DOI 10.1016/S0303-7207(00)00352-X; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; NORSIGIAN J, 2005, BOSTON GLOBE    0225, pA13; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; ROBL JM, 1987, J ANIM SCI, V64, P642, DOI 10.2527/jas1987.642642x; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Schurmann A, 2006, REPRODUCTION, V132, P839, DOI 10.1530/REP-06-0054; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANDERVEN HH, 1985, ANN NY ACAD SCI, V442, P88; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2000, NAT GENET, V24, P108, DOI 10.1038/72749; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf JP, 1997, FERTIL STERIL, V67, P1095, DOI 10.1016/S0015-0282(97)81445-8; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; 2004, FERTIL STERIL, V81, P1207	53	213	235	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					679	U8		10.1038/nature05879	http://dx.doi.org/10.1038/nature05879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554301				2022-12-24	WOS:000247030700036
J	Kaurah, P; MacMillan, A; Boyd, N; Senz, J; De Luca, A; Chun, N; Suriano, G; Zaor, S; Van Manen, L; Gilpin, C; Nikkel, S; Connolly-Wilson, M; Weissman, S; Rubinstein, WS; Sebold, C; Greenstein, R; Stroop, J; Yim, D; Panzini, B; McKinnon, W; Greenblatt, M; Wirtzfeld, D; Fontaine, D; Coit, D; Yoon, S; Chung, D; Lauwers, G; Pizzuti, A; Vaccaro, C; Redal, MA; Oliveira, C; Tischkowitz, M; Olschwang, S; Gallinger, S; Lynch, H; Green, J; Ford, J; Pharoah, P; Fernandez, B; Huntsman, D				Kaurah, Pardeep; MacMillan, Andree; Boyd, Niki; Senz, Janine; De Luca, Alessandro; Chun, Nicki; Suriano, Gianpaolo; Zaor, Sonya; Van Manen, Lori; Gilpin, Cathy; Nikkel, Sarah; Connolly-Wilson, Mary; Weissman, Scott; Rubinstein, Wendy S.; Sebold, Courtney; Greenstein, Robert; Stroop, Jennifer; Yim, Dwight; Panzini, Benoit; McKinnon, Wendy; Greenblatt, Marc; Wirtzfeld, Debrah; Fontaine, Daniel; Coit, Daniel; Yoon, Sam; Chung, Daniel; Lauwers, Gregory; Pizzuti, Antonio; Vaccaro, Carlos; Redal, Maria Ana; Oliveira, Carla; Tischkowitz, Marc; Olschwang, Sylviane; Gallinger, Steven; Lynch, Henry; Green, Jane; Ford, James; Pharoah, Paul; Fernandez, Bridget; Huntsman, David			Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E-CADHERIN GENE; PROPHYLACTIC TOTAL GASTRECTOMY; GERMLINE MISSENSE MUTATIONS; BREAST-CANCER; COLORECTAL-CANCER; MESSENGER-RNA; CARCINOMA; PREDISPOSITION; NEWFOUNDLAND; MANAGEMENT	Context Hereditary diffuse gastric cancer is caused by germline mutations in the epithelial cadherin ( CDH1) gene and is characterized by an increased risk for diffuse gastric cancer and lobular breast cancer. Objective To determine whether recurring germline CDH1 mutations occurred due to independent mutational events or common ancestry. Design, Setting, and Patients Thirty-eight families diagnosed clinically with hereditary diffuse gastric cancer were accrued between November 2004 and January 2006 and were analyzed for CDH1 mutations as part of an ongoing study at the British Columbia Cancer Agency. Twenty-six families had at least 2 gastric cancer cases with 1 case of diffuse gastric cancer in a person younger than 50 years; 12 families had either a single case of diffuse gastric cancer diagnosed in a person younger than 35 years or multiple cases of diffuse gastric cancer diagnosed in persons older than 50 years. Main Outcome Measures Classification of family members as carriers or noncarriers of CDH1 mutations. Haplotype analysis to assess recurring mutations for common ancestry was performed on 7 families from this study and 7 previously reported families with the same mutations. Results Thirteen mutations ( 6 novel) were identified in 15 of the 38 families ( 40% detection rate). The 1137G > A splicing mutation and the 1901C > T ( A634V) missense/splicing mutation occurred on common haplotypes in 2 families but on different haplotypes in a third family. The 2195G > A ( R732Q) missense/splicing mutation occurred in 2 families on different haplotypes. The 2064-2065delTG mutation occurred on a common haplotype in 2 families. Two families from this study plus 2 additional families carrying the novel 2398delC mutation shared a common haplotype, suggesting a founder effect. All 4 families originate from the southeast coast of Newfoundland. Due to concentrations of lobular breast cancer cases, 2 branches of this family had been diagnosed as having hereditary breast cancer and were tested for BRCA mutations. Within these 4 families, the cumulative risk by age 75 years in mutation carriers for clinically detected gastric cancer was 40% ( 95% confidence interval [ CI], 12%91%) for males and 63% ( 95% CI, 19%-99%) for females and the risk for breast cancer in female mutation carriers was 52% ( 95% CI, 29%-94%). Conclusions Recurrent CDH1 mutations in families with hereditary diffuse gastric cancer are due to both independent mutational events and common ancestry. The presence of a founder mutation from Newfoundland is strongly supported.	British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; Hlth Sci Ctr, Prov Med Genet Program, St John, NF, Canada; Stanford Univ, Sch Med, Canc Genet Program, Div Oncol, Stanford, CA 94305 USA; Univ Porto, Inst Mol Pathol & Immunol, Fac Med, P-4100 Oporto, Portugal; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; Kingston Gen Hosp, Familial Oncol Program, Canc Ctr SE Ontario, Kingston, ON K7L 2V7, Canada; Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; Evanston NW Healthcare, Ctr Med Genet, Evanston, IL USA; Wilford Hall USAF Med Ctr, Pediat Subspecialty Clin, San Antonio, TX 78236 USA; Univ Connecticut, Ctr Hlth, Hereditary Canc Program, Div Med Genet, Farmington, CT USA; Kaiser Permanente, Dept Pediat, Honolulu, HI USA; CHUM Hotel Dieu, Clin Canc Hereditaires, Montreal, PQ, Canada; CHUM Hop Notre Dame, Serv Gastroenterol, Montreal, PQ, Canada; Univ Vermont, Coll Med, Familial Canc Program, Burlington, VT USA; Mem Univ Newfoundland, Div Surg, St John, NF, Canada; Mem Univ Newfoundland, Div Clin Genet, St John, NF, Canada; Mem Univ Newfoundland, Dept Anat Pathol, St John, NF, Canada; Mem Univ Newfoundland, Discipline Genet, Fac Med, St John, NF, Canada; Mem Sloan Kettering Canc Ctr, Gastric & Mixed Tumor Serv, Dept Surg, New York, NY 10021 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Pathol Serv, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; IRCCS, CCS Hosp, San Giovanni Rotondo, Italy; CSS Mendel Inst, Rome, Italy; Hosp Italiano Buenos Aires, Serv Gen Surg, Buenos Aires, DF, Argentina; Hosp Italiano Buenos Aires, Inst Ciencias Basicas & Med Expt, Buenos Aires, DF, Argentina; McGill Univ, Program Canc Genet, Montreal, PQ, Canada; McGill Univ, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Inst J Paoli I Calmettes, INSERM, U599, F-13009 Marseille, France; Univ Toronto, Hepatobiliary & Pancreat Surg Grp, Div Gen Surg, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Univ Cambridge, Dept Oncol, Cambridge, England	British Columbia Cancer Agency; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Stanford University; Universidade do Porto; McGill University; Cancer Care Ontario; Queens University - Canada; University of Ottawa; Children's Hospital of Eastern Ontario; NorthShore University Health System; United States Department of Defense; United States Air Force; University of Connecticut; Kaiser Permanente; Universite de Montreal; Universite de Montreal; University of Vermont; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Creighton University; University of Cambridge	Huntsman, D (corresponding author), British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	dhuntsma@bccancer.bc.ca	Oliveira, Carla/F-8188-2011; Huntsman, David/ABE-6082-2020; Pharoah, Paul/V-6658-2019; Gallinger, Steven/E-4575-2013; Tischkowitz, Marc/O-4452-2018; Olschwang, Sylviane/G-2716-2013; De Luca, Alessandro/B-2179-2017	Oliveira, Carla/0000-0001-8340-2264; Pharoah, Paul/0000-0001-8494-732X; Tischkowitz, Marc/0000-0002-7880-0628; Olschwang, Sylviane/0000-0001-7078-3029; De Luca, Alessandro/0000-0002-4408-8062; Vaccaro, Carlos/0000-0002-1299-5864; Ford, James/0000-0002-2513-7025; PIZZUTI, Antonio/0000-0003-3245-1925	NATIONAL CANCER INSTITUTE [U01CA086389] Funding Source: NIH RePORTER; NCI NIH HHS [5UO1 CA86389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Bacani JT, 2006, J MED GENET, V43, P867, DOI 10.1136/jmg.2006.043133; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1996, ONCOGENE, V13, P1919; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Caldas C, 1999, J MED GENET, V36, P873; *CAN CANC SOC, 2006, CAN CANC STAT; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; Chun YS, 2001, CANCER, V92, P181, DOI 10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dussaulx-Garin L, 2001, EUR J GASTROEN HEPAT, V13, P711, DOI 10.1097/00042737-200106000-00016; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Frebourg T, 2006, J MED GENET, V43, P138, DOI 10.1136/jmg.2005.031385; Gayther SA, 1998, CANCER RES, V58, P4086; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Humar B, 2002, HUM MUTAT, V19, P518, DOI 10.1002/humu.10067; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jonsson BA, 2002, INT J CANCER, V98, P838, DOI 10.1002/ijc.10258; Keller G, 1999, AM J PATHOL, V155, P337, DOI 10.1016/S0002-9440(10)65129-2; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kim HC, 2000, GUT, V47, P262, DOI 10.1136/gut.47.2.262; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lewis FR, 2001, SURGERY, V130, P612, DOI 10.1067/msy.2001.117099; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Norton JA, 2007, ANN SURG, V245, P873, DOI 10.1097/01.sla.0000254370.29893.e4; Oliveira C, 2006, INT J SURG PATHOL, V14, P21, DOI 10.1177/106689690601400105; Oliveira C, 2004, EUR J CANCER, V40, P1897, DOI 10.1016/j.ejca.2004.04.027; Oliveira C, 2003, EXPERT REV MOL DIAGN, V3, P201; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira Carla, 2004, Hered Cancer Clin Pract, V2, P51, DOI 10.1186/1897-4287-2-2-51; PFEIFFER CJ, 1977, DIGESTION, V16, P1, DOI 10.1159/000198048; PFEIFFER CJ, 1973, CAN MED ASSOC J, V108, P1374; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Suriano G, 2003, HUM MOL GENET, V12, P3007, DOI 10.1093/hmg/ddg316; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; van Kouwen MCA, 2004, CLIN CANCER RES, V10, P6456, DOI 10.1158/1078-0432.CCR-04-0599; VARLEY JM, 1995, J MED GENET, V32, P942, DOI 10.1136/jmg.32.12.942; Vecsey-Semjen B, 2002, ONCOGENE, V21, P4646, DOI 10.1038/sj.onc.1205577; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	56	301	308	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2360	2372		10.1001/jama.297.21.2360	http://dx.doi.org/10.1001/jama.297.21.2360			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17545690	Bronze			2022-12-24	WOS:000247007200018
J	Thorpe, SKS; Holder, RL; Crompton, RH				Thorpe, S. K. S.; Holder, R. L.; Crompton, R. H.			Origin of human bipedalism as an adaptation for locomotion on flexible branches	SCIENCE			English	Article							CHIMPANZEES; EVOLUTION; ECOLOGY; WALKING	Human bipedalism is commonly thought to have evolved from a quadrupedal terrestrial precursor, yet some recent paleontological evidence suggests that adaptations for bipedalism arose in an arboreal context. However, the adaptive benefit of arboreal bipedalism has been unknown. Here we show that it allows the most arboreal great ape, the orangutan, to access supports too flexible to be negotiated otherwise. Orangutans react to branch flexibility like humans running on springy tracks, by increasing knee and hip extension, whereas all other primates do the reverse. Human bipedalism is thus less an innovation than an exploitation of a locomotor behavior retained from the common great ape ancestor.	Univ Liverpool, Sch Biomed Sci, Liverpool L69 3GE, Merseyside, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Liverpool; University of Birmingham; University of Birmingham	Crompton, RH (corresponding author), Univ Liverpool, Sch Biomed Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	rhcromp@liv.ac.uk						Alexander RM., 2003, PRINCIPLES ANIMAL LO; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Crompton RH, 2003, COUR FOR SEKENBG, V243, P135; FLEAGLE JG, 1981, S ZOOLOGICAL SOC LON, V48, P359; Gommery Dominique, 2002, Annales de Paleontologie, V88, P167, DOI 10.1016/S0753-3969(02)01044-3; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; KINGDON J, 2003, LOWLY ORIGINS; KOVAROVIC K, IN PRESS J HUM EVOL, DOI DOI 10.1016/J.JHEVOI.2007.01.001; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Payne RC, 2006, J ANAT, V208, P709, DOI 10.1111/j.1469-7580.2006.00563.x; PICKFORD M, 2005, ANTHROPOLOGIE, V69, P191; Pickford Martin, 1999, P27; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Senut B, 2006, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/0-387-29798-7_15; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Ward CV, 2007, HDB PALEOANTHROPOLOG, V2, P1011; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	29	185	192	2	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1328	1331		10.1126/science.1140799	http://dx.doi.org/10.1126/science.1140799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540902				2022-12-24	WOS:000246885600048
J	Silverman, JG; Decker, MR; Gupta, J; Maheshwari, A; Willis, BM; Raj, A				Silverman, Jay G.; Decker, Michele R.; Gupta, Jhumka; Maheshwari, Ayonija; Willis, Brian M.; Raj, Anita			HIV prevalence and predictors of infection in sex-trafficked Nepalese girls and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; INDIA; WORKERS; MUMBAI; PROSTITUTION; EXPERIENCE; EPIDEMIC; ASIA	Context Sex trafficking of girls and women is widespread across South Asia and is recognized as both a violent gender-based crime and major human rights violation. Inadequate empirical data exist to characterize this phenomenon and its related health consequences, such as human immunodeficiency virus (HIV) infection. Objective To determine the prevalence of HIV infection among repatriated sex-trafficked Nepalese girls and women and to identify trafficking-related predictors of such infection. Design Medical and case records of 287 repatriated girls and women reporting being trafficked from Nepal for sexual exploitation and receiving rehabilitative services between January 1997 and December 2005 at a major nongovernmental organization were systematically reviewed in January 2006. Setting Major Nepalese nongovernmental organization providing shelter and care to repatriated survivors of sex trafficking. Main Outcome Measures Prevalence of and risk for HIV based on demographic characteristics and on trafficking- and prostitution-related experiences. Results Among 287 repatriated Nepalese sex-trafficked girls and women, 109 (38.0%) tested positive for HIV. Among those with complete documentation of trafficking experiences (n=225), median age at time of trafficking was 17.0 years, with 33 (14.7%) trafficked prior to age 15 years. Compared with those trafficked at 18 years or older, girls trafficked prior to age 15 years were at increased risk for HIV ( adjusted odds ratio [AOR], 3.70; 95% confidence interval [CI], 1.32-10.34), with 20 of 33 (60.6%) infected among this youngest age group. Additional factors associated with HIV positivity included being trafficked to Mumbai ( AOR, 4.85; 95% CI, 2.16-10.89) and longer duration of forced prostitution ( AOR, 1.02; 95% CI, 1.01-1.03; indicating increased risk per additional month of brothel servitude). In post hoc analyses, girls trafficked prior to age 15 years had increased odds of having been detained in multiple brothels ( odds ratio [ OR], 5.03; 95% CI, 1.96-12.93) and in brothels for a duration of 1 year or more ( OR, 2.67; 95% CI, 1.12-6.33) vs those trafficked at 18 years or older. Conclusions In this study, repatriated Nepalese sex-trafficked girls and women were found to have a high prevalence of HIV infection, with increased risk among those trafficked prior to age 15 years. Present findings demonstrate the need for greater attention to reducing and intervening in sex trafficking in South Asia, particularly among the very young.	Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; ECPAT Int, Washington, DC USA; Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Boston University	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 667 Huntington Ave, Boston, MA 02115 USA.	jsilverm@hsph.harvard.edu		Decker, Michele/0000-0002-7085-7080	NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bansal R K, 1992, Indian J Matern Child Health, V3, P108; Beyrer C, 2001, SOC SCI MED, V53, P543, DOI 10.1016/S0277-9536(00)00358-0; BEYRER C, 2003, BROWN J WORLD AFFAIR, V10, P105; *C RES SERV, 2001, TRAFF WOM CHILDR US; Chakraborty A. K., 1994, Journal of Communicable Diseases, V26, P161; Chander Anil, 2004, Nepal Med Coll J, V6, P60; Hennick M., 2004, ASIAN PAC MIGR J, V13, P305, DOI [10.1177/011719680401300302, DOI 10.1177/011719680401300302]; Hosain GMM, 2005, PUBLIC HEALTH, V119, P371, DOI 10.1016/j.puhe.2004.08.015; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Human Rights Watch, 1995, RAP PROF TRAFF NEP G; *JOINT UN PROGR HI, 2 5 MILL PEOPL LIV H; *JOINT UN PROGR HI, DEC 06 AIDS EP UPD; *JOINT UN PROGR HI, 2006, NEP COUNTR PROF; Kannangai R, 2003, JAIDS-J ACQ IMM DEF, V32, P573, DOI 10.1097/00126334-200304150-00018; Madhivanan P, 2005, SEX TRANSM DIS, V32, P685, DOI 10.1097/01.olq.0000175405.36124.3b; Nair P, 2004, REPORT TRAFFICKING W, VI; *NAT AIDS CONTROL, 2006, HIV AIDS EP SURV EST; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Raymond JG, 2004, VIOLENCE AGAINST WOM, V10, P1156, DOI 10.1177/1077801204268609; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Sharma V, 1996, Sex Marital Ther, V11, P147, DOI 10.1080/02674659608404426; Silverman JG, 2007, INT J GYNECOL OBSTET, V97, P221, DOI 10.1016/j.ijgo.2006.12.003; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Singh S, 2005, PLOS MED, V2, P705, DOI 10.1371/journal.pmed.0020216; UN, 2000, PROTOCOL PREVENT SUP; *US DEP STAT, 2005, VICT TRAFF VIOL PROT; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; *WORLD BANK, 2006, HIV AIDS NEP; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	128	130	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					536	542		10.1001/jama.298.5.536	http://dx.doi.org/10.1001/jama.298.5.536			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666674	Bronze			2022-12-24	WOS:000248438100021
J	Carpten, JD; Faber, AL; Horn, C; Donoho, GP; Briggs, SL; Robbins, CM; Hostetter, G; Boguslawski, S; Moses, TY; Savage, S; Uhlik, M; Lin, AM; Du, J; Qian, YW; Zeckner, DJ; Tucker-Kellogg, G; Touchman, J; Patel, K; Mousses, S; Bittner, M; Schevitz, R; Lai, MHT; Blanchard, KL; Thomas, JE				Carpten, John D.; Faber, Andrew L.; Horn, Candice; Donoho, Gregory P.; Briggs, Stephen L.; Robbins, Christiane M.; Hostetter, Galen; Boguslawski, Sophie; Moses, Tracy Y.; Savage, Stephanie; Uhlik, Mark; Lin, Aimin; Du, Jian; Qian, Yue-Wei; Zeckner, Douglas J.; Tucker-Kellogg, Greg; Touchman, Jeffrey; Patel, Ketan; Mousses, Spyro; Bittner, Michael; Schevitz, Richard; Lai, Mei-Huei T.; Blanchard, Kerry L.; Thomas, James E.			A transforming mutation in the pleckstrin homology domain of AKT1 in cancer	NATURE			English	Article							PROTEIN-KINASE-B; PIK3CA GENE; BREAST CANCERS; PHOSPHATIDYLINOSITOL 3-KINASE; ONCOGENIC TRANSFORMATION; SIGNALING PATHWAY; HIGH-FREQUENCY; ACTIVATION; AKT/PKB; PROTOONCOGENE	Although AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is a central member of possibly the most frequently activated proliferation and survival pathway in cancer, mutation of AKT1 has not been widely reported. Here we report the identification of a somatic mutation in human breast, colorectal and ovarian cancers that results in a glutamic acid to lysine substitution at amino acid 17 (E17K) in the lipid-binding pocket of AKT1. Lys 17 alters the electrostatic interactions of the pocket and forms new hydrogen bonds with a phosphoinositide ligand. This mutation activates AKT1 by means of pathological localization to the plasma membrane, stimulates downstream signalling, transforms cells and induces leukaemia in mice. This mechanism indicates a direct role of AKT1 in human cancer, and adds to the known genetic alterations that promote oncogenesis through the phosphatidylinositol-3-OH kinase/AKT pathway. Furthermore, the E17K substitution decreases the sensitivity to an allosteric kinase inhibitor, so this mutation may have important clinical utility for AKT drug development.	Lilly Corp Ctr, Lilly Res Labs, Canc Discovery Res, Indianapolis, IN 46285 USA; Translat Genom Res Inst, Div Integrated Canc Genom, Phoenix, AZ 85004 USA; Lilly Corp Ctr, Lilly Res Labs, Global Struct Biol, Indianapolis, IN 46285 USA; Lilly Corp Ctr, Lilly Res Labs, Integrat Biol, Indianapolis, IN 46285 USA; Lilly Singapore, Ctr Drug Discovery, Singapore 117528, Singapore; Translat Genom Res Inst, Scottsdale, AZ 85259 USA	Eli Lilly; Translational Genomics Research Institute; Eli Lilly; Eli Lilly; Translational Genomics Research Institute	Blanchard, KL (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Canc Discovery Res, Indianapolis, IN 46285 USA.	kblanc@lilly.com; thomas_james_e@lilly.com	Tucker-Kellogg, Greg/G-3344-2012	Tucker-Kellogg, Greg/0000-0001-8407-9251				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1991, BIOCHIM BIOPHYS ACTA, V1072, P9, DOI 10.1016/0304-419X(91)90004-5; AHMED NN, 1993, ONCOGENE, V8, P1957; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; HAWLEY RG, 1994, GENE THER, V1, P136; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soung YH, 2006, ONCOLOGY-BASEL, V70, P285, DOI 10.1159/000096289; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	37	945	982	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					439	U1		10.1038/nature05933	http://dx.doi.org/10.1038/nature05933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17611497				2022-12-24	WOS:000248302700040
J	Richter, S; Geldner, N; Schrader, J; Wolters, H; Stierhof, YD; Rios, G; Koncz, C; Robinson, DG; Jurgens, G				Richter, Sandra; Geldner, Niko; Schrader, Jarmo; Wolters, Hanno; Stierhof, York-Dieter; Rios, Gabino; Koncz, Csaba; Robinson, David G.; Juergens, Gerd			Functional diversification of closely related ARF-GEFs in protein secretion and recycling	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; BREFELDIN-A; AUXIN TRANSPORT; FACTORS GEA1P; PLANT-CELLS; ARABIDOPSIS; GOLGI; GNOM; LOCALIZATION; TRAFFICKING	Guanine-nucleotide exchange factors on ADP-ribosylation factor GTPases (ARF-GEFs) regulate vesicle formation in time and space by activating ARF substrates on distinct donor membranes(1). Mammalian GBF1 (ref. 2) and yeast Gea1/2 ( ref. 3) ARF-GEFs act at Golgi membranes, regulating COPI-coated vesicle formation. In contrast, their Arabidopsis thaliana homologue GNOM (GN) is required for endosomal recycling, playing an important part in development(4). This difference indicates an evolutionary divergence of trafficking pathways between animals and plants, and raised the question of how endoplasmic reticulum - Golgi transport is regulated in plants. Here we demonstrate that the closest homologue of GNOM in Arabidopsis, GNOM-LIKE1 (GNL1; NM_ 123312; At5g39500), performs this ancestral function. GNL1 localizes to and acts primarily at Golgi stacks, regulating COPI-coated vesicle formation. Surprisingly, GNOM can functionally substitute for GNL1, but not vice versa. Our results suggest that large ARF-GEFs of the GBF1 class perform a conserved role in endoplasmic reticulum - Golgi trafficking and secretion, which is done by GNL1 and GNOM in Arabidopsis, whereas GNOM has evolved to perform an additional plant-specific function of recycling from endosomes to the plasma membrane. Duplication and diversification of ARF-GEFs in plants contrasts with the evolution of entirely new classes of ARF-GEFs(5) for endosomal trafficking in animals, which illustrates the independent evolution of complex endosomal pathways in the two kingdoms.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; Max Planck Inst Pflanzenzuchtung, D-50829 Cologne, Germany; Heidelberg Univ, Dept Cell Biol, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Ruprecht Karls University Heidelberg	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Auf Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Geldner, Niko/Y-2481-2019; Rios, Gabino/F-4046-2011	Rios, Gabino/0000-0002-1398-282X; Geldner, Niko/0000-0002-2300-9644				Barzilay E, 2005, TRAFFIC, V6, P794, DOI 10.1111/j.1600-0854.2005.00317.x; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee GJ, 2004, PLANT CELL PHYSIOL, V45, P1211, DOI 10.1093/pcp/pch142; MAYER U, 1993, DEVELOPMENT, V117, P149; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Volker A, 2001, J CELL SCI, V114, P3001; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	30	181	194	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					488	U10		10.1038/nature05967	http://dx.doi.org/10.1038/nature05967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653190	Green Published			2022-12-24	WOS:000248302700050
J	Tsai, TT; Evangelista, A; Nienaber, CA; Myrmel, T; Meinhardt, G; Cooper, JV; Smith, DE; Suzuki, T; Fattori, R; Llovet, A; Froehlich, J; Hutchison, S; Distante, A; Sundt, T; Beckman, J; Januzzi, JL; Isselbacher, EM; Eagle, KA				Tsai, Thomas T.; Evangelista, Arturo; Nienaber, Christoph A.; Myrmel, Truls; Meinhardt, Gabriel; Cooper, Jeanna V.; Smith, Dean E.; Suzuki, Toru; Fattori, Rossella; Llovet, Alfredo; Froehlich, James; Hutchison, Stuart; Distante, Alessandro; Sundt, Thoralf; Beckman, Joshua; Januzzi, James L., Jr.; Isselbacher, Eric M.; Eagle, Kim A.		Int Registry Acute Aortic Dissecti	Partial thrombosis of the false lumen in patients with acute type B aortic dissection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRALUMINAL THROMBUS; MANAGEMENT; ANEURYSM; ECHOCARDIOGRAPHY; PROGNOSIS; DIAGNOSIS; THERAPY; ELASTIN; RUPTURE	Background: Patency or thrombosis of the false lumen in type B acute aortic dissection has been found to predict outcomes. The prognostic implications of partial thrombosis of the false lumen have not yet been elucidated. Methods: We examined 201 patients with type B acute aortic dissection who were enrolled in the International Registry of Acute Aortic Dissection between 1996 and 2003 and who survived to hospital discharge. Kaplan-Meier mortality curves were stratified according to the status of the false lumen (patent, partial thrombosis, or complete thrombosis) as determined during the index hospitalization. Cox proportional-hazards analysis was performed to identify independent predictors of death. Results: During the index hospitalization, 114 patients (56.7%) had a patent false lumen, 68 patients (33.8%) had partial thrombosis of the false lumen, and 19 (9.5%) had complete thrombosis of the false lumen. The mean (+/-SD) 3-year mortality rate for patients with a patent false lumen was 13.7+/-7.1%, for those with partial thrombosis was 31.6+/-12.4%, and for those with complete thrombosis was 22.6+/-22.6% (median follow-up, 2.8 years; P=0.003 by the log-rank test). Independent predictors of postdischarge mortality were partial thrombosis of the false lumen (relative risk, 2.69; 95% confidence interval [CI], 1.45 to 4.98; P=0.002), a history of aortic aneurysm (relative risk, 2.05; 95% CI, 1.07 to 3.93; P=0.03), and a history of atherosclerosis (relative risk, 1.87; 95% CI, 1.01 to 3.47; P=0.05). Conclusions: Mortality is high after discharge from the hospital among patients with type B acute aortic dissection. Partial thrombosis of the false lumen, as compared with complete patency, is a significant independent predictor of postdischarge mortality in these patients.	Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; Hosp Gen Univ Vall dHebron, Barcelona, Spain; Univ Rostock, Rostock, Germany; Univ Tromso Hosp, N-9012 Tromso, Norway; Robert Bosch Krankenhaus, Stuttgart, Germany; Univ Tokyo, Tokyo, Japan; Univ Hosp S Orsola, Bologna, Italy; Hosp Univ 12 Octubre, Madrid, Spain; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; CNR, Lecce, Italy; Mayo Clin, Rochester, MN USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Michigan System; University of Michigan; Hospital Universitari Vall d'Hebron; University of Rostock; UiT The Arctic University of Tromso; University Hospital of North Norway; Bosch; Robert Bosch Krankenhaus; University of Tokyo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Hospital Universitario 12 de Octubre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Consiglio Nazionale delle Ricerche (CNR); Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Tsai, TT (corresponding author), Univ Michigan, Ctr Cardiovasc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hsianshi@umich.edu	Januzzi, James/Y-2436-2019; Fattori, Rossella/L-1017-2016; Beckman, Joshua/A-7537-2016	DISTANTE, Alessandro/0000-0003-2776-0192; Beckman, Joshua/0000-0001-8332-8439	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NHLBI NIH HHS [5T32HL007853-08] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akutsu K, 2004, EUR J CARDIO-THORAC, V26, P359, DOI 10.1016/j.ejcts.2004.03.026; Bernard Y, 2001, AM J CARDIOL, V87, P1378, DOI 10.1016/S0002-9149(01)01556-9; Carmo M, 2002, EUR J VASC ENDOVASC, V23, P543, DOI 10.1053/ejvs.2002.1620; Chung JW, 2000, RADIOLOGY, V214, P87, DOI 10.1148/radiology.214.1.r00ja3287; Daily P O, 1970, Ann Thorac Surg, V10, P237; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DINSMORE RE, 1972, RADIOLOGY, V105, P567, DOI 10.1148/105.3.567; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; Ehrlich M, 1998, CIRCULATION, V98, pII294; Elefteriades JA, 1999, ANN THORAC SURG, V67, P2002, DOI 10.1016/S0003-4975(99)00428-2; ERBEL R, 1989, LANCET, V1, P457; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; ERGIN MA, 1994, ANN THORAC SURG, V57, P820, DOI 10.1016/0003-4975(94)90182-1; GLOWER DD, 1991, ANN SURG, V214, P31; Gysi J, 1997, EUR J CARDIO-THORAC, V11, P1163, DOI 10.1016/S1010-7940(97)00091-2; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HAVERICH A, 1985, CIRCULATION, V72, P22; Juvonen T, 1999, J THORAC CARDIOV SUR, V117, P776, DOI 10.1016/S0022-5223(99)70299-0; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Lansman SL, 1999, ANN THORAC SURG, V67, P1975, DOI 10.1016/S0003-4975(99)00419-1; Marui A, 1999, CIRCULATION, V100, P275; MASUDA Y, 1991, CIRCULATION, V84, P7; Mehta RH, 2002, J AM COLL CARDIOL, V40, P685, DOI 10.1016/S0735-1097(02)02005-3; MOHRKAHALY S, 1989, CIRCULATION, V80, P24, DOI 10.1161/01.CIR.80.1.24; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Parodi JC, 2001, J VASC SURG, V34, P909, DOI 10.1067/mva.2001.119038; Pretre R, 1997, LANCET, V349, P1461, DOI 10.1016/S0140-6736(96)09372-5; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Satta J, 1998, EUR J VASC ENDOVASC, V15, P313, DOI 10.1016/S1078-5884(98)80034-8; Schor JS, 1996, ANN THORAC SURG, V61, P1339, DOI 10.1016/0003-4975(96)00105-1; Sesso HD, 2000, AM J EPIDEMIOL, V152, P107, DOI 10.1093/aje/152.2.107; Sueyoshi E, 2004, CIRCULATION, V110, pII256, DOI 10.1161/01.CIR.0000138386.48852.b6; Umana JP, 2002, J THORAC CARDIOV SUR, V124, P896, DOI 10.1067/mtc.2002.123131; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Williams DM, 1997, RADIOLOGY, V203, P37, DOI 10.1148/radiology.203.1.9122414; WOLF YG, 1994, J VASC SURG, V20, P529, DOI 10.1016/0741-5214(94)90277-1; WOLF YG, 1995, J VASC SURG, V21, P499, DOI 10.1016/S0741-5214(95)70293-8	37	466	495	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					349	359		10.1056/NEJMoa063232	http://dx.doi.org/10.1056/NEJMoa063232			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652650				2022-12-24	WOS:000248283500006
J	Nordestgaard, BG; Benn, M; Schnohr, P; Tybjaerg-Hansen, A				Nordestgaard, Borge G.; Benn, Marianne; Schnohr, Peter; Tybjaerg-Hansen, Anne			Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; LIPASE GENE; FOLLOW-UP; MUTATIONS; PLASMA; RABBITS; ATHEROGENESIS	Context Elevated nonfasting triglycerides indicate the presence of remnant lipoproteins, which may promote atherosclerosis. Objective To test the hypothesis that very high levels of nonfasting triglycerides predict myocardial infarction (MI), ischemic heart disease (IHD), and death. Design, Setting, and Participants A prospective cohort study of 7587 women and 6394 men from the general population of Copenhagen, Denmark, aged 20 to 93 years, followed up from baseline (1976-1978) until 2004. Main Outcome Measures Hazard ratios (HRs) for incident MI, IHD, and total death according to baseline nonfasting triglyceride level categories of 1 to 1.99 mmol/L (88.5-176.1 mg/dL), 2 to 2.99 mmol/L (177.0-264.6 mg/dL), 3 to 3.99 mmol/L (265.5-353.0 mg/dL), 4 to 4.99 mmol/L (354.0-441.6 mg/dL), and 5 mmol/L or more (>= 442.5 mg/dL) vs triglyceride levels of less than 1 mmol/L (<88.5 mg/dL). Results With increasing levels of nonfasting triglycerides, levels of remnant lipoprotein cholesterol increased. During a mean follow-up of 26 years, 1793 participants (691 women and 1102 men) developed MI, 3479 (1567 women and 1912 men) developed IHD, and 7818 (3731 women and 4087 men) died. For MI, among women, the age-adjusted HRs and multifactorially adjusted HRs (aHRs) for each respective category per 1-mmol/L increase in nonfasting triglyceride levels were 2.2 (aHR, 1.7), 4.4 (aHR, 2.5), 3.9 (aHR, 2.1), 5.1 (aHR, 2.4), and 16.8 (aHR, 5.4); for both, P for trend < .001. For MI, among men, the values were 1.6 (aHR, 1.4), 2.3 (aHR, 1.6), 3.6 (aHR, 2.3), 3.3 (aHR, 1.9), and 4.6 (aHR, 2.4); for both, P for trend < .001. For IHD, among women, the values were 1.7 (aHR, 1.4), 2.8 (aHR, 1.8), 3.0 (aHR, 1.8), 2.1 (aHR, 1.2), and 5.9 (aHR, 2.6); for both, P for trend < .001. For IHD, among men, the values were 1.3 (aHR, 1.1), 1.7 (aHR, 1.3), 2.1 (aHR, 1.3), 2.0 (aHR, 1.2), and 2.9 (aHR, 1.5); P for trend < .001 for age-adjusted and P for trend = .03 for multifactorially adjusted. For total death, among women, the values were 1.3 (aHR, 1.3), 1.7 (aHR, 1.6), 2.2 (aHR, 2.2), 2.2 (aHR, 1.9), and 4.3 (aHR, 3.3); for both, P for trend < .001. For total death, among men, the values were 1.3 (aHR, 1.2), 1.4 (aHR, 1.4), 1.7 (aHR, 1.5), 1.8 (aHR, 1.6), and 2.0 (aHR, 1.8); for both, P for trend < .001. Conclusion In this general population cohort, elevated nonfasting triglyceride levels were associated with increased risk of MI, IHD, and death in men and women.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Bispebjerg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@heh.regionh.dk	Adiels, Martin/C-9278-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Benn, Marianne/O-4164-2019; Gonzalez, Javier T/K-6910-2014	Benn, Marianne/0000-0002-1701-595X; Gonzalez, Javier T/0000-0002-9939-0074; Nordestgaard, Borge/0000-0002-1954-7220				Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; Benn M, 2007, ARTERIOSCL THROM VAS, V27, P661, DOI 10.1161/01.ATV.0000255580.73689.8e; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COHN JS, 1988, J LIPID RES, V29, P925; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hokanson JE, 1999, CURR OPIN LIPIDOL, V10, P393, DOI 10.1097/00041433-199910000-00003; Hokanson JE, 2002, DIABETES, V51, P1208, DOI 10.2337/diabetes.51.4.1208; Julian DG, 1997, EUR HEART J, V18, P394; Kofoed SC, 2002, J VASC SURG, V36, P783, DOI 10.1067/mva.2002.126552; Kolovou GD, 2005, CURR MED CHEM, V12, P1931, DOI 10.2174/0929867054546609; Mahley RW., 2001, METABOLIC MOL BASES, V8th ed, P2835; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rutledge JC, 2000, CIRC RES, V86, P768, DOI 10.1161/01.RES.86.7.768; Sarti C, 2006, J DIABETES COMPLICAT, V20, P121, DOI 10.1016/j.jdiacomp.2005.06.014; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; STENSVOLD I, 1993, BMJ-BRIT MED J, V307, P1318, DOI 10.1136/bmj.307.6915.1318; Wittrup HH, 1997, J CLIN INVEST, V99, P1606, DOI 10.1172/JCI119323; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	36	1506	1559	3	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2007	298	3					299	308		10.1001/jama.298.3.299	http://dx.doi.org/10.1001/jama.298.3.299			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190US	17635890				2022-12-24	WOS:000248086700024
J	Ameres, SL; Martinez, J; Schroeder, R				Ameres, Stefan Ludwig; Martinez, Javier; Schroeder, Renee			Molecular basis for target RNA recognition and cleavage by human RISC	CELL			English	Article							INFLUENCES SIRNA EFFICACY; DOUBLE-STRANDED-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; PASSENGER-STRAND; INTERFERENCE; ARGONAUTE2; MICRORNA; PROTEIN; GENE	The RNA- Induced Silencing Complex ( RISC) is a ribonucleoprotein particle composed of a single- stranded short interfering RNA ( siRNA) and an endonucleolytically active Argonaute protein, capable of cleaving mRNAs complementary to the siRNA. The mechanism by which RISC cleaves a target RNA is well understood, however it remains enigmatic how RISC finds its target RNA. Here, we show, both in vitro and in vivo, that the accessibility of the target site correlates directly with the efficiency of cleavage, demonstrating that RISC is unable to unfold structured RNA. In the course of target recognition, RISC transiently contacts single-stranded RNA nonspecifically and promotes siRNA- target RNA annealing. Furthermore, the 50 part of the siRNA within RISC creates a thermodynamic threshold that determines the stable association of RISC and the target RNA. We therefore provide mechanistic insights by revealing features of RISC and target RNAs that are crucial to achieve efficiency and specificity in RNA interference.	Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; renee.schroeder@univie.ac.at	Ameres, Stefan Ludwig/B-4046-2012; Ameres, Stefan/G-3775-2010	Ameres, Stefan Ludwig/0000-0002-8248-3098; Martinez, Javier/0000-0001-9152-7323				Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boese Q, 2005, METHOD ENZYMOL, V392, P73, DOI 10.1016/S0076-6879(04)92005-8; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen GL, 2005, DIFFERENTIATION, V73, P287, DOI 10.1111/j.1432-0436.2005.00029.x; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	379	416	3	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					101	112		10.1016/j.cell.2007.04.037	http://dx.doi.org/10.1016/j.cell.2007.04.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632058	Bronze			2022-12-24	WOS:000248587000014
J	Teklehaimanot, A; Sachs, JD; Curtis, C				Teklehaimanot, Awash; Sachs, Jeffrey D.; Curtis, Chris			Malaria control needs mass distribution of insecticidal bednets	LANCET			English	Editorial Material							TREATED BEDNETS; CHILD-MORTALITY; NETS; TRANSMISSION; INFECTION; MORBIDITY; MOSQUITOS; COVERAGE; DISTRICT; IMPACT		Columbia Univ, Earth Inst, Ctr Global Hlth & Econ Dev, New York, NY 10025 USA; London Sch Hyg & Trop Med, London WC1, England	Columbia University; University of London; London School of Hygiene & Tropical Medicine	Teklehaimanot, A (corresponding author), Columbia Univ, Earth Inst, Ctr Global Hlth & Econ Dev, New York, NY 10025 USA.	at2076@columbia.edu						[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Cham MK, 1997, HEALTH POLICY PLANN, V12, P240, DOI 10.1093/heapol/12.3.240; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P846, DOI 10.1046/j.1365-3156.2002.00929.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Snow RW, 1999, HEALTH POLICY PLANN, V14, P18, DOI 10.1093/heapol/14.1.18; Soremekun S, 2004, TROP MED INT HEALTH, V9, P664, DOI 10.1111/j.1365-3156.2004.01250.x; TEKLEHAIMANOT A, IN PRESS AM J TROP M; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; Whitworth JAG, 2005, LANCET, V365, P196; *WORK GROUP MAL, 2005, COM GRIPS MAL NEW MI	23	86	88	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2007	369	9580					2143	2146		10.1016/S0140-6736(07)60951-9	http://dx.doi.org/10.1016/S0140-6736(07)60951-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LX	17597200				2022-12-24	WOS:000247644200009
J	Blow, N				Blow, Nathan			Antibodies: The generation game	NATURE			English	Editorial Material																			0	32	36	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					741	+		10.1038/447741a	http://dx.doi.org/10.1038/447741a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554312	Bronze			2022-12-24	WOS:000247030700049
J	Colell, A; Ricci, JE; Tait, S; Milasta, S; Maurer, U; Bouchier-Hayes, L; Fitzgerald, P; Guio-Carrion, A; Waterhouse, NJ; Li, CW; Mari, B; Barbry, P; Newmeyer, DD; Beere, HM; Green, DR				Colell, Anna; Ricci, Jean-Ehrland; Tait, Stephen; Milasta, Sandra; Maurer, Ulrich; Bouchier-Hayes, Lisa; Fitzgerald, Patrick; Guio-Carrion, Ana; Waterhouse, Nigel J.; Li, Cindy Wei; Mari, Bernard; Barbry, Pascal; Newmeyer, Donald D.; Beere, Helen M.; Green, Douglas R.			GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation	CELL			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; CELL-DEATH; MITOCHONDRIAL-FUNCTION; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; PROSTATE-CANCER; MEMBRANE-FUSION; OVARIAN-CANCER; BREAST-CANCER; ACTINOMYCIN-D	In cells undergoing apoptosis, mitochondrial outer-membrane permeabilization (MOMP) is followed by paspase activation promoted by released cytochrome c. Although caspases mediate the apoptotic phenotype, caspase inhibition is generally not sufficient for survival following MOMP; instead cells undergo a "caspase-independent cell death" (CICD). Thus, MOMP may represent a point of commitment to cell death. Here, we identify glyceraidehyde-3-phosphate dehydrogenase (GAPDH) as a critical regulator of CICD. GAPDH-expressing cells preserved their clonogenic potential following MOMP, provided that caspase activation was blocked. GAPDHmediated protection of cells from CICD involved an elevation in glycolysis and a nuclear function that correlated with and was replaced by an increase in Atg12 expression. Consistent with this, protection from CICD reflected an increase in and a dependence upon autophagy, associated with a transient decrease in mitochondrial mass. Therefore, GAPDH mediates an elevation in glycolysis and enhanced autophagy that cooperate to protect cells from CICD.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; CSIC, IDIBAPS, Dept Cell Death & Proliferat, IIBB, Barcelona 08036, Spain; Univ Nice Sophia Antipolis, Inserm U526, Equipe Avenir, IFR 50,Fac Med, F-06107 Nice, France; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia; Univ Melbourne, Dept Pathol, Melbourne, Vic 8006, Australia; Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France	St Jude Children's Research Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Freiburg; La Jolla Institute for Immunology; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Mari, Bernard P/D-7445-2015; Colell, Anna/N-8710-2014; RICCI, Jean Ehrland/AAS-4379-2020; Mari, Bernard P/GVS-3100-2022; Mari, Bernard/Q-5832-2019; Bouchier-Hayes, Lisa/T-9491-2019; Green, Douglas R/N-8083-2018; Mari, Bernard P/F-8960-2013; Barbry, Pascal/O-5021-2016; Ricci, Jean Ehrland/I-7117-2016; Waterhouse, Nigel/I-9813-2016	Mari, Bernard P/0000-0002-0422-9182; Colell, Anna/0000-0001-5236-1834; RICCI, Jean Ehrland/0000-0003-1585-8117; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Green, Douglas R/0000-0002-7332-1417; Mari, Bernard P/0000-0002-0422-9182; Barbry, Pascal/0000-0001-9632-6483; Ricci, Jean Ehrland/0000-0003-1585-8117; Tait, Stephen/0000-0001-7697-132X; Guio-Carrion, Ana/0000-0002-8963-4389	NIAID NIH HHS [AI40646] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dastoor Z, 2001, J CELL SCI, V114, P1643; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneda M, 1997, J BIOCHEM-TOKYO, V122, P1233; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu JR, 2002, CANCER RES, V62, P924; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; Onishi M, 1996, EXP HEMATOL, V24, P324; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rondinelli RH, 1997, PROSTATE CANCER P D, V1, P66, DOI 10.1038/sj.pcan.4500208; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; SAWICKI SG, 1972, J CELL BIOL, V55, P299, DOI 10.1083/jcb.55.2.299; SCHEK N, 1988, CANCER RES, V48, P6354; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Yang W, 2003, BRIT J PHARMACOL, V140, P402, DOI 10.1038/sj.bjp.0705450; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	61	401	421	1	44	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					983	997		10.1016/j.cell.2007.03.045	http://dx.doi.org/10.1016/j.cell.2007.03.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540177	Bronze			2022-12-24	WOS:000247084600017
J	Stewart, AJ; Schmidt, MW; van Westrenen, W; Liebske, C				Stewart, Andrew J.; Schmidt, Max W.; van Westrenen, Wim; Liebske, Christian			Mars: A new core-crystallization regime	SCIENCE			English	Article							THERMAL EVOLUTION; HIGH-PRESSURE; INNER-CORE; DYNAMO; INTERIOR; EQUATION; SULFUR; POINT; STATE; MODEL	The evolution of the martian core is widely assumed to mirror the characteristics observed for Earth's core. Data from experiments performed on iron-sulfur and iron-nickel-sulfur systems at pressures corresponding to the center of Mars indicate that its core is presently completely liquid and that it will not form an outwardly crystallizing iron-rich inner core, as does Earth. Instead, planetary cooling will lead to core crystallization following either a "snowing-core" model, whereby iron-rich solids nucleate in the outer portions of the core and sink toward the center, or a "sulfide inner-core" model, where an iron-sulfide phase crystallizes to form a solid inner core.	ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vrije Universiteit Amsterdam	Schmidt, MW (corresponding author), ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland.	max.schmidt@erdw.ethz.ch	Schmidt, Max/A-1676-2008; van Westrenen, Wim/D-6495-2012	van Westrenen, Wim/0000-0001-5828-8885; Schmidt, Max W./0000-0002-3870-5781				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Balog PS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001646; Bertka CM, 1997, J GEOPHYS RES-SOL EA, V102, P5251, DOI 10.1029/96JB03270; BESSON JM, 1990, J GEOPHYS RES-SOLID, V95, P21717, DOI 10.1029/JB095iB13p21717; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Fei YW, 2005, SCIENCE, V308, P1120, DOI 10.1126/science.1110531; Fei YW, 2000, AM MINERAL, V85, P1830; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Hauck SA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002557; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; Ito E, 1998, GEOPHYS RES LETT, V25, P821, DOI 10.1029/98GL00519; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Li J, 2001, EARTH PLANET SC LETT, V193, P509, DOI 10.1016/S0012-821X(01)00521-0; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Sakuraba A, 1999, PHYS EARTH PLANET IN, V111, P105, DOI 10.1016/S0031-9201(98)00150-2; Sanloup C, 1999, PHYS EARTH PLANET IN, V112, P43, DOI 10.1016/S0031-9201(98)00175-7; Sanloup C, 2000, GEOPHYS RES LETT, V27, P811, DOI 10.1029/1999GL008431; Seagle CT, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004091; Sohl F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002520; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Von Platen B., 1962, MODERN VERY HIGH PRE, P118; WALKER D, 1991, AM MINERAL, V76, P1092; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Williams JP, 2004, GEOLOGY, V32, P97, DOI 10.1130/G19975.1; Yoder CF, 2003, SCIENCE, V300, P299, DOI 10.1126/science.1079645	28	161	164	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1323	1325		10.1126/science.1140549	http://dx.doi.org/10.1126/science.1140549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540900				2022-12-24	WOS:000246885600046
J	Deindl, S; Kadlecek, TA; Brdicka, T; Cao, XX; Weiss, A; Kuriyan, J				Deindl, Sebastian; Kadlecek, Theresa A.; Brdicka, Tomas; Cao, Xiaoxian; Weiss, Arthur; Kuriyan, John			Structural basis for the inhibition of tyrosine kinase activity of ZAP-70	CELL			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; GROWTH-FACTOR RECEPTOR; CRYSTAL-STRUCTURE; ZETA-CHAIN; T-CELLS; C-SRC; 3-DIMENSIONAL STRUCTURE; ADAPTER PROTEIN; INTERDOMAIN B	ZAP-70, a cytoplasmic tyrosine kinase required for T cell antigen receptor signaling, is controlled by a regulatory segment that includes a tandem SH2 unit responsible for binding to immunoreceptor tyrosine-based activation motifs (ITAMs). The crystal structure of autoinhibited ZAP-70 reveals that the inactive kinase domain adopts a conformation similar to that of cyclin-dependent kinases and Src kinases. The auto-inhibitory mechanism of ZAP-70 is, however, distinct and involves interactions between the regulatory segment and the hinge region of the kinase domain that reduce its flexibility. Two tyrosine residues in the SH2-kinase linker that activate ZAP-70 when phosphorylated are involved in aromatic-aromatic interactions that connect the linker to the kinase domain. These interactions are inconsistent with ITAM binding, suggesting that destabilization of this autoinhibited ZAP-70 conformation is the first step in kinase activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA.	aweiss@medicine.ucsf.edu; kuriyan@berkeley.edu	Brdicka, Tomas/G-6205-2014; Cao, Xiaoxian/C-9333-2019	Brdicka, Tomas/0000-0002-1560-4398; Cao, Xiaoxian/0000-0001-9097-6231; Kadlecek, Theresa/0000-0002-1020-8169; Deindl, Sebastian/0000-0001-6807-8654				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Di Bartolo V, 2002, EUR J IMMUNOL, V32, P568; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Gong Q, 2001, J EXP MED, V194, P507, DOI 10.1084/jem.194.4.507; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Magnan A, 2001, J EXP MED, V194, P491, DOI 10.1084/jem.194.4.491; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu JJ, 1997, APPL PHYS LETT, V70, P185, DOI 10.1063/1.118352; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao QH, 1999, MOL CELL BIOL, V19, P948	47	177	181	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					735	746		10.1016/j.cell.2007.03.039	http://dx.doi.org/10.1016/j.cell.2007.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512407	Bronze			2022-12-24	WOS:000246788300018
J	Yuzawa, S; Opatowsky, Y; Zhang, ZT; Mandiyan, V; Lax, I; Schlessinger, J				Yuzawa, Satoru; Opatowsky, Yarden; Zhang, Zhongtao; Mandiyan, Valsan; Lax, Irit; Schlessinger, Joseph			Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor	CELL			English	Article							C-KIT; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; BIVALENT BINDING; LIGAND-BINDING; DIMERIZATION; ADHESION; DOMAIN; PIEBALDISM; PROTEIN	Stem Cell Factor (SCF) initiates its multiple cellular responses by binding to the ectodomain of KIT, resulting in tyrosine kinase activation. We describe the crystal structure of the entire ectodomain of KIT before and after SCF stimulation. The structures show that KIT dimerization is driven by SCF binding whose sole role is to bring two KIT molecules together. Receptor dimerization is followed by conformational changes that enable lateral interactions between membrane proximal Ig-like domains D4 and D5 of two KIT molecules. Experiments with cultured cells show that KIT activation is compromised by point mutations in amino acids critical for D4-D4 interaction. Moreover, a variety of oncogenic mutations are mapped to the D5-D5 interface. Since key hallmarks of KIT structures, ligand-induced receptor dimerization, and the critical residues in the D4-D4 interface, are conserved in other receptors, the mechanism of KIT stimulation unveiled in this report may apply for other receptor activation.	New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	New York Medical College; Yale University	Schlessinger, J (corresponding author), New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA.	joseph.schlessinger@yale.edu		zhang, zhongtao/0000-0002-1910-4753; Yuzawa, Satoru/0000-0002-1031-5781	NIAMS NIH HHS [AR 051886, AR 051448, P50 AR 054086] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448, R01AR051886, P50AR054086] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BESMER P, 1986, J VIROL, V60, P194, DOI 10.1128/JVI.60.1.194-203.1986; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fleischman RA, 1996, J INVEST DERMATOL, V107, P703, DOI 10.1111/1523-1747.ep12365596; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Hsu YR, 1998, BIOCHEMISTRY-US, V37, P2251, DOI 10.1021/bi972372z; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEV S, 1992, J BIOL CHEM, V267, P15970; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Murakami T, 2005, J INVEST DERMATOL, V124, P670, DOI 10.1111/j.0022-202X.2005.23637.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILO JS, 1996, KIT J BIOL CHEM, V271, P6895; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732	35	238	262	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					323	334		10.1016/j.cell.2007.05.055	http://dx.doi.org/10.1016/j.cell.2007.05.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662946	Bronze			2022-12-24	WOS:000248588000021
J	Taguchi, A; Wartschow, LM; White, MF				Taguchi, Akiko; Wartschow, Lynn M.; White, Morris F.			Brain IRS2 signaling coordinates life span and nutrient homeostasis	SCIENCE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; DISRUPTION; EXTENSION; LONGEVITY; GROWTH; MICE	Reduced insulin-like signaling extends the life span of Caenorhabditis elegans and Drosophila. Here, we show that, in mice, less insulin receptor substrate-2 (Irs2) signaling throughout the body or just in the brain extended life span up to 18%. At 22 months of age, brain-specific Irs2 knockout mice were overweight, hyperinsulinemic, and glucose intolerant; however, compared with control mice, they were more active and displayed greater glucose oxidation, and during meals they displayed stable superoxide dismutase-2 concentrations in the hypothalamus. Thus, less Irs2 signaling in aging brains can promote healthy metabolism, attenuate meal-induced oxidative stress, and extend the life span of overweight and insulin-resistant mice.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Div Endocrinol,Childrens Hosp Boston, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu	Gimenez, Luis E Diaz/D-9291-2011		NIDDK NIH HHS [DK55326, DK38712] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK038712, R01DK055326, R29DK038712, R01DK038712] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbieri M, 2003, EXP GERONTOL, V38, P137, DOI 10.1016/S0531-5565(02)00153-5; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kabil H, 2007, BIOGERONTOLOGY, V8, P201, DOI 10.1007/s10522-006-9065-3; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Miller RA, 2005, J AM GERIATR SOC, V53, pS284, DOI 10.1111/j.1532-5415.2005.53490.x; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Wang Y, 2006, PHYSIOL GENOMICS, V27, P131, DOI 10.1152/physiolgenomics.00239.2005; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	23	407	436	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					369	372		10.1126/science.1142179	http://dx.doi.org/10.1126/science.1142179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641201	Green Submitted			2022-12-24	WOS:000248150200046
J	Steinbrook, R				Steinbrook, Robert			Organ donation after cardiac death	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; DeVita M A, 2001, Prog Transplant, V11, P58; DuBois JM, 2006, CRIT CARE MED, V34, P3045, DOI 10.1097/01.CCM.0000248525.53130.57; *I MED, 2006, ORG DON OPP ACT; Mandell MS, 2006, CRIT CARE MED, V34, P2952, DOI 10.1097/01.CCM.0000247718.27324.65	5	149	158	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2007	357	3					209	213		10.1056/NEJMp078066	http://dx.doi.org/10.1056/NEJMp078066			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	191FH	17634455				2022-12-24	WOS:000248115100001
J	Poole, A; Penny, D				Poole, Anthony; Penny, David			Engulfed by speculation	NATURE			English	Editorial Material							EUKARYOTES; ORIGIN		Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden; Massey Univ, Inst Mol Biosci, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Stockholm University; Massey University	Poole, A (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden.		Penny, David/E-9410-2011	Poole, Anthony/0000-0001-9940-2824				Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Pace NR, 2006, NATURE, V441, P289, DOI 10.1038/441289a; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440	5	47	50	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					913	913		10.1038/447913a	http://dx.doi.org/10.1038/447913a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581566				2022-12-24	WOS:000247373100026
J	Wadman, M				Wadman, Meredith			Anaemic outlook for Amgen	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					899	899		10.1038/447899a	http://dx.doi.org/10.1038/447899a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581554	Bronze			2022-12-24	WOS:000247373100012
J	Himmelfarb, J				Himmelfarb, Jonathan			Chronic kidney disease and the public health - Gaps in evidence from interventional trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STAGE RENAL-DISEASE; RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; PERITONEAL-DIALYSIS; UNITED-STATES; HEMODIALYSIS; ASSOCIATION; OUTCOMES; MORTALITY		Maine Med Ctr, Div Nephrol, Portland, ME 04102 USA	Maine Medical Center	Himmelfarb, J (corresponding author), Maine Med Ctr, Div Nephrol, 22 Bramhall St, Portland, ME 04102 USA.	himmej@mmc.org						Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Califf RM, 2007, HEALTH AFFAIR, V26, P62, DOI 10.1377/hlthaff.26.1.62; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Coyne DW, 2007, JAMA-J AM MED ASSOC, V297, P1713, DOI 10.1001/jama.297.15.1713; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greene T, 2005, J AM SOC NEPHROL, V16, P3371, DOI 10.1681/ASN.2005030321; Himmelfarb J, 2007, ANNU REV MED, V58, P387, DOI 10.1146/annurev.med.58.061705.151442; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; Rocco MV, 2006, ANN INTERN MED, V145, P512, DOI 10.7326/0003-4819-145-7-200610030-00009; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schoolwerth Anton C, 2006, Prev Chronic Dis, V3, pA57; Shlipak M, 2005, J AM SOC NEPHROL, V16, P3477, DOI 10.1681/ASN.2005080806; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; White CA, 2007, KIDNEY INT, V71, P312, DOI 10.1038/sj.ki.5002037	25	45	47	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2630	2633		10.1001/jama.297.23.2630	http://dx.doi.org/10.1001/jama.297.23.2630			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579231				2022-12-24	WOS:000247352600026
J	Li, W; Baker, NE				Li, Wei; Baker, Nicholas E.			Engulfment is required for cell competition	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; CORPSE ENGULFMENT; WING DISK; DROSOPHILA; DEATH; PHAGOCYTOSIS; CLEARANCE; GENES	Genetic mosaics that place cells in competition within tissues may model features of tissue repair and tumor development and may reveal mechanisms of growth regulation. In one example, normal cells eliminate "Minute" cells that have reduced ribosomal protein gene dose and grow at their expense, replacing the Minute cells within developing compartments. We describe genes that are required by wild-type cells to kill Minute neighbors in Drosophila. The engulfment genes draper, wasp, the phosphatidylserine receptor, mbc/dock180, and rac1 are needed in wild-type cells for the death of Minute neighbors, whose corpses are engulfed by wild-type cells. Wild-type cells can themselves be killed by cells with elevated engulfing activity. Thus engulfment genes act downstream of growth differences between cells to eliminate cells with reduced ribosomal gene dose.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nbaker@aecom.yu.edu		Li, Wei/0000-0001-5696-4309	NIGMS NIH HHS [R01 GM061230, GM61230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; BAKER BS, 1983, ANNU REV GENET, V17, P345, DOI 10.1146/annurev.ge.17.120183.002021; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; BORING LF, 1989, DEV BIOL, V132, P343, DOI 10.1016/0012-1606(89)90231-5; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cohen Stephen M., 1993, P747; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Firth LC, 2006, METHOD ENZYMOL, V407, P711, DOI 10.1016/S0076-6879(05)07056-4; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; FRISTROM D, 1969, MOL GEN GENET, V103, P363, DOI 10.1007/BF00383486; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	63	173	176	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1215	1225		10.1016/j.cell.2007.03.054	http://dx.doi.org/10.1016/j.cell.2007.03.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574031	Bronze			2022-12-24	WOS:000247390400023
J	Moreau, JW; Weber, PK; Martin, MC; Gilbert, B; Hutcheon, ID; Banfield, JF				Moreau, John W.; Weber, Peter K.; Martin, Michael C.; Gilbert, Benjamin; Hutcheon, Ian D.; Banfield, Jillian F.			Extracellular proteins limit the dispersal of biogenic nanoparticles	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; METAL; RESISTANCE; ZINC; ION; CONTAMINATION; GEOCHEMISTRY; AGGREGATION; SPHALERITE; PRODUCTS	High-spatial-resolution secondary ion microprobe spectrometry, synchrotron radiation-based Fourier-transform infrared spectroscopy, and polyacrylamide gel analysis demonstrated the intimate association of proteins with spheroidal aggregates of biogenic zinc sulfide nanocrystals, an example of extracellular biomineralization. Experiments involving synthetic zinc sulfide nanoparticles and representative amino acids indicated a driving role for cysteine in rapid nanoparticle aggregation. These findings suggest that microbially derived extracellular proteins can limit the dispersal of nanoparticulate metal-bearing phases, such as the mineral products of bioremediation, that may otherwise be transported away from their source by subsurface fluid flow.	Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Moreau, JW (corresponding author), US Geol Survey, Div Water Resources, Middleton, WI 53562 USA.	jwmoreau@usgs.gov	Weber, Peter Kilian/AAP-9517-2020; Gilbert, Benjamin/E-3182-2010; 1.4, ALS Beamline/I-1886-2014; Moreau, John/A-8061-2013; Martin, Michael C./ABH-9841-2020	Weber, Peter Kilian/0000-0001-6022-6050; Martin, Michael C./0000-0002-6611-070X; Moreau, John W/0000-0002-5997-522X; Banfield, Jill/0000-0001-8203-8771; Gilbert, Benjamin/0000-0003-0853-0826				Ahn JS, 2005, ENVIRON GEOCHEM HLTH, V27, P147, DOI 10.1007/s10653-005-0121-8; Allain C, 1996, J COLLOID INTERF SCI, V178, P411, DOI 10.1006/jcis.1996.0135; Barkay T, 2001, CURR OPIN MICROBIOL, V4, P318, DOI 10.1016/S1369-5274(00)00210-1; Bebie J., 2000, GEOCHEM T, V1, P47, DOI DOI 10.1186/1467-4866-1-47; Blindauer CA, 2001, P NATL ACAD SCI USA, V98, P9593, DOI 10.1073/pnas.171120098; Bradford SA, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001340; Bridge TAM, 1999, MICROBIOL-SGM, V145, P2987, DOI 10.1099/00221287-145-10-2987; Diallo MS, 2005, J NANOPART RES, V7, P325, DOI 10.1007/s11051-005-8543-x; Hauri EH, 2002, CHEM GEOL, V185, P149, DOI 10.1016/S0009-2541(01)00400-4; HERING JG, 1990, REV MINERAL, V23, P427; Hochella MF, 2002, GEOCHIM COSMOCHIM AC, V66, P735, DOI 10.1016/S0016-7037(01)00868-7; Hockin SL, 2003, APPL ENVIRON MICROB, V69, P7063, DOI 10.1128/AEM.69.12.7063-7072.2003; Honeyman BD, 1999, NATURE, V397, P23, DOI 10.1038/16150; KHAZAELI MB, 1981, APPL ENVIRON MICROB, V41, P46, DOI 10.1128/AEM.41.1.46-50.1981; Kloepfer JA, 2005, APPL ENVIRON MICROB, V71, P2548, DOI 10.1128/AEM.71.5.2548-2557.2005; KUREK E, 1991, ARCH ENVIRON CON TOX, V21, P106, DOI 10.1007/BF01055564; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4; Lu QY, 2002, NANOTECHNOLOGY, V13, P741, DOI 10.1088/0957-4484/13/6/309; Luther GW, 1999, GEOCHIM COSMOCHIM AC, V63, P3159, DOI 10.1016/S0016-7037(99)00243-4; Mantsch H. H., 1996, INFRARED SPECTROSCOP; Moreau JW, 2004, AM MINERAL, V89, P950; Naz N, 2005, APPL ENVIRON MICROB, V71, P4610, DOI 10.1128/AEM.71.8.4610-4618.2005; NIES DH, 1992, J BACTERIOL, V174, P8102, DOI 10.1128/JB.174.24.8102-8110.1992; RONNGREN L, 1991, J COLLOID INTERF SCI, V145, P396, DOI 10.1016/0021-9797(91)90370-N; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; STUMM W, 1996, AQUATIC CHEM CHEM EQ, P400; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Torres-Martinez CL, 1999, NANOTECHNOLOGY, V10, P340, DOI 10.1088/0957-4484/10/3/319; Vogel W, 2000, LANGMUIR, V16, P2032, DOI 10.1021/la9910071; WAYCHUNAS GA, 1990, REV MINERAL GEOCHEM, V44, P105; ZHANG JW, 1990, REV MINERAL, V23, P365	32	214	222	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1600	1603		10.1126/science.1141064	http://dx.doi.org/10.1126/science.1141064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569859	Green Submitted			2022-12-24	WOS:000247239900036
J	Sridhar, VV; Kapoor, A; Zhang, KL; Zhu, JJ; Zhou, T; Hasegawa, PM; Bressan, RA; Zhu, JK				Sridhar, Vaniyambadi V.; Kapoor, Avnish; Zhang, Kangling; Zhu, Jianjun; Zhou, Tao; Hasegawa, Paul M.; Bressan, Ray A.; Zhu, Jian-Kang			Control of DNA methylation and heterochromatic silencing by histone H2B deubiquitination	NATURE			English	Article							ARABIDOPSIS-THALIANA; GLYCOSYLASE/LYASE ROS1; H3 METHYLTRANSFERASE; UBIQUITINATION; PLANTS; CHROMATIN; PATHWAYS; PATTERNS; CLONING	Epigenetic regulation involves reversible changes in DNA-methylation and/or histone modification patterns(1-7). Short interfering RNAs ( siRNAs) can direct DNA methylation and heterochromatic histone modifications, causing sequence-specific transcriptional gene silencing(1,4,8,9). In animals and yeast, histone H2B is known to be monoubiquitinated, and this regulates the methylation of histone H3 ( refs 10, 11). However, the relationship between histone ubiquitination and DNA methylation has not been investigated. Here we show that mutations in an Arabidopsis deubiquitination enzyme, SUP32/UBP26, decrease the dimethylation on lysine 9 of H3, suppress siRNA-directed methylation of DNA and release heterochromatic silencing of transgenes as well as transposons. We found that Arabidopsis histone H2B is monoubiquitinated at lysine 143 and that the levels of ubiquitinated H2B and trimethyl H3 at lysine 4 increase in sup32 mutant plants. SUP32/UBP26 can deubiquitinate H2B, and chromatin immunoprecipitation assays suggest an association between H2B ubiquitination and release of silencing. These data suggest that H2B deubiquitination by SUP32/UBP26 is required for heterochromatic histone H3 methylation and DNA methylation.	Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Mass Spectrometry Facil, Dept Chem, Riverside, CA 92521 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Grieshaber-Bouyer, Ricardo/R-7512-2016; Zhu, Jian-Kang/F-7658-2011; Hu, Ruogu/B-2203-2008	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Zhu, Jian-Kang/0000-0001-5134-731X; 				Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chinnusamy V., 2002, SCI STKE, V140, pPL10; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Rao-Naik C, 2000, ARCH BIOCHEM BIOPHYS, V379, P198, DOI 10.1006/abbi.2000.1874; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	28	184	219	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					735	U18		10.1038/nature05864	http://dx.doi.org/10.1038/nature05864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554311				2022-12-24	WOS:000247030700048
J	Giraud, E; Moulin, L; Vallenet, D; Barbe, V; Cytryn, E; Avarre, JC; Jaubert, M; Simon, D; Cartieaux, F; Prin, Y; Bena, G; Hannibal, L; Fardoux, J; Kojadinovic, M; Vuillet, L; Lajus, A; Cruveiller, S; Rouy, Z; Mangenot, S; Segurens, B; Dossat, C; Franck, WL; Chang, WS; Saunders, E; Bruce, D; Richardson, P; Normand, P; Dreyfus, B; Pignol, D; Stacey, G; Emerich, D; Vermeglio, A; Medigue, C; Sadowsky, M				Giraud, Eric; Moulin, Lionel; Vallenet, David; Barbe, Valerie; Cytryn, Eddie; Avarre, Jean-Christophe; Jaubert, Marianne; Simon, Damien; Cartieaux, Fabienne; Prin, Yves; Bena, Gilles; Hannibal, Laure; Fardoux, Joel; Kojadinovic, Mila; Vuillet, Laurie; Lajus, Aurelie; Cruveiller, Stephane; Rouy, Zoe; Mangenot, Sophie; Segurens, Beatrice; Dossat, Carole; Franck, William L.; Chang, Woo-Suk; Saunders, Elizabeth; Bruce, David; Richardson, Paul; Normand, Philippe; Dreyfus, Bernard; Pignol, David; Stacey, Gary; Emerich, David; Vermeglio, Andre; Medigue, Claudine; Sadowsky, Michael			Legumes symbioses: Absence of Nod genes in photosynthetic bradyrhizobia	SCIENCE			English	Article							RHIZOBIUM-LEGUMINOSARUM; SINORHIZOBIUM-MELILOTI; ROOT-NODULE; MOLECULAR-BASIS; NODULATION; JAPONICUM; GENOME; BACTERIA; AUXOTROPHS; SEQUENCE	Leguminous plants ( such as peas and soybeans) and rhizobial soil bacteria are symbiotic partners that communicate through molecular signaling pathways, resulting in the formation of nodules on legume roots and occasionally stems that house nitrogen-fixing bacteria. Nodule formation has been assumed to be exclusively initiated by the binding of bacterial, host-specific lipochito-oligosaccharidic Nod factors, encoded by the nodABC genes, to kinase-like receptors of the plant. Here we show by complete genome sequencing of two symbiotic, photosynthetic, Bradyrhizobium strains, BTAi1 and ORS278, that canonical nodABC genes and typical lipochito-oligosaccharidic Nod factors are not required for symbiosis in some legumes. Mutational analyses indicated that these unique rhizobia use an alternative pathway to initiate symbioses, where a purine derivative may play a key role in triggering nodule formation.	Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, F-34398 Montpellier 5, France; Genoscope, CNRS, UMR 8030, F-91057 Evry, France; Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; Univ Aix Marseille, CNRS,UMR 6191,CEA Cadarache,Direct Sci Vivant, Inst Biol Environm & Biotechnol,Serv Biol Vegetal, Lab Bioenerget Cellulaire DSV IBEB SBVME LBC, F-13108 St Paul Les Durance, France; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Plant Sci, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Biochem, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Los Alamos Natl Lab, US DOE, Joint Genome Inst, Los Alamos, NM 87545 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Lyon 1, CNRS, UMR 5557, F-69365 Lyon, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Giraud, E (corresponding author), Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, TA A-82-J,Campus Baillarguet, F-34398 Montpellier 5, France.	giraud@mpl.ird.fr; sadowsky@umn.edu	Giraud, Eric/GLS-1036-2022; Moulin, Lionel/C-2921-2008; Normand, Philippe/ABD-2235-2020; Bena, Gilles/GOG-7902-2022; Normand, Philippe/A-1142-2012; Cartieaux, Fabienne/GNH-3617-2022; Sadowsky, Michael/J-2507-2016; Avarre, Jean-Christophe/E-4170-2019	Moulin, Lionel/0000-0001-9068-6912; Normand, Philippe/0000-0002-2139-2141; Bena, Gilles/0000-0003-3080-8441; Vallenet, David/0000-0001-6648-0332; Cartieaux, Fabienne/0000-0002-8992-0131; Sadowsky, Michael/0000-0001-8779-2781; Avarre, Jean-Christophe/0000-0001-6899-7052; PIGNOL, David/0000-0002-8070-0319				Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Chaintreuil C, 2001, FEMS MICROBIOL LETT, V194, P83, DOI 10.1111/j.1574-6968.2001.tb09450.x; Collavino M, 2005, MOL PLANT MICROBE IN, V18, P742, DOI 10.1094/MPMI-18-0742; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DENARIE J, COMMUNICATION; DENARIE J, 1975, SYMBIOTIC NITROGEN F, P47; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Geurts R, 2005, CURR OPIN PLANT BIOL, V8, P346, DOI 10.1016/j.pbi.2005.05.013; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; NEWMAN JD, 1994, J BACTERIOL, V176, P3286, DOI 10.1128/jb.176.11.3286-3294.1994; NOEL KD, 1988, ARCH MICROBIOL, V149, P499, DOI 10.1007/BF00446751; PANKHURST CE, 1974, ARCH MICROBIOL, V100, P219, DOI 10.1007/BF00446319; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Reeve WG, 1999, MICROBIOL-SGM, V145, P1307, DOI 10.1099/13500872-145-6-1307; ROCHE P, 1991, J BIOL CHEM, V266, P10933; SADOWSKY MJ, 1986, ARCH MICROBIOL, V144, P334, DOI 10.1007/BF00409881; Schluter A, 2000, MICROBIOL-SGM, V146, P2987, DOI 10.1099/00221287-146-11-2987; SO JS, 1987, MOL GEN GENET, V207, P15, DOI 10.1007/BF00331485; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; STURTEVANT DB, 1989, PLANT PHYSIOL, V89, P1247, DOI 10.1104/pp.89.4.1247; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; YOUNG JPW, 1991, J BACTERIOL, V173, P2271	41	430	1116	5	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1307	1312		10.1126/science.1139548	http://dx.doi.org/10.1126/science.1139548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540897				2022-12-24	WOS:000246885600042
J	Jayachandran, R; Sundaramurthy, V; Combaluzier, B; Mueller, P; Korf, H; Huygen, K; Miyazaki, T; Albrecht, I; Massner, J; Pieters, J				Jayachandran, Rajesh; Sundaramurthy, Varadharajan; Combaluzier, Benoit; Mueller, Philipp; Korf, Hannelie; Huygen, Kris; Miyazaki, Toru; Albrecht, Imke; Massner, Jan; Pieters, Jean			Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin	CELL			English	Article							GREEN FLUORESCENT PROTEIN; ACTIN-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; INTRACELLULAR SURVIVAL; TUBERCULOSIS; PHAGOCYTOSIS; CHOLESTEROL; INHIBITION; MEMBRANE; DYNAMICS	Pathogenic mycobacteria survive within macrophages by avoiding lysosomal delivery, instead residing in mycobacterial phagosomes. Upon infection, the leukocyte- specific protein coronin 1 is actively recruited to mycobacterial phagosomes, where it blocks lysosomal delivery by an unknown mechanism. Analysis of macrophages from coronin 1- deficient mice showed that coronin 1 is dispensable for Factindependent processes such as phagocytosis, motility, and membrane ruffling. However, upon mycobacterial infection, coronin 1 was required for activation of the Ca2+- dependent phosphatase calcineurin, thereby blocking lysosomal delivery of mycobacteria. In the absence of coronin 1, calcineurin activity did not occur, resulting in lysosomal delivery and killing of mycobacteria. Furthermore, blocking calcineurin activation with cyclosporin A or FK506 led to lysosomal delivery and intracellular mycobacterial killing. These results demonstrate a role for coronin 1 in activating Ca2+ dependent signaling processes in macrophages and reveal a function for calcineurin in the regulation of phagosome- lysosome fusion upon mycobacterial infection.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; WIV Pasteur Inst Brussels, Brussels, Belgium; Univ Tokyo, Tokyo 106, Japan	University of Basel; University of Tokyo	Pieters, J (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50, CH-4056 Basel, Switzerland.	jean.pieters@unibas.ch	Sundaramurthy, Varadharajan/AGK-2349-2022	Sundaramurthy, Varadharajan/0000-0003-2562-8518; Miyazaki, Toru/0000-0003-3842-4362; Pieters, Jean/0000-0002-5284-9757; Huygen, Kris/0000-0001-7808-0512; Korf, Hannelie/0000-0003-3540-0138				Albrecht I, 2006, INT IMMUNOL, V18, P755, DOI 10.1093/intimm/dxl013; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOSLOVER S, 2001, BIOCHEM J, V356, P345; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Butcher SP, 1997, J NEUROSCI, V17, P6939; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	49	212	226	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					37	50		10.1016/j.cell.2007.04.043	http://dx.doi.org/10.1016/j.cell.2007.04.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632055	Bronze			2022-12-24	WOS:000248587000009
J	Rennert, G; Bisland-Naggan, S; Barnett-Griness, O; Bar-Joseph, N; Zhang, SY; Rennert, HS; Narod, SA				Rennert, Gad; Bisland-Naggan, Shantih; Barnett-Griness, Ofra; Bar-Joseph, Naomi; Zhang, Shiyu; Rennert, Hedy S.; Narod, Steven A.			Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVAL; CARCINOMA; FREQUENCY	BACKGROUND: Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based study of Israeli women to determine the influence, if any, of a BRCA1 or a BRCA2 mutation on the prognosis in breast cancer. METHODS: We obtained data on all incident cases of invasive breast cancer that were diagnosed from January 1, 1987, to December 31, 1988, and recorded in the Israel National Cancer Registry. We requested a paraffin-embedded tumor block or an unstained slide and the corresponding pathological and clinical records for all such cases. DNA extracted from the tumor specimens was analyzed for the three founder mutations in BRCA1 and BRCA2. For each subject, available pathological and oncologic records were reviewed. RESULTS: We were able to retrieve a pathological sample from 1794 of 2514 subjects (71%). Among those women, we obtained medical records for 1545 (86%). A BRCA1 or BRCA2 mutation was identified in 10% of the women who were of Ashkenazi Jewish ancestry. The adjusted hazard ratios for death from breast cancer were not significantly different among mutation carriers and noncarriers (hazard ratio among BRCA1 carriers, 0.76; 95% confidence interval [CI], 0.45 to 1.30; P=0.31; hazard ratio among BRCA2 carriers, 1.31; 95% CI, 0.80 to 2.15; P=0.28). Among women who were treated with chemotherapy, the hazard ratio for death among BRCA1 carriers was 0.48 (95% CI, 0.19 to 1.21; P=0.12). CONCLUSIONS: Breast cancer-specific rates of death among Israeli women are similar for carriers of a BRCA founder mutation and noncarriers.	Carmel Hosp, Natl Canc Control Ctr, Clalit Hlth Serv, IL-34362 Haifa, Israel; Carmel Hosp, Dept Community Med & Epidemiol, IL-34362 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada	Clalit Health Services; Carmel Medical Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Toronto; University Toronto Affiliates; Womens College Hospital	Rennert, G (corresponding author), Carmel Hosp, Natl Canc Control Ctr, Clalit Hlth Serv, IL-34362 Haifa, Israel.	rennert@tx.technion.ac.il	Narod, Steven A/AAA-6112-2022	Rennert, Gad/0000-0002-8512-068X	NCI NIH HHS [CA8097] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brekelmans CTM, 2006, ANN ONCOL, V17, P391, DOI 10.1093/annonc/mdj095; Eerola H, 2001, INT J CANCER, V93, P368, DOI 10.1002/ijc.1341; El-Tamer M, 2004, ANN SURG ONCOL, V11, P157, DOI 10.1245/ASO.2004.05.018; Goffin JR, 2003, CANCER-AM CANCER SOC, V97, P527, DOI 10.1002/cncr.11080; Goode EL, 2002, CANCER RES, V62, P3052; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y; Kauff ND, 2002, J MED GENET, V39, P611, DOI 10.1136/jmg.39.8.611; Kuperstein G, 2000, CLIN GENET, V57, P213, DOI 10.1034/j.1399-0004.2000.570307.x; *MIN HLTH, 1997, ISR CANC REG 1997; Moller P, 2002, INT J CANCER, V101, P555, DOI 10.1002/ijc.10641; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; PARKIN DM, 2000, IARC SCI PUBLICATION, V155; Phelan CM, 2002, HUM MUTAT, V20, P352, DOI 10.1002/humu.10123; RENNERT G, 1999, BREAST CANC SCREENIN; RENNERT G, 1999, INT EP ASS M FLOR IT; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	20	234	239	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2007	357	2					115	123		10.1056/NEJMoa070608	http://dx.doi.org/10.1056/NEJMoa070608			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188NX	17625123				2022-12-24	WOS:000247927700005
J	Chevrier, V; Poulet, F; Bibring, JP				Chevrier, Vincent; Poulet, Francois; Bibring, Jean-Pierre			Early geochemical environment of Mars as determined from thermodynamics of phyllosilicates	NATURE			English	Article							MERIDIANI; CLIMATE	Images of geomorphological features that seem to have been produced by the action of liquid water have been considered evidence for wet surface conditions on early Mars(1). Moreover, the recent identification of large deposits of phyllosilicates, associated with the ancient Noachian terrains(2,3) suggests long-timescale weathering(4) of the primary basaltic crust by liquid water(2,5). It has been proposed that a greenhouse effect resulting from a carbon-dioxide-rich atmosphere sustained the temperate climate required to maintain liquid water on the martian surface during the Noachian(6,7). The apparent absence of carbonates and the low escape rates of carbon dioxide(8), however, are indicative of an early martian atmosphere with low levels of carbon dioxide. Here we investigate the geochemical conditions prevailing on the surface of Mars during the Noachian period using calculations of the aqueous equilibria of phyllosilicates. Our results show that Fe3+-rich phyllosilicates probably precipitated under weakly acidic to alkaline pH, an environment different from that of the following period, which was dominated by strongly acid weathering(9) that led to the sulphate deposits identified on Mars(10-12). Thermodynamic calculations demonstrate that the oxidation state of the martian surface was already high, supporting early escape of hydrogen. Finally, equilibrium with carbonates implies that phyllosilicate precipitation occurs preferentially at a very low partial pressure of carbon dioxide. We suggest that the possible absence of Noachian carbonates more probably resulted from low levels of atmospheric carbon dioxide, rather than primary acidic conditions(13). Other greenhouse gases may therefore have played a part in sustaining a warm and wet climate on the early Mars.	Univ Arkansas, WM Keck Lab Space Simulat, Arkansas Ctr Space & Planetary Sci, Fayetteville, AR 72701 USA; Univ Paris Sud, Inst Astrophys Spatiale, F-91405 Orsay, France; CNRS, UMR 8617, F-91405 Orsay, France	University of Arkansas System; University of Arkansas Fayetteville; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay	Chevrier, V (corresponding author), Univ Arkansas, WM Keck Lab Space Simulat, Arkansas Ctr Space & Planetary Sci, MUSE 202, Fayetteville, AR 72701 USA.	vchevrie@uark.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Barabash S, 2007, SCIENCE, V315, P501, DOI 10.1126/science.1134358; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Chevrier V, 2004, GEOLOGY, V32, P1033, DOI 10.1130/G21078.1; EGGLETON RA, 1987, CLAY CLAY MINER, V35, P161, DOI 10.1346/CCMN.1987.0350301; Encrenaz T, 2004, ICARUS, V170, P424, DOI 10.1016/j.icarus.2004.05.008; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Glotch TD, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002672; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Madden MEE, 2004, NATURE, V431, P821, DOI 10.1038/nature02971; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Meunier A, 2007, TERRA NOVA, V19, P95, DOI 10.1111/j.1365-3121.2006.00719.x; Naumov MV, 2005, GEOFLUIDS, V5, P165, DOI 10.1111/j.1468-8123.2005.00092.x; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; Wang A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002516	29	151	151	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					60	63		10.1038/nature05961	http://dx.doi.org/10.1038/nature05961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611538				2022-12-24	WOS:000247720900037
J	Ng, SS; Kavanagh, KL; McDonough, MA; Butler, D; Pilka, ES; Lienard, BMR; Bray, JE; Savitsky, P; Gileadi, O; von Delft, F; Rose, NR; Offer, J; Scheinost, JC; Borowski, T; Sundstrom, M; Schofield, CJ; Oppermann, U				Ng, Stanley S.; Kavanagh, Kathryn L.; McDonough, Michael A.; Butler, Danica; Pilka, Ewa S.; Lienard, Benoit M. R.; Bray, James E.; Savitsky, Pavel; Gileadi, Opher; von Delft, Frank; Rose, Nathan R.; Offer, John; Scheinost, Johanna C.; Borowski, Tomasz; Sundstrom, Michael; Schofield, Christopher J.; Oppermann, Udo			Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; KETOGLUTARATE DIOXYGENASE; LYSINE METHYLATION; FAMILY; TRANSCRIPTION; INTERMEDIATE	Post-translational histone modification has a fundamental role in chromatin biology and is proposed to constitute a 'histone code' in epigenetic regulation(1,2). Differential methylation of histone H3 and H4 lysyl residues regulates processes including heterochromatin formation, X-chromosome inactivation, genome imprinting, DNA repair and transcriptional regulation(3). The discovery of lysyl demethylases using flavin (amine oxidases)(4) or Fe( II) and 2-oxoglutarate as cofactors (2OG oxygenases)(5-7) has changed the view of methylation as a stable epigenetic marker. However, little is known about how the demethylases are selective for particular lysyl-containing sequences in specific methylation states, a key to understanding their functions. Here we reveal how human JMJD2A ( jumonji domain containing 2A), which is selective towards tri- and dimethylated histone H3 lysyl residues 9 and 36 (H3K9me3/me2 and H3K36me3/me2), discriminates between methylation states and achieves sequence selectivity for H3K9. We report structures of JMJD2A - Ni( II) - Zn( II) inhibitor complexes bound to tri-, di- and monomethyl forms of H3K9 and the trimethyl form of H3K36. The structures reveal a lysyl-binding pocket in which substrates are bound in distinct bent conformations involving the Zn-binding site. We propose a mechanism for achieving methylation state selectivity involving the orientation of the substrate methyl groups towards a ferryl intermediate. The results suggest distinct recognition mechanisms in different demethylase subfamilies and provide a starting point to develop chemical tools for drug discovery and to study and dissect the complexity of reversible histone methylation and its role in chromatin biology.	Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England; Univ Oxford, Dept Chem, Oxford OX1 3TA, England; Univ Oxford, Oxford Ctr Integrated Syst Biol, Oxford OX1 3TA, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; PAS Univ, Inst Catalysis & Surface Chem, PL-830239 Krakow, Poland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Polish Academy of Sciences; Jerzy Haber Institute of Catalysis & Surface Chemistry	Schofield, CJ (corresponding author), Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England.	christopher.schofield@chemistry.oxford.ac.uk	McDonough, Michael/N-8913-2019; Gileadi, Opher/F-1105-2013; McDonough, Michael A/G-2744-2013; Rose, Nathan R/A-9270-2013; Borowski, Tomasz/E-8569-2016	McDonough, Michael/0000-0003-4664-6942; Gileadi, Opher/0000-0001-6886-898X; McDonough, Michael A/0000-0003-4664-6942; Rose, Nathan R/0000-0002-1871-1156; Borowski, Tomasz/0000-0002-3450-3576; BRAY, JAMES/0000-0003-3554-4254; von Delft, Frank/0000-0003-0378-0017; offer, john/0000-0002-2471-1216; Schofield, Christopher/0000-0002-0290-6565; Savitsky, Pavel/0000-0001-8584-7750	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Flashman E, 2007, NAT CHEM BIOL, V3, P86, DOI 10.1038/nchembio0207-86; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	17	255	260	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					87	91		10.1038/nature05971	http://dx.doi.org/10.1038/nature05971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17589501				2022-12-24	WOS:000247720900043
J	Arnesen, H; Lunde, K; Aakhus, S; Forfang, K				Arnesen, Harald; Lunde, Ketil; Aakhus, Svend; Forfang, Kolbjorn			Cell therapy in myocardial infarction	LANCET			English	Editorial Material							LEFT-VENTRICULAR VOLUME; PROGENITOR CELLS; MARROW; REPAIR; TRIAL		Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway; Rikshosp Radiumhosp Univ Hosp, Dept Cardiol, Oslo, Norway	University of Oslo; University of Oslo	Arnesen, H (corresponding author), Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway.	harald.arnesen@ulleval.no						DODGE HT, 1960, AM HEART J, V60, P762, DOI 10.1016/0002-8703(60)90359-8; Grebe O, 2004, Z KARDIOL, V93, P686; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; LUNDE K, 2006, NO LONG TERM EFFECTS; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; SHEEHAN FH, 1989, AM J CARDIOL, V64, P661, DOI 10.1016/0002-9149(89)90498-0; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C	11	39	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2007	369	9580					2142	2143		10.1016/S0140-6736(07)60992-1	http://dx.doi.org/10.1016/S0140-6736(07)60992-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LX	17604783				2022-12-24	WOS:000247644200008
J	Kawai, T; Akira, S				Kawai, Taro; Akira, Shizuo			SnapShot: Pattern-recognition receptors	CELL			English	Editorial Material									Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan	Osaka University	Kawai, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan.			Kawai, Taro/0000-0001-7510-4662					0	25	28	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					1024	U20	1024.e1	10.1016/j.cell.2007.05.017	http://dx.doi.org/10.1016/j.cell.2007.05.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540179	Bronze			2022-12-24	WOS:000247084600020
J	Boutet, SC; Disatnik, MH; Chan, LS; Iori, K; Rando, TA				Boutet, Stephane C.; Disatnik, Marie-Helene; Chan, Lauren S.; Iori, Kevin; Rando, Thomas A.			Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors	CELL			English	Article							MULTIUBIQUITIN-CHAIN; MET RECEPTOR; UBA DOMAINS; UBIQUITIN; BINDING; SUBUNIT; CELLS; EXPRESSION; MIGRATION; KINASE	Pax3 and Pax7 play distinct but overlapping roles in developmental and postnatal myogenesis. The mechanisms involved in the differential regulation of these highly homologous proteins are unknown. We present evidence that Pax3, but not Pax7, is regulated by ubiquitination and proteasomal degradation during adult muscle stem cell activation. Intriguingly, only monoubiquitinated forms of Pax3 could be detected. Mutation of two specific lysine residues in the C-terminal region of Pax3 reduced the extent of its monoubiquitination and susceptibility to proteasomal degradation, whereas introduction of a key lysine into the C-terminal region of Pax7 rendered that protein susceptible to monoubiquitination and proteasomal degradation. Monoubiquitinated Pax3 was shuttled to the intrinsic proteasomal protein S5a by interacting specifically with the ubiquitin-binding protein Rad23B. Functionally, sustained expression of Pax3 proteins inhibited myogenic differentiation, demonstrating that Pax3 degradation is an essential step for the progression of the myogenic program. These results reveal an important mechanism of Pax3 regulation in muscle progenitors and an unrecognized role of protein monoubiquitination in mediating proteasomal degradation.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 34304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564	NIA NIH HHS [AG23806] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023806, R37AG023806] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOBER E, 1994, DEVELOPMENT, V120, P603; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yang XM, 1996, DEVELOPMENT, V122, P2163; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	43	145	148	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					349	362		10.1016/j.cell.2007.05.044	http://dx.doi.org/10.1016/j.cell.2007.05.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662948	Bronze			2022-12-24	WOS:000248588000023
J	Chen, MH; Wilson, CW; Chuang, PT				Chen, Miao-Hsueh; Wilson, Christopher W.; Chuang, Pao-Tien			SnapShot: Hedgehog signaling pathway	CELL			English	Editorial Material							MECHANISM; TRANSDUCTION; DIVERGENCE; DROSOPHILA		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Chen, MH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.			Chen, Miao-Hsueh/0000-0002-9715-3067				Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Eaton S, 2006, CURR OPIN GENET DEV, V16, P17, DOI 10.1016/j.gde.2005.12.006; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Guerrero I, 2007, TRENDS CELL BIOL, V17, P1, DOI 10.1016/j.tcb.2006.11.002; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016	17	24	28	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					386	U26	e1	10.1016/j.cell.2007.07.017	http://dx.doi.org/10.1016/j.cell.2007.07.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662951	Bronze			2022-12-24	WOS:000248588000028
J	Vergoz, V; Schreurs, HA; Mercer, AR				Vergoz, Vanina; Schreurs, Haley A.; Mercer, Alison R.			Queen pheromone blocks aversive learning in young worker bees	SCIENCE			English	Article							APIS-MELLIFERA L.; MANDIBULAR GLAND PHEROMONE; HONEY-BEES; OVARY DEVELOPMENT; DOPAMINE; BEHAVIOR; MEMORY	Queen mandibular pheromone (QMP) has profound effects on dopamine signaling in the brain of young worker honey bees. As dopamine in insects has been strongly implicated in aversive learning, we examined QMP's impact on associative olfactory learning in bees. We found that QMP blocks aversive learning in young workers, but leaves appetitive learning intact. We postulate that QMP's effects on aversive learning enhance the likelihood that young workers remain in close contact with their queen by preventing them from forming an aversion to their mother's pheromone bouquet. The results provide an interesting twist to a story of success and survival.	Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Mercer, AR (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	alison.mercer@stonebow.otago.ac.nz	Vergoz, Vanina/L-9638-2015	Mercer, Alison/0000-0001-8110-4247				Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HARRIS JW, 1995, COMP BIOCHEM PHYS C, V111, P271, DOI 10.1016/0742-8413(95)00048-S; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Ledoux MN, 2001, INSECT SOC, V48, P14, DOI 10.1007/PL00001738; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Moritz RFA, 2001, ETHOLOGY, V107, P465, DOI 10.1046/j.1439-0310.2001.00681.x; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; PHAM MH, 1982, APIDOLOGIE, V13, P143, DOI 10.1051/apido:19820203; RHODES J, 2003, PUBLICATION RURAL IN; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Vaitkevieiene G, 1999, PHEROMONES, V6, P39; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Winston, 1987, BIOL HONEYBEE; WINSTON ML, 1991, ANN ENTOMOL SOC AM, V84, P234	22	79	83	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					384	386		10.1126/science.1142448	http://dx.doi.org/10.1126/science.1142448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641204				2022-12-24	WOS:000248150200050
J	De Wals, P; Tairou, F; Van Allen, MI; Uh, S; Lowry, R B; Sibbald, B; Evans, JA; Van den Hof, MC; Zimmer, P; Crowley, M; Fernandez, B; Lee, NS; Niyonsenga, T				De Wals, Philippe; Tairou, Fassiatou; Van Allen, Margot I.; Uh, Soo-Hong; Lowry, R. Brian; Sibbald, Barbara; Evans, Jane A.; Van den Hof, Michiel C.; Zimmer, Pamela; Crowley, Marian; Fernandez, Bridget; Lee, Nora S.; Niyonsenga, Theophile			Reduction in neural-tube defects after folic acid fortification in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD FORTIFICATION; AFFECTED PREGNANCIES; FOLATE; WOMEN; PREVALENCE; DIAGNOSIS; RISK; AGE	BACKGROUND: In 1998, folic acid fortification of a large variety of cereal products became mandatory in Canada, a country where the prevalence of neural-tube defects was historically higher in the eastern provinces than in the western provinces. We assessed changes in the prevalence of neural-tube defects in Canada before and after food fortification with folic acid was implemented. METHODS: The study population included live births, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces from 1993 to 2002. On the basis of published results of testing of red-cell folate levels, the study period was divided into prefortification, partial-fortification, and full-fortification periods. We evaluated the relationship between baseline rates of neural-tube defects in each province and the magnitude of the decrease after fortification was implemented. RESULTS: A total of 2446 subjects with neural-tube defects were recorded among 1.9 million births. The prevalence of neural-tube defects decreased from 1.58 per 1000 births before fortification to 0.86 per 1000 births during the full-fortification period, a 46% reduction (95% confidence interval, 40 to 51). The magnitude of the decrease was proportional to the prefortification baseline rate in each province, and geographical differences almost disappeared after fortification began. The observed reduction in rate was greater for spina bifida (a decrease of 53%) than for anencephaly and encephalocele (decreases of 38% and 31%, respectively). CONCLUSIONS: Food fortification with folic acid was associated with a significant reduction in the rate of neural-tube defects in Canada. The decrease was greatest in areas in which the baseline rate was high.	Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; British Columbia Minist Hlth, Victoria, BC, Canada; Alberta Hlth & Wellness, Calgary, AB, Canada; Univ Manitoba, Winnipeg, MB, Canada; Dalhousie Univ, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada; Hlth Sci Ctr, St John, NF, Canada; Hlth Canada, Food Directorate, Ottawa, ON K1A 0L2, Canada; Florida Int Univ, Robert Stempel Sch Publ Hlth, Miami, FL 33199 USA	Laval University; University of British Columbia; Alberta Health Services (AHS); University of Manitoba; Dalhousie University; Dalhousie University; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Health Canada; State University System of Florida; Florida International University	De Wals, P (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Pavillon Est,Local 1110,2180 Chemin St Foy, Quebec City, PQ G1K 7P4, Canada.	dewals@msp.ulaval.ca	Niyonsenga, Theo/C-3759-2014	Niyonsenga, Theo/0000-0002-6723-0316; , Fassiatou O./0000-0002-9410-4278				Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Caudill MA, 1997, J NUTR, V127, P2363, DOI 10.1093/jn/127.12.2363; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362; CRANE JMG, 2001, J SOC OBSTET GYNAECO, V23, P510; De Wals P, 1999, CAN J PUBLIC HEALTH, V90, P237, DOI 10.1007/BF03404123; De Wals P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124; Food and Nutrition Board, 1998, DIET REF INT THIAM R, P196; French MR, 2003, J AM DIET ASSOC, V103, P181, DOI 10.1053/jada.2003.50062; House JD, 2006, CAN J PUBLIC HEALTH, V97, P132, DOI 10.1007/BF03405331; LEMIRE RJ, 1988, JAMA-J AM MED ASSOC, V259, P558, DOI 10.1001/jama.259.4.558; LITTLE J, 1992, EPIDEMIOLOGY CONTROL, P92; Liu Shiliang, 2004, BMC Pregnancy Childbirth, V4, P20, DOI 10.1186/1471-2393-4-20; Morin P, 2002, PREV MED, V35, P143, DOI 10.1006/pmed.2002.1041; Morin P, 2002, CAN J PUBLIC HEALTH, V93, P259, DOI 10.1007/BF03405012; NEVIN NC, 1983, ILLUSTRATED GUIDE MA; Pacheco-Jacome E, 2003, NEUROIMAG CLIN N AM, V13, P327, DOI 10.1016/S1052-5149(03)00028-5; Persad VL, 2002, CAN MED ASSOC J, V167, P241; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Ray JG, 2002, LANCET, V360, P2047, DOI 10.1016/S0140-6736(02)11994-5; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026; Ray JG, 2002, CAN J PUBLIC HEALTH, V93, P249, DOI 10.1007/BF03405010; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Tairou Fassiatou, 2006, Chronic Dis Can, V27, P120; Van Allen MI, 2006, J APPL GENET, V47, P151, DOI 10.1007/BF03194615; Velie EM, 2006, PAEDIATR PERINAT EP, V20, P219, DOI 10.1111/j.1365-3016.2006.00722.x	27	558	571	2	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2007	357	2					135	142		10.1056/NEJMoa067103	http://dx.doi.org/10.1056/NEJMoa067103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188NX	17625125				2022-12-24	WOS:000247927700007
J	Landry, CR; Lemos, B; Rifkin, SA; Dickinson, WJ; Hartl, DL				Landry, Christian R.; Lemos, Bernardo; Rifkin, Scott A.; Dickinson, W. J.; Hartl, Daniel L.			Genetic properties influencing the evolvability of gene expression	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTION; GENOME; CANALIZATION; PROFILES; MUTATION; REVEALS; YEAST; NOISE; CONSEQUENCES	Identifying the properties of gene networks that influence their evolution is a fundamental research goal. However, modes of evolution cannot be inferred solely from the distribution of natural variation, because selection interacts with demography and mutation rates to shape polymorphism and divergence. We estimated the effects of naturally occurring mutations on gene expression while minimizing the effect of natural selection. We demonstrate that sensitivity of gene expression to mutations increases with both increasing trans-mutational target size and the presence of a TATA box. Genes with greater sensitivity to mutations are also more sensitive to systematic environmental perturbations and stochastic noise. These results provide a mechanistic basis for gene expression evolvability that can serve as a foundation for realistic models of regulatory evolution.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Harvard University; Utah System of Higher Education; University of Utah	Landry, CR (corresponding author), Univ Montreal, Dept Biochim, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	clandry@post.harvard.edu; blemos@oeb.harvard.edu	Landry, Christian R/F-3890-2011; Lemos, Bernardo/AAL-2429-2020	Lemos, Bernardo/0000-0001-6996-9483; Landry, Christian/0000-0003-3028-6866; Rifkin, Scott/0000-0001-8476-3256				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2005, EVOLUTION, V59, P126; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Lynch M., 1998, GENETICS ANAL QUANTI; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	24	234	236	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					118	121		10.1126/science.1140247	http://dx.doi.org/10.1126/science.1140247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17525304				2022-12-24	WOS:000247776700065
J	Chen, Z; Odstrcil, EA; Tu, BP; McKnight, SL				Chen, Zheng; Odstrcil, Elizabeth A.; Tu, Benjamin P.; McKnight, Steven L.			Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity	SCIENCE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CANCER-CELLS; YEAST; INSTABILITY; INHIBITOR; MUTATIONS; MECHANISM; STRESS; DAMAGE	When prototrophic yeast cells are cultured under nutrient-limited conditions that mimic growth in the wild, rather than in the high-glucose solutions used in most laboratory studies, they exhibit a robustly periodic metabolic cycle. Over a cycle of 4 to 5 hours, yeast cells rhythmically alternate between glycolysis and respiration. The cell division cycle is tightly constrained to the reductive phase of this yeast metabolic cycle, with DNA replication taking place only during the glycolytic phase. We show that cell cycle mutants impeded in metabolic cycle-directed restriction of cell division exhibit substantial increases in spontaneous mutation rate. In addition, disruption of the gene encoding a DNA checkpoint kinase that couples the cell division cycle to the circadian cycle abolishes synchrony of the metabolic and cell cycles. Thus, circadian, metabolic, and cell division cycles may be coordinated similarly as an evolutionarily conserved means of preserving genome integrity.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Baylor Univ, Med Ctr, Dallas, TX 75246 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Steven.McKnight@UTSouthwestern.edu		Chen, Jake/0000-0001-8829-7504				Canaple L, 2003, CANCER RES, V63, P7545; Chen JH, 2005, DNA REPAIR, V4, P1140, DOI 10.1016/j.dnarep.2005.06.003; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Futcher B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-107; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Leroy C, 2001, EMBO J, V20, P2896, DOI 10.1093/emboj/20.11.2896; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Sidorova JM, 2003, MUTAT RES-FUND MOL M, V532, P5, DOI 10.1016/j.mrfmmm.2003.08.006; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; WHELAN WL, 1979, GENETICS, V91, P35	26	169	172	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1916	1919		10.1126/science.1140958	http://dx.doi.org/10.1126/science.1140958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600220				2022-12-24	WOS:000247602700045
J	Pao, M; Ballard, ED; Rosenstein, DL				Pao, Maryland; Ballard, Elizabeth D.; Rosenstein, Donald L.			Growing up in the hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN; DEPRESSION; ADOLESCENT; PREVALENCE; CARE		NIMH, NIH, Clin Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Pao, M (corresponding author), NIMH, NIH, Clin Res Ctr, 6-5340, Bethesda, MD 20892 USA.	paom@mail.nih.gov	Ballard, Elizabeth/O-6856-2017	Ballard, Elizabeth/0000-0001-5304-0127				Anderson GM, 2000, CHILD ADOL PSYCH CL, V9, P23; Armstrong FD, 2006, MENT RETARD DEV D R, V12, P168, DOI 10.1002/mrdd.20114; BENNETT DS, 1994, J PEDIATR PSYCHOL, V19, P149, DOI 10.1093/jpepsy/19.2.149; Bhutta AT, 2002, CLIN PERINATOL, V29, P357, DOI 10.1016/S0095-5108(02)00011-8; Dejong M, 2006, PSYCHO-ONCOLOGY, V15, P553, DOI 10.1002/pon.1002; Drotar D, 2006, CHILD HEALTH CARE, V35, P91, DOI 10.1207/s15326888chc3501_8; Erikson E., 1968, IDENTITY YOUTH CRISI; Jellinek M., 2002, BRIGHT FUTURES PRACT; Kanner L, 1937, J PEDIATR-US, V11, P418, DOI 10.1016/S0022-3476(37)80027-X; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Mahan, 2005, M CHILDRENS PSYCHOSO; Mayes LC, 2003, CHILD ADOL PSYCH CL, V12, P401, DOI 10.1016/S1056-4993(03)00022-1; Newacheck PW, 1998, AM J PUBLIC HEALTH, V88, P610, DOI 10.2105/AJPH.88.4.610; OWENS PL, 2003, CARE CHILDEN ADOLESC; Peebles-Kleiger MJ, 2000, B MENNINGER CLIN, V64, P257; PERRIN JM, 1993, PEDIATRICS, V92, P876; Schechter NL, 1997, PEDIATRICS, V99, P890, DOI 10.1542/peds.99.6.890; Stuber ML, 2006, CHILD ADOL PSYCH CL, V15, P597, DOI 10.1016/j.chc.2006.02.006; Stuber ML, 2006, CNS SPECTRUMS, V11, P137, DOI 10.1017/S1092852900010671; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; THOMASGARD M, 1995, J DEV BEHAV PEDIATR, V16, P47; Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179; Yoshida K, 2005, NEUROPSYCHOBIOLOGY, V52, P55, DOI 10.1159/000086605; Zielinski Tanya A., 2000, Prim Care Companion J Clin Psychiatry, V2, P153	24	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2752	2755		10.1001/jama.297.24.2752	http://dx.doi.org/10.1001/jama.297.24.2752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595276				2022-12-24	WOS:000247528700025
J	Wald, NJ; Oakley, GP				Wald, Nicholas J.; Oakley, Godfrey P.			Should folic acid fortification be mandatory?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England; Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; Queen Mary University London; Emory University; Rollins School Public Health	Wald, NJ (corresponding author), Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021						0	22	23	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1252	1252		10.1136/bmj.39232.493252.47	http://dx.doi.org/10.1136/bmj.39232.493252.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569931	Green Published			2022-12-24	WOS:000247545100030
J	Wadman, M				Wadman, Meredith			Meeting in the middle	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					629	629		10.1038/447629a	http://dx.doi.org/10.1038/447629a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554281	Bronze			2022-12-24	WOS:000247030700014
J	Behrens, MR; Mutlu, N; Chakraborty, S; Dumitru, R; Jiang, WZ; LaVallee, BJ; Herman, PL; Clemente, TE; Weeks, DP				Behrens, Mark R.; Mutlu, Nedim; Chakraborty, Sarbani; Dumitru, Razvan; Jiang, Wen Zhi; LaVallee, Bradley J.; Herman, Patricia L.; Clemente, Thomas E.; Weeks, Donald P.			Dicamba resistance: Enlarging and preserving biotechnology-based weed management strategies	SCIENCE			English	Article							PSEUDOMONAS-MALTOPHILIA; O-DEMETHYLASE; STRAIN DI-6; HEALTH	The advent of biotechnology-derived, herbicide-resistant crops has revolutionized farming practices in many countries. Facile, highly effective, environmentally sound, and profitable weed control methods have been rapidly adopted by crop producers who value the benefits associated with biotechnology-derived weed management traits. But a rapid rise in the populations of several troublesome weeds that are tolerant or resistant to herbicides currently used in conjunction with herbicide-resistant crops may signify that the useful lifetime of these economically important weed management traits will be cut short. We describe the development of soybean and other broadleaf plant species resistant to dicamba, a widely used, inexpensive, and environmentally safe herbicide. The dicamba resistance technology will augment current herbicide resistance technologies and extend their effective lifetime. Attributes of both nuclear- and chloroplast-encoded dicamba resistance genes that affect the potency and expected durability of the herbicide resistance trait are examined.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Weeks, DP (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dweeks1@unl.edu	Mutlu, Nedim/B-9280-2016; MUTLU, Nedim/AAB-9844-2020	MUTLU, Nedim/0000-0001-7252-5883; Behrens, Mark/0000-0001-8230-120X				[Anonymous], [No title captured]; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Chakraborty S, 2005, ARCH BIOCHEM BIOPHYS, V437, P20, DOI 10.1016/j.abb.2005.02.024; CORK DJ, 1991, ADV APPL MICROBIOL, V36, P1; Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4; Herman PL, 2005, J BIOL CHEM, V280, P24759, DOI 10.1074/jbc.M500597200; Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; *INT SERV ACQ AGR, 2006, GLOB STAT COMM BIOT; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; Maliga P, 2005, PHOTOCH PHOTOBIO SCI, V4, P971, DOI 10.1039/b514699m; Steven JT, 1991, HDB PESTICIDE TOXICO, P1317; *US EPA OFF DRINK, 1988, HLTH ADV SUMM DIC; Wang XZ, 1997, APPL ENVIRON MICROB, V63, P1623, DOI 10.1128/AEM.63.4.1623-1626.1997; *WEED SCI SOC AM, 1994, HERB HDB; YANG J, 1994, ANAL BIOCHEM, V219, P37, DOI 10.1006/abio.1994.1228; EXTOXNET PESTICDE IN	17	197	241	6	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1185	1188		10.1126/science.1141596	http://dx.doi.org/10.1126/science.1141596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525337	Green Published			2022-12-24	WOS:000246724300041
J	Barsh, G; Attardi, LD				Barsh, Gregory; Attardi, Laura D.			Clinical implications of basic research: A healthy tan?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PIGMENTATION; RECEPTOR		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Barsh, G (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x	5	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2208	2210		10.1056/NEJMcibr071775	http://dx.doi.org/10.1056/NEJMcibr071775			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522405				2022-12-24	WOS:000246673100016
J	Kelly, PN; Dakic, A; Adams, JM; Nutt, SL; Strasser, A				Kelly, Priscilla N.; Dakic, Aleksandar; Adams, Jerry M.; Nutt, Stephen L.; Strasser, Andreas			Tumor growth need not be driven by rare cancer stem cells	SCIENCE			English	Article							IDENTIFICATION		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Dakic, Aleksandar/B-8290-2013; Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013	Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637; Adams, Jerry/0000-0002-4360-8628				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128	6	624	671	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					337	337		10.1126/science.1142596	http://dx.doi.org/10.1126/science.1142596			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641192				2022-12-24	WOS:000248150200036
J	Dabelea, D; Bell, RA; D'Agostino, RB; Imperatore, G; Johansen, JM; Linder, B; Liu, LL; Loots, B; Marcovina, S; Mayer-Davis, EJ; Pettitt, DJ; Waitzfelder, B				Dabelea, Dana; Bell, Ronny A.; D'Agostino, Ralph B., Jr.; Imperatore, Giuseppina; Johansen, Judith M.; Linder, Barbara; Liu, Lenna L.; Loots, Beth; Marcovina, Santica; Mayer-Davis, Elizabeth J.; Pettitt, David J.; Waitzfelder, Beth		Writing Grp SEARCH Diabet Youth St	Incidence of diabetes in youth in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACID DECARBOXYLASE GAD65; ALLEGHENY-COUNTY; AFRICAN-AMERICAN; MELLITUS; CHILDREN; ADOLESCENTS; TYPE-2; PREVALENCE; EPIDEMIC; TRENDS	Context Data on the incidence of diabetes mellitus (DM) among US youth according to racial/ethnic background and DM type are limited. Objective To estimate DM incidence in youth aged younger than 20 years according to race/ethnicity and DM type. Design, Setting, and Participants A multiethnic, population-based study (The SEARCH for Diabetes in Youth Study) of 2435 youth with newly diagnosed, nonsecondary DM in 2002 and 2003, ascertained at 10 study locations in the United States, covering a population of more than 10 million person-years. Main Outcome Measure Incidence rates by age group, sex, race/ethnicity, and DM type were calculated per 100 000 person-years at risk. Diabetes mellitus type ( type 1/type 2) was based on health care professional assignment and, in a subset, further characterized with glutamicacid decarboxylase( GAD65) autoantibody and fasting C peptide measures. Results The incidence of DM ( per 100 000 person-years) was 24.3 (95% confidence interval [CI], 23.3-25.3). Among children younger than 10 years, most had type 1 DM, regardless of race/ethnicity. The highest rates of type 1 DM were observed in non-Hispanic white youth (18.6, 28.1, and 32.9 for age groups 0-4, 5-9, and 10-14 years, respectively). Even among older youth ( >= 10 years), type 1 DM was frequent among non-Hispanic white, Hispanic, and African American adolescents. Overall, type 2 DM was still relatively infrequent, but the highest rates (17.0 to 49.4 per 100 000 person-years) were documented among 15- to 19-year-old minority groups. Conclusions Our data document the incidence rates of type 1 DM among youth of all racial/ethnic groups, with the highest rates in non-Hispanic white youth. Overall, type 2 DM is still relatively infrequent; however, the highest rates were observed among adolescent minority populations.	Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; NIDDK, Bethesda, MD USA; Univ Washington, Inst Child Hlth, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ S Carolina, Columbia, SC 29208 USA; Sansum Diabet Res Inst, Santa Barbara, CA USA; Pacific Hlth Res Inst, Honolulu, HI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Wake Forest University; Wake Forest Baptist Medical Center; Centers for Disease Control & Prevention - USA; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; William Sansum Diabetes Center; Pacific Health Research & Education Institute	Dabelea, D (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, 4200 E 9th Ave,Box C245, Denver, CO 80262 USA.	dana.dabelea@uchsc.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	NCRR NIH HHS [M01RR00037, M01 RR08084, M01 RR01070, M01 RR00069, M01RR001271] Funding Source: Medline; PHS HHS [00097] Funding Source: Medline; NCCDPHP CDC HHS [U01 DP000254, U01 DP000250, U01 DP000248, U01 DP000247, U01 DP000246, U01 DP000245, DP-05-069, U01 DP000244] Funding Source: Medline; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000248, U01DP000245, U01DP000244, U01DP000250, U01DP000254, U01DP000247, U01DP000246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR008084, M01RR001070, M01RR000037, M01RR001271, M01RR000069] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NCCDPHP CDC HHS; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; BISHOP YMM, 1975, FSHPW DISCRETE MULTI; Brooks-Worrell BM, 2004, J CLIN ENDOCR METAB, V89, P2222, DOI 10.1210/jc.2003-031360; Chen WS, 2004, ANN EPIDEMIOL, V14, P339, DOI 10.1016/j.annepidem.2003.07.002; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; Dean HJ, 1998, LANCET, V352, P1523, DOI 10.1016/S0140-6736(05)60329-7; DOKHEEL TM, 1993, DIABETES CARE, V16, P1606, DOI 10.2337/diacare.16.12.1606; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; ESPELAND MA, 1986, COMMUN STAT SIMULAT, V15, P405, DOI 10.1080/03610918608812515; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Harris SB, 1997, DIABETES CARE, V20, P185, DOI 10.2337/diacare.20.2.185; Hathout EH, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e102; HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104; Ingram DD., 2003, VITAL HLTH STAT SERI, V2; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; KITAGAWA T, 1983, Tohoku Journal of Experimental Medicine, V141, P171; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LAPORTE RE, 1981, DIABETES, V30, P279, DOI 10.2337/diabetes.30.4.279; Libman IM, 1998, DIABETES CARE, V21, P1278, DOI 10.2337/diacare.21.8.1278; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Lipman TH, 2006, DIABETES CARE, V29, P2391, DOI 10.2337/dc06-0517; Lipman TH, 2002, DIABETES CARE, V25, P1969, DOI 10.2337/diacare.25.11.1969; Lipton R, 2002, DIABETES-METAB RES, V18, P135, DOI 10.1002/dmrr.265; Macaluso CJ, 2002, PUBLIC HEALTH REP, V117, P373, DOI 10.1016/S0033-3549(04)50174-7; Marcovina SM, 2000, INT J CLIN LAB RES, V30, P21, DOI 10.1007/s005990070029; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Ortega-Rodriguez E, 2001, DIABETES METAB, V27, P574; Petitti DB, 2007, ARCH PEDIAT ADOL MED, V161, P159, DOI 10.1001/archpedi.161.2.159; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; Pihoker C, 1998, CLIN PEDIATR, V37, P97, DOI 10.1177/000992289803700206; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rewers M, 2004, ADV EXP MED BIOL, V552, P219; REWERS M, 1987, DIABETES, V36, P106, DOI 10.2337/diabetes.36.1.106; SCHOBER E, 1988, ACTA PAEDIATR SCAND, V77, P299, DOI 10.1111/j.1651-2227.1988.tb10646.x; Scott CR, 1997, PEDIATRICS, V100, P84, DOI 10.1542/peds.100.1.84; STONE RA, 1990, DIABETES, V39, P858; TUOMILEHTO J, 1995, INT J EPIDEMIOL, V24, P984, DOI 10.1093/ije/24.5.984; Verlato G, 2000, DIABETES CARE, V23, P759, DOI 10.2337/diacare.23.6.759	46	671	683	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2716	2724						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595272				2022-12-24	WOS:000247528700021
J	Stearns, V				Stearns, Vered			Clinical update: new treatments for hot flushes	LANCET			English	Editorial Material							VASOMOTOR SYMPTOMS; POSTMENOPAUSAL WOMEN; BREAST-CANCER; FLASHES; MENOPAUSE; TRIAL; ESTROGEN; VENLAFAXINE; MANAGEMENT; THERAPIES		Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Stearns, V (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	vstearn1@jhmi.edu						*AM COLL OBST GYN, 2004, OBSTET GYNECOL S, V104, pS106; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Butt DA, 2007, MENOPAUSE, V14, P203, DOI 10.1097/01.gme.0000235370.32103.4c; Deecher DC, 2005, EXPERT OPIN INV DRUG, V14, P435, DOI 10.1517/13543784.14.4.435; Fabre A, 2007, BRIT J CANCER, V96, P841, DOI 10.1038/sj.bjc.6603618; Freedman RR, 2005, MENOPAUSE, V12, P156, DOI 10.1097/00042192-200512020-00009; Freedman RR, 2002, FERTIL STERIL, V77, P487, DOI 10.1016/S0015-0282(01)03009-6; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Loibl S, 2007, ANN ONCOL, V18, P689, DOI 10.1093/annonc/mdl478; Loprinzi CL, 2007, J CLIN ONCOL, V25, P308, DOI 10.1200/JCO.2006.07.5390; Loprinzi CL, 2006, J CLIN ONCOL, V24, P1409, DOI 10.1200/JCO.2005.04.7324; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; Newton KM, 2006, ANN INTERN MED, V145, P869, DOI 10.7326/0003-4819-145-12-200612190-00003; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santoro NF, 2004, MENOPAUSE, V11, P11; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0	20	25	28	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2007	369	9579					2062	2064		10.1016/S0140-6736(07)60959-3	http://dx.doi.org/10.1016/S0140-6736(07)60959-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GM	17586289				2022-12-24	WOS:000247493100009
J	Barry, M				Barry, Michele			The tail end of guinea worm - Global eradication without a drug or a vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Barry, M (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.							[Anonymous], 2004, Wkly Epidemiol Rec, V79, P234; Hopkins DR, 2005, AM J TROP MED HYG, V73, P669, DOI 10.4269/ajtmh.2005.73.669; Rwakimari JB, 2006, AM J TROP MED HYG, V75, P3, DOI 10.4269/ajtmh.2006.75.3; 2007, WKLY EPIDEMIOL REC, V82, P133	4	36	37	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2561	2564		10.1056/NEJMp078089	http://dx.doi.org/10.1056/NEJMp078089			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180GN	17582064				2022-12-24	WOS:000247351200001
J	Roman-Leshkov, Y; Barrett, CJ; Liu, ZY; Dumesic, JA				Roman-Leshkov, Yuriy; Barrett, Christopher J.; Liu, Zhen Y.; Dumesic, James A.			Production of dimethylfuran for liquid fuels from biomass-derived carbohydrates	NATURE			English	Article							SUPPORTED COPPER; HYDROGENATION; CATALYSTS; FRUCTOSE; 2-METHYLFURAN; EQUILIBRIA; MEDIA	Diminishing fossil fuel reserves and growing concerns about global warming indicate that sustainable sources of energy are needed in the near future. For fuels to be useful in the transportation sector, they must have specific physical properties that allow for efficient distribution, storage and combustion; these properties are currently fulfilled by non-renewable petroleum-derived liquid fuels. Ethanol, the only renewable liquid fuel currently produced in large quantities, suffers from several limitations, including low energy density, high volatility, and contamination by the absorption of water from the atmosphere. Here we present a catalytic strategy for the production of 2,5-dimethylfuran from fructose ( a carbohydrate obtained directly from biomass or by the isomerization of glucose) for use as a liquid transportation fuel. Compared to ethanol, 2,5-dimethylfuran has a higher energy density ( by 40 per cent), a higher boiling point ( by 20 K), and is not soluble in water. This catalytic strategy creates a route for transforming abundant renewable biomass resources(1,2) into a liquid fuel suitable for the transportation sector, and may diminish our reliance on petroleum.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Barrett, Christopher J/B-7474-2008; Knafo-Noam, Ariel/E-8067-2011; Roman-Leshkov, Yuriy/E-1387-2014	Barrett, Christopher J/0000-0001-6194-9066; Knafo-Noam, Ariel/0000-0003-0613-1960; Roman-Leshkov, Yuriy/0000-0002-0025-4233				Barlow M. T., 1983, Fuel composition. Eur. Pat., Patent No. [EP0082689, 0082689]; Broughton D.B., 1961, Patent No. [US2985589A, 2985589, 2,985,589]; BROWN DW, 1982, J CHEM TECHNOL BIOT, V32, P920, DOI 10.1002/jctb.5030320730; EISEN EO, 1966, J CHEM ENG DATA, V11, P480, DOI 10.1021/je60031a007; GRABOSKI M, 2003, ANAL ALTERNATIVES UN; Hashimoto K., 1993, PREPARATIVE PRODUCTI, P395; HELMS CR, 1978, SURF SCI, V72, P229, DOI 10.1016/0039-6028(78)90292-3; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; JONES JH, 2001, IND ENG CHEM PROD RD, V10, P57; KUSTER BFM, 1990, STARCH-STARKE, V42, P314, DOI 10.1002/star.19900420808; MANLY DG, 1958, J ORG CHEM, V23, P1093, DOI 10.1021/jo01102a002; Moreau C, 2004, TOP CATAL, V27, P11, DOI 10.1023/B:TOCA.0000013537.13540.0e; NEIER W, 1982, Patent No. 3040997; Parikka M, 2004, BIOMASS BIOENERG, V27, P613, DOI 10.1016/j.biombioe.2003.07.005; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ramey D. E., 1998, US Patent, Patent No. [5753474, 5,753,474]; Rao RS, 1999, CATAL LETT, V60, P51, DOI 10.1023/A:1019090520407; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; SINFELT JH, 1976, J CATAL, V42, P227, DOI 10.1016/0021-9517(76)90257-8; SINFELT JH, 1973, J CATAL, V29, P308, DOI 10.1016/0021-9517(73)90234-0; SZMANT HH, 1981, J CHEM TECHNOL BIOT, V31, P135, DOI 10.1002/jctb.280310119; Tan TC, 1999, FLUID PHASE EQUILIBR, V163, P243, DOI 10.1016/S0378-3812(99)00231-9; Twigg MV, 2001, APPL CATAL A-GEN, V212, P161, DOI 10.1016/S0926-860X(00)00854-1; VANDAM HE, 1986, STARCH-STARKE, V38, P95, DOI 10.1002/star.19860380308; Zheng HY, 2006, J MOL CATAL A-CHEM, V246, P18, DOI 10.1016/j.molcata.2005.10.003	25	1757	1887	24	1050	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					982	U5		10.1038/nature05923	http://dx.doi.org/10.1038/nature05923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	180NU	17581580				2022-12-24	WOS:000247373100042
J	Jacob, M; Chappell, D; Rehm, M				Jacob, Matthias; Chappell, Daniel; Rehm, Markus			Clinical update: perioperative fluid management	LANCET			English	Article							RADICAL HYSTERECTOMY; INDUCED HYPOTENSION; SURGERY; TRIAL; RESTRICTION; VOLUME; RESPONSIVENESS; RESECTION; RECOVERY; THERAPY		Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany	University of Munich	Jacob, M (corresponding author), Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany.	matthias.jacob@med.uni-muenchen.de						Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Holte K, 2006, J AM COLL SURGEONS, V202, P971, DOI 10.1016/j.jamcollsurg.2006.01.003; JACKSON R, 1995, BRIT J ANAESTH, V75, P262, DOI 10.1093/bja/75.3.262; LAMKE LO, 1977, ACTA CHIR SCAND, V143, P279; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; MacKay G, 2006, BRIT J SURG, V93, P1469, DOI 10.1002/bjs.5593; Moller AM, 2002, EUR J ANAESTH, V19, P57, DOI 10.1017/S0265021502000091; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Noblett SE, 2006, BRIT J SURG, V93, P1069, DOI 10.1002/bjs.5454; Rehm M, 2001, ANESTHESIOLOGY, V95, P849, DOI 10.1097/00000542-200110000-00011; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; SHIRES T, 1961, ANN SURG, V154, P803, DOI 10.1097/00000658-196111000-00005; SHOEMAKER WC, 1973, ARCH SURG-CHICAGO, V106, P630; Solus-Biguenet H, 2006, BRIT J ANAESTH, V97, P808, DOI 10.1093/bja/ael250; Spahn DR, 2006, ANESTH ANALG, V102, P344, DOI 10.1213/01.ane.0000196511.48033.0b; Tavernier B, 1998, ANESTHESIOLOGY, V89, P1313, DOI 10.1097/00000542-199812000-00007; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	20	90	95	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					1984	1986		10.1016/S0140-6736(07)60926-X	http://dx.doi.org/10.1016/S0140-6736(07)60926-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574081				2022-12-24	WOS:000247354400009
J	Higashi, T; Wenger, NS; Adams, JL; Fung, C; Roland, M; McGlynn, EA; Reeves, D; Asch, SM; Kerr, EA; Shekelle, PG				Higashi, Takahiro; Wenger, Neil S.; Adams, John L.; Fung, Constance; Roland, Martin; McGlynn, Elizabeth A.; Reeves, David; Asch, Steven M.; Kerr, Eve A.; Shekelle, Paul G.			Relationship between number of medical conditions and quality of care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VULNERABLE OLDER-PEOPLE; UNITED-STATES; HEALTH-CARE; PRACTICE GUIDELINES; PERFORMANCE DATA; DIABETES CARE; DISEASES; ELDERS; PAY; GENERALIST	BACKGROUND: There is emerging concern that the methods used to measure the quality of care unfairly penalize providers caring for patients with multiple chronic conditions. We therefore sought to study the relationship between the quality of care and the number of medical conditions a patient has. METHODS: We assessed measurements of the quality of medical care received in three cohorts of community-dwelling adult patients in the Community Quality Index study, the Assessing Care of Vulnerable Elders study, and the Veterans Health Administration project (7680 patients in total). We analyzed the relationship between the quality of care that patients received, defined as the percentage of quality indicators satisfied among those for which patients were eligible, and the number of chronic medical conditions each patient had. We further explored the roles of characteristics of patients, use of health care (number of office visits and hospitalizations), and care provided by specialists as explanations for the observed relationship. RESULTS: The quality of care increased as the number of medical conditions increased. Each additional condition was associated with an increase in the quality score of 2.2% (95% confidence interval [CI], 1.7 to 2.7) in the Community Quality Index cohort, of 1.7% (95% CI, 1.1 to 2.4) in the Assessing Care of Vulnerable Elders cohort, and of 1.7% (95% CI, 0.7 to 2.8) in the Veterans Health Administration cohort. The relationship between the quality of care and the number of conditions was little affected by adjustment for the difficulty of delivering the care recommended in a quality indicator and for the fact that, because of multiple conditions requiring the same care, a patient could be eligible to receive the same care process more than once. Adjustment for characteristics of patients, use of health care, and care provided by specialists diminished the relationship, but it remained positive. CONCLUSIONS: The quality of care, measured according to whether patients were offered recommended services, increases as a patient's number of chronic conditions increases.	RAND Corp, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Kyoto Univ, Kyoto, Japan; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England; Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	RAND Corporation; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Kyoto University; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	shekelle@rand.org	Reeves, David/H-6203-2014; Adams, John/ABE-6170-2021; Kerr, Eve/I-3330-2013	Reeves, David/0000-0001-6377-6859; Roland, Martin/0000-0002-8533-3060				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Davies HTO, 1999, LANCET, V353, P1639, DOI 10.1016/S0140-6736(99)90047-8; Davies HTO, 2002, J HEALTH POLIT POLIC, V27, P379, DOI 10.1215/03616878-27-3-379; Desai MM, 2002, AM J PSYCHIAT, V159, P1584, DOI 10.1176/appi.ajp.159.9.1584; Diette GB, 2001, PEDIATRICS, V108, P432, DOI 10.1542/peds.108.2.432; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Forrest CB, 2006, AM J MANAG CARE, V12, P83; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Heflin MT, 2002, J AM GERIATR SOC, V50, P1651, DOI 10.1046/j.1532-5415.2002.50456.x; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kizer KW, 2000, MED CARE, V38, pS7; Mannion Russell, 2005, J Health Serv Res Policy, V10, P18; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; *RAND, 2006, QUAL HLTH CAR DEL AD; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shen YJ, 2003, HEALTH SERV RES, V38, P535, DOI 10.1111/1475-6773.00132; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	34	209	210	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2496	2504		10.1056/NEJMsa066253	http://dx.doi.org/10.1056/NEJMsa066253			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	178DR	17568030				2022-12-24	WOS:000247201900009
J	Rothman, DH; Forney, DC				Rothman, Daniel H.; Forney, David C.			Physical model for the decay and preservation of marine organic carbon	SCIENCE			English	Article							MATTER DECOMPOSITION; SEDIMENTS; FLUXES; SOILS	Degradation of marine organic carbon provides a major source of atmospheric carbon dioxide, whereas preservation in sediments results in accumulation of oxygen. These processes involve the slow decay of chemically recalcitrant compounds and physical protection. To assess the importance of physical protection, we constructed a reaction-diffusion model in which organic matter differs only in its accessibility to microbial degradation but not its intrinsic reactivity. The model predicts that organic matter decays logarithmically with time t and that decay rates decrease approximately as 0.2 x t(-1) until burial. Analyses of sediment-core data are consistent with these predictions.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rothman, DH (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dhr@mit.edu						ABELSON PH, 1978, ANNU REV EARTH PL SC, V6, P325, DOI 10.1146/annurev.ea.06.050178.001545; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bender C.M., 1978, ADV MATH METHODS SCI; Berner R.A., 1980, EARLY DIAGENESIS THE; Berner R.A., 2004, PHANEROZOIC CARBON C; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Burdige DJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1507, DOI 10.1016/S0016-7037(99)00066-6; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P29; KEIL RG, 1994, GEOCHIM COSMOCHIM AC, V58, P879, DOI 10.1016/0016-7037(94)90512-6; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; Knoll AH., 2003, LIFE YOUNG PLANET; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; MAYER LM, 1994, CHEM GEOL, V114, P347, DOI 10.1016/0009-2541(94)90063-9; MIDDELBURG JJ, 1993, GLOBAL PLANET CHANGE, V8, P47, DOI 10.1016/0921-8181(93)90062-S; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Ransom B, 1997, MAR GEOL, V138, P1, DOI 10.1016/S0025-3227(97)00012-1; REIMERS CE, 1983, MAR CHEM, V13, P141, DOI 10.1016/0304-4203(83)90022-1; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Steen AD, 2006, MAR CHEM, V101, P266, DOI 10.1016/j.marchem.2006.04.001; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Vetter YA, 1998, MICROBIAL ECOL, V36, P75, DOI 10.1007/s002489900095	32	91	93	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1325	1328		10.1126/science.1138211	http://dx.doi.org/10.1126/science.1138211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540901				2022-12-24	WOS:000246885600047
J	Samet, JM; Geyh, AS; Utell, MJ				Samet, Jonathan M.; Geyh, Alison S.; Utell, Mark J.			The legacy of World Trade Center dust	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTER DISASTER; EXPOSURE; COLLAPSE; FIRE		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester	Samet, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.							Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702	5	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2233	2236		10.1056/NEJMp068287	http://dx.doi.org/10.1056/NEJMp068287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172PO	17538082				2022-12-24	WOS:000246816500001
J	Lee, SH; Lim, CS; Park, H; Lee, JA; Han, JH; Kim, H; Cheang, YH; Lee, SH; Lee, YS; Ko, HG; Jang, DH; Kim, H; Miniaci, MC; Bartsch, D; Kim, E; Bailey, CH; Kandel, ER; Kaang, BK				Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kim, Hyongkyu; Miniaci, Maria C.; Bartsch, Dusan; Kim, Eunjoon; Bailey, Craig H.; Kandel, Eric R.; Kaang, Bong-Kiun			Nuclear translocation of CAM-associated protein activates transcription for long-term facilitation in Aplysia	CELL			English	Article							CELL-ADHESION MOLECULES; SYNAPTIC PLASTICITY; SENSORY NEURONS; MOTOR SYNAPSES; MEMORY STORAGE; PHOSPHORYLATION; EXPRESSION; OVEREXPRESSION; CONSOLIDATION; MODULATION	Repeated pulses of serotonin (5-HT) induce long-term facilitation (LTF) of the synapses between sensory and motor neurons of the gill-withdrawal reflex in Aplysia. To explore how apCAM downregulation at the plasma membrane and CREB-mediated transcription in the nucleus, both of which are required for the formation of LTF, might relate to each other, we cloned an apCAM-associated protein (CAMAP) by yeast two-hybrid screening. We found that 5-HT signaling at the synapse activates PKA which in turn phosphorylates CAMAP to induce the dissociation of CAMAP from apCAM and the subsequent translocation of CAMAP into the nucleus of sensory neurons. In the nucleus, CAMAP acts as a transcriptional coactivator for CREB1 and is essential for the activation of ApC/EBP required for the initiation of LTF. Combined, our data suggest that CAMAP is a retrograde signaling component that translocates from activated synapses to the nucleus during synapse-specific LTF.	[Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, Seoul 151747, South Korea; [Kim, Hyongkyu] Chungbuk Natl Univ, Coll Med, Cheongju 361763, South Korea; [Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, D-68159 Mannheim, Germany; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kandel, Eric R.] Howard Hughes Med Inst, New York, NY 10032 USA; [Miniaci, Maria C.; Bailey, Craig H.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kavli Inst Brain Sci, New York State Psychiat Inst, New York, NY 10032 USA	Seoul National University (SNU); Chungbuk National University; Central Institute of Mental Health; Korea Advanced Institute of Science & Technology (KAIST); Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, San 56-1 Silim Dong, Seoul 151747, South Korea.	kaang@snu.ac.kr	Han, Jin-Hee/C-2069-2011; Lee, Sue-Hyun/F-5490-2015; Lee, Seung-Hee/J-5971-2013; Park, Hyungju/C-4608-2016; Kim, Eunjoon/C-1566-2011	Lee, Sue-Hyun/0000-0002-5318-5657; Park, Hyungju/0000-0002-9010-9434; Ko, Hyoung-Gon/0000-0002-7730-6986; Miniaci, Maria/0000-0003-3844-0581; Han, Jin-Hee/0000-0002-2139-5596				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Byrne JH, 1996, J NEUROSCI, V16, P425; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Han JH, 2004, LEARN MEMORY, V11, P421, DOI 10.1101/lm.61104; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Lee JA, 2001, LEARN MEMORY, V8, P220, DOI 10.1101/lm.40201; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200	29	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					801	812		10.1016/j.cell.2007.03.041	http://dx.doi.org/10.1016/j.cell.2007.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512412	Bronze			2022-12-24	WOS:000246788300023
J	Zhang, LF; Huynh, KD; Lee, JT				Zhang, Li-Feng; Huynh, Khanh D.; Lee, Jeannie T.			Perinucleolar targeting of the inactive X during S phase: Evidence for a role in the maintenance of silencing	CELL			English	Article							EARLY MOUSE EMBRYOS; TRANSFER-RNA GENES; CHROMOSOME INACTIVATION; DNA-REPLICATION; HUMAN-FIBROBLASTS; XIST GENE; INTERPHASE; TSIX; LOCALIZATION; CELL	In mammalian females, two X chromosomes are epigenetically distinguished as active and inactive chromosomes to balance X-linked gene dosages between males and females. How the Xs are maintained differently in the same nucleus remains unknown. Here, we demonstrate that the inactive X (Xi) is targeted to a distinct nuclear compartment following pairing with its homologous partner. During mid-to-late S phase, 80%-90% of Xi contact the nucleolus and reside within a Snf2h-enriched ring. Autosomes carrying ectopic X-inactivation center sequences are also targeted to the perinucleolar compartment. Deleting Xist results in a loss of nucleolar association and an inability to maintain Xi heterochromatin, leading to Xi reactivation at the single gene level. We propose that the Xi must continuously visit the perinucleolar compartment to maintain its epigenetic state. These data raise a mechanism by which chromatin states can be replicated by spatial and temporal separation in the nucleus.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Zhang, Li-Feng/A-2209-2011	Zhang, Li-Feng/0000-0003-0917-0017	NCI NIH HHS [K01-CA115593] Funding Source: Medline; NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA115593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bailis JM, 2003, CELL CYCLE, V2, P303, DOI 10.4161/cc.2.4.434; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BARTON DE, 1964, ANN HUM GENET, V28, P123, DOI 10.1111/j.1469-1809.1964.tb00467.x; BELMONT AS, 1986, EXP CELL RES, V165, P165, DOI 10.1016/0014-4827(86)90541-0; BORDEN J, 1988, SCIENCE, V242, P1687, DOI 10.1126/science.3201257; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOURGEOIS CA, 1985, HUM GENET, V69, P122, DOI 10.1007/BF00293281; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; COMINGS DE, 1968, AM J HUM GENET, V20, P440; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Diaz-Perez SV, 2006, GENETICS, V174, P1115, DOI 10.1534/genetics.105.051375; DYER KA, 1989, CYTOGENET CELL GENET, V50, P116, DOI 10.1159/000132736; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	47	251	263	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					693	706		10.1016/j.cell.2007.03.036	http://dx.doi.org/10.1016/j.cell.2007.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512404	Bronze			2022-12-24	WOS:000246788300015
J	Bolton, P; Bass, J; Betancourt, T; Speelman, L; Onyango, G; Clougherty, KF; Neugebauer, R; Murray, L; Verdeli, H				Bolton, Paul; Bass, Judith; Betancourt, Theresa; Speelman, Liesbeth; Onyango, Grace; Clougherty, Kathleen F.; Neugebauer, Richard; Murray, Laura; Verdeli, Helen			Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERPERSONAL PSYCHOTHERAPY; DIFFICULTIES QUESTIONNAIRE; MENTAL-HEALTH; PRIMARY-CARE; STRENGTHS; CHILD; EFFICACY; VALIDITY; IMPACT	Context Prior qualitative work with internally displaced persons in war-affected northern Uganda showed significant mental health and psychosocial problems. Objective To assess effect of locally feasible interventions on depression, anxiety, and conduct problem symptoms among adolescent survivors of war and displacement in northern Uganda. Design, Setting, and Participants A randomized controlled trial from May 2005 through December 2005 of 314 adolescents ( aged 14-17 years) in 2 camps for internally displaced persons in northern Uganda. Interventions Locally developed screening tools assessed the effectiveness of interventions in reducing symptoms of depression and anxiety, ameliorating conduct problems, and improving function among those who met study criteria and were randomly allocated ( 105, psychotherapy-based intervention [ group interpersonal psychotherapy]; 105, activity-based intervention [ creative play]; 104, wait-control group [ individuals wait listed to receive treatment at study end]). Intervention groups met weekly for 16 weeks. Participants and controls were reassessed at end of study. Main Outcome Measures Primary measure was a decrease in score ( denoting improvement) on a depression symptom scale. Secondary measures were improvements in scores on anxiety, conduct problem symptoms, and function scales. Depression, anxiety, and conduct problems were assessed using the Acholi Psychosocial Assessment Instrument with a minimum score of 32 as the lower limit for clinically significant symptoms ( maximum scale score, 105). Results Difference in change in adjusted mean score for depression symptoms between group interpersonal psychotherapy and control groups was 9.79 points (95% confidence interval [CI], 1.66-17.93). Girls receiving group interpersonal psychotherapy showed substantial and significant improvement in depression symptoms compared with controls (12.61 points; 95% CI, 2.09-23.14). Improvement among boys was not statistically significant (5.72 points; 95% CI, - 1.86 to 13.30). Creative play showed no effect on depression severity (-2.51 points; 95% CI, - 11.42 to 6.39). There were no statistically different improvements in anxiety in either intervention group. Neither intervention improved conduct problem or function scores. Conclusions Both interventions were locally feasible. Group interpersonal psychotherapy was effective for depression symptoms among adolescent girls affected by war and displacement. Other interventions should be investigated to assist adolescent boys in this population who have symptoms of depression.	Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Dept Mental Hlth, Baltimore, MD 21205 USA; Boston Univ, Sch Publ Hlth, Appl Mental Hlth Res Grp, Ctr Int Hlth & Dev, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Dept Populat & Int Hlth, Boston, MA 02115 USA; War child Holland, Gulu, Uganda; World Vis Uganda, Kampala, Uganda; Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Div Epidemiol, New York, NY USA; Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, Fac Med, New York, NY USA; Columbia Univ, Teachers Coll, New York, NY 10027 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Columbia University Teachers College	Bolton, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Refugee & Disaster Response, Dept Mental Hlth, 615 N Wolfe St,Room E8646, Baltimore, MD 21205 USA.	pbolton@jhsph.edu		Bass, Judith/0000-0002-5192-628X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], CHILD SOLD GLOB REP; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Barenbaum J, 2004, J CHILD PSYCHOL PSYC, V45, P41, DOI 10.1046/j.0021-9630.2003.00304.x; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P151; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Igreja V, 2004, BRIT J PSYCHIAT, V184, P251, DOI 10.1192/bjp.184.3.251; KALKSMAVANLITH B, 2005, STATE ART PSYCHOSOCI; KASHALA E, 2006, CO EXISTING SYMPTOMS; Lin EHB, 2000, ARCH FAM MED, V9, P1052, DOI 10.1001/archfami.9.10.1052; Lustig SL, 2004, J AM ACAD CHILD PSY, V43, P24, DOI 10.1097/00004583-200401000-00012; Mufson L, 1999, ARCH GEN PSYCHIAT, V56, P573, DOI 10.1001/archpsyc.56.6.573; Mufson Laura, 2004, American Journal of Psychotherapy, V58, P220; Omar RZ, 2000, STAT MED, V19, P2675, DOI 10.1002/1097-0258(20001015)19:19<2675::AID-SIM556>3.3.CO;2-1; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; PROSCHAN MA, 1995, AM STAT, V49, P144, DOI 10.2307/2684628; Samad L, 2005, INT J METH PSYCH RES, V14, P158, DOI 10.1002/mpr.3; Stichick T, 2001, CHILD ADOL PSYCH CL, V10, P797, DOI 10.1016/S1056-4993(18)30031-2; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; Thabet AAM, 2004, CHILD ABUSE NEGLECT, V28, P77, DOI 10.1016/j.chiabu.2002.12.002; WEISSMAN MM, 1981, ARCH GEN PSYCHIAT, V38, P51; WEISSMAN MM, 2000, COMPREHENSIVE GUIDE; Young JF, 2006, J AM ACAD CHILD PSY, V45, P904, DOI 10.1097/01.chi.0000222791.23927.5f	29	340	340	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					519	527		10.1001/jama.298.5.519	http://dx.doi.org/10.1001/jama.298.5.519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666672	Bronze			2022-12-24	WOS:000248438100019
J	Matheu, A; Maraver, A; Klatt, P; Flores, I; Garcia-Cao, I; Borras, C; Flores, JM; Vina, J; Blasco, MA; Serrano, M				Matheu, Ander; Maraver, Antonio; Klatt, Peter; Flores, Ignacio; Garcia-Cao, Isabel; Borras, Consuelo; Flores, Juana M.; Vina, Jose; Blasco, Maria A.; Serrano, Manuel			Delayed ageing through damage protection by the Arf/p53 pathway	NATURE			English	Article							P53 TUMOR-SUPPRESSOR; MAMMALIAN LIFE-SPAN; ONCOGENIC RAS; DNA-DAMAGE; MICE; SENESCENCE; RESISTANT; STRESS; GROWTH; AGE	The tumour-suppressor pathway formed by the alternative reading frame protein of the Cdkn2a locus (Arf) and by p53 (also called Trp53) plays a central part in the detection and elimination of cellular damage, and this constitutes the basis of its potent cancer protection activity(1,2). Similar to cancer, ageing also results from the accumulation of damage and, therefore, we have reasoned that Arf/p53 could have anti-ageing activity by alleviating the load of age-associated damage. Here we show that genetically manipulated mice with increased, but otherwise normally regulated, levels of Arf and p53 present strong cancer resistance and have decreased levels of ageing-associated damage. These observations extend the protective role of Arf/p53 to ageing, revealing a previously unknown anti-ageing mechanism and providing a rationale for the co-evolution of cancer resistance and longevity.	Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid 28029, Spain; Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, Madrid 28029, Spain; Univ Valencia, Dept Physiol, Valencia 46010, Spain; Univ Complutense Madrid, Dept Anim Surg & Med, E-28040 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia; Complutense University of Madrid	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid 28029, Spain.	mserrano@cnio.es	Flores, Ignacio/E-8304-2016; Vina, Jose/AAB-3069-2021; Maraver, Antonio/G-2666-2015; Serrano, Manuel/H-2634-2015; Blasco, Maria A./M-1694-2014; borras, consuelo/Y-3407-2019; matheu, ander/G-9906-2014	Flores, Ignacio/0000-0001-8789-6396; Vina, Jose/0000-0001-9709-0089; Serrano, Manuel/0000-0001-7177-9312; Blasco, Maria A./0000-0002-4211-233X; borras, consuelo/0000-0003-4606-1792; matheu, ander/0000-0002-1848-0781; Maraver, Antonio/0000-0002-5527-5680				Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X; ASENSI M, 1994, METHOD ENZYMOL, V234, P367; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; INGRAM DK, 1986, EXP AGING RES, V12, P155; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2005, J BIOL CHEM, V280, P42433, DOI 10.1074/jbc.M508270200; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WEXLER H, 1979, J NATL CANCER I, V63, P1393; WONG SHY, 1987, CLIN CHEM, V33, P214; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	38	371	383	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					375	U14		10.1038/nature05949	http://dx.doi.org/10.1038/nature05949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637672				2022-12-24	WOS:000248118300063
J	Sato, T; Mushiake, S; Kato, Y; Sato, K; Sato, M; Takeda, N; Ozono, K; Miki, K; Kubo, Y; Tsuji, A; Harada, R; Harada, A				Sato, Takashi; Mushiake, Sotaro; Kato, Yukio; Sato, Ken; Sato, Miyuki; Takeda, Naoki; Ozono, Keiichi; Miki, Kazunori; Kubo, Yoshiyuki; Tsuji, Akira; Harada, Reiko; Harada, Akihiro			The Rab8 GTPase regulates apical protein localization in intestinal cells	NATURE			English	Article							CONGENITAL MICROVILLOUS ATROPHY; BETA-LACTAM ANTIBIOTICS; EPITHELIAL-CELLS; MEMBRANE; MICE; ABSORPTION; MECHANISMS; TRANSPORT; POLARITY; NEURONS	A number of proteins are known to be involved in apical/basolateral transport of proteins in polarized epithelial cells(1-7). The small GTP-binding protein Rab(8) was thought to regulate basolateral transport in polarized kidney epithelial cells through the AP1B-complex-mediated pathway(8,9). However, the role of Rab8 (Rab8A) in cell polarity in vivo remains unknown. Here we show that Rab8 is responsible for the localization of apical proteins in intestinal epithelial cells. We found that apical peptidases and transporters localized to lysosomes in the small intestine of Rab8-deficient mice. Their mislocalization and degradation in lysosomes led to a marked reduction in the absorption rate of nutrients in the small intestine, and ultimately to death. Ultrastructurally, a shortening of apical microvilli, an increased number of enlarged lysosomes, and microvillus inclusions in the enterocytes were also observed. One microvillus inclusion disease patient who shows an identical phenotype to Rab8-deficient mice expresses a reduced amount of RAB8 (RAB8A; NM_005370). Our results demonstrate that Rab8 is necessary for the proper localization of apical proteins and the absorption and digestion of various nutrients in the small intestine.	Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; Kanazawa Univ, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; Kumamoto Univ, Div Transgen Technol, CARD, IRDA, Kumamoto 8600811, Japan; Itami Municipal Hosp, Dept Pediat, Itami, Hyogo 6648540, Japan	Osaka University; Kanazawa University; Kumamoto University	Harada, A (corresponding author), Gunma Univ, Lab Mol Traff, Dept Mol & Cellular Biol, Inst Mol & Cellular Regulat, Gunma 3718512, Japan.	aharada@showa.gunma-u.ac.jp	KATO, Yukio/D-8396-2015; Sato, Miyuki/S-5112-2018; Kubo, Yoshiyuki/Q-6069-2019	Sato, Miyuki/0000-0002-1944-4918; Kubo, Yoshiyuki/0000-0002-7905-5666				Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; DAVIDSON GP, 1978, GASTROENTEROLOGY, V75, P783; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HARADA A, 1990, CELL STRUCT FUNCT, V15, P329, DOI 10.1247/csf.15.329; HOMAREDA H, 1993, FEBS LETT, V327, P99, DOI 10.1016/0014-5793(93)81048-5; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Ishida Y, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e35; Kagitani K, 1998, J BONE MINER RES, V13, P1946, DOI 10.1359/jbmr.1998.13.12.1946; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cb.08.110192.001105; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Nakamura N, 2001, J BIOCHEM-TOKYO, V130, P765, DOI 10.1093/oxfordjournals.jbchem.a003047; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; PHILLIPS AD, 1985, ARCH DIS CHILD, V60, P135, DOI 10.1136/adc.60.2.135; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rodriguez-Boulan E, 2004, CURR OPIN CELL BIOL, V16, P436, DOI 10.1016/j.ceb.2004.06.013; Sabatini DD, 2005, ANNU REV CELL DEV BI, V21, P1, DOI 10.1146/annurev.cellbio.21.020904.151711; Saito H, 1995, J PHARMACOL EXP THER, V275, P1631; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sasaki T, 2002, TRANSPLANTATION, V73, P560, DOI 10.1097/00007890-200202270-00013; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tamai I, 1997, J PHARM PHARMACOL, V49, P796, DOI 10.1111/j.2042-7158.1997.tb06115.x; UMESAKI Y, 1982, J BIOCHEM-TOKYO, V92, P373, DOI 10.1093/oxfordjournals.jbchem.a133943; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	28	240	246	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					366	369		10.1038/nature05929	http://dx.doi.org/10.1038/nature05929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17597763				2022-12-24	WOS:000248118300061
J	Fountain, SJ; Parkinson, K; Young, MT; Cao, LS; Thompson, CRL; North, RA				Fountain, Samuel J.; Parkinson, Katie; Young, Mark T.; Cao, Lishuang; Thompson, Christopher R. L.; North, R. Alan			An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum	NATURE			English	Article							CONTRACTILE VACUOLE; ION CHANNELS; MOLECULAR-PROPERTIES; MEMBRANE; TRIMERS; PROTEIN; MOTIF; LVSA	P2X receptors are membrane ion channels gated by extracellular ATP(1,2) that are found widely in vertebrates, but not previously in microbes. Here we identify a weakly related gene in the genome of the social amoeba Dictyostelium discoideum, and show, with the use of heterologous expression in human embryonic kidney cells, that it encodes a membrane ion channel activated by ATP (30-100 mu M). Site-directed mutagenesis revealed essential conservation of structure-function relations with P2X receptors of higher organisms. The receptor was insensitive to the usual P2X antagonists(3) but was blocked by nanomolar concentrations of Cu2+ ions. In D. discoideum, the receptor was found on intracellular membranes, with prominent localization to an osmoregulatory organelle, the contractile vacuole. Targeted disruption of the gene in D. discoideum resulted in cells that were unable to regulate cell volume in hypotonic conditions. Cell swelling in these mutant cells was accompanied by a marked inhibition of contractile vacuole emptying. These findings demonstrate a new functional role for P2X receptors on intracellular organelles, in this case in osmoregulation.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Thompson, CRL (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	christopher.thompson@manchester.ac.uk; r.a.north@manchester.ac.uk	North, Richard/GQA-6156-2022; Young, Mark T/E-8928-2010; Fountain, Samuel J/C-2142-2011	Young, Mark T/0000-0002-9615-9002; 	Medical Research Council [G0400103, G0400103(70396)] Funding Source: Medline; Wellcome Trust [074950] Funding Source: Medline; MRC [G0400103] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen RD, 2000, BIOESSAYS, V22, P1035; Allen RD, 2002, INT REV CYTOL, V215, P351; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Masse K, 2006, GENOMICS, V87, P366, DOI 10.1016/j.ygeno.2005.11.003; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wu WI, 2004, TRAFFIC, V5, P346, DOI 10.1111/j.1600-0854.2004.00177.x; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	19	115	118	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					200	203		10.1038/nature05926	http://dx.doi.org/10.1038/nature05926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625565	Green Accepted			2022-12-24	WOS:000247934500044
J	Lyerly, AD; Faden, RR				Lyerly, Anne Drapkin; Faden, Ruth R.			Embryonic stem cells - Willingness to donate frozen embryos for stem cell research	SCIENCE			English	Editorial Material							COUPLES DECISIONS; ATTITUDES		Duke Univ, Med Ctr, Durham, NC 27710 USA; Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA	Duke University; Johns Hopkins University	Lyerly, AD (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	lyerl003@mc.duke.edu		Lyerly, Anne/0000-0003-2211-6920	NHLBI NIH HHS [K01 HL79517-01] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRIDGES A, 2007, WASHINGTON POST 0319; Burton PJ, 2004, MED J AUSTRALIA, V180, P559, DOI 10.5694/j.1326-5377.2004.tb06091.x; Choudhary M, 2004, HUM REPROD, V19, P2091, DOI 10.1093/humrep/deh401; de Lacey S, 2005, HUM REPROD, V20, P1661, DOI 10.1093/humrep/deh831; Hammarberg K, 2006, FERTIL STERIL, V86, P86, DOI 10.1016/j.fertnstert.2005.11.071; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; HUDSON K, 2005, VALUES CONFLICT PUBL; LARUELLE C, 1995, FERTIL STERIL, V63, P1047, DOI 10.1016/S0015-0282(16)57546-3; Lyerly AD, 2006, FERTIL STERIL, V85, P1623, DOI 10.1016/j.fertnstert.2005.11.056; McMahon CA, 2003, HUM REPROD, V18, P871, DOI 10.1093/humrep/deg167; Van Voorhis BJ, 1999, FERTIL STERIL, V71, P604, DOI 10.1016/S0015-0282(98)00545-7; 2006, PRESIDENT DISCUSSES	12	39	39	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					46	47		10.1126/science.1145067	http://dx.doi.org/10.1126/science.1145067			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17588897				2022-12-24	WOS:000247776700030
J	Perrin, JM; Bloom, SR; Gortmaker, SL				Perrin, James M.; Bloom, Sheila R.; Gortmaker, Steven L.			The increase of childhood chronic conditions in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUNG ADULTHOOD; CHILDREN; OBESITY; PREVALENCE; OVERWEIGHT; ASTHMA; ADOLESCENTS; DISABILITY; DISORDERS; TRENDS		MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Perrin, JM (corresponding author), MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, 50 Staniford St,Suite 901, Boston, MA 02114 USA.	jperrin@partners.org		Perrin, James/0000-0002-1810-3708	PHS HHS [U 53 MC 04473, U48/CCU115807] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akinbami, 2006, STATE CHILDHOOD ASTH, V381; American Psychiatric Association, 1968, DIAGN STAT MAN MENT; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GORTMAKER SL, 1984, PEDIATR CLIN N AM, V31, P3; GREEN M, 1999, DIAGNOSIS ATTENTION, V3; Koplan J., 2005, PREVENTING CHILDHOOD; *NAT COMM CHILDH D, 1995, SUPPL SEC INC CHILDR; National Center for Health Statistics, 2006, HLTH US CHARTB TREND; NEWACHECK PW, 1984, AM J PUBLIC HEALTH, V74, P232, DOI 10.2105/AJPH.74.3.232; Newacheck PW, 2000, ARCH PEDIAT ADOL MED, V154, P287, DOI 10.1001/archpedi.154.3.287; Newacheck PW, 1998, PEDIATRICS, V102, P117, DOI 10.1542/peds.102.1.117; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; *SOC SEC ADM, 2005, CHILDR REC SSI; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; World Health Organization, INT CLASS FUNCT DIS	25	338	346	1	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2755	2759		10.1001/jama.297.24.2755	http://dx.doi.org/10.1001/jama.297.24.2755			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595277				2022-12-24	WOS:000247528700026
J	Mann, DL				Mann, Douglas L.			MicroRNAs and the failing heart	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FAILURE		Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA; St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute	Mann, DL (corresponding author), Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA.		Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145				JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MANN DL, 2005, CIRCULATION, V112, pE75; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103	5	42	46	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2644	2645		10.1056/NEJMcibr072068	http://dx.doi.org/10.1056/NEJMcibr072068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180GN	17582077				2022-12-24	WOS:000247351200014
J	Kruhlak, M; Crouch, EE; Orlov, M; Montano, C; Gorski, SA; Nussenzweig, A; Misteli, T; Phair, RD; Casellas, R				Kruhlak, Michael; Crouch, Elizabeth E.; Orlov, Marika; Montano, Carolina; Gorski, Stanislaw A.; Nussenzweig, Andre; Misteli, Tom; Phair, Robert D.; Casellas, Rafael			The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; CELLS; PHOSPHORYLATION; COMPONENTS; NUCLEOLUS; STRESS; GENOME; KINASE; VIVO	DNA lesions interfere with DNA and RNA polymerase activity. Cyclobutane pyrimidine dimers and photoproducts generated by ultraviolet irradiation cause stalling of RNA polymerase II, activation of transcription-coupled repair enzymes, and inhibition of RNA synthesis(1,2). During the S phase of the cell cycle, collision of replication forks with damaged DNA blocks ongoing DNA replication while also triggering a biochemical signal that suppresses the firing of distant origins of replication(3,4). Whether the transcription machinery is affected by the presence of DNA double-strand breaks remains a long-standing question. Here we monitor RNA polymerase I ( Pol I) activity in mouse cells exposed to genotoxic stress and show that induction of DNA breaks leads to a transient repression in Pol I transcription. Surprisingly, we find Pol I inhibition is not itself the direct result of DNA damage but is mediated by ATM kinase activity and the repair factor proteins NBS1 ( also known as NLRP2) and MDC1. Using live-cell imaging, laser micro-irradiation, and photobleaching technology we demonstrate that DNA lesions interfere with Pol I initiation complex assembly and lead to a premature displacement of elongating holoenzymes from ribosomal DNA. Our data reveal a novel ATM/NBS1/MDC1-dependent pathway that shuts down ribosomal gene transcription in response to chromosome breaks.	NIAMS, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; Integrat Bioinformat, Los Altos, CA 94024 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Casellas, R (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov		Montano, Carolina/0000-0002-2772-2025; Gorski, Stan/0000-0003-0539-3395; Crouch, Elizabeth/0000-0002-4110-9892; Orlov, Marika/0000-0003-1961-0813	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283, ZIABC010309, Z01BC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, Z01AR041149] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; MAYNE LV, 1982, CANCER RES, V42, P1473; Michaelidis TM, 2002, BIOL CHEM, V383, P1683, DOI 10.1515/BC.2002.189; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Seither P, 1997, MOL GEN GENET, V255, P180, DOI 10.1007/s004380050487; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023	22	215	220	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					730	U16		10.1038/nature05842	http://dx.doi.org/10.1038/nature05842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554310				2022-12-24	WOS:000247030700047
J	Buhler, M; Haas, W; Gygi, SP; Moazed, D				Buehler, Marc; Haas, Wilhelm; Gygi, Steven P.; Moazed, Danesh			RNAi-dependent and -independent RNA turnover mechanisms contribute to heterochromatic gene silencing	CELL			English	Article							FISSION YEAST; EPIGENETIC CONTROL; LYSINE-9 METHYLATION; POLY(A) POLYMERASE; QUALITY-CONTROL; MESSENGER-RNAS; COMPLEX; INTERFERENCE; PROTEIN; RITS	In fission yeast, the RNAi pathway is required for heterochromatin-dependent silencing of transgene insertions at centromeric repeats and acts together with other pathways to silence transgenes at the silent mating-type locus. Here, we show that transgene transcripts at centromeric repeats are processed into siRNAs and are therefore direct targets of RNAL Furthermore, we show that Cid14, a member of the Trf4/5 family of poly(A) polymerases, has poly(A) polymerase activity that is required for heterochromatic gene silencing. Surprisingly, while siRNA levels in cid14 Delta cells are dramatically reduced, the structural integrity of heterochromatin appears to be preserved. Cid14 resides in a complex similar to the TRAMP complex found in budding yeast, which is part of a nuclear surveillance mechanism that degrades aberrant transcripts. Our findings indicate that polyadenylation by a TRAMP-like complex contributes to robust silencing of heterochromatic genes in fission yeast via the recruitment of the exosome and/or the RNAi machinery.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Buehler, Marc/S-5866-2019; Bühler, Marc/B-1134-2010	Buehler, Marc/0000-0001-6661-9795; Bühler, Marc/0000-0001-6661-9795				Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Partridge JF, 2000, GENE DEV, V14, P783; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; THON G, 1992, GENETICS, V131, P287; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	49	190	197	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					707	721		10.1016/j.cell.2007.03.038	http://dx.doi.org/10.1016/j.cell.2007.03.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512405	Bronze			2022-12-24	WOS:000246788300016
J	Albert, MS				Albert, Marilyn S.			Changing the trajectory of cognitive decline?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; AMYLOID DEPOSITION; TRANSGENIC MICE		Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Albert, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.							Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	5	9	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					502	503		10.1056/NEJMcibr073273	http://dx.doi.org/10.1056/NEJMcibr073273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671260				2022-12-24	WOS:000248436300016
J	Gazelle, G				Gazelle, Gail			Understanding hospice - An underutilized option for life's final chapter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		MD Can Help, Boston, MA USA		Gazelle, G (corresponding author), MD Can Help, Boston, MA USA.							Emanuel L L, 2000, J Palliat Med, V3, P419, DOI 10.1089/jpm.2000.3.4.419; National Hospice and Palliative Care Organization, 2006, NHCPOS FACTS FIG 200; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011	5	48	48	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					321	324		10.1056/NEJMp078067	http://dx.doi.org/10.1056/NEJMp078067			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652645				2022-12-24	WOS:000248283500001
J	Watts, G				Watts, Geoff			Commentary: Liquid automation refreshes Dr Papanicolaou	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						DAVEY E, 2007, BMJ; DAWSON AE, 2004, CANC CYTOPATHOLOGY; Henstock E., 2002, EVALUATION HPV LBC C; LINDER J, 2004, EUR INT EXP M NIC OC; RONCO G, 2007, BMJ	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 7	2007	335	7609					35	36		10.1136/bmj.39260.482616.DE	http://dx.doi.org/10.1136/bmj.39260.482616.DE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	191LY	17615223	Green Published			2022-12-24	WOS:000248133900033
J	Cognet, L; Tsyboulski, DA; Rocha, JDR; Doyle, CD; Tour, JM; Weisman, RB				Cognet, Laurent; Tsyboulski, Dmitri A.; Rocha, John-David R.; Doyle, Condell D.; Tour, James M.; Weisman, R. Bruce			Stepwise quenching of exciton fluorescence in carbon nanotubes by single-molecule reactions	SCIENCE			English	Article							FUNCTIONALIZATION	Single-molecule chemical reactions with individual single-walled carbon nanotubes were observed through near-infrared photoluminescence microscopy. The emission intensity within distinct submicrometer segments of single nanotubes changed in discrete steps after exposure to acid, base, or diazonium reactants. The steps were uncorrelated in space and time and reflected the quenching of mobile excitons at localized sites of reversible or irreversible chemical attack. Analysis of step amplitudes revealed an exciton diffusional range of about 90 nanometers, independent of nanotube structure. Each exciton visited about 10,000 atomic sites during its lifetime, providing highly efficient sensing of local chemical and physical perturbations.	Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France; CNRS, F-33405 Talence, France; Rice Univ, Dept Chem, Ctr Biol & Environm Nanotechnol, Houston, TX 77005 USA; Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Rice University; Rice University	Cognet, L (corresponding author), Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France.	lcognet@u-bordeaux1.fr; weisman@rice.edu	Rocha, John-David Ray/AAV-1170-2020; Cognet, Laurent/F-4163-2011; Cognet, Laurent/M-4505-2019	Rocha, John-David Ray/0000-0001-6394-4349; Cognet, Laurent/0000-0002-3573-5387; Tour, James/0000-0002-8479-9328; Weisman, R. Bruce/0000-0001-8546-9980				Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bonifazi D, 2006, NANO LETT, V6, P1408, DOI 10.1021/nl060394d; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Dresselhaus M. S., 2001, CARBON NANOTUBES SYN; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Dyke CA, 2004, SYNLETT, P155, DOI 10.1055/s-2003-44983; Hagen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.197401; Hartschuh A, 2003, SCIENCE, V301, P1354, DOI 10.1126/science.1087118; Heller DA, 2004, J AM CHEM SOC, V126, P14567, DOI 10.1021/ja046450z; Htoon H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.027401; Jones M, 2007, NANO LETT, V7, P300, DOI 10.1021/nl0622808; Korovyanko OJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017403; Lefebvre J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075403; Ma YZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157402; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Pedersen TG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.073401; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Russo RM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041405; Spataru CD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247402; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Usrey ML, 2005, J AM CHEM SOC, V127, P16129, DOI 10.1021/ja0537530; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403	29	387	393	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1465	1468		10.1126/science.1141316	http://dx.doi.org/10.1126/science.1141316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556581	Green Submitted			2022-12-24	WOS:000247066400039
J	MacDonald, R				MacDonald, Rhona			The continuing battle over baby-milk formula	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), Lancet, London NW1 7BY, England.							Cawthorne P, 2007, LANCET, V369, P974, DOI 10.1016/S0140-6736(07)60473-5; Ferriman A, 1999, BRIT MED J, V318, P417, DOI 10.1136/bmj.318.7181.417a; Moorhead Joanna, 2007, GUARDIAN        0515; PARSONS H, 2007, GUARDIAN        0522, P35; *SAV CHILDR UK, 2007, GEN BAB MILK MARK ST	5	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1773	1773		10.1016/S0140-6736(07)60795-8	http://dx.doi.org/10.1016/S0140-6736(07)60795-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17531871				2022-12-24	WOS:000246819300009
J	Berghuis, P; Rajnicek, AM; Morozov, YM; Ross, RA; Mulder, J; Urban, GM; Monory, K; Marsicano, G; Matteoli, M; Canty, A; Irving, AJ; Katona, I; Yanagawa, Y; Rakic, P; Lutz, B; Mackie, K; Harkany, T				Berghuis, Paul; Rajnicek, Ann M.; Morozov, Yury M.; Ross, Ruth A.; Mulder, Jan; Urban, Gabriella M.; Monory, Krisztina; Marsicano, Giovanni; Matteoli, Michela; Canty, Alison; Irving, Andrew J.; Katona, Istvan; Yanagawa, Yuchio; Rakic, Pasko; Lutz, Beat; Mackie, Ken; Harkany, Tibor			Hardwiring the brain: Endocannabinoids shape neuronal connectivity	SCIENCE			English	Article							GROWTH CONE GUIDANCE; RHO GTPASES; CANNABINOIDS; INTERNEURONS; EXPRESSION; SYNAPSES; KINASE	The roles of endocannabinoid signaling during central nervous system development are unknown. We report that CB1 cannabinoid receptors (CB(1)Rs) are enriched in the axonal growth cones of gamma-aminobutyric acid-containing ( GABAergic) interneurons in the rodent cortex during late gestation. Endocannabinoids trigger CB1R internalization and elimination from filopodia and induce chemorepulsion and collapse of axonal growth cones of these GABAergic interneurons by activating RhoA. Similarly, endocannabinoids diminish the galvanotropism of Xenopus laevis spinal neurons. These findings, together with the impaired target selection of cortical GABAergic interneurons lacking CB(1)Rs, identify endocannabinoids as axon guidance cues and demonstrate that endocannabinoid signaling regulates synaptogenesis and target selection in vivo.	Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Hungarian Acad Sci, Inst Expt Med, Lab Cerebral Cortex Res, H-1083 Budapest, Hungary; Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Milan, Dept Med Pharmacol, I-20129 Milan, Italy; Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Gunma Univ, Grad Sch Med, Maebashi, Gunma 3718511, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Maebashi, Gunma 3718511, Japan; Univ Washington, Dept Anesthesiol Physiol, Seattle, WA 98195 USA; Univ Washington, Dept Biophys, Seattle, WA 98195 USA	Karolinska Institutet; University of Aberdeen; Yale University; Karolinska Institutet; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johannes Gutenberg University of Mainz; University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Dundee; Gunma University; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Harkany, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	Tibor.Harkany@ki.se	Lutz, Beat/AFK-6229-2022; Mulder, Jan/G-3909-2011; Rajnicek, Ann/K-7991-2014; Mulder, Jan/B-2972-2010; Canty, Alison/J-7649-2014; Mackie, Ken/E-3715-2013; Mulder, Jan/AAG-9761-2021; Katona, Istvan/D-9729-2011; Lutz, Beat/AAG-4538-2022; Matteoli, Michela/K-4526-2018; Mackie, Kenneth P/B-7358-2011; Marsicano, Giovanni/I-9603-2016	Mulder, Jan/0000-0003-3717-5018; Rajnicek, Ann/0000-0003-2706-0014; Canty, Alison/0000-0001-5165-2365; Mackie, Ken/0000-0001-8501-6199; Katona, Istvan/0000-0003-2808-3330; Matteoli, Michela/0000-0002-3569-7843; Morozov, Yury/0000-0002-3679-6819; Marsicano, Giovanni/0000-0003-3804-1951	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA015916, K02DA000286, R01DA011322] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00286, DA11322, DA015916] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim D, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0004.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Mato S, 2003, EUR J NEUROSCI, V17, P1747, DOI 10.1046/j.1460-9568.2003.02599.x; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Morozov YM, 2003, EUR J NEUROSCI, V18, P1213, DOI 10.1046/j.1460-9568.2003.02852.x; Morozov YM, 2006, J NEUROSCI, V26, P5017, DOI 10.1523/JNEUROSCI.0272-06.2006; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang X, 2003, NEUROSCIENCE, V118, P681, DOI 10.1016/S0306-4522(03)00020-4; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	28	366	378	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1212	1216		10.1126/science.1137406	http://dx.doi.org/10.1126/science.1137406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525344				2022-12-24	WOS:000246724300049
J	Ferguson, AD; McKeever, BM; Xu, SH; Wisniewski, D; Miller, DK; Yamin, TT; Spencer, RH; Chu, L; Ujjainwalla, F; Cunningham, BR; Evans, JF; Becker, JW				Ferguson, Andrew D.; McKeever, Brian M.; Xu, Shihua; Wisniewski, Douglas; Miller, Douglas K.; Yamin, Ting-Ting; Spencer, Robert H.; Chu, Lin; Ujjainwalla, Feroze; Cunningham, Barry R.; Evans, Jilly F.; Becker, Joseph W.			Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein	SCIENCE			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITORS; MICROSOMAL GLUTATHIONE TRANSFERASE; AMINO-ACID-RESIDUES; ACTIVATING PROTEIN; C-4 SYNTHASE; IN-VIVO; BINDING; IDENTIFICATION; LEUKOCYTES; PROJECTION	Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4.0 and 4.2 angstrom resolution, respectively. The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis. This structural information provides a platform for the development of therapeutics for respiratory and cardiovascular diseases.	Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; Merck Res Labs, Dept Infect Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pain Res, West Point, PA 19486 USA; Vitae Pharmaceut, Ft Washington, PA 19034 USA; Wyeth Ayerst Res, Collegeville, PA 19426 USA; Cara Therapeut, Tarrytown, NY 10591 USA; Amira Pharmaceut, San Diego, CA 92121 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Pfizer	Becker, JW (corresponding author), Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA.	joseph_becker@merck.com	Wisniewski, Douglas/AAT-9198-2021					ANDERSSON C, 1994, BBA-PROTEIN STRUCT M, V1204, P298, DOI 10.1016/0167-4838(94)90021-3; Binkowski TA, 2003, J MOL BIOL, V332, P505, DOI 10.1016/S0022-2836(03)00882-9; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; DIAMANT Z, 1995, J ALLERGY CLIN IMMUN, V95, P42, DOI 10.1016/S0091-6749(95)70151-6; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; MANCINI JA, 1994, LIFE SCI, V54, P137; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; Plante H, 2006, BIOCHEM J, V393, P211, DOI 10.1042/BJ20060669; Radmark O, 2005, BIOCHEM BIOPH RES CO, V338, P102, DOI 10.1016/j.bbrc.2005.08.013; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; VICKERS PJ, 1993, J LIPID MEDIATOR, V6, P31; VICKERS PJ, 1992, MOL PHARMACOL, V42, P94; Weinander R, 1997, J BIOL CHEM, V272, P8871; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; YOUNG RN, 1993, J LIPID MEDIATOR, V6, P233; Young RN, 1999, EUR J MED CHEM, V34, P671, DOI 10.1016/S0223-5234(99)00225-1	28	182	190	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					510	512		10.1126/science.1144346	http://dx.doi.org/10.1126/science.1144346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17600184				2022-12-24	WOS:000248339800044
J	Iwasawa, T; Hooley, RJ; Rebek, J				Iwasawa, Tetsuo; Hooley, Richard J.; Rebek, Julius, Jr.			Stabilization of labile carbonyl addition intermediates by a synthetic receptor	SCIENCE			English	Article							MOLECULAR RECOGNITION; TRIOSEPHOSPHATE ISOMERASE; ENZYME; CATALYSIS; CAVITANDS; MECHANISM; CAGE	Products of unfavorable chemical equilibria are not readily observed because their high energy and increased reactivity result in low concentrations. Biological macromolecules use binding forces to access unfavorable equilibria and stabilize reactive intermediates by isolating them from the medium. In a similar vein, we describe here a synthetic receptor that allows direct observation of labile tetrahedral intermediates: hemiaminals formed in the reaction of an aldehyde carbonyl group with amines. The receptor encapsulates alkyl-substituted primary amines, then orients them toward a covalently tethered aldehyde function. The hemiaminal intermediates appear at high concentration, confined from the bulk solution and observable at ambient temperature by conventional nuclear magnetic resonance spectroscopy.	Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Rebek, J (corresponding author), Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrebek@scripps.edu	Iwasawa, Tetsuo/E-4047-2016	Iwasawa, Tetsuo/0000-0002-5913-5167	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050174] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50174] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Anslyn E. V., 2006, MODERN PHYS ORGANIC; CHUDEK JA, 1985, J CHEM SOC PERK T 2, P1285, DOI 10.1039/p29850001285; Dong VM, 2006, J AM CHEM SOC, V128, P14464, DOI 10.1021/ja0657915; Evans DA, 2002, ANGEW CHEM INT EDIT, V41, P3188, DOI 10.1002/1521-3773(20020902)41:17<3188::AID-ANIE3188>3.0.CO;2-H; Fersht AA, 1984, ENZYME STRUCTURE MEC, P47; Fiedler D, 2004, ANGEW CHEM INT EDIT, V43, P6748, DOI 10.1002/anie.200461776; FLORIANI L, 1984, J CHEM RES, P126; Gottschalk T, 2007, ANGEW CHEM INT EDIT, V46, P260, DOI 10.1002/anie.200603366; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hooley RJ, 2005, J AM CHEM SOC, V127, P11904, DOI 10.1021/ja052910s; Iwasawa T, 2006, J AM CHEM SOC, V128, P9308, DOI 10.1021/ja062768a; Kawano M, 2006, J AM CHEM SOC, V128, P6558, DOI 10.1021/ja0609250; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lin SN, 2005, TETRAHEDRON LETT, V46, P4315, DOI 10.1016/j.tetlet.2005.04.101; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Masel R.I., 2001, CHEM KINETICS CATALY; Purse BW, 2005, J AM CHEM SOC, V127, P11222, DOI 10.1021/ja052877+; Purse BW, 2003, J AM CHEM SOC, V125, P14682, DOI 10.1021/ja036595q; REBEK J, 1979, TETRAHEDRON, V35, P723, DOI 10.1016/0040-4020(79)80087-3; Renslo AR, 2000, ANGEW CHEM INT EDIT, V39, P3281, DOI 10.1002/1521-3773(20000915)39:18<3281::AID-ANIE3281>3.0.CO;2-P; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Rudkevich DM, 1999, EUR J ORG CHEM, V1999, P1991; Yoshizawa M, 2000, J AM CHEM SOC, V122, P6311, DOI 10.1021/ja000779c; Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s; Ziegler M, 2000, ANGEW CHEM INT EDIT, V39, P4119, DOI 10.1002/1521-3773(20001117)39:22<4119::AID-ANIE4119>3.0.CO;2-1	26	220	220	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					493	496		10.1126/science.1143272	http://dx.doi.org/10.1126/science.1143272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	194JD	17656719				2022-12-24	WOS:000248339800039
J	Oh, SD; Lao, JP; Hwang, PYH; Taylor, AF; Smith, GR; Hunter, N				Oh, Steve D.; Lao, Jessica P.; Hwang, Patty Yi-Hwa; Taylor, Andrew F.; Smith, Gerald R.; Hunter, Neil			BLM ortholog, Sgs1, prevents aberrant crossing-over by suppressing formation of multichromatid joint molecules	CELL			English	Article							DOUBLE-STRAND-BREAK; SYNDROME GENE-PRODUCT; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; HOMOLOGOUS RECOMBINATION; HOLLIDAY JUNCTIONS; GENOME STABILITY; RECQ HELICASES; MEIOSIS	Bloom's helicase (BLM) is thought to prevent crossing-over during DNA double-strand-break repair (DSBR) by disassembling double-Holliday junctions (dHJs) or by preventing their formation. We show that the Saccharomyces cerevisiae BLM ortholog, Sgs1, prevents aberrant crossing-over during meiosis by suppressing formation of joint molecules (JMs) comprising three and four interconnected duplexes. Sgs1 and procrossover factors, Msh5 and Mlh3, are antagonistic since Sgs1 prevents dHJ formation in msh5 cells and sgs1 mutation alleviates crossover defects of both msh5 and mlh3 mutants. We propose that differential activity of Sgs1 and procrossover factors at the two DSB ends effects productive formation of dHJs and crossovers and prevents multichromatid JMs and counterproductive crossing-over. Strand invasion of different templates by both DSB ends may be a common feature of DSBR that increases repair efficiency but also the likelihood of associated crossing-over. Thus, by disrupting aberrant JMs, BLM-related helicases maximize repair efficiency while minimizing the risk of deleterious crossing-over.	Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, Davis, CA 95616 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California Davis; Fred Hutchinson Cancer Center	Hunter, N (corresponding author), Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	nhunter@ucdavis.edu		Smith, Gerald/0000-0002-8747-1352	NIGMS NIH HHS [R01 GM031693-25, GM031693, GM074223, R01 GM031693, R56 GM031693, R01 GM074223, R01 GM074223-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; de los Santos T, 2003, GENETICS, V164, P81; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOYON C, 1993, MOL CELL BIOL, V13, P373, DOI 10.1128/MCB.13.1.373; Grushcow JM, 1999, GENETICS, V153, P607; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Hoffmann ER, 2003, GENETICS, V163, P515; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Langland G, 2001, J BIOL CHEM, V276, P30031, DOI 10.1074/jbc.M009664200; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; MAGUIRE MP, 1980, HEREDITY, V45, P127, DOI 10.1038/hdy.1980.56; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Moens PB, 2002, J CELL SCI, V115, P1611; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MULLER K, 2000, GENE FUNCT DIS, V1, P154; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; NILSSON NO, 1995, J THEOR BIOL, V173, P93, DOI 10.1006/jtbi.1995.0046; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; PERKINS DD, 1949, GENETICS, V34, P607; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van Veen JE, 2003, CURR BIOL, V13, pR831, DOI 10.1016/j.cub.2003.10.014; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Watt PM, 1996, GENETICS, V144, P935; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	65	213	216	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					259	272		10.1016/j.cell.2007.05.035	http://dx.doi.org/10.1016/j.cell.2007.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662941	Bronze, Green Accepted			2022-12-24	WOS:000248588000016
J	Richards, T				Richards, Tessa			Who is at the helm on patient journeys?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						2007, BRIT MED J, V334, P1130	1	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 14	2007	335	7610					76	76		10.1136/bmj.39272.484248.59	http://dx.doi.org/10.1136/bmj.39272.484248.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192JM	17626961	Green Published			2022-12-24	WOS:000248197500031
J	Lai, CL; Yuen, MF				Lai, Ching-Lung; Yuen, Man-Fung			The natural history and evaluation of standard treatment of chronic hepatitis B: A critical treatment criteria and end points	ANNALS OF INTERNAL MEDICINE			English	Article							HBV-DNA LEVELS; LAMIVUDINE THERAPY; CONSENSUS STATEMENT; UNITED-STATES; INFECTION; MANAGEMENT; CHINESE; CIRRHOSIS; UPDATE; LIVER	The definite indications for the treatment of chronic hepatitis B are serum hepatitis B virus (HBV) DNA levels greater than 10(5) copies/mL and alanine aminotransferase (ALT) levels more than 2 times the upper limit of normal. if cirrhosis is present, an HBV DNA level greater than 105 copies/mL is the sole criterion for treatment. Treatment end points include hepatitis B e antigen (HEeAg) seroconversion for HBeAg-positive patients, reduction of HEV DNA levels to less than 105 copies/mL, and normalization of ALT values. These guidelines may apply to patients who acquire the hepatitis B infection during adolescence or adulthood but are less suitable for most hepatitis B carriers, who are infected in early life. Cirrhosis complications, including hepatocellular carcinoma, often occur in this latter group despite HBeAg seroconversion, HBV DNA levels less than 10(4) copies/mL, or ALT levels between 0.5 and 2 times the upper limit of normal. Therefore, HBeAg seroconversion may not be an adequate end point for these patients; the ideal treatment end points are permanent suppression of HBV DNA to levels undetectable by polymerase chain reaction and reduction of ALT levels to less than 0.5 times the upper limit of normal.	Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lai, CL (corresponding author), Queen Mary Hosp, Dept Med, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hrmelcl@hkucc.hku.hk	Lai, Ching Lung/C-4298-2009; Yuen, Man-Fung/C-4466-2009	Yuen, Man-Fung/0000-0001-7985-7725; Lai, Ching-Lung/0000-0002-5927-2436				Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; de Franchis R, 2003, J HEPATOL, V39, pS3, DOI 10.1016/S0168-8278(03)00378-7; DIBISCEGLIE AM, 1987, GASTROENTEROLOGY, V93, P1236, DOI 10.1016/0016-5085(87)90250-2; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Lee TA, 2004, J CLIN GASTROENTEROL, V38, pS144, DOI 10.1097/00004836-200411003-00005; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Nguyen MH, 2005, HEPATOLOGY, V42, p593A; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Sherman M, 2005, GUT, V54, P1521, DOI 10.1136/gut.2005.071332; *TAIW COMM BAS CAN, 2002, NEW ENGL J MED, V347, P168; Wong DKH, 2006, ANTIVIR THER, V11, P909; Yuan HJ, 2005, J VIRAL HEPATITIS, V12, P373, DOI 10.1111/j.1365-2893.2005.00603.x; Yuen MF, 2005, AM J GASTROENTEROL, V100, P1099, DOI 10.1111/j.1572-0241.2005.41530.x; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2005, HEPATOLOGY, V42, p583A; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136	26	144	150	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					58	61		10.7326/0003-4819-147-1-200707030-00010	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	186MN	17606962				2022-12-24	WOS:000247782900008
J	Liu, B; Yang, YH; Chernishof, V; Loo, RRO; Jang, H; Tahk, S; Yang, R; Mink, S; Shultz, D; Bellone, CJ; Loo, JA; Shuai, K				Liu, Bin; Yang, Yonghui; Chernishof, Vasili; Loo, Rachel R. Ogorzalek; Jang, Hyunduk; Tahk, Samuel; Yang, Randy; Mink, Sheldon; Shultz, David; Bellone, Clifford J.; Loo, Joseph A.; Shuai, Ke			Proinflammatory stimuli induce IKK alpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity	CELL			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; GENE-ACTIVATION; KINASE-ALPHA; PROTEINS; TRANSCRIPTION; INHIBITION; CYTOKINE	How inflammatory stimuli signal to the nucleus to restrict inflammation is poorly understood. Protein inhibitor of activated STAT1 (PIAS1), a transcriptional regulator that possesses small ubiquitin-related modifier (SUMO) E3 ligase activity, inhibits immune responses by selectively blocking the binding of NF-kappa B and STAT1 to gene promoters. We report here that PIAS1 becomes rapidly phosphorylated on Ser90 residue in response to various inflammatory stimuli. Mutational studies indicate that Ser90 phosphorylation is required for PIAS1 to repress transcription. Upon TNF treatment, wild-type PIAS1, but not the Ser90A mutant, becomes rapidly associated with the promoters of NF-kappa B target genes. Furthermore, IKK alpha, but not IKK beta, interacts with PIAS1 in vivo and mediates PIAS1 Ser90 phosphorylation, a process that requires the SUMO ligase activity of PIAS1. Our results identify a signaling pathway in which proinflammatory stimuli activate the IKK alpha-mediated sumoylation-dependent phosphorylation of PIAS1 for the immediate repression of inflammatory gene activation.	Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA, DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; Saint Louis University	Shuai, K (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	kshuai@mednet.ucla.edu		Shultz, David/0000-0001-8242-6555	NIAMS NIH HHS [K01 AR52717-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Godambe Sandip A., 1995, Am J Ther, V2, P677, DOI 10.1097/00045391-199509000-00017; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	26	124	130	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					903	914		10.1016/j.cell.2007.03.056	http://dx.doi.org/10.1016/j.cell.2007.03.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540171	Bronze			2022-12-24	WOS:000247084600011
J	Raval, A; Tanner, SM; Byrd, JC; Angerman, EB; Perko, JD; Chen, SS; Hackanson, B; Grever, MR; Lucas, DM; MatkoviC, JJ; Lin, TS; Kipps, TJ; Murray, F; Weisenburger, D; Sanger, W; Lynch, J; Watson, P; Jansen, M; Yoshinaga, Y; Rosenquist, R; de Jong, PJ; Coggill, P; Beck, S; Lynch, H; de la Chapelle, A; Plass, C				Raval, Aparna; Tanner, Stephan M.; Byrd, John C.; Angerman, Elizabeth B.; Perko, James D.; Chen, Shih-Shih; Hackanson, Bjoern; Grever, Michael R.; Lucas, David M.; MatkoviC, Jennifer J.; Lin, Thomas S.; Kipps, Thomas J.; Murray, Fiona; Weisenburger, Dennis; Sanger, Warren; Lynch, Jane; Watson, Patrice; Jansen, Mary; Yoshinaga, Yuko; Rosenquist, Richard; de Jong, Pieter J.; Coggill, Penny; Beck, Stephan; Lynch, Henry; de la Chapelle, Albert; Plass, Christoph			Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia	CELL			English	Article							TUMOR-SUPPRESSOR GENES; P2X7 RECEPTOR GENE; DNA HYPERMETHYLATION; APOPTOTIC CHECKPOINT; CPG ISLAND; KINASE; CANCER; METHYLATION; TRANSCRIPTION; POLYMORPHISM	The heritability of B cell chronic lymphocytic leukemia (CLL) is relatively high; however, no predisposing mutation has been convincingly identified. We show that loss or reduced expression of death-associated protein kinase 1 (DAPK1) underlies cases of heritable predisposition to CLL and the majority of sporadic CLL. Epigenetic silencing of DAPK1 by promoter methylation occurs in almost all sporadic CLL cases. Furthermore, we defined a disease haplotype, which segregates with the CLL phenotype in a large family. DAM expression of the CLL allele is downregulated by 75% in germline cells due to increased HOXB7 binding. In the blood cells from affected family members, promoter methylation results in additional loss of DAM expression. Thus, reduced expression of DAM can result from germline predisposition, as well as epigenetic or somatic events causing or contributing to the CILL phenotype.	Ohio State Univ, Ctr Comprehens Canc, Human Canc Gent Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43214 USA; Ohio State Univ, Div Hematol & Oncol, Dept Internal Med, Columbus, OH 43214 USA; Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Wellcome Trust Sanger Inst, Cambridge, England; Univ Calif San Diego, Dept Internal Med, San Diego, CA 92093 USA; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Univ Freiburg, Ctr Med, Dept Hematol Oncol, Freiburg, Germany	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Creighton University; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Uppsala University; University of Freiburg	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Tzagournis Med Res Facil 464A, 420 W 12th Ave, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu; christoph.plass@osumc.edu	Plass, Christoph/H-7192-2014; Lucas, David M/E-3555-2011	Rosenquist, Richard/0000-0002-0211-8788; Edsall, Lee Elizabeth/0000-0002-0326-2829	NATIONAL CANCER INSTITUTE [P30CA016058, P01CA081534, R21CA110496, T32CA106196, P01CA101956, U01CA086389, P20CA081534] Funding Source: NIH RePORTER; NCI NIH HHS [CA101956, P01 CA101956, U01 CA086389, CA81534, P30 CA16058, 5U01 CA86389, P01 CA081534, T32 CA106196, R21 CA110496, P30 CA016058, CA110496] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Bullrich F, 2001, CANCER RES, V61, P6640; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Caporaso N, 2006, BLOOD, V108, P415, DOI 10.1182/blood-2006-05-019489; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chim CS, 2006, J HUM GENET, V51, P832, DOI 10.1007/s10038-006-0029-x; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; Corcoran M, 2005, HAEMATOLOGICA, V90, P1078; Dao-Ung LP, 2004, BRIT J HAEMATOL, V125, P815, DOI 10.1111/j.1365-2141.2004.04976.x; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Frissora F, 2003, EUR J IMMUNOL, V33, P907, DOI 10.1002/eji.200323657; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2003, BRIT J HAEMATOL, V121, P866, DOI 10.1046/j.1365-2141.2003.04372.x; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338; LILL MC, 1995, BLOOD, V85, P692, DOI 10.1182/blood.V85.3.692.bloodjournal853692; Lynch HT, 2002, AM J MED GENET, V115, P113, DOI 10.1002/ajmg.10686; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Raval A, 2005, J CLIN ONCOL, V23, P3877, DOI 10.1200/JCO.2005.02.196; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Sellick GS, 2005, AM J HUM GENET, V77, P420, DOI 10.1086/444472; SHEN WF, 1989, ADV EXP MED BIOL, V271, P211; Stilgenbauer S, 2005, CURR TOP MICROBIOL, V294, P147, DOI 10.1007/3-540-29933-5_9; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yuille MR, 2000, BRIT J HAEMATOL, V109, P794, DOI 10.1046/j.1365-2141.2000.02111.x	52	284	303	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					879	890		10.1016/j.cell.2007.03.043	http://dx.doi.org/10.1016/j.cell.2007.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540169	Green Published, Bronze			2022-12-24	WOS:000247084600009
J	Wahlman, J; DeMartino, GN; Skach, WR; Bulleid, NJ; Brodsky, JL; Johnson, AE				Wahlman, Judit; DeMartino, George N.; Skach, William R.; Bulleid, Neil J.; Brodsky, Jeffrey L.; Johnson, Arthur E.			Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system	CELL			English	Article							PROTEIN DISULFIDE-ISOMERASE; RETICULUM-ASSOCIATED DEGRADATION; MISFOLDED SECRETORY PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MOLECULAR CHAPERONES; CHOLERA-TOXIN; PROTEASOME	Secretory proteins unable to assemble into their native states in the endoplasmic reticulum (ER) are transported back or "retrotranslocated" into the cytosol for ER-associated degradation (ERAD). To examine the roles of different components in ERAD, one fluorescencelabeled ERAD substrate was encapsulated with selected lumenal factors inside mammalian microsomes. After mixing microsomes with fluorescence-quenching agents and selected cytosolic proteins, the rate of substrate efflux was monitored continuously in real time by the decrease in fluorescence intensity as cytosolic quenchers contacted dye-labeled substrates. The retrotranslocation kinetics of nonglycosylated pro-alpha factor were not significantly altered by replacing all lumenal proteins with only protein disuifide isomerase or all cytosolic proteins with only PA700, the 19S regulatory particle of the 26S proteasome. Retrotranslocation was blocked by antibodies against a putative retrotranslocation channel protein, derlin-1, but not Sec61 alpha. In addition, pro-alpha factor photocrosslinked derlin-1, but not Sec61 alpha. Thus, derlin-1 appears to be involved in pro-alpha factor retrotranslocation.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Texas A&M Univ Syst, Ctr Hlth Sci, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu	Johnson, Arthur E/G-3457-2012	Bulleid, Neil/0000-0002-9839-5279	Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: Medline; NIDDK NIH HHS [R01 DK046181, R56 DK046181, R01 DK051818, DK51818, DK46181] Funding Source: Medline; NIGMS NIH HHS [R01 GM026494, GM26494, GM75061, GM53457, R01 GM075061, R01 GM053457] Funding Source: Medline; Wellcome Trust [074081] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181, R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R01GM053457, R01GM026494] Funding Source: NIH RePORTER; BBSRC [BB/D00764X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CAI H, 1994, J BIOL CHEM, V269, P24550; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gaczynska Maria, 2005, V301, P3; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PUIG A, 1994, J BIOL CHEM, V269, P7764; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; SU K, 1993, J BIOL CHEM, V268, P14301; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YE J, 1991, J BIOL CHEM, V266, P23016; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	67	106	107	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					943	955		10.1016/j.cell.2007.03.046	http://dx.doi.org/10.1016/j.cell.2007.03.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540174	hybrid, Green Published			2022-12-24	WOS:000247084600014
J	Dettman, JR; Sirjusingh, C; Kohn, LM; Anderson, JB				Dettman, Jeremy R.; Sirjusingh, Caroline; Kohn, Linda M.; Anderson, James B.			Incipient speciation by divergent adaptation and antagonistic epistasis in yeast	NATURE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; MISMATCH REPAIR SYSTEM; EXPERIMENTAL EVOLUTION; BUDDING YEAST; SACCHAROMYCES; HYBRID; BOTTLENECKS; MECHANISMS; DROSOPHILA; STERILITY	Establishing the conditions that promote the evolution of reproductive isolation and speciation has long been a goal in evolutionary biology(1-3). In ecological speciation, reproductive isolation between populations evolves as a by-product of divergent selection and the resulting environment-specific adaptations(4-6). The leading genetic model of reproductive isolation predicts that hybrid inferiority is caused by antagonistic epistasis between incompatible alleles at interacting loci(1,7). The fundamental link between divergent adaptation and reproductive isolation through genetic incompatibilities has been predicted(1,4,5), but has not been directly demonstrated experimentally. Here we empirically tested key predictions of speciation theory by evolving the initial stages of speciation in experimental populations of the yeast Saccharomyces cerevisiae. After replicate populations adapted to two divergent environments, we consistently observed the evolution of two forms of postzygotic isolation in hybrids: reduced rate of mitotic reproduction and reduced efficiency of meiotic reproduction. This divergent selection resulted in greater reproductive isolation than parallel selection, as predicted by the ecological speciation theory. Our experimental system allowed controlled comparison of the relative importance of ecological and genetic isolation, and we demonstrated that hybrid inferiority can be ecological and/or genetic in basis. Overall, our results show that adaptation to divergent environments promotes the evolution of reproductive isolation through antagonistic epistasis, providing evidence of a plausible common avenue to speciation and adaptive radiation in nature.	Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Dettman, JR (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada.	jdettman@utm.utoronto.ca						Anderson JB, 2006, EUKARYOT CELL, V5, P1243, DOI 10.1128/EC.00048-06; Anderson JB, 2003, GENETICS, V163, P1287; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Coyne JA, 2004, SPECIATION, V37; de Oliveira A. K., 1980, HEREDITY, V44, P123; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Greig D, 2003, J EVOLUTION BIOL, V16, P429, DOI 10.1046/j.1420-9101.2003.00546.x; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Leu JY, 2006, CURR BIOL, V16, P280, DOI 10.1016/j.cub.2005.12.028; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Mooers AO, 1999, AM NAT, V153, P437, DOI 10.1086/303186; Muller HJ, 1942, BIOL S, V6, P71; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2005, PLOS BIOL, V3, P1988, DOI 10.1371/journal.pbio.0030368; Rundle HD, 2003, EVOLUTION, V57, P2557; Rundle HD, 2001, EVOLUTION, V55, P198; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD	30	143	145	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					585	+		10.1038/nature05856	http://dx.doi.org/10.1038/nature05856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538619				2022-12-24	WOS:000246842000047
J	Dunckley, T; Huentelman, MJ; Craig, DW; Pearson, JV; Szelinger, S; Joshipura, K; Halperin, RF; Stamper, C; Jensen, KR; Letizia, D; Hesterlee, SE; Pestronk, A; Levine, T; Bertorini, T; Graves, MC; Mozaffar, T; Jackson, CE; Bosch, P; McVey, A; Dick, A; Barohn, R; Lomen-Hoerth, C; Rosenfeld, J; O'Connor, DT; Zhang, KX; Crook, R; Ryberg, H; Hutton, M; Katz, J; Simpson, EP; Mitsumoto, H; Bowser, R; Miller, RG; Appel, SH; Stephan, DA				Dunckley, Travis; Huentelman, Matthew J.; Craig, David W.; Pearson, John V.; Szelinger, Szabolcs; Joshipura, Keta; Halperin, Rebecca F.; Stamper, Chelsea; Jensen, Kendall R.; Letizia, David; Hesterlee, Sharon E.; Pestronk, Alan; Levine, Todd; Bertorini, Tulio; Graves, Michael C.; Mozaffar, Tahseen; Jackson, Carlayne E.; Bosch, Peter; McVey, April; Dick, Arthur; Barohn, Richard; Lomen-Hoerth, Catherine; Rosenfeld, Jeffrey; O'Connor, Daniel T.; Zhang, Kuixing; Crook, Richard; Ryberg, Henrik; Hutton, Michael; Katz, Jonathan; Simpson, Ericka P.; Mitsumoto, Hiroshi; Bowser, Robert; Miller, Robert G.; Appel, Stanley H.; Stephan, Dietrich A.			Whole-genome analysis of sporadic amyotrophic lateral sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOTOR-NEURON DEGENERATION	Background: Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have the sporadic form, which may be caused by the interaction of multiple environmental factors and previously unknown genes. Methods: We performed a genomewide association analysis using 766,955 single-nucleotide polymorphisms (SNPs) found in 386 white patients with sporadic ALS and 542 neurologically normal white controls (the discovery series). Associations of SNPs with sporadic ALS were confirmed in two independent replication populations: replication series 1, with 766 case patients with the disease and 750 neurologically normal controls, and replication series 2, with 135 case patients and 275 controls. Results: We identified 10 genetic loci that are significantly associated (P<0.05) with sporadic ALS in three independent series of case patients and controls and an additional 41 loci that had significant associations in two of the three series. The most significant association with disease in white case patients as compared with controls was found for a SNP near an uncharacterized gene known as FLJ10986 (P=3.0 x 10(sup -4); odds ratio for having the genotype in patients vs. controls, 1.35; 95% confidence interval, 1.13 to 1.62). The FLJ10986 protein was found to be expressed in the spinal cord and cerebrospinal fluid of patients and of controls. Specific SNPs seem to be associated with sex, age at onset, and site of onset of sporadic ALS. Conclusions: Variants of FLJ10986 may confer susceptibility to sporadic ALS. FLJ10986 and 50 other candidate loci warrant further investigation for their potential role in conferring susceptibility to the disease.	Translat Genom Res Inst, Phoenix, AZ 85004 USA; Muscular Dystrophy Assoc, Tucson, AZ USA; Washington Univ, Sch Med, St Louis, MO USA; Phoenix Neurol Assoc, Phoenix, AZ USA; Univ Tennessee, Memphis, TN USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif Irvine, Irvine, CA USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Mayo Clin, Scottsdale, AZ USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Carolinas Med Ctr, Charlotte, NC 28203 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Mayo Clin, Coll Med, Jacksonville, FL 32224 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Calif Pacific Med Ctr, San Francisco, CA USA; Methodist Neurol Inst, Houston, TX USA; Columbia Univ, Med Ctr, New York, NY USA	Translational Genomics Research Institute; Washington University (WUSTL); University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; Mayo Clinic; Mayo Clinic Phoenix; University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; Carolinas Medical Center; University of California System; University of California San Diego; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Pacific Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Columbia University	Stephan, DA (corresponding author), Translat Genom Res Inst, 445 N 5th St, Phoenix, AZ 85004 USA.	dstephan@tgen.org	Craig, David Wesley/K-6961-2019; Pearson, John/AAT-4211-2020; Mozaffar, Tahseen/AAE-6971-2020; Ryberg, Henrik/AFT-8978-2022; Pearson, John V/F-2249-2011	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Ryberg, Henrik/0000-0002-2652-6612				Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Frey D, 2000, J NEUROSCI, V20, P2534; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Wang W, 2004, J BIOL CHEM, V279, P53491, DOI 10.1074/jbc.M410370200; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103	16	190	199	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					775	788		10.1056/NEJMoa070174	http://dx.doi.org/10.1056/NEJMoa070174			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202MU	17671248	Bronze			2022-12-24	WOS:000248906700006
J	Sun, YG; Chen, ZF				Sun, Yan-Gang; Chen, Zhou-Feng			A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord	NATURE			English	Article							PROTEINASE-ACTIVATED RECEPTOR; BOMBESIN-LIKE PEPTIDES; SCRATCHING BEHAVIOR; HUMAN SKIN; MICE; PRURITUS; AGONISTS; PATHWAY; BRAIN	Itching, or pruritus, is defined as an unpleasant cutaneous sensation that serves as a physiological self-protective mechanism to prevent the body from being hurt by harmful external agents. Chronic itch represents a significant clinical problem resulting from renal diseases and liver diseases, as well as several serious skin diseases such as atopic dermatitis(1-3). The identity of the itch-specific mediator in the central nervous system, however, remains elusive. Here we describe that the gastrin-releasing peptide receptor (GRPR) plays an important part in mediating itch sensation in the dorsal spinal cord. We found that gastrin-releasing peptide is specifically expressed in a small subset of peptidergic dorsal root ganglion neurons, whereas expression of its receptor GRPR is restricted to lamina I of the dorsal spinal cord. GRPR mutant mice showed comparable thermal, mechanical, inflammatory and neuropathic pain responses relative to wild-type mice. In contrast, induction of scratching behaviour was significantly reduced in GRPR mutant mice in response to pruritogenic stimuli, whereas normal responses were evoked by painful stimuli. Moreover, direct spinal cerebrospinal fluid injection of a GRPR antagonist significantly inhibited scratching behaviour in three independent itch models. These data demonstrate that GRPR is required for mediating the itch sensation rather than pain, at the spinal level. Our results thus indicate that GRPR may represent the first molecule that is dedicated to mediating the itch sensation in the dorsal horn of the spinal cord, and thus may provide a central therapeutic target for antipruritic drug development.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	chenz@wustl.edu						Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; BATTEY J, 1991, TRENDS NEUROSCI, V14, P524, DOI 10.1016/0166-2236(91)90005-F; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; COWAN A, 1985, LIFE SCI, V37, P135, DOI 10.1016/0024-3205(85)90416-3; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; GMEREK DE, 1983, PEPTIDES, V4, P907, DOI 10.1016/0196-9781(83)90089-X; GREAVES MW, 2005, DERMATOL THER, V1, P323; Green AD, 2006, PAIN, V124, P50, DOI 10.1016/j.pain.2006.03.023; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Inan S, 2004, EUR J PHARMACOL, V502, P233, DOI 10.1016/j.ejphar.2004.09.010; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Moody TW, 2004, PEPTIDES, V25, P511, DOI 10.1016/j.peptides.2004.02.012; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; ODONOHUE TL, 1984, J NEUROSCI, V4, P2956; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Roesler R., 2006, CNS & Neurological Disorders-Drug Targets, V5, P197, DOI 10.2174/187152706776359673; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; SOWUNMI A, 1989, LANCET, V2, P213; Stander S, 2006, EUR J PAIN, V10, P473, DOI 10.1016/j.ejpain.2006.03.005; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; WANG LH, 1990, J BIOL CHEM, V265, P15695; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006	30	529	550	7	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					700	U10		10.1038/nature06029	http://dx.doi.org/10.1038/nature06029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17653196				2022-12-24	WOS:000248598000046
J	Korn, T; Bettelli, E; Gao, W; Awasthi, A; Jager, A; Strom, TB; Oukka, M; Kuchroo, VK				Korn, Thomas; Bettelli, Estelle; Gao, Wenda; Awasthi, Amit; Jaeger, Anneli; Strom, Terry B.; Oukka, Mohamed; Kuchroo, Vijay K.			IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS; IL-6-DEFICIENT MICE; CHRONIC INFLAMMATION; HELPER-CELLS; DIFFERENTIATION; ACTIVATION; CYTOKINE; BETA	On activation, naive T cells differentiate into effector T-cell subsets with specific cytokine phenotypes and specialized effector functions(1). Recently a subset of T cells, distinct from T helper (T-H) 1 and T(H)2 cells, producing interleukin (IL)-17 (T(H)17) was defined and seems to have a crucial role in mediating autoimmunity and inducing tissue inflammation(2-5). We and others have shown that transforming growth factor (TGF)-beta and IL-6 together induce the differentiation of T(H)17 cells, in which IL-6 has a pivotal function in dictating whether T cells differentiate into Foxp3(+) regulatory T cells (T-reg cells) or T(H)17 cells(6-9). Whereas TGF-beta induces Foxp3 and generates T-reg cells, IL-6 inhibits the generation of T-reg cells and induces the production of IL-17, suggesting a reciprocal developmental pathway for T(H)17 and T-reg cells. Here we show that IL-6-deficient (Il6(-/-)) mice do not develop a T(H)17 response and their peripheral repertoire is dominated by Foxp3(+) T-reg cells. However, deletion of T-reg cells leads to the reappearance of T(H)17 cells in Il6(-/-) mice, suggesting an additional pathway by which T(H)17 cells might be generated in vivo. We show that an IL-2 cytokine family member, IL-21, cooperates with TGF-beta to induce T(H)17 cells in naive Il6(-/-) T cells and that IL-21-receptor-deficient T cells are defective in generating a T(H)17 response.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Res Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Oukka, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Strom, Terry B./E-9268-2010; Korn, Thomas/AAE-6960-2019	Strom, Terry B./0000-0002-7570-0736; Korn, Thomas/0000-0002-3633-0955	NIAID NIH HHS [R01 AI073542, R01 AI073542-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nakamura T, 1997, J IMMUNOL, V158, P1085; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Reddy J, 2003, J IMMUNOL, V170, P870, DOI 10.4049/jimmunol.170.2.870; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	30	1432	1554	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					484	U9		10.1038/nature05970	http://dx.doi.org/10.1038/nature05970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17581588	Green Accepted			2022-12-24	WOS:000248302700049
J	Williams, DA				Williams, David A.			Clinical implications of basic research - A new mechanism of leukemia drug resistance?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS		Univ Cincinnati, Coll Med, Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Williams, DA (corresponding author), Univ Cincinnati, Coll Med, Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45221 USA.							DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; SCHOFIELD R, 1983, BIOMED PHARMACOTHER, V37, P375; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Williams DA, 2006, NATURE, V444, P827, DOI 10.1038/444827a	5	12	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2007	357	1					77	78		10.1056/NEJMcibr072412	http://dx.doi.org/10.1056/NEJMcibr072412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OR	17611211				2022-12-24	WOS:000247720800016
J	Moskowitz, IPG; Kim, JB; Moore, ML; Wolf, CM; Peterson, MA; Shendure, J; Nobrega, MA; Yokota, Y; Berul, C; Izumo, S; Seidman, JG; Seidman, CE				Moskowitz, Ivan P. G.; Kim, Jae B.; Moore, Meredith L.; Wolf, Cordula M.; Peterson, Michael A.; Shendure, Jay; Nobrega, Marcelo A.; Yokota, Yoshifumi; Berul, Charles; Izumo, Seigo; Seidman, J. G.; Seidman, Christine E.			A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development	CELL			English	Article							HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR TBX5; P204 PROTEIN OVERCOMES; PURKINJE-FIBERS; HEART-DISEASE; DIFFERENTIATION; EXPRESSION; GENE; INHIBITION; MUTATIONS	The cardiac conduction system is an anatomically discrete segment of specialized myocardium that initiates and propagates electrical impulses to coordinate myocardial contraction. To define the molecular composition of the mouse ventricular conduction system we used microdissection and transcriptional profiling by serial analysis of gene expression (SAGE). Conduction-system-specific expression for Id2, a member of the Id gene family of transcriptional repressors, was identified. Analyses of Id2-deficient mice demonstrated structural and functional conduction system abnormalities, including left bundle branch block. A 1.2 kb fragment of the Id2 promoter proved sufficient for cooperative regulation by Nkx2-5 and Tbx5 in vitro and for conduction-system-specific gene expression in vivo. Furthermore, compound haploinsufficiency of Tbx5 and Nkx2-5 or Tbx5 and Id2 prevented embryonic specification of the ventricular conduction system. We conclude that a molecular pathway including Tbx5, Nkx2-5, and Id2 coordinates specification of ventricular myocytes into the ventricular conduction system lineage.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Cardiac Registry, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Fukui, Sch Med, Dept Mol Genet, Matsuoka, Fukui 9111193, Japan; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Novartis Inst BioMed Res, Cambridge, MA 02139 USA; Univ Chicago, Inst Mol Pediat Sci, Dept Pediat & Pathol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Chicago; University of Fukui; Harvard University; Boston Children's Hospital; Novartis; University of Chicago	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865				BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Bonaldo MF, 2004, GENOME RES, V14, P2053, DOI 10.1101/gr.2601304; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cheng G, 1999, DEVELOPMENT, V126, P5041; DELORME B, 1995, DEV DYNAM, V204, P358, DOI 10.1002/aja.1002040403; Ding B, 2006, J BIOL CHEM, V281, P14893, DOI 10.1074/jbc.M511748200; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Harris BS, 2006, DEV DYNAM, V235, P38, DOI 10.1002/dvdy.20580; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kondo RP, 2003, J CARDIOVASC ELECTR, V14, P383, DOI 10.1046/j.1540-8167.2003.02467.x; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; LEV M, 1973, ACTA ANAT, V85, P342; Li QY, 1997, NAT GENET, V15, P21; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Morley GE, 2001, MICROSC RES TECHNIQ, V52, P241, DOI 10.1002/1097-0029(20010201)52:3<241::AID-JEMT1010>3.0.CO;2-3; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Palaniswamy SK, 2005, BIOINFORMATICS, V21, P835, DOI 10.1093/bioinformatics/bti119; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Prall OWJ, 2002, ANN MED, V34, P148; Rentschler S, 2001, DEVELOPMENT, V128, P1785; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; St Croix B, 2000, SCIENCE, V289, P1197; TAWARA S, 1906, REIZLETIUNGSSYSTEM S; Thomas PS, 2001, ANAT RECORD, V263, P307, DOI 10.1002/ar.1106; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; ZAHLER R, 1992, P NATL ACAD SCI USA, V89, P99, DOI 10.1073/pnas.89.1.99; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693	37	192	196	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1365	1376		10.1016/j.cell.2007.04.036	http://dx.doi.org/10.1016/j.cell.2007.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604724	Bronze			2022-12-24	WOS:000247911400021
J	Kim, JB; Porreca, GJ; Song, L; Greenway, SC; Gorham, JM; Church, GM; Seidman, CE; Seidman, JG				Kim, Jae Bum; Porreca, Gregory J.; Song, Lei; Greenway, Steven C.; Gorham, Joshua M.; Church, George M.; Seidman, Christine E.; Seidman, J. G.			Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy	SCIENCE			English	Article							GROWTH; REPRODUCIBILITY; TRANSCRIPTOME; MORPHOGENESIS; ABUNDANCE; MUTATION; RATS; HOP	We describe a sensitive mRNA profiling technology, PMAGE ( for "polony multiplex analysis of gene expression"), which detects messenger RNAs ( mRNAs) as rare as one transcript per three cells. PMAGE incorporates an improved ligation-based method to sequence 14-nucleotide tags derived from individual mRNA molecules. One sequence tag from each mRNA molecule is amplified onto a separate 1-micrometer bead, denoted as a polymerase colony or polony, and about 5 million polonies are arrayed in a flow cell for parallel sequencing. Using PMAGE, we identified early transcriptional changes that preceded pathological manifestations of hypertrophic cardiomyopathy in mice carrying a disease-causing mutation. PMAGE provided a comprehensive profile of cardiac mRNAs, including low-abundance mRNAs encoding signaling molecules and transcription factors that are likely to participate in disease pathogenesis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu; seidman@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019	church, george/0000-0001-6232-9969				Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; BLACKSHAW S, 2002, CURRENT PROTOCOLS MO; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dinel S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni025; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; LEE RT, 1988, J CLIN INVEST, V81, P431, DOI 10.1172/JCI113337; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	29	146	229	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1481	1484		10.1126/science.1137325	http://dx.doi.org/10.1126/science.1137325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556586				2022-12-24	WOS:000247066400044
J	Tanne, JH				Tanne, Janice Hopkins			Study links diabetes-drug to heart deaths	BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1073	1073		10.1136/bmj.39224.364630.DB	http://dx.doi.org/10.1136/bmj.39224.364630.DB			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525413	Green Published			2022-12-24	WOS:000246975000012
J	Fuss, SH; Omura, M; Mombaerts, P				Fuss, Stefan H.; Omura, Masayo; Mombaerts, Peter			Local and cis effects of the H element on expression of odorant receptor genes in mouse	CELL			English	Article							OLFACTORY SENSORY NEURONS; AXON GUIDANCE; EPITHELIUM; GLOMERULI; CHOICE; SYSTEM; LHX2; BULB; PROJECTION; IDENTITY	From the similar to 1,200 odorant receptor (OR) genes in the mouse genome, an olfactory sensory neuron is thought to express only one gene. The mechanisms of OR gene choice are not understood. A 2.1 kilobase region (the H element) adjacent to a cluster of seven OR genes has been proposed as a trans- and pan-enhancer for OR gene expression. Here, we deleted the H element by gene targeting in mice. The deletion abolishes expression of a family of three OR genes proximal to H, and H operates in cis on these genes. Deletion of H has a graded effect on expression of a distal group of four OR genes, commensurate with genomic distance. There is no demonstrable effect on expression of OR genes located outside the cluster. Our findings are not consistent with the hypothesis of H as an essential trans-acting enhancer for genome-wide regulation of OR gene expression.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	peter@rockefeller.edu	Fuss, Stefan H/G-2065-2011	Fuss, Stefan H/0000-0002-3076-1121				Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	144	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					373	384		10.1016/j.cell.2007.06.023	http://dx.doi.org/10.1016/j.cell.2007.06.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662950	Bronze			2022-12-24	WOS:000248588000025
J	Mameli, M; Balland, B; Lujan, R; Luscher, C				Mameli, Manuel; Balland, Benedicte; Lujan, Rafael; Luescher, Christian			Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area	SCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-PERMEABLE AMPA RECEPTORS; PROTEIN-SYNTHESIS; DOPAMINE NEURONS; IN-VIVO; DEPENDENT REGULATION; PLASTICITY; POLYRIBOSOMES; REQUIREMENT; ACTIVATION	The activation of metabotropic glutamate receptors (mGluRs) leads to long-term depression (mGluR-LTD) at many synapses of the brain. The induction of mGluR-LTD is well characterized, whereas the mechanisms underlying its expression remain largely elusive. mGluR-LTD in the ventral tegmental area (VTA) efficiently reverses cocaine-induced strengthening of excitatory inputs onto dopamine neurons. We show that mGluR-LTD is expressed by an exchange of GluR2-lacking AMPA receptors for GluR2-containing receptors with a lower single-channel conductance. The synaptic insertion of GluR2 depends on de novo protein synthesis via rapid messenger RNA translation of GluR2. Regulated synthesis of GluR2 in the VTA is therefore required to reverse cocaine-induced synaptic plasticity.	Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland; Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland.	Christian.Luscher@medecine.unige.ch	Lujan, Rafael/G-2555-2015; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Lujan Miras, Rafael/0000-0003-2001-9545; Mameli, Manuel/0000-0002-0570-6964				Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hartmann J, 2004, J NEUROSCI, V24, P5119, DOI 10.1523/JNEUROSCI.4193-03.2004; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Oguro K, 1999, J NEUROSCI, V19, P9218; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	26	216	221	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					530	533		10.1126/science.1142365	http://dx.doi.org/10.1126/science.1142365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656725				2022-12-24	WOS:000248339800050
J	Annas, GJ				Annas, George J.			Cancer and the constitution - Choice at life's end	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANAND G, 2007, WALL STREET J   0315, pA1; Annas G J, 1992, Health Matrix Clevel, V2, P119; Annas George J, 2005, Stetson Law Rev, V35, P49; Annas George J, 1989, Villanova Law Rev, V34, P771; Annas GJ, 1997, NEW ENGL J MED, V337, P1098, DOI 10.1056/NEJM199710093371523; Appelbaum PS, 2006, KENNEDY INST ETHIC J, V16, P367, DOI 10.1353/ken.2006.0021; Berezikov E, 2000, GENOME BIOL, V1; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Callahan Daniel., 1998, FALSE HOPES WHY AM Q; Coetzee J., 1990, AGE IRON; CULBERT M, 1974, VITAMIN B17 FORBIDDE; *FDA, 2006, PROP RUL CHARG INV D; *FDA, 2006, FDA PROP RUL OV EXP; Groopman Jerome, 2006, New Yorker, P40; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; KATZ J, 1984, SILENT WORLD DOCTOR, P151; MILLER HI, 2006, WALL STREET J   0302, pA15; NATHAN D, 2007, CANC TREATMENT REVOL; Patterson James T., 1987, DREAD DIS CANC MODER; PRUDHOMME A, 2004, CELL GAME S WAKSALS; Robertson JA, 2006, HASTINGS CENT REP, V36, P15, DOI 10.1353/hcr.2006.0101; 2005, WALL STREET J   0329, pA14; 2005, WALL STREET J   0324, pA14	23	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					408	413		10.1056/NEJMhle070625	http://dx.doi.org/10.1056/NEJMhle070625			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652658	Green Published			2022-12-24	WOS:000248283500016
J	Einhorn, LH; Williams, SD; Chamness, A; Brames, MJ; Perkins, SM; Abonour, R				Einhorn, Lawrence H.; Williams, Stephen D.; Chamness, Amy; Brames, Mary J.; Perkins, Susan M.; Abonour, Rafat			High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 02-06, 2006	Atlanta, GA	Amer Soc Clin Oncol			LONG-TERM SURVIVAL; SALVAGE CHEMOTHERAPY; PHASE-II; PROGNOSTIC VARIABLES; TESTICULAR CANCER; 2ND-LINE THERAPY; RANDOMIZED-TRIAL; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL	Background: Metastatic testicular tumors that have not been successfully treated by means of initial chemotherapy are potentially curable with salvage chemotherapy. Methods: We conducted a retrospective review of 184 consecutive patients with metastatic testicular cancer that had progressed after they received cisplatin-containing combination chemotherapy. We gave 173 patients two consecutive courses of high-dose chemotherapy consisting of 700 mg of carboplatin per square meter of body-surface area and 750 mg of etoposide per square meter, each for 3 consecutive days, and each followed by an infusion of autologous peripheral-blood hematopoietic stem cells; the other 11 patients received a single course of this treatment. In 110 patients, cytoreduction with one or two courses of vinblastine plus ifosfamide plus cisplatin preceded the high-dose chemotherapy. Results: Of the 184 patients, 116 had complete remission of disease without relapse during a median follow-up of 48 months (range, 14 to 118). Of the 135 patients who received the treatment as second-line therapy, 94 were disease-free during follow-up; 22 of 49 patients who received treatment as third-line or later therapy were disease-free. Of 40 patients with cancer that was refractory to standard-dose platinum, 18 were disease-free. A total of 98 of 144 patients who had platinum-sensitive disease were disease-free, and 26 of 35 patients with seminoma and 90 of 149 patients with nonseminomatous germ-cell tumors were disease-free. Among the 184 patients, there were three drug-related deaths during therapy. Acute leukemia developed in three additional patients after therapy. Conclusions: Testicular tumors are potentially curable by means of high-dose chemotherapy plus hematopoietic stem-cell rescue, even when this regimen is used as third-line or later therapy or in patients with platinum-refractory disease.	Indiana Univ, Ctr Canc, Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Walther Canc Inst, Indianapolis, IN 46202 USA; Indiana Univ, Div Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis	Einhorn, LH (corresponding author), Indiana Univ, Ctr Canc, Sch Med, Div Hematol Oncol, 535 Barnhill Dr,Rm 473, Indianapolis, IN 46202 USA.	leinhorn@iupui.edu						Beyer J, 1997, CANCER, V79, P161, DOI 10.1002/(SICI)1097-0142(19970101)79:1<161::AID-CNCR23>3.0.CO;2-1; Beyer J, 1996, J CLIN ONCOL, V14, P2638, DOI 10.1200/JCO.1996.14.10.2638; Bhatia S, 2000, J CLIN ONCOL, V18, P3346, DOI 10.1200/JCO.2000.18.19.3346; Bosl GJ, 1997, NEW ENGL J MED, V337, P1403; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; BUCKNER CD, 1974, CANCER CHEMOTH REP 1, V58, P709; COOPER MA, 1995, J CLIN ONCOL, V13, P1167, DOI 10.1200/JCO.1995.13.5.1167; Efron B, 1998, INTRO BOOTSTRAP; Einhorn LH, 2007, J CLIN ONCOL, V25, P513, DOI 10.1200/JCO.2006.07.7271; EINHORN LH, 1990, J CLIN ONCOL, V8, P1777, DOI 10.1200/JCO.1990.8.11.1777; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Hartmann JT, 2001, J CLIN ONCOL, V19, P1641, DOI 10.1200/JCO.2001.19.6.1641; Houck W, 2004, J CLIN ONCOL, V22, P2155, DOI 10.1200/JCO.2004.11.054; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Loehrer PJ, 1998, J CLIN ONCOL, V16, P2500, DOI 10.1200/JCO.1998.16.7.2500; Lotz JP, 2005, ANN ONCOL, V16, P411, DOI 10.1093/annonc/mdi087; Mead GM, 1997, J CLIN ONCOL, V15, P594; Motzer RJ, 2000, J CLIN ONCOL, V18, P1173, DOI 10.1200/JCO.2000.18.6.1173; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413, DOI 10.1200/JCO.2000.18.12.2413; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; MURPHY BR, 1993, J CLIN ONCOL, V11, P324, DOI 10.1200/JCO.1993.11.2.324; NICHOLS CR, 1989, J CLIN ONCOL, V7, P932, DOI 10.1200/JCO.1989.7.7.932; Pico JL, 2005, ANN ONCOL, V16, P1152, DOI 10.1093/annonc/mdi228; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Rick O, 2001, J CLIN ONCOL, V19, P81, DOI 10.1200/JCO.2001.19.1.81; Rick O, 1998, EUR J CANCER, V34, P1883, DOI 10.1016/S0959-8049(98)00272-X; Rodenhuis S, 1999, ANN ONCOL, V10, P1467, DOI 10.1023/A:1008328012040; Rosti G, 2002, CANCER, V95, P309, DOI 10.1002/cncr.10672; SIEGERT W, 1994, J CLIN ONCOL, V12, P1223, DOI 10.1200/JCO.1994.12.6.1223; Vaena DA, 2003, J CLIN ONCOL, V21, P4100, DOI 10.1200/JCO.2003.06.067; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	32	334	348	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					340	348		10.1056/NEJMoa067749	http://dx.doi.org/10.1056/NEJMoa067749			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652649				2022-12-24	WOS:000248283500005
J	Wright, AA; Katz, IT				Wright, Alexi A.; Katz, Ingrid T.			Letting go of the rope - Aggressive treatment, hospice care, and open access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER; LIFE; END						Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Finn JW, 2002, P AN M AM SOC CLIN, P21; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; *NAT HOSP PALL CAR, 2006, 2005 NAT SUMM HOSP C, P4; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458	5	61	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					324	327		10.1056/NEJMp078074	http://dx.doi.org/10.1056/NEJMp078074			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652646				2022-12-24	WOS:000248283500002
J	Vassylyev, DG; Vassylyeva, MN; Perederina, A; Tahirov, TH; Artsimovitch, I				Vassylyev, Dmitry G.; Vassylyeva, Marina N.; Perederina, Anna; Tahirov, Tahir H.; Artsimovitch, Irina			Structural basis for transcription elongation by bacterial RNA polymerase	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; ELECTRON-DENSITY MAPS; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; LID ELEMENT; DNA HYBRID; COMPLEX; MECHANISM; TRANSLOCATION; INITIATION	The RNA polymerase elongation complex (EC) is both highly stable and processive, rapidly extending RNA chains for thousands of nucleotides. Understanding the mechanisms of elongation and its regulation requires detailed information about the structural organization of the EC. Here we report the 2.5-angstrom resolution structure of the Thermus thermophilus EC; the structure reveals the post-translocated intermediate with the DNA template in the active site available for pairing with the substrate. DNA strand separation occurs one position downstream of the active site, implying that only one substrate at a time can specifically bind to the EC. The upstream edge of the RNA/DNA hybrid stacks on the beta'-subunit 'lid' loop, whereas the first displaced RNA base is trapped within a protein pocket, suggesting a mechanism for RNA displacement. The RNA is threaded through the RNA exit channel, where it adopts a conformation mimicking that of a single strand within a double helix, providing insight into a mechanism for hairpin-dependent pausing and termination.	Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Dent, Birmingham, AL 35294 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Lied Transplant Ctr, Omaha, NE 68198 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Nebraska System; University of Nebraska Medical Center; University System of Ohio; Ohio State University	Vassylyev, DG (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, 402B Kaul Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dmitry@uab.edu	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019; Ganesh, Dunna Sai/AGX-5170-2022	Tahirov, Tahir/0000-0002-1238-0069				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; BAKER D, 1993, ACTA CRYSTALLOGR D, V49, P429, DOI 10.1107/S0907444993004032; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Jiang ML, 2004, MOL CELL, V15, P777, DOI 10.1016/j.molcel.2004.07.019; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; MATTHEWS BW, 1975, ACTA CRYSTALLOGR A, V31, P480, DOI 10.1107/S0567739475001040; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang JH, 1996, ACTA CRYSTALLOGR D, V52, P369, DOI 10.1107/S0907444995012352; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	50	318	330	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					157	U3		10.1038/nature05932	http://dx.doi.org/10.1038/nature05932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17581590				2022-12-24	WOS:000247934500034
J	Cooper, D; Cahn, P; Lewin, S; Kaldor, J; McClure, C; Kort, R; Boyd, M				Cooper, David; Cahn, Pedro; Lewin, Sharon; Kaldor, John; McClure, Craig; Kort, Rodney; Boyd, Mark			The Sydney Declaration: a call to scale up research	LANCET			English	Editorial Material									Int AIDS Soc, CH-1216 Geneva, Switzerland; Univ New S Wales, Sydney, NSW, Australia; Fdn Huesped, Buenos Aires, DF, Argentina; Monash Univ, Clayton, Vic 3168, Australia; Alfred Hosp, Prahran, Vic 3181, Australia	University of New South Wales Sydney; Monash University; Florey Institute of Neuroscience & Mental Health	Kort, R (corresponding author), Int AIDS Soc, CH-1216 Geneva, Switzerland.	Rodney.Kort@iasociety.org	Kaldor, John M/D-4545-2011; Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241					0	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					7	8		10.1016/S0140-6736(07)61024-1	http://dx.doi.org/10.1016/S0140-6736(07)61024-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187QE	17617252				2022-12-24	WOS:000247862300006
J	Wilson, JF				Wilson, Jennifer Fisher			Strategies to stop abuse of prescribed opioid drugs	ANNALS OF INTERNAL MEDICINE			English	News Item							CHRONIC PAIN; ASSOCIATION; DISORDERS					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Gourlay DL, 2005, PAIN MED, V6, P107, DOI 10.1111/j.1526-4637.2005.05031.x; GOURLAY DL, 2004, DRUG TESTING CLIN PR, P4349; Hariharan J, 2007, J GEN INTERN MED, V22, P485, DOI 10.1007/s11606-006-0084-1; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Sullivan MD, 2005, PAIN, V119, P95, DOI 10.1016/j.pain.2005.09.020; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x	9	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					897	900		10.7326/0003-4819-146-12-200706190-00017	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577013				2022-12-24	WOS:000247347100013
J	Hao, X				Hao, Xin			Monkey research in China: Developing a natural resource	CELL			English	Editorial Material								China's contribution to primate research is no longer limited to supplying monkeys to scientists abroad. With an abundance of wild rhesus macaques, low labor costs, and a nonhostile environment for animal research, scientists are finding that China is the place to be for research using macaques as models of human disease.											0	14	15	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1033	1036		10.1016/j.cell.2007.05.051	http://dx.doi.org/10.1016/j.cell.2007.05.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574013	Bronze			2022-12-24	WOS:000247390400004
J	Mizuguchi, G; Xiao, H; Wisniewski, J; Smith, MM; Wu, C				Mizuguchi, Gaku; Xiao, Hua; Wisniewski, Jan; Smith, M. Mitchell; Wu, Carl			Nonhistone Scm3 and histones CenH3-H4 assemble the core of centromere-specific nucleosomes	CELL			English	Article							A CENP-A; BUDDING YEAST; KINETOCHORE COMPLEX; CHROMATIN; PROTEIN; DNA; CSE4P; H3; EPIGENETICS; COMPONENT	The budding yeast histone H3 variant, Cse4, replaces conventional histone H3 in centromeric chromatin and, together with centromere-specific DNA-binding factors, directs assembly of the kinetochore, a multiprotein complex mediating chromosome segregation. We have identified Scm3, a nonhistone protein that colocalizes with Cse4 and is required for its centromeric association. Bacterially expressed Scm3 binds directly to and reconstitutes a stoichiometric complex with Cse4 and histone H4 but not with conventional histone H3 and H4. A conserved acidic domain of Scm3 is responsible for directing the Cse4-specific interaction. Strikingly, binding of Scm3 can replace histones H2A-H2B from preassembled Cse4-containing histone octamers. This incompatibility between Scm3 and histones H2A-H2B is correlated with diminished in vivo occupancy of histone H2B, H2A, and H2AZ at centromeres. Our findings indicate that nonhistone Scm3 serves to assemble and maintain Cse4-H4 at centromeres and may replace histone H2A-H2B dimers in a centromere-specific nucleosome core.	NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia	Wu, C (corresponding author), NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC005263] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM28930] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Choo KHA., 1997, CENTROMERE; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2005, MOL BIOL CELL, V16, P5649, DOI 10.1091/mbc.E05-08-0771; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Crotti LB, 2004, EMBO J, V23, P1804, DOI 10.1038/sj.emboj.7600161; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gardner RD, 2001, GENETICS, V157, P1493; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; GODFREY JE, 1980, BIOCHEMISTRY-US, V19, P1339, DOI 10.1021/bi00548a012; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Keith KC, 2000, GENETICS, V156, P973; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Sharp JA, 2003, GENE DEV, V17, P2356, DOI 10.1101/gad.1131103; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Smith MM, 1996, MOL CELL BIOL, V16, P1017; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	65	233	244	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1153	1164		10.1016/j.cell.2007.04.026	http://dx.doi.org/10.1016/j.cell.2007.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574026	Bronze			2022-12-24	WOS:000247390400018
J	Saschenbrecker, S; Bracher, A; Rao, KV; Rao, BV; Hartl, FU; Hayer-Hartl, M				Saschenbrecker, Sandra; Bracher, Andreas; Rao, Karnam Vasudeva; Rao, Bharathi Vasudeva; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structure and function of RbcX, an assembly chaperone for hexadecameric rubisco	CELL			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; LARGE SUBUNITS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; NASCENT CHAIN; OXYGENASE; PROTEINS; CATALYSIS	After folding, many proteins must assemble into oligomeric complexes to become biologically active. Here we describe the role of RbcX as an assembly chaperone of ribulose-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme responsible for the fixation of atmospheric carbon dioxide. In cyanobacteria and plants, Rubisco is an similar to 520 kDa complex composed of eight large subunits (RbcL) and eight small subunits (RbcS). We found that cyanobacterial RbcX functions downstream of chaperonin-mediated RbcL folding in promoting the formation of RbcL(8) core complexes. Structural analysis revealed that the 15 kDa RbcX forms a homodimer with two cooperating RbcL-binding regions. A central cleft specifically binds the exposed C-terminal peptide of RbcL subunits, enabling a peripheral surface of RbcX to mediate RbcL8 assembly. Due to the dynamic nature of these interactions, RbcX is readily displaced from RbcL8 complexes by RbcS, producing the active enzyme. The strategies employed by RbcX in achieving substrate specificity and efficient product release may be generally relevant in assisted assembly reactions.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Bracher, A (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	bracher@biochem.mpg.de; uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P18; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CURMI PMG, 1992, J BIOL CHEM, V267, P16980; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; HUBBS AE, 1993, J BIOL CHEM, V268, P13519; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; ROY H, 1989, PLANT CELL, V1, P1035, DOI 10.1105/tpc.1.11.1035; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhu GH, 1998, PHOTOSYNTH RES, V57, P71, DOI 10.1023/A:1006020424581; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	30	103	106	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1189	1200		10.1016/j.cell.2007.04.025	http://dx.doi.org/10.1016/j.cell.2007.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574029	hybrid, Green Accepted			2022-12-24	WOS:000247390400021
J	Quarrie, KL; Gianotti, SM; Hopkins, WG; Hume, PA				Quarrie, Kenneth L.; Gianotti, Simon M.; Hopkins, Will G.; Hume, Patria A.			Effect of nationwide injury prevention programme on serious spinal injuries in New Zealand rugby union: ecological study	BRITISH MEDICAL JOURNAL			English	Article							CORD; LESSONS	Objective To investigate the effect of RugbySmart, a nationwide educational injury prevention programme, on the frequency of spinal cord injuries. Design Ecological study. Setting New Zealand rugby union. Participants Population at risk of injury comprised all New Zealand rugby union players. Intervention From 2001, all New Zealand rugby coaches and referees have been required to complete RugbySmart, which focuses on educating rugby participants about physical conditioning, injury management, and safe techniques in the contact phases of rugby. Main outcome measures Numbers of all spinal injuries due to participation in rugby union resulting in permanent disablement in 1976-2005, grouped into five year periods; observed compared with predicted number of spinal injuries in 2001-5. Results Eight spinal injuries occurred in 2001-5, whereas the predicted number was 18.9 (relative rate=0.46, 95% confidence interval 0.19 to 1.14). Only one spinal injury resulted from scrums over the period; the predicted number was 9.0 (relative rate=0.11, 0.02 to 0.74). Corresponding observed and predicted rates for spinal injuries resulting from other phases of play (tackle, ruck, and maul) were 7 and 9.0 (relative rate=0.83, 0.29 to 2.36). Conclusions The introduction of the RugbySmart programme coincided with a reduction in the rate of disabling spinal injuries arising from scrums in rugby union. This study exemplifies the benefit of educational initiatives in injury prevention and the need for comprehensive injury surveillance systems for evaluating injury prevention initiatives in sport.	New Zealand Rugby Unit, Wellington, New Zealand; Accid Compensat Corp, Sport & Rd, Wellington, New Zealand; AUT Unit, Fac Hlth & Environm Sci, Inst Sport & Recreat Res New Zealand, Auckland, New Zealand	Auckland University of Technology	Quarrie, KL (corresponding author), New Zealand Rugby Unit, POB 2172, Wellington, New Zealand.	ken.quarrie@nzrugby.co.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Quarrie, Ken/0000-0003-1703-8489				Berry JG, 2006, AUST NZ J PUBL HEAL, V30, P268, DOI 10.1111/j.1467-842X.2006.tb00869.x; Bourke JB, 2006, BRIT MED J, V332, P1281, DOI 10.1136/bmj.332.7552.1281; Carmody DJ, 2005, MED J AUSTRALIA, V182, P561, DOI 10.5694/j.1326-5377.2005.tb06814.x; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; GARRAWAY WM, 1991, BRIT MED J, V303, P1082, DOI 10.1136/bmj.303.6810.1082; Haylen PT, 2004, MED J AUSTRALIA, V181, P48, DOI 10.5694/j.1326-5377.2004.tb06161.x; *INT RUGB BOARD, 2004, RUGB WORLD CUP 2003; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Quarrie KL, 2007, J SPORT SCI, V25, P895, DOI 10.1080/02640410600944659; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	11	93	94	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1150	1153		10.1136/bmj.39185.605914.AE	http://dx.doi.org/10.1136/bmj.39185.605914.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17513314	Green Published, Bronze			2022-12-24	WOS:000247137000030
J	Sablina, AA; Chen, W; Arroyo, JD; Corral, L; Hector, M; Bulmer, SE; DeCaprio, JA; Hahn, WC				Sablina, Anna A.; Chen, Wen; Arroyo, Jason D.; Corral, Laura; Hector, Melissa; Bulmer, Sara E.; DeCaprio, James A.; Hahn, William C.			The tumor suppressor PP2A A beta regulates the RaIA GTPase	CELL			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN CELL-TRANSFORMATION; SMALL-T-ANTIGEN; RAL-GTPASES; SUBUNIT INTERACTION; SIGNALING PATHWAY; PPP2R1B GENE; CANCER-CELLS; ACTIVATION; ALPHA	The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme family that regulates numerous signaling pathways. Biallelic mutations of the structural PP2A A beta subunit occur in several types of human tumors; however, the functional consequences of these cancer-associated PP2A A beta mutations in cell transformation remain undefined. Here we show that suppression of PP2A A beta expression permits immortalized human cells to achieve a tumorigenic state. Cancer-associated A beta mutants fail to reverse tumorigenic phenotype induced by PP2A A beta suppression, indicating that these mutants function as null alleles. Wild-type PP2A A beta but not cancer-derived A beta mutants form a complex with the small GTPase RalA. PP2A A beta-containing complexes dephosphorylate RalA at Ser183 and Ser194, inactivating RalA and abolishing its transforming function. These observations identify PP2A A beta as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA.	Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou 510080, Peoples R China; Dana Farber Canc Inst, DF HCC Monoclonal Antibody Core, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute	Hahn, WC (corresponding author), Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, 75 Francis St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Sablina, Anna/B-2217-2017; Sablina, Anna/P-2818-2019	Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Hector-Greene, Melissa/0000-0001-7263-1440; Arroyo, Jason/0000-0002-5674-6739	NATIONAL CANCER INSTITUTE [P01CA050661] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA050661-190009, P01 CA50661, P01 CA050661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Broach JR, 1997, CURR OPIN GENET DEV, V7, P1, DOI 10.1016/S0959-437X(97)80102-5; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Feinstein E, 2005, ONCOGENE, V24, P326, DOI 10.1038/sj.onc.1208252; Gildea JJ, 2002, CANCER RES, V62, P982; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Panner A, 2006, MOL CELL BIOL, V26, P7345, DOI 10.1128/MCB.00126-06; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SUGANO S, 1982, J VIROL, V41, P1073, DOI 10.1128/JVI.41.3.1073-1075.1982; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TAKATA K, 2000, BREED RES, V2, P11; Tamaki M, 2004, ONCOL REP, V11, P655; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	58	160	169	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					969	982		10.1016/j.cell.2007.03.047	http://dx.doi.org/10.1016/j.cell.2007.03.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540176	Bronze, Green Accepted			2022-12-24	WOS:000247084600016
J	Chretien, JP; Fukuda, M; Noedl, H				Chretien, Jean-Paul; Fukuda, Mark; Noedl, Harald			Improving surveillance for antimalarial drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MALARIA; ARTEMISININ; MUTATIONS; EFFICACY		US Dept Def, Global Emerging Infect Surveillance & Response Sy, Silver Spring, MD 20910 USA; Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand; Med Univ Vienna, Dept Specif Prophylaxis & Trop Med, Vienna, Austria	United States Department of Defense; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Medical University of Vienna	Chretien, JP (corresponding author), US Dept Def, Global Emerging Infect Surveillance & Response Sy, 2900 Linden Lane, Silver Spring, MD 20910 USA.	jean-paul.chretien@na.amedd.army.mil		Chretien, Jean-Paul/0000-0001-8143-6823				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; *GLOB FUND FIGHT A, 2004, TUB MAL REV ANT TREA; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING, P1125; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kachur SP, 2006, LANCET, V368, P10, DOI 10.1016/S0140-6736(06)68945-9; Kerr C, 2006, LANCET INFECT DIS, V6, P397, DOI 10.1016/S1473-3099(06)70508-4; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Magill A, 2005, NEW ENGL J MED, V353, P335, DOI 10.1056/NEJMp058167; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Noedl H, 2005, TRENDS PARASITOL, V21, P404, DOI 10.1016/j.pt.2005.06.012; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; WHO, 2005, SUSC PLASM FALC ANT; WHO, 2006, GUID TREATM MAL; *WHO, 2006, FACTS ACTS; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 1993, GLOB STRAT MAL CONTR	23	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2278	2281		10.1001/jama.297.20.2278	http://dx.doi.org/10.1001/jama.297.20.2278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17522014				2022-12-24	WOS:000246659700027
J	May, J; Evans, JA; Timmann, C; Ehmen, C; Busch, W; Thye, T; Agbenyega, T; Horstmann, RD				May, Juergen; Evans, Jennifer A.; Timmann, Christian; Ehmen, Christa; Busch, Wibke; Thye, Thorsten; Agbenyega, Tsiri; Horstmann, Rolf D.			Hemoglobin variants and disease manifestations in severe falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SICKLE-CELL TRAIT; AFRICAN CHILDREN; ALPHA(+)-THALASSEMIA PROTECTS; ALPHA-THALASSEMIA; GHANAIAN CHILDREN; POLYMORPHISM; CHLOROQUINE; POPULATION; RESISTANCE; PARASITES	Context The geographical distributions of hemoglobin S (HbS), hemoglobin C (HbC), and alpha(+)-thalassemia (-alpha) strongly suggest balancing selection with malaria. However, whereas several studies indicate that the HbS carrier state protects against all major forms of clinical malaria, malaria protection on clinical grounds has been more difficult to confirm for HbC and -alpha, and questions remain as to whether it applies to all forms of the disease. Objective To assess the association between major clinical forms of severe falciparum malaria and HbS, HbC, and -alpha. Design, Setting, and Participants Case-control study of 2591 children with severe falciparum malaria enrolled at a tertiary referral center in Ghana, West Africa, and 2048 age-, sex-, and ethnicity-matched control participants recruited by community surveys. Main Outcome Measures Frequencies of HbS, HbC, and -alpha in patients and controls, including stratifications of patients for signs of disease. Results Patients presented with partly overlapping signs of disease, including severe anemia (64%), cerebral malaria (22%), respiratory distress (30%), hyperparasitemia (32%), prostration (52%), acidosis (59%), and hyperlactatemia (56%). Carrier states of HbS, HbC, and -alpha were found in 1.4%, 9.4%, and 25.2% of the patients, respectively, and 14.8%, 8.7%, and 27.3% of controls. The HbS carrier state was negatively associated with all forms of the disease studied (overall odds ratio [OR], 0.08; 95% confidence interval [CI], 0.06-0.12). The HbC carrier state showed a negative association selectively with cerebral malaria (OR, 0.64; 95% CI, 0.45-0.91), and the -alpha carrier state showed a negative association selectively with severe anemia (OR, 0.82; 95% CI, 0.69-0.96). Conclusion Whereas the HbS carrier state was found to be negatively associated with all major forms of severe falciparum malaria, the negative associations of the carrier states of HbC and -alpha appeared to be limited to cerebral malaria and severe anemia, respectively.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; Univ Schleswig Holstein, Inst Med Biometry & Stat, Kiel, Germany; Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; Komfo Anokye Teaching Hosp, Dept Child Hlth, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Kiel; Schleswig Holstein University Hospital; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	horstmann@bni-hamburg.de	May, Jürgen/E-7857-2011	May, Jurgen/0000-0001-7831-8420				Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Allen S, 1996, LANCET, V348, P1168, DOI 10.1016/S0140-6736(05)65301-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P581; CARSON JL, 1988, LANCET, V1, P727; Chong SS, 2000, BLOOD, V95, P360; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; GILLES HM, 1967, LANCET, V1, P138; Herrmann MG, 2000, CLIN CHEM, V46, P425; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Pasvol G, 2006, PLOS MED, V3, P591, DOI 10.1371/journal.pmed.0030235; Rees DC, 1998, BRIT J HAEMATOL, V103, P365; Roberts DJ, 2005, CURR TOP MICROBIOL, V295, P137; Shute G. T., 1988, Malaria: principles and practice of malariology. Volume 1., P781; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SNOW R, 2003, 11 NIH FOG INT CTR, P1; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	37	122	123	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2220	2226		10.1001/jama.297.20.2220	http://dx.doi.org/10.1001/jama.297.20.2220			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519411				2022-12-24	WOS:000246659700021
J	Watts, G				Watts, Geoff			The locked code	BRITISH MEDICAL JOURNAL			English	Article												geoff@scileg.freeserve.co.uk						CRICHTON M, 2007, NY TIMES        0213; *NUFF COUNC BIOETH, 2002, ETH PAT DNA; *U SUSS SCI TECHN, 2006, PAT HUM DNA GLOB TRE; *UN, 1997, UN DECL HUM GEN HUM; *WELLC TRUST, SNP CONS INT HAPM PR	5	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1032	1033		10.1136/bmj.39190.654132.94	http://dx.doi.org/10.1136/bmj.39190.654132.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510149	Green Published			2022-12-24	WOS:000246913500029
J	Chuang, CF; VanHoven, MK; Fetter, RD; Verselis, VK; Bargmann, CI				Chuang, Chiou-Fen; VanHoven, Miri K.; Fetter, Richard D.; Verselis, Vytas K.; Bargmann, Cornelia I.			An innexin-dependent cell network establishes left-right neuronal asymmetry in C. elegans	CELL			English	Article							GAP-JUNCTION PROTEINS; ODORANT RECEPTOR EXPRESSION; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; OLFACTORY NEURONS; XENOPUS-OOCYTES; DROSOPHILA; CHANNELS; FAMILY; MECHANISMS	Gap junctions are widespread in immature neuronal circuits, but their functional significance is poorly understood. We show here that a transient network formed by the innexin gap-junction protein NSY-5 coordinates left-right asymmetry in the developing nervous system of Caenorhabditis elegans. nsy-5 is required for the left and right AWC olfactory neurons to establish stochastic, asymmetric patterns of gene expression during embryogenesis. nsy-5-dependent gap junctions in the embryo transiently connect the AWC cell bodies with those of numerous other neurons. Both AWCs and several other classes of nsy-5-expressing neurons participate in signaling that coordinates left-right AWC asymmetry. The right AWC can respond to nsy-5 directly, but the left AWC requires nsy-5 function in multiple cells of the network. NSY-5 forms hemichannels and intercellular gap-junction channels in Xenopus oocytes, consistent with a combination of cell-intrinsic and network functions. These results provide insight into gap-junction activity in developing circuits.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		VanHoven, Miri/0000-0001-7714-1555; Bargmann, Cornelia/0000-0002-8484-0618; Chuang, Chiou-Fen/0000-0001-7469-076X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04089] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BRENNER S, 1974, GENETICS, V77, P71; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Curtin KD, 2002, J NEUROSCI, V22, P7088; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kandler K, 1998, J NEUROSCI, V18, P1419; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Landesman Y, 1999, J CELL SCI, V112, P2391; LEE SH, 1994, GLIA, V11, P315, DOI 10.1002/glia.440110404; Levin M, 1999, DEVELOPMENT, V126, P4703; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; Starich TA, 2003, DEV BIOL, V256, P403, DOI 10.1016/S0012-1606(02)00116-1; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; VanHoven MK, 2006, NEURON, V51, P291, DOI 10.1016/j.neuron.2006.06.029; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZAMPIGHI G, 1980, J CELL BIOL, V86, P190, DOI 10.1083/jcb.86.1.190	43	105	118	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					787	799		10.1016/j.cell.2007.02.052	http://dx.doi.org/10.1016/j.cell.2007.02.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512411	Bronze			2022-12-24	WOS:000246788300022
J	Donsante, A; Miller, DG; Li, Y; Vogler, C; Brunt, EM; Russell, DW; Sands, MS				Donsante, Anthony; Miller, Daniel G.; Li, Yi; Vogler, Carole; Brunt, Elizabeth M.; Russell, David W.; Sands, Mark S.			AAV vector integration sites in mouse hepatocellular carcinoma	SCIENCE			English	Article							LIVER; CELLS; TUMOR		Univ Washington, Dept Med, Seattle, WA 98112 USA; Univ Washington, Dept Biochem, Seattle, WA 98112 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Washington, Dept Pediat, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Mail Stop 357720, Seattle, WA 98112 USA.	drussell@u.washington.edu; msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Miller, Daniel/0000-0002-5700-3048; Donsante, Anthony/0000-0002-7591-7417	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071657] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Embury JE, 2006, MOL THER, V13, pS83, DOI 10.1016/j.ymthe.2006.08.241; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Miller DG, 2005, J VIROL, V79, P11434, DOI 10.1128/JVI.79.17.11434-11442.2005; Nakai H, 2005, J VIROL, V79, P3606, DOI 10.1128/JVI.79.6.3606-3614.2005	8	443	468	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					477	477		10.1126/science.1142658	http://dx.doi.org/10.1126/science.1142658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656716				2022-12-24	WOS:000248339800034
J	Iheanacho, I				Iheanacho, Ike			All together now	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39234.611505.59	http://dx.doi.org/10.1136/bmj.39234.611505.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556482	Green Published			2022-12-24	WOS:000247277000043
J	Yeh, BJ; Rutigliano, RJ; Deb, A; Bar-Sagi, D; Lim, WA				Yeh, Brian J.; Rutigliano, Robert J.; Deb, Anrica; Bar-Sagi, Dafna; Lim, Wendell A.			Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors	NATURE			English	Article							RHO GTPASES; PROTEIN-KINASE; N-WASP; DOMAINS; ACTIVATION; MECHANISMS; CIRCUITS; SIGNALS; COMPLEX; CASCADE	Eukaryotic cells mobilize the actin cytoskeleton to generate a remarkable diversity of morphological behaviours, including motility, phagocytosis and cytokinesis. Much of this diversity is mediated by guanine nucleotide exchange factors ( GEFs) that activate Rho family GTPases - the master regulators of the actin cytoskeleton(1-3). There are over 80 Rho GEFs in the human genome ( compared to only 22 genes for the Rho GTPases themselves), and the evolution of new and diverse GEFs is thought to provide a mechanism for linking the core cytoskeletal machinery to a wide range of new control inputs. Here we test this hypothesis and ask if we can systematically reprogramme cellular morphology by engineering synthetic GEF proteins. We focused on Dbl family Rho GEFs, which have a highly modular structure common to many signalling proteins(4,5): they contain a catalytic Dbl homology (DH) domain linked to diverse regulatory domains, many of which autoinhibit GEF activity(2,3). Here we show that by recombining catalytic GEF domains with new regulatory modules, we can generate synthetic GEFs that are activated by non-native inputs. We have used these synthetic GEFs to reprogramme cellular behaviour in diverse ways. The GEFs can be used to link specific cytoskeletal responses to normally unrelated upstream signalling pathways. In addition, multiple synthetic GEFs can be linked as components in series to form an artificial cascade with improved signal processing behaviour. These results show the high degree of evolutionary plasticity of this important family of modular signalling proteins, and indicate that it may be possible to use synthetic biology approaches to manipulate the complex spatio-temporal control of cell morphology.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; Univ Calif San Francisco, Cell Propuls Lab, UCSF UCB NIH Nanomed Dev Ctr, San Francisco, CA USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA USA; SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University	Bar-Sagi, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA.	dafna.bar-sagi@med.nyu.edu; lim@cmp.ucsf.edu		Bar-Sagi, Dafna/0000-0003-2597-8948				Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; DUEBER JE, 2007, IN PRESS NATURE BIOT; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	30	98	102	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					596	600		10.1038/nature05851	http://dx.doi.org/10.1038/nature05851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17515921				2022-12-24	WOS:000246842000050
J	Shiroguchi, K; Kinosita, K				Shiroguchi, Katsuyuki; Kinosita, Kazuhiko, Jr.			Myosin V walks by lever action and Brownian motion	SCIENCE			English	Article							HAND-OVER-HAND; UNCONVENTIONAL MYOSIN; PROCESSIVE MYOSIN; MECHANISM; MOTOR; KINESIN; STEPS; FILAMENTS; DYNAMICS; HEAD	Myosin V is a molecular motor that moves cargo along actin filaments. Its two heads, each attached to a long and relatively stiff neck, move alternately forward in a "hand-over-hand" fashion. To observe under a microscope how the necks move, we attached a micrometer-sized rod to one of the necks. The leading neck swings unidirectionally forward, whereas the trailing neck, once lifted, undergoes extensive Brownian rotation in all directions before landing on a site ahead of the leading head. The neck-neck joint is essentially free, and the neck motion supports a mechanism where the active swing of the leading neck biases the random motion of the lifted head to let it eventually land on a forward site.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	kazuhiko@waseda.jp						Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; KINOSITA K, 1984, BIOCHEMISTRY-US, V23, P5963, DOI 10.1021/bi00320a012; Kinosita K, 2005, ADV EXP MED BIOL, V565, P205; Kinosita K, 2007, ADV EXP MED BIOL, V592, P369; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	99	103	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1208	1212		10.1126/science.1140468	http://dx.doi.org/10.1126/science.1140468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525343				2022-12-24	WOS:000246724300048
J	Hermann, JC; Marti-Arbona, R; Fedorov, AA; Fedorov, E; Almo, SC; Shoichet, BK; Raushel, FM				Hermann, Johannes C.; Marti-Arbona, Ricardo; Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.; Shoichet, Brian K.; Raushel, Frank M.			Structure-based activity prediction for an enzyme of unknown function	NATURE			English	Article							DOCKING; INHIBITORS; CATALYSIS; ERRORS	With many genomes sequenced, a pressing challenge in biology is predicting the function of the proteins that the genes encode. When proteins are unrelated to others of known activity, bioinformatics inference for function becomes problematic. It would thus be useful to interrogate protein structures for function directly. Here, we predict the function of an enzyme of unknown activity, Tm0936 from Thermotoga maritima, by docking high- energy intermediate forms of thousands of candidate metabolites. The docking hit list was dominated by adenine analogues, which appeared to undergo C6- deamination. Four of these, including 5- methylthioadenosine and S- adenosylhomocysteine ( SAH), were tested as substrates, and three had substantial catalytic rate constants ( 10(5) M-1 s(-1)). The X- ray crystal structure of the complex between Tm0936 and the product resulting from the deamination of SAH, S- inosylhomocysteine, was determined, and it corresponded closely to the predicted structure. The deaminated products can be further metabolized by T. maritima in a previously uncharacterized SAH degradation pathway. Structure- based docking with high- energy forms of potential substrates may be a useful tool to annotate enzymes for function.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Yeshiva University; Albert Einstein College of Medicine	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, MC 2550 1700 4th St, San Francisco, CA 94158 USA.	shoichet@cgl.ucsf.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071896, R01GM059957] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059957, R01 GM059957-09, R01 GM071896, R01 GM071896-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W W, 1979, Methods Enzymol, V63, P500; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Gerlt JA, 2000, GENOME BIOL, V1; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; Gschwend DA, 1996, J COMPUT AID MOL DES, V10, P123, DOI 10.1007/BF00402820; Hermann JC, 2006, ORG BIOMOL CHEM, V4, P206, DOI 10.1039/b512969a; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Macchiarulo A, 2004, NAT BIOTECHNOL, V22, P1039, DOI 10.1038/nbt999; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mohan V, 2005, CURR PHARM DESIGN, V11, P323, DOI 10.2174/1381612053382106; MUSZBEK L, 1985, CLIN CHEM, V31, P35; Nowlan C, 2006, J AM CHEM SOC, V128, P15892, DOI 10.1021/ja0658618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Rao MS, 1999, PROTEINS, V34, P173, DOI 10.1002/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Schramm VL, 2005, CURR OPIN STRUC BIOL, V15, P604, DOI 10.1016/j.sbi.2005.10.017; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; SPEEDIE MK, 1988, J BACTERIOL, V170, P4376, DOI 10.1128/jb.170.9.4376-4378.1988; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sukuru SCK, 2006, J COMPUT AID MOL DES, V20, P159, DOI 10.1007/s10822-006-9043-5; Tantillo DJ, 2002, J COMPUT CHEM, V23, P84, DOI 10.1002/jcc.10019; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; Warshel A, 1998, P NATL ACAD SCI USA, V95, P5950, DOI 10.1073/pnas.95.11.5950; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901	43	202	215	2	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					775	U2		10.1038/nature05981	http://dx.doi.org/10.1038/nature05981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17603473	Green Accepted			2022-12-24	WOS:000248754200032
J	Ago, H; Kanaoka, Y; Irikura, D; Lam, BK; Shimamura, T; Austen, KF; Miyano, M				Ago, Hideo; Kanaoka, Yoshihide; Irikura, Daisuke; Lam, Bing K.; Shimamura, Tatsuro; Austen, K. Frank; Miyano, Masashi			Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis	NATURE			English	Article							C-4 SYNTHASE; GLUTATHIONE; IDENTIFICATION; TRANSFERASE; EXPRESSION; SUBSTANCE; CLONING; ENZYME	The cysteinyl leukotrienes, namely leukotriene (LT)C-4 and its metabolites LTD4 and LTE4, the components of slow-reacting substance of anaphylaxis(1,2), are lipid mediators of smooth muscle constriction(3-5) and inflammation(6,7), particularly implicated in bronchial asthma(8,9). LTC4 synthase (LTC4S), the pivotal enzyme for the biosynthesis of LTC4 (ref. 10), is an 18-kDa integral nuclear membrane protein(11,12) that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase- activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref. 13). LTC4S conjugates glutathione to LTA(4), the endogenous substrate derived from arachidonic acid through the 5-lipoxygenase pathway(14). In contrast with MGST2 and MGST3 (refs 15, 16), LTC4S does not conjugate glutathione to xenobiotics(17). Here we show the atomic structure of human LTC4S in a complex with glutathione at 3.3 angstrom resolution by X-ray crystallography and provide insights into the high substrate specificity for glutathione and LTA(4) that distinguishes LTC4S from other MGSTs. The LTC4S monomer has four transmembrane alpha-helices and forms a threefold symmetric trimer as a unit with functional domains across each interface. Glutathione resides in a U-shaped conformation within an interface between adjacent monomers, and this binding is stabilized by a loop structure at the top of the interface. LTA(4) would fit into the interface so that Arg 104 of one monomer activates glutathione to provide the thiolate anion that attacks C6 of LTA(4) to form a thioether bond, and Arg 31 in the neighbouring monomer donates a proton to form a hydroxyl group at C5, resulting in 5(S)-hydroxy-6(R)-S-glutathionyl-7,9-trans-11,14-cis-eicosatetraenoic acid (LTC4). These findings provide a structural basis for the development of LTC4S inhibitors for a proinflammatory pathway mediated by three cysteinyl leukotriene ligands whose stability and potency are different and by multiple cysteinyl leukotriene receptors whose functions may be non-redundant.	Harima Inst, Struct Biophys Lab, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Miyano, M (corresponding author), Harima Inst, Struct Biophys Lab, RIKEN SPring Ctr 8, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	fausten@rics.bwh.harvard.edu; miyano@spring8.or.jp	Miyano, Masashi/R-2785-2016	Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; BROCKLEHURST WE, 1960, J PHYSIOL-LONDON, V151, P416, DOI 10.1113/jphysiol.1960.sp006449; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christmas P, 2002, J BIOL CHEM, V277, P28902, DOI 10.1074/jbc.M203074200; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1996, J BIOL CHEM, V271, P22203, DOI 10.1074/jbc.271.36.22203; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kellaway CH, 1940, Q J EXP PHYSIOL CMS, V30, P121; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; MARFAT A, 1985, ADV PROSTAG THROMB L, V14, P155; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396; Zimmer JSD, 2004, J LIPID RES, V45, P2138, DOI 10.1194/jlr.M400240-JLR200	31	122	127	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					609	U12		10.1038/nature05936	http://dx.doi.org/10.1038/nature05936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632548				2022-12-24	WOS:000248446700047
J	Niemann, HH; Jager, V; Butler, PJG; van den Heuvel, J; Schmidt, S; Ferraris, D; Gherardi, E; Heinz, DW				Niemann, Hartmut H.; Jaeger, Volker; Butler, P. Jonathan G.; van den Heuvel, Joop; Schmidt, Sabine; Ferraris, Davide; Gherardi, Ermanno; Heinz, Dirk W.			Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InIB	CELL			English	Article							GROWTH FACTOR/SCATTER FACTOR; HOST-CELL INVASION; SURFACE PROTEIN; L-MONOCYTOGENES; SEMA DOMAIN; GW DOMAINS; INTERNALIN; INLB; ENTRY; SUFFICIENT	The tyrosine kinase Met, the product of the c-met proto-oncogene and the receptor for hepatocyte growth factor/scatter factor (HGF/SF), mediates signals critical for cell survival and migration. The human pathogen Listeria monocytogenes exploits Met signaling for invasion of host cells via its surface protein InlB. We present the crystal structure of the complex between a large fragment of the human Met ectodomain and the Met-binding domain of InlB. The concave face of the InlB leucine-rich repeat region interacts tightly with the first immunoglobulin-like domain of the Met stalk, a domain which does not bind HGF/SF. A second contact between InlB and the Met Sema domain locks the otherwise flexible receptor in a rigid, signaling competent conformation. Full Met activation requires the additional C-terminal domains of InlB which induce heparin-mediated receptor clustering and potent signaling. Thus, although it elicits a similar cellular response, InlB is not a structural mimic of HGF/SF.	Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany; MRC Ctr & Lab Mol Biol, Cambridge CB2 2QH, England	Helmholtz Association; Helmholtz-Center for Infection Research	Gherardi, E (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Inhoffenstr 7, Braunschweig, Germany.	egherard@mrc-lmb.cam.ac.uk; dirk.heinz@helmholtz-hzi.de	Gherardi, Ermanno/AAB-9608-2022; Ferraris, Davide Maria/AAP-7110-2020; Ferraris, Davide Maria/AAO-9743-2020; Niemann, Hartmut/F-7947-2011	Ferraris, Davide Maria/0000-0001-5112-9910; Niemann, Hartmut/0000-0002-8582-0360; GHERARDI, ERMANNO/0000-0002-0016-2945	MRC [G9704528] Funding Source: UKRI; Medical Research Council [G9704528] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BRAUN J, 2000, P SOC PHOTO-OPT INS, V1, P32; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAYES DB, 2006, RASMB SOFTWARE ARCH; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Prat M, 1998, J CELL SCI, V111, P237; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubert WD, 2003, CHEMBIOCHEM, V4, P1285, DOI 10.1002/cbic.200300624; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0	51	123	135	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					235	246		10.1016/j.cell.2007.05.037	http://dx.doi.org/10.1016/j.cell.2007.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662939	Green Submitted, Bronze			2022-12-24	WOS:000248588000014
J	Yan, L; Vatner, DE; O'Connor, JP; Ivessa, A; Ge, H; Chen, W; Hirotani, S; Ishikawa, Y; Sadoshima, J; Vatner, SF				Yan, Lin; Vatner, Dorothy E.; O'Connor, J. Patrick; Ivessa, Andreas; Ge, Hui; Chen, Wei; Hirotani, Shinichi; Ishikawa, Yoshihiro; Sadoshima, Junichi; Vatner, Stephen F.			Type 5 adenylyl cyclase disruption increases longevity and protects against stress	CELL			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; PRESERVES CARDIAC-FUNCTION; LIFE-SPAN; OXIDATIVE STRESS; CALORIC RESTRICTION; CAENORHABDITIS-ELEGANS; HEART-FAILURE; DWARF MOUSE; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE	Mammalian models of longevity are related primarily to caloric restriction and alterations in metabolism. We examined mice in which type 5 adenylyl cyclase (AC5) is knocked out (AC5 KO) and which are resistant to cardiac stress and have increased median lifespan of similar to 30%. AC5 KO mice are protected from reduced bone density and susceptibility to fractures of aging. Old AC5 KO mice are also protected from aging-induced cardiomyopathy, e.g., hypertrophy, apoptosis, fibrosis, and reduced cardiac function. Using a proteomic-based approach, we demonstrate a significant activation of the Raf/MEK/ERK signaling pathway and upregulation of cell protective molecules, including superoxide dismutase. Fibroblasts isolated from AC5 KO mice exhibited ERK-dependent resistance to oxidative stress. These results suggest that AC is a fundamentally important mechanism regulating lifespan and stress resistance.	UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; UMDNJ, Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sadoshju@umdnj.edu; vatnersf@umdnj.edu		Ivessa, Andreas/0000-0002-7578-1337; Sadoshima, Junichi/0000-0003-3724-4132	NHLBI NIH HHS [HL069020, HL033107, HL059139, HL069752, HL65183] Funding Source: Medline; NIA NIH HHS [AG028854, AG023137, AG014121] Funding Source: Medline; NICHD NIH HHS [HD01457] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065183, P01HL069020, R37HL033107, R01HL033107, P01HL059139, T32HL069752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023137, R01AG028854, R01AG014121] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Du XJ, 2000, CARDIOVASC RES, V48, P448, DOI 10.1016/S0008-6363(00)00187-5; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Geng YJ, 1999, CIRC RES, V84, P34; GLOBOCNIK E, 1978, Folia Morphologica (Prague), V26, P1; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Liggett SB, 2000, CIRCULATION, V101, P1707; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lithgow GJ, 1996, BIOESSAYS, V18, P809, DOI 10.1002/bies.950181007; Lorenzini A, 2002, EXP GERONTOL, V37, P1149, DOI 10.1016/S0531-5565(02)00133-X; LOUTIT JF, 1976, J ANAT, V122, P357; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Meloche S, 2000, CYTOGENET CELL GENET, V88, P249, DOI 10.1159/000015530; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB297, DOI 10.1093/gerona/54.7.B297; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Naf D, 2002, CANCER RES, V62, P1235; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRCULATION, V108, P48; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Romanick MA, 2004, MECH AGEING DEV, V125, P269, DOI 10.1016/j.mad.2004.02.001; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 2002, GENETICS, V161, P661; SWYNGHEDAUW B, 1995, AM J CARDIOL, V76, pD2, DOI 10.1016/S0002-9149(99)80484-6; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wolff JE, 2001, DEV MED CHILD NEUROL, V43, P71, DOI 10.1017/S0012162201230114; Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001; Yoon SO, 2002, MECH AGEING DEV, V123, P1597, DOI 10.1016/S0047-6374(02)00095-7; Zhen XC, 1999, J GERONTOL A-BIOL, V54, pB539, DOI 10.1093/gerona/54.12.B539; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071	65	265	272	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					247	258		10.1016/j.cell.2007.05.038	http://dx.doi.org/10.1016/j.cell.2007.05.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662940	Bronze			2022-12-24	WOS:000248588000015
J	Wong, TY; Liew, G; Mitchell, P				Wong, Tien Y.; Liew, Gerald; Mitchell, Paul			Clinical update: new treatments for age-related macular degeneration	LANCET			English	Article							RANIBIZUMAB; RISK		Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117548, Singapore; Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia	University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Sydney	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014; Liew, Gerald/AAB-6870-2022	Wong, Tien Yin/0000-0002-8448-1264; 				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, BRIT J OPHTHALMOL, V90, P1188, DOI 10.1136/bjo.2005.082255; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598; *GEN, 2007, SAF UPD LUC; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; *MAC AMD STUD GROU, 2007, PEG 1 YEAR SYST SAF, DOI DOI 10.1016/J.OPHTHA.2007.02.021; *NAT EYE I, 2006, NIH STIM DEV TEST NE; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2006, AM J OPHTHALMOL, V142, P141, DOI 10.1016/j.ajo.2006.03.036; *ROYAL COLL OPHTH, 2006, AMD INT GUID ROYAL C; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	18	113	117	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					204	206		10.1016/S0140-6736(07)61104-0	http://dx.doi.org/10.1016/S0140-6736(07)61104-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658379				2022-12-24	WOS:000248347900010
J	Spillane, C; Schmid, KJ; Laoueille-Duprat, S; Pien, S; Escobar-Restrepo, JM; Baroux, C; Gagliardini, V; Page, DR; Wolfe, KH; Grossniklaus, U				Spillane, Charles; Schmid, Karl J.; Laoueille-Duprat, Sylvia; Pien, Stephane; Escobar-Restrepo, Juan-Miguel; Baroux, Celia; Gagliardini, Valeria; Page, Damian R.; Wolfe, Kenneth H.; Grossniklaus, Ueli			Positive darwinian selection at the imprinted MEDEA locus in plants	NATURE			English	Article							POLYCOMB-GROUP GENE; DETECTING MOLECULAR ADAPTATION; SET DOMAIN PROTEINS; ARABIDOPSIS-THALIANA; SEED DEVELOPMENT; ENDOSPERM DEVELOPMENT; EXPRESSION PATTERNS; DNA POLYMORPHISM; EVOLUTION; GENOME	In mammals and seed plants, a subset of genes is regulated by genomic imprinting where an allele's activity depends on its parental origin. The parental conflict theory suggests that genomic imprinting evolved after the emergence of an embryo-nourishing tissue (placenta and endosperm), resulting in an intragenomic parental conflict over the allocation of nutrients from mother to offspring(1,2). It was predicted that imprinted genes, which arose through antagonistic co-evolution driven by a parental conflict, should be subject to positive darwinian selection(3). Here we show that the imprinted plant gene MEDEA (MEA)(4,5), which is essential for seed development, originated during a whole-genome duplication 35 to 85 million years ago. After duplication, MEA underwent positive darwinian selection consistent with neo-functionalization and the parental conflict theory. MEA continues to evolve rapidly in the out-crossing species Arabidopsis lyrata but not in the self-fertilizing species Arabidopsis thaliana, where parental conflicts are reduced. The paralogue of MEA, SWINGER (SWN; also called EZA1)(6), is not imprinted and evolved under strong purifying selection because it probably retained the ancestral function of the common precursor gene. The evolution of MEA suggests a late origin of genomic imprinting within the Brassicaceae, whereas imprinting is thought to have originated early within the mammalian lineage(7).	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; Univ Coll Cork, Genet & Biotechnol Lab, Dept Biochem, Cork, Ireland; Univ Coll Cork, Biosci Inst, Cork, Ireland; Max Planck Inst Chem Ecol, Dept Genet & Evolut, D-07745 Jena, Germany; Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin, Ireland	University of Zurich; University of Zurich; University College Cork; University College Cork; Max Planck Society; Trinity College Dublin	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	c.spillane@ucc.ie; grossnik@botinst.uzh.ch	Wolfe, Kenneth H/B-4653-2009; Grossniklaus, Ueli/E-9995-2016; Baroux, Célia/J-5359-2013; Grossniklaus, Ueli/A-2736-2012; Spillane, Charles/H-3786-2013	Grossniklaus, Ueli/0000-0002-0522-8974; Baroux, Célia/0000-0001-6307-2229; Gagliardini, Valeria/0000-0001-9471-0764; Spillane, Charles/0000-0003-3318-323X; Wolfe, Kenneth/0000-0003-4992-4979				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Fay JC, 2000, GENETICS, V155, P1405; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Huang SR, 1997, PLANT MOL BIOL, V33, P125, DOI 10.1023/A:1005741514764; HUDSON RR, 1987, GENETICS, V116, P153; JACKSON D, 1991, PLANT CELL, V3, P115, DOI 10.1105/tpc.3.2.115; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Mayama T, 2003, PLANT CELL PHYSIOL, V44, P811, DOI 10.1093/pcp/pcg102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GT, 1997, P ROY SOC B-BIOL SCI, V264, P739, DOI 10.1098/rspb.1997.0105; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Springer NM, 2002, PLANT PHYSIOL, V128, P1332, DOI 10.1104/pp.010742; TAJIMA F, 1989, GENETICS, V123, P585; Thakur JK, 2003, GENE, V314, P1, DOI 10.1016/S0378-1119(03)00723-6; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Walter J, 2003, HUM MOL GENET, V12, pR215, DOI 10.1093/hmg/ddg296; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	40	116	118	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					349	U8		10.1038/nature05984	http://dx.doi.org/10.1038/nature05984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637669				2022-12-24	WOS:000248118300057
J	Hardy, WR; Li, LY; Wang, Z; Sedy, J; Fawcett, J; Frank, E; Kucera, J; Pawson, T				Hardy, W. Rod; Li, Lingying; Wang, Zhi; Sedy, Jiri; Fawcett, James; Frank, Eric; Kucera, Jan; Pawson, Tony			Combinatorial ShcA docking interactions support diversity in tissue morphogenesis	SCIENCE			English	Article							MUSCLE-SPINDLE; SIGNAL TRANSDUCTION; ADAPTER PROTEIN; SENSORY NEURONS; CRE RECOMBINASE; IN-VIVO; RECEPTOR; EXPRESSION; PHOSPHOTYROSINE; PATHWAY	Changes in protein-protein interactions may allow polypeptides to perform unexpected regulatory functions. Mammalian ShcA docking proteins have amino-terminal phosphotyrosine (pTyr) binding (PTB) and carboxyl-terminal Src homology 2 (SH2) domains, which recognize specific pTyr sites on activated receptors, and a central region with two phosphorylated tyrosine-X-asparagine (pYXN) motifs ( where X represents any amino acid) that each bind the growth factor receptor-bound protein 2 (Grb2) adaptor. Phylogenetic analysis indicates that ShcA may signal through both pYXN-dependent and - independent pathways. We show that, in mice, cardiomyocyte-expressed ShcA directs mid-gestational heart development by a PTB-dependent mechanism that does not require the pYXN motifs. In contrast, the pYXN motifs are required with PTB and SH2 domains in the same ShcA molecule for the formation of muscle spindles, skeletal muscle sensory organs that regulate motor behavior. Thus, combinatorial differences in ShcA docking interactions may yield multiple signaling mechanisms to support diversity in tissue morphogenesis.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Vet Adm Med Ctr, Boston, MA 02130 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Charles Univ Prague, Inst Anat, Fac Med 1, Prague 12000, Czech Republic; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Vet Adm Med Ctr, Boston, MA 02130 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Tufts University; Charles University Prague; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kucera, J (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	jfkucera@bu.edu; pawson@mshri.on.ca	Pawson, Tony J/E-4578-2013	Fawcett, Jim/0000-0003-0043-2164	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024373] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS024373-19, R01 NS024373-18, R01 NS024373, R01 NS024373-20] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Chen HH, 2002, J NEUROSCI, V22, P3512; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lai KMV, 2000, GENE DEV, V14, P1132; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; MAEDA N, 1983, NATURE, V302, P61, DOI 10.1038/302061a0; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Postigo A, 2002, GENE DEV, V16, P633, DOI 10.1101/gad.217902; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	31	47	47	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					251	256		10.1126/science.1140114	http://dx.doi.org/10.1126/science.1140114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626887	Green Accepted			2022-12-24	WOS:000247968600045
J	Kelly, BC; Ikonomou, MG; Blair, JD; Morin, AE; Gobas, FAPC				Kelly, Barry C.; Ikonomou, Michael G.; Blair, Joel D.; Morin, Anne E.; Gobas, Frank A. P. C.			Food web-specific biomagnification of persistent organic pollutants	SCIENCE			English	Article							TROUT ONCORHYNCHUS-MYKISS; DECABROMODIPHENYL ETHER; PERFLUOROOCTANE SULFONATE; DIETARY ACCUMULATION; AQUATIC ORGANISMS; TROPHIC TRANSFER; BIOACCUMULATION; MAGNIFICATION; MECHANISM; CHEMICALS	Substances that accumulate to hazardous levels in living organisms pose environmental and human-health risks, which governments seek to reduce or eliminate. Regulatory authorities identify bioaccumulative substances as hydrophobic, fat-soluble chemicals having high octanol-water partition coefficients (K-OW) (>= 100,000). Here we show that poorly metabolizable, moderately hydrophobic substances with a K-OW between 100 and 100,000, which do not biomagnify ( that is, increase in chemical concentration in organisms with increasing trophic level) in aquatic food webs, can biomagnify to a high degree in food webs containing air-breathing animals ( including humans) because of their high octanol-air partition coefficient (K-OA) and corresponding low rate of respiratory elimination to air. These low K-OW-high K-OA chemicals, representing a third of organic chemicals in commercial use, constitute an unidentified class of potentially bioaccumulative substances that require regulatory assessment to prevent possible ecosystem and human-health consequences.	Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; Fisheries & Oceans Canada, Inst Ocean Sci, Ocean Sci Div, Sidney, BC V8L 4B2, Canada	Simon Fraser University; Fisheries & Oceans Canada	Gobas, FAPC (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	gobas@sfu.ca		Kelly, Barry/0000-0002-3449-6310				Arnot JA, 2006, ENVIRON REV, V14, P257, DOI [10.1139/A06-005, 10.1139/a06-005]; CHEN YCJ, 1992, JAMA-J AM MED ASSOC, V268, P3213, DOI 10.1001/jama.268.22.3213; CONNOLLY JP, 1988, ENVIRON SCI TECHNOL, V22, P99, DOI 10.1021/es00166a011; Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m; Fisk AT, 1998, ENVIRON TOXICOL CHEM, V17, P951, DOI [10.1002/etc.5620170526, 10.1897/1551-5028(1998)017&lt;0951:DAADOH&gt;2.3.CO;2]; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; Gobas FAPC, 1999, ENVIRON SCI TECHNOL, V33, P133, DOI 10.1021/es980681m; Gobas FAPC, 2003, QSAR COMB SCI, V22, P329, DOI 10.1002/qsar.200390022; GOBAS FAPC, 1993, ENVIRON SCI TECHNOL, V27, P2855, DOI 10.1021/es00049a028; Hoekstra PF, 2003, ENVIRON POLLUT, V124, P509, DOI 10.1016/S0269-7491(02)00482-7; Hop H, 2002, ENVIRON SCI TECHNOL, V36, P2589, DOI 10.1021/es010231l; Ikonomou MG, 2002, ENVIRON SCI TECHNOL, V36, P1886, DOI 10.1021/es011401x; Kannan K, 2001, ENVIRON SCI TECHNOL, V35, P1593, DOI 10.1021/es001873w; Kelly BC, 2001, ENVIRON SCI TECHNOL, V35, P325, DOI 10.1021/es0011966; Kelly BC, 2003, ENVIRON SCI TECHNOL, V37, P2966, DOI 10.1021/es021035x; Kierkegaard A, 1999, ENVIRON SCI TECHNOL, V33, P1612, DOI 10.1021/es9807082; MACKAY D, 1982, ENVIRON SCI TECHNOL, V16, P274, DOI 10.1021/es00099a008; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P189, DOI [10.1002/etc.5620220125, 10.1897/1551-5028(2003)022&lt;0189:DAOPAI&gt;2.0.CO;2]; Morck A, 2003, DRUG METAB DISPOS, V31, P900, DOI 10.1124/dmd.31.7.900; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Stapleton HM, 2004, ENVIRON SCI TECHNOL, V38, P112, DOI 10.1021/es034746j; Tomy GT, 2004, ENVIRON SCI TECHNOL, V38, P6475, DOI 10.1021/es049620g; UNEP, 2001, C PLEN STOCKH CONV P; WOODWELL GM, 1967, SCI AM, V216, P24, DOI 10.1038/scientificamerican0367-24	26	645	692	24	622	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					236	239		10.1126/science.1138275	http://dx.doi.org/10.1126/science.1138275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626882				2022-12-24	WOS:000247968600040
J	Spangler, JG				Spangler, John G.			The sounds of silence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jspangle@wfubmc.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2329	2330		10.1001/jama.297.21.2329	http://dx.doi.org/10.1001/jama.297.21.2329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17551118				2022-12-24	WOS:000247007200001
J	Gao, HX; Zhou, ZH; Rawat, U; Huang, C; Bouakaz, L; Wang, CH; Cheng, ZH; Liu, YY; Zavialov, A; Gursky, R; Sanyal, S; Ehrenberg, M; Frank, J; Song, HW				Gao, Haixiao; Zhou, Zhihong; Rawat, Urmila; Huang, Chenhui; Bouakaz, Lamine; Wang, Chernhoe; Cheng, Zhihong; Liu, Yuying; Zavialov, Andrey; Gursky, Richard; Sanyal, Suparna; Ehrenberg, Mans; Frank, Joachim; Song, Haiwei			RF3 induces ribosomal conformational changes responsible for dissociation of class I release factors	CELL			English	Article							COLI 70S RIBOSOME; ELONGATION-FACTOR-G; FACTOR EF-TU; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLATION TERMINATION; GTPASE ACTIVITY; TRANSFER-RNA; PROTEIN; VISUALIZATION	During translation termination, class II release factor RF3 binds to the ribosome to promote rapid dissociation of a class I release factor (RF) in a GTP-dependent manner. We present the crystal structure of E coli RF39GDP, which has a three-domain architecture strikingly similar to the structure of EF-Tu center dot GTP. Biochemical data on RF3 mutants show that a surface region involving domains II and III is important for distinct steps in the action cycle of RF3. Furthermore, we present a cryo-electron microscopy (cryo-EM) structure of the posttermination ribosome bound with RF3 in the GTP form. Our data show that RF3 center dot GTP binding induces large conformational changes in the ribosome, which break the interactions of the class I RF with both the decoding center and the GTPase-associated center of the ribosome, apparently leading to the release of the class I RF.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Watsworth Ctr, Albany, NY 12201 USA; Inst Mol & Cell Biol, Lab Macromol Struct, Singapore 138673, Singapore; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Health Research Inc; Howard Hughes Medical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Uppsala University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National University of Singapore	Ehrenberg, M (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	ehrenberg@xray.bmc.uu.se; joachim@wadsworth.org; haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011; Cheng, Zhihong/F-8933-2011	Zavialov, Andrey/0000-0001-6420-0368	NIGMS NIH HHS [R01 GM 55440, R37 GM29169, GM70768] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moorhouse E. R., 1992, Biocontrol Science and Technology, V2, P49, DOI 10.1080/09583159209355217; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2003, TRENDS BIOCHEM SCI, V28, P99, DOI 10.1016/S0968-0004(03)00006-9; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	57	102	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					929	941		10.1016/j.cell.2007.03.050	http://dx.doi.org/10.1016/j.cell.2007.03.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540173	Bronze			2022-12-24	WOS:000247084600013
J	Zender, L; Zuber, J; Lowe, SW				Zender, Lars; Zuber, Johannes; Lowe, Scott W.			SnapShot: Genetic mouse models of cancer	CELL			English	Editorial Material									Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zender, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835	NCI NIH HHS [P30 CA008748, P01 CA013106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	8	8	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					838	838		10.1016/j.cell.2007.05.013	http://dx.doi.org/10.1016/j.cell.2007.05.013			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512415	Green Accepted, Bronze			2022-12-24	WOS:000246788300026
J	Bayer, CP; Klasen, F; Adam, H				Bayer, Christophe Pierre; Klasen, Fionna; Adam, Hubertus			Association of trauma and PTSD symptoms with openness to reconciliation and feelings of revenge among former Ugandan and Congolese child soldiers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Tens of thousands of the estimated 250 000 child soldiers worldwide are abused or have been abused during the last decade in Africa's Great Lakes Region. In the process of rebuilding the war-torn societies, it is important to understand how psychological trauma may shape the former child soldiers' ability to reconcile. Objective To investigate the association of posttraumatic stress disorder ( PTSD) symptoms and openness to reconciliation and feelings of revenge in former Ugandan and Congolese child soldiers. Design, Setting, and Participants Cross-sectional field study of 169 former child soldiers ( aged 11-18 years) in rehabilitation centers in Uganda and the Democratic Republic of the Congo, conducted in 2005. Main Outcome Measures Potentially traumatic war-related experiences assessed via a sample-specific events scale; PTSD symptoms assessed using the Child Posttraumatic Stress Disorder Reaction Index (CPTSD-RI), with a score of 35 or higher indicating clinically important PTSD symptoms; and openness to reconciliation and feelings of revenge assessed via structured questionnaires. Results Children participating in this study were a mean of 15.3 years old. These former child soldiers reported that they had been ( violently) recruited by armed forces at a young age ( mean [ SD], 12.1 [ 2] years), had served a mean of 38 months ( SD, 24 months), and had been demobilized a mean of 2.3 months before data collection ( SD, 2.4 months). The children were exposed to a high level of potentially traumatic events ( mean [ SD], 11.1 [2.99]). The most commonly reported traumatic experiences were having witnessed shooting (92.9%), having witnessed someone wounded (89.9%), and having been seriously beaten (84%). A total of 54.4% reported having killed someone, and 27.8% reported that they were forced to engage in sexual contact. Of the 169 interviewed, 59 (34.9%; 95% confidence interval, 34.4%-35.4%) had a PTSD symptom score higher than 35. Children who showed more PTSD symptoms had significantly less openness to reconciliation (rho=- 0.34, P <. 001) and more feelings of revenge (rho= 0.29, P <. 001). Conclusions PTSD symptoms are associated with less openness to reconciliation and more feelings of revenge among former Ugandan and Congolese child soldiers. The effect of psychological trauma should be considered when these children are rehabilitated and reintegrated into civilian society.	Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, D-20246 Hamburg, Germany; Hosp PSychiat Neurol & Child & Adolescent Psychia, Eberswalde, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Klasen, F (corresponding author), Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, Martinistr 52, D-20246 Hamburg, Germany.	klasen@children-for-tomorrow.de						ADAM H, 2006, MENTAL HLTH REFUGEE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boothby NG, 2000, SCI AM, V282, P60, DOI 10.1038/scientificamerican0600-60; *DEM REP CONG, 2006, DRC CHILDR WAR CREAT; Derluyn I, 2004, LANCET, V363, P861, DOI 10.1016/S0140-6736(04)15734-6; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; *INT LAB ORG, 2003, WOUND CHILDH US CHIL; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; NADER K, 1990, AM J PSYCHIAT, V147, P1526; NADER KO, 1993, BRIT J CLIN PSYCHOL, V32, P407, DOI 10.1111/j.2044-8260.1993.tb01075.x; *OFF SPEC REPR SEC, 2005, REP GEN ASS A 60 335; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; SAVJAK N, 2003, PSIHOLOGIJA ONLINE, V36, P59; Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Weiss DSMC, 1997, ASSESSING PSYCHOL TR; 1989, ARES4425 UN GEN ASS; 2006, AFRICA RES B, V43, DOI UNSP 17043A-17044A	18	186	186	1	40	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					555	559		10.1001/jama.298.5.555	http://dx.doi.org/10.1001/jama.298.5.555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666676	Bronze			2022-12-24	WOS:000248438100023
J	Adachi, K; Oiwa, K; Nishizaka, T; Furuike, S; Noji, H; Itoh, H; Yoshida, M; Kinosita, K				Adachi, Kengo; Oiwa, Kazuhiro; Nishizaka, Takayuki; Furuike, Shou; Noji, Hiroyuki; Itoh, Hiroyasu; Yoshida, Masasuke; Kinosita, Kazuhiko, Jr.			Coupling of rotation and catalysis in F-1-ATPase revealed by single-molecule imaging and manipulation	CELL			English	Article							ATP SYNTHASE; ACTIVITY-COEFFICIENTS; MECHANISM; F1-ATPASE; MOTOR; HYDROLYSIS; RESOLUTION; SUBSTEPS; DISTINCT; PATHWAY	F1-ATPase is a rotary molecular motor that proceeds in 120 degrees steps, each driven by ATP hydrolysis. How the chemical reactions that occur in three catalytic sites are coupled to mechanical rotation is the central question. Here, we show by high-speed imaging of rotation in single molecules of F1 that phosphate release drives the last 40 degrees of the 120 degrees step, and that the 40 degrees rotation accompanies reduction of the affinity for phosphate. We also show, by single-molecule imaging of a fluorescent ATP analog Cy3-ATP while F1 is forced to rotate slowly, that release of Cy3-ADP occurs at similar to 240 degrees after it is bound as Cy3-ATP at 0 degrees. This and other results suggest that the affinity for ADP also decreases with rotation, and thus ADP release contributes part of energy for rotation. Together with previous results, the coupling scheme is now basically complete.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; Natl Inst Informat & Commun Technol, Kobe Adv Res Ctr, Kobe, Hyogo 6512492, Japan; Gakushuin Univ, Dept Phys, Tokyo 1718588, Japan; Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; CREST, Tsukuba, Ibaraki 3002635, Japan; ERATO, ATP Syst Project, Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Waseda University; National Institute of Information & Communications Technology (NICT) - Japan; Gakushuin University; Osaka University; Hamamatsu Photonics; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan.	kazuhiko@waseda.jp	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Cohn EJ, 1927, J AM CHEM SOC, V49, P173, DOI 10.1021/ja01400a021; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; ESTESO MA, 1987, J ELECTROANAL CHEM, V230, P69, DOI 10.1016/0022-0728(87)80132-8; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oiwa K, 2003, BIOPHYS J, V84, P634, DOI 10.1016/S0006-3495(03)74883-8; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sillen L.G., 1964, SPEC PUBL, V17; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1994, J BIOL CHEM, V269, P20462; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	31	298	300	0	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					309	321		10.1016/j.cell.2007.05.020	http://dx.doi.org/10.1016/j.cell.2007.05.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662945	Bronze			2022-12-24	WOS:000248588000020
J	Datta, SD; Sternberg, M; Johnson, RE; Berman, S; Papp, JR; McQuillan, G; Weinstock, H				Datta, S. Deblina; Sternberg, Maya; Johnson, Robert E.; Berman, Stuart; Papp, John R.; McQuillan, Geraldine; Weinstock, Hillard			Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; INFECTION; TRACHOMATIS; PREVALENCE; BEHAVIOR; POLICY; CARE	Background: Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs. Objective: To measure chlamydia and gonorrhea prevalence in the United States. Design: Analysis of sexual history information and urine specimens collected in the National Health and Nutrition Examination Survey (NHANES), 1999-2002. Setting: U.S. civilian noninstitutionalized population as sampled by NHANES, 1999-2002. Participants: 6632 NHANES respondents. Measurements: Urine specimens were tested for chlamydia and gonorrhea. Results were weighted to represent the U.S. civilian, non institutionalized population between 14 and 39 years of age. Results: Prevalence of gonorrheal infection was 0.24% (95% Cl, 0.16% to 0.38%). Prevalence of gonorrheal infection was higher among non-Hispanic black persons (1.2% [Cl, 0.7% to 1.9%]) than among non-Hispanic white persons (0.07% [Cl, 0.02% to 0.24%]). Among those with gonorrheal infection, 46% also had chlamydial infection. Prevalence of chlamyclial infection was 2.2% (Cl, 1.8% to 2.8%) and was similar between males (2.0% [Cl, 1.6% to 2.5%]) and females (2.5% [Cl, 1.8% to 3.4%]). Among females, the highest prevalence was in those age 14 to 19 years, whereas among males, it was highest in those age 14 to 29 years. Prevalence was higher among non-Hispanic black persons (6.4% [Cl, 5.4% to 7.5%]) than non-Hispanic white persons (1.5% [Cl, 1.0% to 2.4%]). Among females with a history of gonorrhea or chlamydia in the previous 12 months, chlamydia prevalence was 16.7% (Cl, 5.5% to 50.7%). Limitations: The specificity of urine-based assays for chlamydia and gonorrhea is limited, and the possible misclassification of sexual experience status may have affected the accuracy of some estimates. Conclusions: The findings support current recommendations to screen sexually active females age 25 years or younger for chlamydia, to retest infected females for chlamyclial infection, and to co-treat individuals with gonorrhea for chlamydia.	Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Datta, SD (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	ddatta@cdc.gov	Papp, John/AAA-3073-2019	Papp, John/0000-0002-7495-5454				*ABB LAB, 1996, ABB LCX PROB SYST CH; *ABB LAB, 1996, ABB LCX PROB SYST NE; Adekoya N., 2005, Morbidity and Mortality Weekly Report, V54, P9; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; *CDCP, 2006, SEX TRANSM DIS SURV; *CDCP NAT CTR DIS, 2005, AN REP GUID NAT HLTH; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; ENG TR, 1997, HIDDEN EPIDEMIC CONF; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; Hollblad-Fadiman K, 2003, AM J PREV MED, V24, P287, DOI 10.1016/S0749-3797(02)00636-0; Hook Er., 1999, SEX TRANSM DIS; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Klausner JD, 2001, J INFECT DIS, V183, P1087, DOI 10.1086/319276; KOOPMAN JS, 1994, AM J PUBLIC HEALTH, V84, P836, DOI 10.2105/AJPH.84.5.836; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Levine WC, 2004, AM J EPIDEMIOL, V160, P91, DOI 10.1093/aje/kwh162; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; National Committee for Quality Assurance, STAT HLTH CAR QUAL 2; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peterman TA, 2006, ANN INTERN MED, V145, P564, DOI 10.7326/0003-4819-145-8-200610170-00005; Skeate RC, 2005, AM J CLIN PATHOL, V123, P809, DOI 10.1309/1LD8LU7YFFW75WQA; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; *US CENS BUR, MONTHL POP EST 2000	30	191	199	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2007	147	2					89	96		10.7326/0003-4819-147-2-200707170-00007	http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192CV	17638719				2022-12-24	WOS:000248179300003
J	Melnick, JG; Parkin, G				Melnick, Jonathan G.; Parkin, Gerard			Cleaving mercury-alkyl bonds: A functional model for mercury detoxification by MerB	SCIENCE			English	Article							ORGANOMERCURIAL LYASE MERB; HG-C BOND; CRYSTAL-STRUCTURE; COMPLEXES; COORDINATION; PROTEINS; PROTONOLYSIS; RESISTANCE; MECHANISM; CATALYSIS	The extreme toxicity of organomercury compounds that are found in the environment has focused attention on the mechanisms of action of bacterial remediating enzymes. We describe facile room-temperature protolytic cleavage by a thiol of the Hg-C bond in mercury-alkyl compounds that emulate the structure and function of the organomercurial lyase MerB. Specifically, the tris( 2-mercapto-1-t-butylimidazolyl) hydroborato ligand [Tm-But], which features three sulfur donors, has been used to synthesize [Tm-But] HgR alkyl compounds (R = methyl or ethyl) that react with phenylthiol (PhSH) to yield [Tm-But] HgSPh and RH. Although [Tm-But] HgR compounds exist as linear two-coordinate complexes in the solid state, H-1 nuclear magnetic resonance spectroscopy indicates that the complexes exist in rapid equilibrium with their higher-coordinate [kappa(2)-Tm-But] HgR and [kappa(3)-Tm-But] HgR isomers in solution. Facile access to a higher-coordinate species is proposed to account for the exceptional reactivity of [ TmBut] HgR relative to that of other two-coordinate mercury-alkyl compounds.	Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Parkin, G (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	parkin@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046502] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM046502] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBARO P, 1994, INORG CHEM, V33, P6163, DOI 10.1021/ic00104a029; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Benison GC, 2004, BIOCHEMISTRY-US, V43, P8333, DOI 10.1021/bi049662h; CANTY AJ, 1987, AUST J CHEM, V40, P1609, DOI 10.1071/CH9871609; Cassidy I, 2002, EUR J INORG CHEM, P1235; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; GOPINATH E, 1987, J AM CHEM SOC, V109, P7903, DOI 10.1021/ja00259a061; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; HOLLOWAY CE, 1995, J ORGANOMET CHEM, V495, P1, DOI 10.1016/0022-328X(95)05395-6; KREEVOY MM, 1957, J AM CHEM SOC, V79, P5927, DOI 10.1021/ja01579a025; Lobbia GG, 1998, J ORGANOMET CHEM, V552, P31; MOORE MJ, 1990, ACCOUNTS CHEM RES, V23, P301, DOI 10.1021/ar00177a006; Ni B, 2006, J PHYS CHEM A, V110, P9451, DOI 10.1021/jp061852+; NORRIS AR, 1983, CAN J CHEM, V61, P1536, DOI 10.1139/v83-267; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; Pitts KE, 2002, BIOCHEMISTRY-US, V41, P10287, DOI 10.1021/bi0259148; Rabinovich D, 2006, STRUCT BOND, V120, P143, DOI 10.1007/430_031; Razmiafshari M, 2001, TOXICOL APPL PHARM, V172, P1, DOI 10.1006/taap.2001.9132; Strasdeit H, 2000, ANGEW CHEM INT EDIT, V39, P784, DOI 10.1002/(SICI)1521-3773(20000218)39:4<784::AID-ANIE784>3.3.CO;2-Q; Tai HC, 2006, J PHYS CHEM A, V110, P452, DOI 10.1021/jp0529826; White JL, 2002, J CHEM SOC DALTON, P2987, DOI 10.1039/b111558h; Wilhelm M, 2004, EUR J INORG CHEM, P2301, DOI 10.1002/ejic.200300907; Witkiewicz-Kucharczyk A, 2006, TOXICOL LETT, V162, P29, DOI 10.1016/j.toxlet.2005.10.018; WRIGHT JG, 1990, PROG INORG CHEM, V38, P323	26	83	85	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					225	227		10.1126/science.1144314	http://dx.doi.org/10.1126/science.1144314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	189DC	17626880				2022-12-24	WOS:000247968600036
J	Nash, R				Nash, Robert			Health-care workers in influenza pandemics	LANCET			English	Editorial Material							DUTY		Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England	University of Oxford	Nash, R (corresponding author), Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England.	robertnash@doctors.org.uk	Nash, Robert/AAO-9847-2020	Nash, Robert/0000-0002-7861-3734				*ECDC INFL TEAM, 2005, EURO SURVEILL, V10; Ehrenstein BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-311; Harrod ME, 2006, MED J AUSTRALIA, V185, pS58; Irvin C., 2007, ACAD EMERG MED S1, V14, P13; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Ruderman Carly, 2006, BMC Med Ethics, V7, pE5, DOI 10.1186/1472-6939-7-5; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Yen MY, 2006, J HOSP INFECT, V62, P195, DOI 10.1016/j.jhin.2005.02.011	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					300	301		10.1016/S0140-6736(07)61140-4	http://dx.doi.org/10.1016/S0140-6736(07)61140-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662865	Green Published, Bronze			2022-12-24	WOS:000248426100009
J	Krimsky, S; Simoncelli, T				Krimsky, Sheldon; Simoncelli, Tania			Testing pesticides in humans - Of mice and men divided by ten	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; Amer Civil Liberties Union, Tech Liberty Program, New York, NY USA	Columbia University	Krimsky, S (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	sheldon.krimsky@tufts.edu	Krimsky, Sheldon/F-3147-2010					CAIN WS, 2005, HUMAN SENSORY IRRITA; Committee on International Human Rights of the Association of the Bar of the City of New York and The Center for Human Rights and Global Justice New York University School of Law, 2004, INT HUM DOS STUD EPA, P4; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Lockwood AH, 2004, AM J PUBLIC HEALTH, V94, P1908, DOI 10.2105/AJPH.94.11.1908; NEEDLEMAN H, 2000, COMMENTS USE DATA TE, pC1; Needleman HL, 2005, ENVIRON HEALTH PERSP, V113, pA804, DOI 10.1289/ehp.113-a804; Oleskey C, 2004, ENVIRON HEALTH PERSP, V112, P914, DOI 10.1289/ehp.6522; Resnik David B, 2007, Account Res, V14, P35, DOI 10.1080/08989620601122842; Resnik DB, 2007, AM J PUBLIC HEALTH, V97, P414, DOI 10.2105/AJPH.2005.081729; World Medical Association, DECL HELS ETH PRINC; 2006, FED REG, V71, P6137	11	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2405	2407		10.1001/jama.297.21.2405	http://dx.doi.org/10.1001/jama.297.21.2405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551133				2022-12-24	WOS:000247007200022
J	Gupta, S; Ramjaun, AR; Haiko, P; Wang, YH; Warne, PH; Nicke, B; Nye, E; Stamp, G; Alitalo, K; Downward, J				Gupta, Surbhi; Ramjaun, Antoine R.; Haiko, Paula; Wang, Yihua; Warne, Patricia H.; Nicke, Barbara; Nye, Emma; Stamp, Gordon; Alitalo, Kari; Downward, Julian			Binding of Ras to phosphoinositide 3-kinase p110 alpha is required for Ras-driven tumorigenesis in mice	CELL			English	Article							PROTEIN-KINASE B; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; VEGF RECEPTOR-3; ACTIVATION; TRANSFORMATION; CANCER; INHIBITION; DROSOPHILA; DEFICIENT	Ras proteins signal through direct interaction with a number of effector enzymes, including type I phosphoinositide (PI) 3-kinases. Although the ability of Ras to control PI 3-kinase has been well established in manipulated cell culture models, evidence for a role of the interaction of endogenous Ras with PI 3-kinase in normal and malignant cell growth in vivo has been lacking. Here we generate mice with mutations in the Pi3kca gene encoding the catalytic p110 alpha isoform that block its interaction with Ras. Cells from these mice show proliferative defects and selective disruption of signaling from growth factors to PI 3-kinase. The mice display defective development of the lymphatic vasculature, resulting in perinatal appearance of chylous ascites. Most importantly, they are highly resistant to endogenous Ras oncogene-induced tumorigenesis. The interaction of Ras with p110 alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.	Canc Res UK, London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK, London Res Inst, Expt Pathol Lab, London WC2A 3PX, England; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	Cancer Research UK; Cancer Research UK; University of Helsinki	Downward, J (corresponding author), Canc Res UK, London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	downward@cancer.org.uk	Downward, Julian/A-3251-2012; Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902; Wang, Yihua/0000-0001-5561-0648; Downward, Julian/0000-0002-2331-4729				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joukov V, 1996, EMBO J, V15, P1751; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Nakahara R, 2001, THORAX, V56, P302, DOI 10.1136/thorax.56.4.302; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PRESS OW, 1982, ANN INTERN MED, V96, P358, DOI 10.7326/0003-4819-96-3-358; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	43	434	445	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					957	968		10.1016/j.cell.2007.03.051	http://dx.doi.org/10.1016/j.cell.2007.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540175	Bronze			2022-12-24	WOS:000247084600015
J	Beral, V; Bull, D; Green, J; Reeves, G				Beral, Valerie; Bull, Diana; Green, Jane; Reeves, Gillian		Million Women Study Collaborators	Ovarian cancer and hormone replacement therapy in the Million Women Study	LANCET			English	Article							NONCONTRACEPTIVE ESTROGEN USE; RISK; HEALTH	Background Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of hormone replacement therapy (HRT). Methods 948 576 postmenopausal women from the UK Million Women Study who did not have previous cancer or bilateral oophorectomy were followed-up for an average of 5.3 years for incident ovarian cancer and 6.9 years for death. Information on HRT use was obtained at recruitment and updated where possible. Relative risks for ovarian cancer were calculated, stratified by age and hysterectomy status, and adjusted by area of residence, socioeconomic group, time since menopause, parity; body-mass index, alcohol consumption, and use of oral contraceptives. Findings When they last reported HRT use, 287143 women (30%) were current users and 186 751 (20%) were past users. During follow-up, 2273 incident ovarian cancers and 15 91 deaths from the malignancy were recorded. Current users were significantly more likely to develop and die from ovarian cancer than never users (relative risk 1.20 [95% Cl 1.09-1.32; p=0.0002] for incident disease and 1.23 [1.09-1.38; p=0.0006] for death). For current users of HRT incidence of ovarian cancer increased with increasing duration of use, but did not differ significantly by type of preparation used, its constituents, or mode of administration. Risks associated with HRT varied significantly according to tumour histology (p < 0.0001), and in women with epithelial tumours the relative risk for current versus never use of HRT was greater for serous than for mucinous, endometroid, or clear cell tumours (1.53 [1.31-1.79], 0.72 [0.52-1.00], 1.05 [0.77-1.43], or 0.77 [0.48-1.23], respectively). Past users of HRT were not at an increased risk of ovarian cancer (0.98 [0.88-1.11] and 0.97 [0.84-1.11], respectively, for incident and fatal disease). Over 5 years, the standardised. incidence rates for ovarian cancer in current and never users of HRT were 2.6 (2.4-2.9) and 2.2 (2.1-2.3) per 1000, respectively-ie, one extra ovarian cancer in roughly 2500 users; death rates were 1.6 (1.4-1.8) and 1.3 (1.2-1.4) per 1000, respectively-ie, one extra ovarian cancer death in roughly 3300 users. Interpretation Women who use HRT are at an increased risk of both incident and fatal ovarian cancer. Since 1991, use of HRT has resulted in some 1300 additional ovarian cancers and 1000 additional deaths from the malignancy in the UK.	Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX3 7LF, England	Cancer Research UK; University of Oxford	Beral, V (corresponding author), Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	pa.valerie.beral@ceu.ox.ac.uk			MRC [G0700474] Funding Source: UKRI; Medical Research Council [G0700474] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; BOSETTI C, 2001, JAMA-J AM MED ASSOC, V285, P308; Folsom AR, 2004, EPIDEMIOLOGY, V15, P100, DOI 10.1097/01.ede.0000091606.31903.8e; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; HARTGE P, 1988, AM J EPIDEMIOL, V127, P990, DOI 10.1093/oxfordjournals.aje.a114902; Hempling RE, 1997, OBSTET GYNECOL, V89, P1012, DOI 10.1016/S0029-7844(97)00118-X; *IARC, 1999, IARC MON EV CARC RIS, V72; KAUFMAN DW, 1989, AM J EPIDEMIOL, V130, P1142, DOI 10.1093/oxfordjournals.aje.a115441; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LAVECCHIA C, 1982, J NATL CANCER I, V69, P1207; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; Purdie DM, 1999, BRIT J CANCER, V81, P559, DOI 10.1038/sj.bjc.6690731; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Risch HA, 1996, GYNECOL ONCOL, V63, P254, DOI 10.1006/gyno.1996.0315; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; WEISS NS, 1982, J NATL CANCER I, V68, P95; World Health Organization, 2022, INT CLASS DIS, V11th	28	298	314	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1703	1710		10.1016/S0140-6736(07)60534-0	http://dx.doi.org/10.1016/S0140-6736(07)60534-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512855				2022-12-24	WOS:000246631300026
J	Cibelli, J				Cibelli, Jose			A decade of cloning mystique	SCIENCE			English	Editorial Material							NUCLEAR TRANSFER; MOUSE EMBRYOS; CELLS; CULTURE; MICE		Program Cell Therapy & Regenerat Med, Andalucia, Spain		Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci & Physiol, Cellular Reprogramming Lab, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Arnold DR, 2006, REPRODUCTION, V132, P279, DOI 10.1530/rep.1.01217; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; MA B, 2005, NAT REV GENET, V6, P611; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	13	26	28	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					990	992		10.1126/science.1143512	http://dx.doi.org/10.1126/science.1143512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510352				2022-12-24	WOS:000246554000033
J	Halfar, J; Fujita, RM				Halfar, Jochen; Fujita, Rodney M.			Danger of deep-sea mining	SCIENCE			English	Editorial Material									Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; Environm Def, Oakland, CA 94618 USA	University of Toronto; University Toronto Mississauga	Halfar, J (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	jochen.halfar@utoronto.ca; rfujita@environmentaldefense.org	Halfar, Jochen/C-7317-2014					CLIFFORD D, 2005, MINING MAGAZINE  SEP, P58; Glasby GP, 2000, SCIENCE, V289, P551, DOI 10.1126/science.289.5479.551; GLOWKA L, 2001, MANAGING RISKS BIODI, P195; Halfar J, 2002, MAR POLICY, V26, P103, DOI 10.1016/S0308-597X(01)00041-0; Hannington M. D., 2004, GLOBAL DATABASE SEAF; HEILMAN K, 2006, NAUTILUS ONE STEP CL; Mero J.L., 1965, MINERAL RESOURCES SE, DOI DOI 10.1016/S0422-9894(08)70765-7; Rona PA, 2003, SCIENCE, V299, P673, DOI 10.1126/science.1080679; SCHNEIDER J, 1998, N JB GEOL PALAEONT A, V208, P397; THIEL H, 1995, ISOPE OC MIN S P TSU, P39; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Wolfrum R., 1990, P INT S KIEL I INT L	12	71	71	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					987	987		10.1126/science.1138289	http://dx.doi.org/10.1126/science.1138289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510349				2022-12-24	WOS:000246554000030
J	Peltecu, G				Peltecu, Gheorghe			Cellulitis after treatment for breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Carol Davila Univ Med, Bucharest 010455, Romania	Carol Davila University of Medicine & Pharmacy	Peltecu, G (corresponding author), Carol Davila Univ Med, Bucharest 010455, Romania.	peltecu@dnt.ro							0	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					488	488		10.1056/NEJMicm065836	http://dx.doi.org/10.1056/NEJMicm065836			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671257				2022-12-24	WOS:000248436300010
J	Ramaswamy, S				Ramaswamy, Sridhar			Rational design of cancer-drug combinations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.				NATIONAL CANCER INSTITUTE [K08CA100339] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA100339-05, K08 CA100339] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	1	38	41	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2007	357	3					299	300		10.1056/NEJMcibr072593	http://dx.doi.org/10.1056/NEJMcibr072593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	191FH	17634467				2022-12-24	WOS:000248115100014
J	Fimia, GM; Stoykova, A; Romagnoli, A; Giunta, L; Di Bartolomeo, S; Nardacci, R; Corazzari, M; Fuoco, C; Ucar, A; Schwartz, P; Gruss, P; Piacentini, M; Chowdhury, K; Cecconi, F				Fimia, Gian Maria; Stoykova, Anastassia; Romagnoli, Alessandra; Giunta, Luigi; Di Bartolomeo, Sabrina; Nardacci, Roberta; Corazzari, Marco; Fuoco, Claudia; Ucar, Ahmet; Schwartz, Peter; Gruss, Peter; Piacentini, Mauro; Chowdhury, Kamal; Cecconi, Francesco			Ambra1 regulates autophagy and development of the nervous system	NATURE			English	Article							CELL-DEATH; EMBRYONIC-DEVELOPMENT; MOLECULAR MACHINERY; TUMOR-SUPPRESSOR; GENE; APOPTOSIS; MICE; PROTEINS; BECLIN-1; TUMORIGENESIS	Autophagy is a self-degradative process involved both in basal turnover of cellular components and in response to nutrient starvation or organelle damage in a wide range of eukaryotes(1-3). During autophagy, portions of the cytoplasm are sequestered by double-membraned vesicles called autophagosomes, and are degraded after fusion with lysosomes for subsequent recycling(4). In vertebrates, this process acts as a pro-survival or pro-death mechanism in different physiological and pathological conditions, such as neurodegeneration and cancer(2,5-7); however, the roles of autophagy during embryonic development are still largely uncharacterized(3). Beclin1 (Becn1; coiled-coil, myosin-like BCL2-interacting protein) is a principal regulator in autophagosome formation, and its deficiency results in early embryonic lethality(8,9). Here we show that Ambra1 (activating molecule in Beclin1-regulated autophagy), a large, previously unknown protein bearing a WD40 domain at its amino terminus, regulates autophagy and has a crucial role in embryogenesis. We found that Ambra1 is a positive regulator of the Becn1-dependent programme of autophagy, as revealed by its overexpression and by RNA interference experiments in vitro. Notably, Ambra1 functional deficiency in mouse embryos leads to severe neural tube defects associated with autophagy impairment, accumulation of ubiquitinated proteins, unbalanced cell proliferation and excessive apoptotic cell death. In addition to identifying a new and essential element regulating the autophagy programme, our results provide in vivo evidence supporting the existence of a complex interplay between autophagy, cell growth and cell death required for neural development in mammals.	Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; IRCCS L Spallanzani, Natl Inst Infect Dis, I-00149 Rome, Italy; IRCCS, Fdn St Lucia, Lab Mol Neuroembryol, I-00143 Rome, Italy; Univ Gottingen, Dept Anat & Embryol, D-37085 Gottingen, Germany	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Rome Tor Vergata; Max Planck Society; IRCCS Lazzaro Spallanzani; IRCCS Santa Lucia; University of Gottingen	Cecconi, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy.	kchowdh@gwdg.de; francesco.cecconi@uniroma2.it	Nardacci, Roberta/K-6555-2016; Corazzari, Marco/B-4631-2019; Ucar, Ahmet/E-8981-2012; Piacentini, Mauro/I-2411-2016; Fuoco, Claudia/AAB-2268-2019; Fimia, Gian Maria/K-3232-2016; Cecconi, Francesco/K-3969-2016; Romagnoli, Alessandra/B-5779-2017; Corazzari, Marco/J-5825-2019; Corazzari, Marco/K-6422-2016; Di+Bartolomeo, Sabrina/AAB-9791-2019	Nardacci, Roberta/0000-0002-9209-1207; Corazzari, Marco/0000-0002-6246-5968; Piacentini, Mauro/0000-0003-2919-1296; Fimia, Gian Maria/0000-0003-4438-3325; Cecconi, Francesco/0000-0002-5614-4359; Corazzari, Marco/0000-0002-6246-5968; Corazzari, Marco/0000-0002-6246-5968; DI BARTOLOMEO, Sabrina/0000-0002-5748-1541; Fuoco, Claudia/0000-0001-8372-305X; romagnoli, alessandra/0000-0003-4946-6138; Ucar, Ahmet/0000-0002-6551-3486	Telethon [TCR04004] Funding Source: Medline	Telethon(Fondazione Telethon)		Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chowdhury K, 1997, NUCLEIC ACIDS RES, V25, P1531, DOI 10.1093/nar/25.8.1531; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Edinger AL, 2003, CANCER CELL, V4, P422, DOI 10.1016/S1535-6108(03)00306-4; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ranga U, 1997, J VIROL, V71, P7020, DOI 10.1128/JVI.71.9.7020-7029.1997; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Stoykova A, 1998, DEV DYNAM, V212, P198; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	34	752	788	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1121	U14		10.1038/nature05925	http://dx.doi.org/10.1038/nature05925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17589504	Green Published			2022-12-24	WOS:000247564600039
J	He, L; He, XY; Lim, LP; De Stanchina, E; Xuan, ZY; Liang, Y; Xue, W; Zender, L; Magnus, J; Ridzon, D; Jackson, AL; Linsley, PS; Chen, CF; Lowe, SW; Cleary, MA; Hannon, GJ				He, Lin; He, Xingyue; Lim, Lee P.; De Stanchina, Elisa; Xuan, Zhenyu; Liang, Yu; Xue, Wen; Zender, Lars; Magnus, Jill; Ridzon, Dana; Jackson, Aimee L.; Linsley, Peter S.; Chen, Caifu; Lowe, Scott W.; Cleary, Michele A.; Hannon, Gregory J.			A microRNA component of the p53 tumour suppressor network	NATURE			English	Article							SHORT-INTERFERING RNAS; HUMAN CANCERS; EXPRESSION; TRANSCRIPTION; RESPONSES; PATHWAY; TARGETS; GENES; PCR	A global decrease in microRNA (miRNA) levels is often observed in human cancers(1,2), indicating that small RNAs may have an intrinsic function in tumour suppression. To identify miRNA components of tumour suppressor pathways, we compared miRNA expression profiles of wild-type and p53-deficient cells. Here we describe a family of miRNAs, miR-34a-c, whose expression reflected p53 status. Genes encoding miRNAs in the miR-34 family are direct transcriptional targets of p53, whose induction by DNA damage and oncogenic stress depends on p53 both in vitro and in vivo. Ectopic expression of miR-34 induces cell cycle arrest in both primary and tumour-derived cell lines, which is consistent with the observed ability of miR-34 to downregulate a programme of genes promoting cell cycle progression. The p53 network suppresses tumour formation through the coordinated activation of multiple transcriptional targets, and miR-34 may act in concert with other effectors to inhibit inappropriate cell proliferation.	Rosetta Inpharmat, Seattle, WA 98109 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Appl Biosyst Inc, Adv Res & Technol, Foster City, CA 94404 USA	Merck & Company; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Thermo Fisher Scientific; Applied Biosystems	Cleary, MA (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	michele_cleary@merck.com; hannon@cshl.org	Hannon, Gregory/AAB-3568-2019	Xuan, Zhenyu/0000-0001-9344-8493; Jackson, Aimee/0000-0002-3786-7391; Xue, Wen/0000-0002-9797-8042	NCI NIH HHS [K99 CA126186-01, P30 CA008748, K99 CA126186, P01 CA013106, P01 CA087497] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087497, P01CA013106, P30CA008748, K99CA126186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MIYASHITA T, 1995, CELL, V80, P293; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sutcliffe JE, 2004, FEBS LETT, V567, P86, DOI 10.1016/j.febslet.2004.03.122; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WELCH C, 2007, ONCOGENE; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	29	2129	2301	6	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1130	U16		10.1038/nature05939	http://dx.doi.org/10.1038/nature05939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17554337	Green Accepted			2022-12-24	WOS:000247564600041
J	Lipsky, PE				Lipsky, Peter E.			Why does rheumatoid arthritis involve the joints?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Lipsky, PE (corresponding author), NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.							Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lipsky PE, 2005, HARRISONS PRINCIPLES, P1968	5	24	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2419	2420		10.1056/NEJMcibr070846	http://dx.doi.org/10.1056/NEJMcibr070846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554126				2022-12-24	WOS:000247029300015
J	Marris, E				Marris, Emma			Counting the chemicals	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					516	517						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17563934				2022-12-24	WOS:000246842000010
J	Joura, EA; Leodolter, S; Hernandez-Avila, M; Wheeler, CM; Perez, G; Koutsky, LA; Garland, SM; Harper, DM; Tang, GWK; Ferris, DG; Steben, M; Jones, RW; Bryan, J; Taddeo, FJ; Bautista, OM; Esser, MT; Sings, HL; Nelson, M; Boslego, JW; Sattler, C; Barr, E; Paavonen, J				Joura, Elmar A.; Leodolter, Sepp; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Koutsky, Laura A.; Garland, Suzanne M.; Harper, Diane M.; Tang, Grace W. K.; Ferris, Daron G.; Steben, Marc; Jones, Ronald W.; Bryan, Janine; Taddeo, Frank J.; Bautista, Oliver M.; Esser, Mark T.; Sings, Heather L.; Nelson, Micki; Boslego, John W.; Sattler, Carlos; Barr, Eliav; Paavonen, Jorma			Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 02-06, 2006	Atlanta, GA	Amer Soc Clin Oncol			CERVICAL INTRAEPITHELIAL NEOPLASIA; SQUAMOUS-CELL CARCINOMA; COLD-KNIFE CONIZATION; TERM FOLLOW-UP; NATURAL-HISTORY; YOUNG-WOMEN; RISK; TRENDS; CANCER; HPV	Background Vulval and vaginal cancers among younger women are often related to infection with human papillomavirus (HPV). These cancers are preceded by high-grade vulval intraepithelial neoplasia (VIN2-3) and vaginal intraepithelial neoplasia (VaIN2-3). Our aim was to do a combined analysis of three randomised clinical trials to assess the effect of a prophylactic quadrivalent HPV vaccine on the incidence of these diseases. Methods 18 174 women (16-26 years) were enrolled and randomised to receive either quadrivalent HPV6/11/16/18 L1 virus-like-particle vaccine or placebo at day 1, and months 2 and 6. Individuals underwent detailed anogenital examination at day 1, 1 month after dose three, and at 6-12-month intervals for up to 48 months. Suspect genital lesions were biopsied and read by a panel of pathologists and vaccine HPV type-specific DNA testing was done. The primary endpoint was the combined incidence of VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. Primary efficacy analyses were done in a per-protocol population. Findings The mean follow-up time was 3 years. Among women naive to HPV16 or HPV18 through 1 month after dose three (per-protocol population; vaccine n=7811; placebo n=7785), the vaccine was 100% effective (95% Cl 72-100) against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. In the intention-to-treat population (which included 18174 women who, at day 1, could have been infected with HPV16 or HPV18), vaccine efficacy against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18 was 71% (37-88). The vaccine was 49% (18-69) effective against all VIN2-3 or VaIN2-3, irrespective of whether or not HPV DNA was detected in the lesion. The most common treatment-related adverse event was injection-site pain. Interpretation Prophylactic administration of quadrivalent HPV vaccine was effective in preventing high-grade vulval and vaginal lesions associated with HPV16 or HPV18 infection in women who were naive to these types before vaccination. With time, such vaccination could result in reduced rates of HPV-related vulval and vaginal cancers.	Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki 00290, Finland; Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Melbourne, Dept Microbiol & Infect Dis, Royal Hosp Women, Melbourne, Vic, Australia; Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Hanover, NH USA; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Community & Family Med, Hanover, NH USA; Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Peoples R China; Med Coll Georgia, Dept Family Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; Inst Natl Sante Publ Quebec, Direct Risques Biol Environn & Occupat, Montreal, PQ, Canada; Natl Womens Hosp, Vulvar Clin, Dept Gynecol Oncol, Auckland, New Zealand; Merck Res Labs, West Point, PA USA	University of Helsinki; Helsinki University Central Hospital; Medical University of Vienna; Instituto Nacional de Salud Publica; University of New Mexico; University of New Mexico; University of Washington; University of Washington Seattle; University of Melbourne; University of Melbourne; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University of Hong Kong; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Institut national de sante publique du Quebec (INSPQ); Merck & Company	Paavonen, J (corresponding author), Univ Cent Hosp, Dept Obstet & Gynecol, Haartmaninkatu 2, Helsinki 00290, Finland.	jorma.paavonen@hus.fi	Harper, Diane M./I-2180-2014; Chahchahi, Sarah/Q-6499-2016	Harper, Diane M./0000-0001-7648-883X; Bryan, Janine/0000-0002-4923-6247; Steben, Marc/0000-0002-1136-3208; Paavonen, Jorma/0000-0003-4775-606X				AHO M, 1991, CANCER, V68, P195, DOI 10.1002/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L; *AM CANC SOC, DET GUID VAG CANC WH; American College of Obstetricians and Gynecologists, HPV VACC ACOG REC; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dodge JA, 2001, GYNECOL ONCOL, V83, P363, DOI 10.1006/gyno.2001.6401; *FUTURE 2 STUD GRO, 2007, IN PRESS LANCET; Garland SM, 2003, CURR OPIN INFECT DIS, V16, P85, DOI 10.1097/00001432-200304000-00004; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goffin F, 2006, J MED VIROL, V78, P814, DOI 10.1002/jmv.20628; Hampl M, 2006, OBSTET GYNECOL, V108, P1361, DOI 10.1097/01.AOG.0000245786.86267.80; Herod JJO, 1996, BRIT J OBSTET GYNAEC, V103, P446, DOI 10.1111/j.1471-0528.1996.tb09771.x; Hillemanns P, 2006, GYNECOL ONCOL, V100, P276, DOI 10.1016/j.ygyno.2005.10.003; Hillemanns P, 2006, GYNECOL ONCOL, V100, P271, DOI 10.1016/j.ygyno.2005.08.012; Jones RW, 2005, OBSTET GYNECOL, V106, P1319, DOI 10.1097/01.AOG.0000187301.76283.7f; Jones RW, 2000, OBSTET GYNECOL, V96, P470, DOI 10.1016/S0029-7844(00)00949-2; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Jones RW, 2001, EUR J GYNAECOL ONCOL, V22, P393; Joura EA, 2002, CURR OPIN OBSTET GYN, V14, P39, DOI 10.1097/00001703-200202000-00007; Joura EA, 2000, J REPROD MED, V45, P613; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Le T, 2006, AM J OBSTET GYNECOL, V194, P377, DOI 10.1016/j.ajog.2005.08.022; Lehtinen M, 2006, VACCINE, V24, P233, DOI 10.1016/j.vaccine.2006.05.109; Madeleine MM, 1997, JNCI-J NATL CANCER I, V89, P1516, DOI 10.1093/jnci/89.20.1516; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OLSSON SE, 2007, VACCINE         0420; Parkin DM, 2002, IARC SCI PUBL, P8; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Reich O, 2002, OBSTET GYNECOL, V99, P193, DOI 10.1016/S0029-7844(01)01683-0; Reich O, 2001, OBSTET GYNECOL, V97, P428, DOI 10.1016/S0029-7844(00)01174-1; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; STURGEON SS, 1987, AM J OBSTET GYNECOL, V166, P1482; TOKI T, 1991, INT J GYNECOL PATHOL, V10, P107, DOI 10.1097/00004347-199104000-00001; van Seters M, 2005, GYNECOL ONCOL, V97, P645, DOI 10.1016/j.ygyno.2005.02.012; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109	46	383	397	1	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1693	1702		10.1016/S0140-6736(07)60777-6	http://dx.doi.org/10.1016/S0140-6736(07)60777-6			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512854				2022-12-24	WOS:000246631300025
J	de Jong, N; Verhagen, H; Wolfs, MCJ; Ockfe, MC; Klungel, OH; Leufkens, HGM				de Jong, Nynke; Verhagen, Hans; Wolfs, Marion C. J.; Ockfe, Marga C.; Klungel, Olaf H.; Leufkens, Hubert G. M.			Functional foods: the case for closer evaluation	BRITISH MEDICAL JOURNAL			English	Editorial Material							SERUM-CHOLESTEROL; PLANT STANOL; MEDICINES; REDUCTION; THERAPY; STEROLS; PROGRAM; ESTERS; SAFETY; RISK					Nynke.de.jong@rivm.nl	Verhagen, Hans/ABB-9361-2020	Verhagen, Hans/0000-0001-7952-3530				Aggett PJ, 2005, EUR J NUTR, V44, P5, DOI 10.1007/s00394-005-1104-3; Allgood GS, 2001, REGUL TOXICOL PHARM, V33, P224, DOI 10.1006/rtph.2001.1460; [Anonymous], HLTH NUTR CLAIMS; [Anonymous], INT MARK FUNCT FOODS; Blair SN, 2000, AM J CARDIOL, V86, P46, DOI 10.1016/S0002-9149(00)00976-0; Butchko HH, 2001, REGUL TOXICOL PHARM, V34, P221, DOI 10.1006/rtph.2001.1500; DEJONG N, 2005, POSTLAUNCH MONITORIN, V3; DEJONG N, 2007, EUR J CLIN NUTR 0214; *EUR COMM, 2007, NOV FOODS LEG; Gilbert D, 2000, BRIT MED J, V321, P1341, DOI 10.1136/bmj.321.7272.1341; Hendriks HFJ, 1999, EUR J CLIN NUTR, V53, P319, DOI 10.1038/sj.ejcn.1600728; *HOM HLTH CAN, 2001, HLTH CAN ADV BEC PRO; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Lea LJ, 2006, FOOD CHEM TOXICOL, V44, P1213, DOI 10.1016/j.fct.2006.01.017; Mantel-Teeuwisse AK, 2005, BRIT J CLIN PHARMACO, V60, P83, DOI 10.1111/j.1365-2125.2005.02367.x; Mantel-Teeuwisse AK, 2004, HEART, V90, P1065, DOI 10.1136/hrt.2003.026187; Miettinen TA, 2004, ANN MED, V36, P126, DOI 10.1080/07853890310021625; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; PARIZA MW, 1999, NUTR TODAY, V34, P3; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; Pletscher W, 2004, SWISS MED WKLY, V134, P367; Ratnayake W. M. N., 2004, Phytosterols as functional food components and nutraceuticals, P365; *SCI COMM FOOD, 2002, OP SCI COMM FOOD REP; Wolfs M, 2006, FOOD CHEM TOXICOL, V44, P1682, DOI 10.1016/j.fct.2006.05.006; Zureik M, 1996, BMJ-BRIT MED J, V313, P649, DOI 10.1136/bmj.313.7058.649	27	15	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1037	1039		10.1136/bmj.39196.666377.BE	http://dx.doi.org/10.1136/bmj.39196.666377.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510152	Green Published, Green Submitted			2022-12-24	WOS:000246913500032
J	Tarantola, D; Gruskin, S				Tarantola, Daniel; Gruskin, Sofia			New guidance on recommended HIV testing and counselling	LANCET			English	Editorial Material									Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Harvard Univ, Sch Publ Hlth, Program Int Hlth & Human Rights, Boston, MA 02115 USA	University of New South Wales Sydney; Harvard University; Harvard T.H. Chan School of Public Health	Tarantola, D (corresponding author), Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	d.tarantola@unsw.edu.au						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], REV REC HIV TEST AD; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; *HUM RIGHTS WATCH, 2007, COMM WHO UNAIDS DRAF; JURGENS R, 2007, ROUTINIZING HIV TEST; KIPPAX S, 2006, COMMENTS GUIDANCE PR; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; *UNAIDS REF GROUP, 2007, CRIM HIV TRANSM	9	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					202	203		10.1016/S0140-6736(07)61102-7	http://dx.doi.org/10.1016/S0140-6736(07)61102-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MG	17658377				2022-12-24	WOS:000248347900008
J	DeLong, EF				DeLong, Edward F.			Life on the thermodynamic edge	SCIENCE			English	Editorial Material							SYNTROPHUS-ACIDITROPHICUS; METHANE OXIDATION; SEDIMENTS		MIT, Inst Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Inst Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu						Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534	11	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					327	328		10.1126/science.1145970	http://dx.doi.org/10.1126/science.1145970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641187				2022-12-24	WOS:000248150200031
J	Petraglia, M; Korisettar, R; Boivin, N; Clarkson, C; Ditchfield, P; Jones, S; Koshy, J; Lahr, MM; Oppenheimer, C; Pyle, D; Roberts, R; Schwenninger, JL; Arnold, L; White, K				Petraglia, Michael; Korisettar, Ravi; Boivin, Nicole; Clarkson, Christopher; Ditchfield, Peter; Jones, Sacha; Koshy, Jinu; Lahr, Marta Mirazon; Oppenheimer, Clive; Pyle, David; Roberts, Richard; Schwenninger, Jean-Luc; Arnold, Lee; White, Kevin			Middle paleolithic assemblages from the Indian subcontinent before and after the Toba super-eruption	SCIENCE			English	Article							MODERN HUMAN ORIGINS; VOLCANIC WINTER; ASH; DISPERSAL; EVOLUTION; BEHAVIOR; SOUTH	The Youngest Toba Tuff (YTT) eruption, which occurred in Indonesia 74,000 years ago, is one of Earth's largest known volcanic events. The effect of the YTT eruption on existing populations of humans, and accordingly on the course of human evolution, is debated. Here we associate the YTT with archaeological assemblages at Jwalapuram, in the Jurreru River valley of southern India. Broad continuity of Middle Paleolithic technology across the YTT event suggests that hominins persisted regionally across this major eruptive event.	Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Karnatak Univ, Dept Hist & Archaeol, Dharwad 580003, Karnataka, India; Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia; Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Wollongong, GeoQUEST Res Ctr, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Univ Reading, Dept Geog, Reading RG6 6AB, Berks, England	University of Cambridge; Smithsonian Institution; Smithsonian National Museum of Natural History; Karnatak University; University of Queensland; University of Oxford; University of Cambridge; University of Oxford; University of Wollongong; University of Reading	Petraglia, M (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England.	m.petraglia@human-evol.cam.ac.uk	Pyle, David M/C-5707-2009; Oppenheimer, Clive/G-9881-2013; Arnold, Lee J/J-4356-2018; Petraglia, Michael/ABA-9748-2021; Roberts, Richard Graham/B-8245-2013	Pyle, David M/0000-0002-2663-9940; Oppenheimer, Clive/0000-0003-4506-7260; Arnold, Lee J/0000-0001-9603-3824; Roberts, Richard Graham/0000-0002-0128-4119; BOIVIN, NICOLE/0000-0002-7783-4199; Jones, Sacha/0000-0003-0492-2662; Petraglia, Michael/0000-0003-2522-5727; Koshy, Jinu/0000-0003-3246-0485; Mirazon Lahr, Marta/0000-0001-5752-5770; Clarkson, Chris/0000-0002-8938-8974	Natural Environment Research Council [NER/T/S/2002/00468] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACHARYYA SK, 1993, QUATERNARY RES, V40, P10, DOI 10.1006/qres.1993.1051; Ambrose SH, 2003, J HUM EVOL, V45, P231, DOI 10.1016/j.jhevol.2003.08.001; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; CHESNER CA, 1991, GEOLOGY, V19, P200, DOI 10.1130/0091-7613(1991)019<0200:EHOESL>2.3.CO;2; Gathorne-Hardy FJ, 2003, J HUM EVOL, V45, P227, DOI 10.1016/S0047-2484(03)00105-2; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; Jones GS, 2005, CLIM DYNAM, V25, P725, DOI 10.1007/s00382-005-0066-8; Jones SC, 2007, VERTEBR PALEOBIOL PA, P173, DOI 10.1007/1-4020-5562-5_8; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mason BG, 2004, B VOLCANOL, V66, P735, DOI 10.1007/s00445-004-0355-9; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; MISRA VN, 1989, MAN ENV, V14, P1764; MURTY MLK, 1974, P AM PHILOS SOC, V118, P196; Oppenheimer C, 2002, QUATERNARY SCI REV, V21, P1593, DOI 10.1016/S0277-3791(01)00154-8; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; RAMPINO MR, 1993, QUATERNARY RES, V40, P269, DOI 10.1006/qres.1993.1081; RAMPINO MR, 1992, NATURE, V359, P50, DOI 10.1038/359050a0; RAMPINO MR, 1993, SCIENCE, V262, P1955, DOI 10.1126/science.8266085; Reddy K. T., 1977, ASIAN PERSPECT, V20, P206; ROSE WI, 1990, GLOBAL PLANET CHANGE, V89, P269, DOI 10.1016/0921-8181(90)90023-6; ROSE WI, 1987, GEOLOGY, V15, P913, DOI 10.1130/0091-7613(1987)15<913:DOAITG>2.0.CO;2; SHANE P, 1995, QUATERNARY RES, V44, P200, DOI 10.1006/qres.1995.1064; Westgate JA, 1998, QUATERNARY RES, V50, P107, DOI 10.1006/qres.1998.1974	25	208	216	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2007	317	5834					114	116		10.1126/science.1141564	http://dx.doi.org/10.1126/science.1141564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615356				2022-12-24	WOS:000247776700063
J	Check, E				Check, Erika			Abbott's AIDS fight-back	NATURE			English	News Item								In March 2007, Abbott Laboratories withdrew its application to register the AIDS drug Aluvia in Thailand because since November 2006, the Thai government has issued a series of compulsory licences to enable it to manufacture or purchase generic copies of patented medicines from third parties without the consent of the patent holder. In May, the company sued the French activist group Act Up-Paris in a Paris court after it had launched an attack on the company's website. Abbott's hardball tactics reflect the high stakes of the latest round of disputes to break out between the industry and governments over drug pricing and access.											0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					14	14		10.1038/448014a	http://dx.doi.org/10.1038/448014a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611514	Bronze			2022-12-24	WOS:000247720900012
J	Lindholm, P; Voutilainen, MH; Lauren, J; Peranen, J; Leppanen, VM; Andressoo, JO; Lindahl, M; Janhunen, S; Kalkkinen, N; Timmusk, T; Tuominen, RK; Saarma, M				Lindholm, Pivi; Voutilainen, Merja H.; Lauren, Juha; Peranen, Johan; Leppanen, Veli-Matti; Andressoo, Jaan-Olle; Lindahl, Maria; Janhunen, Sanna; Kalkkinen, Nisse; Timmusk, Tonis; Tuominen, Raimo K.; Saarma, Mart			Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo	NATURE			English	Article							MICE LACKING GDNF; PARTIAL LESION MODEL; PARKINSONS-DISEASE; INFUSION; RAT; 6-HYDROXYDOPAMINE; EXPRESSION; DEGENERATION; RECOVERY; 6-OHDA	In Parkinson's disease, brain dopamine neurons degenerate most prominently in the substantia nigra(1). Neurotrophic factors promote survival, differentiation and maintenance of neurons in developing and adult vertebrate nervous system(2,3). The most potent neurotrophic factor for dopamine neurons described so far is the glial-cell-line-derived neurotrophic factor (GDNF)(4). Here we have identified a conserved dopamine neurotrophic factor (CDNF) as a trophic factor for dopamine neurons. CDNF, together with its previously described vertebrate and invertebrate homologue the mesencephalic-astrocyte-derived neurotrophic factor(5), is a secreted protein with eight conserved cysteine residues, predicting a unique protein fold and defining a new, evolutionarily conserved protein family. CDNF (Armetl1) is expressed in several tissues of mouse and human, including the mouse embryonic and postnatal brain. In vivo, CDNF prevented the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons in a rat experimental model of Parkinson's disease. A single injection of CDNF before 6-OHDA delivery into the striatum significantly reduced amphetamine-induced ipsilateral turning behaviour and almost completely rescued dopaminergic tyrosine-hydroxylase-positive cells in the substantia nigra. When administered four weeks after 6-OHDA, intrastriatal injection of CDNF was able to restore the dopaminergic function and prevent the degeneration of dopaminergic neurons in substantia nigra. Thus, CDNF was at least as efficient as GDNF in both experimental settings. Our results suggest that CDNF might be beneficial for the treatment of Parkinson's disease.	Univ Helsinki, Inst Biotechnol, Viikki Bioctr, FIN-00014 Helsinki, Finland; Univ Helsinki, Div Pharmacol & Toxicol, Viikki Bioctr, Fac Pharm, FIN-00014 Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	University of Helsinki; University of Helsinki; Tallinn University of Technology	Saarma, M (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, POB 56, FIN-00014 Helsinki, Finland.	mart.saarma@helsinki.fi	Voutilainen, Merja/D-9601-2014; Kalkkinen, Nisse EJ/B-3923-2010; Lindahl, Maria/AHE-1252-2022; Andressoo, Jaan-Olle/AAA-1216-2021; Andressoo, Jaan-Olle/AFU-7846-2022; Timmusk, Tonis/H-4889-2015	Andressoo, Jaan-Olle/0000-0002-0271-3157; Voutilainen, Merja/0000-0002-9832-7655; Timmusk, Tonis/0000-0002-1015-3348; Leppanen, Veli-Matti/0000-0001-7100-965X; Pulkkila, Paivi/0000-0003-3022-5035; Lindahl, Maria/0000-0002-5674-8830				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Aoi M, 2000, NEUROSCI RES, V36, P319, DOI 10.1016/S0168-0102(00)00097-3; BOWENKAMP KE, 1995, J COMP NEUROL, V355, P479, DOI 10.1002/cne.903550402; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Granholm ACE, 1997, J NEUROSCI, V17, P1168; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jaaro H, 2001, TRENDS NEUROSCI, V24, P79, DOI 10.1016/S0166-2236(00)01690-8; Janhunen S, 2005, NEUROSCI LETT, V381, P314, DOI 10.1016/j.neulet.2005.02.038; Kearns CM, 1997, J NEUROSCI, V17, P7111; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Peranen J, 2001, METHOD ENZYMOL, V329, P188; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	35	320	349	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					73	77		10.1038/nature05957	http://dx.doi.org/10.1038/nature05957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611540				2022-12-24	WOS:000247720900040
J	Okie, S				Okie, Susan			An elusive balance - Residents' work hours and the continuity of care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE EVENTS											Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Vidyarthi AR, 2006, J HOSP MED, V1, P257, DOI 10.1002/jhm.103	4	67	68	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2007	356	26					2665	2667		10.1056/NEJMp078085	http://dx.doi.org/10.1056/NEJMp078085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183HS	17596598				2022-12-24	WOS:000247564500001
J	Ohto, U; Fukase, K; Miyake, K; Satow, Y				Ohto, Umeharu; Fukase, Koichi; Miyake, Kensuke; Satow, Yoshinori			Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa	SCIENCE			English	Article							LIPOPOLYSACCHARIDE; TLR4; RECOGNITION; IMMUNITY; BINDING	Endotoxic lipopolysaccharide (LPS) with potent immunostimulatory activity is recognized by the receptor complex of MD-2 and Toll-like receptor 4. Crystal structures of human MD-2 and its complex with the antiendotoxic tetra-acylated lipid A core of LPS have been determined at 2.0 and 2.2 angstrom resolutions, respectively. MD-2 shows a deep hydrophobic cavity sandwiched by two beta sheets, in which four acyl chains of the ligand are fully confined. The phosphorylated glucosamine moieties are located at the entrance to the cavity. These structures suggest that MD-2 plays a principal role in endotoxin recognition and provide a basis for antiseptic drug development.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Satow, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	satowy@mol.f.u-tokyo.ac.jp						Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alexander C, 2002, TRENDS GLYCOSCI GLYC, V14, P69, DOI 10.4052/tigg.14.69; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright CS, 2004, J MOL BIOL, V342, P585, DOI 10.1016/j.jmb.2004.07.063	29	371	380	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1632	1634		10.1126/science.1139111	http://dx.doi.org/10.1126/science.1139111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569869				2022-12-24	WOS:000247239900046
J	Gill, SS; Bronskill, SE; Normand, SLT; Anderson, GM; Sykora, K; Lam, K; Bell, CM; Lee, PE; Fischer, HD; Herrmann, N; Gurwitz, JH; Rochon, PA				Gill, Sudeep S.; Bronskill, Susan E.; Normand, Sharon-Lise T.; Anderson, Geoffrey M.; Sykora, Kathy; Lam, Kelvin; Bell, Chaim M.; Lee, Philip E.; Fischer, Hadas D.; Herrmann, Nathan; Gurwitz, Jerry H.; Rochon, Paula A.			Antipsychotic drug use and mortality in older adults with dementia	ANNALS OF INTERNAL MEDICINE			English	Article							SUDDEN CARDIAC DEATH; RANDOMIZED CONTROLLED-TRIAL; PROPENSITY SCORE MODELS; QUALITY-OF-LIFE; NURSING-HOMES; ATYPICAL ANTIPSYCHOTICS; PSYCHOLOGICAL SYMPTOMS; ELDERLY-PATIENTS; NEUROPSYCHIATRIC SYMPTOMS; VENOUS THROMBOEMBOLISM	Background: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. Objective: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. Design: Population -based, retrospective cohort study. Setting: Ontario, Canada. Patients: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. Measurements: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. Results: A total of 27 259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that in- crease the risk for death could diminish or eliminate the observed associations. Limitations: Information on causes of death was not available. Many patents did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. Conclusions: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.	Queens Univ, Kingston, ON K7L 2V7, Canada; Univ Toronto, Toronto, ON M4X 1K9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4X 1K9, Canada; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Clin Fdn, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Community Hlth Plan, Worcester, MA 01605 USA	Queens University - Canada; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gill, SS (corresponding author), St Marys Lake Hosp, 340 Union St, Kingston, ON K7L 5A2, Canada.		Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151; Normand, Sharon-Lise/0000-0001-7027-4769				Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Ballard C, 2005, INT PSYCHOGERIATR, V17, P4, DOI 10.1017/S1041610205221026; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P23; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Berzlanovich AM, 1999, AM J MED, V107, P351, DOI 10.1016/S0002-9343(99)00242-9; Bronskill SE, 2004, J AM GERIATR SOC, V52, P749, DOI 10.1111/j.1532-5415.2004.52212.x; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2006, ANN INTERN MED, V145, P780, DOI 10.7326/0003-4819-145-10-200611210-00011; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAGOSTINO RB, 2004, TUTORIALS BIOSTSATIS, V1; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Gill SS, 2006, JAMA-J AM MED ASSOC, V295, P495, DOI 10.1001/jama.295.5.495-b; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Hennessy S, 2004, BRIT J CLIN PHARMACO, V58, P81, DOI 10.1111/j.1365-2125.2004.02098.x; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; *HLTH CAN, 2005, 200563 HLTH CAN; Joukamaa M, 2006, BRIT J PSYCHIAT, V188, P122, DOI 10.1192/bjp.188.2.122; Keene J, 2001, INT J GERIATR PSYCH, V16, P969, DOI 10.1002/gps.474; Kern LM, 2005, ANN INTERN MED, V142, P173, DOI 10.7326/0003-4819-142-3-200502010-00007; Kryzhanovskaya LA, 2006, J CLIN PSYCHIAT, V67, P933, DOI 10.4088/JCP.v67n0610; Lanctot KL, 1998, J CLIN PSYCHIAT, V59, P550, DOI 10.4088/JCP.v59n1010; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; Liperoti R, 2005, J CLIN PSYCHIAT, V66, P1090, DOI 10.4088/JCP.v66n0901; Liperoti R, 2005, ARCH INTERN MED, V165, P2677, DOI 10.1001/archinte.165.22.2677; Liperoti R, 2005, ARCH INTERN MED, V165, P696, DOI 10.1001/archinte.165.6.696; Livingston G, 2007, J NEUROL NEUROSUR PS, V78, P25, DOI 10.1136/jnnp.2006.094342; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; Meador KG, 1997, J AM GERIATR SOC, V45, P207, DOI 10.1111/j.1532-5415.1997.tb04509.x; Nasrallah HA, 2004, AM J GERIAT PSYCHIAT, V12, P437, DOI 10.1176/appi.ajgp.12.4.437; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Rabins PV, 2005, JAMA-J AM MED ASSOC, V294, P1963, DOI 10.1001/jama.294.15.1963; Rapoport M, 2005, INT J GERIATR PSYCH, V20, P749, DOI 10.1002/gps.1358; RAY WA, 1993, ARCH INTERN MED, V153, P713, DOI 10.1001/archinte.153.6.713; Ray WA, 2005, NEW ENGL J MED, V353, P2319, DOI 10.1056/NEJMp058267; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2002, BRIT J PSYCHIAT, V180, P483, DOI 10.1192/bjp.180.6.483; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Ruschena D, 2003, BRIT J PSYCHIAT, V183, P446, DOI 10.1192/bjp.183.5.446; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Shah A, 2005, INT PSYCHOGERIATR, V17, P12, DOI 10.1017/S1041610205231022; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Suh GH, 2005, INT PSYCHOGERIATR, V17, P429, DOI 10.1017/S1041610205002243; THAPA PB, 1994, J AM GERIATR SOC, V42, P280, DOI 10.1111/j.1532-5415.1994.tb01752.x; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; TRIFIRO G, 2006, PHARMACOEPIDEMIOL DR; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; *US FDA, T0513 US FDA; van Reekum R, 2002, INT PSYCHOGERIATR, V14, P197, DOI 10.1017/S1041610202008396; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Warner J, 2004, LANCET, V363, P674, DOI 10.1016/S0140-6736(04)15664-X; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	67	410	417	0	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					775	786		10.7326/0003-4819-146-11-200706050-00006	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17548409	Green Published			2022-12-24	WOS:000247005200003
J	Dosa, DM				Dosa, David M.			A day in the life of oscar the cat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rhode Isl Hosp, Providence, RI 02902 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Dosa, DM (corresponding author), Rhode Isl Hosp, Providence, RI 02902 USA.								0	20	20	5	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					328	329		10.1056/NEJMp078108	http://dx.doi.org/10.1056/NEJMp078108			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193OL	17652647				2022-12-24	WOS:000248283500003
J	Bacon, CJ; Hey, EN				Bacon, C. J.; Hey, E. N.			Uncertainty in classification of repeat sudden unexpected infant deaths in Care of the Next Infant programme	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Chrisjbacon@googlemail.com						Arnestad M, 2005, AM J MED GENET A, V134A, P459, DOI 10.1002/ajmg.a.30614; Bacon C, 2005, LANCET, V365, P1137, DOI 10.1016/S0140-6736(05)71872-9; Carpenter RG, 2007, BRIT MED J, V334, P7, DOI 10.1136/bmj.39070.643009.3A; Carpenter RG, 2005, LANCET, V365, P29, DOI 10.1016/S0140-6736(04)17662-9; *CROWN PROS SERV, 2004, COD CROWN PROS; DENMARK JC, 1966, BRIT J MED PSYCHOL, V39, P117, DOI 10.1111/j.2044-8341.1966.tb01320.x; Di Maio VM, 2005, LANCET, V365, P1137, DOI 10.1016/S0140-6736(05)71873-0; DORRIES C, 2004, CORONERS COURTS GUID, P272; Emery JL, 2000, BRIT MED J, V320, P310, DOI 10.1136/bmj.320.7230.310; EMERY JL, 1986, LANCET, V1, P313; EMERY JL, 1993, AM J DIS CHILD, V147, P1097, DOI 10.1001/archpedi.1993.02160340083019; Gornall J, 2006, BRIT MED J, V333, P1165, DOI 10.1136/bmj.39031.590914.68; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KRUGMAN RD, 1994, PEDIATRICS, V94, P124; Limerick SR, 2004, J CLIN PATHOL, V57, P309, DOI 10.1136/jcp.2003.013052; Maguire S, 2006, CHILD ABUSE NEGLECT, V30, P739, DOI 10.1016/j.chiabu.2005.12.007; WOLKIND S, 1993, ACTA PAEDIATR, V82, P873, DOI 10.1111/j.1651-2227.1993.tb12583.x	18	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2007	335	7611					129	131		10.1136/bmj.39203.430984.AD	http://dx.doi.org/10.1136/bmj.39203.430984.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641347	Green Published			2022-12-24	WOS:000248428100032
J	Rosebrock, TR; Zeng, LR; Brady, JJ; Abramovitch, RB; Xiao, FM; Martin, GB				Rosebrock, Tracy R.; Zeng, Lirong; Brady, Jennifer J.; Abramovitch, Robert B.; Xiao, Fangming; Martin, Gregory B.			A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity	NATURE			English	Article							PROGRAMMED CELL-DEATH; PATHOGEN PSEUDOMONAS-SYRINGAE; III EFFECTORS; DISEASE RESISTANCE; INNATE IMMUNITY; BASAL DEFENSE; GENE FAMILY; TOMATO; PTO; ARABIDOPSIS	Many bacterial pathogens of plants and animals use a type III secretion system to deliver diverse virulence-associated 'effector' proteins into the host cell(1). The mechanisms by which these effectors act are mostly unknown; however, they often promote disease by suppressing host immunity(2). One type III effector, AvrPtoB, expressed by the plant pathogen Pseudomonas syringae pv. tomato, has a carboxy-terminal domain that is an E3 ubiquitin ligase(3). Deletion of this domain allows an amino-terminal region of AvrPtoB (AvrPtoB(1-387)) to be detected by certain tomato varieties leading to immunity-associated programmed cell death(4). Here we show that a host kinase, Fen, physically interacts with AvrPtoB(1-387) and is responsible for activating the plant immune response. The AvrPtoB E3 ligase specifically ubiquitinates Fen and promotes its degradation in a proteasome-dependent manner. This degradation leads to disease susceptibility in Fen-expressing tomato lines. Various wild species of tomato were found to exhibit immunity in response to AvrPtoB(1-387) and not to full-length AvrPtoB. Thus, by acquiring an E3 ligase domain, AvrPtoB has thwarted a highly conserved host resistance mechanism.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Martin, Gregory B/F-6262-2011; Abramovitch, Robert B/A-5324-2013; Abramovitch, Robert/O-6798-2019	Martin, Gregory B/0000-0003-0044-6830; Abramovitch, Robert/0000-0002-4119-4169; Rosebrock, Tracy/0000-0001-6339-6661; Zeng, Lirong/0000-0001-8802-4872	NIGMS NIH HHS [R01 GM078021, R01 GM078021-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078021] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Anderson JC, 2006, PLANT CELL, V18, P502, DOI 10.1105/tpc.105.036590; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jia YL, 1997, PLANT CELL, V9, P61, DOI 10.1105/tpc.9.1.61; Kim HS, 2005, P NATL ACAD SCI USA, V102, P6496, DOI 10.1073/pnas.0500792102; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Lin NC, 2006, APPL ENVIRON MICROB, V72, P702, DOI 10.1128/AEM.72.1.702-712.2006; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; PASCUZZI PE, 2006, THESIS CORNELL U; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Xing T, 2001, PLANT MOL BIOL, V46, P109, DOI 10.1023/A:1010633215445; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	32	235	244	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					370	U13		10.1038/nature05966	http://dx.doi.org/10.1038/nature05966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637671	Green Accepted			2022-12-24	WOS:000248118300062
J	Butman, JA; Kim, HJ; Baggenstos, M; Ammerman, JM; Dambrosia, J; Patsalides, A; Patronas, NJ; Oldfield, EH; Lonser, RR				Butman, John A.; Kim, H. Jeffrey; Baggenstos, Martin; Ammerman, Joshua M.; Dambrosia, James; Patsalides, Athos; Patronas, Nicholas J.; Oldfield, Edward H.; Lonser, Russell R.			Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY; VHL GENE; HEMANGIOBLASTOMAS; IDENTIFICATION; ADENOCARCINOMA; MANAGEMENT	Context Endolymphatic sac tumors (ELSTs) are associated with von Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy. The underlying mechanisms of audiovestibular morbidity remain unclear and optimal timing of treatment is not known. Objective To define the mechanisms underlying audiovestibular pathophysiology associated with ELSTs. Design, Setting, and Patients Prospective and serial evaluation of patients with von Hippel-Lindau disease and ELSTs at the National Institutes of Health between May 1990 and December 2006. Main Outcome Measures Clinical findings and audiologic data were correlated with serial magnetic resonance imaging and computed tomography imaging studies to determine mechanisms underlying audiovestibular dysfunction. Results Thirty-five patients with von Hippel-Lindau disease and ELSTs in 38 ears (3 bilateral ELSTs) were identified. Tumor invasion of the otic capsule was associated with larger tumors (P = .01) and occurred in 7 ears (18%) causing SNHL (100%). No evidence of otic capsule invasion was present in the remaining 31 ears (82%). SNHL developed in 27 of these 31 ears (87%) either suddenly (14 ears; 52%) or gradually (13 ears; 48%) and 4 ears had normal hearing. Intralabyrinthine hemorrhage was found in 11 of 14 ears with sudden SNHL (79%; P < .001) but occurred in none of the 17 ears with gradual SNHL or normal hearing. Tumor size was not related to SNHL (P = .23) or vestibulopathy (P = .83). Conclusions ELST-associated SNHL and vestibulopathy may occur suddenly due to tumor-associated intralabyrinthine hemorrhage, or insidiously, consistent with endolymphatic hydrops. Both of these pathophysiologic mechanisms occur with small tumors that are not associated with otic capsule invasion.	NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA; Natl Inst Hlth & Other Commun Disorders, Neurootol Branch, NIH, Bethesda, MD USA; NINDS, Biostat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Butman, JA (corresponding author), NIH, Dept Diagnost Radiol, Ctr Clin, Bldg 10,Room 1C365, Bethesda, MD 20892 USA.	jbutman@nih.gov	Butman, John/J-2780-2013; Butman, John A/A-2694-2008	Butman, John/0000-0002-1547-9195; 	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003053, Z01NS002855, Z01NS003053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000064, Z01DC000064] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Choo D, 2004, J NEUROSURG, V100, P480, DOI 10.3171/jns.2004.100.3.0480; Gaeta M, 1999, NEURORADIOLOGY, V41, P799, DOI 10.1007/s002340050845; Hansen MR, 2004, LARYNGOSCOPE, V114, P1470, DOI 10.1097/00005537-200408000-00028; HEFFNER DK, 1989, CANCER, V64, P2292, DOI 10.1002/1097-0142(19891201)64:11<2292::AID-CNCR2820641119>3.0.CO;2-#; Kim HJ, 2005, J NEUROSURG, V102, P503, DOI 10.3171/jns.2005.102.3.0503; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Libutti SK, 1998, SURGERY, V124, P1153, DOI 10.1067/msy.1998.91823; Libutti SK, 2000, SURGERY, V128, P1022, DOI 10.1067/msy.2000.110239; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lonser RR, 2005, ANN NEUROL, V58, P392, DOI 10.1002/ana.20584; Lonser RR, 2004, NEW ENGL J MED, V350, P2481, DOI 10.1056/NEJMoa040666; Lonser RR, 2003, J NEUROSURG, V98, P106, DOI 10.3171/jns.2003.98.1.0106; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Manski TJ, 1997, JAMA-J AM MED ASSOC, V277, P1461, DOI 10.1001/jama.277.18.1461; Megerian CA, 2002, OTOL NEUROTOL, V23, P378, DOI 10.1097/00129492-200205000-00026; MEGERIAN CA, 1995, LARYNGOSCOPE, V105, P801, DOI 10.1288/00005537-199508000-00006; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Richard S, 1998, J INTERN MED, V243, P547; Rodrigues S, 2004, OTOL NEUROTOL, V25, P599, DOI 10.1097/00129492-200407000-00030; SCHUKNECHT HF, 1975, J LARYNGOL OTOL, V89, P985, DOI 10.1017/S0022215100081305; Thomassin J M, 2000, Ann Otolaryngol Chir Cervicofac, V117, P274; Vortmeyer AO, 1997, JNCI-J NATL CANCER I, V89, P970, DOI 10.1093/jnci/89.13.970-a; Vortmeyer AO, 2000, NEUROLOGY, V55, P460, DOI 10.1212/WNL.55.3.460; Wait SD, 2004, ANN NEUROL, V55, P236, DOI 10.1002/ana.10807; WALTHER MM, 1995, J UROLOGY, V154, P2010, DOI 10.1016/S0022-5347(01)66674-6; Wanebo JE, 2003, J NEUROSURG, V98, P82, DOI 10.3171/jns.2003.98.1.0082	26	54	56	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2007	298	1					41	48		10.1001/jama.298.1.41	http://dx.doi.org/10.1001/jama.298.1.41			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OU	17609489				2022-12-24	WOS:000247721100020
J	Odegaard, JI; Ricardo-Gonzalez, RR; Goforth, MH; Morel, CR; Subramanian, V; Mukundan, L; Eagle, AR; Vats, D; Brombacher, F; Ferrante, AW; Chawla, A				Odegaard, Justin I.; Ricardo-Gonzalez, Roberto R.; Goforth, Matthew H.; Morel, Christine R.; Subramanian, Vidya; Mukundan, Lata; Eagle, Alex Red; Vats, Divya; Brombacher, Frank; Ferrante, Anthony W.; Chawla, Ajay			Macrophage-specific PPAR gamma controls alternative activation and improves insulin resistance	NATURE			English	Article							ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE-METABOLISM; OBESITY; INFLAMMATION; EXPRESSION; ADIPOCYTES; MONOCYTE; MICE	Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation(1,2). In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance(3,4). For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance(5,6). Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity(5,7). These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment(8). While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage(5,8), resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype(9). Despite their higher capacity to repair tissue(10), the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPAR gamma), we showhere that PPAR gamma is required for maturation of alternatively activated macrophages. Disruption of PPAR gamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.	Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; Stanford Univ, Grad Program Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Cape Town, Observ, Fac Hlth Sci, Inst Infect Dis & Mol Med,Div Immunol, ZA-7925 Cape Town, South Africa; Columbia Univ Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Stanford University; Stanford University; Stanford University; University of Cape Town; Columbia University	Chawla, A (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA.	achawla@stanford.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	NHLBI NIH HHS [R01 HL076746-04, R01 HL076746-05, R01 HL076746-01, R01 HL076746, R01 HL076746-03, R01 HL076746-02] Funding Source: Medline; NIAID NIH HHS [AI07290, T32 AI007290, F31 AI066402] Funding Source: Medline; NIDDK NIH HHS [R01 DK066525, K08 DK062386, R01 DK066525-05, K08 DK062386-05, R01 DK076760, K08 DK062386-06] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, F31AI066402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062386, R01DK066525, R01DK076760] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexander J, 1999, J CELL SCI, V112, P2993; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	30	1525	1609	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1116	U12		10.1038/nature05894	http://dx.doi.org/10.1038/nature05894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17515919	Green Accepted			2022-12-24	WOS:000247564600038
J	Longmore, GD				Longmore, Gregory D.			Do cancer cells express functional erythropoietin receptors?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Longmore, GD (corresponding author), Washington Univ, St Louis, MO 63130 USA.								0	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2447	2447		10.1056/NEJMp078112	http://dx.doi.org/10.1056/NEJMp078112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568024				2022-12-24	WOS:000247201900002
J	Rivalan, P; Delmas, V; Angulo, E; Bull, LS; Hall, RJ; Courchamp, F; Rosser, AM; Leader-Williams, N				Rivalan, Philippe; Delmas, Virginie; Angulo, Elena; Bull, Leigh S.; Hall, Richard J.; Courchamp, Franck; Rosser, Alison M.; Leader-Williams, Nigel			Can bans stimulate wildlife trade?	NATURE			English	Editorial Material									Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Kent	Rivalan, P (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.		Hall, Richard John/A-3931-2013; Courchamp, Franck/ABE-7204-2020; Angulo, Elena/A-8107-2013	Hall, Richard John/0000-0002-6102-4183; Courchamp, Franck/0000-0001-7605-4548; Angulo, Elena/0000-0001-5545-4032				Baillie J. E. M., 2004, 2004 IUCN RED LIST T; *FAO, 2001, FAO FOR RES ASS; *FAO FISH DEP, 2004, STAT WORLDS FISH AQ; Food and Agriculture Organization (FAO), 2007, 833 FAO; Hutton J., 2000, ENDANGERED SPECIES T; Hutton JM, 2003, ORYX, V37, P215, DOI 10.1017/S0030605303000395; *IUCN, 2000, TRAD MEAS MULT ENV A; Jackson P., 1996, BIOL CONSERVATION; Oldfield S., 1998, WORLD LIST THREATENE; PERALA J, 2003, 2006 IUCN RED LIST T; VANRIJSOORT J, 2000, NONTIMBER FOREST PRO	11	104	105	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					529	530		10.1038/447529a	http://dx.doi.org/10.1038/447529a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172YZ	17538599	Green Submitted			2022-12-24	WOS:000246842000023
J	Widboom, PF; Fielding, EN; Liu, Y; Bruner, SD				Widboom, Paul F.; Fielding, Elisha N.; Liu, Ye; Bruner, Steven D.			Structural basis for cofactor-independent dioxygenation in vancomycin biosynthesis	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; MECHANISM; CATALYSIS; SUPERFAMILY; REQUIREMENT; POLYKETIDE; ACTIVATION; HYDRATASE; OXIDATION	Enzyme-catalysed oxidations are some of the most common transformations in primary and secondary metabolism. The vancomycin biosynthetic enzyme DpgC belongs to a small class of oxygenation enzymes that are not dependent on an accessory cofactor or metal ion(1). The detailed mechanism of cofactor-independent oxygenases has not been established. Here we report the first structure of an enzyme of this oxygenase class in complex with a bound substrate mimic. The use of a designed, synthetic substrate analogue allows unique insights into the chemistry of oxygen activation. The structure confirms the absence of cofactors, and electron density consistent with molecular oxygen is present adjacent to the site of oxidation on the substrate. Molecular oxygen is bound in a small hydrophobic pocket and the substrate provides the reducing power to activate oxygen for downstream chemical steps. Our results resolve the unique and complex chemistry of DpgC, a key enzyme in the biosynthetic pathway of an important class of antibiotics(2). Furthermore, mechanistic parallels exist between DpgC and cofactor-dependent flavoenzymes(3), providing information regarding the general mechanism of enzymatic oxygen activation.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Bruner, SD (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	bruner@bc.edu						ADAM W, 1977, J AM CHEM SOC, V99, P5768, DOI 10.1021/ja00459a038; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 2002, PROTEIN SCI, V11, P974, DOI 10.1110/ps.4310102; Beinker P, 2006, J MOL BIOL, V359, P728, DOI 10.1016/j.jmb.2006.03.060; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fetzner S, 2002, APPL MICROBIOL BIOT, V60, P243, DOI 10.1007/s00253-002-1123-4; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; KOO JY, 1978, P NATL ACAD SCI USA, V75, P30, DOI 10.1073/pnas.75.1.30; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Tseng CC, 2004, CHEM BIOL, V11, P1195, DOI 10.1016/j.chembiol.2004.06.012; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Xiang H, 1999, BIOCHEMISTRY-US, V38, P7638, DOI 10.1021/bi9901432	29	64	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					342	345		10.1038/nature05702	http://dx.doi.org/10.1038/nature05702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507985				2022-12-24	WOS:000246520300051
J	Gregg, EW; Gu, Q; Cheng, YJ; Narayan, V; Cowie, CC				Gregg, Edward W.; Gu, Qiuping; Cheng, Yiling J.; Narayan, Venkat; Cowie, Catherine C.			Mortality trends in men and women with diabetes, 1971 to 2000	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE MORTALITY; UNITED-STATES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; SEX-DIFFERENCES; SECULAR TRENDS; ADULTS; POPULATION; PREVALENCE	Background: Whether mortality rates among diabetic adults or excess mortality associated with diabetes in the United States has declined in recent decades is not known. Objective: To examine whether all-cause and cardiovascular disease mortality rates have declined among the U.S. population with and without self-reported diabetes. Design: Comparison of 3 consecutive, nationally representative cohorts. Setting: Population-based health surveys (National Health and Nutrition Examination Surveys I, II, and III) with mortality follow-up assessment. Patients: Survey participants age 35 to 74 years with and without diabetes. Measurements: Diabetes was determined by self-report for each survey (1971-1975, 1976-1980, and 1988-1994), and mortality rates were determined through 1986, 1992, and 2000 for the 3 surveys, respectively. Results: Among diabetic men, the all-cause mortality rate decreased by 18.2 annual deaths per 1000 persons (from 42.6 to 24.4 annual deaths per 1000 persons; P = 0.03) between 1971 to 1986 and 1988 to 2000, accompanying decreases in the nondiabetic population. Trends for cardiovascular disease mortality paralleled those of all-cause mortality, with 26.4 annual deaths per 1000 persons in 1971 to 1986 and 12.8 annual deaths per 1000 persons in 1988 to 2000 (P = 0.06). Among women with diabetes, however, neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000, and the all-cause mortality rate difference between diabetic and nondiabetic women more than doubled (from a difference of 8.3 to 18.2 annual deaths per 1000 persons). The difference in all-cause mortality rates by sex among people with diabetes in 1971 to 1986 were essentially eliminated in 1988 to 2000. Limitations: Diabetes was assessed by self-report, and statistical power to examine the factors explaining mortality trends was limited. Conclusions: Progress in reducing mortality rates among persons with diabetes has been limited to men. Diabetes continues to greatly increase the risk for death, particularly among women.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, K 10,4770 Buford Highway NE, Atlanta, GA 30341 USA.		Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822				ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Cohen B B, 1987, Vital Health Stat 1, P1; Cooper R, 2000, CIRCULATION, V102, P3137; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Ergin A, 2004, AM J MED, V117, P219, DOI 10.1016/j.amjmed.2004.03.017; Ernst ND, 1997, AM J CLIN NUTR, V66, P965; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FORTHOFER RN, 1983, AM J EPIDEMIOL, V117, P507, DOI 10.1093/oxfordjournals.aje.a113568; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gustafsson I, 2004, J AM COLL CARDIOL, V43, P771, DOI 10.1016/j.jacc.2003.11.024; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hoehner CM, 2006, J DIABETES COMPLICAT, V20, P8, DOI 10.1016/j.jdiacomp.2005.06.003; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; KORN EL, 1999, ANAL HLTH SURVEYS, P279; LABBATE A, 2005, PHARM REP, V57; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Loria C M, 1999, Vital Health Stat 1, P1; McDowell A, 1981, Vital Health Stat 1, P1; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Pavkov ME, 2004, DIABETES CARE, V27, P1132, DOI 10.2337/diacare.27.5.1132; Persell SD, 2004, ARCH INTERN MED, V164, P2492, DOI 10.1001/archinte.164.22.2492; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, VITAL HLTH STAT, P1; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; Tierney EF, 2004, DIABETES CARE, V27, P2723, DOI 10.2337/diacare.27.11.2723	48	339	343	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					149	155		10.7326/0003-4819-147-3-200708070-00167	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00167			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17576993				2022-12-24	WOS:000248454700001
J	Jack, A				Jack, Andrew			No cure no cost	BRITISH MEDICAL JOURNAL			English	Article												Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*DEP HLTH, HSC 2002 004 COST EF	1	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					122	123		10.1136/bmj.39267.432153.94	http://dx.doi.org/10.1136/bmj.39267.432153.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17641343	Green Published			2022-12-24	WOS:000248428100027
J	Nozue, K; Covington, MF; Duek, PD; Lorrain, S; Fankhauser, C; Harmer, SL; Maloof, JN				Nozue, Kazunari; Covington, Michael F.; Duek, Paula D.; Lorrain, Severine; Fankhauser, Christian; Harmer, Stacey L.; Maloof, Julin N.			Rhythmic growth explained by coincidence between internal and external cues	NATURE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; LIGHT-SIGNAL-TRANSDUCTION; STEM ELONGATION; TRANSCRIPTION FACTORS; FLOWERING TIME; TOMATO PLANTS; ARABIDOPSIS; DEGRADATION; EXPRESSION; PHOSPHORYLATION	Most organisms use circadian oscillators to coordinate physiological and developmental processes such as growth with predictable daily environmental changes like sunrise and sunset. The importance of such coordination is highlighted by studies showing that circadian dysfunction causes reduced fitness in bacteria(1) and plants(2), as well as sleep and psychological disorders in humans(3). Plant cell growth requires energy and water-factors that oscillate owing to diurnal environmental changes. Indeed, two important factors controlling stem growth are the internal circadian oscillator(4-6) and external light levels(7). However, most circadian studies have been performed in constant conditions, precluding mechanistic study of interactions between the clock and diurnal variation in the environment. Studies of stem elongation in diurnal conditions have revealed complex growth patterns, but no mechanism has been described(8-10). Here we show that the growth phase of Arabidopsis seedlings in diurnal light conditions is shifted 8-12 h relative to plants in continuous light, and we describe a mechanism underlying this environmental response. We find that the clock regulates transcript levels of two basic helix-loop-helix genes, phytochrome-interacting factor 4 (PIF4) and PIF5, whereas light regulates their protein abundance. These genes function as positive growth regulators; the coincidence of high transcript levels (by the clock) and protein accumulation (in the dark) allows them to promote plant growth at the end of the night. Thus, these two genes integrate clock and light signalling, and their coordinated regulation explains the observed diurnal growth rhythms. This interaction may serve as a paradigm for understanding how endogenous and environmental signals cooperate to control other processes.	Univ Calif Davis, Plant Biol Sect, Coll Biol Sci, Davis, CA 95616 USA; Univ Lausanne, Ctr Integrative Genom, CH-1015 Lausanne, Switzerland	University of California System; University of California Davis; University of Lausanne	Maloof, JN (corresponding author), Univ Calif Davis, Plant Biol Sect, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	jnmaloof@ucdavis.edu	Fankhauser, Christian/ABE-8757-2021; Covington, Michael/G-9208-2014; Duek, Paula/AAV-2308-2020; Fankhauser, Christian/C-4291-2018	Fankhauser, Christian/0000-0003-4719-5901; Covington, Michael/0000-0002-0555-6409; Fankhauser, Christian/0000-0003-4719-5901; Duek Roggli, Paula/0000-0002-0819-0473; Maloof, Julin/0000-0002-9623-2599; Harmer, Stacey/0000-0001-6813-6682	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069418] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069418] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BERTRAM L, 1994, SCI HORTIC-AMSTERDAM, V58, P139, DOI 10.1016/0304-4238(94)90134-1; Bertram L, 1997, PHOTOCHEM PHOTOBIOL, V66, P396, DOI 10.1111/j.1751-1097.1997.tb03164.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; DUNLAP JC, 2005, CHRONOBIOLOGY; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; IBRAHIM C A, 1981, Plant Physiology (Rockville), V67, P113; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; LECHARNY A, 1984, PHYSIOL PLANTARUM, V60, P437, DOI 10.1111/j.1399-3054.1984.tb06089.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; R Development Core Team, 2005, R LANG ENV STAT COMP; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Thain SC, 2004, PLANT PHYSIOL, V136, P3751, DOI 10.1104/pp.104.042523; Tsuda M, 2000, J EXP BOT, V51, P823, DOI 10.1093/jexbot/51.345.823; TUTTY JR, 1994, J AM SOC HORTIC SCI, V119, P138, DOI 10.21273/JASHS.119.2.138; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078	41	498	520	0	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					358	U11		10.1038/nature05946	http://dx.doi.org/10.1038/nature05946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17589502				2022-12-24	WOS:000248118300059
J	Calmy, A; Hirschel, B; Cooper, DA; Carr, A				Calmy, Alexandra; Hirschel, Bernard; Cooper, David A.; Carr, Andrew			Clinical update: adverse effects of antiretroviral therapy	LANCET			English	Article							HIV-INFECTED PATIENTS; TENOFOVIR DF; ADULTS; ZIDOVUDINE; EFAVIRENZ; ABACAVIR; DISEASE; COHORT; TRIAL		St Vincents Hosp, Sydney, NSW 2010, Australia; Univ Geneva, Hop Cantonal, Serv Malad Infect, CH-1211 Geneva, Switzerland; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of Geneva; University of New South Wales Sydney; Kirby Institute	Calmy, A (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.	acalmy@gmail.com						Brar I, 2007, JAIDS-J ACQ IMM DEF, V45, P66, DOI 10.1097/QAI.0b013e318031d7e3; *DHSS, 2006, GUID US ANT AG HIV 1; Fitch KV, 2006, AIDS, V20, P1843, DOI 10.1097/01.aids.0000244203.95758.db; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Law M, 2006, ANTIVIR THER, V11, P179; Mallet V, 2007, AIDS, V21, P187, DOI 10.1097/QAD.0b013e3280119e47; Mallon PWG, 2006, AIDS, V20, P1003, DOI 10.1097/01.aids.0000222072.37749.5a; MOCROFT A, 2006, 16 INT AIDS C; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Ssali F, 2006, ANTIVIR THER, V11, P741; Stein JH, 2007, NEW ENGL J MED, V356, P1773, DOI 10.1056/NEJMe078037; SUTINEN J, 2005, 7 INT WORKSH ADV EV, P7	16	57	58	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					12	14		10.1016/S0140-6736(07)61027-7	http://dx.doi.org/10.1016/S0140-6736(07)61027-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187QE	17617255				2022-12-24	WOS:000247862300009
J	Furuhashi, M; Tuncman, G; Gorgun, CZ; Makowski, L; Atsumi, G; Vaillancourt, E; Kono, K; Babaev, VR; Fazio, S; Linton, MF; Sulsky, R; Robl, JA; Parker, RA; Hotamisligil, GS				Furuhashi, Masato; Tuncman, Guerol; Goerguen, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Sulsky, Richard; Robl, Jeffrey A.; Parker, Rex A.; Hotamisligil, Goekhan S.			Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2	NATURE			English	Article							HUMAN THP-1 MACROPHAGES; FOAM CELL-FORMATION; INSULIN-RESISTANCE; METABOLIC-RESPONSES; MURINE MACROPHAGES; DEFICIENT MICE; EXPRESSION; OBESITY; GENE; ACTIVATION	Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis. Here we demonstrate that an orally active small-molecule inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models. In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chemical intervention and its mechanisms of action on metabolic and inflammatory pathways. Our findings demonstrate that targeting aP2 with small-molecule inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; Bristol-Myers Squibb	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Eckhardt, Erik/G-1567-2010; Vaillancourt, Eric/HGD-0666-2022	Furuhashi, Masato/0000-0002-0145-3541; Vaillancourt, Eric/0000-0002-1810-126X; Makowski, Liza/0000-0002-5337-8037	NHLBI NIH HHS [F32 HL075970] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL075970] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fu YC, 2000, J LIPID RES, V41, P2017; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MELKI SA, 1993, J LIPID RES, V34, P1527; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; SULSKY R, IN PRESS BIOORG MED; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388	28	528	570	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					959	U2		10.1038/nature05844	http://dx.doi.org/10.1038/nature05844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554340	Green Accepted			2022-12-24	WOS:000247373100038
J	Wohrl, S; Geusau, A				Woehrl, Stefan; Geusau, Alexandra			Clinical update: syphilis in adults	LANCET			English	Article							NEUROSYPHILIS; EPIDEMIC; HIV; TESTS		Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria	Medical University of Vienna	Wohrl, S (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria.	stefan.woehrl@meduniwien.ac.at	Wöhrl, Stefan/B-6954-2013; Geusau, Alexandra/AAL-5272-2020	Wöhrl, Stefan/0000-0002-6324-0007; Geusau, Alexandra/0000-0003-0347-065X				Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Augenbraun MH, 2002, CLIN INFECT DIS, V35, pS187, DOI 10.1086/342106; Aynalem G, 2006, SEX TRANSM INFECT, V82, P439, DOI 10.1136/sti.2006.020412; *BRIT ASS SEX HLTH, 2006, BASHH CLIN EFF GUID; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Flood JM, 1998, J INFECT DIS, V177, P931, DOI 10.1086/515245; Geusau A, 2005, INT J STD AIDS, V16, P722, DOI 10.1258/095646205774763207; Goh BT, 2001, INT J STD AIDS, V12, P14, DOI 10.1258/0956462011924065; JOHNS DR, 1987, NEW ENGL J MED, V316, P1569, DOI 10.1056/NEJM198706183162503; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Romano A, 2004, ANN INTERN MED, V141, P16, DOI 10.7326/0003-4819-141-1-200407060-00010; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Wohrl S, 2006, ACTA DERM-VENEREOL, V86, P335, DOI 10.2340/00015555-0092	19	20	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1912	1914		10.1016/S0140-6736(07)60895-2	http://dx.doi.org/10.1016/S0140-6736(07)60895-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177IQ	17560432				2022-12-24	WOS:000247147200009
J	Parmentier, E; Colleye, O; Fine, ML; Frederich, B; Vandewalle, P; Herrel, A				Parmentier, Eric; Colleye, Orphal; Fine, Michael L.; Frederich, Bruno; Vandewalle, Pierre; Herrel, Anthony			Sound production in the clownfish Amphiprion clarkii	SCIENCE			English	Article									Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, B-4000 Liege, Belgium; Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; Univ Antwerp, Dept Biol, Lab Funct Morphol, B-2610 Antwerp, Belgium	University of Liege; Virginia Commonwealth University; University of Antwerp	Parmentier, E (corresponding author), Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, Batiment B6, B-4000 Liege, Belgium.	E.Parmentier@ulg.ac.be	Herrel, Anthony/C-3712-2013; Fine, Michael/I-2656-2019; Parmentier, Eric/P-9733-2018	Herrel, Anthony/0000-0003-0991-4434; Fine, Michael/0000-0001-9665-1462; Parmentier, Eric/0000-0002-0391-7530; Frederich, Bruno/0000-0003-3438-0243				Ladich Friedrich, 2006, P3; Mann DA, 1997, J ACOUST SOC AM, V101, P3783, DOI 10.1121/1.418425; Osse J.W.M., 1969, NETH J ZOOL, V19, P290; Parmentier E, 2005, P ROY SOC B-BIOL SCI, V272, P1697, DOI 10.1098/rspb.2005.3146; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Tavolga W.N., 1971, FISH PHYSIOL BIOCHEM, V5, P135; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919; VERWEY J., 1930, TREUBIA, V12, P305	8	45	45	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1006	1006		10.1126/science.1139753	http://dx.doi.org/10.1126/science.1139753			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510359	Green Submitted			2022-12-24	WOS:000246554000040
J	Fath, S; Mancias, JD; Bi, XP; Goldberg, J				Fath, Stephan; Mancias, Joseph D.; Bi, Xiping; Goldberg, Jonathan			Structure and organization of coat proteins in the COPII cage	CELL			English	Article							MEMBRANE DEFORMATION; VESICLE FORMATION; CLATHRIN COAT; HYDROLYSIS; TRANSPORT; SOFTWARE; BINDING	COPII-coated vesicles export newly synthesized proteins from the endoplasmic reticulum. The COPII coat consists of the Sec23/24-Sar1 complex that selects cargo and the Sec13/31 assembly unit that can polymerize into an octahedral cage and deform the membrane into a bud. Crystallographic analysis of the assembly unit reveals a 28 nm long rod comprising a central alpha-solenoid dimer capped by two beta-propeller domains at each end. We construct a molecular model of the COPII cage by fitting Sec13/31 crystal structures into a recently determined electron microscopy density map. The vertex geometry involves four copies of the Sec31 beta-propeller that converge through their axial ends; there is no interdigitation of assembly units of the kind seen in clathrin cages. We also propose that the assembly unit has a central hinge-an arrangement of interlocked alpha-solenoids-about which it can bend to adapt to cages of variable curvature.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; CROWTHER RA, 1976, J MOL BIOL, V103, P785, DOI 10.1016/0022-2836(76)90209-6; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shugrue CA, 1999, J CELL SCI, V112, P4547; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708	39	210	219	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1325	1336		10.1016/j.cell.2007.05.036	http://dx.doi.org/10.1016/j.cell.2007.05.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604721	Bronze			2022-12-24	WOS:000247911400018
J	Kaiser, SM; Malik, HS; Emerman, M				Kaiser, Shari M.; Malik, Harmit S.; Emerman, Michael			Restriction of an extinct retrovirus by the human TRIM5 alpha antiviral protein	SCIENCE			English	Article							OLD-WORLD; PRIMATE TRIM5-ALPHA; ADAPTIVE EVOLUTION; HIV-1 INFECTION; DOMAIN; SELECTION; VARIANTS; VIRUSES; CAPSIDS	Primate genomes contain a large number of endogenous retroviruses and encode evolutionarily dynamic proteins that provide intrinsic immunity to retroviral infections. We report here the resurrection of the core protein of a 4-million-year-old endogenous virus from the chimpanzee genome and show that the human variant of the intrinsic immune protein TRIM5 alpha can actively prevent infection by this virus. However, we suggest that selective changes that have occurred in the human lineage during the acquisition of resistance to this virus, and perhaps similar viruses, may have left our species more susceptible to infection by human immunodeficiency virus type 1 (HIV-1).	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Emerman, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	memerman@fhcrc.org	Malik, Harmit S/E-8519-2012; Liu, FL/D-1795-2009; Malik, Harmit S/I-5591-2019	Malik, Harmit S/0000-0001-6005-0016				Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Lee SK, 2005, J VIROL, V79, P4159, DOI 10.1128/JVI.79.7.4159-4169.2005; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Liu HF, 2005, GENE, V362, P109, DOI 10.1016/j.gene.2005.06.045; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	22	106	107	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1756	1758		10.1126/science.1140579	http://dx.doi.org/10.1126/science.1140579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588933				2022-12-24	WOS:000247400500050
J	Li, XH; Monks, B; Ge, QY; Birnbaum, MJ				Li, Xinghai; Monks, Bobby; Ge, Qingyuan; Birnbaum, Morris J.			Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1 alpha transcription coactivator	NATURE			English	Article							FATTY LIVER-DISEASE; PROTEIN-KINASE-B; CARDIOVASCULAR-DISEASE; RECEPTOR-ALPHA; INSULIN; GLUCONEOGENESIS; ACTIVATION; GLUCOSE; PGC-1; EXPRESSION	Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism(1-3). In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition(4,5). The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus(6,7). Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1 alpha (PGC-1 alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1 alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.	Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA; Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	University of Pennsylvania; Howard Hughes Medical Institute	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu		Birnbaum, Morris/0000-0001-9972-8680				Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kanaya E, 2004, BIOCHEM J, V382, P913, DOI 10.1042/BJ20040432; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	356	367	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1012	U8		10.1038/nature05861	http://dx.doi.org/10.1038/nature05861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554339				2022-12-24	WOS:000247373100049
J	Lachmann, HJ; Goodman, HJB; Gilbertson, JA; Gallimore, JR; Sabin, CA; Gillmore, JD; Hawkins, PN				Lachmann, Helen J.; Goodman, Hugh J. B.; Gilbertson, Janet A.; Gallimore, J. Ruth; Sabin, Caroline A.; Gillmore, Julian D.; Hawkins, Philip N.			Natural history and outcome in systemic AA amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY AMYLOIDOSIS; SERUM; AL; PROTEIN; SCINTIGRAPHY; REGRESSION; BINDING; DISEASE	BACKGROUND: Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes systemic AA amyloidosis, a serious complication of many chronic inflammatory disorders. Little is known about the natural history of AA amyloidosis or its response to treatment. METHODS: We evaluated clinical features, organ function, and survival among 374 patients with AA amyloidosis who were followed for a median of 86 months. The SAA concentration was measured serially, and the amyloid burden was estimated with the use of whole-body serum amyloid P component scintigraphy. Therapy for inflammatory diseases was administered to suppress the production of SAA. RESULTS: Median survival after diagnosis was 133 months; renal dysfunction was the predominant disease manifestation. Mortality, amyloid burden, and renal prognosis all significantly correlated with the SAA concentration during follow-up. The risk of death was 17.7 times as high among patients with SAA concentrations in the highest eighth, or octile, (greater/equal 155 mg per liter) as among those with concentrations in the lowest octile (< 4 mg per liter); and the risk of death was four times as high in the next-to-lowest octile (4 to 9 mg per liter). The median SAA concentration during follow-up was 6 mg per liter in patients in whom renal function improved and 28 mg per liter in those in whom it deteriorated (P < 0.001). Amyloid deposits regressed in 60% of patients who had a median SAA concentration of less than 10 mg per liter, and survival among these patients was superior to survival among those in whom amyloid deposits did not regress (P=0.04). CONCLUSIONS: The effects of renal dysfunction dominate the course of AA amyloidosis, which is associated with a relatively favorable outcome in patients with SAA concentrations that remain in the low-normal range (< 4 mg per liter).	UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England; UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, Dept Med, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Lachmann, HJ (corresponding author), UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England.		Hawkins, Philip N/C-5573-2008; Sabin, Caroline/C-2464-2008	Sabin, Caroline/0000-0001-5173-2760; Lachmann, Helen/0000-0001-8378-2498	Medical Research Council [G7900510] Funding Source: Medline; MRC [G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; HAZENBERG BPC, 1991, AMYLOID AND AMYLOIDOSIS 1990, P809; KISILEVSKY R, 1995, AMYLOID, V2, P128, DOI 10.3109/13506129509031899; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rajkumar, 2006, MAYO CLIN PROC, V81, P1509; Rajkumar SV, 2006, MAYO CLIN PROC, V81, P693, DOI 10.4065/81.5.693; Rydh A, 1998, EUR J NUCL MED, V25, P709; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Shimojima Y, 2006, AMYLOID, V13, P184, DOI 10.1080/13506120600876930; Singh G, 2007, J RHEUMATOL, V34, P371; TANAKA K, 1995, INTERNAL MED, V34, P122, DOI 10.2169/internalmedicine.34.122; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; WERDELIN O, 1966, ACTA PATHOL MIC SC, V68, P1	26	588	634	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2361	2371		10.1056/NEJMoa070265	http://dx.doi.org/10.1056/NEJMoa070265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554117	Green Published			2022-12-24	WOS:000247029300005
J	Millard, SS; Flanagan, JJ; Pappu, KS; Wu, W; Zipursky, SL				Millard, S. Sean; Flanagan, John J.; Pappu, Kartik S.; Wu, Wei; Zipursky, S. Lawrence			Dscam2 mediates axonal tiling in the Drosophila visual system	NATURE			English	Article							REPRESSIBLE CELL MARKER; SENSORY NEURONS; MOLECULAR DIVERSITY; MOSAIC ANALYSIS; NERVOUS-SYSTEM; MORPHOGENESIS; SPECIFICITY; EXPRESSION	Sensory processing centres in both the vertebrate and the invertebrate brain are often organized into reiterated columns, thus facilitating an internal topographic representation of the external world. Cells within each column are arranged in a stereotyped fashion and form precise patterns of synaptic connections within discrete layers. These connections are largely confined to a single column, thereby preserving the spatial information from the periphery. Other neurons integrate this information by connecting to multiple columns. Restricting axons to columns is conceptually similar to tiling. Axons and dendrites of neighbouring neurons of the same class use tiling to form complete, yet non-overlapping, receptive fields(1-3). It is thought that, at the molecular level, cell-surface proteins mediate tiling through contact-dependent repulsive interactions(1,2,4,5), but proteins serving this function have not yet been identified. Here we show that the immunoglobulin superfamily member Dscam2 restricts the connections formed by L1 lamina neurons to columns in the Drosophila visual system. Our data support a model in which Dscam2 homophilic interactions mediate repulsion between neurites of L1 cells in neighbouring columns. We propose that Dscam2 is a tiling receptor for L1 neurons.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Millard, Sean/A-8522-2013	Millard, Sean/0000-0001-8573-4625; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barlow GM, 2002, BIOCHEM BIOPH RES CO, V299, P1, DOI 10.1016/S0006-291X(02)02548-2; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meinertzhagen I.A., 1993, DEV DROSOPHILA MELAN; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	30	108	108	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					720	U14		10.1038/nature05855	http://dx.doi.org/10.1038/nature05855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554308	Green Accepted			2022-12-24	WOS:000247030700045
J	Stuart, DR; Fagnou, K				Stuart, David R.; Fagnou, Keith			The catalytic cross-coupling of unactivated arenes	SCIENCE			English	Article							ARYL BOND FORMATION; DIRECT ARYLATION; DERIVATIVES; BENZENE; INDOLES	The industrially important coupling of aromatic compounds has generally required differential prefunctionalization of the arene coupling partners with a halide and an electropositive group. Here we report that palladium, in conjunction with a copper oxidant, can catalyze the cross-coupling of N-acetylindoles and benzenes in high yield and high regioselectivity across a range of indoles without recourse to activating groups. These reactions are completely selective for arene cross-coupling, with no products arising from indole or benzene homo-coupling detected by spectroscopic analysis. This efficient reactivity should be useful in the design of other oxidative arene cross-couplings as well.	Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Fagnou, K (corresponding author), Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.	keith.fagnou@uottawa.ca						Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Diederich F., 1998, METAL CATALYZED CROS; Ding KL, 1997, CHEM COMMUN, P693, DOI 10.1039/a608256d; Ferreira EM, 2003, J AM CHEM SOC, V125, P9578, DOI 10.1021/ja035054y; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Goossen LJ, 2006, SCIENCE, V313, P662, DOI 10.1126/science.1128684; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Jia CG, 2000, J AM CHEM SOC, V122, P7252, DOI 10.1021/ja0005845; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Lafrance M, 2006, J AM CHEM SOC, V128, P8754, DOI 10.1021/ja062509L; Lane BS, 2005, J AM CHEM SOC, V127, P8050, DOI 10.1021/ja043273t; Li RS, 2006, ORGANOMETALLICS, V25, P5973, DOI 10.1021/om060889d; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Mukhopadhyay S, 2001, ADV SYNTH CATAL, V343, P455, DOI 10.1002/1615-4169(200107)343:5<455::AID-ADSC455>3.3.CO;2-F; Park CH, 2004, ORG LETT, V6, P1159, DOI 10.1021/ol049866q; SMRCINA M, 1992, J ORG CHEM, V57, P1917, DOI 10.1021/jo00032a055; Takahashi M, 2006, J AM CHEM SOC, V128, P10930, DOI 10.1021/ja060749v	18	898	900	6	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1172	1175		10.1126/science.1141956	http://dx.doi.org/10.1126/science.1141956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	171GQ	17525334				2022-12-24	WOS:000246724300037
J	Smith, KL; Robison, BH; Helly, JJ; Kaufmann, RS; Ruhl, HA; Shaw, TJ; Twining, BS; Vernet, M				Smith, Kenneth L., Jr.; Robison, Bruce H.; Helly, John J.; Kaufmann, Ronald S.; Ruhl, Henry A.; Shaw, Timothy J.; Twining, Benjamin S.; Vernet, Maria			Free-drifting icebergs: Hot spots of chemical and biological enrichment in the Weddell Sea	SCIENCE			English	Article							SOUTHERN-OCEAN; ANTARCTIC PENINSULA; MARINE MAMMALS; CLIMATE-CHANGE; IRON; ICE; PHYTOPLANKTON; DISSOLUTION; OXIDE	The proliferation of icebergs from Antarctica over the past decade has raised questions about their potential impact on the surrounding pelagic ecosystem. Two free-drifting icebergs, 0.1 and 30.8 square kilometers in aerial surface area, and the surrounding waters were sampled in the northwest Weddell Sea during austral spring 2005. There was substantial enrichment of terrigenous material, and there were high concentrations of chlorophyll, krill, and seabirds surrounding each iceberg, extending out to a radial distance of similar to 3.7 kilometers. Extrapolating these results to all icebergs in the same size range, with the use of iceberg population estimates from satellite surveys, indicates that they similarly affect 39% of the surface ocean in this region. These results suggest that free-drifting icebergs can substantially affect the pelagic ecosystem of the Southern Ocean and can serve as areas of enhanced production and sequestration of organic carbon to the deep sea.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; Univ San Diego, Marine Sci & Environm Studies Dept, San Diego, CA 92110 USA; Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; Univ Calif San Diego, Integrat Oceanog Div, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Monterey Bay Aquarium Research Institute; University of California System; University of California San Diego; University of San Diego; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Smith, KL (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	ksmith@mbari.org		Twining, Benjamin/0000-0002-1365-9192; Shaw, Timothy/0000-0002-0032-457X				Arrigo K.R., 2002, GEOPHYS RES LETT, V29; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; de Baar H.J.W., 2001, BIOGEO CHEM IRON SEA, P123; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; FINDEN DAS, 1984, NATURE, V309, P783, DOI 10.1038/309783a0; JOIRIS CR, 1991, POLAR BIOL, V11, P415; Kaufmann RS, 1995, MAR BIOL, V124, P387, DOI 10.1007/BF00363912; Kraemer SM, 2005, REV MINERAL GEOCHEM, V59, P53, DOI 10.2138/rmg.2005.59.4; KRISTENSEN M, 1983, PROG PHYS GEOG, V7, P313, DOI 10.1177/030913338300700301; Loscher BM, 1997, DEEP-SEA RES PT II, V44, P143, DOI 10.1016/S0967-0645(96)00101-4; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Orheim O, 1988, ANN GLACIOL, V11, P205; Pakhomov EA, 2002, DEEP-SEA RES PT II, V49, P1881, DOI 10.1016/S0967-0645(02)00017-6; RIBIC CA, 1991, ANTARCT SCI, V3, P181, DOI 10.1017/S0954102091000214; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; STONE G, 2001, NAT GEOG MAG     DEC, P36; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; WAITE TD, 1984, J COLLOID INTERF SCI, V102, P121, DOI 10.1016/0021-9797(84)90206-6; WELLS ML, 1983, J MAR RES, V41, P731, DOI 10.1357/002224083788520478; Williams RN, 1999, INT J REMOTE SENS, V20, P3183, DOI 10.1080/014311699211697; [No title captured]	31	185	191	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					478	482		10.1126/science.1142834	http://dx.doi.org/10.1126/science.1142834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17588896				2022-12-24	WOS:000248339800035
J	Wood, E; Kerr, T; Montaner, JSG				Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.			HIV treatment, injection drug use, and illicit drug policies	LANCET			English	Editorial Material									St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Montaner, JSG (corresponding author), St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					Aceijas C, 2006, ADDICTION, V101, P1246, DOI 10.1111/j.1360-0443.2006.01509.x; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; Des Jarlais DC, 1999, PUBLIC HEALTH, V113, P182; GRUND JPC, 1992, J PSYCHOACTIVE DRUGS, V24, P41, DOI 10.1080/02791072.1992.10471617; Kerr T, 2004, LANCET, V364, P1918, DOI 10.1016/S0140-6736(04)17490-4; Mattick RP, 2003, COCHRANE DB SYST REV, V2; Small Dan, 2007, Harm Reduct J, V4, P13, DOI 10.1186/1477-7517-4-13; Swan N, 1999, JAMA-J AM MED ASSOC, V281, P1782, DOI 10.1001/jama.281.19.1782; UNAIDS, 2006, REP GLOB AIDS EP; Wainberg MA, 2006, CAN MED ASSOC J, V175, P1395, DOI 10.1503/cmaj.061404; Wood E, 2005, LANCET, V366, P1834, DOI 10.1016/S0140-6736(05)67737-9; 2005, LANCET, V365, P629	12	16	16	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					8	10		10.1016/S0140-6736(07)61025-3	http://dx.doi.org/10.1016/S0140-6736(07)61025-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187QE	17617253				2022-12-24	WOS:000247862300007
J	Lewis, MH; Gohagan, JK; Merenstein, DJ				Huckaby Lewis, Michelle; Gohagan, John K.; Merenstein, Daniel J.			The locality rule and the physician's dilemma - Local medical practices vs the national standard of care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Berman Inst Bioeth, Greenwall Fellowship Program Bioeth & Hlth Policy, Baltimore, MD 21201 USA; Johns Hopkins Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Georgetown Univ, Dept Family Med, Washington, DC USA; NCI, Div Canc Prevent, US Natl Inst Hlth, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewis, MH (corresponding author), Johns Hopkins Berman Inst Bioeth, Greenwall Fellowship Program Bioeth & Hlth Policy, 100 N Charles St,Suite 740, Baltimore, MD 21201 USA.	michellelewismd@yahoo.com						CRAMM T, 2002, WAKE FOREST LAW REV, V37, P699; Eddy DM, 2001, J HEALTH POLIT POLIC, V26, P387, DOI 10.1215/03616878-26-2-387; Garner B. A., 2004, BLACKS LAW DICT, V8th; GROSS SR, 1991, WISC LAW REV, P1113; Merenstein D, 2004, JAMA-J AM MED ASSOC, V291, P15, DOI 10.1001/jama.291.1.15; Peters Jr. Philip G., 2000, WASHINGTON LEE LAW R, V57, P163; Peters PG, 2002, IOWA LAW REV, V87, P909; SWARTZ LC, 2005, 3698 PBI; WALTZ JR, 1969, DEPAUL L REV, V18, P408; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0	10	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2633	2637		10.1001/jama.297.23.2633	http://dx.doi.org/10.1001/jama.297.23.2633			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579232				2022-12-24	WOS:000247352600027
J	Weitzel, JN; Lagos, VI; Cullinane, CA; Gambol, PJ; Culver, JO; Blazer, KR; Palomares, MR; Lowstuter, KJ; MacDonald, DJ				Weitzel, Jeffrey N.; Lagos, Veronica I.; Cullinane, Carey A.; Gambol, Patricia J.; Culver, Julie O.; Blazer, Kathleen R.; Palomares, Melanie R.; Lowstuter, Katrina J.; MacDonald, Deborah J.			Limited family structure and BRCA gene mutation status in single cases of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTRALATERAL PROPHYLACTIC MASTECTOMY; ASHKENAZI JEWISH CARRIERS; OF-CLINICAL-ONCOLOGY; OVARIAN-CANCER; RISK-ASSESSMENT; SCORING SYSTEM; SUSCEPTIBILITY; WOMEN; STATEMENT; HISTORY	Context An autosomal dominant pattern of hereditary breast cancer may be masked by small family size or transmission through males given sex-limited expression. Objective To determine if BRCA gene mutations are more prevalent among single cases of early onset breast cancer in families with limited vs adequate family structure than would be predicted by currently available probability models. Design, Setting, and Participants A total of 1543 women seen at US high-risk clinics for genetic cancer risk assessment and BRCA gene testing were enrolled in a prospective registry study between April 1997 and February 2007. Three hundred six of these women had breast cancer before age 50 years and no first- or second-degree relatives with breast or ovarian cancers. Main Outcome Measure The main outcome measure was whether family structure, assessed from multigenerational pedigrees, predicts BRCA gene mutation status. Limited family structure was defined as fewer than 2 first- or second-degree female relatives surviving beyond age 45 years in either lineage. Family structure effect and mutation probability by the Couch, Myriad, and BRCAPRO models were assessed with stepwise multiple logistic regression. Model sensitivity and specificity were determined and receiver operating characteristic curves were generated. Results Family structure was limited in 153 cases (50%). BRCA gene mutations were detected in 13.7% of participants with limited vs 5.2% with adequate family structure. Family structure was a significant predictor of mutation status ( odds ratio, 2.8; 95% confidence interval, 1.19-6.73; P=.02). Although none of the models performed well, receiver operating characteristic analysis indicated that modification of BRCAPRO output by a corrective probability index accounting for family structure was the most accurate BRCA gene mutation status predictor ( area under the curve, 0.72; 95% confidence interval, 0.63- 0.81; P <. 001) for single cases of breast cancer. Conclusions Family structure can affect the accuracy of mutation probability models. Genetic testing guidelines may need to be more inclusive for single cases of breast cancer when the family structure is limited and probability models need to be recreated using limited family history as an actual variable.	City Hope Natl Med Ctr, Dept Clin Canc Genet, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Dept Gen Oncol Surg, Duarte, CA 91010 USA	City of Hope; City of Hope	Weitzel, JN (corresponding author), City Hope Natl Med Ctr, Dept Clin Canc Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jweitzel@coh.org	Blazer, Kathleen/ABC-8530-2021		NCI NIH HHS [R25 CA85771, R25 CA085771] Funding Source: Medline; NCRR NIH HHS [M01 RR00043, M01 RR000043] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA085771] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM COLL MED GEN, 1999, GEN SUSC BREAST OV C, P1; *AM SOC HUM GEN, 1994, AM J HUM GENET, V55, P22; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1365; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Barcenas CH, 2006, J CLIN ONCOL, V24, P354, DOI 10.1200/JCO.2005.02.2368; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Culver JO, 2005, ANN INTERN MED; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Evans DGR, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031989; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herrinton LJ, 2005, J CLIN ONCOL, V23, P4275, DOI 10.1200/JCO.2005.10.080; James PA, 2006, J CLIN ONCOL, V24, P707, DOI 10.1200/JCO.2005.01.9737; KANDEL MJ, 2006, 42 ANN M AM SOC CLIN; KRIEGE M, 2003, AM SOC CLIN ONC 39 A; McDonnell SK, 2001, J CLIN ONCOL, V19, P3938, DOI 10.1200/JCO.2001.19.19.3938; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Metcalfe KA, 2005, GYNECOL ONCOL, V96, P222, DOI 10.1016/j.ygyno.2004.09.039; National Comprehensive Cancer Network, 2007, NCCN CLIN PRACT GUID; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Peralta EA, 2000, AM J SURG, V180, P439, DOI 10.1016/S0002-9610(00)00505-5; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Satagopan JM, 2002, CLIN CANCER RES, V8, P3776; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Schwartz MD, 2004, J CLIN ONCOL, V22, P1823, DOI 10.1200/JCO.2004.04.086; Shih HA, 2002, J CLIN ONCOL, V20, P994, DOI 10.1200/JCO.20.4.994; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; WAMER E, 2004, JAMA-J AM MED ASSOC, V292, P1317; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323; Weitzel JN, 1999, CANCER, V86, P2483, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2483::AID-CNCR5>3.3.CO;2-W; Weitzel JN, 2004, BREAST DIS YB Q, V14, P354; Yong MC, 2003, ONCOLOGY-BASEL, V64, P220, DOI 10.1159/000069309	40	139	141	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2587	2595		10.1001/jama.297.23.2587	http://dx.doi.org/10.1001/jama.297.23.2587			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579227	Bronze			2022-12-24	WOS:000247352600021
J	Spence, D				Spence, Des			Wanted: stress monkeys	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39237.429178.59	http://dx.doi.org/10.1136/bmj.39237.429178.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556483	Green Published			2022-12-24	WOS:000247277000042
J	Villa, L; Perez, G; Kjaer, S; Lehtinen, M; Paavonen, J; Munoz, N; Sigurdsson, K; Hernandez-Avila, M; Iversen, OE; Thoresen, S; Garcia, P; Majewski, S; Tay, EH; Bosch, FX; Dillner, J; Olsson, SE; Ault, K; Brown, D; Ferris, D; Giuliano, A; Koutsky, L; Kurman, R; Myers, E; Barr, E; Boslego, J; Bryan, J; Esser, M; Hesley, T; Lupinacci, L; Railkar, R; Sings, H; Taddeo, F; Thornton, A				Villa, L.; Perez, G.; Kjaer, S.; Lehtinen, M.; Paavonen, J.; Munoz, N.; Sigurdsson, K.; Hernandez-Avila, M.; Iversen, O. E.; Thoresen, S.; Garcia, P.; Majewski, S.; Tay, E. H.; Bosch, F. X.; Dillner, J.; Olsson, S. E.; Ault, K.; Brown, D.; Ferris, D.; Giuliano, A.; Koutsky, L.; Kurman, R.; Myers, E.; Barr, E.; Boslego, J.; Bryan, J.; Esser, M.; Hesley, T.; Lupinacci, L.; Railkar, R.; Sings, H.; Taddeo, F.; Thornton, A.		Future II Study Grp	Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials	LANCET			English	Article							QUADRIVALENT VACCINE; SUSTAINED EFFICACY; FOLLOW-UP; TYPE-18; ADOLESCENTS; LESIONS; WOMEN	Background Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS), are caused by oncogenic human papillomavirus (HPV). In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases. Methods 20 583 women aged 16-26 years were randomised to receive quadrivalent HPV6/11/16/18 vaccine (n=9087), its HPV16 vaccine component (n=1204), or placebo (n=10292). They underwent periodic Papanicolaou testing, with colposcopy or biopsy for detected abnormalities. The primary composite endpoint was the combined incidence of HPV16/18-related CIN2/3, AIS, or cervical cancer. These trials are registered at ClinicalTrials.gov, numbers NCT00365378, NCT00365716, NCT00092521, and NCT00092534. Findings Mean follow-up was 3.0 years (SD 0.66) after first dose. In women negative for HPV16 or HPV18 infection during the vaccination regimen (n=17129, per protocol), vaccine efficacy was 99% for the primary endpoint (95% Cl 93-100), meeting the statistical criterion for success. In an intention-to-treat analysis of all randomised women (including those who were HPV16/18 naive or HPV16/18-infected at day 1), efficacy was 44% (95% Cl 31-55); all but one case in vaccine recipients occurred in women infected with HPV16 or HPV18 before vaccination. In a second intention-to-treat analysis we noted an 18% reduction (95% CI 7-29) in the overall rate of CIN2/3 or AIS due to any HPV type. Interpretation Administration of HPV vaccine to HPV-naive women, and women who are already sexually active, could substantially reduce the incidence of HPV16/18-related cervical precancers and cervical cancer.	Emory Univ, Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30303 USA; Ludwig Inst Canc Res, Dept Virol, Sao Paulo, Brazil; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Danish Canc Soc Rigshosp, Inst Canc Epidemiol, Dept Virus Hormones & Canc, Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Oulu, Oulu, Finland; Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; Int Agcy Res Canc, F-69372 Lyon, France; Natl Canc Detent Clin, Reykjavik, Iceland; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; Univ Bergen, Inst Clin Med, Bergen, Norway; Canc Registry Norway, Montebello, Norway; Univ Peruana Cayetano Heredia, Epidemiol HIV & STD Unit, Lima, Peru; Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Dept Dermatol & Venereol, Warsaw, Poland; KK Womens & Childrens Hosp, Singapore, Singapore; IDIBELL, Inst Catala Oncol, Barcelona, Spain; Lund Univ, Dept Med Microbiol, S-22100 Lund, Sweden; Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Med Coll Georgia, Dept Family Med & Obstet & Gynecol, Augusta, GA 30912 USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; Merck Res Labs, West Point, PA USA	Emory University; Ludwig Institute for Cancer Research; Danish Cancer Society; Finland National Institute for Health & Welfare; University of Helsinki; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Universidad Peruana Cayetano Heredia; Medical University of Warsaw; KK Women's & Children's Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Lund University; Danderyds Hospital; Karolinska Institutet; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Georgia; Augusta University; University of Arizona; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Merck & Company	Ault, K (corresponding author), Emory Univ, Sch Med, Dept Obstet & Gynecol, 69 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.	kevin.ault@emory.edu	JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; VILLA, LUISA/AAH-4761-2019	JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; VILLA, LUISA/0000-0003-4074-2335; lehtinen, matti/0000-0002-9481-0535				Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Collins S, 2002, BJOG-INT J OBSTET GY, V109, P96, DOI 10.1111/j.1471-0528.2002.01053.x; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Ferlay J., 2002, GLOBOCAN 2002 CANC I; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Moscicki AB, 1996, OBSTET GYN CLIN N AM, V23, P675; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; PRATT D, 1 FDA; Sheets EE, 2002, CURR OPIN OBSTET GYN, V14, P53, DOI 10.1097/00001703-200202000-00009; STOELR MH, 2004, CERVICAL CANC ETIOLO, P3; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Zaino RJ, 2002, INT J GYNECOL PATHOL, V21, P314, DOI 10.1097/00004347-200210000-00002	25	432	449	2	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1861	1868		10.1016/S0140-6736(07)60852-6	http://dx.doi.org/10.1016/S0140-6736(07)60852-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544766				2022-12-24	WOS:000246911600029
J	Talarico, EF; Prather, AD				Talarico, Ernest F., Jr.; Prather, Andrew D.			Connecting the dots to make a difference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPEROSTOSIS-FRONTALIS-INTERNA					etalaric@iun.edu						Hershkovitz I, 1999, AM J PHYS ANTHROPOL, V109, P303, DOI 10.1002/(SICI)1096-8644(199907)109:3<303::AID-AJPA3>3.0.CO;2-I; MORGAGNI G, 1769, SED CAUS MORB SEATS; Ruhli FJ, 2004, HOMO, V55, P91, DOI 10.1016/j.jchb.2004.04.003; Sohmiya M, 2001, Nihon Ronen Igakkai Zasshi, V38, P218	4	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					381	382		10.1001/jama.298.4.381	http://dx.doi.org/10.1001/jama.298.4.381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652284				2022-12-24	WOS:000248269100001
J	Moglia, A; Menciassi, A; Dario, P; Cuschieri, A				Moglia, Andrea; Menciassi, Arianna; Dario, Paolo; Cuschieri, Alfted			Clinical update: endoscopy for small-bowel turnours	LANCET			English	Article							DOUBLE-BALLOON ENTEROSCOPY; WIRELESS CAPSULE ENDOSCOPY; INTRAOPERATIVE ENTEROSCOPY; TUMORS; LIMITATIONS; EXPERIENCE; DIAGNOSIS; YIELD		Scuola Super Sant Anna, I-56127 Pisa, Italy; Italian Inst Technol Network, Genoa, Italy	Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT	Moglia, A (corresponding author), Scuola Super Sant Anna, I-56127 Pisa, Italy.	andrea.moglia@crim.sssup.it	Moglia, Andrea/Y-5433-2018; Cuschieri, Alfred/A-7634-2013; Cuschieri, Alfred/O-4092-2019; Menciassi, Arianna/A-2664-2010	Moglia, Andrea/0000-0002-3365-580X; Cuschieri, Alfred/0000-0003-0764-5947; 				Bailey AA, 2006, AM J GASTROENTEROL, V101, P2237, DOI 10.1111/j.1572-0241.2006.00749.x; Chong AKH, 2006, GASTROINTEST ENDOSC, V64, P445, DOI 10.1016/j.gie.2006.04.007; Cobrin GM, 2006, CANCER-AM CANCER SOC, V107, P22, DOI 10.1002/cncr.21975; De Leusse A, 2007, GASTROENTEROLOGY, V132, P855, DOI 10.1053/j.gastro.2006.12.002; Flieger D, 2005, ENDOSCOPY, V37, P1174, DOI 10.1055/s-2005-921045; Hadithi M, 2006, AM J GASTROENTEROL, V101, P52, DOI 10.1111/j.1572-0241.2005.00346.x; Hartmann D, 2005, GASTROINTEST ENDOSC, V61, P826, DOI 10.1016/S0016-5107(05)00372-X; Hatzaras I, 2007, ARCH SURG-CHICAGO, V142, P229, DOI 10.1001/archsurg.142.3.229; HERBERT J, 2005, CANC PRINCIPLES PRAC, P1035; Hsu CM, 2007, DIGEST DIS SCI, V52, P162, DOI 10.1007/s10620-006-9554-x; Jakobs R, 2006, WORLD J GASTROENTERO, V12, P313, DOI 10.3748/wjg.v12.i2.313; Lepage C, 2006, AM J GASTROENTEROL, V101, P2826, DOI 10.1111/j.1572-0241.2006.00854.x; Matsumoto T, 2005, ENDOSCOPY, V37, P827, DOI 10.1055/s-2005-870207; May A, 2007, AM J GASTROENTEROL, V102, P527, DOI 10.1111/j.1572-0241.2007.01063.x; Mehdizadeh S, 2006, GASTROINTEST ENDOSC, V64, P740, DOI 10.1016/j.gie.2006.05.022; Moglia A, 2007, BIOMED MICRODEVICES, V9, P235, DOI 10.1007/s10544-006-9025-3; Rondonotti E, 2005, GASTROINTEST ENDOSC, V62, P712, DOI 10.1016/j.gie.2005.05.002; Suzuki T, 2007, DIGEST DIS SCI, V52, P1914, DOI 10.1007/s10620-007-9749-9; Triester SL, 2005, AM J GASTROENTEROL, V100, P2407, DOI 10.1111/j.1572-0241.2005.00274.x; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1016/S1542-3565(04)00453-7	20	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2007	370	9582					114	116		10.1016/S0140-6736(07)61066-6	http://dx.doi.org/10.1016/S0140-6736(07)61066-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190WP	17630023				2022-12-24	WOS:000248091600009
J	Sakamoto, N; Seto, Y; Itoh, S; Kuramoto, K; Fujino, K; Nagashima, K; Krot, AN; Yurimoto, H				Sakamoto, Naoya; Seto, Yusuke; Itoh, Shoichi; Kuramoto, Kiyoshi; Fujino, Kiyoshi; Nagashima, Kazuhide; Krot, Alexander N.; Yurimoto, Hisayoshi			Remnants of the early solar system water enriched in heavy oxygen isotopes	SCIENCE			English	Article							CARBONACEOUS CHONDRITES; NEBULA; METEORITES; MAGNETITE; RESERVOIR; EVOLUTION; ALLENDE; MATRIX; ORIGIN; GAS	Oxygen isotopic composition of our solar system is believed to have resulted from mixing of two isotopically distinct nebular reservoirs, O-16-rich and O-17,O-18-rich relative to Earth. The nature and composition of the O-17,O-18-rich reservoir are poorly constrained. We report an in situ discovery of a chemically and isotopically unique material distributed ubiquitously in fine-grained matrix of a primitive carbonaceous chondrite Acfer 094. This material formed by oxidation of Fe, Ni-metal and sulfides by water either in the solar nebula or on a planetesimal. Oxygen isotopic composition of this material indicates that the water was highly enriched in O-17 and O-18 (delta O-17,18(SMOW) = + 180 parts per thousand per mil), providing the first evidence for an extremely O-17,O-18-rich reservoir in the early solar system.	Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Hokkaido Univ, Isotope Imaging Lab, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; University of Hawaii System; University of Hawaii Manoa; Hokkaido University	Yurimoto, H (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	yuri@ep.sci.hokudai.ac.jp	Seto, Yusuke/D-5751-2015; Yurimoto, Hisayoshi/S-9938-2018	Seto, Yusuke/0000-0002-5423-2136; Yurimoto, Hisayoshi/0000-0003-0702-0533; Kuramoto, Kiyoshi/0000-0002-6757-8064; Nagashima, Kazuhide/0000-0002-9322-3187; Itoh, Shoichi/0000-0001-9431-0525				CHASE JMW, 1998, J PHYS CHEM REFERE 1, V9; CHASE JMW, 1998, J PHYS CHEM REFERE 2, V9; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Clayton RN, 2006, SCIENCE, V313, P1743, DOI 10.1126/science.1133137; Fuchs L. H., 1973, SMITHSON CONTRIB EAR, V10, P1, DOI DOI 10.5479/SI.00810274.10.1; Greshake A, 1997, GEOCHIM COSMOCHIM AC, V61, P437, DOI 10.1016/S0016-7037(96)00332-8; Hong Y, 1998, METEORIT PLANET SCI, V33, P1101, DOI 10.1111/j.1945-5100.1998.tb01715.x; Ireland TR, 2006, NATURE, V440, P776, DOI 10.1038/nature04611; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot A. N., 2000, Protostars and planets 4, P1019; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2005, ASTROPHYS J, V622, P1333, DOI 10.1086/428382; Kunihiro T, 2005, GEOCHIM COSMOCHIM AC, V69, P763, DOI 10.1016/j.gca.2004.07.024; Lauretta DS, 1996, ICARUS, V122, P288, DOI 10.1006/icar.1996.0126; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900; YOUNG ED, 2006, LUNAR PLANET SCI, V37; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153; Yurimoto H., 2007, PROTOSTARS PLANETS, P849; Yurimoto L, 2003, APPL SURF SCI, V203, P793, DOI 10.1016/S0169-4332(02)00825-5	30	204	206	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					231	233		10.1126/science.1142021	http://dx.doi.org/10.1126/science.1142021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569827	Green Submitted			2022-12-24	WOS:000247968600038
J	Imrie, J; Elford, J; Kippax, S; Hart, GJ				Imrie, John; Elford, Jonathan; Kippax, Susan; Hart, Graham J.			Biomedical HIV prevention - and social science	LANCET			English	Editorial Material							SEXUAL RISK BEHAVIOR; MEN		Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia; City Univ London, Inst Hlth Sci, London EC1V 0HB, England; UCL, Ctr Sexual Hlth & HIV Res, London, England	University of New South Wales Sydney; City University London; University of London; University College London	Imrie, J (corresponding author), Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia.	j.imrie@unsw.edu.au		Hart, Graham/0000-0001-9676-6577				Aral SO, 1998, LANCET, V351, P33; AYODO H, 2007, E AFRICAN STAND 0331; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANSA E, 2007, E AFRICAN STAND 0228; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; *GLOB CAMP MICR, CELL SULF TRIALS CLO; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; PETERSON L, 2007, PLOS CLIN TRIALS MAY; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; UNAIDS & WHO, 2007, WHO UNAIDS ANN REC E	12	31	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2007	370	9581					10	11		10.1016/S0140-6736(07)61026-5	http://dx.doi.org/10.1016/S0140-6736(07)61026-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187QE	17617254				2022-12-24	WOS:000247862300008
J	Kowalski, MP; Dubouix-Bourandy, A; Bajmoczi, M; Golan, DE; Zaidi, T; Coutinho-Sledge, YS; Gygi, MP; Gygi, SP; Wiemer, EAC; Pier, GB				Kowalski, Michael P.; Dubouix-Bourandy, Anne; Bajmoczi, Milan; Golan, David E.; Zaidi, Tanweer; Coutinho-Sledge, Yamara S.; Gygi, Melanie P.; Gygi, Steven P.; Wiemer, Erik A. C.; Pier, Gerald B.			Host resistance to lung infection mediated by major vault protein in epithelial cells	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA INFECTION; CYSTIC-FIBROSIS PATIENTS; DRUG-RESISTANCE; MUTANT CFTR; DEFENSE; DISEASE; LOCALIZATION; PHOSPHATASE; CLEARANCE	The airway epithelium plays an essential role in innate immunity to lung pathogens. Ribonucleoprotein particles primarily composed of major vault protein (MVP) are highly expressed in cells that encounter xenobiotics. However, a clear biologic function for MVP is not established. We report here that MVP is rapidly recruited to lipid rafts when human lung epithelial cells are infected with Pseudomonas aeruginosa, and maximal recruitment is dependent on bacterial binding to the cystic fibrosis transmembrane conductance regulator. MVP was also essential for optimal epithelial cell internalization and clearance of P. aeruginosa. These results suggest that MVP makes a substantial contribution to epithelial cell-mediated resistance to infection.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Inst Federatif Biol Purpan, Lab Bacteriol Hyg, Toulouse, France; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Erasmus MC, Josephine Nefkens Inst, Dept Med Oncol, NL-3015 GE Rotterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Erasmus MC	Pier, GB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	gpier@channing.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Wiemer, Erik/0000-0002-0673-7236	NHLBI NIH HHS [R01 HL058398, R37 HL032854, R01 HL 58398-08, R37 HL 32854-22] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058398, R37HL032854] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Cortes G, 2002, INFECT IMMUN, V70, P1075, DOI 10.1128/IAI.70.3.1075-1080.2002; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Herrmann C, 1999, J CELL BIOL, V144, P1163, DOI 10.1083/jcb.144.6.1163; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; Mossink MH, 2003, IMMUNOLOGY, V110, P58, DOI 10.1046/j.1365-2567.2003.01708.x; Mossink MH, 2002, CANCER RES, V62, P7298; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Pier GB, 1996, AM J RESP CRIT CARE, V154, pS175, DOI 10.1164/ajrccm/154.4_Pt_2.S175; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Reiniger N, 2005, INFECT IMMUN, V73, P6822, DOI 10.1128/IAI.73.10.6822-6830.2005; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; STGEME JW, 1992, J INFECT DIS, V165, pS117, DOI 10.1093/infdis/165-Supplement_1-S117; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xiang ZM, 2006, BIOCHEM BIOPH RES CO, V347, P288, DOI 10.1016/j.bbrc.2006.06.076; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	30	93	96	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					130	132		10.1126/science.1142311	http://dx.doi.org/10.1126/science.1142311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615361	Green Accepted			2022-12-24	WOS:000247776700069
J	Perkins, HS				Perkins, Henry S.			Controlling death: The false promise of advance directives	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; SELF-DETERMINATION ACT; DECISION-MAKING; HEALTH-CARE; PHYSICIAN ORDERS; END; COMPLETION; DISCUSSIONS; FACILITIES; ETHNICITY	Advance directives promise patients a say in their future care but actually have had little effect. Many experts blame problems with completion and implementation, but the advance directive concept itself may be fundamentally flawed. Advance directives simply presuppose more control over future care than is realistic. Medical crises cannot be predicted in detail, making most prior instructions difficult to adapt, irrelevant, or even misleading. Furthermore, many proxies either do not know patients' wishes or do not pursue those wishes effectively. Thus, unexpected problems arise often to defeat advance directives, as the case in this paper illustrates. Because advance directives offer only limited benefit, advance care planning should emphasize not the completion of directives but the emotional preparation of patients and families for future crises. The existentialist Albert Camus might suggest that physicians should warn patients and families that momentous, unforeseeable decisions lie ahead. Then, when the crisis hits, physicians should provide guidance; should help make decisions despite the inevitable uncertainties; should share responsibility for those decisions; and, above all, should courageously see patients and families through the fearsome experience of dying.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Gen Med, San Antonio, TX 78229 USA; Ecumenical Ctr Relig & Hlth, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio	Perkins, HS (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Gen Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.							Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; Balaban RB, 2000, J GEN INTERN MED, V15, P195, DOI 10.1046/j.1525-1497.2000.07228.x; BECK RN, 1969, PERSPECTIVES PHILOS, P437; Bloche MG, 2005, NEW ENGL J MED, V352, P2371, DOI 10.1056/NEJMp058104; Bradley EH, 2001, AM J MED, V111, P218, DOI 10.1016/S0002-9343(01)00798-7; BRETT AS, 1991, JAMA-J AM MED ASSOC, V266, P825, DOI 10.1001/jama.266.6.825; BURT RA, 2005, HASTINGS CENT REP; CALLAHAN D, 2005, HASTINGS CENT REP; CAMUS A, 1972, PLAGUE, P286; CUGLIARI AM, 1995, ARCH INTERN MED, V155, P1893, DOI 10.1001/archinte.155.17.1893; Dresser R, 2005, HASTINGS CENT REP, V35, P20, DOI 10.1353/hcr.2005.0061; DUBLER NN, 2005, HASTINGS CENT REP; Eleazer GP, 1996, J AM GERIATR SOC, V44, P938, DOI 10.1111/j.1532-5415.1996.tb01864.x; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; EMANUEL LL, 1989, JAMA-J AM MED ASSOC, V261, P3288, DOI 10.1001/jama.261.22.3288; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fischer GS, 1998, J GEN INTERN MED, V13, P447, DOI 10.1046/j.1525-1497.1998.00133.x; FOLEY KM, 2005, HASTING CENT REP; Galambos CM, 1998, HEALTH SOC WORK, V23, P275, DOI 10.1093/hsw/23.4.275; Gordon NP, 1999, ARCH INTERN MED, V159, P701, DOI 10.1001/archinte.159.7.701; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1996, ARCH INTERN MED, V156, P1018, DOI 10.1001/archinte.156.9.1018; Hickman SE, 2004, J AM GERIATR SOC, V52, P1424, DOI 10.1111/j.1532-5415.2004.52402.x; HICKMAN SE, 2005, HASTING CENT REP; Hoffmann DE, 1996, J LAW MED ETHICS, V24, P5, DOI 10.1111/j.1748-720X.1996.tb01829.x; JENNINGS B, 2005, HASTINGS CENT REP; Kahana B, 2004, J AM GERIATR SOC, V52, P1163, DOI 10.1111/j.1532-5415.2004.52316.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG B, 2006, BIOETHICS EXAMINER, V9, P4; KOENIG B, 2006, BIOETHICS EXAMINER, V9, P1; Lee MA, 2000, J AM GERIATR SOC, V48, P1219, DOI 10.1111/j.1532-5415.2000.tb02594.x; LEVINE C, 2005, NY TIMES        1206, pD5; Lo B, 2004, ARCH INTERN MED, V164, P1501, DOI 10.1001/archinte.164.14.1501; LYNN J, 1993, HASTINGS CENT REP, V23, P20, DOI 10.2307/3562275; MacIntyre A., 1967, ENCYCL PHILOS, V3, P147; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; Morrison RS, 1998, J CLIN ETHIC, V9, P118; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; MURRAY TH, 2005, HASTINGS CENT REP; Palker N B, 1995, Nurse Pract, V20, P7; PALKER NB, 1995, NURSE PRACTITIONER, V20, P17; PALKER NB, 1995, NURSE PRACTITIONER, V20, P13; Patel RV, 2004, J CRIT CARE, V19, P1, DOI 10.1016/j.jcrc.2004.02.002; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; PEARLMAN RA, 2002, YOUR LIFE YOUR CHOIC; Perkins HS, 2002, J GEN INTERN MED, V17, P48, DOI 10.1046/j.1525-1497.2002.01032.x; Perkins HS, 2004, AM J MED SCI, V327, P25, DOI 10.1097/00000441-200401000-00006; PERKINS HS, 2008, IN PRESS; REILLY BM, 1995, ARCH INTERN MED, V155, P2317, DOI 10.1001/archinte.155.21.2317; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; RUBIN SM, 1994, JAMA-J AM MED ASSOC, V271, P209, DOI 10.1001/jama.271.3.209; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Singer PA, 1997, J GEN INTERN MED, V12, P729, DOI 10.1046/j.1525-1497.1997.07157.x; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SINGER PA, 1992, ARCH INTERN MED, V152, P22, DOI 10.1001/archinte.152.1.22; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; SUGARMAN J, 1992, ARCH INTERN MED, V152, P343, DOI 10.1001/archinte.152.2.343; Sulmasy DP, 1996, J GEN INTERN MED, V11, P657, DOI 10.1007/BF02600156; Teno JM, 1998, J GEN INTERN MED, V13, P439, DOI 10.1046/j.1525-1497.1998.00132.x; Thorevska N, 2005, J CRIT CARE, V20, P26, DOI 10.1016/j.jcrc.2004.11.002; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1111/j.1525-1497.2001.00215.x; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Volicer L, 2002, J AM GERIATR SOC, V50, P761, DOI 10.1046/j.1532-5415.2002.50175.x; Wolfson J, 2005, HASTINGS CENT REP, V35, P16, DOI 10.2307/3528798; 1978, LIVING WILL; MED ORDERS LIFE SUST	69	252	254	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					51	57		10.7326/0003-4819-147-1-200707030-00008	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	186MN	17606961				2022-12-24	WOS:000247782900007
J	Mata-Haro, V; Cekic, C; Martin, M; Chilton, PM; Casella, CR; Mitchell, TC				Mata-Haro, Veronica; Cekic, Caglar; Martin, Michael; Chilton, Paula M.; Casella, Carolyn R.; Mitchell, Thomas C.			The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4	SCIENCE			English	Article							SIGNALING PATHWAY; TOLL; LIPOPOLYSACCHARIDE; EXPRESSION; ACTIVATION; ENDOTOXIN; RESPONSES; GENES; CELLS; BETA	The inflammatory toxicity of lipopolysaccharide (LPS), a component of bacterial cell walls, is driven by the adaptor proteins myeloid differentiation factor 88 (MyD88) and Toll-interleukin 1 receptor domain-containing adapter inducing interferon-beta (TRIF), which together mediate signaling by the endotoxin receptor Toll-like receptor 4 (TLR4). Monophosphoryl lipid A (MPLA) is a low-toxicity derivative of LPS with useful immunostimulatory properties, which is nearing regulatory approval for use as a human vaccine adjuvant. We report here that, in mice, the low toxicity of MPLA's adjuvant function is associated with a bias toward TRIF signaling, which we suggest is likely caused by the active suppression, rather than passive loss, of proinflammatory activity of this LPS derivative. This finding may have important implications for the development of future vaccine adjuvants.	Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; Univ Louisville, Oral Hlth & Systemat Dis Res Grp, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Inst Cellular Therapeut, 570 S Preston St, Louisville, KY 40202 USA.	tom.mitchell@louisville.edu	Mata-Haro, Veronica/K-2559-2015; Mitchell, Thomas C/B-4193-2013	Mata-Haro, Veronica/0000-0002-7394-4569; Chilton, Paula/0000-0002-8749-0975; Cekic, Caglar/0000-0001-8081-508X	NIAID NIH HHS [R01 AI071047, R01 AI051377, K02 AI059023, AI51377, AI059023] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071047, K02AI059023, R01AI051377] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; OKERNOTO K, 2006, J IMMUNOL, V176, P1203; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	26	615	662	4	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1628	1632		10.1126/science.1138963	http://dx.doi.org/10.1126/science.1138963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569868				2022-12-24	WOS:000247239900045
J	Moore, DD				Moore, David D.			Sister act	SCIENCE			English	Editorial Material							KLOTHO; HOMEOSTASIS; RECEPTORS; REGULATOR; SIGNAL; FGF23		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu						Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	16	37	45	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1436	1438		10.1126/science.1144837	http://dx.doi.org/10.1126/science.1144837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556573				2022-12-24	WOS:000247066400028
J	Taylor, PD; Day, T; Wild, G				Taylor, Peter D.; Day, Troy; Wild, Geoff			Evolution of cooperation in a finite homogeneous graph	NATURE			English	Article							KIN SELECTION; VISCOUS POPULATIONS; INCLUSIVE FITNESS; STABILITY; ALTRUISM; EVOLVE; MODEL	Recent theoretical studies of selection in finite structured populations(1-7) have worked with one of two measures of selective advantage of an allele: fixation probability and inclusive fitness. Each approach has its own analytical strengths, but given certain assumptions they provide equivalent results(1). In most instances the structure of the population can be specified by a network of nodes connected by edges ( that is, a graph)(8-10), and much of the work here has focused on a continuous-time model of evolution, first described by ref. 11. Working in this context, we provide an inclusive fitness analysis to derive a surprisingly simple analytical condition for the selective advantage of a cooperative allele in any graph for which the structure satisfies a general symmetry condition ('bi-transitivity'). Our results hold for a broad class of population structures, including most of those analysed previously, as well as some for which a direct calculation of fixation probability has appeared intractable. Notably, under some forms of population regulation, the ability of a cooperative allele to invade is seen to be independent of the nature of population structure ( and in particular of how game partnerships are specified) and is identical to that for an unstructured population. For other types of population regulation our results reveal that cooperation can invade if players choose partners along relatively 'high-weight' edges.	Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Taylor, PD (corresponding author), Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada.	peter.taylor@queensu.ca		Day, Troy/0000-0002-1052-6140				FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Lessard S, 2005, THEOR POPUL BIOL, V68, P19, DOI 10.1016/j.tpb.2005.04.001; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; MICHOD RE, 1980, NATURE, V288, P694, DOI 10.1038/288694a0; Moran P., 1962, STAT PROCESSES EVOLU; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Orzack SH, 2005, EVOLUTION, V59, P1183; Proulx S. R., 2001, SELECTION, V2, P1, DOI DOI 10.1556/SELECT.2.2001.1-2.1; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Taylor P. A. I., 2000, SELECTION, V1, P83, DOI [10.1556/select. 1.2000.1-3.15, DOI 10.1556/SELECT.1.2000.1-3.15]; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Wild G, 2004, P ROY SOC B-BIOL SCI, V271, P2345, DOI 10.1098/rspb.2004.2862; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wright S, 1943, GENETICS, V28, P114	19	233	235	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					469	472		10.1038/nature05784	http://dx.doi.org/10.1038/nature05784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522682				2022-12-24	WOS:000246693100046
J	Sayegh, MH; Remuzzi, G				Sayegh, Mohamed H.; Remuzzi, Giuseppe			Clinical update: immunosuppression minimisation	LANCET			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; SIROLIMUS-BASED THERAPY; RENAL-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; REJECTION; TOLERANCE; CHALLENGES; BELATACEPT; CAMPATH-1H; SURVIVAL		Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	; Remuzzi, Giuseppe/V-9766-2017	Sayegh, Mohamed/0000-0002-2847-588X; Remuzzi, Giuseppe/0000-0002-6194-3446				Barth RN, 2006, TRANSPL INT, V19, P885, DOI 10.1111/j.1432-2277.2006.00388.x; Curtis JJ, 2004, AM J TRANSPLANT, V4, P671, DOI 10.1111/j.1600-6143.2004.00474.x; Ekberg H, 2007, AM J TRANSPLANT, V7, P560, DOI 10.1111/j.1600-6143.2006.01645.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Harmon W, 2006, J AM SOC NEPHROL, V17, P1735, DOI 10.1681/ASN.2006010049; Hricik DE, 2002, AM J TRANSPLANT, V2, P19, DOI 10.1034/j.1600-6143.2002.020105.x; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mota A, 2004, AM J TRANSPLANT, V4, P953, DOI 10.1111/j.1600-6143.2004.00446.x; Najafian N, 2006, J AM SOC NEPHROL, V17, P2652, DOI 10.1681/ASN.2005070707; Salama AD, 2001, J CLIN INVEST, V108, P943, DOI 10.1172/JCI200114142; Sayegh MH, 2006, NAT CLIN PRACT NEPHR, V2, P134, DOI 10.1038/ncpneph0125; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3; Strom TB, 2005, NEW ENGL J MED, V353, P2394, DOI 10.1056/NEJMe058257; Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085	20	26	28	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1676	1678		10.1016/S0140-6736(07)60762-4	http://dx.doi.org/10.1016/S0140-6736(07)60762-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512842				2022-12-24	WOS:000246631300010
J	Yates, JRW; Sepp, T; Matharu, BK; Khan, JC; Thurlby, DA; Shahid, H; Clayton, DG; Hayward, C; Morgan, J; Wright, AF; Armbrecht, AM; Dhillon, B; Deary, IJ; Redmond, E; Bird, AC; Moore, AT				Yates, John R. W.; Sepp, Tiina; Matharu, Baljinder K.; Khan, Jane C.; Thurlby, Deborah A.; Shahid, Humma; Clayton, David G.; Hayward, Caroline; Morgan, Joanne; Wright, Alan F.; Armbrecht, Ana Maria; Dhillon, Baljean; Deary, Ian J.; Redmond, Elizabeth; Bird, Alan C.; Moore, Anthony T.		Genetic Factors AMD Study G	Complement C3 variant and the risk of age-related macular degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULONEPHRITIS TYPE-II; DENSE DEPOSIT DISEASE; FACTOR-H POLYMORPHISM; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; CHOROIDAL NEOVASCULARIZATION; GENETIC-POLYMORPHISM; MOLECULAR ANALYSIS; COMMON; CFH; SUSCEPTIBILITY	Background: Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation is implicated in the pathogenesis. Methods: We tested for an association between age-related macular degeneration and 13 single-nucleotide polymorphisms (SNPs) spanning the complement genes C3 and C5 in case subjects and control subjects from the southeastern region of England. All subjects were examined by an ophthalmologist and had independent grading of fundus photographs to confirm their disease status. To test for replication of the most significant findings, we genotyped a set of Scottish cases and controls. Results: The common functional polymorphism rs2230199 (Arg80Gly) in the C3 gene, corresponding to the electrophoretic variants C3S (slow) and C3F (fast), was strongly associated with age-related macular degeneration in both the English group (603 cases and 350 controls, P=5.9 x 10(sup -5)) and the Scottish group (244 cases and 351 controls, P=5.0 x 10(sup -5)). The odds ratio for age-related macular degeneration in C3 S/F heterozygotes as compared with S/S homozygotes was 1.7 (95% confidence interval [CI], 1.3 to 2.1); for F/F homozygotes, the odds ratio was 2.6 (95% CI, 1.6 to 4.1). The estimated population attributable risk for C3F was 22%. Conclusions: Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease.	Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Med Genet,Addenbrookes Hosp, Cambridge CB2 0XY, England; Med Res Council Human Genet Unit, Edinburgh, Midlothian, Scotland; Univ Edinburgh, Edinburgh, Midlothian, Scotland; UCL, London, England; Moorfields Eye Hosp, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Edinburgh; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Yates, JRW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Med Genet,Addenbrookes Hosp, MRC Bldg,Box 139,, Cambridge CB2 0XY, England.	jrwy1@cam.ac.uk	Deary, Ian J/C-6297-2009; Hayward, Caroline/M-8818-2016	Deary, Ian J/0000-0002-1733-263X; Hayward, Caroline/0000-0002-9405-9550	Medical Research Council [G0000067, MC_U127584475] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U127584475, G0000067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Appel GB, 2005, J AM SOC NEPHROL, V16, P1392, DOI 10.1681/ASN.2005010078; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; AZEN EA, 1968, SCIENCE, V162, P905, DOI 10.1126/science.162.3856.905; BARTOK I, 1995, J IMMUNOL, V154, P5367; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Colville D, 2003, AM J KIDNEY DIS, V42, DOI 10.1016/S0272-6386(03)00665-6; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; Hughes AE, 2007, NAT GENET, V39, P567, DOI 10.1038/ng0407-567c; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KOCH C, 1986, IMMUNOGENETICS, V23, P322, DOI 10.1007/BF00398796; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; MCLEAN RH, 1984, J PEDIATR-US, V105, P179, DOI 10.1016/S0022-3476(84)80110-9; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Patel D, 2006, POSTGRAD MED J, V82, P774, DOI 10.1136/pgmj.2006.047001; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WELCH TR, 1990, J PEDIATR-US, V116, pS92, DOI 10.1016/S0022-3476(05)82709-X; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	41	641	685	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2007	357	6					553	561		10.1056/NEJMoa072618	http://dx.doi.org/10.1056/NEJMoa072618			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197VP	17634448	Green Published, Bronze			2022-12-24	WOS:000248584900006
J	Pilling, S; Strang, J; Gerada, C				Pilling, Stephen; Strang, John; Gerada, Clare		Guideline Dev Grp	Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England; Kings Coll London, Natl Addict Ctr, Inst Psychiat, London SE5 8AF, England; Hurley Clin, London SE11 4HJ, England	University of London; University College London; University of London; King's College London	Pilling, S (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England.	s.pilting@uct.ac.uk	Gerada, Clare/O-8264-2019; Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				*NAT I HLTH CLIN E, 2007, DRUG MIS OP DET; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT; Strang J, 2005, BRIT J GEN PRACT, V55, P444	3	38	39	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					203	205		10.1136/bmj.39265.639641.AD	http://dx.doi.org/10.1136/bmj.39265.639641.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	198YA	17656545	Green Submitted, Green Published			2022-12-24	WOS:000248662200033
J	Ortega-Martinez, O; Pernas, M; Carol, RJ; Dolan, L				Ortega-Martinez, Olga; Pernas, Monica; Carol, Rachel J.; Dolan, Liam			Ethylene modulates stem cell division in the Arabidopsis thaliana root	SCIENCE			English	Article							AUXIN; PROTEIN; DIFFERENTIATION; BIOSYNTHESIS; MUTANTS; GROWTH; NICHE; FATE; ETO1	The construction of multicellular organisms depends on stem cells-cells that can both regenerate and produce daughter cells that undergo differentiation. Here, we show that the gaseous messenger ethylene modulates cell division in the cells of the quiescent center, which act as a source of stem cells in the seedling root. The cells formed through these ethylene-induced divisions express quiescent center-specific genes and can repress differentiation of surrounding initial cells, showing that quiescence is not required for these cells to signal to adjacent stem cells. We propose that ethylene is part of a signaling pathway that modulates cell division in the quiescent center in the stem cell niche during the postembryonic development of the root system.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Pernas, Monica/G-3485-2015	Pernas, Monica/0000-0002-6521-9164; Dolan, Liam/0000-0003-1206-7096; Carol, Rachel/0000-0002-6193-5163	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; van den Berg C, 1998, PLANTA, V205, P483, DOI 10.1007/s004250050347; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	18	170	177	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					507	510		10.1126/science.1143409	http://dx.doi.org/10.1126/science.1143409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656722				2022-12-24	WOS:000248339800043
J	Stiffler, MA; Chen, JR; Grantcharova, VP; Lei, Y; Fuchs, D; Allen, JE; Zaslavskaia, LA; MacBeath, G				Stiffler, Michael A.; Chen, Jiunn R.; Grantcharova, Viara P.; Lei, Ying; Fuchs, Daniel; Allen, John E.; Zaslavskaia, Lioudmila A.; MacBeath, Gavin			PDZ domain binding selectivity is optimized across the mouse proteome	SCIENCE			English	Article							INTERACTION NETWORK; LIGAND RECOGNITION; ERBIN; SPECIFICITY; MICROARRAYS; MOTIFS	PDZ domains have long been thought to cluster into discrete functional classes defined by their peptide-binding preferences. We used protein microarrays and quantitative fluorescence polarization to characterize the binding selectivity of 157 mouse PDZ domains with respect to 217 genome-encoded peptides. We then trained a multidomain selectivity model to predict PDZ domain-peptide interactions across the mouse proteome with an accuracy that exceeds many large-scale, experimental investigations of protein-protein interactions. Contrary to the current paradigm, PDZ domains do not fall into discrete classes; instead, they are evenly distributed throughout selectivity space, which suggests that they have been optimized across the proteome to minimize cross-reactivity. We predict that focusing on families of interaction domains, which facilitates the integration of experimentation and modeling, will play an increasingly important role in future investigations of protein function.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	macbeath@chemistry.harvard.edu		MacBeath, Gavin/0000-0003-2585-6772; Allen, John/0000-0001-5005-5139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072872, T32GM007598] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM07598-25, R01 GM072872-04, R01 GM072872, 1 RO1 GM072872-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Harris BZ, 2003, BIOCHEMISTRY-US, V42, P2797, DOI 10.1021/bi027061p; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Tropsha A, 2006, ANN REP COMP CHEM, V2, P113, DOI 10.1016/S1574-1400(06)02007-X; Van Dongen SM, 2000, THESIS U UTRECHT NET; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	24	305	312	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					364	369		10.1126/science.1144592	http://dx.doi.org/10.1126/science.1144592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641200	Green Accepted			2022-12-24	WOS:000248150200045
J	Jimenez-Guri, E; Philippe, H; Okamura, B; Holland, PWH				Jimenez-Guri, Eva; Philippe, Herve; Okamura, Beth; Holland, Peter W. H.			Buddenbrockia is a Cnidarian worm	SCIENCE			English	Article							BILATERAL SYMMETRY; ANIMAL PHYLOGENY; SEA-ANEMONE; MYXOZOA; ORIGIN; VERTEBRATES; EVOLUTION; PROTISTS	A major evolutionary divide occurs in the animal kingdom between the so-called radially symmetric animals, which includes the cnidarians, and the bilaterally symmetric animals, which includes all worm phyla. Buddenbrockia plumatellae is an active, muscular, parasitic worm that belongs to the phylum Myxozoa, a group of morphologically simplified microscopic endoparasites that has proved difficult to place phylogenetically. Phylogenetic analyses of multiple protein-coding genes demonstrate that Buddenbrockia is a cnidarian. This active muscular worm increases the known diversity in cnidarian body plans and demonstrates that a muscular, wormlike form can evolve in the absence of overt bilateral symmetry.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Montreal, Canadian Inst Adv Res, Ctr Robert Cedergren, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; Canadian Institute for Advanced Research (CIFAR); Universite de Montreal; University of Reading; Natural History Museum London	Holland, PWH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	peter.holland@zoo.ox.ac.uk		Holland, Peter/0000-0003-1533-9376; jimenez-guri, eva/0000-0002-9592-1077	Biotechnology and Biological Sciences Research Council [G19271] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anderson CL, 1998, NATURE, V392, P346, DOI 10.1038/32801; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Canning EU, 2002, J EUKARYOT MICROBIOL, V49, P280, DOI 10.1111/j.1550-7408.2002.tb00371.x; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; Collins AG, 2006, BIOL LETT-UK, V2, P120, DOI 10.1098/rsbl.2005.0372; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 2005, BIOESSAYS, V27, P1174, DOI 10.1002/bies.20299; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Monteiro AS, 2002, MOL BIOL EVOL, V19, P968, DOI 10.1093/oxfordjournals.molbev.a004155; Okamura B, 2002, PARASITOLOGY, V124, P215, DOI 10.1017/S0031182001001184; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; PICKENS PE, 1988, J EXP BIOL, V135, P133; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Schroder O, 1910, Z WISS ZOOL ABT A, V96, P525; Seipel K, 2006, INT J DEV BIOL, V50, P589, DOI 10.1387/ijdb.062150ks; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stolc A, 1899, B INT ACAD SCI BOHEM, V22, P1; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Weill R, 1938, TRAVAUX STATION ZOOL, V13, P727; Westfall JA, 2004, HYDROBIOLOGIA, V530, P117, DOI 10.1007/s10750-004-2678-0; Zrzavy J, 2003, CLADISTICS, V19, P164, DOI 10.1016/S0748-3007(03)00007-0	29	117	122	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2007	317	5834					116	118		10.1126/science.1142024	http://dx.doi.org/10.1126/science.1142024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615357				2022-12-24	WOS:000247776700064
J	Khuri, FR				Khuri, Fadlo R.			Weighing the hazards of erythropoirsis stimulation in patients with cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOUBLE-BLIND		Emory Winship Canc Inst, Atlanta, GA USA		Khuri, FR (corresponding author), Emory Winship Canc Inst, Atlanta, GA USA.		Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618				Goldberg P, 2007, CANC LETT, V33, P1; Henke, 2007, J CLIN ONCOL, V25, P1457, DOI 10.1200/JCO.2007.11.6244; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514	6	83	93	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2445	2448		10.1056/NEJMp078101	http://dx.doi.org/10.1056/NEJMp078101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568023				2022-12-24	WOS:000247201900001
J	Nijnik, A; Woodbine, L; Marchetti, C; Dawson, S; Lambe, T; Liu, C; Rodrigues, NP; Crockford, TL; Cabuy, E; Vindigni, A; Enver, T; Bell, JI; Slijepcevic, P; Goodnow, CC; Jeggo, PA; Cornall, RJ				Nijnik, Anastasia; Woodbine, Lisa; Marchetti, Caterina; Dawson, Sara; Lambe, Teresa; Liu, Cong; Rodrigues, Neil P.; Crockford, Tanya L.; Cabuy, Erik; Vindigni, Alessandro; Enver, Tariq; Bell, John I.; Slijepcevic, Predrag; Goodnow, Christopher C.; Jeggo, Penelope A.; Cornall, Richard J.			DNA repair is limiting for haematopoietic stem cells during ageing	NATURE			English	Article							STRAND BREAK REPAIR; LIGASE-IV; COMBINED IMMUNODEFICIENCY; MUTATIONS; TELOMERE; IDENTIFICATION; LETHALITY; MECHANISM; APOPTOSIS; COMPLEX	Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal mechanism of ageing. Here we address this question by taking advantage of the highly specific role of DNA ligase IV in the repair of DNA double-strand breaks by non-homologous end-joining, and by the discovery of a unique mouse strain with a hypomorphic Lig4(Y288C) mutation. The Lig4(Y288C) mouse, identified by means of a mutagenesis screening programme, is a mouse model for human LIG4 syndrome, showing immunodeficiency and growth retardation. Diminished DNA double-strand break repair in the Lig4(Y288C) strain causes a progressive loss of haematopoietic stem cells and bone marrow cellularity during ageing, and severely impairs stem cell function in tissue culture and transplantation. The sensitivity of haematopoietic stem cells to non-homologous end-joining deficiency is therefore a key determinant of their ability to maintain themselves against physiological stress over time and to withstand culture and transplantation.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Oxford, Oxford OX3 9DU, England; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Australian Natl Univ, Australia & Australian Phenom Facil, Australian Canc Res Fdn Genet Lab, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 3PH, Middx, England	University of Sussex; University of Oxford; International Center for Genetic Engineering & Biotechnology (ICGEB); Australian National University; John Curtin School of Medical Research; University of Oxford; Brunel University	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; richard.cornall@ndm.ox.ac.uk	Liu, Cong/GOE-5572-2022; Goodnow, Christopher C/V-8108-2018; Lambe, Teresa/E-5733-2016; Nijnik, Anastasia/W-2697-2019	Liu, Cong/0000-0001-5192-6784; Goodnow, Christopher C/0000-0001-5296-6155; Lambe, Teresa/0000-0001-7711-897X; Rodrigues, Neil/0000-0002-1925-7733	Medical Research Council [G0300662B] Funding Source: researchfish; MRC [MC_U137884178, G0500897, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137884178, MC_U137973817, G0500897] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Ben-Omran TI, 2005, AM J MED GENET A, V137A, P283, DOI 10.1002/ajmg.a.30869; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cabuy E, 2004, CYTOM PART A, V62A, P150, DOI 10.1002/cyto.a.20096; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Enders A, 2006, J IMMUNOL, V176, P5060, DOI 10.4049/jimmunol.176.8.5060; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; OKADA S, 1992, BLOOD, V80, P3044; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rodriguez-Lopez J, 2005, LECT SER COMPUTER CO, V2, P106; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Toita N, 2007, AM J MED GENET A, V143A, P742, DOI 10.1002/ajmg.a.31644; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003	42	411	432	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					686	U9		10.1038/nature05875	http://dx.doi.org/10.1038/nature05875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554302				2022-12-24	WOS:000247030700037
J	Radelet, S; Siddiqi, B				Radelet, Steven; Siddiqi, Bilal			Global Fund grant programmes: an analysis of evaluation scores	LANCET			English	Article								Background The Global Fund to Fight AIDS, Tuberculosis and Malaria evaluates programme performance after 2 years to help decide whether to continue funding. We aimed to identify the correlation between programme evaluation scores and characteristics of the programme, the health sector, and the recipient country. Methods We obtained data on the first 140 Global Fund grants evaluated in 2006, and analysed 134 of these. We used an ordered probit multivariate analysis to link evaluation scores to different characteristics, allowing us to record the association between changes in those characteristics and the probability of a programme receiving a particular evaluation score. Findings Programmes that had government agencies as principal recipients, had a large amount of funding, were focused on malaria, had weak initial proposals, or were evaluated by the accounting firm KPMG, scored lowest. Countries with a high number of doctors per head, high measles immunisation rates, few health-sector donors, and high disease-prevalence rates had higher evaluation scores. Poor countries, those with small government budget deficits, and those that have or have had socialist governments also received higher scores. Interpretation Our results show associations, not causality, and they focus on evaluation scores rather than actual performance of the programmes. Yet they provide some early indications of characteristics that can help the Global Fund identify and monitor programmes that might be at risk. The results should not be used to influence the distribution of funding, but rather to allocate resources for oversight and risk management.	Ctr Global Dev, Washington, DC 20036 USA		Radelet, S (corresponding author), Ctr Global Dev, 1776 Massachusetts Ave NW, Washington, DC 20036 USA.	sradelet@cgdev.org						*AIDSPAN, 2005, AN GLOB FUND GRANTS; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GLOB FUND FIGHT A, 2006, INV IMP MID RES REP; *GLOB FUND FIGHT A, 2005, 3 GFATM; *GLOB FUND FIGHT A, TUB MAL PHAS 2 GRANT; *GLOB FUND FIGHT A, CURR GRNT COMM DISB; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Radelet S., 2004, GLOBAL FUND FIGHT AI; *TECHN EV REF GROU, 2005, REP ASS COUNTR COORD; *US GOV ACC OFF, 2005, GLOB FUND FIGHT AIDS; *WORLD BANK, 2006, WORLDW GOV IND	11	20	20	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1807	1813		10.1016/S0140-6736(07)60818-6	http://dx.doi.org/10.1016/S0140-6736(07)60818-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531888				2022-12-24	WOS:000246819300031
J	Saadat, I; Higashi, H; Obuse, C; Umeda, M; Murata-Kamiya, N; Saito, Y; Lu, HS; Ohnishi, N; Azuma, T; Suzuki, A; Ohno, S; Hatakeyama, M				Saadat, Iraj; Higashi, Hideaki; Obuse, Chikashi; Umeda, Mayumi; Murata-Kamiya, Naoko; Saito, Yasuhiro; Lu, Huaisheng; Ohnishi, Naomi; Azuma, Takeshi; Suzuki, Atsushi; Ohno, Shigeo; Hatakeyama, Masanori			Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity	NATURE			English	Article							VIRULENCE FACTOR CAGA; ELEGANS EMBRYOS; PROTEIN; LOCALIZATION; MARK/PAR-1; MUTATIONS; PAR-1; ESTABLISHMENT; LEUKEMIA; GENE	Helicobacter pylori cagA-positive strains are associated with gastritis, ulcerations and gastric adenocarcinoma(1). CagA is delivered into gastric epithelial cells(2) and, on tyrosine phosphorylation, specifically binds and activates the SHP2 oncoprotein(3-7), thereby inducing the formation of an elongated cell shape known as the 'hummingbird' phenotype(2,3). In polarized epithelial cells, CagA also disrupts the tight junction and causes loss of apical basolateral polarity(8,9). We show here that H. pylori CagA specifically interacts with PAR1/MARK kinase, which has an essential role in epithelial cell polarity(10,11). Association of CagA inhibits PAR1 kinase activity and prevents atypical protein kinase C ( aPKC)-mediated PAR1 phosphorylation, which dissociates PAR1 from the membrane(12,13), collectively causing junctional and polarity defects. Because of the multimeric nature of PAR1 (ref. 14), PAR1 also promotes CagA multimerization, which stabilizes the CagA - SHP2 interaction(15). Furthermore, induction of the hummingbird phenotype by CagA-activated SHP2 requires simultaneous inhibition of PAR1 kinase activity by CagA. Thus, the CagA - PAR1 interaction not only elicits the junctional and polarity defects but also promotes the morphogenetic activity of CagA. Our findings revealed that PAR1 is a key target of H. pylori CagA in the disorganization of gastric epithelial architecture underlying mucosal damage, inflammation and carcinogenesis.	Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan; Kobe Univ, Grad Sch Med, Internal Ctr Med Res & Treatment, Kobe, Hyogo 6500017, Japan; Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Kobe University; Yokohama City University	Hatakeyama, M (corresponding author), Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Ohno, Shigeo/B-1768-2010; Obuse, Chikashi/F-5273-2011; Higashi, Hideaki/F-6872-2012; OHNISHI, Naomi/F-6914-2012	Ohno, Shigeo/0000-0002-1294-5269; OHNISHI, Naomi/0000-0002-2382-3152; Saadat, Iraj/0000-0002-8169-4707				Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; NOACH LA, 1994, J CLIN PATHOL, V47, P699, DOI 10.1136/jcp.47.8.699; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Watts JL, 1996, DEVELOPMENT, V122, P3133	30	353	366	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					330	U8		10.1038/nature05765	http://dx.doi.org/10.1038/nature05765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507984				2022-12-24	WOS:000246520300048
J	Perkins, S; de Wit, M				Perkins, Sarah; de Wit, Melanie			The African private sector steps in to fill the drug gap	LANCET			English	Editorial Material									Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Toronto	Perkins, S (corresponding author), Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada.	s.perkins@utoronto.ca						*GLOB FUND FIGHT A, LIST COUNTR BEL ICH; *GOV CAN, REV CAN ACC MED REG; HEMS J, 2007, CAMR CONSULTATION PA; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *W AFR HLTH ORG, REP EXTR ASS WAHO HL	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					722	723		10.1016/S0140-6736(07)61094-0	http://dx.doi.org/10.1016/S0140-6736(07)61094-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17658595				2022-12-24	WOS:000249209300009
J	Lydeard, JR; Jain, S; Yamaguchi, M; Haber, JE				Lydeard, John R.; Jain, Suvi; Yamaguchi, Miyuki; Haber, James E.			Break-induced replication and telomerase-independent telomere maintenance require Pol32	NATURE			English	Article							DNA-POLYMERASE-DELTA; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GENE CONVERSION; BYPASS PATHWAY; RECOMBINATION; YEAST; REPAIR; CHECKPOINT	Break- induced replication ( BIR) is an efficient homologous recombination process to initiate DNA replication when only one end of a chromosome double- strand break shares homology with a template(1-5). BIR is thought to re- establish replication at stalled and broken replication forks and to act at eroding telomeres in cells that lack telomerase in pathways known as ' alternative lengthening of telomeres' ( reviewed in refs 2, 6). Here we show that, in haploid budding yeast, Rad51- dependent BIR induced by HO endonuclease requires the lagging strand DNA Pol alpha- primase complex as well as Pol delta to initiate new DNA synthesis. Pol epsilon is not required for the initial primer extension step of BIR but is required to complete 30 kb of new DNA synthesis. Initiation of BIR also requires the nonessential DNA Pol delta subunit Pol32 primarily through its interaction with another Pol delta subunit, Pol31. HO-induced gene conversion, in which both ends of a double- strand break engage in homologous recombination, does not require Pol32. Pol32 is also required for the recovery of both Rad51-dependent and Rad51- independent survivors in yeast strains lacking telomerase. These results strongly suggest that both types of telomere maintenance pathways occur by recombination-dependent DNA replication. Thus Pol32, dispensable for replication and for gene conversion, is uniquely required for BIR; this finding provides an opening into understanding how DNA replication re- start mechanisms operate in eukaryotes. We also note that Pol32 homologues have been identified both in fission yeast and in metazoans where telomerase- independent survivors with alternative telomere maintenance have also been identified(2,6,7).	Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr, MS029, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM076020, R01GM020056] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM020056-32, R01 GM076020-01A1, R01 GM076020-03, R01 GM020056, T32 GM007122, R01 GM076020, R01 GM020056-33, R01 GM076020-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUDD ME, 1993, MOL CELL BIOL, V13, P496, DOI 10.1128/MCB.13.1.496; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Corrette-Bennett SE, 2004, NUCLEIC ACIDS RES, V32, P6268, DOI 10.1093/nar/gkh965; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Giot L, 1997, GENETICS, V146, P1239; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Huang ME, 2002, GENETICS, V160, P1409; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Le S, 1999, GENETICS, V152, P143; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Morrow DM, 1997, GENETICS, V147, P371; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(05)00094-8; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004	32	354	362	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					820	U10		10.1038/nature06047	http://dx.doi.org/10.1038/nature06047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17671506				2022-12-24	WOS:000248754200043
J	Kumar, P; Wu, HQ; McBride, JL; Jung, KE; Kim, MH; Davidson, BL; Lee, SK; Shankar, P; Manjunath, N				Kumar, Priti; Wu, Haoquan; McBride, Jodi L.; Jung, Kyeong-Eun; Kim, Moon Hee; Davidson, Beverly L.; Lee, Sang Kyung; Shankar, Premlata; Manjunath, N.			Transvascular delivery of small interfering RNA to the central nervous system	NATURE			English	Article							CELL-PENETRATING PEPTIDES; INHIBITS TUMOR-GROWTH; IN-VIVO DELIVERY; INTRACELLULAR DELIVERY; MODIFIED SIRNAS; GENE-THERAPY; BRAIN; VIRUS; RECEPTORS; TRANSPORTERS	A major impediment in the treatment of neurological diseases is the presence of the blood - brain barrier, which precludes the entry of therapeutic molecules from blood to brain. Here we show that a short peptide derived from rabies virus glycoprotein (RVG) enables the transvascular delivery of small interfering RNA ( siRNA) to the brain. This 29-amino-acid peptide specifically binds to the acetylcholine receptor expressed by neuronal cells. To enable siRNA binding, a chimaeric peptide was synthesized by adding nonamer arginine residues at the carboxy terminus of RVG. This RVG-9R peptide was able to bind and transduce siRNA to neuronal cells in vitro, resulting in efficient gene silencing. After intravenous injection into mice, RVG-9R delivered siRNA to the neuronal cells, resulting in specific gene silencing within the brain. Furthermore, intravenous treatment with RVG-9R-bound antiviral siRNA afforded robust protection against fatal viral encephalitis in mice. Repeated administration of RVG-9R-bound siRNA did not induce inflammatory cytokines or anti-peptide antibodies. Thus, RVG-9R provides a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules across the blood - brain barrier.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ Iowa, Dept Internal Med, Roy J & Lucille J Carver Coll Med, Iowa City, IA 52242 USA; Samchully Pharm Co Ltd, Res Ctr, Seoul 135735, South Korea; Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea; Hanyang Univ, Hanyang Fus Mat Program, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Iowa; Hanyang University; Hanyang University	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	shankar@cbrinstitute.org; swamy@cbrinstitute.org	Kumar, Priti/C-5699-2009; McBride, Jodi/C-4494-2016	McBride, Jodi/0000-0002-4816-7569; Davidson, Beverly/0000-0002-3715-6290; Wu, Haoquan/0000-0001-9386-3187				Akaneya Y, 2005, J NEUROPHYSIOL, V93, P594, DOI 10.1152/jn.00161.2004; Chen TJ, 2005, CHINESE J PHYSIOL, V48, P129; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Juliano RL, 2005, CURR OPIN MOL THER, V7, P132; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lentz T L, 1990, J Mol Recognit, V3, P82, DOI 10.1002/jmr.300030205; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Leonard S, 2001, Nicotine Tob Res, V3, P203; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Miller G, 2002, SCIENCE, V297, P1116, DOI 10.1126/science.297.5584.1116; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Neyts J, 1999, Verh K Acad Geneeskd Belg, V61, P661; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; NOTTER MFD, 1985, J CELL PHYSIOL, V125, P476, DOI 10.1002/jcp.1041250317; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schlachetzki F, 2004, NEUROLOGY, V62, P1275, DOI 10.1212/01.WNL.0000120551.38463.D9; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	36	927	1061	16	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					39	43		10.1038/nature05901	http://dx.doi.org/10.1038/nature05901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572664				2022-12-24	WOS:000247720900032
J	Zuo, T; Wang, LZ; Morrison, C; Chang, X; Zhang, HM; Li, WQ; Liu, Y; Wang, Y; Liu, XL; Chan, MWY; Liu, JQ; Love, R; Liu, CG; Godfrey, V; Shen, RL; Huang, THM; Yang, TY; Park, BK; Wang, CY; Zheng, P; Liu, Y				Zuo, Tao; Wang, Lizhong; Morrison, Carl; Chang, Xing; Zhang, Huiming; Li, Weiquan; Liu, Yan; Wang, Yin; Liu, Xingluo; Chan, Michael W. Y.; Liu, Jin-Qing; Love, Richard; Liu, Chang-gong; Godfrey, Virginia; Shen, Rulong; Huang, Tim H. -M.; Yang, Tianyu; Park, Bae Keun; Wang, Cun-Yu; Zheng, Pan; Liu, Yang			FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene	CELL			English	Article							IN-SITU HYBRIDIZATION; SCURFY SF MOUSE; LYMPHORETICULAR DISEASE; OVARIAN-CANCER; NEU ONCOGENE; T-CELLS; PROTEIN; AMPLIFICATION; CHROMOSOME; IMMUNOHISTOCHEMISTRY	The X-linked Foxp3 is a member of the forkhead/winged helix transcription factor family. Germline mutations cause lethal autoimmune diseases in males. Serendipitously, we observed that female mice heterozygous for the "scurfin'' mutation of the Foxp3 gene (Foxp3(sf/+)) developed cancer at a high rate. The majority of the cancers were mammary carcinomas in which the wild-type Foxp3 allele was inactivated and HER-2/ErbB2 was overexpressed. Foxp3 bound and repressed the HER-2/ErbB2 promoter. Deletion, functionally significant somatic mutations, and downregulation of the FOXP3 gene were commonly found in human breast cancer samples and correlated significantly with HER-2/ErbB2 overexpression, regardless of the status of HER-2 amplification. Our data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.	Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA; Univ Michigan, Program Mol Mech Dis, Ann Arbor, MI 48109 USA; Ohio State Univ, Med Ctr, Dept Virol Immunol & Med Genet, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Sch Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Zheng, P (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Wang, Lizhong/J-4268-2019; Li, Weiquan/B-4897-2011; Zheng, Pan/E-8691-2011; Chan, Michael/F-9615-2018; Shen, Rulong/E-4079-2011	Wang, Lizhong/0000-0003-1980-4730; Zheng, Pan/0000-0003-2598-3544; Chan, Michael/0000-0003-1431-322X; Liu, Yang/0000-0002-9442-700X; Chang, Xing/0000-0002-5072-9225; Chan, Michael/0000-0003-0314-2437	NATIONAL CANCER INSTITUTE [R01CA058033, R01CA112001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350, R01AI051342] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA058033-15, R01 CA112001-02, R01 CA058033, R01 CA112001] Funding Source: Medline; NIAID NIH HHS [R01 AI064350-01A2, R01 AI051342, R01 AI051342-05, R01 AI064350] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DEPALAZZO IG, 1993, INT J BIOL MARKER, V8, P233; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jimenez RE, 2000, MODERN PATHOL, V13, P37, DOI 10.1038/modpathol.3880007; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kristiansen M, 2005, J MED GENET, V42, P877, DOI 10.1136/jmg.2005.032433; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Piao Z, 2002, GENE CHROMOSOME CANC, V33, P262, DOI 10.1002/gcc.10024; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roncuzzi L, 2002, CANCER GENET CYTOGEN, V135, P173, DOI 10.1016/S0165-4608(01)00652-5; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Todorovic-Rakovic N, 2005, PATHOL INT, V55, P318, DOI 10.1111/j.1440-1827.2005.01831.x; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	35	310	335	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1275	1286		10.1016/j.cell.2007.04.034	http://dx.doi.org/10.1016/j.cell.2007.04.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570480	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000247911400014
J	Persson, L; Amundsen, PA; De Roos, AM; Klemetsen, A; Knudsen, R; Primicerio, R				Persson, Lennart; Amundsen, Per-Arne; De Roos, Andre M.; Klemetsen, Anders; Knudsen, Rune; Primicerio, Raul			Culling prey promotes predator recovery - Alternative states in a whole-lake experiment	SCIENCE			English	Article							LIFE-HISTORY TRAITS; TROUT SALMO-TRUTTA; SALVELINUS-ALPINUS; ARCTIC CHARR; BROWN TROUT; STABLE EQUILIBRIA; FOOD-WEB; SIZE; POPULATIONS; GROWTH	Many top-predator fish stocks in both freshwater and marine systems have collapsed as a result of overharvesting. Consequently, some of these communities have shifted into seemingly irreversible new states. We showed, for predators feeding on prey that exhibit food-dependent growth, that culling of fish prey may promote predator recovery. We removed old stunted individuals of a prey-fish species in a large, low-productive lake, which caused an increase in the availability of small-sized prey and allowed the predator to recover. The shift in community state has been sustained for more than 15 years after the cull ended and represents an experimental demonstration of an alternative stable state in a large-scale field system. Because most animals exhibit food-dependent growth, shifts into alternative stable states resulting from overcompensating prey growth may be common in nature and may require counterintuitive management strategies.	Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; Univ Tromso, Norwegian Coll Fishery Sci, Dept Aquat Biosci, N-9037 Tromso, Norway; Univ Amsterdam, Inst Biodivers & Ecosyst, NL-1090 GB Amsterdam, Netherlands	Umea University; UiT The Arctic University of Tromso; University of Amsterdam	Persson, L (corresponding author), Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden.	lennart.persson@emg.umu.se	De Roos, Andre M./A-1590-2008; Persson, Lennart/B-2885-2012	De Roos, Andre M./0000-0002-6944-2048; Amundsen, Per-Arne/0000-0002-2203-8216				Amundsen PA, 2007, J ANIM ECOL, V76, P149, DOI 10.1111/j.1365-2656.2006.01179.x; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Chase JM, 2003, ECOL LETT, V6, P733, DOI 10.1046/j.1461-0248.2003.00482.x; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Duplisea DE, 2005, ICES J MAR SCI, V62, P412, DOI 10.1016/j.icesjms.2004.11.005; Edison TW, 2006, N AM J FISH MANAGE, V26, P800, DOI 10.1577/M04-020.1; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hyvarinen P, 2006, J FISH BIOL, V68, P87, DOI 10.1111/j.0022-1112.2006.00879.x; Jansen PA, 2002, CAN J FISH AQUAT SCI, V59, P6, DOI 10.1139/F01-184; Jansen PA, 2002, ENVIRON BIOL FISH, V64, P313, DOI 10.1023/A:1016009625754; JOHNSON L, 2002, IMPERFECT SYMMETRY T; Klemetsen A, 2002, ENVIRON BIOL FISH, V64, P39, DOI 10.1023/A:1016062421601; LABEELUND JH, 1992, J FISH BIOL, V41, P91, DOI 10.1111/j.1095-8649.1992.tb03172.x; Mora C, 2006, SCIENCE, V314, P758; PAINE RT, 1985, AM NAT, V125, P679, DOI 10.1086/284371; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; TONN WM, 1992, ECOLOGY, V73, P951, DOI 10.2307/1940171; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Werner E.E., 1988, P60	28	146	151	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1743	1746		10.1126/science.1141412	http://dx.doi.org/10.1126/science.1141412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588929				2022-12-24	WOS:000247400500046
J	Cushing, MC; Anseth, KS				Cushing, Melinda C.; Anseth, Kristi S.			Hydrogel cell cultures	SCIENCE			English	Editorial Material							PROTEIN; GROWTH		Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cushing, MC (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL089260-01A1, R01 HL089260] Funding Source: Medline; NIDCR NIH HHS [R01 DE016523-04, R01 DE016523] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747; Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Malkoch M, 2006, CHEM COMMUN, P2774, DOI 10.1039/b603438a; Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com	15	402	413	16	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1133	1134		10.1126/science.1140171	http://dx.doi.org/10.1126/science.1140171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525324				2022-12-24	WOS:000246724300025
J	Chan, AT; Ogino, S; Fuchs, CS				Chan, Andrew T.; Ogino, Shuji; Fuchs, Charles S.			Aspirin and the risk of colorectal cancer in relation to the expression of COX-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2 GENE-EXPRESSION; FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; CORONARY-HEART-DISEASE; RANDOMIZED-TRIAL; ADENOMA RECURRENCE; COMPETING RISKS; UP-REGULATION; PREVENTION	Background: Regular use of aspirin reduces the risk of a colorectal neoplasm, but the mechanism by which aspirin affects carcinogenesis in the colon is not well understood. Methods: We estimated cyclooxygenase-2 (COX-2) expression by immunohistochemical assay of sections from paraffin-embedded colorectal-cancer specimens from two large cohorts of participants who provided data on aspirin use from a questionnaire every 2 years. We applied Cox regression to a competing-risks analysis to compare the effects of aspirin use on the relative risk of colorectal cancer in relation to the expression of COX-2 in the tumor. Results: During 2,446,431 person-years of follow-up of 82,911 women and 47,363 men, we found 636 incident colorectal cancers that were accessible for determination of COX-2 expression. Of the tumors, 423 (67%) had moderate or strong COX-2 expression. The effect of aspirin use differed significantly in relation to COX-2 expression (P for heterogeneity=0.02). Regular aspirin use conferred a significant reduction in the risk of colorectal cancers that overexpressed COX-2 (multivariate relative risk, 0.64; 95% confidence interval [CI], 0.52 to 0.78), whereas regular aspirin use had no influence on tumors with weak or absent expression of COX-2 (multivariate relative risk, 0.96; 95% CI, 0.73 to 1.26). The age-standardized incidence rate for cancers that overexpressed COX-2 was 37 per 100,000 person-years among regular aspirin users, as compared with 56 per 100,000 person-years among those who did not use aspirin regularly; in contrast, the rate for cancers with weak or absent COX-2 expression was 27 per 100,000 person-years among regular aspirin users, as compared with 28 per 100,000 person-years among nonregular aspirin users. Conclusions: Regular use of aspirin appears to reduce the risk of colorectal cancers that overexpress COX-2 but not the risk of colorectal cancers with weak or absent expression of COX-2.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 728A, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014; Chan, Andy/D-3361-2013	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	NCI NIH HHS [CA87969, CA10741, CA55075] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2003, CANCER CAUSE CONTROL, V14, P413, DOI 10.1023/A:1024986220526; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chulada PC, 2000, CANCER RES, V60, P4705; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Haile Robert W, 2005, Clin Colorectal Cancer, V4, P390, DOI 10.3816/CCC.2005.n.011; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shureiqi I, 2000, CANCER RES, V60, P6846; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	42	590	616	2	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2131	2142		10.1056/NEJMoa067208	http://dx.doi.org/10.1056/NEJMoa067208			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522398	Bronze			2022-12-24	WOS:000246673100003
J	Su, LL; Chong, YS; Chan, YH; Chan, YS; Fok, D; Tun, KT; Ng, FSP; Rauff, M				Su, Lin-Lin; Chong, Yap-Seng; Chan, Yiong-Huak; Chan, Yah-Shih; Fok, Doris; Tun, Kay-Thwe; Ng, Faith S. P.; Rauff, Mary			Antenatal education and postnatal support strategies for improving rates of exclusive breast feeding: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LACTATION CONSULTANT INTERVENTION; HEALTH-CARE; INFANT; PROMOTION; MOTHERS; COUNSELORS; DURATION; ILLNESS	Objective To investigate whether antenatal breast feeding education alone or postnatal lactation support alone improves rates of exclusive breast feeding compared with routine hospital care. Design Randomised controlled trial. Setting A tertiary hospital in Singapore. Participants 450 women with uncomplicated pregnancies. Main outcome measures Primary outcomes were rates of exclusive breast feeding at discharge from hospital and two weeks, six weeks, three months, and six months after delivery. Secondary outcomes were rates of any breast feeding. Results Compared with women who received routine care, women in the postnatal support group were more likely to breastfeed exclusively at two weeks (relative risk 1.82, 95% confidence interval 1.14 to 2.90), six weeks (1.85, 1.11 to 3.09), three months (1.87, 1.03 to 3.41), and six months (2.12, 1.03 to 4.37) postnatally. Women receiving antenatal education were more likely to breast feed exclusively at six weeks (1.73, 1.04 to 2.90), three months (1.92, 1.07 to 3.48), and six months (2.16, 1.05 to 4.43) postnatally. The numbers needed to treat to achieve one woman exclusively breast feeding at six months were 11 (6 to 80) for postnatal support and 10 (6 to 60) for antenatal education. Women who received postnatal support were more likely to exclusively or predominantly breast feed two weeks after delivery compared with women who received antenatal education (1.53, 1.01 to 2.31). The rate of any breastfeeding six weeks after delivery was also higher in the postnatal support group compared with women who received routine care (1.16, 1.02 to 1.31). Conclusions Antenatal breast feeding education and postnatal lactation support, as single interventions based in hospital both significantly improve rates of exclusive breast feeding up to six months after delivery. Postnatal support was marginally more effective than antenatal education.	Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; Clin Trials & Epidemiol Res Unit, Singapore 1699039, Singapore; Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119074, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Chong, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore.	obgcys@nus.edu.sg	CHAN, YAH SHIH/R-7423-2019	Chong, Yap Seng/0000-0002-7232-8473				[Anonymous], 2002, INFANT FEEDING 2000; Ball TM, 1999, PEDIATRICS, V103, P870; Bartington S, 2006, INT J EPIDEMIOL, V35, P1178, DOI 10.1093/ije/dyl155; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bonuck KA, 2005, PEDIATRICS, V116, P1413, DOI 10.1542/peds.2005-0435; Bonuck KA, 2006, ARCH PEDIAT ADOL MED, V160, P953, DOI 10.1001/archpedi.160.9.953; Cattaneo A, 2006, ACTA PAEDIATR, V95, P540, DOI 10.1080/08035250500447936; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; DANNER S, 1998, NURSING YOUR BABY 1; Dyson L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001688.pub2; Dyson L., 2006, PROMOTION BREASTFEED, P242; Fok D, 1998, Breastfeed Rev, V6, P5; Foo LL, 2005, HEALTH PROMOT INT, V20, P229, DOI 10.1093/heapro/dai002; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; HAMLYN B, 2002, INFANT FEEDIGN 2000; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; Hoddinott P, 1999, BRIT MED J, V318, P30, DOI 10.1136/bmj.318.7175.30; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LEE J, 1994, INT J EPIDEMIOL, V23, P201, DOI 10.1093/ije/23.1.201; Mattar CN, 2007, OBSTET GYNECOL, V109, P73, DOI 10.1097/01.AOG.0000249613.15466.26; Memmott MM, 2006, MATERN CHILD NUTR, V2, P40, DOI 10.1111/j.1740-8709.2006.00040.x; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; *NAT U HOSP, 2002, BREASTF NAT IS BEST; *NICE, 2006, 37 NICE; Oddy WH, 2003, ARCH DIS CHILD, V88, P224, DOI 10.1136/adc.88.3.224; Radford A, 1998, BRIT MED J, V317, P1385, DOI 10.1136/bmj.317.7169.1385; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sikorski J, 2002, COCHRANE DB SYST REV, pCD001141; WEIMER J, 2001, 13120 USDA EC RES SE; WEIMER J, 2001, 13 USDA FOOD RUR EC, P1; World Health Organization, 2001, OPT DUR EXCL BREASTF	33	108	113	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2007	335	7620					596	599		10.1136/bmj.39279.656343.55	http://dx.doi.org/10.1136/bmj.39279.656343.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215TR	17670909	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000249832400033
J	Tang, CL; Toomajian, C; Sherman-Broyles, S; Plagnol, V; Guo, YL; Hu, TT; Clark, RM; Nasrallah, JB; Weigel, D; Nordborg, M				Tang, Chunlao; Toomajian, Christopher; Sherman-Broyles, Susan; Plagnol, Vincent; Guo, Ya-Long; Hu, Tina T.; Clark, Richard M.; Nasrallah, June B.; Weigel, Detlef; Nordborg, Magnus			The evolution of selfing in Arabidopsis thaliana	SCIENCE			English	Article							S-LOCUS; INCOMPATIBILITY	Unlike most of its close relatives, Arabidopsis thaliana is capable of self-pollination. In other members of the mustard family, outcrossing is ensured by the complex self-incompatibility (S) locus, which harbors multiple diverged specificity haplotypes that effectively prevent selfing. We investigated the role of the S locus in the evolution of and transition to selfing in A. thaliana. We found that the S locus of A. thaliana harbored considerable diversity, which is an apparent remnant of polymorphism in the outcrossing ancestor. Thus, the fixation of a single inactivated S-locus allele cannot have been a key step in the transition to selfing. An analysis of the genome-wide pattern of linkage disequilibrium suggests that selfing most likely evolved roughly a million years ago or more.	Univ So Calif, Los Angeles, CA 90089 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Univ Cambridge, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 2XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; Cornell University; University of Cambridge; Max Planck Society; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Weigel, Detlef/AAR-3312-2021; Tang, Chunlao/F-9203-2010; Weigel, Detlef/GSJ-0799-2022; Toomajian, Christopher/ABA-2615-2021; Plagnol, Vincent/A-5667-2011; Weigel, Detlef/C-1418-2008; Guo, Yalong/G-4742-2011	Weigel, Detlef/0000-0002-2114-7963; Toomajian, Christopher/0000-0002-6763-0678; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748; Guo, Yalong/0000-0002-4643-4889; Plagnol, Vincent/0000-0002-5597-9215	NHGRI NIH HHS [P50 HG002790] Funding Source: Medline; NIGMS NIH HHS [GM62932, R01 GM062932] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Charlesworth D, 2005, BIOESSAYS, V27, P472, DOI 10.1002/bies.20231; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; KAPLAN NL, 1989, GENETICS, V123, P887; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2000, GENETICS, V154, P923; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]	18	122	138	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1070	1072		10.1126/science.1143153	http://dx.doi.org/10.1126/science.1143153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17656687				2022-12-24	WOS:000248946700041
J	Fortin, PD; Walsh, CT; Magarvey, NA				Fortin, Pascal D.; Walsh, Christopher T.; Magarvey, Nathan A.			A transglutaminase homologue as a condensation catalyst in antibiotic assembly lines	NATURE			English	Article							HETEROLOGOUS EXPRESSION; BIOSYNTHESIS; GENE; IDENTIFICATION; INACTIVATION; AMINOMUTASE; POLYKETIDE; BACTERIUM	The unrelenting emergence of antibiotic- resistant bacterial pathogens demands the investigation of antibiotics with new modes of action. The pseudopeptide antibiotic andrimid is a nanomolar inhibitor of the bacterial acetyl- CoA carboxylase that catalyses the first committed step in prokaryotic fatty acid biosynthesis(1). Recently, the andrimid ( adm) biosynthetic gene cluster was isolated and heterologously expressed in Escherichia coli(2). This establishes a heterologous biological host in which to rapidly probe features of andrimid formation and to use biosynthetic engineering to make unnatural variants of this important and promising new class of antibiotics. Bioinformatic analysis of the adm cluster revealed a dissociated biosynthetic assembly system lacking canonical amide synthases between the first three carrier protein domains. Here we report that AdmF, a transglutaminase ( TGase) homologue, catalyses the formation of the first amide bond, an N-acyl-beta-peptide link, in andrimid biosynthesis. Hence, AdmF is a newly discovered biosynthetic enzyme that acts as a stand- alone amide synthase between protein- bound, thiotemplated substrates in an antibiotic enzymatic assembly line. TGases ( enzyme class ( EC) 2.3.2.13) normally catalyse the cross- linking of ( poly) peptides by creating isopeptidic bonds between the gamma-carboxamide group of a glutamine side chain of one protein and various amine donors, including lysine side chains(3). To the best of our knowledge, the present study constitutes the first report of a TGase- like enzyme recruited for the assembly of an antibiotic. Moreover, genome mining using the AdmF sequence yielded additional TGases in unassigned natural product biosynthetic pathways. With many more microbial genomes being sequenced, such a strategy could potentially unearth biosynthetic pathways producing new classes of antibiotics.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Fortin, Pascal/0000-0001-9796-791X				Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FREDENHAGEN A, 1987, J AM CHEM SOC, V109, P4409, DOI 10.1021/ja00248a055; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Jin M, 2006, J AM CHEM SOC, V128, P10660, DOI 10.1021/ja063194c; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Molnar-Perl I, 2001, J CHROMATOGR A, V913, P283, DOI 10.1016/S0021-9673(00)01200-0; NEEDHAM J, 1994, J ORG CHEM, V59, P2058, DOI 10.1021/jo00087a020; OCLARIT JM, 1994, MICROBIOS, V78, P7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; SAMPSON BA, 1989, GENETICS, V122, P491; STAAB HA, 1962, CHEM BER-RECL, V95, P1275, DOI 10.1002/cber.19620950526; Tonge PJ, 1995, BIOSPECTROSCOPY, V1, P387, DOI 10.1002/bspy.350010604; Walker KD, 2004, J BIOL CHEM, V279, P53947, DOI 10.1074/jbc.M411215200; Walsh C., 2006, POSTTRANSLATIONAL MO; Xiang LK, 2002, J BIOL CHEM, V277, P32505, DOI 10.1074/jbc.M204171200; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	19	49	51	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					824	U11		10.1038/nature06068	http://dx.doi.org/10.1038/nature06068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653193				2022-12-24	WOS:000248754200044
J	Klein, DF; O'Brien, CP				Klein, Donald F.; O'Brien, Charles P.			Improving detection of adverse effects of marketed drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTIDEPRESSANTS; RISK		Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Columbia Univ, Dept Psychiat, New York, NY USA	University of Pennsylvania; Columbia University	O'Brien, CP (corresponding author), Univ Penn, Dept Psychiat, 3900 Chestnut St, Philadelphia, PA 19104 USA.	obrien@mail.trc.upenn.edu						*I DRUG OUTR, 2007, PHARMA WEB SIT; Institute of Medicine, 2007, ADV DRUG EV REP ROL; Klein DF, 2006, NEUROPSYCHOPHARMACOL, V31, P689, DOI 10.1038/sj.npp.1300996; Libby AM, 2007, AM J PSYCHIAT, V164, P884, DOI 10.1176/appi.ajp.164.6.884; Lopez J, 2004, AM J HYPERTENS, V17, P1095, DOI 10.1016/j.amjhyper.2004.07.015; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Woo JJY, 2007, AM J CLIN NUTR, V85, p323S, DOI 10.1093/ajcn/85.1.323S	8	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2007	298	3					333	334		10.1001/jama.298.3.333	http://dx.doi.org/10.1001/jama.298.3.333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190US	17635895				2022-12-24	WOS:000248086700029
J	Ma, JF; Yamaji, N; Mitani, N; Tamai, K; Konishi, S; Fujiwara, T; Katsuhara, M; Yano, M				Ma, Jian Feng; Yamaji, Naoki; Mitani, Namiki; Tamai, Kazunori; Konishi, Saeko; Fujiwara, Toru; Katsuhara, Maki; Yano, Masahiro			An efflux transporter of silicon in rice	NATURE			English	Article							PLANTS; ROOTS; RESISTANCE	Silicon is an important nutrient for the optimal growth and sustainable production of rice(1-4). Rice accumulates up to 10% silicon in the shoot, and this high accumulation is required to protect the plant from multiple abiotic and biotic stresses(1-5). A gene, Lsi1, that encodes a silicon influx transporter has been identified in rice(6). Here we describe a previously uncharacterized gene, low silicon rice 2 (Lsi2), which has no similarity to Lsi1. This gene is constitutively expressed in the roots. The protein encoded by this gene is localized, like Lsi1, on the plasma membrane of cells in both the exodermis and the endodermis, but in contrast to Lsi1, which is localized on the distal side, Lsi2 is localized on the proximal side of the same cells. Expression of Lsi2 in Xenopus oocytes did not result in influx transport activity for silicon, but preloading of the oocytes with silicon resulted in a release of silicon, indicating that Lsi2 is a silicon efflux transporter. The identification of this silicon transporter revealed a unique mechanism of nutrient transport in plants: having an influx transporter on one side and an efflux transporter on the other side of the cell to permit the effective transcellular transport of the nutrients.	Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Tokyo 1030027, Japan; Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Okayama University; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Agrobiological Sciences - Japan	Ma, JF (corresponding author), Okayama Univ, Bioresources Res Inst, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	Feng, Jian/C-7213-2009; Yano, Masahiro/AAC-5441-2019; FUJIWARA, Toru/A-4119-2011; YAMAJI, Naoki/B-2524-2011; Ma, Jianfeng/GZB-0110-2022	Feng, Jian/0000-0003-3411-827X; YAMAJI, Naoki/0000-0002-7499-3004; Katsuhara, Maki/0000-0002-8264-3063; Yano, Masahiro/0000-0003-1510-4622				[Anonymous], 2005, MINERAL NUTR PLANTS; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Gong HJ, 2006, PLANT CELL ENVIRON, V29, P1970, DOI 10.1111/j.1365-3040.2006.01572.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HILDEBRAND M, 1993, GENE, V132, P213, DOI 10.1016/0378-1119(93)90198-C; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Kawai M, 1998, PLANTA, V204, P277, DOI 10.1007/s004250050257; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2003, PLANT SOIL, V249, P383, DOI 10.1023/A:1022842421926; Ma JF, 2002, PLANT PHYSIOL, V130, P2111, DOI 10.1104/pp.010348; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma JianFeng, 2002, Soil, fertilizer and plant silicon research in Japan, DOI 10.1016/B978-044451166-9/50007-5; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Rains DW, 2006, PLANT SOIL, V280, P223, DOI 10.1007/s11104-005-3082-x; Raven J.A., 2001, SILICON AGR, P41, DOI DOI 10.1016/S0928-3420(01)80007-0; Savant NK, 1997, ADV AGRON, V58, P151; Taiz L, 1998, PLANT PHYSIOL, P103; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P191; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P183; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Tallberg P, 2002, WATER RES, V36, P956, DOI 10.1016/S0043-1354(01)00312-8; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1	28	568	623	13	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					209	U12		10.1038/nature05964	http://dx.doi.org/10.1038/nature05964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625566				2022-12-24	WOS:000247934500046
J	Gornall, J				Gornall, Jonathan			Protection for the innocent	BMJ-BRITISH MEDICAL JOURNAL			English	Article												jgornall@mac.com						BATT J, 2004, STOLEN INNOCENCE STO; *BRIS CHILDR YOUNG, 2002, SUDD UN DEATHS CHILD; *DEP ED SKILLS, 2006, WORK SAF CHILDR; Dyer C, 2005, BRIT MED J, V331, P1355, DOI 10.1136/bmj.331.7529.1355-a; Dyer C, 2005, BRIT MED J, V330, P1463, DOI 10.1136/bmj.330.7506.1463-a; Dyer C, 2007, BRIT MED J, V334, P602, DOI 10.1136/bmj.39160.770637.DB; Dyer O, 2004, BRIT MED J, V329, P366, DOI 10.1136/bmj.329.7462.366-a; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV; *ROYAL COLL PAED C, 2007, INV NAT IMP COMPL MA; *ROYAL COLL PATH R, 2004, SUDD UN DEATH INF; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1083	1085		10.1136/bmj.39206.389711.AD	http://dx.doi.org/10.1136/bmj.39206.389711.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525445	Green Published			2022-12-24	WOS:000246975000025
J	Idro, R; Ndiritu, M; Ogutu, B; Mithwani, S; Maitland, K; Berkley, J; Crawley, J; Fegan, G; Bauni, E; Peshu, N; Marsh, K; Neville, B; Newton, C				Idro, Richard; Ndiritu, Moses; Ogutu, Bernhards; Mithwani, Sadik; Maitland, Kathryn; Berkley, James; Crawley, Jane; Fegan, Gregory; Bauni, Evasius; Peshu, Norbert; Marsh, Kevin; Neville, Brian; Newton, Charles			Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; PROGNOSTIC INDICATORS; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; CHILDHOOD MALARIA; TRANSMISSION; CONVULSIONS; EPILEPSY; AFRICA	Context Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described. Objectives To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria. Design, Setting, and Patients A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma. Main Outcome Measures The incidence, pattern, and outcome of neurological involvement. Results Of 58 239 children admitted, 19 560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17517 [37.5%]), agitation (316/11193 [2.8%]), prostration (3223/15643 [20.6%]), and impaired consciousness or coma (2129/16080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100 000 persons and the incidence of malaria with neurological involvement was 1156 per 100 000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P < .001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P < .001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/mu L; P < .001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P < .001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits. Conclusions Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.	Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, Kilifi 80108, Kenya; Makerere Univ, Mulago Hosp, Dept Pediat & Child Hlth, Kampala, Uganda; Kenya Govt Med Res Ctr, Clin Res Ctr, Walter Reed Project, Kisumu, Kenya; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Trop Med, London, England; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, London WC1, England; UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England	Kenya Medical Research Institute; Makerere University; Mulago National Referral Hospital; Kenya Medical Research Institute; Imperial College London; Imperial College London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Idro, R (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, POB 230, Kilifi 80108, Kenya.	ridro@kilifi.kemri-wellcome.org	Newton, Charles/V-7872-2019; Newton, Charles/C-6222-2009; , Ridro/ABD-3556-2020; Newton, Charles RJC/B-7578-2014; Fegan, Greg W/O-8079-2018	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Fegan, Greg W/0000-0002-2663-2765; Berkley, James/0000-0002-1236-849X; Idro, Richard/0000-0003-4728-4605; Maitland, Kathryn/0000-0002-0007-0645	Wellcome Trust [070114] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKPEDE GO, 1993, J TROP PEDIATRICS, V39, P350, DOI 10.1093/tropej/39.6.350; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; *CENTR BUR STAT, 2001, KEN 1999 POP HOUS CE, V1; Central Bureau of Statistics, 1994, KEN POP CENS 1989, VI; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kirigia JM, 1998, TROP MED INT HEALTH, V3, P145, DOI 10.1046/j.1365-3156.1998.00204.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Newton CRJC, 1998, ANN NEUROL, V43, P695, DOI 10.1002/ana.410430603; Newton CRJC, 1997, T ROY SOC TROP MED H, V91, P161, DOI 10.1016/S0035-9203(97)90207-8; Ngoungou EB, 2006, EPILEPSIA, V47, P2147, DOI 10.1111/j.1528-1167.2006.00890.x; Snow Robert W., 1994, Afr J Health Sci, V1, P71; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; Versteeg AC, 2003, TROP MED INT HEALTH, V8, P12, DOI 10.1046/j.1365-3156.2003.00965.x; Waruiru CM, 1996, T ROY SOC TROP MED H, V90, P152, DOI 10.1016/S0035-9203(96)90120-0; WATTANAGOON Y, 1994, T ROY SOC TROP MED H, V88, P426, DOI 10.1016/0035-9203(94)90415-4	34	96	97	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2232	2240		10.1001/jama.297.20.2232	http://dx.doi.org/10.1001/jama.297.20.2232			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519413	Bronze, Green Accepted			2022-12-24	WOS:000246659700023
J	Crosby, SS; Apovian, CM; Grodin, MA				Crosby, Sondra S.; Apovian, Caroline M.; Grodin, Michael A.			Hunger strikes, force-feeding, and physicians' responsibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA USA	Boston University; Boston University; Boston University	Crosby, SS (corresponding author), Boston Med Ctr, Sect Gen Internal Med ACC5, 850 Harrison Ave, Boston, MA 02118 USA.	scrosby@bu.edu		Apovian, Caroline/0000-0002-8029-1922; Grodin, Michael/0000-0002-0929-8929; Crosby, Sondra/0000-0002-1672-5407				Altun G, 2004, FORENSIC SCI INT, V146, P35, DOI 10.1016/j.forsciint.2004.03.022; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; APOVIAN CM, 1990, CRIT CARE MED, V18, P1030, DOI 10.1097/00003246-199009000-00021; Cahill GF, 1998, AM J CLIN NUTR, V68, P1; Crook MA, 2001, NUTRITION, V17, P632, DOI 10.1016/S0899-9007(01)00542-1; FELIG P, 1970, NEW ENGL J MED, V282, P166; Fessler DMT, 2003, J MED ETHICS, V29, P243, DOI 10.1136/jme.29.4.243; GOLDEN T, 2007, NY TIMES        0409, pA12; Golden Tim, 2006, N Y Times Web, pA20; *J WEIR FDN HLTH H, 1995, ASS HUNG STRIK MAN P; KALK WJ, 1991, LANCET, V337, P660, DOI 10.1016/0140-6736(91)92465-E; KERNDT PR, 1982, WESTERN J MED, V137, P379; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; OCONNOR A, 1988, MED SCI LAW, V28, P62, DOI 10.1177/002580248802800115; Peel M, 1997, BRIT MED J, V315, P829, DOI 10.1136/bmj.315.7112.829	15	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					563	566		10.1001/jama.298.5.563	http://dx.doi.org/10.1001/jama.298.5.563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666678				2022-12-24	WOS:000248438100025
J	Galan, JE				Galan, Jorge E.			SnapShot: Effector proteins of type III secretion systems	CELL			English	Editorial Material							HOST-CELLS; IMMUNE-RESPONSES; SHIGELLA; MIMICRY		Yale Univ, Sch Med, Clin Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Clin Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.							Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhang L, 2006, MOL PHARMACEUT, V3, P62, DOI 10.1021/mp050095h	16	17	19	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					192	U5	e1	10.1016/j.cell.2007.06.042	http://dx.doi.org/10.1016/j.cell.2007.06.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632065	Bronze			2022-12-24	WOS:000248587000021
J	Tomita, K; Cooper, JP				Tomita, Kazunori; Cooper, Julia Promisel			The telomere bouquet controls the meiotic spindle	CELL			English	Article							OSCILLATORY NUCLEAR-MOVEMENT; YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; POLE BODY; CHROMOSOME SYNAPSIS; TAZ1 PROTEIN; MEIOSIS; RECOMBINATION; PROPHASE; MICROTUBULES	Bouquet formation, in which telomeres gather to a small region of the nuclear membrane in early meiosis, has been observed in diverse eukaryotes, but the function of the bouquet has remained a mystery. Here, we demonstrate that the telomere bouquet plays a crucial role in controlling the behavior of the fission yeast microtubule- organizing center ( known as the spindle pole body or SPB) and the meiotic spindle. Using mutations that specifically disrupt the bouquet, we analyze chromosome, SPB, and spindle dynamics throughout meiosis. If the bouquet fails to form, the SPB becomes fragmented at meiosis I, leading to monopolar, multiple, and mislocalized spindles. Correct SPB and spindle behavior require not only the SPB recruitment of telomere proteins but also that the proteins are properly bound to telomeric DNA. This discovery illuminates an unanticipated level of communication between chromosomes and the spindle apparatus that may be widely conserved among eukaryotes.	Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England.	julie.cooper@cancer.org.uk	Tomita, Kazunori/P-6363-2019	Tomita, Kazunori/0000-0003-1096-6725; cooper, julia promisel/0000-0003-2171-2587				Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; DEVEAUX LC, 1992, GENETICS, V130, P251; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Golubovskaya IN, 2002, GENETICS, V162, P1979; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; MESSINGER SM, 1991, J CELL SCI, V100, P289; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Niccoli T, 2004, J CELL SCI, V117, P5543, DOI 10.1242/jcs.01475; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Saito TT, 2006, J CELL BIOL, V173, P27, DOI 10.1083/jcb.200512129; Saito TT, 2005, J CELL SCI, V118, P447, DOI 10.1242/jcs.01629; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Tanaka K, 2005, CURR BIOL, V15, P1479, DOI 10.1016/j.cub.2005.07.058; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Tuzon CT, 2004, J CELL BIOL, V165, P759, DOI 10.1083/jcb.200312061; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Wu HY, 2006, MOL CELL BIOL, V26, P3683, DOI 10.1128/MCB.26.10.3683-3694.2006; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 2006, GENETICS, V173, P1187, DOI 10.1534/genetics.105.050062; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	55	83	83	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					113	126		10.1016/j.cell.2007.05.024	http://dx.doi.org/10.1016/j.cell.2007.05.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632059	Bronze			2022-12-24	WOS:000248587000015
J	Rakoff-Nahoum, S; Medzhitov, R				Rakoff-Nahoum, Seth; Medzhitov, Ruslan			Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88	SCIENCE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; SYSTEMIC INFLAMMATION; COLORECTAL-CANCER; KNOCKOUT MICE; MUTATION; INJURY; MOUSE; SUPPRESSION; INHIBITION	Inflammation is increasingly recognized as an important component of tumorigenesis, although the mechanisms and pathways involved are not well understood. Tumor development is regulated by products of several modifier genes, but instructions for their tumor-specific expression are currently unknown. We show that the signaling through the adaptor protein MyD88 has a critical role in spontaneous tumor development in mice with heterozygous mutation in the adenomatous polyposis coli (APC) gene. We found that MyD88-dependent signaling controls the expression of several key modifier genes of intestinal tumorigenesis and has a critical role in both spontaneous and carcinogen-induced tumor development. This study thus reveals the important role of an innate immune signaling pathway in intestinal tumorigenesis.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu						Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CHO CH, 2002, FRONTIERS GASTROINTE, V25; Chulada PC, 2000, CANCER RES, V60, P4705; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; GUKATA M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kettunen HL, 2003, CANCER RES, V63, P5136; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402	28	460	479	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					124	127		10.1126/science.1140488	http://dx.doi.org/10.1126/science.1140488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615359				2022-12-24	WOS:000247776700067
J	Jackson, DJ; Macis, L; Reitner, J; Degnan, BM; Worheide, G				Jackson, Daniel J.; Macis, Luciana; Reitner, Joachim; Degnan, Bernard M.; Woerheide, Gert			Sponge paleogenomics reveals an ancient role for carbonic anhydrase in skeletogenesis	SCIENCE			English	Article							MATRIX PROTEIN; EVOLUTION; SHELL	Sponges (phylum Porifera) were prolific reef-building organisms during the Paleozoic and Mesozoic similar to 542 to 65 million years ago. These ancient animals inherited components of the first multicellular skeletogenic toolkit from the last common ancestor of the Metazoa. Using a paleogenomics approach, including gene- and protein-expression techniques and phylogenetic reconstruction, we show that a molecular component of this toolkit was the precursor to the alpha-carbonic anhydrases (alpha-CAs), a gene family used by extant animals in a variety of fundamental physiological processes. We used the coralline demosponge Astrosclera willeyana, a "living fossil" that has survived from the Mesozoic, to provide insight into the evolution of the ability to biocalcify, and show that the alpha-CA family expanded from a single ancestral gene through several independent gene- duplication events in sponges and eumetazoans.	Geosci Ctr Gottingen, Dept Geobiol, D-37077 Gottingen, Germany; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Gottingen; University of Queensland	Worheide, G (corresponding author), Geosci Ctr Gottingen, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	gert.woerheide@geo.uni-goettingen.de	Wörheide, Gert/C-1080-2008; Jackson, Daniel J./J-5158-2012	Wörheide, Gert/0000-0002-6380-7421; Jackson, Daniel J./0000-0001-9045-381X; Degnan, Bernard/0000-0001-7573-8518				BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; deBoer ML, 2006, BIOL BULL-US, V211, P18, DOI 10.2307/4134574; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; JACKSON DJ, 2006, BMC BIOL, V4; Kawasaki K, 2006, J EXP ZOOL PART B, V306B, P295, DOI 10.1002/jez.b.21088; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Love AC, 2007, EVOL DEV, V9, P51, DOI 10.1111/j.1525-142X.2006.00137.x; Miyamoto H, 2003, J MOLLUS STUD, V69, P87, DOI 10.1093/mollus/69.1.87; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; WILBUR KM, 1948, J BIOL CHEM, V176, P147; WOOD R, 1990, AM SCI, V78, P224; Worheide G, 1998, FACIES, V38, P1, DOI 10.1007/BF02537358	21	98	102	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1893	1895		10.1126/science.1141560	http://dx.doi.org/10.1126/science.1141560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17540861				2022-12-24	WOS:000247602700038
J	Karsak, M; Gaffal, E; Date, R; Wang-Eckhardt, L; Rehnelt, J; Petrosino, S; Starowicz, K; Steuder, R; Schlicker, E; Cravatt, B; Mechoulam, R; Buettner, R; Werner, S; Di Marzo, V; Tuting, T; Zimmer, A				Karsak, Meliha; Gaffal, Evelyn; Date, Rahul; Wang-Eckhardt, Lihua; Rehnelt, Jennifer; Petrosino, Stefania; Starowicz, Katarzyna; Steuder, Regina; Schlicker, Eberhard; Cravatt, Benjamin; Mechoulam, Raphael; Buettner, Reinhard; Werner, Sabine; Di Marzo, Vincenzo; Tueting, Thomas; Zimmer, Andreas			Attenuation of allergic contact dermatitis through the endocannabinoid system	SCIENCE			English	Article							CANNABINOID CB2 RECEPTOR; INVERSE AGONIST; GENE ONTOLOGY; KNOCKOUT MICE; ANANDAMIDE; HYPERSENSITIVITY; INVOLVEMENT; NEUTROPHILS; PROTEIN-1; DEFICIENT	Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation. These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.	Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany; Univ Bonn, Dept Dermatol, Lab Expt Dermatol, D-5300 Bonn, Germany; Life & Brain GmbH, Bonn, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; Univ Bonn, Inst Pharmacol & Toxicol, D-5300 Bonn, Germany; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91905 Jerusalem, Israel; Univ Bonn, Dept Pathol, D-5300 Bonn, Germany; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Bonn; University of Bonn; Consiglio Nazionale delle Ricerche (CNR); University of Bonn; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Hebrew University of Jerusalem; University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zimmer, A (corresponding author), Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de; a.zimmer@uni-bonn.de	Starowicz, Katarzyna/AAB-8595-2022; Schlicker, Eberhard/GVT-2661-2022; Di Marzo, Vincenzo/AAD-7742-2019; Tüting, Thomas/AAJ-3610-2021; Zimmer, Andreas/B-8357-2009	Di Marzo, Vincenzo/0000-0002-1490-3070; Tüting, Thomas/0000-0001-7146-0934; Werner, Sabine/0000-0001-7397-8710; Date, Rahul/0000-0002-6322-1201; Starowicz, Katarzyna/0000-0003-0091-0066; Karsak, Meliha/0000-0001-6612-6317				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; de Paulis A, 2001, INT ARCH ALLERGY IMM, V124, P146, DOI 10.1159/000053694; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; KNOP J, 1982, NATURE, V296, P757, DOI 10.1038/296757a0; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; LEHRER RI, 1969, NATURE, V223, P78, DOI 10.1038/223078a0; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Ueda Y, 2005, EUR J PHARMACOL, V520, P164, DOI 10.1016/j.ejphar.2005.08.013; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	23	252	278	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1494	1497		10.1126/science.1142265	http://dx.doi.org/10.1126/science.1142265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556587				2022-12-24	WOS:000247066400048
J	Ford, ES; Ajani, UA; Croft, JB; Critchley, JA; Labarthe, DR; Kottke, TE; Giles, WH; Capewell, S				Ford, Earl S.; Ajani, Umed A.; Croft, Janet B.; Critchley, Julia A.; Labarthe, Darwin R.; Kottke, Thomas E.; Giles, Wayne H.; Capewell, Simon			Explaining the decrease in US deaths from coronary disease, 1980-2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTOR CHANGES; HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; MYOCARDIAL-INFARCTION; MORTALITY-RATES; DECLINE; PREVALENCE	BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.	Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Healthpartners Res Fdn, Minneapolis, MN USA	University of Liverpool; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Newcastle University - UK; HealthPartners Institute for Education & Research	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk	Shao, Ruitai/AAU-7642-2021	Critchley, Julia/0000-0002-5248-4188	MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], MED EXP PAN SURV; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Burt VL, 1996, HYPERTENSION, V27, P1192; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; *CDCP, PERC AD WHO CURR FOR; Cooper Keith, 2002, Health Care Manag Sci, V5, P259, DOI 10.1023/A:1020378022303; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DOLISZNY KM, 1994, J AM COLL CARDIOL, V24, P95, DOI 10.1016/0735-1097(94)90547-9; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hippisley-Cox J, 2006, BRIT MED J, V332, P912; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2003, LANCET, V361, P1060; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McAlister FA, 2002, INT J EPIDEMIOL, V31, P76, DOI 10.1093/ije/31.1.76; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; *MORB MORT, 2004, 2004 CHART BOOK CARD; *NAT CTR HLTH STAT, 2000, DHHS PUBL; *NAT CTR HLTH STAT, NHANES 1999 2000; Nichol MB, 1999, ANN PHARMACOTHER, V33, P531, DOI 10.1345/aph.18233; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; RYAN R, 2001, HLTH STAT Q, V12, P34; Thom T, 2006, CIRCULATION, V113, pE696, DOI 10.1161/CIRCULATIONAHA.106.174501; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Thom T, 2006, CIRCULATION, V114, pE630, DOI 10.1161/CIRCULATIONAHA.106.180110; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; URAL B, 2006, IMPACT VALIDATED COM; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization, 1980, INT CLASSIFICATION D; 2004, MMWR MORB MORTAL WKL, V53, P82; [No title captured]	53	1931	2020	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2388	2398		10.1056/NEJMsa053935	http://dx.doi.org/10.1056/NEJMsa053935			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554120				2022-12-24	WOS:000247029300008
J	Richards, T				Richards, Tessa			Europe on the rocks - Doctors should do more to tackle alcohol abuse - could a European initiative help galvanise them?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1142	1142		10.1136/bmj.39227.654838.59	http://dx.doi.org/10.1136/bmj.39227.654838.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17540942	Green Published			2022-12-24	WOS:000247137000027
J	Mangan, KP; Levenson, JM				Mangan, Kile P.; Levenson, Jonathan M.			Turning back the clock on neurodegeneration	CELL			English	Editorial Material							MEMORY; P25		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53719 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53719 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53719 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Levenson, JM (corresponding author), Galenea Corp, 300 Technol Sq, Cambridge, MA 02139 USA.	jlevenson@wisc.edu						Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VECSEY CG, 2007, J NEUROSCI; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1	8	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					851	853		10.1016/j.cell.2007.05.033	http://dx.doi.org/10.1016/j.cell.2007.05.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540162	Bronze			2022-12-24	WOS:000247084600002
J	Murata, S; Sasaki, K; Kishimoto, T; Niwa, S; Hayashi, H; Takahama, Y; Tanaka, K				Murata, Shigeo; Sasaki, Katsuhiro; Kishimoto, Toshihiko; Niwa, Shin-ichiro; Hayashi, Hidemi; Takahama, Yousuke; Tanaka, Keiji			Regulation of CD8+ T cell development by thymus-specific proteasomes	SCIENCE			English	Article							20S PROTEASOME; ANTIGEN PRESENTATION; MICE LACKING; GENERATION; SELECTION; PROTEINS; IMMUNOPROTEASOMES; TOLERANCE	Proteasomes are responsible for generating peptides presented by the class I major histocompatibility complex (MHC) molecules of the immune system. Here, we report the identification of a previously unrecognized catalytic subunit called beta 5t. beta 5t is expressed exclusively in cortical thymic epithelial cells, which are responsible for the positive selection of developing thymocytes. Although the chymotrypsin-like activity of proteasomes is considered to be important for the production of peptides with high affinities for MHC class I clefts, incorporation of beta 5t into proteasomes in place of beta 5 or beta 5i selectively reduces this activity. We also found that beta 5t-deficient mice displayed defective development of CD8(+) T cells in the thymus. Our results suggest a key role for beta 5t in generating the MHC class I-restricted CD8(+) T cell repertoire during thymic selection.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & TEchnol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Toho Univ, Fac Sci, Proteome Anal Ctr, Chiba 2748510, Japan; Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan; Link Genom, Chuo Ku, Tokyo 1030024, Japan; Univ Tokushima, Grad Sch Med Sci, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Toho University; Toho University; Tokushima University	Murata, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan.	smurata@rinshoken.or.jp	Murata, Shigeo/A-1426-2010; Takahama, Yousuke/A-5863-2010	Murata, Shigeo/0000-0002-3177-3503; Takahama, Yousuke/0000-0002-4992-9174				Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; COUK O, 1996, ANNU REV BIOCHEM, V65, P801; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tanaka K, 1998, IMMUNOL REV, V163, P161; URINO M, 2002, STRUCTURE, V10, P609; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756	26	424	432	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1349	1353		10.1126/science.1141915	http://dx.doi.org/10.1126/science.1141915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540904				2022-12-24	WOS:000246885600053
J	Porter, SM				Porter, Susannah M.			Seawater chemistry and early carbonate biomineralization	SCIENCE			English	Article							FLUID INCLUSIONS; OSCILLATIONS; HALITE; RATIO		Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Porter, SM (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	porter@geol.ucsb.edu						Bengtson S., 1992, ORIGIN EARLY EVOLUTI, P447; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kovalevych VM, 2006, TERRA NOVA, V18, P95, DOI 10.1111/j.1365-3121.2006.00668.x; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Maloof AC, 2005, CAN J EARTH SCI, V42, P2195, DOI 10.1139/E05-062; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Petrychenko OY, 2005, CHEM GEOL, V219, P149, DOI 10.1016/j.chemgeo.2005.02.003; Ries JB, 2005, PALEOBIOLOGY, V31, P445, DOI 10.1666/0094-8373(2005)031[0445:APICSE]2.0.CO;2; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001	11	138	145	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1302	1302		10.1126/science.1137284	http://dx.doi.org/10.1126/science.1137284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540895				2022-12-24	WOS:000246885600040
J	Hakonarson, H; Grant, SFA; Bradfield, JP; Marchand, L; Kim, CE; Glessner, JT; Grabs, R; Casalunovo, T; Taback, SP; Frackelton, EC; Lawson, ML; Robinson, LJ; Skraban, R; Lu, Y; Chiavacci, RM; Stanley, CA; Kirsch, SE; Rappaport, EF; Orange, JS; Monos, DS; Devoto, M; Qu, HQ; Polychronakos, C				Hakonarson, Hakon; Grant, Struan F. A.; Bradfield, Jonathan P.; Marchand, Luc; Kim, Cecilia E.; Glessner, Joseph T.; Grabs, Rosemarie; Casalunovo, Tracy; Taback, Shayne P.; Frackelton, Edward C.; Lawson, Margaret L.; Robinson, Luke J.; Skraban, Robert; Lu, Yang; Chiavacci, Rosetta M.; Stanley, Charles A.; Kirsch, Susan E.; Rappaport, Eric F.; Orange, Jordan S.; Monos, Dimitri S.; Devoto, Marcella; Qu, Hui-Qi; Polychronakos, Constantin			A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene	NATURE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; NATURAL-KILLER-CELLS; SUSCEPTIBILITY GENES; FUNCTIONAL VARIANT; INSULIN GENE; LOCUS; MELLITUS; AUTOIMMUNITY; MHC; POLYMORPHISMS	Type 1 diabetes (T1D) in children results from autoimmune destruction of pancreatic beta cells, leading to insufficient production of insulin(1). A number of genetic determinants of T1D have already been established through candidate gene studies, primarily within the major histocompatibility complex(2-4) but also within other loci(5-12). To identify new genetic factors that increase the risk of T1D, we performed a genome-wide association study in a large paediatric cohort of European descent. In addition to confirming previously identified loci(2-9), we found that T1D was significantly associated with variation within a 233-kb linkage disequilibrium block on chromosome 16p13. This region contains KIAA0350, the gene product of which is predicted to be a sugar-binding, C-type lectin. Three common non-coding variants of the gene (rs2903692, rs725613 and rs17673553) in strong linkage disequilibrium reached genome-wide significance for association with T1D. A subsequent transmission disequilibrium test replication study in an independent cohort confirmed the association. These results indicate that KIAA0350 might be involved in the pathogenesis of T1D and demonstrate the utility of the genome-wide association approach in the identification of previously unsuspected genetic determinants of complex traits.	Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Abramson Res Ctr, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0Z2, Canada; Univ Ottawa, Div Endocrinol, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; Markham Stouffville Hosp, Markham, ON L3P 7P3, Canada; Childrens Hosp Philadelphia Nucleic Acid & Prot C, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; McGill University; University of Manitoba; University of Ottawa; Children's Hospital of Eastern Ontario; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; constantin.polychronakos@mcgill.ca	Devoto, Marcella/AAP-7595-2021; Rappaport, Eric/GRO-4051-2022; Orange, Jordan S/D-5239-2009; Polychronakos, Constantin/B-8151-2008; Qu, Hui-Qi/B-4719-2009; Lawson, Margaret/M-6969-2015	Qu, Hui-Qi/0000-0001-9317-4488; orange, jordan/0000-0001-7117-7725; Lawson, Margaret/0000-0002-2370-9552; DEVOTO, MARCELLA/0000-0002-4431-5114; STANLEY, CHARLES/0000-0003-4881-9392; Grant, Struan/0000-0003-2025-5302; Polychronakos, Constantin/0000-0002-7624-6635; Glessner, Joseph/0000-0001-5131-2811				Anjos SM, 2004, J CLIN ENDOCR METAB, V89, P6257, DOI 10.1210/jc.2004-0881; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Biason-Lauber A, 2005, DIABETOLOGIA, V48, P900, DOI 10.1007/s00125-005-1723-5; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fisher R.A., 1958, STAT METHODS RES WOR; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; NERUP J, 1974, LANCET, V2, P864; Noble JA, 1996, AM J HUM GENET, V59, P1134; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PURCELL S, IN PRESS AM J HUM GE; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TODD JA, 2007, NATURE GENET, DOI DOI 10.1038/NG2068; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843	35	412	431	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					591	U7		10.1038/nature06010	http://dx.doi.org/10.1038/nature06010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632545				2022-12-24	WOS:000248446700043
J	Kerszberg, M; Wolpert, L				Kerszberg, Michel; Wolpert, Lewis			Specifying positional information in the embryo: Looking beyond morphogens	CELL			English	Article							GRADIENT FORMATION; SONIC HEDGEHOG; CELL POLARITY; TRANSPORT; PATTERN; ESTABLISHMENT; XENOPUS	Concentration gradients of small diffusible molecules called morphogens are key regulators of development, specifying position during pattern formation in the embryo. It is now becoming clear that additional or alternative mechanisms involving interactions among cells are also crucial for positional specification.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Paris 06, UMR 7138, CNRS, Paris, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Kerszberg, M (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	mkersz@ccr.jussieu.fr; profwolpert@yahoo.com						Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MEINHARDT H, 1978, J THEOR BIOL, V74, P307, DOI 10.1016/0022-5193(78)90078-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WOLPERT L, 2006, PRINCIPLES DEV, P24; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	37	109	110	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					205	209		10.1016/j.cell.2007.06.038	http://dx.doi.org/10.1016/j.cell.2007.06.038			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662932	Bronze			2022-12-24	WOS:000248588000007
J	Mehl, MR; Vazire, S; Ramirez-Esparza, N; Slatcher, RB; Pennebaker, JW				Mehl, Matthias R.; Vazire, Simine; Ramirez-Esparza, Nairan; Slatcher, Richard B.; Pennebaker, James W.			Are women really more talkative than men?	SCIENCE			English	Article									Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	University of Arizona; Washington University (WUSTL); University of Texas System; University of Texas Austin	Mehl, MR (corresponding author), Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA.	mehl@email.arizona.edu	Pennebaker, James W/E-5997-2013; Pennebaker, James/GLR-6058-2022; Ramirez-Esparza, Nairan/Q-2854-2018	Pennebaker, James W/0000-0001-9091-214X; Vazire, Simine/0000-0002-3933-9752	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052391] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 52391] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brizendine L., 2006, FEMALE BRAIN; James D., 1993, GENDER CONVERSATIONA, P281; LAKOFF R, 1975, LANGUAGE WORNANS PLA; LIBERMAN M, SEX LINKED LEXICAL B; Litosseliti L., 2006, GENDER LANGUAGE THEO; Mehl MR, 2001, BEHAV RES METH INS C, V33, P517, DOI 10.3758/BF03195410; Rayson Paul., 1997, INT J CORPUS LINGUIS, V2, P133, DOI DOI 10.1075/IJCL.2.1.07RAY	7	219	224	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					82	82		10.1126/science.1139940	http://dx.doi.org/10.1126/science.1139940			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615349				2022-12-24	WOS:000247776700054
J	Johnson, DS; Bai, L; Smith, BY; Patel, SS; Wang, MD				Johnson, Daniel S.; Bai, Lu; Smith, Benjamin Y.; Patel, Smita S.; Wang, Michelle D.			Single-molecule studies reveal dynamics of DNA unwinding by the ring-shaped T7 helicase	CELL			English	Article							STRANDED-DNA; CRYSTAL-STRUCTURE; HEXAMERIC HELICASE; BACTERIOPHAGE T7; RECBCD ENZYME; MACROMOLECULAR MACHINES; ACTIVE MECHANISM; GENE-4 PROTEIN; COLI UVRD; TRANSLOCATION	Helicases are molecular motors that separate DNA strands for efficient replication of genomes. We probed the kinetics of individual ring-shaped T7 helicase molecules as they unwound double-stranded DNA (dsDNA) or translocated on single-stranded DNA (ssDNA). A distinctive DNA sequence dependence was observed in the unwinding rate that correlated with the local DNA unzipping energy landscape. The unwinding rate increased similar to 10- fold (approaching the ssDNA translocation rate) when a destabilizing force on the DNA fork junction was increased from 5 to 11 pN. These observations reveal a fundamental difference between the mechanisms of ring-shaped and nonring-shaped helicases. The observed force-velocity and sequence dependence are not consistent with a simple passive unwinding model. However, an active unwinding model fully supports the data even though the helicase on its own does not unwind at its optimal rate. This work offers insights into possible ways helicase activity is enhanced by associated proteins.	Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	mdw17@cornell.edu		Johnson, Daniel/0000-0001-8906-0509	NIGMS NIH HHS [R01 GM059849-05, R01 GM059849, R01 GM059849-04, R01 GM055310, R01 GM059849-07, R01 GM059849-09, GM55310, R01 GM059849-06A1, R01 GM059849-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059849, R01GM055310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; AMARATUNGA M, 1993, BIOCHEMISTRY-US, V32, P6815, DOI 10.1021/bi00078a003; [Anonymous], 1992, INTERMOLECULAR SURFA; Bertram RD, 2002, BIOCHEMISTRY-US, V41, P7725, DOI 10.1021/bi025755s; BETTERDON MD, 2005, SOFT MATTER PHYS, V71; Betterton MD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.258103; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; CHEN YZ, 1992, J BIOMOL STRUCT DYN, V10, P415, DOI 10.1080/07391102.1992.10508656; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2004, BIOPHYS J, V86, p328A; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350	58	186	190	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1299	1309		10.1016/j.cell.2007.04.038	http://dx.doi.org/10.1016/j.cell.2007.04.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604719	Bronze, Green Accepted			2022-12-24	WOS:000247911400016
J	Vega, FM; Ridley, AJ				Vega, Francisco M.; Ridley, Anne J.			SnapShot: Rho family GTPases	CELL			English	Editorial Material							PROTEINS; CANCER		Kings Coll London, Randall Div Cell & Mol Biophys, London, England	University of London; King's College London	Vega, FM (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London, England.		Vega, Francisco M./C-4678-2008	Vega, Francisco M./0000-0002-9015-864X				Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sorokina EM, 2005, J CELL BIOCHEM, V94, P225, DOI 10.1002/jcb.20327; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012	9	50	56	3	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1430	U2		10.1016/j.cell.2007.06.021	http://dx.doi.org/10.1016/j.cell.2007.06.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604728	Bronze			2022-12-24	WOS:000247911400027
J	Chan, CS; Guzman, JN; Ilijic, E; Mercer, JN; Rick, C; Tkatch, T; Meredith, GE; Surmeier, DJ				Chan, C. Savio; Guzman, Jaime N.; Ilijic, Ema; Mercer, Jeff N.; Rick, Caroline; Tkatch, Tatiana; Meredith, Gloria E.; Surmeier, D. James			'Rejuvenation' protects neurons in mouse models of Parkinson's disease	NATURE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; MEDIUM SPINY NEURONS; CA2+ CHANNELS; CHOLINERGIC INTERNEURONS; CALCIUM-ANTAGONISTS; STRIATAL LEVEL; PATHOGENESIS; MECHANISMS	Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Mol & Cellular Pharmacol, Chicago, IL 60064 USA	Northwestern University; Feinberg School of Medicine; Chicago Medical School; Rosalind Franklin University Medical & Science	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011	Chan, C. Savio/0000-0002-3474-1718; Tkatch, Tatiana/0000-0001-6626-7435	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Beal MF, 1998, ANN NEUROL, V44, pS110; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bywood PT, 2003, EXP NEUROL, V179, P47, DOI 10.1006/exnr.2002.8044; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GROSSMAN E, 1991, AM J CARDIOL, V68, P65, DOI 10.1016/0002-9149(91)90712-T; Hasbani DM, 2005, J NEUROSCI, V25, P9428, DOI 10.1523/JNEUROSCI.0130-05.2005; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Hows MEP, 2004, J NEUROSCI METH, V137, P221, DOI 10.1016/j.jneumeth.2004.02.011; Jiang Q, 2006, J NEUROSCI, V26, P4318, DOI 10.1523/JNEUROSCI.0118-06.2006; Johnson BA, 2001, AM J PSYCHIAT, V158, P1191, DOI 10.1176/appi.ajp.158.8.1191; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; KUPSCH A, 1995, NEUROREPORT, V6, P621, DOI 10.1097/00001756-199503000-00009; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MERCURI NB, 1994, BRIT J PHARMACOL, V113, P831, DOI 10.1111/j.1476-5381.1994.tb17068.x; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; MICHEL D, 1990, CERAM TRANS, V6, P435; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Phinney AL, 2006, PARKINSONISM RELAT D, V12, P228, DOI 10.1016/j.parkreldis.2005.12.002; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rodnitzky RL, 1999, DRUGS, V57, P845, DOI 10.2165/00003495-199957060-00001; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Shepard PD, 1999, BRAIN RES, V817, P104, DOI 10.1016/S0006-8993(98)01231-1; Song WJ, 1998, J NEUROSCI, V18, P3124; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zecca L, 2003, TRENDS NEUROSCI, V26, P578, DOI 10.1016/j.tins.2003.08.009; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	66	614	631	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1081	U5		10.1038/nature05865	http://dx.doi.org/10.1038/nature05865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17558391				2022-12-24	WOS:000247564600031
J	Feudtner, C; Feinstein, JA; Satchell, M; Zhao, HQ; Kang, TI				Feudtner, Chris; Feinstein, James A.; Satchell, Marlon; Zhao, Huaqing; Kang, Tammy I.			Shifting place of death among children with complex chronic conditions in the United States, 1989-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MULTIPLE IMPUTATION; ETHNIC-DIFFERENCES; WASHINGTON-STATE; PALLIATIVE CARE; CANCER-PATIENTS; HOME; HOSPICE; TRENDS; SITE	Context The place where children with complex chronic conditions are dying may be shifting toward residential homes due to the evolving epidemiology of life-threatening childhood conditions, advances in home-based medical technology, and changes in attitudes about pediatric palliative care and hospice services. Objectives To determine whether pediatric deaths attributed to complex chronic conditions are increasingly occurring in the home and to assess race and ethnicity disparities in the location of death. Design, Setting, and Participants Retrospective national-level case series drawn from the National Center for Health Statistics' Multiple Cause of Death Files spanning 1989-2003. Participants included all deceased individuals aged 19 years or younger with a complex chronic condition excluding injury and noncomplex chronic conditions ( as classified by International Classification of Diseases, Ninth Revision or International Classification of Diseases, Tenth Revision). Main Outcome Measure Place where death occurred. Results Among the 22.1% of deaths ( 198 160 of 896 509 total deaths) attributed to a complex chronic condition between 1989 and 2003, the percentage of individuals dying at home increased significantly ( P <. 001) over time for infants ( aged < 1 year) (4.9% in 1989 and 7.3% in 2003); 1- to 9-year-olds (17.9% and 30.7%); and for 10- to 19-year-olds (18.4% and 32.2%). Adjusting for decedent characteristics, the odds of dying at home increased significantly each year ( odds ratio, 1.04; 95% confidence interval, 1.03-1.04) and were reduced among both black and Hispanic decedents ( odds ratio, 0.50; 95% confidence interval, 0.48-0.52 and odds ratio, 0.52; 95% confidence interval, 0.50-0.54, respectively) compared with white decedents. Conclusions Children who die with underlying complex chronic conditions increasingly are dying at home. Racial and ethnic disparities regarding place of death may represent important limitations and opportunities for improvement in the current systems of pediatric chronic and palliative care.	Childrens Hosp Philadelphia, Pediat Adv Care Team, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Pediat Generalist Res Grp, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Biostat & Data Management Core, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Pediat Adv Care Team, 3535 Market St,Room 1523,34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	feudtner@email.chop.edu	Feudtner, Chris/AAI-1126-2019; Feinstein, James Aaron/I-6373-2013	Feudtner, Chris/0000-0002-5879-0434; Feinstein, James Aaron/0000-0003-3074-8805	AHRQ HHS [K08 HS00002] Funding Source: Medline; NINR NIH HHS [R21-NR008614] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR008614] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Burge F, 2003, CAN MED ASSOC J, V168, P265; Burge FI, 2005, J RURAL HEALTH, V21, P233, DOI 10.1111/j.1748-0361.2005.tb00088.x; Caveney AF, 2006, PUBLIC HEALTH REP, V121, P275, DOI 10.1177/003335490612100309; *CDCP, 1996, DOC PUBL US MULT CAU; *COMM PALL END OF, 2003, CHILDR DIE IMPR PALL; Davies E, 2006, BRIT J CANCER, V95, P593, DOI 10.1038/sj.bjc.6603305; Enguidanos S, 2005, J AM GERIATR SOC, V53, P1411, DOI 10.1111/j.1532-5415.2005.53410.x; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Feudtner Chris, 2005, BMC Pediatr, V5, P8, DOI 10.1186/1471-2431-5-8; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Fox CS, 2005, AM J CARDIOL, V95, P856, DOI 10.1016/j.amjcard.2004.12.011; GOLDMAN A, 1990, ARCH DIS CHILD, V65, P641, DOI 10.1136/adc.65.6.641; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Guyer B, 2000, PEDIATRICS, V106, P1307, DOI 10.1542/peds.106.6.1307; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; Iwashyna TJ, 2002, J AM GERIATR SOC, V50, P1113, DOI 10.1046/j.1532-5415.2002.50269.x; Johnson KS, 2005, J AM GERIATR SOC, V53, P2209, DOI 10.1111/j.1532-5415.2005.00502.x; KATZ BP, 1979, PUBLIC HEALTH REP, V94, P522; Kreicbergs U, 2005, J CLIN ONCOL, V23, P9162, DOI 10.1200/JCO.2005.08.557; LAUER ME, 1989, CANCER, V63, P988, DOI 10.1002/1097-0142(19890301)63:5<988::AID-CNCR2820630534>3.0.CO;2-Y; Leuthner Steven R, 2004, J Palliat Med, V7, P269, DOI 10.1089/109662104773709396; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MCCUSKER J, 1983, PUBLIC HEALTH REP, V98, P170; Meier DE, 2007, J PALLIAT MED, V10, P284, DOI 10.1089/jpm.2006.9985; MOINPOUR CM, 1989, AM J PUBLIC HEALTH, V79, P1549, DOI 10.2105/AJPH.79.11.1549; MOR V, 1983, J HEALTH SOC BEHAV, V24, P375, DOI 10.2307/2136403; Mor Vincent, 2005, J Palliat Med, V8, P58, DOI 10.1089/jpm.2005.8.58; MULHERN RK, 1983, PEDIATRICS, V71, P743; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; PALFREY JS, 1994, PUBLIC HEALTH REP, V109, P226; Polissar L, 1987, J Community Health, V12, P40, DOI 10.1007/BF01321396; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Stuart G, 2002, HEART, V88, pI1; Surkan PJ, 2006, PALLIATIVE MED, V20, P161, DOI 10.1191/0269216306pm1139oa; Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (full printed version), 2003, UN TREATM CONFR RAC; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	40	159	163	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2725	2732		10.1001/jama.297.24.2725	http://dx.doi.org/10.1001/jama.297.24.2725			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595273	Bronze			2022-12-24	WOS:000247528700022
J	Jordan, N; Boody, G; Broussard, W; Glover, JD; Keeney, D; McCown, BH; McIsaac, G; Muller, M; Murray, H; Neal, J; Pansing, C; Turner, RE; Warner, K; Wyse, D				Jordan, N.; Boody, G.; Broussard, W.; Glover, J. D.; Keeney, D.; McCown, B. H.; McIsaac, G.; Muller, M.; Murray, H.; Neal, J.; Pansing, C.; Turner, R. E.; Warner, K.; Wyse, D.			Environment - Sustainable development of the agricultural bio-economy	SCIENCE			English	Editorial Material							UNITED-STATES; BIOMASS; BIOFUELS		Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA; Land Stewardship Project, White Bear Lake, MN 55110 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Land Inst, Salina, KS 67401 USA; Inst Agr & Trade Policy, Minneapolis, MN 55404 USA; Univ Wisconsin, Ctr Integrated Agr Syst, Madison, WI 53706 USA; Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; Univ Minnesota, Minnesota Inst Sustainable Agr, St Paul, MN 55108 USA; Iowa State Univ, Leopold Ctr Sustainable Agr, Ames, IA 50011 USA; Mississippi River Basin Alliance, Minneapolis, MN USA; Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA; Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 94053 USA	University of Minnesota System; University of Minnesota Twin Cities; Louisiana State University System; Louisiana State University; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Louisiana State University System; Louisiana State University; Santa Clara University	Jordan, N (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA.	jorda020@umn.edu		Broussard, Whitney/0000-0001-6000-2751				Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Brown RA, 2000, AGR ECOSYST ENVIRON, V78, P31, DOI 10.1016/S0167-8809(99)00115-2; DUFFY M, 2004, AGDM NEWSL       OCT; Eaglesham A., 2006, SUMM P 3 ANN WORLD C; ERS, 2007, FARM INC DAT FIL; GANTZER CJ, 1990, J SOIL WATER CONSERV, V45, P641; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hey DL, 2005, ECOL ENG, V24, P279, DOI 10.1016/j.ecoleng.2004.11.014; *IATP, 2006, ASS BIOEC SURV; Jorgensen U, 2005, BIOMASS BIOENERG, V28, P237, DOI 10.1016/j.biombioe.2004.08.006; Keeney D, 2004, NATO ASI S 4 SCI TEC, V41, P29; Kennedy D, 2007, SCIENCE, V316, P515, DOI 10.1126/science.1142978; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; LUBOWSKI RN, 2006, 25 ERS; Reijnders L, 2006, ENERG POLICY, V34, P863, DOI 10.1016/j.enpol.2004.09.001; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; STOFFERHAN CW, 2006, IND FORMING ITS RELA; SULLIVAN P, 2004, 834 ERS; Thornley P, 2006, ENERG POLICY, V34, P2087, DOI 10.1016/j.enpol.2005.02.006; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *USDA ERS, 2000, HIST AM AGR 1607 200	21	189	196	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1570	1571		10.1126/science.1141700	http://dx.doi.org/10.1126/science.1141700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569847				2022-12-24	WOS:000247239900023
J	Kim, H; Chen, JJ; Yu, XH				Kim, Hongtae; Chen, Junjie; Yu, Xiaochun			Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response	SCIENCE			English	Article							BRCA1; CHECKPOINT; BRCA1-BARD1; INTERACTS; REPAIR; KINASE; FANCD2; CHK1	Mutations in the breast cancer susceptibility gene 1 (BRCA1) are associated with an increased risk of breast and ovarian cancers. BRCA1 participates in the cellular DNA damage response. We report the identification of receptor-associated protein 80 (RAP80) as a BRCA1-interacting protein in humans. RAP80 contains a tandem ubiquitin-interacting motif domain, which is required for its binding with ubiquitin in vitro and its damage-induced foci formation in vivo. Moreover, RAP80 specifically recruits BRCA1 to DNA damage sites and functions with BRCA1 in G(2)/M checkpoint control. Together, these results suggest the existence of a ubiquitination-dependent signaling pathway involved in the DNA damage response.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA	Yale University; University of Michigan System; University of Michigan	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu; xiayu@med.umich.edu	高, 雨莉/HGU-8187-2022		NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA089239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Deng CX, 2000, BIOESSAYS, V22, P728; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Liu QH, 2000, GENE DEV, V14, P1448; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Takai H, 2000, GENE DEV, V14, P1439; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	21	437	446	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1202	1205		10.1126/science.1139621	http://dx.doi.org/10.1126/science.1139621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525342				2022-12-24	WOS:000246724300046
J	Davis, MC; Dahn, RD; Shubin, NH				Davis, Marcus C.; Dahn, Randall D.; Shubin, Neil H.			An autopodial-like pattern of Hox expression in the fins of a basal actinopterygian fish	NATURE			English	Article							SONIC-HEDGEHOG EXPRESSION; PECTORAL FIN; POLARIZING ACTIVITY; POLYODON-SPATHULA; LIMB; EVOLUTION; GENES; ORIGIN; DHAND; BUD	Comparative analyses of Hox gene expression and regulation in teleost fish and tetrapods support the long-entrenched notion that the distal region of tetrapod limbs, containing the wrist, ankle and digits, is an evolutionary novelty(1-4). Data from fossils support the notion that the unique features of tetrapod limbs were assembled over evolutionary time in the paired fins of fish(5). The challenge in linking developmental and palaeontological approaches has been that developmental data for fins and limbs compare only highly derived teleosts and tetrapods; what is lacking are data from extant taxa that retain greater portions of the fin skeletal morphology considered primitive to all bony fish(6,7). Here, we report on the expression and function of genes implicated in the origin of the autopod in a basal actinopterygian, Polyodon spathula. Polyodon exhibits a late-phase, inverted collinear expression of 5' HoxD genes, a pattern of expression long considered a developmental hallmark of the autopod and shown in tetrapods to be controlled by a 'digit enhancer' region. These data show that aspects of the development of the autopod are primitive to tetrapods and that the origin of digits entailed the redeployment of ancient patterns of gene activity.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Field Museum Nat Hist, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Davis, Marcus/0000-0002-2462-0138				Altaba ARI, 1999, DEVELOPMENT, V126, P3205; BEMIS WE, 1992, J MORPHOL, V213, P47, DOI 10.1002/jmor.1052130106; Charite J, 2000, DEVELOPMENT, V127, P2461; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Hoffman L, 2002, INT J DEV BIOL, V46, P949; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mabee PM, 2000, AM ZOOL, V40, P789, DOI 10.1668/0003-1569(2000)040[0789:DDAPSE]2.0.CO;2; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Prince VE, 1998, DEVELOPMENT, V125, P407; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N.H., 2006, NATURE, V440, P747; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Yelon D, 2000, DEVELOPMENT, V127, P2573	22	106	113	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					473	U3		10.1038/nature05838	http://dx.doi.org/10.1038/nature05838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522683				2022-12-24	WOS:000246693100047
J	Potter, S; Govindarajulu, S; Shere, M; Braddon, F; Curran, G; Greenwood, R; Sahu, AK; Cawthorn, SJ				Potter, Shelley; Govindarajulu, Sasi; Shere, Mike; Braddon, Fiona; Curran, Geoffrey; Greenwood, Rosemary; Sahu, Ajay K.; Cawthorn, Simon J.			Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUSPECTED CANCER; 2-WEEK WAIT; IMPACT	Objective To investigate the long term impact of the two week wait rule for breast cancer on referral patterns, cancer diagnoses, and waiting times. Design Prospective cohort study. Setting A specialist breast clinic in a teaching hospital in Bristol. Participants All patients referred to breast clinic from primary care between 1999 and 2005. Main outcome measures Number, route, and outcome of referrals from primary care and waiting times for urgent and routine appointments. Results The annual number of referrals increased by 9% over the seven years from 3499 in 1999 to 3821 in 2005. Routine referrals decreased by 24% (from 1748 to 1331), but two week wait referrals increased by 42% (from 1751 to 2490) during this time. The percentage of patients diagnosed with cancer in the two week wait group decreased from 12.8% (224/1751) in 1999 to 7.7% (191/2490) in 2005 (P<0.001), while the number of cancers detected in the "routine" group increased from 2.5% (43/1748) to 5.3% (70/1331) (P<0.001) over the same period. About 27% (70/261) of people with cancer are currently referred in the non-urgent group. Waiting times for routine referrals have increased with time. Conclusion The two week wait rule for breast cancer is failing patients. The number of cancers detected in the two week wait population is decreasing, and an unacceptable proportion is now being referred via the routine route. If breast cancer services are to be improved, the two week wait rule should be reviewed urgently.	Frenchay Hosp, Breast Care Ctr, Bristol BS16 1JE, Avon, England; Southmead Hosp, Bristol, Avon, England; United Bristol Healthcare Trust, Res & Dev Unit, Bristol, Avon, England	Southmead Hospital	Cawthorn, SJ (corresponding author), Frenchay Hosp, Breast Care Ctr, Bristol BS16 1JE, Avon, England.	Simon.Cawthorn@nbt.nhs.uk	Potter, Shelley/C-5924-2012	Potter, Shelley/0000-0002-6977-312X				Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Cant PJ, 2000, BRIT J SURG, V87, P1082, DOI 10.1046/j.1365-2168.2000.01551.x; Coates AS, 1999, LANCET, V353, P1112, DOI 10.1016/S0140-6736(99)00082-3; Dodds W, 2004, EUR J CANCER CARE, V13, P82, DOI 10.1111/j.1365-2354.2004.00447.x; Fentiman IS, 2005, INT J CLIN PRACT, V59, P1251, DOI 10.1111/j.1368-5031.2005.00728d.x; Ganz Patricia A., 2000, Breast J, V6, P324, DOI 10.1046/j.1524-4741.2000.20042.x; GRIFFITHS C, 2006, EUR J SURG ONCOL, V32, P1042; Hanna SJ, 2005, INT J CLIN PRACT, V59, P1334, DOI 10.1111/j.1368-5031.2005.00687.x; *HCS, 1998, 1998242 HCS; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; Khawaja AR, 2000, EUR J SURG ONCOL, V26, P536, DOI 10.1053/ejso.2000.0942; *NAT I CLIN EXC, 2005, NICE GUID REF SUSP C; PAICE A, 2006, EUR J SURG ONCOL, V32, pA1036; PAICE A, 2006, EUR J SURG ONC, V32, P1036; Patel RS, 2000, EUR J SURG ONCOL, V26, P452, DOI 10.1053/ejso.1999.0920; Sauven P, 2001, BRIT MED J, V323, P864; Sauven P, 2002, BREAST, V11, P262, DOI 10.1054/brst.2001.0390	17	76	77	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2007	335	7614					288	290A		10.1136/bmj.39258.688553.55	http://dx.doi.org/10.1136/bmj.39258.688553.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17631514	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000248987400024
J	Wadman, M				Wadman, Meredith			The pain game	NATURE			English	News Item																		Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	4	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					400	401		10.1038/448400a	http://dx.doi.org/10.1038/448400a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653159				2022-12-24	WOS:000248302700014
J	Light, DW				Light, Donald W.			Is G8 putting pro-fits before the world's poorest children?	LANCET			English	Editorial Material									Ctr Bioeth, Princeton, NJ 08540 USA		Light, DW (corresponding author), Ctr Bioeth, Princeton, NJ 08540 USA.	dlight@princeton.edu						BARDER O, 2006, 80 CTR GLOB DEV; *CTR GLOB DEV, 2005, MAK MARK VACC ID ACT; FARLOW A, 2005, INNOVATION STRATEGY, V1, P66; *GAVI ALL WORLD BA, 2007, Q A ADV MARK COMM AM; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; Kremer M, 2004, STRONG MED CREATING; LEVINE O, 2006, GAVI ALLIANCE INVEST; Light DW, 2005, PLOS MED, V2, P934, DOI 10.1371/journal.pmed.0020271; ROSENTHAL E, 2007, NY TIMES        0210; Tremonti G., 2005, ADV MARKET COMMITMEN; 2006, AMC PILOT PROPOSAL	11	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					297	298		10.1016/S0140-6736(07)61138-6	http://dx.doi.org/10.1016/S0140-6736(07)61138-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662863				2022-12-24	WOS:000248426100007
J	Magnani, F; Mencuccini, M; Borghetti, M; Berbigier, P; Berninger, F; Delzon, S; Grelle, A; Hari, P; Jarvis, PG; Kolari, P; Kowalski, AS; Lankreijer, H; Law, BE; Lindroth, A; Loustau, D; Manca, G; Moncrieff, JB; Rayment, M; Tedeschi, V; Valentini, R; Grace, J				Magnani, Federico; Mencuccini, Maurizio; Borghetti, Marco; Berbigier, Paul; Berninger, Frank; Delzon, Sylvain; Grelle, Achim; Hari, Pertti; Jarvis, Paul G.; Kolari, Pasi; Kowalski, Andrew S.; Lankreijer, Harry; Law, Beverly E.; Lindroth, Anders; Loustau, Denis; Manca, Giovanni; Moncrieff, John B.; Rayment, Mark; Tedeschi, Vanessa; Valentini, Riccardo; Grace, John			The human footprint in the carbon cycle of temperate and boreal forests	NATURE			English	Article							NITROGEN DEPOSITION; EUROPEAN FORESTS; PINE FORESTS; ECOSYSTEM; STORAGE; BALANCE; STAND; CHRONOSEQUENCE; SEQUESTRATION; RESPIRATION	Temperate and boreal forests in the Northern Hemisphere cover an area of about 2 x 10(7) square kilometres and act as a substantial carbon sink (0.6 - 0.7 petagrams of carbon per year)(1). Although forest expansion following agricultural abandonment is certainly responsible for an important fraction of this carbon sink activity, the additional effects on the carbon balance of established forests of increased atmospheric carbon dioxide, increasing temperatures, changes in management practices and nitrogen deposition are difficult to disentangle, despite an extensive network of measurement stations(2,3). The relevance of this measurement effort has also been questioned(4), because spot measurements fail to take into account the role of disturbances, either natural ( fire, pests, windstorms) or anthropogenic ( forest harvesting). Here we show that the temporal dynamics following stand-replacing disturbances do indeed account for a very large fraction of the overall variability in forest carbon sequestration. After the confounding effects of disturbance have been factored out, however, forest net carbon sequestration is found to be overwhelmingly driven by nitrogen deposition, largely the result of anthropogenic activities(5). The effect is always positive over the range of nitrogen deposition covered by currently available data sets, casting doubts on the risk of widespread ecosystem nitrogen saturation(6) under natural conditions. The results demonstrate that mankind is ultimately controlling the carbon balance of temperate and boreal forests, either directly ( through forest management) or indirectly ( through nitrogen deposition).	Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Basilicata, Dept Crop Syst Forestry & Environm Sci, I-85100 Potenza, Italy; INRA, UR1263 EPHYSE, F-33883 Villenave Dornon, France; Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; Swedish Univ Agr Sci, Dept Ecol & Environm Res, SE-75007 Uppsala, Sweden; Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Lund Univ, Dept Forest Geog & Ecosyst Anal, S-22362 Lund, Sweden; Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; Univ Tuscia, Dept Forest Resources & Environm, I-01100 Viterbo, Italy	University of Bologna; University of Edinburgh; University of Basilicata; INRAE; University of Quebec; University of Quebec Montreal; Swedish University of Agricultural Sciences; University of Helsinki; Lund University; Oregon State University; Tuscia University	Magnani, F (corresponding author), Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy.	federico.magnani@unibo.it	Berninger, Frank/A-8891-2010; Sigurdsson, Bjarni D/E-4592-2012; Magnani, Federico/A-2448-2011; Rayment, Mark/L-9848-2016; Delzon, Sylvain/R-9538-2018; Lindroth, Anders/N-4697-2014; Valentini, Riccardo/D-1226-2010; Borghetti, Marco/C-4262-2012; Mencuccini, Maurizio/B-9052-2011; Law, Beverly Elizabeth/G-3882-2010; Kowalski, Andrew S./A-7515-2008; Grace, John/N-9280-2013	Berninger, Frank/0000-0001-7718-1661; Magnani, Federico/0000-0003-4479-0916; Delzon, Sylvain/0000-0003-3442-1711; Lindroth, Anders/0000-0002-7669-784X; Valentini, Riccardo/0000-0002-6756-5634; Borghetti, Marco/0000-0003-3159-6655; Mencuccini, Maurizio/0000-0003-0840-1477; Law, Beverly Elizabeth/0000-0002-1605-1203; Kowalski, Andrew S./0000-0001-9777-9708; Loustau, Denis/0000-0003-3990-400X; Kolari, Pasi/0000-0001-7271-633X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Andren O, 1997, ECOL APPL, V7, P1226, DOI 10.1890/1051-0761(1997)007[1226:ITICBM]2.0.CO;2; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P473, DOI 10.1111/j.1529-8817.2003.0742.x; BOONE RD, 1988, ECOLOGY, V69, P714, DOI 10.2307/1941019; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Harmon ME, 2004, ECOSYSTEMS, V7, P498, DOI 10.1007/s10021-004-0140-9; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Howard EA, 2004, GLOBAL CHANGE BIOL, V10, P1267, DOI 10.1111/j.1529-8817.2003.00804.x; JOHNSON DW, 1992, J ENVIRON QUAL, V21, P1, DOI 10.2134/jeq1992.00472425002100010001x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Landsberg JJ, 1997, FOREST ECOL MANAG, V95, P209, DOI 10.1016/S0378-1127(97)00026-1; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000854; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Mund M., 2004, THESIS G AUGUST U GO; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; PETERSON BJ, 1985, TELLUS B, V37, P117, DOI 10.1111/j.1600-0889.1985.tb00060.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Rothstein DE, 2004, CAN J FOREST RES, V34, P1908, DOI [10.1139/x04-063, 10.1139/X04-063]; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wirth C, 2002, TELLUS B, V54, P611, DOI 10.1034/j.1600-0889.2002.01343.x	30	739	804	19	601	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					848	850		10.1038/nature05847	http://dx.doi.org/10.1038/nature05847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568744				2022-12-24	WOS:000247207500042
J	Steinbrook, R				Steinbrook, Robert			Erythropoietin, the FDA, and oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Berenson Alex, 2007, NY TIMES        0509, pA1; Food and Drug Administration, 2007, FDA AL INF HEALTHC P; *ONC DRUG ADV COMM, 2007, CONT REASS RISKS ER; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9	4	47	50	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2448	2451		10.1056/NEJMp078100	http://dx.doi.org/10.1056/NEJMp078100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568025				2022-12-24	WOS:000247201900003
J	Wolf, M; van Doorn, GS; Leimar, O; Weissing, FJ				Wolf, Max; van Doorn, G. Sander; Leimar, Olof; Weissing, Franz J.			Life-history trade-offs favour the evolution of animal personalities	NATURE			English	Article							INDIVIDUAL-DIFFERENCES; BEHAVIORAL-DIFFERENCES; AVIAN PERSONALITIES; HERITABILITY; CONSEQUENCES; STICKLEBACKS; POPULATIONS; BOLDNESS; SHYNESS	In recent years evidence has been accumulating that personalities are not only found in humans(1) but also in a wide range of other animal species(2-8). Individuals differ consistently in their behavioural tendencies and the behaviour in one context is correlated with the behaviour in multiple other contexts. From an adaptive perspective, the evolution of animal personalities is still a mystery, because a more flexible structure of behaviour should provide a selective advantage(9-11). Accordingly, many researchers view personalities as resulting from constraints imposed by the architecture of behaviour(7) (but see ref. 12). In contrast, we show here that animal personalities can be given an adaptive explanation. Our argument is based on the insight that the trade-off between current and future reproduction(13) often results in polymorphic populations(14) in which some individuals put more emphasis on future fitness returns than others. Life-history theory predicts that such differences in fitness expectations should result in systematic differences in risk-taking behaviour(15). Individuals with high future expectations (who have much to lose) should be more risk-averse than individuals with low expectations. This applies to all kinds of risky situations, so individuals should consistently differ in their behaviour. By means of an evolutionary model we demonstrate that this basic principle results in the evolution of animal personalities. It simultaneously explains the coexistence of behavioural types, the consistency of behaviour through time and the structure of behavioural correlations across contexts. Moreover, it explains the common finding that explorative behaviour and risk-related traits like boldness and aggressiveness are common characteristics of animal personalities(2-8).	Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Groningen; Stockholm University	Weissing, FJ (corresponding author), Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands.	f.j.weissing@rug.nl	van Doorn, G. Sander/G-3247-2011; Leimar, Olof/L-3781-2014; Wolf, Max/L-4903-2013	van Doorn, G. Sander/0000-0002-4703-3788; Leimar, Olof/0000-0001-8621-6977; Wolf, Max/0000-0001-8878-0504; Weissing, Franz J./0000-0003-3281-663X				BAKKER TCM, 1986, BEHAVIOUR, V98, P1, DOI 10.1163/156853986X00937; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Maynard Smith J., 1982, pi; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Pervin L., 1999, HDB PERSONALITY THEO, V2nd; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Roff Derek, 2002, pi; Rueffler C, 2004, THEOR POPUL BIOL, V65, P165, DOI 10.1016/j.tpb.2003.10.001; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2006, J EVOLUTION BIOL, V19, P1437, DOI 10.1111/j.1420-9101.2006.01136.x; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	30	909	926	11	652	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					581	584		10.1038/nature05835	http://dx.doi.org/10.1038/nature05835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538618				2022-12-24	WOS:000246842000046
J	Visbeck, M				Visbeck, Martin			Oceanography - Power of pull	NATURE			English	Editorial Material									Univ Kiel, Leibniz Inst Marine Sci, D-24105 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Visbeck, M (corresponding author), Univ Kiel, Leibniz Inst Marine Sci, Dusternbrooker Weg 20, D-24105 Kiel, Germany.		Visbeck, Martin/G-2461-2011; zhu, xiaoting/E-9873-2011; Visbeck, Martin H/B-6541-2016	Visbeck, Martin/0000-0002-0844-834X; Visbeck, Martin H/0000-0002-0844-834X					0	22	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					383	383		10.1038/447383a	http://dx.doi.org/10.1038/447383a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522660	Bronze			2022-12-24	WOS:000246693100023
J	Hanna, J; Meides, A; Zhang, DP; Finley, D				Hanna, John; Meides, Alice; Zhang, Dan Phoebe; Finley, Daniel			A ubiquitin stress response induces altered proteasome composition	CELL			English	Article							CARBOXY-TERMINAL HYDROLASE; SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME; POLYUBIQUITIN GENE; FEEDBACK-CIRCUIT; HEAT-SHOCK; YEAST; DEGRADATION; TRANSCRIPTION; EXPRESSION	Ubiquitin-dependent protein degradation is essential for cells to survive many environmental stresses. Thus, it may be necessary to buffer ubiquitin and proteasome pools against fluctuation. Proteasome levels are tightly regulated, and proteasome deficiency stimulates a stress response. Here we report a novel pathway of cellular response to ubiquitin depletion. Unlike proteasome, stress, ubiquitin stress does not upregulate proteasome abundance. Instead, ubiquitin stress alters proteasome composition. The proteasome-associated deubiquitinating enzyme Ubp6, which spares ubiquitin from proteasomal degradation, is induced by ubiquitin deficiency. This enhances loading of proteasomes with Ubp6, thereby altering proteasome function. A catalytically inactive mutant of Ubp6 fails to recycle ubiquitin and also inhibits proteasome function directly, thus inducing both ubiquitin stress and proteasome stress. These results show that homeostatic control of the ubiquitin-proteasome pathway can be achieved through signal-dependent, subunit-specific regulation of the proteasome, and indicate a dual role of Ubp6 in regulating ubiquitin levels and proteasome function.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu			NIGMS NIH HHS [R01 GM65592] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 1997, EMBO J, V16, P4826; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; CHEN YP, 1995, BBA-MOL CELL RES, V1268, P59, DOI 10.1016/0167-4889(95)00044-S; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HIROI Y, 1992, FEBS LETT, V307, P156, DOI 10.1016/0014-5793(92)80757-8; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LENKINSKI RE, 1977, BIOCHIM BIOPHYS ACTA, V494, P126, DOI 10.1016/0005-2795(77)90140-4; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; ROSE IA, 1987, P NATL ACAD SCI USA, V84, P1477, DOI 10.1073/pnas.84.6.1477; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Simon JR, 1999, MOL MICROBIOL, V31, P823, DOI 10.1046/j.1365-2958.1999.01220.x; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watt R, 1997, MOL GEN GENET, V253, P439, DOI 10.1007/s004380050341; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	30	153	154	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					747	759		10.1016/j.cell.2007.03.042	http://dx.doi.org/10.1016/j.cell.2007.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512408	Bronze			2022-12-24	WOS:000246788300019
J	Frazer, KA; Eskin, E; Kang, HM; Bogue, MA; Hinds, DA; Beilharz, EJ; Gupta, RV; Montgomery, J; Morenzoni, MM; Nilsen, GB; Pethiyagoda, CL; Stuve, LL; Johnson, FM; Daly, MJ; Wade, CM; Cox, DR				Frazer, Kelly A.; Eskin, Eleazar; Kang, Hyun Min; Bogue, Molly A.; Hinds, David A.; Beilharz, Erica J.; Gupta, Robert V.; Montgomery, Julie; Morenzoni, Matt M.; Nilsen, Geoffrey B.; Pethiyagoda, Charit L.; Stuve, Laura L.; Johnson, Frank M.; Daly, Mark J.; Wade, Claire M.; Cox, David R.			A sequence-based variation map of 8.27 million SNPs in inbred mouse strains	NATURE			English	Article							HAPLOTYPE DIVERSITY; GENETIC-VARIATION; PHENOME PROJECT; LABORATORY MICE; GENOME; PATTERNS; DATABASE; REVEALS; SYSTEM	A dense map of genetic variation in the laboratory mouse genome will provide insights into the evolutionary history of the species(1) and lead to an improved understanding of the relationship between inter-strain genotypic and phenotypic differences. Here we resequence the genomes of four wild-derived and eleven classical strains. We identify 8.27 million high-quality single nucleotide polymorphisms (SNPs) densely distributed across the genome, and determine the locations of the high (divergent subspecies ancestry) and low (common subspecies ancestry) SNP-rate intervals(2-6) for every pairwise combination of classical strains. Using these data, we generate a genome-wide haplotype map containing 40,898 segments, each with an average of three distinct ancestral haplotypes. For the haplotypes in the classical strains that are unequivocally assigned ancestry, the genetic contributions of the Mus musculus subspecies-M. m. domesticus, M. m. musculus, M. m. castaneus and the hybrid M. m. molossinus-are 68%, 6%, 3% and 10%, respectively; the remaining 13% of haplotypes are of unknown ancestral origin. The considerable regional redundancy of the SNP data will facilitate imputation of the majority of these genotypes in less-densely typed classical inbred strains to provide a complete view of variation in additional strains.	Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Jackson Lab, Bar Harbor, ME 04609 USA; NIEHS, Toxicol Operat Branch, Res Triangle Pk, NC 27709 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Frazer, KA (corresponding author), Perlegen Sci, 2021 Stierlin Court, Mountain View, CA 94043 USA.	frazer.kelly@scrippshealth.org	Daly, Mark J/B-2453-2017; Eskin, Eleazar/J-9187-2012	Daly, Mark J/0000-0002-0949-8752; Eskin, Eleazar/0000-0003-1149-4758; Hinds, David/0000-0002-4911-803X; Wade, Claire/0000-0003-3413-4771; Frazer, Kelly/0000-0002-6060-8902	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER; NHLBI NIH HHS [K25 HL080079] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bogue M, 2003, J APPL PHYSIOL, V95, P1335, DOI 10.1152/japplphysiol.00562.2003; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NAKAMURA M, 1962, P JPN ACAD, V38, P348, DOI 10.2183/pjab1945.38.348; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Silver L.M., 1995, MOUSE GENETICS CONCE; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	26	346	359	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1050	U8		10.1038/nature06067	http://dx.doi.org/10.1038/nature06067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17660834				2022-12-24	WOS:000249097600038
J	Weart, RB; Lee, AH; Chien, AC; Haeusser, DP; Hill, NS; Levin, PA				Weart, Richard B.; Lee, Amy H.; Chien, An-Chun; Haeusser, Daniel P.; Hill, Norbert S.; Levin, Petra Anne			A metabolic sensor governing cell size in bacteria	CELL			English	Article							CHROMOSOME SEGREGATION; DIVISION PROTEIN; FTSZ; GROWTH; REPLICATION; INITIATION; LENGTH; PHOSPHOGLUCOMUTASE; IDENTIFICATION; LOCALIZATION	Nutrient availability is one of the strongest determinants of cell size. When grown in rich media, single-celled organisms such as yeast and bacteria can be up to twice the size of their slow-growing counterparts. The ability to modulate size in a nutrient-dependent manner requires cells to: (1) detect when they have reached the appropriate mass for a given growth rate and (2) transmit this information to the division apparatus. We report the identification of a metabolic sensor that couples nutritional availability to division in Bacillus subtilis. A key component of this sensor is an effector, UgtP, which localizes to the division site in a nutrient-dependent manner and inhibits assembly of the tubulin-like cell division protein FtsZ. This sensor serves to maintain a constant ratio of FtsZ rings to cell length regardless of growth rate and ensures that cells reach the appropriate mass and complete chromosome segregation prior to cytokinesis.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	plevin@biology.wustl.edu	Lee, Amy Huei-Yi/K-3896-2019	Lee, Amy Huei-Yi/0000-0003-3250-3246; Levin, Petra/0000-0003-2071-0547; Hill, Norbert/0000-0002-4719-2893	NIGMS NIH HHS [GM64671, R01 GM064671-02, R01 GM064671, R01 GM064671-05, R01 GM064671-04, R01 GM064671-03, R01 GM064671-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; DONACHIE WD, 1989, J BACTERIOL, V171, P4633, DOI 10.1128/jb.171.9.4633-4639.1989; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; JAACKS KJ, 1989, J BACTERIOL, V171, P4121, DOI 10.1128/JB.171.8.4121-4129.1989; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Levin PA, 1998, J BACTERIOL, V180, P6048, DOI 10.1128/JB.180.22.6048-6051.1998; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	36	251	254	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					335	347		10.1016/j.cell.2007.05.043	http://dx.doi.org/10.1016/j.cell.2007.05.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662947	Green Accepted, Bronze			2022-12-24	WOS:000248588000022
J	Gregor, T; Wieschaus, EF; McGregor, AP; Bialek, W; Tank, DW				Gregor, Thomas; Wieschaus, Eric F.; McGregor, Alistair P.; Bialek, William; Tank, David W.			Stability and nuclear dynamics of the bicoid morphogen gradient	CELL			English	Article							DROSOPHILA; DIFFUSION; PROTEIN; CALCIUM; PATTERN; GFP	Patterning in multicellular organisms results from spatial gradients in morphogen concentration, but the dynamics of these gradients remain largely unexplored. We characterize, through in vivo optical imaging, the development and stability of the Bicoid morphogen gradient in Drosophila embryos that express a Bicoid- eGFP fusion protein. The gradient is established rapidly ( similar to 1 hr after fertilization), with nuclear Bicoid concentration rising and falling during mitosis. Interphase levels result from a rapid equilibrium between Bicoid uptake and removal. Initial interphase concentration in nuclei in successive cycles is constant ( +/- 10%), demonstrating a form of gradient stability, but it subsequently decays by approximately 30%. Both direct photobleaching measurements and indirect estimates of Bicoid- eGFP diffusion constants ( D <= 1 mu m(2)/s) provide a consistent picture of Bicoid transport on short ( similar to min) time scales but challenge traditional models of long- range gradient formation. A new model is presented emphasizing the possible role of nuclear dynamics in shaping and scaling the gradient.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Gregor, T (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X; McGregor, Alistair/0000-0002-2908-2420	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM077599] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077599-01, P50 GM071508-01, R01 GM077599-02, R01 GM077599, P50 GM071508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIIZUMI T, 1995, ZOOL SCI, V12, P509, DOI 10.2108/zsj.12.509; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Brown EB, 1999, BIOPHYS J, V77, P2837, DOI 10.1016/S0006-3495(99)77115-8; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Fersht A., 1985, ENZYME STRUCTURE MEC; Foe Victoria E., 1993, P149; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hazelrigg T, 1998, DEV BIOL, V199, P245, DOI 10.1006/dbio.1998.8922; HODGKIN AL, 1957, J PHYSIOL-LONDON, V138, P253, DOI 10.1113/jphysiol.1957.sp005850; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Kiseleva E, 2001, J CELL SCI, V114, P3607; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; LAWRENCE P, 1992, GENETICS ANIMAL DESI; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thummel CS, 1992, DROS INF SERV, V71, P150; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wieschaus E., 1986, P199; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; ZECCA M, 1995, DEVELOPMENT, V121, P2265	31	348	352	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					141	152		10.1016/j.cell.2007.05.026	http://dx.doi.org/10.1016/j.cell.2007.05.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632061	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000248587000017
J	Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, AO; Landthaler, M; Lin, C; Socci, ND; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, RU; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, MC; Weir, DB; Choksi, R; De Vita, G; Frezzetti, D; Trompeter, HI; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; Di Lauro, R; Wernet, P; Macino, G; Rogler, CE; Nagle, JW; Ju, JY; Papavasiliou, FN; Benzing, T; Lichter, P; Tam, W; Brownstein, MJ; Bosio, A; Borkhardt, A; Russo, JJ; Sander, C; Zavolan, M; Tuschl, T				Landgraf, Pablo; Rusu, Mirabela; Sheridan, Robert; Sewer, Alain; Iovino, Nicola; Aravin, Alexei; Pfeffer, Sebastien; Rice, Amanda; Kamphorst, Alice O.; Landthaler, Markus; Lin, Carolina; Socci, Nicholas D.; Hermida, Leandro; Fulci, Valerio; Chiaretti, Sabina; Foa, Robin; Schliwka, Julia; Fuchs, Uta; Novosel, Astrid; Mueller, Roman-Ulrich; Schermer, Bernhard; Bissels, Ute; Inman, Jason; Phan, Quang; Chien, Minchen; Weir, David B.; Choksi, Ruchi; De Vita, Gabriella; Frezzetti, Daniela; Trompeter, Hans-Ingo; Hornung, Veit; Teng, Grace; Hartmann, Gunther; Palkovits, Miklos; Di Lauro, Robert; Wernet, Peter; Macino, Giuseppe; Rogler, Charles E.; Nagle, James W.; Ju, Jingyue; Papavasiliou, F. Nina; Benzing, Thomas; Lichter, Peter; Tam, Wayne; Brownstein, Michael J.; Bosio, Andreas; Borkhardt, Arndt; Russo, James J.; Sander, Chris; Zavolan, Mihaela; Tuschl, Thomas			A mammalian microRNA expression atlas based on small RNA library sequencing	CELL			English	Article							MENTAL-RETARDATION PROTEIN; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; C-ELEGANS; IDENTIFICATION; CLONING; MODULATION; ZEBRAFISH; VIRUSES; TARGETS	MicroRNAs (miRNAs) are small noncoding regulatory RNAs that reduce stability and/or translation of fully or partially sequence-complementary target mRNAs. In order to identify miRNAs and to assess their expression patterns, we sequenced over 250 small RNA libraries from 26 different organ systems and cell types of human and rodents that were enriched in neuronal as well as normal and malignant hematopoietic cells and tissues. We present expression profiles derived from clone count data and provide computational tools for their analysis. Unexpectedly, a relatively small set of miRNAs, many of which are ubiquitously expressed, account for most of the differences in miRNA profiles between cell lineages and tissues. This broad survey also provides detailed and accurate information about mature sequences, precursors, genome locations, maturation processes, inferred transcriptional units, and conservation patterns. We also propose a subclassification scheme for miRNAs for assisting future experimental and computational functional analyses.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, New York, NY 10021 USA; Deutsch Krebsforschungszentrum, Div Mol Genet, D-69120 Heidelberg, Germany; Univ Munich, Dr Von Haunerschen Kinderspital, Dept Hematol & Oncol, D-80337 Munich, Germany; Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Miltenyi Biotec GmbH, D-50829 Cologne, Germany; Inst Genom Res, Rockville, MD 20850 USA; J Craig Venter Inst, Funct Genom, Rockville, MD 20850 USA; Columbia Genome Ctr, Russ Berrie Pavilion, New York, NY 10032 USA; Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany; Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; Hungarian Acad Sci Semmelweis Univ, Lab Neuromorphol, Budapest, Hungary; Albert Einstein Coll Med, Bronx, NY 10461 USA; Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany; Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; IRGS, Biogem Scarl, I-83031 Ariano Irpino, Italy; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; NIH, NINDS, DNA Sequencing Facil, Bethesda, MD 20892 USA; Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80366 Munich, Germany; Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; IBM Corp, CNRS, F-678084 Strasbourg, France; Cold Spring Harbor Lab, Howard Hughes Med Inst, Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA; Univ Dusseldorf, Med Ctr, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; Univ Lausanne, Dept Med Genet, Computat Biol Grp, CH-1005 Lausanne, Switzerland	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Freiburg; Miltenyi Biotec; J. Craig Venter Institute; J. Craig Venter Institute; Columbia University; Heinrich Heine University Dusseldorf; Rockefeller University; Semmelweis University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; University of Bonn; Swiss Institute of Bioinformatics; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Munich; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); International Business Machines (IBM); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Rockefeller University; Heinrich Heine University Dusseldorf; University of Lausanne	Zavolan, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu	Müller, Roman-Ulrich/AAK-3493-2021; Palkovits, Miklos/F-2707-2013; Pfeffer, Sébastien/H-3212-2019; Pfeffer, Sebastien/A-6512-2010; Zavolan, Mihaela/S-3888-2016; Benzing, Thomas/X-5476-2019; Sander, Chris/H-1452-2011; Hartmann, Gunther/P-7492-2017; Fulci, Valerio/J-1963-2015; Schermer, Bernhard/E-9972-2014; Frezzetti, Daniela/AAI-2410-2019; Hornung, Veit/C-3565-2012; Di Lauro, Roberto/A-2746-2012; Landthaler, Markus/A-1427-2010; De Vita, Gabriella/H-4422-2011	Müller, Roman-Ulrich/0000-0001-6910-0745; Palkovits, Miklos/0000-0003-0578-0387; Pfeffer, Sébastien/0000-0002-8458-348X; Pfeffer, Sebastien/0000-0002-8458-348X; Sander, Chris/0000-0001-6059-6270; Hartmann, Gunther/0000-0003-1021-2018; Fulci, Valerio/0000-0002-1173-585X; Schermer, Bernhard/0000-0002-5194-9000; Frezzetti, Daniela/0000-0002-7500-5506; Hornung, Veit/0000-0002-4150-194X; Di Lauro, Roberto/0000-0001-9493-3036; Landthaler, Markus/0000-0002-1075-8734; De Vita, Gabriella/0000-0002-7302-1174; Zavolan, Mihaela/0000-0002-8832-2041; Hermida, Leandro Cruz/0000-0003-3887-518X; CHIARETTI, Sabina/0000-0001-8499-4492; Kamphorst, Alice/0000-0002-9230-9501; Bosio, Andreas/0000-0001-9776-2535; Rusu, Mirabela/0000-0002-0372-0367	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM073047-03, P01 GM073047-01, P01 GM073047] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Shivdasani Ramesh A, 2006, Blood, V108, P3646; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	69	2889	4169	6	342	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1401	1414		10.1016/j.cell.2007.04.040	http://dx.doi.org/10.1016/j.cell.2007.04.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604727	Green Accepted, Bronze			2022-12-24	WOS:000247911400024
J	Puthalakath, H; O'Reilly, LA; Gunn, P; Lee, L; Kelly, PN; Huntington, ND; Hughes, PD; Michalak, EM; McKimm-Breschkin, J; Motoyama, N; Gotoh, T; Akira, S; Bouillet, P; Strasser, A				Puthalakath, Hamsa; O'Reilly, Lorraine A.; Gunn, Priscilla; Lee, Lily; Kelly, Priscilla N.; Huntington, Nicholas D.; Hughes, Peter D.; Michalak, Ewa M.; McKimm-Breschkin, Jennifer; Motoyama, Noburo; Gotoh, Tomomi; Akira, Shizuo; Bouillet, Philippe; Strasser, Andreas			ER stress triggers apoptosis by activating BH3-only protein Bim	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; FAMILY-MEMBER BIM; CELLS; PUMA; EXPRESSION; INHIBITOR; RESPONSES	Endoplasmic reticulum ( ER) stress caused by misfolded proteins or cytotoxic drugs can kill cells and although activation of this pathway has been implicated in the etiology of certain degenerative disorders its mechanism remains unresolved. Bim, a proapoptotic BH3-onlymember of the Bcl-2 family is required for initiation of apoptosis induced by cytokine deprivation or certain stress stimuli. Its proapoptotic activity can be regulated by several transcriptional or posttranslational mechanisms, such as ERK-mediated phosphorylation, promoting its ubiquitination and proteasomal degradation. We found that Bim is essential for ER stress-induced apoptosis in a diverse range of cell types both in culture and within the whole animal. ER stress activates Bim through two novel pathways, involving protein phosphatase 2A-mediated dephosphorylation, which prevents its ubiquitination and proteasomal degradation and CHOP-C/EBP alpha-mediated direct transcriptional induction. These results define the molecular mechanisms of ER stress-induced apoptosis and identify targets for therapeutic intervention in ER stress-related diseases.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; CSIRO, Div Mol & Hlth Technol, Melbourne, Vic, Australia; Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi, Japan; Kumamoto Univ, Dept Mol Genet, Kumamoto 8608556, Japan; Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Univ Melbourne, Dept Biochem, Bio21, Parkville, Vic 3052, Australia; Inst Pasteur, Dept Immunol, Cytokine & Lymphoid Dev Unit, F-75724 Paris, France	Walter & Eliza Hall Institute; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Center for Geriatrics & Gerontology; Kumamoto University; Osaka University; University of Melbourne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Lee, Lily/GWZ-7968-2022; McKimm-Breschkin, Jennifer L/D-1880-2013; Puthalakath, Hamsa/B-8541-2011; Bouillet, Philippe/E-1241-2013; Huntington, NICHOLAS/AAV-4704-2020; Akira, Shizuo/C-3134-2009; Strasser, Andreas/C-7581-2013	Bouillet, Philippe/0000-0002-9012-6058; Huntington, NICHOLAS/0000-0002-5267-7211; Strasser, Andreas/0000-0002-5020-4891; Michalak, Ewa/0000-0002-5772-2122; McKimm-Breschkin, Jennifer/0000-0002-2345-6786	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43540, CA 80188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bouillet P, 2005, CELL DEATH DIFFER, V12, P831, DOI 10.1038/sj.cdd.4401603; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	35	1058	1097	1	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1337	1349		10.1016/j.cell.2007.04.027	http://dx.doi.org/10.1016/j.cell.2007.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604722	Bronze			2022-12-24	WOS:000247911400019
J	Jin, JP; Li, X; Gygi, SP; Harper, JW				Jin, Jianping; Li, Xue; Gygi, Steven P.; Harper, J. Wade			Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging	NATURE			English	Article							CYCLE MUTANT TS85; AFFINITY PURIFICATION; PROTEIN-ACTIVATION; DEGRADATION; CONJUGATION; COMPLEX; TRANSCRIPTOMES; RECRUITMENT; RESOLUTION; MECHANISM	Modification of proteins with ubiquitin or ubiquitin-like proteins (UBLs) by means of an E1-E2-E3 cascade controls many signalling networks(1-3). Ubiquitin conjugation involves adenylation and thioesterification of the carboxy-terminal carboxylate of ubiquitin by the E1-activating enzyme Ube1 (Uba1 in yeast), followed by ubiquitin transfer to an E2-conjugating enzyme through a trans-thiolation reaction(4-7). Charged E2s function with E3s to ubiquitinate substrates(1). It is currently thought that Ube1/Uba1 is the sole E1 for charging of E2s with ubiquitin in animals and fungi(1,8). Here we identify a divergent E1 in vertebrates and sea urchin, Uba6, which specifically activates ubiquitin but not other UBLs in vitro and in vivo. Human Uba6 and Ube1 have distinct preferences for E2 charging in vitro, and their specificity depends in part on their C-terminal ubiquitin-fold domains, which recruit E2s. In tissue culture cells, Uba6 is required for charging a previously uncharacterized Uba6-specific E2 (Use1), whereas Ube1 is required for charging the cell-cycle E2s Cdc34A and Cdc34B. Our data reveal unexpected complexity in the pathways that control the conjugation of ubiquitin, in which dual E1s orchestrate the charging of distinct cohorts of E2s.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Jin, Jianping/K-5002-2018	Jin, Jianping/0000-0003-4175-9104; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GU X, IN PRESS MOL BIOL RE; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	30	256	270	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1135	U17		10.1038/nature05902	http://dx.doi.org/10.1038/nature05902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597759				2022-12-24	WOS:000247564600042
J	Boehm, JS; Zhao, JJ; Yao, J; Kim, SY; Firestein, R; Dunn, IF; Sjostrom, SK; Garraway, LA; Weremowicz, S; Richardson, AL; Greulich, H; Stewart, CJ; Mulvey, LA; Shen, RR; Ambrogio, L; Hirozane-Kishikawa, T; Hill, DE; Vidal, M; Meyerson, M; Grenier, JK; Hinkle, G; Root, DE; Roberts, TM; Lander, ES; Polyak, K; Hahn, WC				Boehm, Jesse S.; Zhao, Jean J.; Yao, Jun; Kim, So Young; Firestein, Ron; Dunn, Ian F.; Sjostrom, Sarah K.; Garraway, Levi A.; Weremowicz, Stanislawa; Richardson, Andrea L.; Greulich, Heidi; Stewart, Carly J.; Mulvey, Laura A.; Shen, Rhine R.; Ambrogio, Lauren; Hirozane-Kishikawa, Tomoko; Hill, David E.; Vidal, Marc; Meyerson, Matthew; Grenier, Jennifer K.; Hinkle, Greg; Root, David E.; Roberts, Thomas M.; Lander, Eric S.; Polyak, Kornelia; Hahn, William C.			Integrative genomic approaches identify IKBKE as a breast cancer oncogene	CELL			English	Article							NF-KAPPA-B; IKK-EPSILON; INDUCED SENESCENCE; GENETIC SCREEN; LUNG-CANCER; RNAI SCREEN; KINASE; MUTATIONS; CELLS; PHOSPHORYLATION	The karyotypic chaos exhibited by human epithelial cancers complicates efforts to identify mutations critical for malignant transformation. Here we integrate complementary genomic approaches to identify human oncogenes. We show that activation of the ERK and phosphatidylinositol 3-kinase (PI3K) signaling pathways cooperate to transform human cells. Using a library of activated kinases, we identify several kinases that replace PI3K signaling and render cells tumorigenic. Whole genome structural analyses reveal that one of these kinases, IKBKE (IKK epsilon), is amplified and overexpressed in breast cancer cell lines and patient-derived tumors. Suppression of IKK epsilon expression in breast cancer cell lines that harbor IKBKE amplifications induces cell death. IKK epsilon activates the nuclear factor-kappaB (NF-kappa B) pathway in both cell lines and breast cancers. These observations suggest a mechanism for NF-kappa B activation in breast cancer, implicate the NF-kappa B pathway as a downstream mediator of PI3K, and provide a framework for integrated genomic approaches in oncogene discovery.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Hill, David E/B-6617-2011	Boehm, Jesse/0000-0002-6795-6336	NATIONAL CANCER INSTITUTE [R01CA030002, R01CA094074, K01CA094223, R37CA030002, P50CA089393, P01CA089021] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA94223, R01 CA094074, P50 CA112962, R01 CA094074-03, R01 CA094074-04, P50 CA089393-060014, R01 CA094074-02, P50 CA089393-070014, R01 CA094074-05, P50 CA089393, CA89021, P50 CA089393-080014, CA30002, R01 CA094074-01A1, CA015607] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BRUNET A, 1994, ONCOGENE, V9, P3379; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrison C, 2005, J CLIN ONCOL, V23, P9369, DOI 10.1200/JCO.2005.03.7127; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Ozes ON, 1999, NATURE, V401, P82; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rennstam K, 2003, CANCER RES, V63, P8861; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shapiro RS, 2006, DEVELOPMENT, V133, P1467, DOI 10.1242/dev.02318; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	55	471	507	2	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1065	1079		10.1016/j.cell.2007.03.052	http://dx.doi.org/10.1016/j.cell.2007.03.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574021	Bronze			2022-12-24	WOS:000247390400012
J	Harbaugh, WT; Mayr, U; Burghart, DR				Harbaugh, William T.; Mayr, Ulrich; Burghart, Daniel R.			Neural responses to taxation and voluntary giving reveal motives for charitable donations	SCIENCE			English	Article							PUBLIC-GOODS; WARM-GLOW; REWARD; ALTRUISM; PREFERENCES; PUNISHMENT; STRIATUM; BRAIN	Civil societies function because people pay taxes and make charitable contributions to provide public goods. One possible motive for charitable contributions, called "pure altruism," is satisfied by increases in the public good no matter the source or intent. Another possible motive, " warm glow," is only fulfilled by an individual's own voluntary donations. Consistent with pure altruism, we find that even mandatory, tax-like transfers to a charity elicit neural activity in areas linked to reward processing. Moreover, neural responses to the charity's financial gains predict voluntary giving. However, consistent with warm glow, neural activity further increases when people make transfers voluntarily. Both pure altruism and warm-glow motives appear to determine the hedonic consequences of financial transfers to the public good.	Univ Oregon, Dept Econ, Eugene, OR 97403 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon; National Bureau of Economic Research; University of Oregon	Harbaugh, WT (corresponding author), Univ Oregon, Dept Econ, Eugene, OR 97403 USA.	harbaugh@uoregon.edu; mayr@uoregon.edu	Harbaugh, William/A-8743-2008	Harbaugh, William/0000-0002-4127-3983	NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG1929601A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; BERGSTROM T, 1986, J PUBLIC ECON, V29, P25, DOI 10.1016/0047-2727(86)90024-1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Diamond P, 2006, J PUBLIC ECON, V90, P897, DOI 10.1016/j.jpubeco.2005.06.001; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Harbaugh WT, 1998, J PUBLIC ECON, V67, P269, DOI 10.1016/S0047-2727(97)00062-5; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kolm S. -C., 1969, PUBLIC EC, P145, DOI DOI 10.1007/978-1-349-15294-0_7; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Palfrey TR, 1997, AM ECON REV, V87, P829; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	27	571	586	19	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1622	1625		10.1126/science.1140738	http://dx.doi.org/10.1126/science.1140738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178SH	17569866				2022-12-24	WOS:000247239900043
J	LaDeau, SL; Kilpatrick, AM; Marra, PP				LaDeau, Shannon L.; Kilpatrick, A. Marm; Marra, Peter P.			West Nile virus emergence and large-scale declines of North American bird populations	NATURE			English	Article							INFECTIOUS-DISEASE; BIODIVERSITY; TRANSMISSION; WILDLIFE; ECOLOGY	Emerging infectious diseases present a formidable challenge to the conservation of native species in the twenty-first century(1). Diseases caused by introduced pathogens have had large impacts on species abundances(2), including the American chestnut(3), Hawaiian bird species(4) and many amphibians(5). Changes in host population sizes can lead to marked shifts in community composition and ecosystem functioning(3,4,6). However, identifying the impacts of an introduced disease and distinguishing it from other forces that influence population dynamics ( for example, climate(7)) is challenging and requires abundance data that extend before and after the introduction(2,5). Here we use 26 yr of Breeding Bird Survey ( BBS)(8) data to determine the impact of West Nile virus ( WNV) on 20 potential avian hosts across North America. We demonstrate significant changes in population trajectories for seven species from four families that concur with a priori predictions and the spatio-temporal intensity of pathogen transmission. The American crow population declined by up to 45% since WNV arrival, and only two of the seven species with documented impact recovered to pre-WNV levels by 2005. Our findings demonstrate the potential impacts of an invasive species on a diverse faunal assemblage across broad geographical scales, and underscore the complexity of subsequent community response.	Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; Consortium Conservat Med, New York, NY 10001 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	LaDeau, SL (corresponding author), Smithsonian Migratory Bird Ctr, Natl Zool Pk, Washington, DC 20008 USA.	ladeaus@si.edu		Marra, Peter/0000-0002-0508-7577; LaDeau, Shannon/0000-0003-4825-5435				ACEVEDO W, 2006, RATES TRENDS CAUSES; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Bonter D.N., 2003, AM BIRDS, V57, P22; Caffrey C, 2005, CONDOR, V107, P128, DOI 10.1650/7646; CAFFREY C, 2003, AM BIRDS, V57, P14; *CDCP, 2006, W NIL VIR STAT SURV; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; GELFAND AE, 2006, MARKOV CHAIN MONTE C, P145; Hochachka W. M, 2004, ECOHEALTH, V1, P60; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; MARZLUFF JM, 2001, AVIAN CONSERATION EC; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Paillet FL, 2002, J BIOGEOGR, V29, P1517, DOI 10.1046/j.1365-2699.2002.00767.x; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sauer J. R., 2005, N AM BREEDING BIRD S; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spielman A., 2001, MOSQUITO NATURAL HIS; Turell MJ, 2002, CURR TOP MICROBIOL, V267, P241; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550	30	340	364	2	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					710	U13		10.1038/nature05829	http://dx.doi.org/10.1038/nature05829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17507930				2022-12-24	WOS:000247030700043
J	Li, B; Gogol, M; Carey, M; Lee, D; Seidel, C; Workman, JL				Li, Bing; Gogol, Madelaine; Carey, Mike; Lee, Daeyoup; Seidel, Chris; Workman, Jerry L.			Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin	SCIENCE			English	Article							METHYLATION; DEACETYLATION; ELONGATION	Nucleosomes must be deacetylated behind elongating RNA polymerase II to prevent cryptic initiation of transcription within the coding region. RNA polymerase II signals for deacetylation through the methylation of histone H3 lysine 36 ( H3K36), which provides the recruitment signal for the Rpd3S histone deacetylase complex ( HDAC). The recognition of methyl H3K36 by Rpd3S requires the chromodomain of its Eaf3 subunit. Paradoxically, Eaf3 is also a subunit of the NuA4 acetyltransferase complex, yet NuA4 does not recognize methyl H3K36 nucleosomes. In Saccharomyces cerevisiae, we found that methyl H3K36 nucleosome recognition by Rpd3S also requires the plant homeobox domain ( PHD) of its Rco1 subunit. Thus, the coupled chromo and PHD domains of Rpd3S specify recognition of the methyl H3K36 mark, demonstrating the first combinatorial domain requirement within a protein complex to read a specific histone code.	Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stowers Institute for Medical Research	Workman, JL (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jlw@stowers-institute.org	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823; Carey, Michael/0000-0003-3899-6280; Gogol, Madelaine/0000-0002-8738-0995				Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572	10	241	245	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1050	1054		10.1126/science.1139004	http://dx.doi.org/10.1126/science.1139004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510366				2022-12-24	WOS:000246554000053
J	Stefansson, H; Rye, DB; Hicks, A; Petursson, H; Ingason, A; Thorgeirsson, TE; Palsson, S; Sigmundsson, T; Sigurdsson, AP; Eiriksdottir, I; Soebech, E; Bliwise, D; Beck, JM; Rosen, A; Waddy, S; Trotti, LM; Iranzo, A; Thambisetty, M; Hardarson, GA; Kristjansson, K; Gudmundsson, LJ; Thorsteinsdottir, U; Kong, A; Gulcher, JR; Gudbjartsson, D; Stefansson, K				Stefansson, Hreinn; Rye, David B.; Hicks, Andrew; Petursson, Hjorvar; Ingason, Andres; Thorgeirsson, Thorgeir E.; Palsson, Stefan; Sigmundsson, Thordur; Sigurdsson, Albert P.; Eiriksdottir, Ingibjorg; Soebech, Emilia; Bliwise, Donald; Beck, Joseph M.; Rosen, Ami; Waddy, Salina; Trotti, Lynn M.; Iranzo, Alex; Thambisetty, Madhav; Hardarson, Gudmundur A.; Kristjansson, Kristleifur; Gudmundsson, Larus J.; Thorsteinsdottir, Unnur; Kong, Augustine; Gulcher, Jeffrey R.; Gudbjartsson, Daniel; Stefansson, Kari			A genetic risk factor for periodic limb movements in sleep	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESTLESS LEGS SYNDROME; GENERAL-POPULATION; PREVALENCE; SYMPTOMS; DISORDER; RLS; EPIDEMIOLOGY; ANTICIPATION; ASSOCIATION; VALIDATION	Background: The restless legs syndrome (RLS) is a common neurologic disorder characterized by an irresistible urge to move the legs. It is a major cause of sleep disruption. Periodic limb movements in sleep are detectable in most patients with RLS and represent an objective physiological metric. Methods: To search for sequence variants contributing to RLS, we performed a genomewide association study and two replication studies. To minimize phenotypic heterogeneity, we focused on patients with RLS who had objectively documented periodic limb movements in sleep. We measured serum ferritin levels, since iron depletion has been associated with the pathogenesis of RLS. Results: In an Icelandic discovery sample of patients with RLS and periodic limb movements in sleep, we observed a genomewide significant association with a common variant in an intron of BTBD9 on chromosome 6p21.2 (odds ratio, 1.8; P=2 x 10(sup -9)). This association was replicated in a second Icelandic sample (odds ratio, 1.8; P=4 x 10(sup -4)) and a U.S. sample (odds ratio, 1.5; P=4 x 10(sup -3)). With this variant, the population attributable risk of RLS with periodic limb movements was approximately 50%. An association between the variant and periodic limb movements in sleep without RLS (and the absence of such an association for RLS without periodic limb movements) suggests that we have identified a genetic determinant of periodic limb movements in sleep (odds ratio, 1.9; P=1 x 10(sup -17)). Serum ferritin levels were decreased by 13% per allele of the at-risk variant (95% confidence interval, 5 to 20; P=0.002). Conclusions: We have discovered a variant associated with susceptibility to periodic limb movements in sleep. The inverse correlation of the variant with iron stores is consistent with the suspected involvement of iron depletion in the pathogenesis of the disease.	deCODE Genet 1, IS-101 Reykjavik, Iceland; Landspitalinn Univ Hosp, Reykjavik, Iceland; Clin Res Ctr, Reykjavik, Iceland; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Program Sleep, Atlanta, GA 30322 USA; Hosp Clin Barcelona, Serv Neurol, Barcelona, Spain; Kings Coll London, Med Res Council Ctr Neurodegenerat Res, Inst Psychiat, London WC2R 2LS, England	Landspitali National University Hospital; Emory University; Emory University; University of Barcelona; Hospital Clinic de Barcelona; University of London; King's College London	Stefansson, K (corresponding author), deCODE Genet 1, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Hicks, Andrew/E-9518-2017	Thorgeirsson, Thorgeir/0000-0002-5149-7040; Hicks, Andrew/0000-0001-6320-0411; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438				Allen R, 2004, SLEEP MED, V5, P385, DOI 10.1016/j.sleep.2004.01.012; Allen Richard P, 2002, Sleep Med, V3, P467, DOI 10.1016/S1389-9457(02)00108-9; Allen RP, 1996, SLEEP, V19, P205, DOI 10.1093/sleep/19.3.205; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; BONNET M, 1993, SLEEP, V16, P748; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Ekbom KA, 1960, NEUROLOGY, V10, P868, DOI 10.1212/WNL.10.9.868; Gretarsdottir S, 2005, NAT GENET, V37, P555, DOI 10.1038/ng0505-555a; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Hening WA, 2004, SLEEP MED, V5, P285, DOI 10.1016/j.sleep.2004.01.006; Hornyak M, 2006, SLEEP MED REV, V10, P169, DOI 10.1016/j.smrv.2005.12.003; Lazzarini A, 1999, MOVEMENT DISORD, V14, P111, DOI 10.1002/1531-8257(199901)14:1<111::AID-MDS1018>3.3.CO;2-0; Lee HB, 2006, SLEEP MED, V7, P642, DOI 10.1016/j.sleep.2006.03.015; MANTEL N, 1959, J NATL CANCER I, V22, P719; Merlino G, 2007, NEUROL SCI, V28, pS37, DOI 10.1007/s10072-007-0736-x; Mizuno S, 2005, PSYCHIAT CLIN NEUROS, V59, P461, DOI 10.1111/j.1440-1819.2005.01399.x; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P547, DOI 10.1016/S0022-3999(02)00443-9; Ondo WG, 2000, NEUROLOGY, V55, P1404, DOI 10.1212/WNL.55.9.1404; Parker KP, 2002, NURS CLIN N AM, V37, P655, DOI 10.1016/S0029-6465(02)00031-2; Phillips B, 2006, CHEST, V129, P76, DOI 10.1378/chest.129.1.76; Phillips B, 2000, ARCH INTERN MED, V160, P2137, DOI 10.1001/archinte.160.14.2137; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; Rye D, 2005, SLEEP, V28, pA270; Santamaria J, 2003, SLEEP MED, V4, P153, DOI 10.1016/S1389-9457(02)00153-3; Sforza E, 2005, SLEEP MED, V6, P407, DOI 10.1016/j.sleep.2005.01.004; Suominen P, 1998, BLOOD, V92, P2934, DOI 10.1182/blood.V92.8.2934.420k07_2934_2939; Trenkwalder C, 2005, LANCET NEUROL, V4, P465, DOI 10.1016/S1474-4422(05)70139-3; Trenkwalder C, 1996, MOVEMENT DISORD, V11, P389, DOI 10.1002/mds.870110407; Tuisku K, 2005, EUR J NEUROL, V12, P385, DOI 10.1111/j.1468-1331.2004.00960.x; Tuisku K, 2003, MOVEMENT DISORD, V18, P442, DOI 10.1002/mds.10381; Ulfberg J, 2001, EUR NEUROL, V46, P17, DOI 10.1159/000050750; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; WALTERS AS, 1990, ARCH NEUROL-CHICAGO, V47, P1219, DOI 10.1001/archneur.1990.00530110079020; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Walters AS, 1996, SLEEP, V19, P825; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; Woloshin S, 2006, PLOS MED, V3, P452, DOI 10.1371/journal.pmed.0030170	41	408	414	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					639	647		10.1056/NEJMoa072743	http://dx.doi.org/10.1056/NEJMoa072743			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17634447				2022-12-24	WOS:000248746000003
J	Lietha, D; Cai, XM; Ceccarelli, DFJ; Li, YQ; Schaller, MD; Eck, MJ				Lietha, Daniel; Cai, Xinming; Ceccarelli, Derek F. J.; Li, Yiqun; Schaller, Michael D.; Eck, Michael J.			Structural basis for the autoinhibition of focal adhesion kinase	CELL			English	Article							PROTEIN-TYROSINE KINASE; FERM DOMAIN; CRYSTAL-STRUCTURE; GROWTH-FACTOR; PHOSPHORYLATION; FAK; BINDING; ACTIVATION; MECHANISMS; COMPLEX	Appropriate tyrosine kinase signaling depends on coordinated sequential coupling of protein-protein interactions with catalytic activation. Focal adhesion kinase (FAK) integrates signals from integrin and growth factor receptors to regulate cellular responses including cell adhesion, migration, and survival. Here, we describe crystal structures representing both autoinhibited and active states of FAK The inactive structure reveals a mechanism of inhibition in which the N-terminal FERM domain directly binds the kinase domain, blocking access to the catalytic cleft and protecting the FAK activation loop from Src phosphorylation. Additionally, the FERM domain sequesters the Tyr397 autophosphorylation and Src recruitment site, which lies in the linker connecting the FERM and kinase domains. The active phosphorylated FAK kinase adopts a conformation that is immune to FERM inhibition. Our biochemical and structural analysis shows how the architecture of autoinhibited FAK orchestrates an activation sequence of FERM domain displacement, linker autophosphorylation, Src recruitment, and full catalytic activation.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Lietha, Daniel/L-8041-2014; Lietha, Daniel/AAD-1952-2022	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486; Ceccarelli, Derek/0000-0002-2674-9234	NATIONAL CANCER INSTITUTE [T32CA009361, R01CA080942] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675, P01HL045100] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009361, 5T32CA09361, R01 CA080942, R01 CA080942-07, CA080942] Funding Source: Medline; NCRR NIH HHS [P41 RR001646-220082, P41 RR001646-230082, P41 RR001646] Funding Source: Medline; NHLBI NIH HHS [P01 HL048675, HL048675, HL45100, P01 HL048675-135389, P01 HL045100] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; ILLC D, 1995, NATURE, V377, P539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	57	316	328	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1177	1187		10.1016/j.cell.2007.05.041	http://dx.doi.org/10.1016/j.cell.2007.05.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574028	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000247390400020
J	Nachury, MV; Loktev, AV; Zhang, Q; Westlake, CJ; Peranen, J; Merdes, A; Slusarski, DC; Scheller, RH; Bazan, JF; Sheffield, VC; Jackson, PK				Nachury, Maxence V.; Loktev, Alexander V.; Zhang, Qihong; Westlake, Christopher J.; Peranen, Johan; Merdes, Andreas; Slusarski, Diane C.; Scheller, Richard H.; Bazan, J. Fernando; Sheffield, Val C.; Jackson, Peter K.			A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis	CELL			English	Article							BARDET-BIEDL-SYNDROME; DIGENIC RETINITIS-PIGMENTOSA; INTRAFLAGELLAR TRANSPORT; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; IFT PARTICLES; CELLS ANTENNA; FLAGELLAR; CILIUM; GENES	Primary cilium dysfunction underlies the pathogenesis of Bardet-Biedl syndrome (BBS), a genetic disorder whose symptoms include obesity, retinal degeneration, and nephropathy. However, despite the identification of 12 BBS genes, the molecular basis of BBS remains elusive. Here we identify a complex composed of seven highly conserved BBS proteins. This complex, the BBSome, localizes to nonmembranous centriolar satellites in the cytoplasm but also to the membrane of the cilium. Interestingly, the BBSome is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Strikingly, Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Conversely, preventing Rab8 GTP production blocks ciliation in cells and yields characteristic BBS phenotypes in zebrafish. Our data reveal that BBS may be caused by defects in vesicular transport to the cilium.	Genentech Inc, San Francisco, CA 94080 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; CNRS, Ctr Rech Pierre Fabre, Inst Sci & Technol Medicament Toulouse, F-31400 Toulouse, France; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	Roche Holding; Genentech; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); University of Iowa	Nachury, MV (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	nachury@gene.com	Nachury, Maxence/H-3695-2019; Westlake, Christopher/AAG-1150-2019; Nachury, Maxence/A-8759-2008; Bazan, J. Fernando/B-4562-2010	Nachury, Maxence/0000-0003-4918-1562; Westlake, Christopher/0000-0001-7476-2014; Nachury, Maxence/0000-0003-4918-1562; Slusarski, Diane/0000-0003-3793-8636; Jackson, Peter/0000-0002-1742-2539; Sheffield, Val/0000-0002-6282-0835	NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054811] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY-11298] Funding Source: Medline; NIGMS NIH HHS [R01-GM-54811] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; CHEESEMAN IM, 2005, SCI STKE, pPI1, DOI DOI 10.1126/STKE.2662005PI1; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Laurier V, 2006, EUR J HUM GENET, V14, P1195, DOI 10.1038/sj.ejhg.5201688; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	964	993	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1201	1213		10.1016/j.cell.2007.03.053	http://dx.doi.org/10.1016/j.cell.2007.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574030	Bronze			2022-12-24	WOS:000247390400022
J	Schug, TT; Berry, DC; Shaw, NS; Travis, SN; Noy, N				Schug, Thaddeus T.; Berry, Daniel C.; Shaw, Natacha S.; Travis, Skylar N.; Noy, Noa			Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors	CELL			English	Article							BINDING PROTEIN-II; ACUTE-PROMYELOCYTIC-LEUKEMIA; TERATOCARCINOMA STEM-CELLS; BREAST-CANCER CELLS; MAMMARY-CARCINOMA; FATTY-ACIDS; SYMPATHETIC NEURONS; TARGET GENE; PPAR-BETA; E-FABP	Transcriptional activation of the nuclear receptor RAR by retinoic acid (RA) often leads to inhibition of cell growth. However, in some tissues, RA promotes cell survival and hyperplasia, activities that are unlikely to be mediated by RAR. Here, we show that, in addition to functioning through RAR, RA activates the "orphan" nuclear receptor PPAR beta/delta, which, in turn, induces the expression of prosurvival genes. Partitioning of RA between the two receptors is regulated by the intracellular lipid binding proteins CRABP-II and FABP5. These proteins specifically deliver RA from the cytosol to nuclear RAR and PPAR beta/delta, respectively, thereby selectively enhancing the transcriptional activity of their cognate receptors. Consequently, RA functions through RAR and is a proapoptotic agent in cells with high CRABP-II/FABP5 ratio, but it signals through PPAR beta/delta and promotes survival in cells that highly express FABP5. Opposing effects of RA on cell growth thus emanate from alternate activation of two different nuclear receptors.	Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Cornell Univ, Div Nutrit Sci, Ithaca, NY 14850 USA; Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Cornell University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, 724 Biomed Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			NCI NIH HHS [R01 CA068150-12, R01 CA068150-11, T32 CA009682, R01 CA068150, R01 CA68150, R01 CA068150-13, 5T32CA009682] Funding Source: Medline; NIDDK NIH HHS [R01 DK088969, R01 DK060684-05, R01 DK060684-06, R01 DK60684, R01 DK060684] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009682, R01CA068150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684, R01DK088969] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Allen GW, 2000, MOL BRAIN RES, V76, P315, DOI 10.1016/S0169-328X(00)00014-0; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Brouard MC, 2002, MELANOMA RES, V12, P627, DOI 10.1097/00008390-200212000-00013; Bucco RA, 1997, BIOCHEMISTRY-US, V36, P4009, DOI 10.1021/bi962094o; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; DeLeon M, 1996, J NEUROSCI RES, V44, P283; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Gutierrez-Gonzalez LH, 2002, BIOCHEM J, V364, P725, DOI 10.1042/BJ20020039; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Kitareewan S, 2002, P NATL ACAD SCI USA, V99, P3806, DOI 10.1073/pnas.052011299; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Laudet V., 2002, NUCL RECEPTOR FACTS; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; Liu Y, 2000, BRAIN RES, V852, P16, DOI 10.1016/S0006-8993(99)02158-7; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mangelsdorf David J., 1994, P319; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Manor D, 2003, CANCER RES, V63, P4426; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Norris AW, 2002, J LIPID RES, V43, P646; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Plum LA, 2001, EXP BIOL MED, V226, P766, DOI 10.1177/153537020222600809; Rochette-Egly C, 2001, HISTOL HISTOPATHOL, V16, P909, DOI 10.14670/HH-16.909; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Sussman F, 2005, J MED CHEM, V48, P6212, DOI 10.1021/jm050285w; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tari AM, 2002, ONCOGENE, V21, P5224, DOI 10.1038/sj.onc.1205660; Toma S, 1998, ANTICANCER RES, V18, P935; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; VERMA AK, 1982, CANCER RES, V42, P3519; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Widstrom RL, 2001, BIOCHEMISTRY-US, V40, P1070, DOI 10.1021/bi001602y; WOLBACH SB, 1978, NUTR REV, V36, P16; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	63	497	521	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					723	733		10.1016/j.cell.2007.02.050	http://dx.doi.org/10.1016/j.cell.2007.02.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512406	Green Accepted, Bronze			2022-12-24	WOS:000246788300017
J	Bryant, DA; Costas, AMG; Maresca, JA; Chew, AGM; Klatt, CG; Bateson, MM; Tallon, LJ; Hostetler, J; Nelson, WC; Heidelberg, JF; Ward, DM				Bryant, Donald A.; Costas, Amaya M. Garcia; Maresca, Julia A.; Chew, Aline Gomez Maqueo; Klatt, Christian G.; Bateson, Mary M.; Tallon, Luke J.; Hostetler, Jessica; Nelson, William C.; Heidelberg, John F.; Ward, David M.			Candidatus Chloracidobacterium thermophilum: An aerobic phototrophic acidobacterium	SCIENCE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL MAT COMMUNITY; PHOTOSYNTHESIS; ENVIRONMENT; DIVERSITY; BACTERIA; GENOMICS	Only five bacterial phyla with members capable of chlorophyll (Chl)-based phototrophy are presently known. Metagenomic data from the phototrophic microbial mats of alkaline siliceous hot springs in Yellowstone National Park revealed the existence of a distinctive bacteriochlorophyll ( BChl)-synthesizing, phototrophic bacterium. A highly enriched culture of this bacterium grew photoheterotrophically, synthesized BChls a and c under oxic conditions, and had chlorosomes and type 1 reaction centers. "Candidatus Chloracidobacterium thermophilum" is a BChl-producing member of the poorly characterized phylum Acidobacteria.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ So Calif, Dept Biol, Wrigley Marine Sci Ctr, Avalon, CA 90704 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; University of Southern California	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu	Gomez Maqueo Chew, Aline/D-8631-2016; Nelson, William C/E-9263-2016; Costas, Amaya Garcia/AAE-6827-2020	Gomez Maqueo Chew, Aline/0000-0001-6075-2907; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Maresca, Julia/0000-0002-3955-1585				Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; WARD DM, 2007, HEREDITY        0606, DOI DOI 10.1038/SJ.HDY.6801011; Yim LC, 2006, FEMS MICROBIOL ECOL, V57, P80, DOI 10.1111/j.1574-6941.2006.00104.x	20	265	275	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					523	526		10.1126/science.1143236	http://dx.doi.org/10.1126/science.1143236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656724				2022-12-24	WOS:000248339800048
J	Takaoka, A; Wang, Z; Choi, MK; Yanai, H; Negishi, H; Ban, T; Lu, Y; Miyagishi, M; Kodama, T; Honda, K; Ohba, Y; Taniguchi, T				Takaoka, Akinori; Wang, ZhiChao; Choi, Myoung Kwon; Yanai, Hideyuki; Negishi, Hideo; Ban, Tatsuma; Lu, Yan; Miyagishi, Makoto; Kodama, Tatsuhiko; Honda, Kenya; Ohba, Yusuke; Taniguchi, Tadatsugu			DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response	NATURE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; DOUBLE-STRANDED-RNA; RIG-I; ANTIVIRAL RESPONSES; GENE INDUCTION; HUMAN ZBP1; LOCALIZATION; VIRUSES; DOMAINS	Central to innate immunity is the sensing of pathogen-associated molecular patterns by cytosolic and membrane-associated receptors(1-4). In particular, DNA is a potent activator of immune responses during infection or tissue damage(5-7), and evidence indicates that, in addition to the membrane-associated Toll-like receptor 9, an unidentified cytosolic DNA sensor(s) can activate type I interferon (IFN) and other immune responses(8-10). Here we report on a candidate DNA sensor, previously named DLM-1 ( also called Z-DNA binding protein 1 (ZBP1))(11), for which biological function had remained unknown; we now propose the alternative name DAI (DNA-dependent activator of IFN-regulatory factors(12)). The artificial expression of otherwise IFN-inducible DAI (DLM-1/ ZBP1) in mouse fibroblasts selectively enhances the DNA-mediated induction of type I IFN and other genes involved in innate immunity. On the other hand, RNA interference of messenger RNA for DAI (DLM-1/ ZBP1) in cells inhibits this gene induction programme upon stimulation by DNA from various sources. Moreover, DAI (DLM-1/ZBP1) binds to double-stranded DNA and, by doing so, enhances its association with the IRF3 transcription factor and the TBK1 serine/threonine kinase. These observations underscore an integral role of DAI (DLM-1/ZBP1) in the DNA-mediated activation of innate immune responses, and may offer new insight into the signalling mechanisms underlying DNA- associated antimicrobial immunity and autoimmune disorders.	Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept 21st Century,Ctr Excellence Program, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Dept Lab Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0600815, Japan; Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Hokkaido University; Hokkaido University; University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Ohba, Yusuke/E-7944-2011; Miyagishi, Makoto/L-8174-2016; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022	Miyagishi, Makoto/0000-0001-7654-3616; Yanai, Hideyuki/0000-0002-0115-9000				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Ha SC, 2006, BBA-PROTEINS PROTEOM, V1764, P320, DOI 10.1016/j.bbapap.2005.12.012; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Pham HT, 2006, BIOCHEM BIOPH RES CO, V348, P145, DOI 10.1016/j.bbrc.2006.07.061; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SUGGS JW, 1986, NUCLEIC ACIDS RES, V14, P3703; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tokunaga T, 1999, JPN J INFECT DIS, V52, P1; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	30	1212	1287	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					501	U14		10.1038/nature06013	http://dx.doi.org/10.1038/nature06013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17618271				2022-12-24	WOS:000248302700053
J	Mattila, HR; Seeley, TD				Mattila, Heather R.; Seeley, Thomas D.			Genetic diversity in honey bee colonies enhances productivity and fitness	SCIENCE			English	Article							APIS-MELLIFERA; SOCIAL HYMENOPTERA; POLYANDRY; PERFORMANCE; PATERNITY; EVOLUTION; SURVIVAL; APIDAE; SIZE	Honey bee queens mate with many males, creating numerous patrilines within colonies that are genetically distinct. The effects of genetic diversity on colony productivity and long-term fitness are unknown. We show that swarms from genetically diverse colonies (15 patrilines per colony) founded new colonies faster than swarms from genetically uniform colonies (1 patriline per colony). Accumulated differences in foraging rates, food storage, and population growth led to impressive boosts in the fitness (i.e., drone production and winter survival) of genetically diverse colonies. These results further our understanding of the origins of polyandry in honey bees and its benefits for colony performance.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Mattila, HR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	hrm24@cornell.edu						Arnold G, 2002, ETHOLOGY, V108, P751, DOI 10.1046/j.1439-0310.2002.00809.x; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BPAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; FELL RD, 1977, J APICULT RES, V16, P170, DOI 10.1080/00218839.1977.11099883; FREE JB, 1968, ENTOMOL EXP APPL, V11, P241, DOI 10.1111/j.1570-7458.1968.tb02048.x; FUCHS S, 1994, APIDOLOGIE, V25, P155, DOI 10.1051/apido:19940204; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; LEE PC, 1987, ECOL ENTOMOL, V12, P187, DOI 10.1111/j.1365-2311.1987.tb00997.x; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; ROBINSON GE, 1989, WESTV STUD, P61; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SEELEY TD, 1978, OECOLOGIA, V32, P109, DOI 10.1007/BF00344695; SEELEY TD, 1978, INSECT SOC, V25, P323, DOI 10.1007/BF02224297; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Strassmann J, 2001, INSECT SOC, V48, P1, DOI 10.1007/PL00001737; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2002, BEHAV ECOL SOCIOBIOL, V52, P143, DOI 10.1007/s00265-002-0498-7	20	335	338	4	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					362	364		10.1126/science.1143046	http://dx.doi.org/10.1126/science.1143046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641199	Green Submitted			2022-12-24	WOS:000248150200044
J	Tinetti, G; Vidal-Madjar, A; Liang, MC; Beaulieu, JP; Yung, Y; Carey, S; Barber, RJ; Tennyson, J; Ribas, I; Allard, N; Ballester, GE; Sing, DK; Selsis, F				Tinetti, Giovanna; Vidal-Madjar, Alfred; Liang, Mao-Chang; Beaulieu, Jean-Philippe; Yung, Yuk; Carey, Sean; Barber, Robert J.; Tennyson, Jonathan; Ribas, Ignasi; Allard, Nicole; Ballester, Gilda E.; Sing, David K.; Selsis, Franck			Water vapour in the atmosphere of a transiting extrasolar planet	NATURE			English	Article							TRANSMISSION SPECTRA; THERMAL EMISSION; LIGHT CURVES; LINE; ABSORPTION; HYDROGEN	Water is predicted to be among the most abundant (if not the most abundant) molecular species after hydrogen in the atmospheres of close-in extrasolar giant planets ('hot Jupiters')(1,2). Several attempts have been made to detect water on such planets, but have either failed to find compelling evidence for it(3,4) or led to claims that should be taken with caution(5). Here we report an analysis of recent observations of the hot Jupiter HD 189733b (ref. 6) taken during the transit, when the planet passed in front of its parent star. We find that absorption by water vapour is the most likely cause of the wavelength-dependent variations in the effective radius of the planet at the infrared wavelengths 3.6 mu m, 5.8 mu m (both ref. 7) and 8 mu m (ref. 8). The larger effective radius observed at visible wavelengths(9) may arise from either stellar variability or the presence of clouds/hazes. We explain the report of a non-detection of water on HD 189733b (ref. 4) as being a consequence of the nearly isothermal vertical profile of the planet's atmosphere.	European Space Agcy, I-00044 Frascati, Italy; UCL, Dept Phys & Astron, London WC1E 6BT, England; Univ Paris 06, CNRS, Inst Astrophys Paris, F-75014 Paris, France; Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, IPAC Spitzer Sci Ctr, Pasadena, CA 91125 USA; CSIC, IEEC, Inst Ciencias Espai, Bellaterra 08193, Spain; Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Ctr Natl Etud Spatiales, F-75001 Paris, France; CNRS, Ecole Normale Super, F-69364 Lyon, France	European Space Agency; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Academia Sinica - Taiwan; California Institute of Technology; California Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Arizona; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Tinetti, G (corresponding author), European Space Agcy, I-00044 Frascati, Italy.	gio@gps.caltech.edu	Ribas, Ignasi/M-2134-2014; Liang, Mao-Chang/P-9796-2018; Tinetti, Giovanna/Q-4697-2019; Tennyson, Jonathan/I-2222-2012; Tinetti, Giovanna/G-7956-2017; Liang, Mao-Chang/AAG-4305-2021	Ribas, Ignasi/0000-0002-6689-0312; Liang, Mao-Chang/0000-0002-5294-9344; Tinetti, Giovanna/0000-0001-6058-6654; Tennyson, Jonathan/0000-0002-4994-5238; Tinetti, Giovanna/0000-0001-6058-6654; Beaulieu, Jean-Philippe/0000-0003-0014-3354; Carey, Sean/0000-0002-0221-6871; Selsis, Franck/0000-0001-9619-5356; Sing, David/0000-0001-6050-7645	Engineering and Physical Sciences Research Council [EP/E043674/1] Funding Source: researchfish; EPSRC [EP/E043674/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Allard NF, 2007, ASTRON ASTROPHYS, V465, P1085, DOI 10.1051/0004-6361:20066616; Allard NF, 2003, ASTRON ASTROPHYS, V411, pL473, DOI 10.1051/0004-6361:20031299; Ballester GE, 2007, NATURE, V445, P511, DOI 10.1038/nature05525; Barber RJ, 2006, MON NOT R ASTRON SOC, V368, P1087, DOI 10.1111/j.1365-2966.2006.10184.x; Barman T, 2007, ASTROPHYS J, V661, pL191, DOI 10.1086/518736; BEAULIEU JP, UNPUB ASTROPHYS J; Borysow A, 2001, J QUANT SPECTROSC RA, V68, P235, DOI 10.1016/S0022-4073(00)00023-6; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Brown TM, 2001, ASTROPHYS J, V553, P1006, DOI 10.1086/320950; Burrows A, 2006, ASTROPHYS J, V650, P1140, DOI 10.1086/507269; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Fortney JJ, 2006, ASTROPHYS J, V652, P746, DOI 10.1086/508442; FORTNEY JJ, UNPUB ASTROPHYS J; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; HANEL RA, 1972, J GEOPHYS RES, V77, P2629, DOI 10.1029/JC077i015p02629; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; Liang MC, 2007, ASTROPHYS J, V661, pL199, DOI 10.1086/518785; Liang MC, 2003, ASTROPHYS J, V596, pL247, DOI 10.1086/379314; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; Richardson LJ, 2006, ASTROPHYS J, V649, P1043, DOI 10.1086/506503; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Tinetti G, 2007, ASTROPHYS J, V654, pL99, DOI 10.1086/510716; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Winn JN, 2007, ASTRON J, V133, P1828, DOI 10.1086/512159; Yung Y.L., 1989, ATMOSPHERIC RAD	30	392	394	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					169	171		10.1038/nature06002	http://dx.doi.org/10.1038/nature06002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625559	Green Submitted, Green Accepted			2022-12-24	WOS:000247934500036
J	Conway, PH; Cnaan, A; Zaoutis, T; Henry, BV; Grundmeier, RW; Keren, R				Conway, Patrick H.; Cnaan, Avital; Zaoutis, Theoklis; Henry, Brandon V.; Grundmeier, Robert W.; Keren, Ron			Recurrent urinary tract infections in children - Risk factors and association with prophylactic antimicrobials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY VESICOURETERAL REFLUX; CONTROLLED-TRIAL; BACTERIURIA; MANAGEMENT; THERAPY	Context The evidence regarding risk factors for recurrent urinary tract infection ( UTI) and the risks and benefits of antimicrobial prophylaxis in children is scant. Objectives To identify risk factors for recurrent UTI in a pediatric primary care cohort, to determine the association between antimicrobial prophylaxis and recurrent UTI, and to identify the risk factors for resistance among recurrent UTIs. Design, Patients, and Setting From a network of 27 primary care pediatric practices in urban, suburban, and semirural areas spanning 3 states, a cohort of children aged 6 years or younger who were diagnosed with first UTI between July 1, 2001, and May 31, 2006, was assembled. Time-to-event analysis was used to determine risk factors for recurrent UTI and the association between antimicrobial prophylaxis and recurrent UTI, and a nested case-control study was performed among children with recurrent UTI to identify risk factors for resistant infections. Main Outcome Measures Time to recurrent UTI and antimicrobial resistance of recurrent UTI pathogens. Results Among 74 974 children in the network, 611 (0.007 per person-year) had a first UTI and 83 (0.12 per person-year after first UTI) had a recurrent UTI. In multivariable Cox time-to-event models, factors associated with increased risk of recurrent UTI included white race (0.17 per person-year; hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.22-3.16), age 3 to 4 years (0.22 per person-year; HR, 2.75; 95% CI, 1.37-5.51), age 4 to 5 years (0.19 per person-year; HR, 2.47; 95% CI, 1.19-5.12), and grade 4 to 5 vesicoureteral reflux (0.60 per person-year; HR, 4.38; 95% CI, 1.26-15.29). Sex and grade 1 to 3 vesicoureteral reflux were not associated with risk of recurrence. Antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI ( HR, 1.01; 95% CI, 0.50-2.02), even after adjusting for propensity to receive prophylaxis, but was a risk factor for antibimicrobial resistance among children with recurrent UTI ( HR, 7.50; 95% CI, 1.60-35.17). Conclusion Among the children in this study, antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI, but was associated with increased risk of resistant infections.	Univ Penn, Robert Wood Johnson Clin Scholars Program, Philadelphia, PA 19104 USA; Univ Penn, Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; Cincinnati Childrens Hosp Med Ctr, Ctr Hlth Care Qual, Cincinnati, OH USA; Cincinnati Childrens Hosp Med Ctr, Div Gen Pediat, Cincinnati, OH USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Conway, PH (corresponding author), Univ Penn, Robert Wood Johnson Clin Scholars Program, 423 Guardian Dr,Bloddey Hall 1303A, Philadelphia, PA 19104 USA.	pconway2@mail.med.upenn.edu			NCRR NIH HHS [U54 RR023567-01] Funding Source: Medline; NICHD NIH HHS [K23 HD043179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD043179] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bergman DA, 1999, PEDIATRICS, V103, P843; BISSET GS, 1987, AM J ROENTGENOL, V148, P479, DOI 10.2214/ajr.148.3.479; Downs SH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e54; Elder JS, 1997, J UROLOGY, V157, P1846, DOI 10.1016/S0022-5347(01)64882-1; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; GLEESON FV, 1991, ARCH DIS CHILD, V66, P1282, DOI 10.1136/adc.66.11.1282; Gorelick MH, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e54; Hellerstein S, 2002, PEDIATR NEPHROL, V17, P506, DOI 10.1007/s00467-002-0899-x; HELLSTROM A, 1991, ARCH DIS CHILD, V66, P232, DOI 10.1136/adc.66.2.232; HOBERMAN A, 1994, J PEDIATR-US, V124, P513, DOI 10.1016/S0022-3476(05)83127-0; Kwok Wing-Yee, 2006, BMC Pediatr, V6, P10, DOI 10.1186/1471-2431-6-10; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; LOHR JA, 1977, PEDIATRICS, V59, P562; Lutter SA, 2005, ARCH PEDIAT ADOL MED, V159, P924, DOI 10.1001/archpedi.159.10.924; Mahant S, 2002, ARCH DIS CHILD, V86, P419, DOI 10.1136/adc.86.6.419; Mazzola BL, 2003, J NEPHROL, V16, P133; MCKERROW W, 1984, BRIT MED J, V289, P299, DOI 10.1136/bmj.289.6440.299; Panaretto KS, 1999, J PAEDIATR CHILD H, V35, P454, DOI 10.1046/j.1440-1754.1999.355417.x; Reddy PP, 1997, PEDIATRICS, V100, P555; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SAVAGE DCL, 1975, LANCET, V1, P358; Shaikh N, 2003, PEDIATRICS, V112, P1134, DOI 10.1542/peds.112.5.1134; SMELLIE JM, 1988, PEDIATR NEPHROL, V2, P12, DOI 10.1007/BF00870372; SMELLIE JM, 1978, LANCET, V2, P175; SNODGRASS W, 1991, UROLOGY, V38, P341, DOI 10.1016/0090-4295(91)80148-Z; UHARI M, 1988, BRIT MED J, V297, P450, DOI 10.1136/bmj.297.6646.450; WAN JL, 1995, J UROLOGY, V154, P797, DOI 10.1016/S0022-5347(01)67167-2; WILLIAMS GJ, 2006, COCHRANE DB SYST REV, V3; WINBERG J, 1974, Acta Paediatrica Scandinavica Supplement, P1; WINBERG J, 1975, KIDNEY INT, V8, pS101	31	244	257	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2007	298	2					179	186		10.1001/jama.298.2.179	http://dx.doi.org/10.1001/jama.298.2.179			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188HI	17622599	Bronze			2022-12-24	WOS:000247910600023
J	Geenen, MM; Cardous-Ubbink, MC; Kremer, LCM; van den Bos, C; van der Pal, HJH; Heinen, RC; Jaspers, MWM; Koning, CCE; Oldenburger, F; Langeveld, NE; Hart, AAM; Bakker, PJM; Caron, HN; van Leeuwen, FE				Geenen, Maud M.; Cardous-Ubbink, Mathilde C.; Kremer, Leontien C. M.; van den Bos, Cor; van der Pal, Helena J. H.; Heinen, Richard C.; Jaspers, Monique W. M.; Koning, Caro C. E.; Oldenburger, Foppe; Langeveld, Nelia E.; Hart, Augustinus A. M.; Bakker, Piet J. M.; Caron, Huib N.; van Leeuwen, Flora E.			Medical assessment of adverse health outcomes in long-term survivors of childhood cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; 2ND MALIGNANT NEOPLASMS; FOLLOW-UP; 5-YEAR SURVIVORS; ADULT SURVIVORS; ADOLESCENT CANCER; HODGKINS-DISEASE; HEART-FAILURE; CLINICAL CARE; BRAIN-TUMORS	Context Improved survival of children with cancer has been accompanied by multiple treatment-related complications. However, most studies in survivors of childhood cancer focused on only 1 late effect. Objective To assess the total burden of adverse health outcomes ( clinical or subclinical disorders ["adverse events"]) following childhood cancer in a large cohort of childhood cancer survivors with long-term and complete medical follow-up. Design, Setting, and Population Retrospective cohort study of 1362 five-year survivors of childhood cancer treated in a single institution in the Netherlands between 1966 and 1996. All survivors were invited to a late-effects clinic for medical assessment of adverse events. Adverse events occurring before January 2004 were graded for severity in a standardized manner. Main Outcome Measures Treatment-specific prevalence of adverse events ( according to severity) at end of follow-up and relative risk of high or severe burden of disease ( >= 2 severe or >= 1 life-threatening or disabling adverse events) associated with various treatments. Results Medical follow-up was complete for 94.3% of survivors ( median follow-up, 17.0 years). The median attained age at end of follow-up was 24.4 years. Almost 75% of survivors had 1 or more adverse events, and 24.6% had 5 or more adverse events. Furthermore, 40% of survivors had at least 1 severe or life-threatening or disabling adverse event. A high or severe burden of adverse events was observed in 55% of survivors who received radiotherapy only and 15% of survivors treated with chemotherapy only, compared with 25% of survivors who had surgery only ( adjusted relative risks, 2.18 [95% confidence interval, 1.62 - 2.95] and 0.65 [ 95% confidence interval, 0.46 - 0.90], respectively). A high or severe burden of adverse events was most often observed in survivors of bone tumors (64%) and least often in survivors of leukemia or Wilms tumor (12% each). Conclusions In young adulthood, a substantial proportion of childhood cancer survivors already has a high or severe burden of disease, particularly after radiotherapy. This underscores the need for lifelong risk-stratified medical surveillance of childhood cancer survivors.	Emma Childrens Hosp, Acad Med Ctr, Late Effects Study Grp, NL-1100 DD Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Outpatient Clin, Poliklin Late Effecten Kindertumoren, NL-1100 DD Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands; Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	Caron, HN (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Late Effects Study Grp, POB 22660, NL-1100 DD Amsterdam, Netherlands.	h.n.caron@amc.uva.nl	koning, caro/A-5339-2008	Kremer, Leontien/0000-0001-7422-3248				Adams MJ, 2004, J CLIN ONCOL, V22, P3139, DOI 10.1200/JCO.2004.09.109; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bhatia S, 2006, PEDIATR BLOOD CANCER, V46, P143, DOI 10.1002/pbc.20613; Bhatia S, 2005, CANCER J, V11, P340, DOI 10.1097/00130404-200507000-00010; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Curry HL, 2006, EUR J CANCER, V42, P501, DOI 10.1016/j.ejca.2005.11.003; DONALDSON SS, 1993, INT J RADIAT ONCOL, V26, P739, DOI 10.1016/0360-3016(93)90487-G; Gleeson HK, 2004, ENDOCR-RELAT CANCER, V11, P589, DOI 10.1677/erc.1.00779; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hawkins MM, 2006, PEDIATR BLOOD CANCER, V46, P174, DOI 10.1002/pbc.20609; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; JOFFE MM, 1995, STAT MED, V14, P2131, DOI 10.1002/sim.4780141907; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Langer T, 2002, MED PEDIATR ONCOL, V38, P320, DOI 10.1002/mpo.10055; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Mackie E, 2000, LANCET, V355, P1310, DOI 10.1016/S0140-6736(00)02112-7; Marks LB, 2003, SEMIN RADIAT ONCOL, V13, P333, DOI 10.1016/S1053-4296(03)00034-1; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Nicholson H S, 1993, Cancer Treat Res, V62, P45; Oeffinger KC, 2004, CA-CANCER J CLIN, V54, P208, DOI 10.3322/canjclin.54.4.208; Oeffinger KC, 2000, CANCER-AM CANCER SOC, V88, P1687, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.3.CO;2-D; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Simbre Valeriano C, 2005, Paediatr Drugs, V7, P187, DOI 10.2165/00148581-200507030-00005; Simone J.V., 2003, CHILDHOOD CANC SURVI; Skinner R, 1996, LANCET, V348, P578, DOI 10.1016/S0140-6736(96)03480-0; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; Sklar CA, 1999, ACTA PAEDIATR, V88, P1, DOI 10.1111/j.1651-2227.1999.tb14395.x; Speechley KN, 2006, J CLIN ONCOL, V24, P2536, DOI 10.1200/JCO.2005.03.9628; Stevens MCG, 1998, EUR J CANCER, V34, P694, DOI 10.1016/S0959-8049(98)00012-4; van Santen HM, 2005, EUR J CANCER, V41, P1767, DOI 10.1016/j.ejca.2005.02.036; Wallace WHB., 2004, LATE EFFECTS CHILDHO, P49; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148	41	579	585	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2705	2715		10.1001/jama.297.24.2705	http://dx.doi.org/10.1001/jama.297.24.2705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182UE	17595271				2022-12-24	WOS:000247528700020
J	Menand, B; Yi, KK; Jouannic, S; Hoffmann, L; Ryan, E; Linstead, P; Schaefer, DG; Dolan, L				Menand, Benoit; Yi, Keke; Jouannic, Stefan; Hoffmann, Laurent; Ryan, Eoin; Linstead, Paul; Schaefer, Didier G.; Dolan, Liam			An ancient mechanism controls the development of cells with a rooting function in land plants	SCIENCE			English	Article							MOSS PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; ORIGIN; GROWTH; FAMILY; AUXIN; HAIRS; GENE	Root hairs and rhizoids are cells with rooting functions in land plants. We describe two basic helix-loop-helix transcription factors that control root hair development in the sporophyte ( 2n) of the angiosperm Arabidopsis thaliana and rhizoid development in the gametophytes ( n) of the bryophyte Physcomitrella patens. The phylogeny of land plants supports the hypothesis that early land plants were bryophyte-like and possessed a dominant gametophyte and later the sporophyte rose to dominance. If this hypothesis is correct, our data suggest that the increase in morphological complexity of the sporophyte body in the Paleozoic resulted at least in part from the recruitment of regulatory genes from gametophyte to sporophyte.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Peoples R China; Univ Lausanne, Dept Biol Mol Vegetale, CH-1015 Lausanne, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Zhejiang University; University of Lausanne	Dolan, L (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Yi, Keke/N-8482-2019; Yi, Keke/P-3964-2017	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X; Menand, Benoit/0000-0001-9713-5275; Dolan, Liam/0000-0003-1206-7096	Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A218] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berner R. A., 2001, PLANTS INVADE LAND E, P173; Blackwell WH, 2003, BOT REV, V69, P125, DOI 10.1663/0006-8101(2003)069[0125:TTOOOT]2.0.CO;2; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; DUCKETT JG, 1998, BRYOLOGY 21 CENTURY, P223; EDWARDS D, 1995, NATURE, V374, P635, DOI 10.1038/374635a0; Gahoonia TS, 1997, PLANT SOIL, V191, P181, DOI 10.1023/A:1004270201418; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 2004, FOSSIL PLANTS; Kerp H, 2004, T ROY SOC EDIN-EARTH, V94, P411, DOI 10.1017/S026359330000078X; Kerp H., 2001, PLANTS INVADE LAND E, P52, DOI 10.7312/gens11160-005; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Thelander M, 2005, J EXP BOT, V56, P653, DOI 10.1093/jxb/eri040; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	21	284	297	10	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1477	1480		10.1126/science.1142618	http://dx.doi.org/10.1126/science.1142618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556585	Green Submitted			2022-12-24	WOS:000247066400043
J	Tomari, Y; Du, T; Zamore, PD				Tomari, Yukihide; Du, Tingting; Zamore, Phillip D.			Sorting of Drosophila small silencing RNAs	CELL			English	Article							ENZYME COMPLEX; MICRORNA TARGETS; PASSENGER-STRAND; DISTINCT ROLES; INTERFERENCE; SIRNA; MELANOGASTER; CLEAVAGE; DICER-2; GENES	In Drosophila, small interfering RNAs (siRNAs), which direct RNA interference through the Argonaute protein Ago2, are produced by a biogenesis pathway distinct from microRNAs (miRNAs), which regulate endogenous mRNA expression as guides for Ago1. Here, we report that siRNAs and miRNAs are sorted into Ago1 and Ago2 by pathways independent from the processes that produce these two classes of small RNAs. Such small-RNA sorting reflects the structure of the double-stranded assembly intermediates-the miRNA/miRNA* and siRNA duplexes-from which Argonaute proteins are loaded. We find that the Dcr-2/R2D2 heterodimer acts as a gatekeeper for the assembly of Ago2 complexes, promoting the incorporation of siRNAs and disfavoring miRNAs as loading substrates for Drosophila Ago2. A separate mechanism acts in parallel to favor miRNA/miRNA* duplexes and exclude siRNAs from assembly into Ago1 complexes. Thus, in flies small-RNA duplexes are actively sorted into Argonaute-containing complexes according to their intrinsic structures.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Japan Science & Technology Agency (JST)	Tomari, Y (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	tomari@iam.u-tokyo.ac.jp; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM062862, GM62862, GM65236, R01 GM062862-09, R01 GM062862, R01 GM065236-08, R01 GM065236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R37GM062862, R01GM062862] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim JH, 2006, MOL CELL TOXICOL, V2, P29; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	47	289	299	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					299	308		10.1016/j.cell.2007.05.057	http://dx.doi.org/10.1016/j.cell.2007.05.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662944	Green Accepted, Bronze			2022-12-24	WOS:000248588000019
J	Wu, RC; Feng, Q; Lonard, DM; O'Malley, BW				Wu, Ray-Chang; Feng, Qin; Lonard, David M.; O'Malley, Bert W.			SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock	CELL			English	Article							ESTROGEN-RECEPTOR; PROTEIN-DEGRADATION; STEROID-RECEPTOR; CYCLIN-E; KINASE; AIB1; PHOSPHORYLATION; LIGASE; CANCER; ACTIVATION	SRC-3/AlB1 is an important growth coactivator whose activity should be tightly regulated since excess activation results in oncogenesis. Herein, we provide evidence that coordinated phosphorylation-dependent ubiquitination regulates SRC-3 coactivator activation and transcriptional specificity. We discovered a critical "actron/degron" element in SRC-3 that is required for this phosphorylation-dependent ubiquitination event and identified GSK3 and SCIFFbw7 alpha as the respective responsible kinase and E3 ubiquitin ligase. Interestingly, despite that SCFFbw7 alpha enhances ubiquitination and promotes eventual transcription-coupled degradation of SRC-3 in a phosphorylation- and Fbw7 alpha dosage-dependent manner, our results also uncovered a nonproteolytic "activation" code for SRC-3 ubiquitination induced by Fbw7a. We propose that ubiquitination of SRC-3 is a phospho-mediated biphasic event and that a transition from multi-(mono)ubiquitination (SRC-3 activation) to long-chain polyubiquitination (SIRC-3 degradation) is processive during the transcriptional coactivation of select transcription factors and can serve as a "transcriptional time clock" to control both the activation and the functional lifetime of coactivators.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	高, 雨莉/HGU-8187-2022; Wu, Ray-chang/X-2018-2019					Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; ELLEDGE SJ, 1998, BIOCHIM BIOPHYS ACTA, V1377, P61; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lonard DM, 2004, MOL CELL BIOL, V24, P14, DOI 10.1128/MCB.24.1.14-24.2004; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005	31	183	188	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1125	1140		10.1016/j.cell.2007.04.039	http://dx.doi.org/10.1016/j.cell.2007.04.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574025	Bronze			2022-12-24	WOS:000247390400016
J	Sobhian, B; Shao, GZ; Lilli, DR; Culhane, AC; Moreau, LA; Xia, B; Livingston, DM; Greenberg, RA				Sobhian, Bijan; Shao, Genze; Lilli, Dana R.; Culhane, Aedin C.; Moreau, Lisa A.; Xia, Bing; Livingston, David M.; Greenberg, Roger A.			RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites	SCIENCE			English	Article							HISTONE H2AX; GENOMIC INSTABILITY; PHOSPHORYLATION; PROTEIN; REPAIR; MDC1; K6	Mutations affecting the BRCT domains of the breast cancer-associated tumor suppressor BRCA1 disrupt the recruitment of this protein to DNA double-strand breaks (DSBs). The molecular structures at DSBs recognized by BRCA1 are presently unknown. We report the interaction of the BRCA1 BRCT domain with RAP80, a ubiquitin-binding protein. RAP80 targets a complex containing the BRCA1-BARD1 (BRCA1-associated ring domain protein 1) E3 ligase and the deubiquitinating enzyme (DUB) BRCC36 to MDC1-gamma H2AX- dependent lysine(6)- and lysine(63)-linked ubiquitin polymers at DSBs. These events are required for cell cycle checkpoint and repair responses to ionizing radiation, implicating ubiquitin chain recognition and turnover in the BRCA1-mediated repair of DSBs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu; rogergr@mail.med.upenn.edu	Culhane, Aedin/AAG-8490-2019	Culhane, Aedin/0000-0002-1395-9734; Sobhian, Bijan/0000-0001-7255-6006	NCI NIH HHS [K08 CA106597, K08 CA106597-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA106597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	22	537	551	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1198	1202		10.1126/science.1139516	http://dx.doi.org/10.1126/science.1139516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525341	Green Accepted, Green Submitted			2022-12-24	WOS:000246724300045
J	Malathi, K; Dong, BH; Gale, M; Silverman, RH				Malathi, Krishnamurthy; Dong, Beihua; Gale, Michael, Jr.; Silverman, Robert H.			Small self-RNA generated by RNase L amplifies antiviral innate immunity	NATURE			English	Article							HEPATITIS-C VIRUS; RIG-I; INTERFERON ACTION; 2-5A-DEPENDENT RNASE; ADAPTER PROTEIN; RESPONSES; INFECTION; IDENTIFICATION; RIBONUCLEASE; EXPRESSION	Antiviral innate immunity is initiated in response to RNA molecules that are produced in virus- infected cells(1). These RNAs activate signalling cascades that activate the genes that encode alpha- and beta- interferon ( IFN). Signalling occurs through the interaction of the RNAs with either of two pathogen recognition receptors, retinoic acid- inducible gene- I ( RIG- I, also known as DDX58) and melanoma differentiation associated gene- 5 ( MDA5, also known as IFIH1), which contain amino- terminal caspase activation and recruitment domains ( CARD) and carboxy- terminal DExD/ H Box RNA helicase motifs(2-5). RIG- I and MDA5 interact with another CARD protein, interferon-beta promotor stimulator protein- 1 ( IPS- 1, also known as MAVS, VISA and Cardif), in the mitochondrial membrane, which relays the signal through the transcription factors interferon regulatory factor 3 ( IRF- 3) and nuclear factor ( NF)- kappa B to the IFN-beta gene(6-10). Although the signalling pathway is well understood, the origin of the RNA molecules that initiate these processes is not. Here we show that activation of the antiviral endoribonuclease, RNase L-11, by 2',5'- linked oligoadenylate ( 2-5A)(12) produces small RNA cleavage products from self- RNA that initiate IFN production. Accordingly, mouse embryonic fibroblasts lacking RNase L were resistant to the induction of IFN-beta expression in response to 2- 5A, dsRNA or viral infection. Single-stranded regions of RNA are cleaved 39 of UpUp and UpAp sequences by RNase L during viral infections, resulting in small, often duplex, RNAs13,14. We show that small self- RNAs produced by the action of RNase L on cellular RNA induce IFN-beta expression and that the signalling involves RIG- I, MDA5 and IPS- 1. Mice lacking RNase L produce significantly less IFN-beta during viral infections than infected wild- type mice. Furthermore, activation of RNase L with 2- 5A in vivo induced the expression of IFN-beta in wild- type but not RNase L- deficient mice. Our results indicate that RNase L has an essential role in the innate antiviral immune response that relieves the requirement for direct sensing of non- self RNA.	Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Cleveland Clinic Foundation; University of Washington; University of Washington Seattle	Silverman, RH (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	silverr@ccf.org		Gale, Michael/0000-0002-6332-7436	NATIONAL CANCER INSTITUTE [R01CA044059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089518] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA044059-24, R01 CA044059] Funding Source: Medline; NIAID NIH HHS [R15 AI089518-01, R15 AI089518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; DONG BH, 1994, J BIOL CHEM, V269, P14153; Flodstrom-Tullberg M, 2005, J IMMUNOL, V174, P1171, DOI 10.4049/jimmunol.174.3.1171; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/1079990042475698; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Thakur CS, 2005, METH MOLEC MED, V116, P103; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	30	461	482	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					816	U9		10.1038/nature06042	http://dx.doi.org/10.1038/nature06042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653195	Green Accepted			2022-12-24	WOS:000248754200042
J	Mocroft, A; Phillips, A; Gatell, J; Ledergerber, B; Fisher, M; Clumeck, N; Losso, M; Lazzarin, A; Fatkenheuer, G; Lundgren, JD				Mocroft, A.; Phillips, A.; Gatell, J.; Ledergerber, B.; Fisher, M.; Clumeck, N.; Losso, M.; Lazzarin, A.; Fatkenheuer, G.; Lundgren, J. D.		EuroSIDA Study Grp	Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study	LANCET			English	Article							CELL COUNT; POSITIVE INDIVIDUALS; CLINICAL-PRACTICE; VIRUS-INFECTION; T-LYMPHOCYTES; RECOVERY; INCREASES; EUROSIDA; INTERRUPTION; PROGRESSION	Background Combination antiretroviral therapy (cART) has been shown to reduce mortality and morbidity in patients with HIV. As viral replication falls, the CD4 count increases, but whether the CD4 count returns to the level seen in HIV-negative people is unknown. We aimed to assess whether the CD4 count for patients with maximum virological suppression (viral load <50 copies per mL) continues to increase with long-term CART to reach levels seen in HIV-negative populations. Methods We compared increases in CD4 counts in 1835 antiretroviral-naive patients who started CART from EuroSIDA, a pan-European observational cohort study. Rate of increase in CD4 count (per year) occurring between pairs of consecutive viral loads below 50 copies per mL was estimated using generalised linear models, accounting for multiple measurements for individual patients. Findings The median CD4 count at starting CART was 204 cells per mu L (IQR 85-330). The greatest mean yearly increase in CD4 count of 100 cells per mu L was seen in the year after starting CART. Significant, but lower, yearly increases in CD4 count, around 50 cells per mu L, were seen even at 5 years after starting CART in patients whose current CD4 count was less than 500 cells per mu L. The only groups without significant increases in CD4 count were those where CART had been taken for more than 5 years with a current CD4 count of more than 500 cells per mu L, (current mean CD4 count 774 cells per mu L; 95% CI 764-783). Patients starting CART with low CD4 counts (<200 cells per mu L) had significant rises in CD4 counts even after 5 years of CART. Interpretation Normalisation. of CD4 counts in HIV-infected patients for all infected individuals might be achievable if viral suppression with cART can be maintained for a sufficiently long period of time.	UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Hosp Clin Barcelona, Barcelona, Spain; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; St Pierre Hosp, Brussels, Belgium; Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; Univ Milan, Osped San Raffaele, I-20127 Milan, Italy; Univ Cologne, Cologne, Germany; Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-1168 Copenhagen, Denmark	University of London; University College London; University of London; University College London; University of Barcelona; Hospital Clinic de Barcelona; University of Zurich; University Zurich Hospital; University of Brighton; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hospital Ramos Mejia; University of Buenos Aires; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cologne; University of Copenhagen	Mocroft, A (corresponding author), UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, Royal Free Campus, London NW3 2PF, England.	a.mocroft@pcps.uci.ac.uk	Mocroft, Amanda/C-1527-2008; VALLET, Yannick/F-9979-2011; Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008; Ledergerber, Bruno/B-5656-2009; Mocroft, Amanda/G-8748-2011; LAZZARIN, Adriano/K-3607-2018	Phillips, Andrew N/0000-0003-2384-4807; Ledergerber, Bruno/0000-0002-6881-4401; Mocroft, Amanda/0000-0001-8316-1122; LAZZARIN, Adriano/0000-0003-2551-7754				AidsInfo, GUID US ANT AG HIV 1; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Coakley EPG, 2000, AIDS, V14, P1147, DOI 10.1097/00002030-200006160-00011; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maini MK, 1996, GENITOURIN MED, V72, P27; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Monforte AD, 2005, JAIDS-J ACQ IMM DEF, V38, P407, DOI 10.1097/01.qai.0000147529.57240.b0; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Taffe P, 2002, AIDS, V16, P747, DOI 10.1097/00002030-200203290-00010; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678	40	195	198	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					407	413		10.1016/S0140-6736(07)60948-9	http://dx.doi.org/10.1016/S0140-6736(07)60948-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17659333				2022-12-24	WOS:000248590200030
J	Deans, TL; Cantor, CR; Collins, JJ				Deans, Tara L.; Cantor, Charles R.; Collins, James J.			A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells	CELL			English	Article							DIPHTHERIA-TOXIN; TRANSGENE EXPRESSION; NOISE-PROPAGATION; TOGGLE SWITCH; APOPTOSIS; SYSTEM; MOUSE; BAX; OVEREXPRESSION; INTERFERENCE	Here, we introduce an engineered, tunable genetic switch that couples repressor proteins and an RNAi target design to effectively turn any gene off. We used the switch to regulate the expression of EGFP in mouse and human cells and found that it offers > 99% repression as well as the ability to tune gene expression. To demonstrate the system's modularity and level of gene silencing, we used the switch to tightly regulate the expression of diphtheria toxin and Cre recombinase, respectively. We also used the switch to tune the expression of a proapoptotic gene and show that a threshold expression level is required to induce apoptosis. This work establishes a system for tight, tunable control of mammalian gene expression that can be used to explore the functional role of various genes as well as to determine whether a phenotype is the result of a threshold response to changes in gene expression.	Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA	Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA.	jcollins@bu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070583] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, METAB ENG, V7, P241, DOI 10.1016/j.ymben.2005.02.005; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Malphettes L, 2006, J BIOTECHNOL, V124, P732, DOI 10.1016/j.jbiotec.2006.01.003; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng WD, 2002, MOL THER, V6, P537, DOI 10.1006/mthe.2002.0694; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	48	199	226	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					363	372		10.1016/j.cell.2007.05.045	http://dx.doi.org/10.1016/j.cell.2007.05.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662949	Bronze			2022-12-24	WOS:000248588000024
J	Myong, S; Bruno, MM; Pyle, AM; Ha, T				Myong, Sua; Bruno, Michael M.; Pyle, Anna M.; Ha, Taekjip			Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase	SCIENCE			English	Article							SINGLE-STRANDED-DNA; UVRD HELICASE; STEP-SIZE; RNA; PROTEIN; TRANSLOCATION; DOMAIN; RESOLUTION; DYNAMICS; TIME	NS3, an essential helicase for replication of hepatitis C virus, is a model enzyme for investigating helicase function. Using single-molecule fluorescence analysis, we showed that NS3 unwinds DNA in discrete steps of about three base pairs ( bp). Dwell time analysis indicated that about three hidden steps are required before a 3-bp step is taken. Taking into account the available structural data, we propose a spring-loaded mechanism in which several steps of one nucleotide per adenosine triphosphate molecule accumulate tension on the protein-DNA complex, which is relieved periodically via a burst of 3-bp unwinding. NS3 appears to shelter the displaced strand during unwinding, and, upon encountering a barrier or after unwinding > 18 bp, it snaps or slips backward rapidly and repeats unwinding many times in succession. Such repetitive unwinding behavior over a short stretch of duplex may help to keep secondary structures resolved during viral genome replication.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Yale Univ, New Haven, CT 06511 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Yale University; Howard Hughes Medical Institute	Myong, S (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	myong@uiuc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01-GM060620, R01 GM065367, R01-GM065367, R01 GM060620] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM060620] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; DIBISCEGLIE AM, 1997, HEPATOLOGY S, V26, P345; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Lavanchy D, 1999, J HEPATOL, V31, P146, DOI 10.1016/S0168-8278(99)80392-4; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Marians KJ, 1997, STRUCTURE, V5, P1129, DOI 10.1016/S0969-2126(97)00263-3; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Seeff LB, 1998, HEPATOLOGY, V28, P1710, DOI 10.1002/hep.510280636; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Yao Hang-Ping, 2002, Zhejiang Da Xue Xue Bao Yi Xue Ban, V31, P2	24	238	242	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					513	516		10.1126/science.1144130	http://dx.doi.org/10.1126/science.1144130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656723	Green Accepted			2022-12-24	WOS:000248339800045
J	Moffatt, MF; Kabesch, M; Liang, LM; Dixon, AL; Strachan, D; Heath, S; Depner, M; von Berg, A; Bufe, A; Rietschel, E; Heinzmann, A; Simma, B; Frischer, T; Willis-Owen, SAG; Wong, KCC; Illig, T; Vogelberg, C; Weiland, SK; von Mutius, E; Abecasis, GR; Farrall, M; Gut, IG; Lathrop, GM; Cookson, WOC				Moffatt, Miriam F.; Kabesch, Michael; Liang, Liming; Dixon, Anna L.; Strachan, David; Heath, Simon; Depner, Martin; von Berg, Andrea; Bufe, Albrecht; Rietschel, Ernst; Heinzmann, Andrea; Simma, Burkard; Frischer, Thomas; Willis-Owen, Saffron A. G.; Wong, Kenny C. C.; Illig, Thomas; Vogelberg, Christian; Weiland, Stephan K.; von Mutius, Erika; Abecasis, Goncalo R.; Farrall, Martin; Gut, Ivo G.; Lathrop, G. Mark; Cookson, William O. C.			Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma	NATURE			English	Article							NORMALIZATION	Asthma is caused by a combination of poorly understood genetic and environmental factors(1,2). We have systematically mapped the effects of single nucleotide polymorphisms ( SNPs) on the presence of childhood onset asthma by genome-wide association. We characterized more than 317,000 SNPs in DNA from 994 patients with childhood onset asthma and 1,243 non-asthmatics, using family and case-referent panels. Here we show multiple markers on chromosome 17q21 to be strongly and reproducibly associated with childhood onset asthma in family and case-referent panels with a combined P value of P < 10(-12). In independent replication studies the 17q21 locus showed strong association with diagnosis of childhood asthma in 2,320 subjects from a cohort of German children (P=0.0003) and in 3,301 subjects from the British 1958 Birth Cohort (P=0.0005). We systematically evaluated the relationships between markers of the 17q21 locus and transcript levels of genes in Epstein - Barr virus (EBV)-transformed lymphoblastoid cell lines from children in the asthma family panel used in our association study. The SNPs associated with childhood asthma were consistently and strongly associated (P < 10(-22)) in cis with transcript levels of ORMDL3, a member of a gene family that encodes transmembrane proteins anchored in the endoplasmic reticulum(3). The results indicate that genetic variants regulating ORMDL3 expression are determinants of susceptibility to childhood asthma.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; Univ Munich, Childrens Hosp, D-80337 Munich, Germany; Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford OX3 7BN, England; Univ London, Div Community Hlth Sci, London SW17 0RE, England; CEA, Ctr Natl Genotypage, Inst Genom, F-91057 Evry, France; Marien Hosp, Res Inst Prevent Allerg Dis, Childrens Dept, D-46483 Wesel, Germany; Ruhr Univ Bochum, Dept Expt Pneumol, D-44789 Bochum, Germany; Univ Cologne, Childrens Hosp, D-50924 Cologne, Germany; Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Feldkirch Hosp, Childrens Dept, A-6800 Feldkirch, Austria; Univ Vienna, Childrens Hosp, A-1090 Vienna, Austria; GSF, Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Tech Univ Dresden, Childrens Hosp, S-01307 Dresden, Germany; Univ Ulm, Inst Epidemiol, D-89081 Ulm, Germany	Imperial College London; University of Munich; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; University of London; CEA; UDICE-French Research Universities; Universite Paris Saclay; St. Marien Hospital; Ruhr University Bochum; University of Cologne; University of Freiburg; University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Ulm University	Cookson, WOC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Heath, Simon C/J-4138-2012; Abecasis, Goncalo R/B-7840-2010; Kabesch, Michael/GZM-1583-2022; Cookson, William/HHC-1790-2022; Kabesch, Michael/AAB-5701-2020; Gut, Ivo/ABF-3188-2020	Heath, Simon C/0000-0002-9550-0897; Gut, Ivo/0000-0001-7219-632X; Abecasis, Goncalo/0000-0003-1509-1825; Willis-Owen, Saffron/0000-0003-2633-1150; von Mutius, Erika/0000-0002-8893-4515; Bufe, Albrecht/0000-0001-7335-9362	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Cardon LR, 1999, AM J HUM GENET, V65, pA245; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; 1987, AM REV RESPIR DIS, V136, P225, DOI 10.1164/ajrccm/136.1.225	22	1153	1217	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					470	U5		10.1038/nature06014	http://dx.doi.org/10.1038/nature06014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17611496	Green Published			2022-12-24	WOS:000248302700046
J	Clark, RM; Schweikert, G; Toomajian, C; Ossowski, S; Zeller, G; Shinn, P; Warthmann, N; Hu, TT; Fu, G; Hinds, DA; Chen, HM; Frazer, KA; Huson, DH; Schoelkopf, B; Nordborg, M; Raetsch, G; Ecker, JR; Weigel, D				Clark, Richard M.; Schweikert, Gabriele; Toomajian, Christopher; Ossowski, Stephan; Zeller, Georg; Shinn, Paul; Warthmann, Norman; Hu, Tina T.; Fu, Glenn; Hinds, David A.; Chen, Huaming; Frazer, Kelly A.; Huson, Daniel H.; Schoelkopf, Bernhard; Nordborg, Magnus; Raetsch, Gunnar; Ecker, Joseph R.; Weigel, Detlef			Common sequence polymorphisms shaping genetic diversity in Arabidopsis thaliana	SCIENCE			English	Article							RESISTANCE GENE; GENOME; SELECTION; REVEALS; DELETIONS	The genomes of individuals from the same species vary in sequence as a result of different evolutionary processes. To examine the patterns of, and the forces shaping, sequence variation in Arabidopsis thaliana, we performed high-density array resequencing of 20 diverse strains (accessions). More than 1 million nonredundant single-nucleotide polymorphisms (SNPs) were identified at moderate false discovery rates (FDRs), and similar to 4% of the genome was identified as being highly dissimilar or deleted relative to the reference genome sequence. Patterns of polymorphism are highly nonrandom among gene families, with genes mediating interaction with the biotic environment having exceptional polymorphism levels. At the chromosomal scale, regional variation in polymorphism was readily apparent. A scan for recent selective sweeps revealed several candidate regions, including a notable example in which almost all variation was removed in a 500-kilobase window. Analyzing the polymorphisms we describe in larger sets of accessions will enable a detailed understanding of forces shaping population-wide sequence variation in A. thaliana.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; Max Planck Inst Biol Cybernet, Dept Empir Inference, D-72076 Tubingen, Germany; Univ So Calif, Los Angeles, CA 90089 USA; Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Perlegen Sci, Mountain View, CA 94043 USA	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society; University of Southern California; Eberhard Karls University of Tubingen; Salk Institute	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Rätsch, Gunnar/O-5914-2017; Zeller, Georg/M-6484-2013; Toomajian, Christopher/ABA-2615-2021; Warthmann, Norman/E-1069-2011; Schölkopf, Bernhard/A-7570-2013; Rätsch, Gunnar/B-8182-2009; Huson, Daniel H./AAC-5494-2019; Weigel, Detlef/AAR-3312-2021; Ecker, Joseph R/B-9144-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Rätsch, Gunnar/0000-0001-5486-8532; Zeller, Georg/0000-0003-1429-7485; Toomajian, Christopher/0000-0002-6763-0678; Warthmann, Norman/0000-0002-1178-8409; Schölkopf, Bernhard/0000-0002-8177-0925; Ecker, Joseph R/0000-0001-5799-5895; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963; Chen, Huaming/0000-0001-5289-7882; Frazer, Kelly/0000-0002-6060-8902; Hinds, David/0000-0002-4911-803X; Nordborg, Magnus/0000-0001-7178-9748				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2002, LEARNING KERNELS; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; HUDSON RR, 1988, GENETICS, V120, P831; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAPLAN NL, 1989, GENETICS, V123, P887; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kling J, 2005, NAT BIOTECHNOL, V23, P1333, DOI 10.1038/nbt1105-1333; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 1997, GENETICS, V146, P1501; Nordborg M, 2003, GENETICS, V163, P1201; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vapnik V., 1982, ESTIMATION DEPENDENC	34	539	556	0	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					338	342		10.1126/science.1138632	http://dx.doi.org/10.1126/science.1138632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641193				2022-12-24	WOS:000248150200037
J	Callen, E; Jankovic, M; Difilippantonio, S; Daniel, JA; Chen, HT; Celeste, A; Pellegrini, M; McBride, K; Wangsa, D; Bredemeyer, AL; Sleckman, BP; Ried, T; Nussenzweig, M; Nussenzweig, A				Callen, Elsa; Jankovic, Mila; Difilippantonio, Simone; Daniel, Jeremy A.; Chen, Hua-Tang; Celeste, Arkady; Pellegrini, Manuela; McBride, Kevin; Wangsa, Danny; Bredemeyer, Andrea L.; Sleckman, Barry P.; Ried, Thomas; Nussenzweig, Michel; Nussenzweig, Andre			ATM prevents the persistence and propagation of chromosome breaks in lymphocytes	CELL			English	Article							CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; CYTIDINE DEAMINASE AID; B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; DEFICIENT MICE; IONIZING-RADIATION; GENE AMPLIFICATION	DNA double- strand breaks ( DSBs) induce a signal transmitted by the ataxia- telangiectasia mutated ( ATM) kinase, which suppresses illegitimate joining of DSBs and activates cell- cycle checkpoints. Here we show that a significant fraction of mature ATM- deficient lymphocytes contain telomere- deleted ends produced by failed end joining during V( D) J recombination. These RAG- 1/ 2 endonuclease- dependent, terminally deleted chromosomes persist in peripheral lymphocytes for at least 2 weeks in vivo and are stable over several generations in vitro. Restoration of ATM kinase activity in mature lymphocytes that have transiently lostATM function leads to loss of cells with terminally deleted chromosomes. Thus, maintenance of genomic stability in lymphocytes requires faithful end joining as well a checkpoint that prevents the long- term persistence and transmission of DSBs. Silencing this checkpoint permits DNA ends produced by V( D) J recombination in a lymphoid precursor to serve as substrates for translocations with chromosomes subsequently damaged by other means in mature cells.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Sect Canc Genom, NIH, Genet Branch, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Nussenzweig, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.	andre_nussenzweig@nih.gov; nussen@mail.rockefeller.edu	mcbride, kevin/E-8230-2011; Pellegrini, manuela/AAC-1423-2022; Daniel, Jeremy/S-4729-2016; Nussenzweig, Michel/AAE-7292-2019	Daniel, Jeremy/0000-0002-1981-5571; pellegrini, manuela/0000-0001-6387-5187; Bredemeyer, Andrea/0000-0003-2970-5998	NATIONAL CANCER INSTITUTE [Z01BC010837, Z01BC010283, ZIABC010837, Z01BC009255, ZICBC009255, ZIABC010283] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HUANG CY, 2007, J EXP MED, V334, P676; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Ramiro AR, 2006, CANCER RES, V66, P7837, DOI 10.1158/0008-5472.CAN-06-0863; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Vacchio MS, 2007, P NATL ACAD SCI USA, V104, P6323, DOI 10.1073/pnas.0611222104; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	52	151	153	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					63	75		10.1016/j.cell.2007.06.016	http://dx.doi.org/10.1016/j.cell.2007.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17599403	Bronze			2022-12-24	WOS:000248587000011
J	Davidson, EA; de Carvalho, CJR; Figueira, AM; Ishida, FY; Ometto, JPHB; Nardoto, GB; Saba, RT; Hayashi, SN; Leal, EC; Vieira, ICG; Martinelli, LA				Davidson, Eric A.; de Carvalho, Claudio J. Reis; Figueira, Adelaine Michela; Ishida, Francoise Yoko; Ometto, Jean Pierre H. B.; Nardoto, Gabriela B.; Saba, Renata Tuma; Hayashi, Sanae N.; Leal, Eliane C.; Vieira, Ima Celia G.; Martinelli, Luiz A.			Recuperation of nitrogen cycling in Amazonian forests following agricultural abandonment	NATURE			English	Article							LAND-USE CHANGE; EASTERN AMAZONIA; BRAZILIAN AMAZON; ISOTOPIC COMPOSITION; OXIDE EMISSIONS; GLOBAL PATTERNS; COSTA-RICA; SOIL; REGROWTH; ECOSYSTEMS	Phosphorus ( P) is generally considered the most common limiting nutrient for productivity of mature tropical lowland forests growing on highly weathered soils(1-5). It is often assumed that P limitation also applies to young tropical forests, but nitrogen (N) losses during land-use change may alter the stoichiometric balance of nutrient cycling processes. In the Amazon basin, about 16% of the original forest area has been cleared(6), and about 30 - 50% of cleared land is estimated now to be in some stage of secondary forest succession following agricultural abandonment(7). Here we use forest age chronosequences to demonstrate that young successional forests growing after agricultural abandonment on highly weathered lowland tropical soils exhibit conservative N-cycling properties much like those of N-limited forests on younger soils in temperate latitudes. As secondary succession progresses, N-cycling properties recover and the dominance of a conservative P cycle typical of mature lowland tropical forests re-emerges. These successional shifts in N: P cycling ratios with forest age provide a mechanistic explanation for initially lower and then gradually increasing soil emissions of the greenhouse gas nitrous oxide (N2O). The patterns of N and P cycling during secondary forest succession, demonstrated here over decadal timescales, are similar to N- and P-cycling patterns during primary succession as soils age over thousands and millions of years, thus revealing that N availability in terrestrial ecosystems is ephemeral and can be disrupted by either natural or anthropogenic disturbances at several timescales.	EMBRAPA Amazonia Oriental, BR-66095100 Belem, Para, Brazil; Woods Hole Res Ctr, Falmouth, MA 02540 USA; Univ Sao Paulo, CENA, BR-13416000 Piracicaba, SP, Brazil; Museu Paraensr Emilio Goeldi, Dept Bot, BR-66040179 Belem, Para, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Woods Hole Research Center; Universidade de Sao Paulo; Museu Paraense Emilio Goeldi	Davidson, EA (corresponding author), Woods Hole Res Ctr, 149 Woods Hole Rd, Falmouth, MA 02540 USA.	edavidson@whrc.org	Davidson, Eric A/K-4984-2013; Martinelli, Luiz Antonio/F-7870-2011; Vieira, Ima C.G./H-6897-2012; Nardoto, Gabriela Bielefeld/J-7459-2012; Ometto, Jean Pierre/B-3351-2013	Davidson, Eric A/0000-0002-8525-8697; Martinelli, Luiz Antonio/0000-0002-7103-7551; Vieira, Ima C.G./0000-0003-1233-318X; Nardoto, Gabriela Bielefeld/0000-0001-8062-7417; Ometto, Jean Pierre/0000-0002-4221-1039; E SILVA FIGUEIRA, ADELAINE MICHELA/0000-0002-3702-3180				Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; [Anonymous], 2001, BIOGEOCHEMISTRY AMAZ; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Davidson EA, 2004, GEOPHYS MONOGR SER, V153, P147, DOI 10.1029/153GM12; Davidson EA, 2004, ECOL APPL, V14, pS150; Dias-Filho M.B., 2001, BIOGEOCHEM AMAZ BASI, P84; Erickson H, 2001, ECOSYSTEMS, V4, P67, DOI 10.1007/s100210000060; Gehring C, 2005, AGR ECOSYST ENVIRON, V111, P237, DOI 10.1016/j.agee.2005.06.009; Gehring C, 1999, BIOGEOCHEMISTRY, V45, P223, DOI 10.1023/A:1006138815453; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Hirsch AI, 2004, GLOBAL CHANGE BIOL, V10, P908, DOI 10.1111/j.1529-8817.2003.00765.x; *INPE, 2004, MON AMB AM SAT; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; KELLER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P399, DOI 10.1029/94GB01660; KELLER M, 1993, NATURE, V365, P244, DOI 10.1038/365244a0; Markewitz D, 2004, ECOL APPL, V14, pS177; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Melillo JM, 2001, J GEOPHYS RES-ATMOS, V106, P34179, DOI 10.1029/2000JD000036; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Verchot LV, 1999, GLOBAL BIOGEOCHEM CY, V13, P31, DOI 10.1029/1998GB900019; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; VIEIRA ICG, 1996, CIENCIA HOJE, V20, P38; VITOUSEK PM, 1982, ECOL MONOGR, V52, P155, DOI 10.2307/1942609; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Zarin DJ, 2005, FRONT ECOL ENVIRON, V3, P365, DOI 10.2307/3868585	29	319	340	11	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					995	U6		10.1038/nature05900	http://dx.doi.org/10.1038/nature05900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581583				2022-12-24	WOS:000247373100045
J	Christakis, NA; Fowler, JH				Christakis, Nicholas A.; Fowler, James H.			The spread of obesity in a large social network over 32 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS-INDEX; SMOKING-CESSATION; FRIENDS; IMPACT	ackground: The prevalence of obesity has increased substantially over the past 30 years. We performed a quantitative analysis of the nature and extent of the person-to-person spread of obesity as a possible factor contributing to the obesity epidemic. Methods: We evaluated a densely interconnected social network of 12,067 people assessed repeatedly from 1971 to 2003 as part of the Framingham Heart Study. The body-mass index was available for all subjects. We used longitudinal statistical models to examine whether weight gain in one person was associated with weight gain in his or her friends, siblings, spouse, and neighbors. Results: Discernible clusters of obese persons (body-mass index [the weight in kilograms divided by the square of the height in meters], greater/equal 30) were present in the network at all time points, and the clusters extended to three degrees of separation. These clusters did not appear to be solely attributable to the selective formation of social ties among obese persons. A person's chances of becoming obese increased by 57% (95% confidence interval [CI], 6 to 123) if he or she had a friend who became obese in a given interval. Among pairs of adult siblings, if one sibling became obese, the chance that the other would become obese increased by 40% (95% CI, 21 to 60). If one spouse became obese, the likelihood that the other spouse would become obese increased by 37% (95% CI, 7 to 73). These effects were not seen among neighbors in the immediate geographic location. Persons of the same sex had relatively greater influence on each other than those of the opposite sex. The spread of smoking cessation did not account for the spread of obesity in the network. Conclusions: Network phenomena appear to be relevant to the biologic and behavioral trait of obesity, and obesity appears to spread through social ties. These findings have implications for clinical and public health interventions.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Mt Auburn Hosp, Dept Med, Cambridge, MA USA; Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Harvard University; Harvard Medical School; Harvard University; Mount Auburn Hospital; Harvard University; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008; 白, 纯歌/V-1853-2017; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	NATIONAL INSTITUTE ON AGING [R01AG024448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrews JA, 2002, HEALTH PSYCHOL, V21, P349, DOI 10.1037//0278-6133.21.4.349; Atwood LD, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2004, MATH VIS, P77; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Beck N, 2001, ANNU REV POLIT SCI, V4, P271, DOI 10.1146/annurev.polisci.4.1.271; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; Carrington P. J., 2005, MODELS METHODS SOCIA; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chang VW, 2002, SOCIOL HEALTH ILL, V24, P151, DOI 10.1111/1467-9566.00289; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; KING G, 2000, AM J POLIT SCI, V0044; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Malchodi CS, 2003, OBSTET GYNECOL, V101, P504, DOI 10.1016/S0029-7844(02)03070-3; MCKNIGHT AJ, 1986, ACCIDENT ANAL PREV, V18, P339, DOI 10.1016/0001-4575(86)90047-3; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Montgomery GH, 2003, PREV MED, V37, P242, DOI 10.1016/S0091-7435(03)00120-8; Moody J, 2005, AM J SOCIOL, V110, P1206, DOI 10.1086/421509; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; SACKETT DL, 1975, CIRCULATION, V52, P589, DOI 10.1161/01.CIR.52.4.589; Schildcrout JS, 2005, BIOSTATISTICS, V6, P633, DOI 10.1093/biostatistics/kxi033; Sobal J, 1999, SOCIAL PROB SO ISS, P231; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WECHSLER H, 1995, J STUD ALCOHOL, V56, P628, DOI 10.15288/jsa.1995.56.628; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132	42	2945	2994	21	609	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					370	379		10.1056/NEJMsa066082	http://dx.doi.org/10.1056/NEJMsa066082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652652	Green Published			2022-12-24	WOS:000248283500008
J	Bianco, A; Poukkula, M; Cliffe, A; Mathieu, J; Luque, CM; Fulga, TA; Rorth, P				Bianco, Ambra; Poukkula, Minna; Cliffe, Adam; Mathieu, Juliette; Luque, Carlos M.; Fulga, Tudor A.; Rorth, Pernille			Two distinct modes of guidance signalling during collective migration of border cells	NATURE			English	Article							ZEBRAFISH LATERAL-LINE; DROSOPHILA OOGENESIS; EGF RECEPTOR; PROTEIN; MORPHOGENESIS; MICROSCOPY; PATHWAY	Although directed migration is a feature of both individual cells and cell groups, guided migration has been studied most extensively for single cells in simple environments(1,2). Collective guidance of cell groups remains poorly understood, despite its relevance for development and metastasis(3). Neural crest cells and neuronal precursors migrate as loosely organized streams of individual cells(4,5), whereas cells of the fish lateral line(6,7), Drosophila tracheal tubes and border-cell clusters(8) migrate as more coherent groups. Here we use Drosophila border cells to examine how collective guidance is performed. We report that border cells migrate in two phases using distinct mechanisms. Genetic analysis combined with live imaging shows that polarized cell behaviour is critical for the initial phase of migration, whereas dynamic collective behaviour dominates later. PDGF- and VEGF-related receptor and epidermal growth factor receptor act in both phases, but use different effector pathways in each. The myoblast city (Mbc, also known as DOCK180) and engulfment and cell motility (ELMO, also known as Ced-12) pathway is required for the early phase, in which guidance depends on subcellular localization of signalling within a leading cell. During the later phase, mitogen-activated protein kinase and phospholipase C gamma are used redundantly, and we find that the cluster makes use of the difference in signal levels between cells to guide migration. Thus, information processing at the multicellular level is used to guide collective behaviour of a cell group.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Natl Univ Singapore, Temasek Life Sci Lab TLL, Singapore 117604, Singapore	European Molecular Biology Laboratory (EMBL); National University of Singapore	Rorth, P (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	Pernille@tll.org.sg	Luque, Carlos M./Q-6043-2019; Ladoux, Benoit/A-9879-2013; Luque, Carlos/H-6810-2015; Rørth, Pernille/H-3020-2011	Luque, Carlos M./0000-0002-2993-4152; Luque, Carlos/0000-0002-2993-4152; Fulga, Tudor/0000-0002-1056-0082; Mathieu, Juliette/0000-0002-7152-4245; Poukkula, Minna Karoliina/0000-0003-4192-2899				Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Starz-Gaiano M, 2004, CURR OPIN GENET DEV, V14, P86, DOI 10.1016/j.gde.2003.12.001; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	27	211	212	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					362	U12		10.1038/nature05965	http://dx.doi.org/10.1038/nature05965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637670				2022-12-24	WOS:000248118300060
J	Okita, K; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of germline-competent induced pluripotent stem cells	NATURE			English	Article							SELF-RENEWAL; MOUSE DEVELOPMENT; ES CELLS; EXPRESSION; NANOG; METHYLATION; GENE; DIFFERENTIATION; IGF2R; LINES	We have previously shown that pluripotent stem cells can be induced from mouse fibroblasts by retroviral introduction of Oct3/4 (also called Pou5f1), Sox2, c-Myc and Klf4, and subsequent selection for Fbx15 (also called Fbxo15) expression. These induced pluripotent stem (iPS) cells (hereafter called Fbx15 iPS cells) are similar to embryonic stem (ES) cells in morphology, proliferation and teratoma formation; however, they are different with regards to gene expression and DNA methylation patterns, and fail to produce adult chimaeras. Here we show that selection for Nanog expression results in germline-competent iPS cells with increased ES-cell-like gene expression and DNA methylation patterns compared with Fbx15 iPS cells. The four transgenes (Oct3/4, Sox2, c-myc and Klf4) were strongly silenced in Nanog iPS cells. We obtained adult chimaeras from seven Nanog iPS cell clones, with one clone being transmitted through the germ line to the next generation. Approximately 20% of the offspring developed tumours attributable to reactivation of the c-myc transgene. Thus, iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application.	Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Yamanaka, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Wilson, Matthew H/K-3193-2013	Okita, Keisuke/0000-0001-5806-1090				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; DAVID B V, 1985, Pesticides (Bombay), V19, P9; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee J, 2002, DEVELOPMENT, V129, P1807; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003	28	3190	3660	60	1570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					313	U1		10.1038/nature05934	http://dx.doi.org/10.1038/nature05934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554338				2022-12-24	WOS:000248118300049
J	Pugacheva, EN; Jablonski, SA; Hartman, TR; Henske, EP; Golemis, EA				Pugacheva, Elena N.; Jablonski, Sandra A.; Hartman, Tiffiney R.; Henske, Elizabeth P.; Golemis, Erica A.			HEF1-Dependent aurora a activation induces disassembly of the primary cilium	CELL			English	Article							HISTONE DEACETYLASE INHIBITORS; INTRAFLAGELLAR TRANSPORT; FLAGELLAR LENGTH; CELL-CYCLE; KINASE; PROTEIN; MICROTUBULES; TUBULIN; HEF1; OVEREXPRESSION	The mammalian cilium protrudes from the apical/lumenal surface of polarized cells and acts as a sensor of environmental cues. Numerous developmental disorders and pathological conditions have been shown to arise from defects in cilia-associated signaling proteins. Despite mounting evidence that cilia are essential sites for coordination of cell signaling, little is known about the cellular mechanisms controlling their formation and disassembly. Here, we show that interactions between the prometastatic scaffolding protein HEF1/Cas-L/NEDD9 and the oncogenic Aurora A (AurA) kinase at the basal body of cilia causes phosphorylation and activation of HDAC6, a tubulin deacetylase, promoting ciliary disassembly. We show that this pathway is both necessary and sufficient for ciliary resorption and that it constitutes an unexpected nonmitotic activity of AurA in vertebrates. Moreover, we demonstrate that small molecule inhibitors of AurA and HDAC6 selectively stabilize cilia from regulated resorption cues, suggesting a novel mode of action for these clinical agents.	Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Golemis, EA (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	ea_golemis@fccc.edu		Jablonski, Sandra/0000-0001-7220-8159; Golemis, Erica/0000-0003-3618-3673; Pugacheva, Elena/0000-0001-9814-7446	NATIONAL CANCER INSTITUTE [R01CA063366, P30CA006927] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006927, R01 CA63366, R01 CA063366, R01 CA063366-11, P30 CA006927-44, CA-06927] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Benzing T, 2006, CURR OPIN NEPHROL HY, V15, P245, DOI 10.1097/01.mnh.0000222690.53970.ca; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fukushige T, 1999, J CELL SCI, V112, P395; Goepfert TM, 2002, CANCER RES, V62, P4115; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pugacheva EN, 2006, CELL CYCLE, V5, P384, DOI 10.4161/cc.5.4.2439; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sloboda RD, 2005, J CELL BIOCHEM, V94, P266, DOI 10.1002/jcb.20323; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	52	601	625	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1351	1363		10.1016/j.cell.2007.04.035	http://dx.doi.org/10.1016/j.cell.2007.04.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604723	Green Accepted, Bronze			2022-12-24	WOS:000247911400020
J	Panne, D; Maniatis, T; Harrison, SC				Panne, Daniel; Maniatis, Tom; Harrison, Stephen C.			An atomic model of the interferon-beta enhanceosome	CELL			English	Article							PROTEIN HMG I(Y); KAPPA-B SITE; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; DNA-BINDING; VIRUS INDUCTION; P50/P65 HETERODIMER; COOPERATIVE BINDING; REGULATORY FACTORS; POSITIVE FEEDBACK	Transcriptional activation of the interferon-beta (IFN-beta) gene requires assembly of an enhanceo-some containing ATF-2/c-Jun, IRF-3/IRF-7, and NF kappa B. These factors bind cooperatively to the IFN-beta enhancer and recruit coactivators and chromatin-remodeling proteins to the IFN-beta promoter. We describe here a crystal structure of the DNA-binding domains of IRF-3, IRF-7, and NF kappa B, bound to one half of the enhancer, and use a previously described structure of the remaining half to assemble a complete picture of enhanceosome architecture in the vicinity of the DNA. Association of eight proteins with the enhancer creates a continuous surface for recognizing a composite DNA-binding element. Paucity of local protein-protein contacts suggests that cooperative occupancy of the enhancer comes from both binding-induced changes in DNA conformation and interactions with additional components such as CBP. Contacts with virtually every nucleotide pair account for the evolutionary invariance of the enhancer sequence.	Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, 250 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Panne, Daniel/I-8368-2017	Panne, Daniel/0000-0001-9158-5507	NIAID NIH HHS [R01 AI020642, R01 AI020642-23, R01AI020642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Bannister AJ, 1995, ONCOGENE, V11, P2509; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carey M, 2000, TRANSCRIPTIONAL REGU; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; PTASHNE M, 2002, GENES SIGNALS; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	59	422	433	1	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1111	1123		10.1016/j.cell.2007.05.019	http://dx.doi.org/10.1016/j.cell.2007.05.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574024	Green Accepted, Bronze			2022-12-24	WOS:000247390400015
J	Prusinkiewicz, P; Erasmus, Y; Lane, B; Harder, LD; Coen, E				Prusinkiewicz, Przemyslaw; Erasmus, Yvette; Lane, Brendan; Harder, Lawrence D.; Coen, Enrico			Evolution and development of inflorescence architectures	SCIENCE			English	Article							REPRODUCTIVE GROWTH; ANNUAL PLANTS; ARABIDOPSIS; ENVIRONMENTS; INITIATION; IDENTITY	To understand the constraints on biological diversity, we analyzed how selection and development interact to control the evolution of inflorescences, the branching structures that bear flowers. We show that a single developmental model accounts for the restricted range of inflorescence types observed in nature and that this model is supported by molecular genetic studies. The model predicts associations between inflorescence architecture, climate, and life history, which we validated empirically. Paths, or evolutionary wormholes, link different architectures in a multidimensional fitness space, but the rate of evolution along these paths is constrained by genetic and environmental factors, which explains why some evolutionary transitions are rare between closely related plant taxa.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Calgary; University of Calgary	Coen, E (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Harder, Lawrence/H-9715-2012; Wilson, Yvette/C-2115-2011	Harder, Lawrence/0000-0002-2303-5076; 				BARTHELEMY D, 1991, ACTA BIOTHEOR, V39, P309, DOI 10.1007/BF00114184; BIAZQUEZ MA, 1997, DEVELOPMENT, V124, P3835; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Etherington I.M.H., 1939, P R SOC EDINBURGH, V59, P153; GATSUK LE, 1980, J ECOL, V68, P675, DOI 10.2307/2259429; Gavrilets S., 2004, MONOGRAPHS POPULATIO; HACCOU P, 1995, THEOR POPUL BIOL, V47, P212, DOI 10.1006/tpbi.1995.1009; Hopper KR, 2003, OIKOS, V101, P219, DOI 10.1034/j.1600-0706.2003.12051.x; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kellogg EA., 2000, MONOCOTS SYSTEMATICS, P84, DOI DOI 10.1016/J.YMPEV.2012.02.005; KING D, 1982, THEOR POPUL BIOL, V21, P194, DOI 10.1016/0040-5809(82)90013-2; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; NIKIAS KJ, 1997, EVOLUTIONARY BIOL PL; PARRY F, 2002, DEVELOPMENT, V129, P2519; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; RAFF RA, 1966, SHAPE LIFE; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; Sachs T, 1999, PLANT CELL ENVIRON, V22, P757, DOI 10.1046/j.1365-3040.1999.00220.x; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Troll W., 1969, INFLORESZENZEN, VII-1; Troll W., 1964, INFLORESZENZEN, VI; Watson L., 2006, FAMILIES FLOWERING P; Weberling F., 1992, MORPHOLOGY FLOWERS I; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; [No title captured]	36	266	274	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1452	1456		10.1126/science.1140429	http://dx.doi.org/10.1126/science.1140429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17525303				2022-12-24	WOS:000247066400035
J	Kuang, SH; Kuroda, K; Le Grand, F; Rudnicki, MA				Kuang, Shihuan; Kuroda, Kazuki; Le Grand, Fabien; Rudnicki, Michael A.			Asymmetric self-renewal and commitment of satellite stem cells in muscle	CELL			English	Article							SKELETAL-MUSCLE; MYOGENIC SPECIFICATION; PROGENITOR CELLS; SOMITIC ORIGIN; M-CADHERIN; EXPRESSION; MYOBLASTS; POPULATION; NUMB; DIFFERENTIATION	Satellite cells play a central role in mediating the growth and regeneration of skeletal muscle. However, whether satellite cells are stem cells, committed progenitors, or dedifferentiated myoblasts has remained unclear. Using Myf5Cre and ROSA26-YFP Cre-reporter alleles, we observed that in vivo 10% of sublaminar Pax7-expressing satellite cells have never expressed Myf5. Moreover, we found that Pax7(+)/ Myf5(-) satellite cells gave rise to Pax7(+)/Myf5(+) satellite cells through apical-basal oriented divisions that asymmetrically generated a basal Pax7(+)/Myf5(-) and an apical Pax7(+)/Myf5(+) cells. Prospective isolation and transplantation into muscle revealed that whereas Pax7(+)/Myf5(+) cells exhibited precocious differentiation, Pax7(+)/ Myf5(-) cells extensively contributed to the satellite cell reservoir throughout the injected muscle. Therefore, we conclude that satellite cells are a heterogeneous population composed of stem cells and committed progenitors. These results provide critical insights into satellite cell biology and open new avenues for therapeutic treatment of neuromuscular diseases.	Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249; Kuang, Shihuan/0000-0001-9180-3180	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044031, R01 AR044031-11] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BORNEMANN A, 1994, ANAT REC, V239, P119, DOI 10.1002/ar.1092390202; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COLLO G, 1993, J BIOL CHEM, V268, P19019; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cousins JC, 2004, J CELL SCI, V117, P3259, DOI 10.1242/jcs.01161; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Delfini MC, 2000, DEVELOPMENT, V127, P5213; El Fahime E, 2003, BIOCHEM CELL BIOL, V81, P81, DOI 10.1139/O03-054; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heslop L, 2000, J CELL SCI, V113, P2299; Hodgetts SI, 2000, CELL TRANSPLANT, V9, P489, DOI 10.1177/096368970000900406; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNOBLICH JA, 2001, S SOC EXP BIOL, V53, P75; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Venters S, 2005, ANAT EMBRYOL, V209, P449, DOI 10.1007/s00429-005-0461-2; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602	54	900	933	5	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					999	1010		10.1016/j.cell.2007.03.044	http://dx.doi.org/10.1016/j.cell.2007.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540178	Bronze, Green Accepted			2022-12-24	WOS:000247084600018
J	Trojer, P; Li, G; Sims, RJ; Vaquero, A; Kalakonda, N; Boccuni, P; Lee, D; Erdjument-Bromage, H; Tempst, P; Nimer, SD; Wang, YH; Reinberg, D				Trojer, Patrick; Li, Guohong; Sims, Robert J., III; Vaquero, Alejandro; Kalakonda, Nagesh; Boccuni, Piernicola; Lee, Donghoon; Erdjument-Bromage, Hediye; Tempst, Paul; Nimer, Stephen D.; Wang, Yuh-Hwa; Reinberg, Danny			L3MBTL1, a histone-methylation-dependent chromatin lock	CELL			English	Article							POLYCOMB GROUP PROTEIN; RNA POLYMERASE-II; LYSINE METHYLATION; TRANSCRIPTIONAL REPRESSOR; MAMMALIAN NUCLEI; MOLECULAR-BASIS; HP1 BINDING; PHD FINGER; IN-VITRO; H3 TAIL	Distinct histone lysine methylation marks are involved in transcriptional repression linked to the formation and maintenance of facultative heterochromatin, although the underlying mechanisms remain unclear. We demonstrate that the malignant-brain-tumor (MBT) protein L3MBTL1 is in a complex with core histones, histone H1b, HP1 gamma, and Rb. The MBT domain is structurally related to protein domains that directly bind methylated histone residues. Consistent with this, we found that the L3MBTL1 MBT domains compact nucleosomal arrays dependent on mono- and dimethylation of histone H4 lysine 20 and of histone H1b lysine 26. The MBT domains bind at least two nuclecisomes simultaneously, linking repression of transcription to recognition of different histone marks by L3MBTL1. Consistently, L3MBTL1 was found to negatively regulate the expression of a subset of genes regulated by E2F, a factor that interacts with Rb.	CSIC IRB, IBMB, Barcelona 08028, Spain; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Dept Biochem, Piscataway, NJ 08854 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Sloan Kettering Inst Canc Res, Lab Mol Aspects Hemaopoiesis, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Prot Ctr, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Mol Biol Program, New York, NY 10021 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Reinberg, D (corresponding author), ICREA, Parc Cientific Barcelona,Josep Samitier 1-5, Barcelona 08028, Spain.	reinbd01@med.nyu.edu	Vaquero, Alejandro/I-9845-2014; Vaquero, Alejandro/ABG-8634-2020	Vaquero, Alejandro/0000-0002-8735-4156; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Reinberg, Danny/0000-0003-4288-2016	NATIONAL CANCER INSTITUTE [R01CA102202, R01CA113863, R01CA085826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071166, R01GM064844] Funding Source: NIH RePORTER; NCI NIH HHS [CA085826, CA 102202, CA113863] Funding Source: Medline; NIGMS NIH HHS [GM-64844, GM-71166] Funding Source: Medline; ICREA Funding Source: Custom	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)		[Anonymous], 2003, EAU UPDATE; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Cheung E, 2002, MOL CELL BIOL, V22, P2463, DOI 10.1128/MCB.22.8.2463-2471.2002; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Loyola A, 2001, GENE DEV, V15, P2837; MacGrogan D, 2001, ONCOGENE, V20, P4150, DOI 10.1038/sj.onc.1204540; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Sato MH, 1999, FEBS LETT, V452, P267, DOI 10.1016/S0014-5793(99)00644-4; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2006, METHODS, V40, P331, DOI 10.1016/j.ymeth.2006.07.031; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; van Holde K, 2006, J BIOL CHEM, V281, P12197, DOI 10.1074/jbc.R500025200; VANHOLDE KE, 1989, CHROMATIN, V1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; WOLLFE A, 1998, CHROMATIN STRUCTURE; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yohn CB, 2003, GENETICS, V165, P1889; Zhao T, 2000, J BIOL CHEM, V275, P28332; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	266	272	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					915	928		10.1016/j.cell.2007.03.048	http://dx.doi.org/10.1016/j.cell.2007.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540172	Bronze			2022-12-24	WOS:000247084600012
J	Takashima, Y; Era, T; Nakao, K; Kondo, S; Kasuga, M; Smith, AG; Nishikawa, SI				Takashima, Yasuhiro; Era, Takumi; Nakao, Kazuki; Kondo, Saki; Kasuga, Masato; Smith, Austin G.; Nishikawa, Shin-Ichi			Neuroepithelial cells supply an initial transient wave of MSC differentiation	CELL			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; NEURAL CREST; BONE-MARROW; MOUSE; EXPRESSION; ORIGIN; GROWTH; MESODERM; LINEAGE	Mesenchymal stem cells (MSCs) are defined as cells that undergo sustained in vitro growth and are able to give rise to multiple mesenchymal lineages. Although MSCs are already used in regenerative medicine little is known about their in vivo behavior and developmental derivation. Here, we show that the earliest wave of MSC in the embryonic trunk is generated from Sox1(+) neuroepithelium but not from mesoderm. Using lineage marking by direct gfp knock- in and Cre-recombinase mediated lineage tracing, we provide evidence that Sox1(+) neuroepithelium gives rise to MSCs in part through a neural crest intermediate stage. This pathway can be distinguished from the pathway through which Sox1(+) cells give rise to oligodendrocytes by expression of PDGFR beta and A2B5. MSC recruitment from this pathway, however, is transient and is replaced by MSCs from unknown sources. We conclude that MSC can be defined as a definite in vivo entity recruited from multiple developmental origins.	Riken Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Riken Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Med, Div Diabet & Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; Univ Tokyo, Inst Med Sci, Mol Genet Lab, Tokyo 1088639, Japan; Univ Cambridge, Inst Stem Cell Biol, Cambridge CB2 1QT, England	RIKEN; RIKEN; Kobe University; University of Tokyo; University of Cambridge	Era, T (corresponding author), Riken Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	tera@cdb.riken.jp		Takashima, Yasuhiro/0000-0003-0126-7260; zhong wei, he gui/0000-0002-3066-3564; Smith, Austin/0000-0002-3029-4682	MRC [G9806702] Funding Source: UKRI; Medical Research Council [G9806702, G0800784] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bailey P, 2001, CURR OPIN CELL BIOL, V13, P679, DOI 10.1016/S0955-0674(00)00271-4; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Dani C, 1997, J CELL SCI, V110, P1279; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; DROZDOFF V, 1991, J BIOL CHEM, V266, P17165; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Kondo S, 2006, MICROBIOL IMMUNOL, V50, P831, DOI 10.1111/j.1348-0421.2006.tb03850.x; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Li M, 2002, Methods Mol Biol, V185, P205; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; PARR BA, 1993, DEVELOPMENT, V119, P247; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Weston JA, 2004, DEV DYNAM, V229, P118, DOI 10.1002/dvdy.10478; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; ZON LI, 1995, BLOOD, V86, P2876	45	389	411	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1377	1388		10.1016/j.cell.2007.04.028	http://dx.doi.org/10.1016/j.cell.2007.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604725	Bronze			2022-12-24	WOS:000247911400022
J	Rock, FL; Mao, WM; Yaremchuk, A; Tukalo, M; Crepin, T; Zhou, HC; Zhang, YK; Hernandez, V; Akama, T; Baker, SJ; Plattner, JJ; Shapiro, L; Martinis, SA; Benkovic, SJ; Cusack, S; Alley, MRK				Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.			An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site	SCIENCE			English	Article							CRYSTAL-STRUCTURE	Aminoacyl-transfer RNA (tRNA) synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets. We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNA(Leu)-AN2690 adduct in the editing site of the enzyme. Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine. The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNA(Leu) and consequentially blocking protein synthesis. This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.	Anacor Pharmaceut Inc, Palo Alto, CA 94303 USA; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine; Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, Stanford, CA 94305 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	European Molecular Biology Laboratory (EMBL); National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Shanghai Jiao Tong University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Alley, MRK (corresponding author), Anacor Pharmaceut Inc, 1060 E Meadow Circle, Palo Alto, CA 94303 USA.	dalley@anacor.com		CREPIN, Thibaut/0000-0003-2663-1794; Martinis, Susan/0000-0001-5730-8346; Cusack, Stephen/0000-0002-9324-0796; Tukalo, Michael/0000-0002-0982-2372	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016835] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE16835] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Hendrickson T.L., 2003, TRANSLATION MECH, P34; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; MCCUTCHAN TF, 1975, NUCLEIC ACIDS RES, V2, P853, DOI 10.1093/nar/2.6.853; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Zhai YX, 2005, BIOCHEMISTRY-US, V44, P15437, DOI 10.1021/bi0514461	9	464	521	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1759	1761		10.1126/science.1142189	http://dx.doi.org/10.1126/science.1142189			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588934				2022-12-24	WOS:000247400500051
J	Whittall, JB; Hodges, SA				Whittall, Justen B.; Hodges, Scott A.			Pollinator shifts drive increasingly long nectar spurs in columbine flowers	NATURE			English	Article							ANCESTRAL CHARACTER STATES; EVOLUTION; RATES	Directional evolutionary trends have long garnered interest because they suggest that evolution can be predictable. However, the identification of the trends themselves and the underlying processes that may produce them have often been controversial(1). In 1862, in explaining the exceptionally long nectar spur of Angraecum sesquipedale, Darwin proposed that a coevolutionary 'race' had driven the directional increase in length of a plant's spur and its pollinator's tongue(2). Thus he predicted the existence of an exceptionally long-tongued moth. Though the discovery of Xanthopan morgani ssp. praedicta in 1903 with a tongue length of 22 cm validated Darwin's prediction(3), his 'race' model for the evolution of long-spurred flowers remains contentious(4). Spurs may also evolve to exceptional lengths by way of pollinator shifts as plants adapt to a series of unrelated pollinators, each with a greater tongue length(5). Here, using a species-level phylogeny of the columbine genus, Aquilegia, we show a significant evolutionary trend for increasing spur length during directional shifts to pollinators with longer tongues. In addition, we find evidence for 'punctuated' change in spur length during speciation events(6), suggesting that Aquilegia nectar spurs rapidly evolve to fit adaptive peaks predefined by pollinator morphology. These findings show that evolution may proceed in predictable pathways without reversals and that change may be concentrated during speciation.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Whittall, JB (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jbwhittall@ucdavis.edu; hodges@lifesci.ucsb.edu		Hodges, Scott/0000-0002-0401-6072				Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Darwin C., 1877, VARIOUS CONTRIVANCES; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gould SJ, 1997, NATURE, V385, P199, DOI 10.1038/385199a0; GRANT V, 1992, P NATL ACAD SCI USA, V89, P9400, DOI 10.1073/pnas.89.20.9400; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; GRANT VERNE, 1952, ALISO, V2, P341; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Lee Chunghau, 2006, Evolutionary Bioinformatics Online, V2, P193; MADDISON WP, 2004, MESQUITE MODULAR SYS; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Millard E., 1997, GENDER EDUC, V9, P31, DOI DOI 10.1080/09540259721439; Nilsson LA, 1998, TRENDS ECOL EVOL, V13, P259, DOI 10.1016/S0169-5347(98)01359-7; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; ROTHENBORG HW, 1972, CRYOBIOLOGY, V9, P1, DOI 10.1016/0011-2240(72)90002-8; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALLACE AR, 1867, Q J SCI S, V140, P471; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x	29	465	485	25	596	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					706	U12		10.1038/nature05857	http://dx.doi.org/10.1038/nature05857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554306				2022-12-24	WOS:000247030700042
J	Mathy, N; Benard, L; Pellegrini, O; Daou, R; Wen, TY; Condon, C				Mathy, Nathalie; Benard, Lionel; Pellegrini, Olivier; Daou, Roula; Wen, Tingyi; Condon, Ciaran			5 '-to-3 ' exoribonuclease activity in Bacteria: Role of RNase J1 in rRNA maturation and 5 ' stability of mRNA	CELL			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC DISTRIBUTION; DEGRADATION; PROTEIN; STABILITY; PURIFICATION; RIBONUCLEASE; TRANSLATION	Although the primary mechanism of eukaryotic messenger RNA decay is exoribonucleolytic degradation in the 5'-to-3' orientation, it has been widely accepted that Bacteria can only degrade RNAs with the opposite polarity, i.e. 3' to 5'. Here we show that maturation of the 5' side of Bacillus subtilis 16S ribosomal RNA occurs via a 5'-to-3'exonucleolytic pathway, catalyzed by the widely distributed essential ribonuclease RNase J1. The presence of a 5'-to-3'exoribonuclease activity in B. subtilis suggested an explanation for the phenomenon whereby mRNAs in this organism are stabilized for great distances downstream of "roadblocks" such as stalled ribosomes or stable secondary structures, whereas upstream sequences are never detected. We show that a 30S ribosomal subunit bound to a Shine Dalgarno-like element (Stab-SID) in the cryIIIA mRNA blocks exonucleolytic progression of RNase J1, accounting for the stabilizing effect of this element in vivo.	Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Condon, C (corresponding author), Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	condon@ibpc.fr	BENARD, LIONEL/E-4057-2019; Condon, Ciaran/F-6798-2011; Wen, Tingyi/M-6095-2014	BENARD, LIONEL/0000-0003-1745-1361; Condon, Ciaran/0000-0002-2199-9621; Wen, Tingyi/0000-0003-2583-7088				Agaisse H, 1996, MOL MICROBIOL, V20, P633, DOI 10.1046/j.1365-2958.1996.5401046.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bechhofer D., 1993, CONTROL MESSENGER RN, P31; BECHHOFER DH, 1987, P NATL ACAD SCI USA, V84, P498, DOI 10.1073/pnas.84.2.498; Belasco J, 1993, CONTROL MESSENGER RN, P3; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dreyfus M., 2002, TRANSLATIONAL MECH; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Hambraeus G, 2002, MICROBIOL-SGM, V148, P1795, DOI 10.1099/00221287-148-6-1795; HUANG J, 1988, NUCLEIC ACIDS RES, V16, P9737, DOI 10.1093/nar/16.20.9737; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; QUSSENKO IA, 2002, J BACTERIOL, V184, P6250; SHIVAKUMAR AG, 1980, P NATL ACAD SCI-BIOL, V77, P3903, DOI 10.1073/pnas.77.7.3903; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	38	260	267	2	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					681	692		10.1016/j.cell.2007.02.051	http://dx.doi.org/10.1016/j.cell.2007.02.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512403	Bronze			2022-12-24	WOS:000246788300014
J	McGillicuddy, DJ; Anderson, LA; Bates, NR; Bibby, T; Buesseler, KO; Carlson, CA; Davis, CS; Ewart, C; Falkowski, PG; Goldthwait, SA; Hansell, DA; Jenkins, WJ; Johnson, R; Kosnyrev, VK; Ledwell, JR; Li, QP; Siegel, DA; Steinberg, DK				McGillicuddy, Dennis J., Jr.; Anderson, Laurence A.; Bates, Nicholas R.; Bibby, Thomas; Buesseler, Ken O.; Carlson, Craig A.; Davis, Cabell S.; Ewart, Courtney; Falkowski, Paul G.; Goldthwait, Sarah A.; Hansell, Dennis A.; Jenkins, William J.; Johnson, Rodney; Kosnyrev, Valery K.; Ledwell, James R.; Li, Qian P.; Siegel, David A.; Steinberg, Deborah K.			Eddy/wind interactions stimulate extraordinary mid-ocean plankton blooms	SCIENCE			English	Article							ATLANTIC TIME-SERIES; NORTH PACIFIC-OCEAN; MESOSCALE EDDY; SARGASSO SEA; PRIMARY PRODUCTIVITY; NITROGEN-FIXATION; BERMUDA; BIOGEOCHEMISTRY; PHYTOPLANKTON; IMPACT	Episodic eddy-driven upwelling may supply a significant fraction of the nutrients required to sustain primary productivity of the subtropical ocean. New observations in the northwest Atlantic reveal that, although plankton blooms occur in both cyclones and mode-water eddies, the biological responses differ. Mode-water eddies can generate extraordinary diatom biomass and primary production at depth, relative to the time series near Bermuda. These blooms are sustained by eddy/wind interactions, which amplify the eddy-induced upwelling. In contrast, eddy/wind interactions dampen eddy-induced upwelling in cyclones. Carbon export inferred from oxygen anomalies in eddy cores is one to three times as much as annual new production for the region.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Bermuda Inst Ocean Sci, Ferry Reach GEO1, Bermuda; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Humboldt State Univ, Arcata, CA 95521 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Woods Hole Oceanographic Institution; Bermuda Institute of Ocean Sciences; Rutgers State University New Brunswick; NERC National Oceanography Centre; University of Southampton; University of California System; University of California Santa Barbara; William & Mary; Virginia Institute of Marine Science; California State University System; California State Polytechnic University, Humboldt; University of Miami	McGillicuddy, DJ (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	dmcgillicuddy@whoi.edu	Li, Qian P/P-7335-2018; Hansell, Dennis A./AAC-1271-2019; Bibby, Thomas/C-9159-2014; Siegel, David A/C-5587-2008	Li, Qian P/0000-0002-9846-3243; Hansell, Dennis A./0000-0001-9275-3445; McGillicuddy, Dennis/0000-0002-1437-2425; Bibby, Thomas/0000-0003-1743-473X				Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARBILLIDO BM, 2006, LIMNOL OCEANOGR, V51, P2675; Dadou I, 1996, J MAR RES, V54, P311, DOI 10.1357/0022240963213411; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; DEWAR WK, 1987, J PHYS OCEANOGR, V17, P1653, DOI 10.1175/1520-0485(1987)017<1653:SEOTWO>2.0.CO;2; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Emerson S, 2001, GLOBAL BIOGEOCHEM CY, V15, P535, DOI 10.1029/2000GB001320; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; FRANKS PJS, 1986, J GEOPHYS RES-OCEANS, V91, P7603, DOI 10.1029/JC091iC06p07603; Goldman JC, 2003, LIMNOL OCEANOGR, V48, P1176, DOI 10.4319/lo.2003.48.3.1176; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HOOD RR, 2004, J GEOPHYS RES, V109; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Leben RR., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Levitus S., 1982, 13 NOAA; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; Mahadevan A, 2000, J GEOPHYS RES-OCEANS, V105, P1209, DOI 10.1029/1999JC900216; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Oschlies A, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001830; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; PLATT T, 1985, NATURE, V318, P55, DOI 10.1038/318055a0; SHULENBERGER E, 1981, DEEP-SEA RES, V28, P901, DOI 10.1016/0198-0149(81)90009-1; Siegel DA, 2001, DEEP-SEA RES PT II, V48, P1865, DOI 10.1016/S0967-0645(00)00167-3; Spall SA, 2000, DEEP-SEA RES PT I, V47, P1261, DOI 10.1016/S0967-0637(99)00081-3; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; WILLIAMS RG, 2003, OCEAN BIOGEOCHEMISTR, V19; WOODS JD, 1988, THEORY BIOL PHYS INT, P1; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	39	598	611	14	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1021	1026		10.1126/science.1136256	http://dx.doi.org/10.1126/science.1136256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510363				2022-12-24	WOS:000246554000045
J	Kinseth, MA; Anjard, C; Fuller, D; Guizzunti, G; Loomis, WF; Malhotra, V				Kinseth, Matthew A.; Anjard, Christophe; Fuller, Danny; Guizzunti, Gianni; Loomis, William F.; Malhotra, Vivek			The golgi-associated protein GRASP is required for unconventional protein secretion during development	CELL			English	Article							DICTYOSTELIUM-DISCOIDEUM; MAMMALIAN-CELLS; TERMINAL DIFFERENTIATION; PLASMA-MEMBRANE; SPORE DIFFERENTIATION; COMPLEX; STACKING; FRAGMENTATION; CISTERNAE; PATHWAYS	During Dictyostelium development, prespore cells secrete acyl-CoA binding protein (AcbA). Upon release, AcbA is processed to generate a peptide called spore differentiation factor-2 (SDF-2), which triggers terminal differentiation of spore cells. We have found that cells lacking Golgi reassembly stacking protein (GRASP), a protein attached peripherally to the cytoplasmic surface of Golgi membranes, fail to secrete AcbA and, thus, produce inviable spores. Surprisingly, AcbA lacks a signal sequence and is not secreted via the conventional secretory pathway (endoplasmic reticulum-Golgi-cell surface). GRASP is not required for conventional protein secretion, growth, and the viability of vegetative cells. Our findings reveal a physiological role of GRASP and provide a means to understand unconventional secretion and its role in development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	vivek@biomail.ucsd.edu	Malhotra, Vivek/O-9811-2014; Anjard, Christophe/H-5012-2017	Malhotra, Vivek/0000-0001-6198-7943; Anjard, Christophe/0000-0002-6905-1493	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078175] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM78175, GM46224, GM53747] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; DEVINE KM, 1983, DEV BIOL, V99, P437, DOI 10.1016/0012-1606(83)90293-2; FARQUHAR MG, 1981, J CELL BIOL, V91, P77; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; FIEGER O, 2003, FEBS LETT, V551, P78; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HUYER G, 2006, CELL, V5, P1560; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Metcalf T, 2003, MICROBIOL-SGM, V149, P305, DOI 10.1099/mic.0.25984-0; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Shaulsky G, 1996, DEV BIOL, V174, P214, DOI 10.1006/dbio.1996.0067; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Wang N, 1999, MOL CELL BIOL, V19, P4750; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; West CM, 2003, INT REV CYTOL, V222, P237; WOOD L, 1985, J CELL BIOL, V101, P2063, DOI 10.1083/jcb.101.6.2063; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	45	177	181	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					524	534		10.1016/j.cell.2007.06.029	http://dx.doi.org/10.1016/j.cell.2007.06.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17655921	Bronze			2022-12-24	WOS:000249038100019
J	Driscoll, CA; Menotti-Raymond, M; Roca, AL; Hupe, K; Johnson, WE; Geffen, E; Harley, EH; Delibes, M; Pontier, D; Kitchener, AC; Yamaguchi, N; O'Brien, SJ; Macdonald, DW				Driscoll, Carlos A.; Menotti-Raymond, Marilyn; Roca, Alfred L.; Hupe, Karsten; Johnson, Warren E.; Geffen, Eli; Harley, Eric H.; Delibes, Miguel; Pontier, Dominique; Kitchener, Andrew C.; Yamaguchi, Nobuyuki; O'Brien, Stephen J.; Macdonald, David W.			The Near Eastern origin of cat domestication	SCIENCE			English	Article							FELIS-SILVESTRIS; WILD; POPULATIONS; RADIATION	The world's domestic cats carry patterns of sequence variation in their genome that reflect a history of domestication and breed development. A genetic assessment of 979 domestic cats and their wild progenitors-Felis silvestris silvestris ( European wildcat), F. s. lybica ( Near Eastern wildcat), F. s. ornata ( central Asian wildcat), F. s. cafra ( southern African wildcat), and F. s. bieti ( Chinese desert cat)indicated that each wild group represents a distinctive subspecies of Felis silvestris. Further analysis revealed that cats were domesticated in the Near East, probably coincident with agricultural village development in the Fertile Crescent. Domestic cats derive from at least five founders from across this region, whose descendants were transported across the world by human assistance.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; JagdEinrichtungsBuro, D-37170 Furstenhagen, Germany; Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; Univ Cape Town, Div Chem Pathol, Observ, ZA-7925 Cape Town, South Africa; CSIC, Dept Appl Biol, Estac Biol Donana, Seville 41013, Spain; Univ Lyon 1, CNRS, Biometrie & Biol Evolut UMR 5558, F-69622 Villeurbanne, France; Natl Museums Scotland, Dept Nat Sci, Edinburgh EH1 1JF, Midlothian, Scotland; Univ Edinburgh, Inst Geog, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; University of Cape Town; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Edinburgh	Macdonald, DW (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	driscoll@ncifcrf.gov; obrien@ncifcrf.gov; david.macdonald@zoology.oxford.ac.uk	OBRIEN, STEPHEN/ABD-1346-2020; Yamaguchi, Nobuyuki/AAN-4884-2020; Johnson, Warren/D-4149-2016; Delibes, Miguel/K-2744-2014	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Johnson, Warren/0000-0002-5954-186X; Delibes, Miguel/0000-0002-3569-567X; Pontier, Dominique/0000-0003-4700-3543; Driscoll, Carlos/0000-0003-2392-505X; OBRIEN, STEPHEN/0000-0001-7857-0757; Roca, Alfred/0000-0001-9217-5593; Kitchener, Andrew/0000-0003-2594-0827	NATIONAL CANCER INSTITUTE [Z01BC005367, Z01BC005385] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AA999999] Funding Source: Medline; NCI NIH HHS [N01CO12400, N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; BUDIANSKY S, 1999, COVENANT WILD WHY AN; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Donalson M.D., 1999, DOMESTIC CAT ROMAN C; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; KITCHENER A., 1991, NATURAL HIST WILD CA; KURTEN BJORN, 1965, ACTA ZOOL FENNICA, V111, P3; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; LEGAY JM, 1986, CR ACAD SCI III-VIE, V303, P709; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Macdonald D.W., 2004, SCOTTISH WILDCAT ANA; Macdonald DW, 1987, ADV ETHOL, V28, P1, DOI DOI 10.1016/0168-1591(88)90058-5; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nowell K., 1996, WILD CATS STATUS SUR; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; Pocock R.I., 1951, CATALOGUE GENUS FELI; Pocock RI, 1907, P ZOOL SOC LOND, V1907, P656; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; RANDI E, 1991, J MAMMAL, V72, P79, DOI 10.2307/1381981; STEPHENS G, 2001, LEGACY CAT ULTIMATE; Sunquist ME, 2002, WILD CATS WORLD; SWOFFORD D. L., 1985, PHYLOGENETIC ANAL US; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P828; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Vella CM, 2003, ROBINSONS GENETICS C; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; WILLCOX G, 2005, 13 IWGP S, P534; Yamaguchi N, 2004, ANIM CONSERV, V7, P339, DOI 10.1017/S1367943004001520	31	317	334	21	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					519	523		10.1126/science.1139518	http://dx.doi.org/10.1126/science.1139518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17600185	Green Submitted, Green Accepted			2022-12-24	WOS:000248339800047
J	Outeiro, TF; Kontopoulos, E; Altmann, SM; Kufareva, I; Strathearn, KE; Amore, AM; Volk, CB; Maxwell, MM; Rochet, JC; McLean, PJ; Young, AB; Abagyan, R; Feany, MB; Hyman, BT; Kazantsev, AG				Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.			Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease	SCIENCE			English	Article							DROSOPHILA MODEL; LEWY BODIES; PROTEIN; AGGREGATION; DEACETYLASE; ACETYLATION; SUPPRESSION; HUNTINGTONS; SIRT2; HDAC6	The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging. We identified a potent inhibitor of sirtuin 2 ( SIRT2) and found that inhibition of SIRT2 rescued alpha-synuclein toxicity and modified inclusion morphology in a cellular model of Parkinson's disease. Genetic inhibition of SIRT2 via small interfering RNA similarly rescued alpha-synuclein toxicity. Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease. The results suggest a link between neurodegeneration and aging.	Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, MGH, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Alzheimers Res Unit, MGH, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Scripps Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kontopoulos, E (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, MGH, CNY 114,16th St, Charlestown, MA 02129 USA.	akazantsev@partners.org	Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Young, Anne/AAF-4283-2020; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Rochet, Jean-Christophe/0000-0002-6484-1541; Kufareva, Irina/0000-0001-9083-7039; McLean, Pamela/0000-0003-4870-5715; Feany, Mel/0000-0003-0315-7970	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372, R01NS049221] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS049221, 5P50-NS38372A-06] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	25	823	857	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					516	519		10.1126/science.1143780	http://dx.doi.org/10.1126/science.1143780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17588900				2022-12-24	WOS:000248339800046
J	Guenther, MG; Levine, SS; Boyer, LA; Jaenisch, R; Young, RA				Guenther, Matthew G.; Levine, Stuart S.; Boyer, Laurie A.; Jaenisch, Rudolf; Young, Richard A.			A chromatin landmark and transcription initiation at most promoters in human cells	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; HISTONE H3; SACCHAROMYCES-CEREVISIAE; ACTIVE GENES; HIV-1 TAT; IN-VIVO; METHYLATION; ELONGATION; METHYLTRANSFERASE	We describe the results of a genome- wide analysis of human cells that suggests that most protein- coding genes, including most genes thought to be transcriptionally inactive, experience transcription initiation. We found that nucleosomes with H3K4me3 and H3K9,14Ac modifications, together with RNA polymerase II, occupy the promoters of most protein- coding genes in human embryonic stem cells. Only a subset of these genes produce detectable full- length transcripts and are occupied by nucleosomes with H3K36me3 modifications, a hallmark of elongation. The other genes experience transcription initiation but show no evidence of elongation, suggesting that they are predominantly regulated at post-initiation steps. Genes encoding most developmental regulators fall into this group. Our results also identify a class of genes that are excluded from experiencing transcription initiation, at which mechanisms that prevent initiation must predominate. These observations extend to differentiated cells, suggesting that transcription initiation at most genes is a general phenomenon in human cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X	NHGRI NIH HHS [HG002668, R01 HG002668, R01 HG002668-04A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; KRUMM A, 1993, BIOESSAYS, V15, P659, DOI 10.1002/bies.950151005; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; LASPIA MF, 1993, J MOL BIOL, V232, P732, DOI 10.1006/jmbi.1993.1427; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ptashne M, 1986, GENETIC SWITCH; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	61	1457	1498	1	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					77	88		10.1016/j.cell.2007.05.042	http://dx.doi.org/10.1016/j.cell.2007.05.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632057	Green Accepted, Bronze			2022-12-24	WOS:000248587000012
J	Rowland, HM; Ihalainen, E; Lindstrom, L; Mappes, J; Speed, MP				Rowland, Hannah M.; Ihalainen, Eira; Lindstrom, Leena; Mappes, Johanna; Speed, Michael P.			Co-mimics have a mutualistic relationship despite unequal defences	NATURE			English	Article							MULLERIAN MIMICRY; NATURAL-SELECTION; PHYLOGENETIC EVIDENCE; ALTERNATIVE PREY; WARNING-COLOR; EVOLUTION; PREDATION; DYNAMICS; MODEL	In the first clear mathematical treatment of natural selection, Muller(1) proposed that a shared warning signal ( mimicry) would benefit defended prey species by sharing out the per capita mortality incurred during predator education. Although mimicry is a mainstay of adaptationist thinking, there has been repeated debate on whether there is a mutualistic or a parasitic relationship between unequally defended co-mimic species(2-5). Here we show that the relationship between unequally defended species is mutualistic. We examined this in a 'novel world'(6) of artificial prey with wild predators ( great tit, Parus major). We kept the abundance of a highly defended prey ('model') constant and increased the density of a moderately defended prey ('defended mimic') of either perfect or imperfect mimetic resemblance to the model. Both model and defended mimic showed a net benefit from a density-dependent decrease in their per capita mortality. Even when the effect of dilution through density was controlled for, defended mimics did not induce additional attacks on the model, but we found selection for accurate signal mimicry. In comparison, the addition of fully edible (batesian) mimics did increase additional attacks on the model, but as a result of dilution this resulted in no overall increase in per capita mortality. By ignoring the effects of density, current theories may have overestimated the parasitic costs imposed by less defended mimics on highly defended models.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Liverpool; University of Jyvaskyla	Rowland, HM (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	h.m.rowland@liv.ac.uk	Lindstrom, Leena/B-2326-2012; Rowland, Hannah/D-8114-2012; Mappes, Johanna/AAZ-3627-2021	Lindstrom, Leena/0000-0002-6452-4538; Rowland, Hannah/0000-0002-1040-555X; Mappes, Johanna/0000-0002-1117-5629				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; DIXEY FA, 1919, REP BR ASS ADVMT SCI, P199; Dumbacher JP, 2001, P ROY SOC B-BIOL SCI, V268, P1971, DOI 10.1098/rspb.2001.1717; Fisher R.A., 1958, GENETICAL THEORY NAT; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1980, J HERPETOL, V14, P223, DOI 10.2307/1563543; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; Lindstrom L, 2006, ANIM BEHAV, V72, P323, DOI 10.1016/j.anbehav.2005.10.015; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Marshall G. A. K., 1908, T ENTOMOLOGICAL SOC, V1908, P93; Muller F., 1878, ZOOL ANZ, V1, P54; NONACS P, 1985, AM NAT, V126, P165, DOI 10.1086/284407; OWEN RE, 1984, J THEOR BIOL, V109, P217, DOI 10.1016/S0022-5193(84)80004-1; Rowe C, 2004, P ROY SOC B-BIOL SCI, V271, P407, DOI 10.1098/rspb.2003.2615; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; SHEPPARD PM, 1975, NATURAL SELECTION HE; Sherratt TN, 2004, J THEOR BIOL, V228, P217, DOI 10.1016/j.jtbi.2003.12.009; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812	30	114	114	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					64	67		10.1038/nature05899	http://dx.doi.org/10.1038/nature05899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611539				2022-12-24	WOS:000247720900038
J	Shimada, A; Niwa, H; Tsujita, K; Suetsugu, S; Nitta, K; Hanawa-Suetsugu, K; Akasaka, R; Nishino, Y; Toyama, M; Chen, LR; Liu, ZJ; Wang, BC; Yamamoto, M; Terada, T; Miyazawa, A; Tanaka, A; Sugano, S; Shirouzu, M; Nagayama, K; Takenawa, T; Yokoyama, S				Shimada, Atsushi; Niwa, Hideaki; Tsujita, Kazuya; Suetsugu, Shiro; Nitta, Koji; Hanawa-Suetsugu, Kyoko; Akasaka, Ryogo; Nishino, Yuri; Toyama, Mitsutoshi; Chen, Lirong; Liu, Zhi-Jie; Wang, Bi-Cheng; Yamamoto, Masaki; Terada, Takaho; Miyazawa, Atsuo; Tanaka, Akiko; Sugano, Sumio; Shirouzu, Mikako; Nagayama, Kuniaki; Takenawa, Tadaomi; Yokoyama, Shigeyuki			Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis	CELL			English	Article							ACTIN CYTOSKELETON; N-WASP; MEDIATED ENDOCYTOSIS; HOMOLOGY DOMAIN; DYNAMIN; PROTEIN; CURVATURE; TUBULATION; FAMILY; CONSTRICTION	Pombe Cdc15 homology (PCH) proteins play an important role in a variety of actin-based processes, including clathrin-mediated endocytosis (CME). The defining feature of the PCH proteins is an evolutionarily conserved EFC/F-BAR domain for membrane association and tubulation. In the present study, we solved the crystal structures of the EFC domains of human FBP17 and CIP4. The structures revealed a gently curved helical-bundle dimer of similar to 220 angstrom in length, which forms filaments through end-to-end interactions in the crystals. The curved EFC dimer fits a tubular membrane with an similar to 600 angstrom diameter. We subsequently proposed a model in which the curved EFC filament drives tubulation. In fact, striation of tubular membranes was observed by phase-contrast cryo-transmission electron microscopy, and mutations that impaired filament formation also impaired membrane tubulation and cell membrane invagination. Furthermore, FBP17 is recruited to clathrin-coated pits in the late stage of CME, indicating its physiological role.	RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30603 USA; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1130033, Japan; Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); RIKEN; University System of Georgia; University of Georgia; University of Tokyo; University of Tokyo	Takenawa, T (corresponding author), RIKEN, SPring Ctr 8, Harima Inst, 1-1 Kouto, Sayo, Hyogo 6795148, Japan.	takenawa@med.kobe-u.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Suetsugu, Shiro/ABB-6033-2020; Liu, Zhi-Jie/A-3946-2012; Yamamoto, Masaki/B-7844-2015; Shirouzu, Mikako/A-6521-2016; Niwa, Hideaki/C-3694-2017; Nagayama, Kuniaki/O-2522-2018; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/B-3300-2010; Yokoyama, Shigeyuki/N-6911-2015	Liu, Zhi-Jie/0000-0001-7279-2893; Yamamoto, Masaki/0000-0002-1311-1768; Niwa, Hideaki/0000-0001-9544-9350; Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Yokoyama, Shigeyuki/0000-0003-3133-7338; Shimada, Atsushi/0000-0002-4108-770X				Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nagayama K, 2005, ADV IMAG ELECT PHYS, V138, P69, DOI 10.1016/S1076-5670(05)38002-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	49	303	314	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					761	772		10.1016/j.cell.2007.03.040	http://dx.doi.org/10.1016/j.cell.2007.03.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512409	Bronze			2022-12-24	WOS:000246788300020
J	Mathonnet, G; Fabian, MR; Svitkin, YV; Parsyan, A; Huck, L; Murata, T; Biffo, S; Merrick, WC; Darzynkiewicz, E; Pillai, RS; Filipowicz, W; Duchaine, TF; Sonenberg, N				Mathonnet, Geraldine; Fabian, Marc R.; Svitkin, Yuri V.; Parsyan, Armen; Huck, Laurent; Murata, Takayuki; Biffo, Stefano; Merrick, William C.; Darzynkiewicz, Edward; Pillai, Ramesh S.; Filipowicz, Witold; Duchaine, Thomas F.; Sonenberg, Nahum			MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex elF4F	SCIENCE			English	Article							MECHANISMS; CELLS; RNA	MicroRNAs (miRNAs) play an important role in gene regulatory networks in animals. Yet, the mechanistic details of their function in translation inhibition or messenger RNA (mRNA) destabilization remain controversial. To directly examine the earliest events in this process, we have developed an in vitro translation system using mouse Krebs-2 ascites cell-free extract that exhibits an authentic miRNA response. We show here that translation initiation, specifically the 5' cap recognition process, is repressed by endogenous let-7 miRNAs within the first 15 minutes of mRNA exposure to the extract when no destabilization of the transcript is observed. Our results indicate that inhibition of translation initiation is the earliest molecular event effected by miRNAs. Other mechanisms, such as mRNA degradation, may subsequently consolidate mRNA silencing.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; Ist Sci San Raffaele, Lab Mol Histol, I-20132 Milan, Italy; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Univ Warsaw, Inst Phys Expt, Dept Biophys, PL-02089 Warsaw, Poland; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	McGill University; McGill University; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Case Western Reserve University; University of Warsaw; Friedrich Miescher Institute for Biomedical Research	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	thomas.duchaine@mcgill.ca; nahum.sonenberg@mcgill.ca	Duchaine, Thomas/U-2399-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Svitkin, Yuri/0000-0003-3819-2143; Mathonnet, Geraldine/0000-0002-9898-6490; biffo, stefano/0000-0002-3780-1050; Duchaine, Thomas/0000-0002-3454-1839				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034	15	379	396	5	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1764	1767		10.1126/science.1146067	http://dx.doi.org/10.1126/science.1146067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17656684	Green Submitted			2022-12-24	WOS:000249585900052
J	Zimmet, P; Alberti, G; Kaufman, F; Tajima, N; Silink, M; Arslanian, S; Wong, G; Bennett, P; Shaw, J; Caprio, S				Zimmet, Paul; Alberti, George; Kaufman, Francine; Tajima, Naoko; Silink, Martin; Arslanian, Silva; Wong, Gary; Bennett, Peter; Shaw, Jonathan; Caprio, Sonia		Int Diabet Federation Task Force E	The metabolic syndrome in children and adolescents	LANCET			English	Editorial Material							3RD NATIONAL-HEALTH; CARDIOVASCULAR RISK-FACTORS; WAIST CIRCUMFERENCE; PREVALENCE; AMERICAN		St Marys Hosp, Dept Endocrinol & Metab Med, London W2 1NY, England; Int Diabet Inst, Melbourne, Vic, Australia; Univ London Imperial Coll Sci Technol & Med, London, England; Childrens Hosp, Los Angeles, CA USA; Jikei Univ, Sch Med, Tokyo, Japan; Westmead Hosp, Sydney, NSW, Australia; Childrens Hosp, Pittsburgh, PA 15213 USA; Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ USA; Yale Univ, Sch Med, New Haven, CT USA	Imperial College London; Imperial College London; Children's Hospital Los Angeles; Jikei University; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Prince of Wales Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University	Alberti, G (corresponding author), St Marys Hosp, Dept Endocrinol & Metab Med, Praed St, London W2 1NY, England.	George.alberti@ncl.ac.uk	Wong, Gary WK/AAY-9207-2020; Bennett, Peter/AAH-9605-2021; Shaw, Jonathan/E-7388-2010; Zimmet, Paul/O-8486-2019	Wong, Gary WK/0000-0001-5939-812X; Shaw, Jonathan/0000-0002-6187-2203; Zimmet, Paul/0000-0003-0627-0776				Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bacha F, 2006, DIABETES CARE, V29, P1599, DOI 10.2337/dc06-0581; Burke V, 2005, INT J OBESITY, V29, P15, DOI 10.1038/sj.ijo.0802750; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gungor N, 2004, PEDIATR RES, V55, p145A; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Lee SJ, 2006, J PEDIATR-US, V149, P809, DOI 10.1016/j.jpeds.2006.08.075; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Singh R, 2004, PEDIATR DIABETES, V5, P154, DOI 10.1111/j.1399-543X.2004.00060.x	14	652	731	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2007	369	9579					2059	2061		10.1016/S0140-6736(07)60958-1	http://dx.doi.org/10.1016/S0140-6736(07)60958-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GM	17586288				2022-12-24	WOS:000247493100008
J	Bakal, C; Aach, J; Church, G; Perrimon, N				Bakal, Chris; Aach, John; Church, George; Perrimon, Norbert			Quantitative morphological signatures define local signaling networks regulating cell morphology	SCIENCE			English	Article							MEMBRANE PROTRUSION; LEADING-EDGE; DROSOPHILA; ADHESION; COMPLEX; LOCALIZATION; ACTIVATION; RESTRICTS; PAXILLIN; BEHAVIOR	Although classical genetic and biochemical approaches have identified hundreds of proteins that function in the dynamic remodeling of cell shape in response to upstream signals, there is currently little systems-level understanding of the organization and composition of signaling networks that regulate cell morphology. We have developed quantitative morphological profiling methods to systematically investigate the role of individual genes in the regulation of cell morphology in a fast, robust, and cost-efficient manner. We analyzed a compendium of quantitative morphological signatures and described the existence of local signaling networks that act to regulate cell protrusion, adhesion, and tension.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02215 USA; MIT, Comp Sci & Technol Lab, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bakal, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Bakal, Chris/0000-0002-0413-6744; church, george/0000-0001-6232-9969; Perrimon, Norbert/0000-0001-7542-472X				Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Mayhew MW, 2006, J PROTEOME RES, V5, P2417, DOI 10.1021/pr060140t; MURAYAMA K, 2006, J BIOL CHEM     1226; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Singh SR, 2006, DEV GROWTH DIFFER, V48, P169, DOI 10.1111/j.1440-169x.2006.00854.x; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	25	224	232	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1753	1756		10.1126/science.1140324	http://dx.doi.org/10.1126/science.1140324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588932				2022-12-24	WOS:000247400500049
J	Walkley, CR; Olsen, GH; Dworkin, S; Fabb, SA; Swann, J; McArthur, GA; Westmoreland, SV; Chambon, P; Scadden, DT; Purton, LE				Walkley, Carl R.; Olsen, Gemma Haines; Dworkin, Sebastian; Fabb, Stewart A.; Swann, Jeremy; McArthur, Grant A.; Westmoreland, Susan V.; Chambon, Pierre; Scadden, David T.; Purton, Louise E.			A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency	CELL			English	Article							TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SELF-RENEWAL; DIFFERENTIATION; MICE; INFLAMMATION; PROGENITORS; EXPRESSION; DISEASE	Myeloproliferative syndromes (IMPS) are a heterogeneous subclass of nonlymphoid hematopoietic neoplasms which are considered to be intrinsic to hematopoietic cells. The causes of MPS are largely unknown. Here, we demonstrate that mice deficient for retinoic acid receptor gamma (RAR gamma), develop MPS induced solely by the RAR gamma-deficient microenvironment. RAR gamma(-/-) mice had significantly increased granulocyte/macrophage progenitors and granulocytes in bone marrow (BM), peripheral blood, and spleen. The MPS phenotype continued for the lifespan of the mice and was more pronounced in older mice. Unexpectedly, transplant studies revealed this disease was not intrinsic to the hematopoietic cells. BM from wild-type mice transplanted into mice with an RAR gamma(-/-) microenvironment rapidly developed the MPS, which was partially caused by significantly elevated TNF alpha in RAR gamma(-/-) mice. These data show that loss of RAR gamma results in a nonhematopoietic cell-intrinsic MPS, revealing the capability of the microenvironment to be the sole cause of hematopoietic disorders.	Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Peter MacCallum Canc Ctr, Dept Haematol & Oncol, Melbourne, Vic 3002, Australia; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; ULP, INSERM, CNRS, Coll France,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Harvard Univ, Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Peter Maccallum Cancer Center; Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts General Hospital	Purton, LE (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia.	lpurton@partners.org	Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168; Dworkin, Sebastian/0000-0001-5828-9992; Fabb, Stewart/0000-0002-8887-7661	NHLBI NIH HHS [R01 HL044851, R01 HL044851-14] Funding Source: Medline; NIDDK NIH HHS [DK84551, R21 DK071773-02, R21 DK071773, R21 DK071773-01A1, DK71773] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x; Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; HANGOC G, 1993, EXP HEMATOL, V21, P502; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Minucci S, 1999, SEMIN CELL DEV BIOL, V10, P215, DOI 10.1006/scdb.1999.0303; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TRENTIN JJ, 1971, AM J PATHOL, V65, P621; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Walkley CR, 2002, LEUKEMIA, V16, P1763, DOI 10.1038/sj.leu.2402625; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; YAN XQ, 1994, ONCOGENE, V9, P163; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	44	396	410	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1097	1110		10.1016/j.cell.2007.05.014	http://dx.doi.org/10.1016/j.cell.2007.05.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574023	Bronze, Green Accepted			2022-12-24	WOS:000247390400014
J	Schwab, JM; Chiang, N; Arita, M; Serhan, CN				Schwab, Jan M.; Chiang, Nan; Arita, Makoto; Serhan, Charles N.			Resolvin E1 and protectin D1 activate inflammation-resolution programmes	NATURE			English	Article							ANTIINFLAMMATORY PROPERTIES; DOCOSAHEXAENOIC ACID; APOPTOTIC LEUKOCYTES; PHAGOCYTOSIS; MACROPHAGES; CELLS; CYCLOOXYGENASE; DOCOSATRIENES	Resolution of acute inflammation is an active process essential for appropriate host responses, tissue protection and the return to homeostasis(1-3). During resolution, specific omega-3 polyunsaturated fatty-acid-derived mediators are generated within resolving exudates, including resolvin E1 (RvE1)(4) and protectin D1 (PD1)(5). It is thus important to pinpoint specific actions of RvE1 and PD1 in regulating tissue resolution. Here we report that RvE1 and PD1 in nanogram quantities promote phagocyte removal during acute inflammation by regulating leukocyte infiltration, increasing macrophage ingestion of apoptotic polymorphonuclear neutrophils in vivo and in vitro, and enhancing the appearance of phagocytes carrying engulfed zymosan in lymph nodes and spleen. In this tissue terrain, inhibition of either cyclooxygenase or lipoxygenases - pivotal enzymes in the temporal generation of both pro-inflammatory and pro-resolving mediators - caused a 'resolution deficit' that was rescued by RvE1, PD1 or aspirin-triggered lipoxin A(4) analogue. Also, new resolution routes were identified that involve phagocytes traversing perinodal adipose tissues and non-apoptotic polymorphonuclear neutrophils carrying engulfed zymosan to lymph nodes. Together, these results identify new active components for postexudate resolution traffic, and demonstrate that RvE1 and PD1 are potent agonists for resolution of inflamed tissues.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Schwab, Jan/0000-0001-6784-4919; Arita, Makoto/0000-0001-9902-0463	NIDCR NIH HHS [P50 DE016191, P50 DE016191-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK074448, R01 DK074448-02] Funding Source: Medline; NIGMS NIH HHS [R37 GM038765, R01 GM038765, R37 GM038765-20] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, R37GM038765] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu YQ, 1999, J IMMUNOL, V162, P3639; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P139, DOI 10.1016/j.plefa.2005.07.001; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	29	886	931	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					869	874		10.1038/nature05877	http://dx.doi.org/10.1038/nature05877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568749	Green Accepted			2022-12-24	WOS:000247207500047
J	Chanock, SJ; Manolio, T; Boehnke, M; Boerwinkle, E; Hunter, DJ; Thomas, G; Hirschhorn, JN; Abecasis, G; Altshuler, D; Bailey-Wilson, JE; Brooks, LD; Cardon, LR; Daly, M; Donnelly, P; Fraumeni, JF; Freimer, NB; Gerhard, DS; Gunter, C; Guttmacher, AE; Guyer, MS; Harris, EL; Hoh, J; Hoover, R; Kong, CA; Merikangas, KR; Morton, CC; Palmer, LJ; Phimister, EG; Rice, JP; Roberts, J; Rotimi, C; Tucker, MA; Vogan, KJ; Wacholder, S; Wijsman, EM; Winn, DM; Collins, FS				Chanock, Stephen J.; Manolio, Teri; Boehnke, Michael; Boerwinkle, Eric; Hunter, David J.; Thomas, Gilles; Hirschhorn, Joel N.; Abecasis, Goncalo; Altshuler, David; Bailey-Wilson, Joan E.; Brooks, Lisa D.; Cardon, Lon R.; Daly, Mark; Donnelly, Peter; Fraumeni, Joseph F., Jr.; Freimer, Nelson B.; Gerhard, Daniela S.; Gunter, Chris; Guttmacher, Alan E.; Guyer, Mark S.; Harris, Emily L.; Hoh, Josephine; Hoover, Robert; Kong, C. Augustine; Merikangas, Kathleen R.; Morton, Cynthia C.; Palmer, Lyle J.; Phimister, Elizabeth G.; Rice, John P.; Roberts, Jerry; Rotimi, Charles; Tucker, Margaret A.; Vogan, Kyle J.; Wacholder, Sholom; Wijsman, Ellen M.; Winn, Deborah M.; Collins, Francis S.		NCI-NHGRI Working Grp Rep	Replicating genotype-phenotype associations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON GENETIC-VARIANTS; FACTOR-H POLYMORPHISM; PARKINSON-DISEASE; PROSTATE-CANCER; DYSBINDIN GENE; RISK LOCUS; DTNBP1; SUSCEPTIBILITY		NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Harvard Univ, Sch Med, Childrens Hosp, Broad Inst MIT & Harvard,Cambridge Ctr 7, Boston, MA 02114 USA; Massachusetts Gen Hosp, Broad Inst MIT & Harvard, Boston, MA 02114 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Univ Oxford, Oxford OX1 3TG, England; Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; Nature, New York, NY 10013 USA; Yale Univ, Sch Med, New Haven, CT 06510 USA; DeCode Genet, IS-101 Reykjavik, Iceland; NIMH, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Western Australian Inst Med Res, Nedlands, WA 6009, Australia; Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; New England Journal Med, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Howard Univ, Genet Epidemiol Unit, Natl Human Genome Ctr, Washington, DC 20060 USA; Nature Genet, Cambridge, MA 02141 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NCI, Epidemiol & Genet Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Oxford; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Western Australia; University of Western Australia; Washington University (WUSTL); Howard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov; manoliot@nhgri.nih.gov	Palmer, Lyle John/N-1948-2019; Tucker, Margaret A/B-4297-2015; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Abecasis, Goncalo R/B-7840-2010; Palmer, Lyle John/K-3196-2014; Gunter, Chris/AHA-7271-2022	Palmer, Lyle John/0000-0002-1628-3055; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Palmer, Lyle John/0000-0002-1628-3055; Merikangas, Kathkeen/0000-0002-4667-2414; Wijsman, Ellen/0000-0002-2725-6669; Vogan, Kyle/0000-0001-9565-9665; Kong, Augustine/0000-0001-8193-5438; Bailey-Wilson, Joan/0000-0002-9153-2920; Gunter, Chris/0000-0001-9369-7537; Abecasis, Goncalo/0000-0003-1509-1825; Donnelly, Peter/0000-0001-9495-3408	NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000153, Z01HG200331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; ANGELL M, 1990, NEW ENGL J MED, V323, P823, DOI 10.1056/NEJM199009203231209; [Anonymous], 1999, NAT GENET, V22, P1; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EASTON DF, 2007, NATURE          0527, DOI DOI 10.1038/NATURE05887; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2005, STROKE, V36, P1824, DOI 10.1161/01.STR.0000176497.94458.27; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2006, JNCI-J NATL CANCER I, V98, P1350, DOI 10.1093/jnci/djj392; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; MCPHERSON R, 2007, SCIENCE         0503, DOI DOI 10.1126/SCIENCE.11142447; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Myers RH, 2006, AM J HUM GENET, V78, P1081; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rosand J, 2006, NAT GENET, V38, P1091, DOI 10.1038/ng1006-1091; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	79	1091	1116	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					655	660		10.1038/447655a	http://dx.doi.org/10.1038/447655a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554299	Bronze, Green Submitted			2022-12-24	WOS:000247030700034
J	Hamer, DH; Ndhlovu, M; Zurovac, D; Fox, M; Yeboah-Antwi, K; Chanda, P; Sipilinyambe, N; Simon, JL; Snow, RW				Hamer, Davidson H.; Ndhlovu, Micky; Zurovac, Dejan; Fox, Matthew; Yeboah-Antwi, Kojo; Chanda, Pascalina; Sipilinyambe, Naawa; Simon, Jonathon L.; Snow, Robert W.			Improved diagnostic testing and malaria treatment practices in Zambia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEBRILE ILLNESS; CASE-MANAGEMENT; MICROSCOPY; TANZANIA	Context Improving the accuracy of malaria diagnosis with rapid antigen-detection diagnostic tests (RDTs) has been proposed as an approach for reducing overtreatment of malaria in the current era of widespread implementation of artemisinin-based combination therapy in sub-Saharan Africa. Objective To assess the association between use of microscopy and RDT and the prescription of antimalarials. Design, Setting, and Participants Cross-sectional, cluster sample survey, carried out between March and May 2006, of all outpatients treated during 1 working day at government and mission health facilities in 4 sentinel districts in Zambia. Main Outcome Measure Proportions of patients undergoing malaria diagnostic procedures and receiving antimalarial treatment. Results Seventeen percent of the 104 health facilities surveyed had functional microscopy, 63% had RDTs available, and 73% had 1 or more diagnostics available. Of patients with fever (suspected malaria), 27.8% (95% confidence interval [CI], 13.1%-42.5%) treated in health facilities with malaria diagnostics were tested and 44.6% had positive test results. Of patients with negative blood smear results, 58.4% (95% CI, 36.7%-80.2%) were prescribed an antimalaria drug, as were 35.5% (95% CI, 16.0%-55.0%) of those with a negative RDT result. Of patients with fever who did not have diagnostic tests done, 65.9% were also prescribed antimalarials. In facilities with artemether-lumefantrine in stock, this antimalarial was prescribed to a large proportion of febrile patients with a positive diagnostic test result (blood smear, 75.0% [95% CI, 51.7%-98.3%]; RDT, 70.4% [95% CI, 39.3%-100.0%]), but also to some of those with a negative diagnostic test result (blood smear, 30.4% [95% CI, 8.0%-52.9%]; RDT, 26.7% [95% CI, 5.7%-47.7%]). Conclusions Despite efforts to expand the provision of malaria diagnostics in Zambia, they continue to be underused and patients with negative test results frequently receive antimalarials. Provision of new tools to reduce inappropriate use of new expensive antimalarial treatments must be accompanied by a major change in clinical treatment of patients presenting with fever but lacking evidence of malaria infection.	Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; Chainama Hills Coll Hosp Hlth Sci, Lusaka, Zambia; KEMRI Wellcome Trust Collaborat Programme, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Minist Hlth, Natl Malaria Control Ctr, Lusaka, Zambia	Boston University; Boston University; University of Oxford	Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, 85 Concord St,5th Floor, Boston, MA 02118 USA.	dhamer@bu.edu	Hamer, Davidson Howes/J-2020-2019; Yeboah-Antwi, Kojo/AAI-8519-2020; Snow, Robert William/AFR-1436-2022	Hamer, Davidson Howes/0000-0002-4700-1495; Snow, Robert William/0000-0003-3725-6088; Simon, Jonathon/0000-0001-6740-549X; Chanda-Kapata, Pascalina/0000-0003-3271-5265; Yeboah-Antwi, Kojo/0000-0002-3516-9266; Fox, Matthew/0000-0001-9887-0634	Wellcome Trust [058992, 079080] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Barnish G, 2004, BRIT MED J, V328, P1151; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Central Board of Health (Zambia), 2003, GUID DIAGN TREATM MA; *MIN HLTH, 2006, ROAD MAP IMP MAL ZAM; *MIN HLTH CENTR ST, 2006, ZAMB NAT MAL IND SUR; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; MUDONDO C, 2005, ARTEMISININ BASED CO; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; *NAT MAL CONTR CTR, 2004, TRAIN DIAGN MAN MAL; *NAT MAL CONTR CTR, 2005, 2004 FOLL UP ROLL BA; Proux S, 2001, TROP MED INT HEALTH, V6, P99, DOI 10.1046/j.1365-3156.2001.00694.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *WHO, 2006, WHOHTMMAL20061108; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31	19	193	193	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2227	2231		10.1001/jama.297.20.2227	http://dx.doi.org/10.1001/jama.297.20.2227			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519412	Green Accepted			2022-12-24	WOS:000246659700022
J	Airan, RD; Meltzer, LA; Roy, M; Gong, YQ; Chen, H; Deisseroth, K				Airan, Raag D.; Meltzer, Leslie A.; Roy, Madhuri; Gong, Yuqing; Chen, Han; Deisseroth, Karl			High-speed Imaging reveals neurophysiological links to behavior in an animal model of depression	SCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; MAJOR DEPRESSION; STRESS; CELLS	The hippocampus is one of several brain areas thought to play a central role in affective behaviors, but the underlying local network dynamics are not understood. We used quantitative voltage-sensitive dye imaging to probe hippocampal dynamics with millisecond resolution in brain slices after bidirectional modulation of affective state in rat models of depression. We found that a simple measure of real-time activity-stimulus-evoked percolation of activity through the dentate gyrus relative to the hippocampal output subfield-accounted for induced changes in animal behavior independent of the underlying mechanism of action of the treatments. Our results define a circuit-level neurophysiological endophenotype for affective behavior and suggest an approach to understanding circuit-level substrates underlying psychiatric disease symptoms.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Yan, Shuo/B-8381-2009	Airan, Raag/0000-0001-5259-5606				Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BIRNSTIEL S, 1995, SYNAPSE, V20, P117, DOI 10.1002/syn.890200204; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cowan WM, 2000, ANNU REV NEUROSCI, V23, P343, DOI 10.1146/annurev.neuro.23.1.343; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lopez-Rubalcava C, 2000, NEUROPSYCHOPHARMACOL, V22, P191, DOI 10.1016/S0893-133X(99)00100-1; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	26	306	312	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					819	823		10.1126/science.1144400	http://dx.doi.org/10.1126/science.1144400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17615305				2022-12-24	WOS:000248624500045
J	Carlton, JG; Martin-Serrano, J				Carlton, Jez G.; Martin-Serrano, Juan			Parallels between cytokinesis and retroviral budding: A role for the ESCRT machinery	SCIENCE			English	Article							PROTEIN; TSG101; MIDBODY; REVEALS; NETWORK; MECHANISMS; ABSCISSION; COMPLEXES; DOMAINS; CEP55	During cytokinesis, as dividing animal cells pull apart into two daughter cells, the final stage, termed abscission, requires breakage of the midbody, a thin membranous stalk connecting the daughter cells. This membrane fission event topologically resembles the budding of viruses, such as HIV-1, from infected cells. We found that two proteins involved in HIV-1 budding-tumor susceptibility gene 101 (Tsg101), a subunit of the endosomal sorting complex required for transport I (ESCRT-I), and Alix, an ESCRT-associated protein-were recruited to the midbody during cytokinesis by interaction with centrosome protein 55 (Cep55), a centrosome and midbody protein essential for abscission. Tsg101, Alix, and possibly other components of ESCRT-I were required for the completion of cytokinesis. Thus, HIV-1 budding and cytokinesis use a similar subset of cellular components to carry out topologically similar membrane fission events.	Kings Coll London, Sch Med, Dept Infect Dis, London, England	University of London; King's College London	Martin-Serrano, J (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London, England.	juan.martin_serrano@kcl.ac.uk	Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014	Carlton, Jeremy/0000-0002-7255-1894; Martin-Serrano, Juan/0000-0002-8183-3914	Medical Research Council [G0400207] Funding Source: Medline; MRC [G0400207] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2006, TRAFFIC, V7, P1551, DOI 10.1111/j.1600-0854.2006.00489.x; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	537	547	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1908	1912		10.1126/science.1143422	http://dx.doi.org/10.1126/science.1143422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17556548	Green Submitted			2022-12-24	WOS:000247602700043
J	Linding, R; Jensen, LJ; Ostheimer, GJ; van Vugt, MATM; Jorgensen, C; Miron, IM; Diella, F; Colwill, K; Taylor, L; Elder, K; Metalnikov, P; Nguyen, V; Pasculescu, A; Jin, J; Park, JG; Samson, LD; Woodgett, JR; Russell, RB; Bork, P; Yaffe, MB; Pawson, T				Linding, Rune; Jensen, Lars Juhl; Ostheimer, Gerard J.; van Vugt, Marcel A. T. M.; Jorgensen, Claus; MIron, Ioana M.; Diella, Francesca; Colwill, Karen; Taylor, Lorne; Elder, Kelly; Metalnikov, Pavel; Nguyen, Vivian; Pasculescu, Adrian; Jin, Jing; Park, Jin Gyoon; Samson, Leona D.; Woodgett, James R.; Russell, Robert B.; Bork, Peer; Yaffe, Michael B.; Pawson, Tony			Systematic discovery of in vivo phosphorylation networks	CELL			English	Article							DNA-DAMAGE RESPONSE; SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; EUKARYOTIC PROTEINS; SIGNALING NETWORKS; KINASE; 53BP1; ATM; ACTIVATION	Protein kinases control cellular decision processes by phosphorylating specific substrates. Thousands of in vivo phosphorylation sites have been identified, mostly by proteome-wide mapping. However, systematically matching these sites to specific kinases is presently infeasible, due to limited specificity of consensus motifs, and the influence of contextual factors, such as protein scaffolds, localization, and expression, on cellular substrate specificity. We have developed an approach ( NetworKIN) that augments motif-based predictions with the network context of kinases and phosphoproteins. The latter provides 60%-80% of the computational capability to assign in vivo substrate specificity. NetworKIN pinpoints kinases responsible for specific phosphorylations and yields a 2.5-fold improvement in the accuracy with which phosphorylation networks can be constructed. Applying this approach to DNA damage signaling, we show that 53BP1 and Rad50 are phosphorylated by CDK1 and ATM, respectively. We describe a scalable strategy to evaluate predictions, which suggests that BCLAF1 is a GSK-3 substrate.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; European Mol Biol Lab, Heidelberg, Germany; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Erasmus University Rotterdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Linding, R (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	linding@mshri.on.ca; bork@embl.de; myaffe@mit.edu; pawson@mshri.on.ca	Jensen, Lars Juhl/C-6492-2008; Russell, Robert/GWU-6389-2022; Bork, Peer/F-1813-2013; Pawson, Tony J/E-4578-2013; Russell, Rob/AAH-9145-2019; Woodgett, Jim/F-1087-2010; Colwill, Karen/K-5101-2012	Jensen, Lars Juhl/0000-0001-7885-715X; Russell, Robert/0000-0002-7213-1398; Bork, Peer/0000-0002-2627-833X; Russell, Rob/0000-0002-1905-4717; Woodgett, Jim/0000-0003-3731-5797; Colwill, Karen/0000-0002-8979-1659; Metalnikov, Pavel/0000-0003-3261-4421; Jorgensen, Claus/0000-0002-7841-943X; Linding, Rune/0000-0003-0420-4839	Canadian Institutes of Health Research [12043] Funding Source: Medline; NCI NIH HHS [U54 CA112967-03, U54-CA112967-03, U54 CA112967] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; HOUTHAEVE T, 1995, FEBS LETT, V376, P91, DOI 10.1016/0014-5793(95)01242-7; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang Y, 2000, GENE DEV, V14, P927; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	46	579	601	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1415	1426		10.1016/j.cell.2007.05.052	http://dx.doi.org/10.1016/j.cell.2007.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570479	Green Accepted, Bronze			2022-12-24	WOS:000247911400025
J	North, TE; Goessling, W; Walkley, CR; Lengerke, C; Kopani, KR; Lord, AM; Weber, GJ; Bowman, TV; Jang, IH; Grosser, T; FitzGerald, GA; Daley, GQ; Orkin, SH; Zon, LI				North, Trista E.; Goessling, Wolfram; Walkley, Carl R.; Lengerke, Claudia; Kopani, Kamden R.; Lord, Allegra M.; Weber, Gerhard J.; Bowman, Teresa V.; Jang, Il-Ho; Grosser, Tilo; FitzGerald, Garret A.; Daley, George Q.; Orkin, Stuart H.; Zon, Leonard I.			Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis	NATURE			English	Article							ZEBRAFISH; EXPRESSION; MICE; CYCLOOXYGENASE-2; TRANSPLANTATION; EMBRYO; BLOOD; STAT5; RUNX1	Haematopoietic stem cell (HSC) homeostasis is tightly controlled by growth factors, signalling molecules and transcription factors. Definitive HSCs derived during embryogenesis in the aorta gonad - mesonephros region subsequently colonize fetal and adult haematopoietic organs(1,2). To identify new modulators of HSC formation and homeostasis, a panel of biologically active compounds was screened for effects on stem cell induction in the zebrafish aorta - gonad - mesonephros region. Here, we show that chemicals that enhance prostaglandin ( PG) E2 synthesis increased HSC numbers, and those that block prostaglandin synthesis decreased stem cell numbers. The cyclooxygenases responsible for PGE2 synthesis were required for HSC formation. A stable derivative of PGE2 improved kidney marrow recovery following irradiation injury in the adult zebrafish. In murine embryonic stem cell differentiation assays, PGE2 caused amplification of multipotent progenitors. Furthermore, ex vivo exposure to stabilized PGE2 enhanced spleen colony forming units at day 12 post transplant and increased the frequency of long-term repopulating HSCs present in murine bone marrow after limiting dilution competitive transplantation. The conserved role for PGE2 in the regulation of vertebrate HSC homeostasis indicates that modulation of the prostaglandin pathway may facilitate expansion of HSC number for therapeutic purposes.	Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol,Harvard Stem Cell Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine	Zon, LI (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	FitzGerald, Garret A/A-4222-2010; Walkley, Carl/AAO-6021-2020; Grosser, Tilo/A-1057-2007; North, Trista/ABG-4789-2020; Lengerke, Claudia/AAV-8745-2021	Walkley, Carl/0000-0002-4784-9031; Grosser, Tilo/0000-0001-8569-8396; North, Trista/0000-0003-1249-563X; Lengerke, Claudia/0000-0001-5442-2805; Goessling, Wolfram/0000-0001-9972-1569; Jang, Il Ho/0000-0002-0820-3035	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL048801-16, R01 HL048801] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Dzierzak E, 2005, CURR OPIN HEMATOL, V12, P197, DOI 10.1097/01.moh.0000160736.44726.0e; FEHER I, 1974, NATURE, V247, P550, DOI 10.1038/247550a0; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; HERTELENDY F, 1973, PROSTAG OTH LIPID M, V3, P223, DOI 10.1016/0090-6980(73)90090-7; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Pini B, 2005, ARTERIOSCL THROM VAS, V25, P315, DOI 10.1161/01.ATV.0000152355.97808.10; Rocca B, 2002, P NATL ACAD SCI USA, V99, P7634, DOI 10.1073/pnas.112202999; Talosi G, 2004, J PERINAT MED, V32, P368, DOI 10.1515/JPM.2004.069; THANOPOULOS BD, 1987, EUR J PEDIATR, V146, P279, DOI 10.1007/BF00716473; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	30	846	912	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1007	U7		10.1038/nature05883	http://dx.doi.org/10.1038/nature05883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581586	Green Accepted			2022-12-24	WOS:000247373100048
J	Yool, A; Martin, AP; Fernandez, C; Clark, DR				Yool, Andrew; Martin, Adrian P.; Fernandez, Camila; Clark, Darren R.			The significance of nitrification for oceanic new production	NATURE			English	Article							MARINE NITRIFYING BACTERIA; ORGANIC NITROGEN; NITRATE; NITRITE; RATES; PHOTOINHIBITION; AMMONIUM; PACIFIC; CARBON; CYCLE	The flux of organic material sinking to depth is a major control on the inventory of carbon in the ocean(1). To first order, the oceanic system is at equilibrium such that what goes down must come up(2). Because the export flux is difficult to measure directly, it is routinely estimated indirectly by quantifying the amount of phytoplankton growth, or primary production, fuelled by the upward flux of nitrate(3). To do so it is necessary to take into account other sources of biologically available nitrogen. However, the generation of nitrate by nitrification in surface waters has only recently received attention. Here we perform the first synthesis of open-ocean measurements of the specific rate of surface nitrification(4-12) and use these to configure a global biogeochemical model(13,14) to quantify the global role of nitrification. We show that for much of the world ocean a substantial fraction of the nitrate taken up is generated through recent nitrification near the surface. At the global scale, nitrification accounts for about half of the nitrate consumed by growing phytoplankton. A consequence is that many previous attempts to quantify marine carbon export, particularly those based on inappropriate use of the f-ratio ( a measure of the efficiency of the 'biological pump'), are significant overestimates.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, F-13288 Marseille, France; Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile; Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental, Concepcion, Chile; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	NERC National Oceanography Centre; Universidad de Concepcion; Universidad de Concepcion; Plymouth Marine Laboratory	Yool, A (corresponding author), Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	axy@noc.soton.ac.uk	Yool, Andrew/B-4799-2012; Fernandez, Camila/F-6938-2010	Yool, Andrew/0000-0002-9879-2776; /0000-0002-8492-5881	Natural Environment Research Council [NER/O/S/2001/00680, soc010008, NE/C00387X/1, pml010001, pml010002] Funding Source: researchfish; NERC [pml010001, pml010002, soc010008] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen AE, 2002, J MARINE SYST, V38, P93, DOI 10.1016/S0924-7963(02)00171-9; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bianchi M, 1997, DEEP-SEA RES PT II, V44, P1017, DOI 10.1016/S0967-0645(96)00109-9; Clark DR, 2007, MAR CHEM, V103, P84, DOI 10.1016/j.marchem.2006.06.005; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Diaz F, 2000, MAR ECOL PROG SER, V197, P51, DOI 10.3354/meps197051; Dore JE, 1996, LIMNOL OCEANOGR, V41, P1619, DOI 10.4319/lo.1996.41.8.1619; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Fernandez C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002616; FERNANDEZ C, 2003, THESIS U MEDITERRANE; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Lipschultz F, 2001, DEEP-SEA RES PT II, V48, P1897, DOI 10.1016/S0967-0645(00)00168-5; Marsh R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022281; Martin AP, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002608; MIYAZAKI T, 1975, MAR SCI COMMUN, V1, P381; OLSON RJ, 1981, J MAR RES, V39, P203; OLSON RJ, 1981, J MAR RES, V39, P227; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oschlies A, 2001, GEOPHYS RES LETT, V28, P1751, DOI 10.1029/2000GL012328; Raimbault P, 1999, J GEOPHYS RES-OCEANS, V104, P3341, DOI 10.1029/1998JC900004; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; SLAWYK G, 1995, MAR ECOL PROG SER, V124, P289, DOI 10.3354/meps124289; Sutka RL, 2004, GEOCHIM COSMOCHIM AC, V68, P517, DOI 10.1016/S0016-7037(03)00483-6; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; WARD BB, 1989, LIMNOL OCEANOGR, V34, P493, DOI 10.4319/lo.1989.34.3.0493; Ward BB, 2005, MAR ECOL PROG SER, V292, P97, DOI 10.3354/meps292097; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	30	293	301	3	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					999	1002		10.1038/nature05885	http://dx.doi.org/10.1038/nature05885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581584				2022-12-24	WOS:000247373100046
J	Haag, AL				Haag, Amanda Leigh			Algae bloom again	NATURE			English	News Item																			0	73	86	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					520	521		10.1038/447520a	http://dx.doi.org/10.1038/447520a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538590				2022-12-24	WOS:000246842000013
J	Brandt, A; Gooday, AJ; Brandao, SN; Brix, S; Brokeland, W; Cedhagen, T; Choudhury, M; Cornelius, N; Danis, B; De Mesel, I; Diaz, RJ; Gillan, DC; Ebbe, B; Howe, JA; Janussen, D; Kaiser, S; Linse, K; Malyutina, M; Pawlowski, J; Raupach, M; Vanreusel, A				Brandt, Angelika; Gooday, Andrew J.; Brandao, Simone N.; Brix, Saskia; Broekeland, Wiebke; Cedhagen, Tomas; Choudhury, Madhumita; Cornelius, Nils; Danis, Bruno; De Mesel, Ilse; Diaz, Robert J.; Gillan, David C.; Ebbe, Brigitte; Howe, John A.; Janussen, Dorte; Kaiser, Stefanie; Linse, Katrin; Malyutina, Marina; Pawlowski, Jan; Raupach, Michael; Vanreusel, Ann			First insights into the biodiversity and biogeography of the Southern Ocean deep sea	NATURE			English	Article							SPECIES-DIVERSITY; BENTHIC DIVERSITY; WEDDELL SEA; ECOLOGY; ORIGIN; SCALE; FORAMINIFERA; ANTARCTICA; PERACARIDA; CRUSTACEA	Shallow marine benthic communities around Antarctica show high levels of endemism, gigantism, slow growth, longevity and late maturity, as well as adaptive radiations that have generated considerable biodiversity in some taxa(1). The deeper parts of the Southern Ocean exhibit some unique environmental features, including a very deep continental shelf(2) and a weakly stratified water column, and are the source for much of the deep water in the world ocean. These features suggest that deep-sea faunas around the Antarctic may be related both to adjacent shelf communities and to those in other oceans. Unlike shallow-water Antarctic benthic communities, however, little is known about life in this vast deep-sea region(2,3). Here, we report new data from recent sampling expeditions in the deep Weddell Sea and adjacent areas ( 748 - 6,348 m water depth) that reveal high levels of new biodiversity; for example, 674 isopods species, of which 585 were new to science. Bathymetric and biogeographic trends varied between taxa. In groups such as the isopods and polychaetes, slope assemblages included species that have invaded from the shelf. In other taxa, the shelf and slope assemblages were more distinct. Abyssal faunas tended to have stronger links to other oceans, particularly the Atlantic, but mainly in taxa with good dispersal capabilities, such as the Foraminifera. The isopods, ostracods and nematodes, which are poor dispersers, include many species currently known only from the Southern Ocean. Our findings challenge suggestions that deep-sea diversity is depressed in the Southern Ocean and provide a basis for exploring the evolutionary significance of the varied biogeographic patterns observed in this remote environment.	Zool Museum Hamburg, D-20146 Hamburg, Germany; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark; Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; Univ Libre Bruxelles, Marine Biol Lab, B-1050 Brussels, Belgium; Forschungsmuseum Konig, Forschungsinst Senckenberg, DZMB CeDAMar, D-53113 Bonn, Germany; Scottish Assoc Marine Sci, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; Forschungs & Nat Museum Senckenberg, D-60325 Frankfurt, Germany; British Antarctic Survey, NERC, Cambridge CB3 0ET, England; FEB RAS, Inst Marine Biol, Vladivostok 690041, Russia; Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Hamburg; NERC National Oceanography Centre; Aarhus University; Ghent University; William & Mary; Virginia Institute of Marine Science; Universite Libre de Bruxelles; Senckenberg Gesellschaft fur Naturforschung (SGN); UHI Millennium Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; University of Geneva; Ruhr University Bochum	Brandt, A (corresponding author), Zool Museum Hamburg, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	abrandt@zoologie.uni-hamburg.de	Danis, Bruno/AAS-8444-2021; Brandao, Simone/C-9416-2013; Cedhagen, Tomas/J-6426-2013; Malyutina, Marina/A-6839-2014; Gooday, Andrew/ABB-4267-2020; Raupach, Michael J./AAF-7566-2020; Raupach, Michael/G-7072-2012; Brandt, Angelika/C-1630-2018; Gooday, Andrew/AAH-8991-2021	Danis, Bruno/0000-0002-9037-7623; Brandao, Simone/0000-0002-3487-6129; Cedhagen, Tomas/0000-0003-4550-8177; Gooday, Andrew/0000-0002-5661-7371; Raupach, Michael J./0000-0001-8299-6697; Linse, Katrin/0000-0003-3477-3047; Kaiser, Stefanie/0000-0003-2026-4663; Malyutina, Marina/0000-0003-2161-3917	Natural Environment Research Council [soc010009, bas010015] Funding Source: researchfish; NERC [bas010015, soc010009] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alve E, 2003, LIMNOL OCEANOGR, V48, P2163, DOI 10.4319/lo.2003.48.6.2163; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A., 1991, Berichte zur Polarforschung, V98, P1; Brandt A, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63s1261; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Cornelius N, 2004, DEEP-SEA RES PT II, V51, P1571, DOI 10.1016/j.dsr2.2004.06.024; De Mesel I, 2006, POLAR BIOL, V29, P860, DOI 10.1007/s00300-006-0124-7; Gage JD, 2004, DEEP-SEA RES PT II, V51, P1689, DOI 10.1016/j.dsr2.2004.07.013; Hessler R., 1983, EVOLUTION TIME SPACE, P227; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Hilbig B, 2006, B MAR SCI, V78, P243; KUSSAKIN OG, 1973, MAR BIOL, V23, P19, DOI 10.1007/BF00394108; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Murray JW, 2004, MAR MICROPALEONTOL, V53, P67, DOI 10.1016/j.marmicro.2004.04.001; PAWLOWSKI J, UNPUB DEEP SEA RES, V2; PAWLOWSKI J, UNPUB MOL ECOL; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; Raupach MJ, 2004, DEEP-SEA RES PT II, V51, P1787, DOI 10.1016/j.dsr2.2004.06.035; RAUPACH MJ, UNPUB DEEP SEA RES, V2; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Tyler PA, 2000, MAR ECOL PROG SER, V192, P173, DOI 10.3354/meps192173; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325	29	360	376	8	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					307	311		10.1038/nature05827	http://dx.doi.org/10.1038/nature05827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507981				2022-12-24	WOS:000246520300043
J	Sirajuddin, M; Farkasovsky, M; Hauer, F; Kuhlmann, D; Macara, IG; Weyand, M; Stark, H; Wittinghofer, A				Sirajuddin, Minhajuddin; Farkasovsky, Marian; Hauer, Florian; Kuehlmann, Dorothee; Macara, Ian G.; Weyand, Michael; Stark, Holger; Wittinghofer, Alfred			Structural insight into filament formation by mammalian septins	NATURE			English	Article							GTP-BINDING; YEAST SEPTINS; COMPLEX; PROTEIN; CLASSIFICATION; ORGANIZATION; CHITIN	Septins are GTP-binding proteins that assemble into homo- and hetero-oligomers and filaments. Although they have key roles in various cellular processes, little is known concerning the structure of septin subunits or the organization and polarity of septin complexes. Here we present the structures of the human SEPT2 G domain and the heterotrimeric human SEPT2-SEPT6-SEPT7 complex. The structures reveal a universal bipolar polymer building block, composed of an extended G domain, which forms oligomers and filaments by conserved interactions between adjacent nucleotide-binding sites and/or the amino- and carboxy-terminal extensions. Unexpectedly, X-ray crystallography and electron microscopy showed that the predicted coiled coils are not involved in or required for complex and/or filament formation. The asymmetrical heterotrimers associate head-to-head to form a hexameric unit that is nonpolarized along the filament axis but is rotationally asymmetrical. The architecture of septin filaments differs fundamentally from that of other cytoskeletal structures.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany; Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; University of Virginia; Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Sirajuddin, Minhaj/H-8040-2019	Sirajuddin, Minhaj/0000-0001-5742-2130; Holger, Stark/0000-0002-6161-1118				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Chant J, 1996, CELL, V84, P187, DOI 10.1016/S0092-8674(00)80972-1; DeLano W., 2006, PYMOL MOL GRAPHICS S; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Macara IG, 2002, MOL BIOL CELL, V13, P4111, DOI 10.1091/mbc.E02-07-0438; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Mitchison TJ, 2002, CURR BIOL, V12, pR788, DOI 10.1016/S0960-9822(02)01295-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen TQ, 2000, J CELL SCI, V113, P3825; Oegema K, 1998, METHOD ENZYMOL, V298, P279, DOI 10.1016/S0076-6879(98)98025-9; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; VANHEEL M, 1989, OPTIK, V82, P114; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Vrabioiu AM, 2004, J BIOL CHEM, V279, P3111, DOI 10.1074/jbc.M310941200	46	321	333	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					311	+		10.1038/nature06052	http://dx.doi.org/10.1038/nature06052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17637674				2022-12-24	WOS:000249557300039
J	Charlat, S; Hornett, EA; Fullard, JH; Davies, N; Roderick, GK; Wedell, N; Hurst, GDD				Charlat, Sylvain; Hornett, Emily A.; Fullard, James H.; Davies, Neil; Roderick, George K.; Wedell, Nina; Hurst, Gregory D. D.			Extraordinary flux in sex ratio	SCIENCE			English	Article									UCL, Dept Biol, 4 Stephenson Way, London NW1 2HE, England; Univ Calif Berkeley, Gump S Pacific Res Stn, F-98728 Moorea, France; Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Univ Calif Berkeley, ESPM, Berkeley, CA 94720 USA; Univ Exeter, Sch Biosci, Tremough TR10 9EZ, Penryn, England	University of London; University College London; University of California System; University of California Berkeley; University of Toronto; University Toronto Mississauga; University of California System; University of California Berkeley; University of Exeter	Charlat, S (corresponding author), UCL, Dept Biol, 4 Stephenson Way, London NW1 2HE, England.	s.charlat@ucl.ac.uk	Hurst, Gregory D D/C-2723-2008; Davies, Neil/E-5863-2012	Hurst, Gregory D D/0000-0002-7163-7784; Davies, Neil/0000-0001-8085-5014; Charlat, Sylvain/0000-0003-0760-0087; Roderick, George/0000-0001-7557-2415	Natural Environment Research Council [NE/B503292/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Charlat S, 2007, CURR BIOL, V17, P273, DOI 10.1016/j.cub.2006.11.068; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283	4	90	96	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					214	214		10.1126/science.1143369	http://dx.doi.org/10.1126/science.1143369			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626876				2022-12-24	WOS:000247968600032
J	Junttila, MR; Puustinen, P; Niemela, M; Ahola, R; Arnold, H; Bottzauw, T; Ala-Aho, R; Nielsen, C; Ivaska, J; Taya, Y; Lu, SL; Lin, SJ; Chan, EKL; Wang, XJ; Grenman, R; Kast, J; Kallunki, T; Sears, R; Kahari, VM; Westermarck, J				Junttila, Melissa R.; Puustinen, Pietri; Niemela, Minna; Ahola, Raija; Arnold, Hugh; Bottzauw, Trine; Ala-aho, Risto; Nielsen, Christina; Ivaska, Johanna; Taya, Yoichi; Lu, Shi-Long; Lin, Shujun; Chan, Edward K. L.; Wang, Xiao-Jing; Grenman, Reidar; Kast, Juergen; Kallunki, Tuula; Sears, Rosalie; Kahari, Veli-Matti; Westermarck, Jukka			CIP2A inhibits PP2A in human malignancies	CELL			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN CELL-TRANSFORMATION; C-MYC; COLON-CANCER; SUBUNIT; ALPHA; SERINE/THREONINE; DEGRADATION; HOLOENZYME; ELEMENTS	Inhibition of protein phosphatase 2A ( PP2A) activity has been identified as a prerequisite for the transformation of human cells. However, the molecular mechanisms by which PP2A activity is inhibited in human cancers are currently unclear. In this study, we describe a cellular inhibitor of PP2A with oncogenic activity. The protein, designated Cancerous Inhibitor of PP2A ( CIP2A), interacts directly with the oncogenic transcription factor c- Myc, inhibits PP2A activity toward c- Myc serine 62 ( S62), and thereby prevents c- Myc proteolytic degradation. In addition to its function in cMyc stabilization, CIP2A promotes anchorage-independent cell growth and in vivo tumor formation. The oncogenic activity of CIP2A is demonstrated by transformation of human cells by overexpression of CIP2A. Importantly, CIP2A is overexpressed in two common human malignancies, head and neck squamous cell carcinoma ( HNSCC) and colon cancer. Thus, our data show that CIP2A is a human oncoprotein that inhibits PP2A and stabilizes c- Myc in human malignancies.	Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland; Abo Akad Univ, FIN-20520 Turku, Finland; Univ Turku, Turku Grad Sch Biomed Sci, FIN-20520 Turku, Finland; Univ Turku, Dept Med Biochem & Mol Biol, FIN-20520 Turku, Finland; Univ Turku, Medic Res Lab, FIN-20520 Turku, Finland; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, DK-2100 Copenhagen, Denmark; VTT Tech Res Ctr Finland, Med Biotechnol, FIN-20520 Turku, Finland; Natl Canc Ctr, Res Inst, Tokyo 1040045, Japan; OHSU, Dept Otolaryngol, Portland, OR 97239 USA; OHSU, Dept Dermatol, Portland, OR 97239 USA; OHSU, Dept Cell & Dev Biol, Portland, OR 97239 USA; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; Turku Univ Hosp, Dept Dermatol, FIN-20520 Turku, Finland; Univ Tampere, Inst Med Technol, FIN-33520 Tampere, Finland; Tampere Univ Hosp, FIN-33520 Tampere, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku; Oregon Health & Science University; Danish Cancer Society; VTT Technical Research Center Finland; National Cancer Center - Japan; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of British Columbia; State University System of Florida; University of Florida; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital	Westermarck, J (corresponding author), Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland.	ltjuwe@uta.fi	Kähäri, Veli-Matti/E-5144-2011; Pope, Janet/G-3342-2011; Chan, Edward K. L./B-5671-2009; Kahari, Veli-Matti/T-4925-2019; Westermarck, Jukka/AAL-6464-2020	Kähäri, Veli-Matti/0000-0003-2421-9368; Pope, Janet/0000-0003-1479-5302; Chan, Edward K. L./0000-0003-3938-9503; Kahari, Veli-Matti/0000-0003-2421-9368; Westermarck, Jukka/0000-0001-7478-3018; Ivaska, Johanna/0000-0002-6295-6556; Kallunki, Tuula/0000-0002-8571-383X	NCI NIH HHS [R01-CA100855] Funding Source: Medline; NIDCR NIH HHS [DE15953] Funding Source: Medline; NIGMS NIH HHS [T32-GM08617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Escamilia-Powers JR, 2007, J BIOL CHEM, V282, P5432, DOI 10.1074/jbc.M611437200; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honeycutt KA, 2004, J DERMATOL, V31, P368, DOI 10.1111/j.1346-8138.2004.tb00687.x; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moule MG, 2004, P NATL ACAD SCI USA, V101, P14063, DOI 10.1073/pnas.0405533101; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Pastula C, 2003, COMB CHEM HIGH T SCR, V6, P341; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	33	475	517	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					51	62		10.1016/j.cell.2007.04.044	http://dx.doi.org/10.1016/j.cell.2007.04.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632056	Bronze			2022-12-24	WOS:000248587000010
J	Dai, SD; Friemann, R; Glauser, DA; Bourquin, F; Manieri, W; Schurmann, P; Eklund, H				Dai, Shaodong; Friemann, Rosmarie; Glauser, Dominique A.; Bourquin, Florence; Manieri, Wanda; Schuermann, Peter; Eklund, Hans			Structural snapshots along the reaction pathway of ferredoxin-thioredoxin reductase	NATURE			English	Article							CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; 4FE-4S CLUSTER; FERREDOXINTHIOREDOXIN REDUCTASE; DISULFIDE REDUCTION; SPINACH FERREDOXIN; ACTIVE-SITE; CHLOROPLAST; PROTEIN; CHEMISTRY	Oxygen-evolving photosynthetic organisms regulate carbon metabolism through a light-dependent redox signalling pathway(1). Electrons are shuttled from photosystem I by means of ferredoxin (Fdx) to ferredoxin - thioredoxin reductase (FTR), which catalyses the two-electron-reduction of chloroplast thioredoxins (Trxs). These modify target enzyme activities by reduction, regulating carbon flow(2). FTR is unique in its use of a [4Fe - 4S] cluster and a proximal disulphide bridge in the conversion of a light signal into a thiol signal(2). We determined the structures of FTR in both its one- and its two-electron-reduced intermediate states and of four complexes in the pathway, including the ternary Fdx - FTR - Trx complex. Here we show that, in the first complex ( Fdx - FTR) of the pathway, the Fdx [2Fe - 2S] cluster is positioned suitably for electron transfer to the FTR [ 4Fe - 4S] centre. After the transfer of one electron, an intermediate is formed in which one sulphur atom of the FTR active site is free to attack a disulphide bridge in Trx and the other sulphur atom forms a fifth ligand for an iron atomin the FTR [ 4Fe - 4S] centre - a unique structure in biology. Fdx then delivers a second electron that cleaves the FTR - Trx heterodisulphide bond, which occurs in the Fdx - FTR - Trx complex. In this structure, the redox centres of the three proteins are aligned to maximize the efficiency of electron transfer from the Fdx [2Fe - 2S] cluster to the active-site disulphide of Trxs. These results provide a structural framework for understanding the mechanism of disulphide reduction by an iron - sulphur enzyme(3) and describe previously unknown interaction networks for both Fdx and Trx ( refs 4 - 6).	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biol, S-75124 Uppsala, Sweden; Univ Neuchatel, Mol & Cellular Biol Lab, CH-2009 Neuchatel, Switzerland	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Swedish University of Agricultural Sciences; University of Neuchatel	Dai, SD (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	dais@njc.org	Glauser, Dominique/B-3918-2012; Friemann, Rosmarie/C-1018-2008	Glauser, Dominique/0000-0002-3228-7304; Friemann, Rosmarie/0000-0002-5633-2894				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Balmer Y, 2001, FEBS LETT, V492, P58, DOI 10.1016/S0014-5793(01)02229-3; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Dai SD, 2000, Q REV BIOPHYS, V33, P67, DOI 10.1017/S0033583500003607; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duin EC, 2002, FEBS LETT, V512, P263, DOI 10.1016/S0014-5793(02)02281-0; Giastas P, 2006, J BIOL INORG CHEM, V11, P445, DOI 10.1007/s00775-006-0094-9; Glauser DA, 2004, J BIOL CHEM, V279, P16662, DOI 10.1074/jbc.M313851200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Jameson GNL, 2003, J AM CHEM SOC, V125, P1146, DOI 10.1021/ja029338e; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Knaff D. B., 1996, ADV PHOTOSYNTHESIS O, P333; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; LELONG C, 1995, BIOCHEMISTRY-US, V34, P14462, DOI 10.1021/bi00044a024; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Manieri W, 2003, FEBS LETT, V549, P167, DOI 10.1016/S0014-5793(03)00811-1; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; SCHURMANN P, 1993, CHIMIA, V47, P245; Schurmann P, 2003, ANTIOXID REDOX SIGN, V5, P69, DOI 10.1089/152308603321223559; Schurmann P, 1995, PHOTOSYNTH RES, V46, P309, DOI 10.1007/BF00020445; SCHURMANN P, 1995, METHOD ENZYMOL, V252, P274; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; STURA EA, 1999, CRYSTALLIZATION NUCL, P99; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Heuvel RHH, 2003, J MOL BIOL, V330, P113, DOI 10.1016/S0022-2836(03)00522-9; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Walters EM, 2004, PHOTOSYNTH RES, V79, P249, DOI 10.1023/B:PRES.0000017195.05870.61; WEDEL N, 1992, PLANT MOL BIOL, V18, P527, DOI 10.1007/BF00040668; Xu XF, 2006, FEBS LETT, V580, P6714, DOI 10.1016/j.febslet.2006.11.027	51	103	111	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					92	102		10.1038/nature05937	http://dx.doi.org/10.1038/nature05937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611542				2022-12-24	WOS:000247720900044
J	Cassenaer, S; Laurent, G				Cassenaer, Stijn; Laurent, Gilles			Hebbian STDP in mushroom bodies facilitates the synchronous flow of olfactory information in locusts	NATURE			English	Article							ODOR REPRESENTATIONS; TEMPORAL INFORMATION; ANTENNAL LOBE; SYNCHRONIZATION; OSCILLATIONS; PROPAGATION; PLASTICITY; RECEPTORS; NEURONS; MEMORY	Odour representations in insects undergo progressive transformations and decorrelation(1-3) from the receptor array to the presumed site of odour learning, the mushroom body(4-7). There, odours are represented by sparse assemblies of Kenyon cells in a large population(2). Using intracellular recordings in vivo, we examined transmission and plasticity at the synapse made by Kenyon cells onto downstream targets in locusts. We find that these individual synapses are excitatory and undergo hebbian spike-timing dependent plasticity (STDP)(8-10) on a+/-25 ms timescale. When placed in the context of odour-evoked Kenyon cell activity (a 20-Hz oscillatory population discharge), this form of STDP enhances the synchronization of the Kenyon cells' targets and thus helps preserve the propagation of the odour-specific codes through the olfactory system.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				[Anonymous], 2006, ADV NEURAL INFORM PR; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Leitch B, 1996, J COMP NEUROL, V372, P487; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MAKRAM H, 1997, SCIENCE, V275, P213; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Nowotny T, 2003, J COMPUT NEUROSCI, V15, P271, DOI 10.1023/A:1025825111088; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Suri RE, 2002, BIOL CYBERN, V87, P440, DOI 10.1007/s00422-002-0355-9; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; ULTSCH A, 1993, FEBS LETT, V324, P171, DOI 10.1016/0014-5793(93)81387-F; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672; Zhigulin VP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021901	31	202	203	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					709	U12		10.1038/nature05973	http://dx.doi.org/10.1038/nature05973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17581587				2022-12-24	WOS:000248598000048
J	Rohatgi, R; Milenkovic, L; Scott, MP				Rohatgi, Rajat; Milenkovic, Ljiljana; Scott, Matthew P.			Patched1 regulates Hedgehog signaling at the primary cilium	SCIENCE			English	Article							INTRAFLAGELLAR TRANSPORT; CELLS; TRANSDUCTION; LOCALIZATION	Primary cilia are essential for transduction of the Hedgehog (Hh) signal in mammals. We investigated the role of primary cilia in regulation of Patched1 (Ptc1), the receptor for Sonic Hedgehog (Shh). Ptc1 localized to cilia and inhibited Smoothened (Smo) by preventing its accumulation within cilia. When Shh bound to Ptc1, Ptc1 left the cilia, leading to accumulation of Smo and activation of signaling. Thus, primary cilia sense Shh and transduce signals that play critical roles in development, carcinogenesis, and stem cell function.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	mscott@stanford.edu			NATIONAL CANCER INSTITUTE [R01CA088060] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA088060] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	16	1010	1048	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2007	317	5836					372	376		10.1126/science.1139740	http://dx.doi.org/10.1126/science.1139740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17641202				2022-12-24	WOS:000248150200047
J	Depue, BE; Curran, T; Banich, MT				Depue, Brendan E.; Curran, Tim; Banich, Marie T.			Prefrontal regions orchestrate suppression of emotional memories via a two-phase process	SCIENCE			English	Article							CORTEX; FMRI; AMYGDALA; MECHANISMS	Whether memories can be suppressed has been a controversial issue in psychology and cognitive neuroscience for decades. We found evidence that emotional memories are suppressed via two time-differentiated neural mechanisms: (i) an initial suppression by the right inferior frontal gyrus over regions supporting sensory components of the memory representation ( visual cortex, thalamus), followed by (ii) right medial frontal gyrus control over regions supporting multimodal and emotional components of the memory representation ( hippocampus, amygdala), both of which are influenced by fronto-polar regions. These results indicate that memory suppression does occur and, at least in nonpsychiatric populations, is under the control of prefrontal regions.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; Univ Denver Hlth Sci, Dept Psychiat, Denver, CO 80208 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Depue, BE (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80309 USA.	depue@colorado.edu		BANICH, MARIE/0000-0001-9373-9194				Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Depue BE, 2006, PSYCHOL SCI, V17, P441, DOI 10.1111/j.1467-9280.2006.01725.x; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hertel PT, 2005, PSYCHON B REV, V12, P484, DOI 10.3758/BF03193792; Jacoby LL, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P383; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kihlstrom JF, 2002, TRENDS COGN SCI, V6, P502, DOI 10.1016/S1364-6613(02)02006-5; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Purdon C, 1999, BEHAV RES THER, V37, P1029, DOI 10.1016/S0005-7967(98)00200-9; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Raye CL, 2007, CORTEX, V43, P135, DOI 10.1016/S0010-9452(08)70451-9; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; vanderKolk BA, 1997, ANN NY ACAD SCI, V821, P99; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wraga M, 2000, J COGNITIVE NEUROSCI, P75	31	301	319	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					215	219		10.1126/science.1139560	http://dx.doi.org/10.1126/science.1139560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626877	Green Submitted			2022-12-24	WOS:000247968600033
J	Giorgi, C; Yeo, GW; Stone, ME; Katz, DB; Burge, C; Turrigiano, G; Moore, MJ				Giorgi, Corinna; Yeo, Gene W.; Stone, Martha E.; Katz, Donald B.; Burge, Christopher; Turrigiano, Gina; Moore, Melissa J.			The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression	CELL			English	Article							MESSENGER-RNA LOCALIZATION; MAMMALIAN-CELLS; ABERRANT TERMINATION; STAUFEN; TRANSLATION; ARC/ARG3.1; NUCLEAR; AMPA; PLASTICITY; COMPLEX	tProper neuronal function and several forms of synaptic plasticity are highly dependent on precise control of mRNA translation, particularly in dendrites. We find that eIF4AIII, a core exon junction complex ( EJC) component loaded onto mRNAs by pre- mRNA splicing, is associated with neuronal mRNA granules and dendritic mRNAs. eIF4AIII knockdown markedly increases both synaptic strength and GLUR1 AMPA receptor abundance at synapses. eIF4AIII depletion also increases ARC, a protein required for maintenance of long- term potentiation; arc mRNA, one of the most abundant in dendrites, is a natural target for nonsense-mediated decay ( NMD). Numerous new NMD candidates, some with potential to affect synaptic activity, were also identified computationally. Two models are presented for how translation- dependent decay pathways such as NMD might advantageously function as critical brakes for protein synthesis in cells such as neurons that are highly dependent on spatially and temporally restricted protein expression.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Dept Psychol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Salk Inst Biol Studies, Crick Jacobs Ctr Computat & Theoret Biol, La Jolla, CA 92037 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University; Brandeis University; Salk Institute; Massachusetts Institute of Technology (MIT)	Moore, MJ (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	mmoore@brandeis.edu	giorgi, corinna/G-7794-2011; Burge, Christopher B./AAH-2177-2020; Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Stone, Martha/0000-0001-6771-994X; giorgi, corinna/0000-0003-1065-369X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amrani N, 2006, BIOCHEM SOC T, V34, P39, DOI 10.1042/BST0340039; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Ichikawa H, 2003, J PHARMACOL SCI, V91, P247; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2005, TRENDS BIOCHEM SCI, V30, P228, DOI 10.1016/j.tibs.2005.03.005; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Macchi P, 2003, J NEUROSCI, V23, P5778; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Monshausen M, 2004, NEUROMOL MED, V6, P127, DOI 10.1385/NMM:6:2-3:127; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wallace CS, 1998, J NEUROSCI, V18, P26; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Weil JE, 2006, RNA, V12, P102, DOI 10.1261/rna.2129806; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; [No title captured]	67	217	221	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					179	191		10.1016/j.cell.2007.05.028	http://dx.doi.org/10.1016/j.cell.2007.05.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632064	Bronze			2022-12-24	WOS:000248587000020
J	Miled, N; Yan, Y; Hon, WC; Perisic, O; Zvelebil, M; Inbar, Y; Schneidman-Duhovny, D; Wolfson, HJ; Backer, JM; Williams, RL				Miled, Nabil; Yan, Ying; Hon, Wai-Ching; Perisic, Olga; Zvelebil, Marketa; Inbar, Yuval; Schneidman-Duhovny, Dina; Wolfson, Haim J.; Backer, Jonathan M.; Williams, Roger L.			Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3'-KINASE; FUNCTIONAL-ANALYSIS; REGULATORY SUBUNIT; PIK3CA MUTATIONS; INTER-SH2 DOMAIN; PI 3-KINASE; ACTIVATION; PATHWAY; TARGETS; GENE	Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3K alpha, with oncogenic mutations identified in both the p110 alpha catalytic and the p85 alpha regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110 alpha domains-the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110 alpha in a complex with the p85 alpha inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu(545) to Lys(545) (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; UCL, Ludwig Inst Canc Res, London, England; Tel Aviv Univ, Sch Comp Sci, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Yeshiva University; Albert Einstein College of Medicine; Ludwig Institute for Cancer Research; University of London; University College London; Tel Aviv University	Backer, JM (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	backer@aecom.yu.edu; rlw@mrc-lmb.cam.ac.uk	Wolfson, Haim/A-1837-2011; Miled, Nabil/ABC-6773-2020; Schneidman, Dina/ABH-6654-2020	Wolfson, Haim/0000-0002-7600-2702; Miled, Nabil/0000-0001-7445-6324; Schneidman, Dina/0000-0003-0480-0438; Williams, Roger/0000-0001-7754-4207; Zvelebil, Marketa/0000-0001-8018-5591; Perisic, Olga/0000-0002-3842-2896	MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: Medline; NIGMS NIH HHS [GM55692] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Elis W, 2006, BIOL CHEM, V387, P1567, DOI 10.1515/BC.2006.195; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jimenez C, 2002, J BIOL CHEM, V277, P41556, DOI 10.1074/jbc.M205893200; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wetzker R, 2004, CURR PHARM DESIGN, V10, P1915, DOI 10.2174/1381612043384402; Workman P, 2004, BIOCHEM SOC T, V32, P393, DOI 10.1042/BST0320393; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199	29	307	325	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					239	242		10.1126/science.1135394	http://dx.doi.org/10.1126/science.1135394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626883				2022-12-24	WOS:000247968600041
J	Jiang, W; Yun, D; Saleh, L; Barr, EW; Xing, G; Hoffart, LM; Maslak, MA; Krebs, C; Bollinger, JM				Jiang, Wei; Yun, Danny; Saleh, Lana; Barr, Eric W.; Xing, Gang; Hoffart, Lee M.; Maslak, Monique-Anne; Krebs, Carsten; Bollinger, J. Martin, Jr.			A manganese(IV)/iron(III) cofactor in Chlamydia trachomatis ribonucleotide reductase	SCIENCE			English	Article							ESCHERICHIA-COLI; NITRIC-OXIDE; INACTIVATION; RADICALS; ENZYME; DIPHOSPHATES; CATALYSIS; MECHANISM; IRON; SITE	In a conventional class I ribonucleotide reductase (RNR), a diiron(II/II) cofactor in the R2 subunit reacts with oxygen to produce a diiron(III/IV) intermediate, which generates a stable tyrosyl radical (Y.). The Y. reversibly oxidizes a cysteine residue in the R1 subunit to a cysteinyl radical (C.), which abstracts the 3'-hydrogen of the substrate to initiate its reduction. The RNR from Chlamydia trachomatis lacks the Y., and it had been proposed that the diiron(III/IV) complex in R2 directly generates the C. in R1. By enzyme activity measurements and spectroscopic methods, we show that this RNR actually uses a previously unknown stable manganese(IV)/iron( III) cofactor for radical initiation.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Krebs, C (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	ckrebs@psu.edu	Bollinger, Joseph/C-1425-2016; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	NIGMS NIH HHS [GM55365] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behravan G, 1995, BBA-GENE STRUCT EXPR, V1264, P323, DOI 10.1016/0167-4781(95)00168-9; ELIASSON R, 1994, J BIOL CHEM, V269, P26116; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Fritscher J, 2005, J AM CHEM SOC, V127, P7729, DOI 10.1021/ja043111x; Guittet O, 1999, CELL MOL LIFE SCI, V55, P1054, DOI 10.1007/s000180050356; HASSAN HM, 1994, FEMS MICROBIOL REV, V14, P315, DOI 10.1111/j.1574-6976.1994.tb00105.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Lawrence CC, 1998, CURR OPIN CHEM BIOL, V2, P650, DOI 10.1016/S1367-5931(98)80097-5; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; SALOWE S, 1993, BIOCHEMISTRY-US, V32, P12749, DOI 10.1021/bi00210a026; Sinnecker S, 2005, J BIOL INORG CHEM, V10, P231, DOI 10.1007/s00775-005-0633-9; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; THELANDER L, 1976, J BIOL CHEM, V251, P1398; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Voevodskaya N, 2005, BIOCHEM BIOPH RES CO, V330, P1213, DOI 10.1016/j.bbrc.2005.03.104; ZHENG M, 1994, INORG CHEM, V33, P382, DOI 10.1021/ic00080a030	25	154	156	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1188	1191		10.1126/science.1141179	http://dx.doi.org/10.1126/science.1141179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525338				2022-12-24	WOS:000246724300042
J	Barton, ES; White, DW; Cathelyn, JS; Brett-McClellan, KA; Engle, M; Diamond, MS; Miller, VL; Virgin, HW				Barton, Erik S.; White, Douglas W.; Cathelyn, Jason S.; Brett-McClellan, Kelly A.; Engle, Michael; Diamond, Michael S.; Miller, Virginia L.; Virgin, Herbert W.			Herpesvirus latency confers symbiotic protection from bacterial infection	NATURE			English	Article							MURINE GAMMAHERPESVIRUS 68; EPSTEIN-BARR-VIRUS; CD8(+) T-CELLS; GAMMA-INTERFERON; CYTOMEGALOVIRUS; IMMUNITY; ANTIGEN; MEMORY; CD4; EBV	All humans become infected with multiple herpesviruses during childhood. After clearance of acute infection, herpesviruses enter a dormant state known as latency. Latency persists for the life of the host and is presumed to be parasitic, as it leaves the individual at risk for subsequent viral reactivation and disease(1). Here we show that herpesvirus latency also confers a surprising benefit to the host. Mice latently infected with either murine gammaherpesvirus 68 or murine cytomegalovirus, which are genetically highly similar to the human pathogens Epstein - Barr virus and human cytomegalovirus(2), respectively, are resistant to infection with the bacterial pathogens Listeria monocytogenes and Yersinia pestis. Latency-induced protection is not antigen specific but involves prolonged production of the antiviral cytokine interferon-gamma and systemic activation of macrophages. Latency thereby upregulates the basal activation state of innate immunity against subsequent infections. We speculate that herpesvirus latency may also sculpt the immune response to self and environmental antigens through establishment of a polarized cytokine environment. Thus, whereas the immune evasion capabilities and lifelong persistence of herpesviruses are commonly viewed as solely pathogenic, our data suggest that latency is a symbiotic relationship with immune benefits for the host.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu	White, D/GRR-2943-2022; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Virgin, Herbert/0000-0001-8580-7628; Barton, Erik/0000-0001-6942-6315; White, Douglas/0000-0002-0366-9047; Miller, Virginia/0000-0002-9522-1767				Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Christensen JP, 1999, J VIROL, V73, P4279, DOI 10.1128/JVI.73.5.4279-4283.1999; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Edelson BT, 2001, IMMUNITY, V14, P503, DOI 10.1016/S1074-7613(01)00139-X; Flano E, 2001, J VIROL, V75, P7744, DOI 10.1128/JVI.75.16.7744-7748.2001; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; McClellan JS, 2004, J VIROL, V78, P6836, DOI 10.1128/JVI.78.13.6836-6845.2004; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; ROIZMAN B, 2007, FIELDS VIROLOGY, P2475; Sarawar SR, 1997, J VIROL, V71, P3916, DOI 10.1128/JVI.71.5.3916-3921.1997; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Tan LC, 1999, J IMMUNOL, V162, P1827; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	511	534	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					326	U7		10.1038/nature05762	http://dx.doi.org/10.1038/nature05762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507983				2022-12-24	WOS:000246520300047
J	Chini, A; Fonseca, S; Fernandez, G; Adie, B; Chico, JM; Lorenzo, O; Garcia-Casado, G; Lopez-Vidriero, I; Lozano, FM; Ponce, MR; Micol, JL; Solano, R				Chini, Andrea; Fonseca, S.; Fernandez, G.; Adie, B.; Chico, J. M.; Lorenzo, O.; Garcia-Casado, G.; Lopez-Vidriero, I.; Lozano, F. M.; Ponce, M. R.; Micol, J. L.; Solano, R.			The JAZ family of repressors is the missing link in jasmonate signalling	NATURE			English	Article							BOX PROTEIN TIR1; PHYTOTOXIN CORONATINE; REGULATED DEFENSE; METHYL JASMONATE; PLANT-RESPONSES; GENE; ACID; TRANSFORMATION; BIOSYNTHESIS; RESISTANCE	Jasmonates are essential phytohormones for plant development and survival. However, the molecular details of their signalling pathway remain largely unknown. The identification more than a decade ago of COI1 as an F-box protein suggested the existence of a repressor of jasmonate responses that is targeted by the SCFCOI1 complex for proteasome degradation in response to jasmonate. Here we report the identification of JASMONATE-INSENSITIVE 3 (JAI3) and a family of related proteins named JAZ (jasmonate ZIM-domain), in Arabidopsis thaliana. Our results demonstrate that JAI3 and other JAZs are direct targets of the SCFCOI1 E3 ubiquitin ligase and jasmonate treatment induces their proteasome degradation. Moreover, JAI3 negatively regulates the key transcriptional activator of jasmonate responses, MYC2. The JAZ family therefore represents the molecular link between the two previously known steps in the jasmonate pathway. Furthermore, we demonstrate the existence of a regulatory feed-back loop involving MYC2 and JAZ proteins, which provides a mechanistic explanation for the pulsed response to jasmonate and the subsequent desensitization of the cell.	CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma, Madrid 28049, Spain; CSIC, Ctr Nacl Biotecnol, Unidad Genom, Madrid 28049, Spain; Univ Miguel Hernandez, Div Genet, Elche 03202, Spain; Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Solano, R (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ Autonoma, Madrid 28049, Spain.	rsolano@cnb.uam.es	Solano, Roberto/O-5908-2017; Lorenzo, Oscar/K-8170-2014; Micol, José Luis/B-4832-2010; Fonseca, Sandra/AAB-3639-2019; Chini, Andrea/D-1336-2009; Ponce, María Rosa/C-8203-2014	Solano, Roberto/0000-0001-5459-2417; Lorenzo, Oscar/0000-0001-9523-0789; Micol, José Luis/0000-0002-0396-1750; Fonseca, Sandra/0000-0002-2021-4482; Ponce, María Rosa/0000-0003-0770-4230; Chini, Andrea/0000-0001-5841-0254				Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; AXEL M, 2004, J PLANT GROWTH REGUL, V23, P170; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chini A, 2005, PLANTA, V221, P597, DOI 10.1007/s00425-005-1499-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; DEMOLE E, 1962, HELV CHIM ACTA, V45, P675, DOI 10.1002/hlca.19620450233; Devoto A, 2003, ANN BOT-LONDON, V92, P329, DOI 10.1093/aob/mcg151; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Farber K, 2003, PHYTOCHEMISTRY, V62, P491, DOI 10.1016/S0031-9422(02)00562-9; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Flescher E, 2005, ANTI-CANCER DRUG, V16, P911, DOI 10.1097/01.cad.0000176501.63680.80; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; LIECHTI R, 2006, SCI STKE, V203, pCM18; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MITA S, 1995, PLANT PHYSIOL, V107, P895, DOI 10.1104/pp.107.3.895; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	46	1547	1671	42	527	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					666	+		10.1038/nature06006	http://dx.doi.org/10.1038/nature06006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17637675				2022-12-24	WOS:000248598000038
J	Vassylyev, DG; Vassylyeva, MN; Zhang, JW; Palangat, M; Artsimovitch, I; Landick, R				Vassylyev, Dmitry G.; Vassylyeva, Marina N.; Zhang, Jinwei; Palangat, Murali; Artsimovitch, Irina; Landick, Robert			Structural basis for substrate loading in bacterial RNA polymerase	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; ELECTRON-DENSITY MAPS; II ELONGATION COMPLEX; ACTIVE-CENTER; CRYSTAL-STRUCTURE; TRANSCRIPTION ELONGATION; CATALYTIC RESIDUES; MECHANISM; NTP; DISCRIMINATION	The mechanism of substrate loading in multisubunit RNA polymerase is crucial for understanding the general principles of transcription yet remains hotly debated. Here we report the 3.0-angstrom resolution structures of the Thermus thermophilus elongation complex (EC) with a non-hydrolysable substrate analogue, adenosine-5'-[(alpha,beta)-methyleno]-triphosphate (AMPcPP), and with AMPcPP plus the inhibitor streptolydigin. In the EC/AMPcPP structure, the substrate binds to the active ('insertion') site closed through refolding of the trigger loop (TL) into two alpha-helices. In contrast, the EC/AMPcPP/streptolydigin structure reveals an inactive ('preinsertion') substrate configuration stabilized by streptolydigin-induced displacement of the TL. Our structural and biochemical data suggest that refolding of the TL is vital for catalysis and have three main implications. First, despite differences in the details, the two-step preinsertion/insertion mechanism of substrate loading may be universal for all RNA polymerases. Second, freezing of the preinsertion state is an attractive target for the design of novel antibiotics. Last, the TL emerges as a prominent target whose refolding can be modulated by regulatory factors.	Univ Alabama, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Birmingham, AL 35294 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University	Vassylyev, DG (corresponding author), Univ Alabama, Dept Biochem & Mol Genet, Sch Med, 402B Kaul Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dmitry@uab.edu	Zhang, Jinwei/AAU-9195-2020; Palangat, Murali/AAK-5445-2021; Zhang, Jinwei/D-8953-2012; Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019	Zhang, Jinwei/0000-0002-2114-173X; Palangat, Murali/0000-0002-3327-3844				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Holmes SF, 2006, J BIOL CHEM, V281, P18677, DOI 10.1074/jbc.M600543200; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Langelier MF, 2005, NUCLEIC ACIDS RES, V33, P2629, DOI 10.1093/nar/gki570; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LEE JY, 1991, P NATL ACAD SCI USA, V88, P6018, DOI 10.1073/pnas.88.14.6018; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; TOULOKHONOV I, IN PRESS MOL CELL; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	41	275	285	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					163	U4		10.1038/nature05931	http://dx.doi.org/10.1038/nature05931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17581591				2022-12-24	WOS:000247934500035
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Lateral habenula as a source of negative reward signals in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; CAUDATE-NUCLEUS; COMPLEX; RATS; PREDICTION; MOTIVATION; SEROTONIN; RESPONSES; SACCADES	Midbrain dopamine neurons are key components of the brain's reward system(1), which is thought to guide reward-seeking behaviours(2-4). Although recent studies have shown how dopamine neurons respond to rewards and sensory stimuli predicting reward(1,5,6), it is unclear which parts of the brain provide dopamine neurons with signals necessary for these actions. Here we show that the primate lateral habenula, part of the structure called the epithalamus, is a major candidate for a source of negative reward-related signals in dopamine neurons. We recorded the activity of habenula neurons and dopamine neurons while rhesus monkeys were performing a visually guided saccade task with positionally biased reward outcomes(7). Many habenula neurons were excited by a no-reward-predicting target and inhibited by a reward-predicting target. In contrast, dopamine neurons were excited and inhibited by reward-predicting and no-reward-predicting targets, respectively. Each time the rewarded and unrewarded positions were reversed, both habenula and dopamine neurons reversed their responses as the bias in saccade latency reversed. In unrewarded trials, the excitation of habenula neurons started earlier than the inhibition of dopamine neurons. Furthermore, weak electrical stimulation of the lateral habenula elicited strong inhibitions in dopamine neurons. These results suggest that the inhibitory input from the lateral habenula plays an important role in determining the reward-related activity of dopamine neurons.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	oh@lsr.nei.nih.gov	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Houk JC, 1995, MODELS INFORMATION P, P249; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; SANDYK R, 1991, INT J NEUROSCI, V61, P189, DOI 10.3109/00207459108990738; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360	31	833	857	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1111	U11		10.1038/nature05860	http://dx.doi.org/10.1038/nature05860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17522629	Green Published			2022-12-24	WOS:000247564600037
J	Smith, CD; Shu, SQ; Mungall, CJ; Karpen, GH				Smith, Christopher D.; Shu, ShengQiang; Mungall, Christopher J.; Karpen, Gary H.			The Release 5.1 annotation of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							HONEY-BEE; IDENTIFICATION; CHROMOSOME; SEQUENCES; INTRONS; ODORANT	The repetitive DNA that constitutes most of the heterochromatic regions of metazoan genomes has hindered the comprehensive analysis of gene content and other functions. We have generated a detailed computational and manual annotation of 24 megabases of heterochromatic sequence in the Release 5 Drosophila melanogaster genome sequence. The heterochromatin contains a minimum of 230 to 254 protein-coding genes, which are conserved in other Drosophilids and more diverged species, as well as 32 pseudogenes and 13 noncoding RNAs. Improved methods revealed that more than 77% of this heterochromatin sequence, including introns and intergenic regions, is composed of fragmented and nested transposable elements and other repeated DNAs. Drosophila heterochromatin contains "islands" of highly conserved genes embedded in these "oceans" of complex repeats, which may require special expression and splicing mechanisms.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA; San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Biomed Ontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Karpen, GH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA.	karpen@fruitfly.org	Mungall, Chris/I-6006-2019	Mungall, Chris/0000-0002-6601-2165; Shu, Shengqiang/0000-0002-4336-8994	NHGRI NIH HHS [R01 HG000747-16, P41 HG000739-15, U54 HG004028, U54 HG004028-01, R01 HG000747, R01-HG000747] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG000739, R01HG000747, U54HG004028] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hild M, 2004, GENOME BIOL, V5; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; KAMINKER JS, 2002, GENOME BIOL, V0003; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Reugels AM, 2000, GENETICS, V154, P759; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	26	152	159	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1586	1591		10.1126/science.1139815	http://dx.doi.org/10.1126/science.1139815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569856	Green Accepted			2022-12-24	WOS:000247239900032
J	Walkley, CR; Shea, JM; Sims, NA; Purton, LE; Orkin, SH				Walkley, Carl R.; Shea, Jeremy M.; Sims, Natalie A.; Purton, Louise E.; Orkin, Stuart H.			Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment	CELL			English	Article							SELF-RENEWAL; IN-VIVO; NONAUTONOMOUS FUNCTION; TUMOR-SUPPRESSOR; DIFFERENTIATION; PROGENITOR; MICE; QUIESCENCE; EXPRESSION; OSTEOBLAST	Hematopoiesis is maintained by stem cells (HSCs) that undergo fate decisions by integrating intrinsic and extrinsic signals, with the latter derived from the bone marrow (BM) microenvironment. Cell-cycle regulation can modulate stem cell fate, but it is unknown whether this represents an intrinsic or extrinsic effector of fate decisions. We have investigated the role of the retinoblastoma protein (RB), a central regulator of the cell cycle, in hematopoiesis. Widespread inactivation of RB in the murine hematopoietic system resulted in profound myeloproliferation. HSCs were lost from the BM due to mobilization to extramedullary sites and differentiation. This phenotype was not intrinsic to HSCs, but, rather, was the consequence of an RB-dependent interaction between myeloid-derived cells and the microenvironment. These findings demonstrate that myeloproliferation may result from perturbed interactions between hematopoietic cells and the niche. Therefore, RB extrinsically regulates HSCs by maintaining the capacity of the BM to support normal hematopoiesis and HSCs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Stem Cell Inst, Childrens Hosp Boston,Stem Cell Program, Boston, MA 02115 USA; Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Sims, Natalie Ann/A-7192-2012; Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Sims, Natalie Ann/0000-0003-1421-8468; Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259-27, R01 HL032259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bradford GB, 1997, EXP HEMATOL, V25, P445; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; Hu NP, 1997, CANCER RES, V57, P4123; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kramer AK, 2002, LEUKEMIA, V16, P1844, DOI 10.1038/sj.leu.2402609; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LERNER C, 1990, EXP HEMATOL, V18, P114; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; OKADA S, 1992, BLOOD, V80, P3044; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rasheed N, 2006, HUM MOL GENET, V15, P1938, DOI 10.1093/hmg/ddl116; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; St Croix B, 2000, SCIENCE, V289, P1197; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tajima F, 2000, BLOOD, V96, P1989, DOI 10.1182/blood.V96.5.1989.h8001989_1989_1993; TASWELL C, 1981, J IMMUNOL, V126, P1614; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Whyatt D, 2002, EMBO REP, V3, P130, DOI 10.1093/embo-reports/kvf033; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	78	318	331	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1081	1095		10.1016/j.cell.2007.03.055	http://dx.doi.org/10.1016/j.cell.2007.03.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574022	Green Accepted, Bronze			2022-12-24	WOS:000247390400013
J	Yagoda, N; von Rechenberg, M; Zaganjor, E; Bauer, AJ; Yang, WS; Fridman, DJ; Wolpaw, AJ; Smukste, I; Peltier, JM; Boniface, JJ; Smith, R; Lessnick, SL; Sahasrabudhe, S; Stockwell, BR				Yagoda, Nicholas; von Rechenberg, Moritz; Zaganjor, Elma; Bauer, Andras J.; Yang, Wan Seok; Fridman, Daniel J.; Wolpaw, Adam J.; Smukste, Inese; Peltier, John M.; Boniface, J. Jay; Smith, Richard; Lessnick, Stephen L.; Sahasrabudhe, Sudhir; Stockwell, Brent R.			RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; HUMAN TUMOR-CELLS; APOPTOSIS; MECHANISM; GENE; PERMEABILITY; ACTIVATION; THERAPY; LIBRARY; CANCER	Therapeutics that discriminate between the genetic makeup of normal cells and tumour cells are valuable for treating and understanding cancer. Small molecules with oncogene-selective lethality may reveal novel functions of oncoproteins and enable the creation of more selective drugs(1). Here we describe the mechanism of action of the selective anti-tumour agent erastin, involving the RAS - RAF - MEK signalling pathway functioning in cell proliferation, differentiation and survival. Erastin exhibits greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. Using affinity purification and mass spectrometry, we discovered that erastin acts through mitochondrial voltage-dependent anion channels (VDACs) - a novel target for anti-cancer drugs. We show that erastin treatment of cells harbouring oncogenic RAS causes the appearance of oxidative species and subsequent death through an oxidative, non-apoptotic mechanism. RNA-interference-mediated knockdown of VDAC2 or VDAC3 caused resistance to erastin, implicating these two VDAC isoforms in the mechanism of action of erastin. Moreover, using purified mitochondria expressing a single VDAC isoform, we found that erastin alters the permeability of the outer mitochondrial membrane. Finally, using a radiolabelled analogue and a filter-binding assay, we show that erastin binds directly to VDAC2. These results demonstrate that ligands to VDAC proteins can induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS - RAF - MEK pathway.	Columbia Univ, Fairchild Ctr, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Prolexys Pharmaceut, Salt Lake City, UT 84116 USA; Huntsman Canc Inst, Ctr Children, Salt Lake City, UT 84112 USA	Columbia University; Columbia University; Huntsman Cancer Institute	Stockwell, BR (corresponding author), Columbia Univ, Fairchild Ctr, Dept Biol Sci, 1212 Amsterdam Ave,MC 2406, New York, NY 10027 USA.	stockwell@biology.columbia.edu	Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; Wolpaw, Adam/0000-0002-1373-7648	NATIONAL CANCER INSTITUTE [R01CA097061] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA097061-08S1, R01 CA097061-01, R01 CA097061-04, R01 CA097061-05A1, R01 CA097061, R01 CA097061-09S1, R01 CA097061-02, R01 CA097061-07, R01 CA097061-06, R01 CA097061-03, R01 CA097061-09, R01 CA097061-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Beck W T, 1991, Semin Cancer Biol, V2, P235; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Graham BH, 2004, CURR TOP DEV BIOL, V59, P87, DOI 10.1016/S0070-2153(04)59004-X; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; MAJNO G, 1995, AM J PATHOL, V146, P3; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhen YJ, 2004, J AM SOC MASS SPECTR, V15, P803, DOI 10.1016/S1044-0305(04)00131-X	24	776	811	18	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					864	868		10.1038/nature05859	http://dx.doi.org/10.1038/nature05859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568748	Green Accepted			2022-12-24	WOS:000247207500046
J	Ito, M; Yang, ZX; Andl, T; Cui, C; Kim, N; Millar, SE; Cotsarelis, G				Ito, Mayumi; Yang, Zaixin; Andl, Thomas; Cui, Chunhua; Kim, Noori; Millar, Sarah E.; Cotsarelis, George			Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding	NATURE			English	Article							EPITHELIAL STEM-CELLS; BETA-CATENIN; TRANSIENT ACTIVATION; DIFFERENTIATION; MORPHOGENESIS; GROWTH; NICHE; CYCLE	The mammalian hair follicle is a complex 'mini-organ' thought to form only during development 1; loss of an adult follicle is considered permanent. However, the possibility that hair follicles develop de novo following wounding was raised in studies on rabbits (2,3), mice(4) and even humans fifty years ago(5). Subsequently, these observations were generally discounted because definitive evidence for follicular neogenesis was not presented(6). Here we show that, after wounding, hair follicles form de novo in genetically normal adult mice. The regenerated hair follicles establish a stem cell population, express known molecular markers of follicle differentiation, produce a hair shaft and progress through all stages of the hair follicle cycle. Lineage analysis demonstrated that the nascent follicles arise from epithelial cells outside of the hair follicle stem cell niche, suggesting that epidermal cells in the wound assume a hair follicle stem cell phenotype. Inhibition of Wnt signalling after re-epithelialization completely abrogates this wounding-induced folliculogenesis, whereas overexpression of Wnt ligand in the epidermis increases the number of regenerated hair follicles. These remarkable regenerative capabilities of the adult support the notion that wounding induces an embryonic phenotype in skin, and that this provides a window for manipulation of hair follicle neogenesis by Wnt proteins. These findings suggest treatments for wounds, hair loss and other degenerative skin disorders.	Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Cotsarelis, G (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA.	cotsarel@mail.med.upenn.edu		Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BREEDIS C, 1954, CANCER RES, V14, P575; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kishimoto J, 2000, GENE DEV, V14, P1181; KLIGMAN AM, 1956, J INVEST DERMATOL, V27, P19, DOI 10.1038/jid.1956.71; LACASSAGNE A, 1946, CANCER RES, V6, P183; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Millar SE, 2005, PLOS BIOL, V3, P1873, DOI 10.1371/journal.pbio.0030372; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; STRAILE WE, 1967, ADV BIOL SKIN, V9, P369; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47	31	693	740	8	308	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					316	U4		10.1038/nature05766	http://dx.doi.org/10.1038/nature05766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507982				2022-12-24	WOS:000246520300045
J	Armani, AM; Kulkarni, RP; Fraser, SE; Flagan, RC; Vahala, KJ				Armani, Andrea M.; Kulkarni, Rajan P.; Fraser, Scott E.; Flagan, Richard C.; Vahala, Kerry J.			Label-free, single-molecule detection with optical microcavities	SCIENCE			English	Article							FLUORESCENCE SPECTROSCOPY; PROTEIN; SURFACE; DNA; CELL; NANOPARTICLES; RESONANCE; DYNAMICS; ARRAYS	Current single-molecule detection techniques require labeling the target molecule. We report a highly specific and sensitive optical sensor based on an ultrahigh quality (Q) factor (Q > 10(8)) whispering-gallery microcavity. The silica surface is functionalized to bind the target molecule; binding is detected by a resonant wavelength shift. Single-molecule detection is confirmed by observation of single-molecule binding events that shift the resonant frequency, as well as by the statistics for these shifts over many binding events. These shifts result from a thermo-optic mechanism. Additionally, label-free, single-molecule detection of interleukin-2 was demonstrated in serum. These experiments demonstrate a dynamic range of 10(12) in concentration, establishing the microcavity as a sensitive and versatile detector.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Fraser, SE (corresponding author), CALTECH, Dept Appl Phys, MC 128-95, Pasadena, CA 91125 USA.	sefraser@caltech.edu; flagan@caltech.edu	Armani, Andrea/X-7611-2019; Fraser, Scott/Y-3406-2019; Armani, Andrea/A-1216-2007; Armani, Andrea/A-8132-2010	Armani, Andrea/0000-0001-9890-5104; Fraser, Scott/0000-0002-5377-0223; Armani, Andrea/0000-0001-9890-5104				Ambrose WP, 1999, CHEM REV, V99, P2929, DOI 10.1021/cr980132z; Armani AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2099529; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Arnold S, 2003, OPT LETT, V28, P272, DOI 10.1364/OL.28.000272; Boyd RW, 2001, APPL OPTICS, V40, P5742, DOI 10.1364/AO.40.005742; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; HUGHES RC, 1991, SCIENCE, V254, P74, DOI 10.1126/science.254.5028.74; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Krioukov E, 2002, OPT LETT, V27, P512, DOI 10.1364/OL.27.000512; Ksendzov A, 2005, OPT LETT, V30, P3344, DOI 10.1364/OL.30.003344; Kulkarni RP, 2006, BIOPHYS J, V90, pL42, DOI 10.1529/biophysj.105.077941; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Mazur B, 2004, HEMATOL ONCOL, V22, P27, DOI 10.1002/hon.725; Moore BD, 2004, NAT BIOTECHNOL, V22, P1133, DOI 10.1038/nbt1003; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Nakatani K, 2001, NAT BIOTECHNOL, V19, P51, DOI 10.1038/83505; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Yeo WS, 2005, ANGEW CHEM INT EDIT, V44, P5480, DOI 10.1002/anie.200501363; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; Zhong ZH, 2003, SCIENCE, V302, P1377, DOI 10.1126/science.1090899	29	939	985	14	435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					783	787		10.1126/science.1145002	http://dx.doi.org/10.1126/science.1145002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17615303				2022-12-24	WOS:000248624500034
J	Bautista, DM; Siemens, J; Glazer, JM; Tsuruda, PR; Basbaum, AI; Stucky, CL; Jordt, SE; Julius, D				Bautista, Diana M.; Siemens, Jan; Glazer, Joshua M.; Tsuruda, Pamela R.; Basbaum, Allan I.; Stucky, Cheryl L.; Jordt, Sven-Eric; Julius, David			The menthol receptor TRPM8 is the principal detector of environmental cold	NATURE			English	Article							PRIMARY SENSORY NEURONS; ION-CHANNEL TRPA1; MOLECULAR LOGIC; TRANSDUCTION; SKIN; THERMOSENSATION; TEMPERATURE; SENSATION; STIMULI; ANKTM1	Sensory nerve fibres can detect changes in temperature over a remarkably wide range, a process that has been proposed to involve direct activation of thermosensitive excitatory transient receptor potential (TRP) ion channels(1-4). One such channel TRP melastatin 8 (TRPM8) or cold and menthol receptor 1 (CMR1)-is activated by chemical cooling agents (such as menthol) or when ambient temperatures drop below similar to 26 degrees C, suggesting that it mediates the detection of cold thermal stimuli by primary afferent sensory neurons(5,6). However, some studies have questioned the contribution of TRPM8 to cold detection or proposed that other excitatory or inhibitory channels are more critical to this sensory modality in vivo(7-10). Here we show that cultured sensory neurons and intact sensory nerve fibres from TRPM8-deficient mice exhibit profoundly diminished responses to cold. These animals also show clear behavioural deficits in their ability to discriminate between cold and warm surfaces, or to respond to evaporative cooling. At the same time, TRPM8 mutant mice are not completely insensitive to cold as they avoid contact with surfaces below 10 degrees C, albeit with reduced efficiency. Thus, our findings demonstrate an essential and predominant role for TRPM8 in thermosensation over a wide range of cold temperatures, validating the hypothesis(2) that TRP channels are the principal sensors of thermal stimuli in the peripheral nervous system.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical College of Wisconsin; Yale University	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	cstucky@mcw.edu; sven.jordt@yale.edu; julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Siemens, Jan/0000-0001-9051-9217	NIEHS NIH HHS [R01 ES015056] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babes A, 2006, EUR J NEUROSCI, V24, P691, DOI 10.1111/j.1460-9568.2006.04941.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; DOERNER JF, 2007, J BIOL CHEM; FRUHSTORFER H, 1983, PAIN, V17, P235, DOI 10.1016/0304-3959(83)90096-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KREH A, 1984, EXP NEUROL, V85, P533, DOI 10.1016/0014-4886(84)90029-3; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Rainville P, 1999, EXP BRAIN RES, V125, P28, DOI 10.1007/s002210050654; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P8509; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	32	849	878	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					204	208		10.1038/nature05910	http://dx.doi.org/10.1038/nature05910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17538622				2022-12-24	WOS:000247934500045
J	Dietzl, G; Chen, D; Schnorrer, F; Su, KC; Barinova, Y; Fellner, M; Gasser, B; Kinsey, K; Oppel, S; Scheiblauer, S; Couto, A; Marra, V; Keleman, K; Dickson, BJ				Dietzl, Georg; Chen, Doris; Schnorrer, Frank; Su, Kuan-Chung; Barinova, Yulia; Fellner, Michaela; Gasser, Beate; Kinsey, Kaolin; Oppel, Silvia; Scheiblauer, Susanne; Couto, Africa; Marra, Vincent; Keleman, Krystyna; Dickson, Barry J.			A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila	NATURE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; INTERFERENCE; EXPRESSION; MELANOGASTER; IDENTIFICATION; INITIATION; PATHWAYS; SCREENS; VECTOR	Forward genetic screens in model organisms have provided important insights into numerous aspects of development, physiology and pathology. With the availability of complete genome sequences and the introduction of RNA-mediated gene interference (RNAi), systematic reverse genetic screens are now also possible. Until now, such genome-wide RNAi screens have mostly been restricted to cultured cells and ubiquitous gene inactivation in Caenorhabditis elegans. This powerful approach has not yet been applied in a tissue-specific manner. Here we report the generation and validation of a genome-wide library of Drosophila melanogaster RNAi transgenes, enabling the conditional inactivation of gene function in specific tissues of the intact organism. Our RNAi transgenes consist of short gene fragments cloned as inverted repeats and expressed using the binary GAL4/UAS system. We generated 22,270 transgenic lines, covering 88% of the predicted protein-coding genes in the Drosophila genome. Molecular and phenotypic assays indicate that the majority of these transgenes are functional. Our transgenic RNAi library thus opens up the prospect of systematically analysing gene functions in any tissue and at any stage of the Drosophila lifespan.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	dickson@imp.ac.at	Schnorrer, Frank/AIE-3578-2022; Dickson, Barry/AAE-7632-2019	Schnorrer, Frank/0000-0002-9518-7263; Dickson, Barry/0000-0003-0715-892X; Couto, Africa/0000-0002-3868-5637; Chen, Doris/0000-0001-8835-0280				Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Beall EL, 2002, GENETICS, V162, P217; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martinek S, 2000, GENETICS, V156, P1717; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rozen S, 2000, Methods Mol Biol, V132, P365; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; TOMANCAK P, 2002, GENOME BIOL, V3; Van Roessel P, 2002, GENESIS, V34, P170, DOI 10.1002/gene.10146; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	43	1903	1950	5	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					151	U1		10.1038/nature05954	http://dx.doi.org/10.1038/nature05954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625558				2022-12-24	WOS:000247934500033
J	Ruby, JG; Jan, CH; Bartel, DP				Ruby, J. Graham; Jan, Calvin H.; Bartel, David P.			Intronic microRNA precursors that bypass Drosha processing	NATURE			English	Article							GENOME; RNAS; MATURATION; SEQUENCE; GENE	MicroRNAs ( miRNAs) are similar to 22-nucleotide endogenous RNAs that often repress the expression of complementary messenger RNAs1. In animals, miRNAs derive from characteristic hairpins in primary transcripts through two sequential RNase III-mediated cleavages; Drosha cleaves near the base of the stem to liberate a similar to 60-nucleotide pre-miRNA hairpin, then Dicer cleaves near the loop to generate a miRNA: miRNA* duplex(2,3). From that duplex, the mature miRNA is incorporated into the silencing complex. Here we identify an alternative pathway for miRNA biogenesis, in which certain debranched introns mimic the structural features of pre-miRNAs to enter the miRNA-processing pathway without Drosha-mediated cleavage. We call these pre-miRNAs/introns 'mirtrons', and have identified 14 mirtrons in Drosophila melanogaster and another four in Caenorhabditis elegans ( including the reclassification of mir-62). Some of these have been selectively maintained during evolution with patterns of sequence conservation suggesting important regulatory functions in the animal. The abundance of introns comparable in size to pre-miRNAs appears to have created a context favourable for the emergence of mirtrons in flies and nematodes. This suggests that other lineages with many similarly sized introns probably also have mirtrons, and that the mirtron pathway could have provided an early avenue for the emergence of miRNAs before the advent of Drosha.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067031-04, R01 GM067031] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Han J, 2001, DRUG DELIV, V8, P125; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LEVERETTE RD, 1992, CELL, V71, P1215, DOI 10.1016/S0092-8674(05)80069-8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LO PCH, 1994, GENETICS, V138, P365; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; RUBY JG, IN PRESS GENOME RES; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015	30	1028	1124	1	86	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					83	86		10.1038/nature05983	http://dx.doi.org/10.1038/nature05983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17589500	Green Accepted			2022-12-24	WOS:000247720900042
J	Bilic, J; Huang, YL; Davidson, G; Zimmermann, T; Cruciat, CM; Bienz, M; Niehrs, C				Bilic, Josipa; Huang, Ya-Lin; Davidson, Gary; Zimmermann, Timo; Cruciat, Cristina-Maria; Bienz, Mariann; Niehrs, Christof			Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; SIGNALING PATHWAY; PLASMA-MEMBRANE; DIX DOMAIN; AXIN; POLARITY; ENCODES	Multiple signaling pathways, including Wnt signaling, participate in animal development, stem cell biology, and human cancer. Although many components of the Wnt pathway have been identified, unresolved questions remain as to the mechanism by which Wnt binding to its receptors Frizzled and Low-density lipoprotein receptor-related protein 6 (LRP6) triggers downstream signaling events. With live imaging of vertebrate cells, we show that Wnt treatment quickly induces plasma membrane-associated LRP6 aggregates. LRP6 aggregates are phosphorylated and can be detergent-solubilized as ribosome-sized multiprotein complexes. Phospho-LRP6 aggregates contain Wnt-pathway components but no common vesicular traffic markers except caveolin. The scaffold protein Dishevelled (Dvl) is required for LRP6 phosphorylation and aggregation. We propose that Wnts induce coclustering of receptors and Dvl in LRP6-signalosomes, which in turn triggers LRP6 phosphorylation to promote Axin recruitment and beta-catenin stabilization.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany; European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany; MRC, Mol Biol Lab, Cambridge C82 2QH, England	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.DE	Zimmermann, Timo/G-1681-2015; Davidson, Gary/J-6059-2013; Davidson, Gary/AAA-7321-2021	Zimmermann, Timo/0000-0001-7098-0700; Davidson, Gary/0000-0002-2264-5518; Huang, Ya-Lin/0000-0002-4965-7543; Bilic Zimmermann, Josipa/0000-0001-9642-6265	Medical Research Council [MC_U105184273, MC_U105192713] Funding Source: Medline; MRC [MC_U105184273] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Polakis P, 2000, GENE DEV, V14, P1837; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	27	653	676	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1619	1622		10.1126/science.1137065	http://dx.doi.org/10.1126/science.1137065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569865				2022-12-24	WOS:000247239900042
J	Imura, A; Tsuji, Y; Murata, M; Maeda, R; Kubota, K; Iwano, A; Obuse, C; Togashi, K; Tominaga, M; Kita, N; Tomiyama, K; Iijima, J; Nabeshima, Y; Fujioka, M; Asato, R; Tanaka, S; Kojima, K; Ito, J; Nozaki, K; Hashimoto, N; Ito, T; Nishio, T; Uchiyama, T; Fujimori, T; Nabeshima, YI				Imura, Akihiro; Tsuji, Yoshihito; Murata, Miyahiko; Maeda, Ryota; Kubota, Koji; Iwano, Akiko; Obuse, Chikashi; Togashi, Kazuya; Tominaga, Makoto; Kita, Naoko; Tomiyama, Ken-ichi; Iijima, Junko; Nabeshima, Yoko; Fujioka, Makio; Asato, Ryo; Tanaka, Shinzo; Kojima, Ken; Ito, Juichi; Nozaki, Kazuhiko; Hashimoto, Nobuo; Ito, Tetsufumi; Nishio, Takeshi; Uchiyama, Takashi; Fujimori, Toshihiko; Nabeshima, Yo-ichi			alpha-klotho as a regulator of calcium homeostasis	SCIENCE			English	Article							MICE; NA,K-ATPASE; GENE; EXPRESSION; CELLS; SUPPRESSION; ACTIVATION; NA,K-PUMP; RECEPTOR; PROTEIN	alpha-klotho was identified as a gene associated with premature aging-like phenotypes characterized by short lifespan. In mice, we found the molecular association of alpha-Klotho (alpha-Kl) and Na+, K+-adenosine triphosphatase (Na+, K+-ATPase) and provide evidence for an increase of abundance of Na+, K+-ATPase at the plasma membrane. Low concentrations of extracellular free calcium ([Ca2+](e)) rapidly induce regulated parathyroid hormone (PTH) secretion in an alpha-Kl- and Na+, K+-ATPase-dependent manner. The increased Na+ gradient created by Na+, K+-ATPase activity might drive the transepithelial transport of Ca2+ in cooperation with ion channels and transporters in the choroid plexus and the kidney. Our findings reveal fundamental roles of alpha-Kl in the regulation of calcium metabolism.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Electron Microscopy, Kyoto 6068501, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; Hokkaido Univ, Grad Sch Life Sci, Lab Funct Networks Chromosome Inheritance, Sapporo, Hokkaido 0010021, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Cell Signaling, Aichi 4448787, Japan; Univ Fukui, Fac Med Sci, Dept Anat, Fukui 9101193, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Fukui	Nabeshima, YI (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	nabemr@lmls.med.kyoto-u.ac.jp	伊藤, 哲史/D-4275-2016; Ito, Tetsufumi/M-2668-2019; Obuse, Chikashi/F-5273-2011; Fujimori, Toshihiko/L-7711-2016	伊藤, 哲史/0000-0003-4516-9283; Ito, Tetsufumi/0000-0003-4516-9283; Fujimori, Toshihiko/0000-0001-5200-4634; Maeda, Ryota/0000-0002-1514-1071				BILEZIKIAN JP, 2005, PARATHYROIDS BASIC C; BRINGHURST FR, 2003, WILLIAMS TXB ENDOCRI; BROWN EM, 1987, METABOLISM, V36, P36, DOI 10.1016/0026-0495(87)90060-6; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOOTMAN SR, 1988, METHOD ENZYMOL, V156, P213; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MURPHY VA, 1989, BRAIN RES, V484, P65, DOI 10.1016/0006-8993(89)90348-X; NABESHIMA Y, 2006, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.2006.8.PE11; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	27	317	337	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1615	1618		10.1126/science.1135901	http://dx.doi.org/10.1126/science.1135901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569864				2022-12-24	WOS:000247239900041
J	Zimmermann, K; Leffler, A; Babes, A; Cendan, CM; Carr, RW; Kobayashi, J; Nau, C; Wood, JN; Reeh, PW				Zimmermann, Katharina; Leffler, Andreas; Babes, Alexandru; Cendan, Cruz Miguel; Carr, Richard W.; Kobayashi, Jin-ichi; Nau, Carla; Wood, John N.; Reeh, Peter W.			Sensory neuron sodium channel Na(v)1.8 is essential for pain at low temperatures	NATURE			English	Article							MEMBRANE-PROPERTIES; NA+ CHANNELS; COLD; TRANSDUCTION; NERVE; POTENTIALS; DEPENDENCE; PATHWAYS; INVITRO; CELLS	Sensory acuity and motor dexterity deteriorate when human limbs cool down, but pain perception persists and cold-induced pain can become excruciating(1). Evolutionary pressure to enforce protective behaviour requires that damage-sensing neurons (nociceptors) continue to function at low temperatures. Here we show that this goal is achieved by endowing superficial endings of slowly conducting nociceptive fibres with the tetrodotoxin-resistant voltage-gated sodium channel (VGSC) Na(v)1.8 ( ref. 2). This channel is essential for sustained excitability of nociceptors when the skin is cooled. We show that cooling excitable membranes progressively enhances the voltage-dependent slow inactivation of tetrodotoxin-sensitive VGSCs. In contrast, the inactivation properties of Na(v)1.8 are entirely cold-resistant. Moreover, low temperatures decrease the activation threshold of the sodium currents and increase the membrane resistance, augmenting the voltage change caused by any membrane current. Thus, in the cold, Na(v)1.8 remains available as the sole electrical impulse generator in nociceptors that transmits nociceptive information to the central nervous system. Consistent with this concept is the observation that Na(v)1.8-null mutant mice(3) show negligible responses to noxious cold and mechanical stimulation at low temperatures. Our data present strong evidence for a specialized role of Na(v)1.8 in nociceptors as the critical molecule for the perception of cold pain and pain in the cold.	Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Fac Med, Dept Anesthesiol, D-91054 Erlangen, Germany; Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Bucharest 050095, Romania; UCL, Dept Biol, London WC1E 6BT, England; Kyushu Univ, Fac Dent Sci, Dept Fixed Prosthodont, Higashi Ku, Fukuoka 8128582, Japan	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bucharest; University of London; University College London; Kyushu University	Zimmermann, K (corresponding author), Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany.	zimmermann@physiologie1.uni-erlangen.de	Carr, Richard/AAE-9188-2020; Leffler, Andreas/K-1191-2012; Carr, Richard/GSD-4859-2022; Babes, Alexandru/ABB-9128-2021; Martínez, Cruz Miguel Cendán/ABH-1404-2020; Reeh, Peter W./J-8981-2012; Babes, Alexandru/A-6212-2010; Leffler, Andreas/C-6552-2009	Carr, Richard/0000-0001-8617-9133; Leffler, Andreas/0000-0003-1121-6387; Babes, Alexandru/0000-0002-7110-6908; Martínez, Cruz Miguel Cendán/0000-0001-5431-4513; Reeh, Peter W./0000-0002-4367-094X; Zimmermann, Katharina/0000-0003-2529-0692	Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Blair NT, 2002, J NEUROSCI, V22, P10277; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Goldin AL, 2002, J EXP BIOL, V205, P575; HODKIN AL, 1949, J PHYSIOL-LONDON, V109, P240; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Solomon S, 1999, P NATL ACAD SCI USA, V96, P13012, DOI 10.1073/pnas.96.23.13012; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; [No title captured]	30	300	309	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					855	858		10.1038/nature05880	http://dx.doi.org/10.1038/nature05880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568746				2022-12-24	WOS:000247207500044
J	Johnson, DS; Mortazavi, A; Myers, RM; Wold, B				Johnson, David S.; Mortazavi, Ali; Myers, Richard M.; Wold, Barbara			Genome-wide mapping of in vivo protein-DNA interactions	SCIENCE			English	Article							NEURON-RESTRICTIVE SILENCER; TRANSCRIPTION-FACTOR	In vivo protein-DNA interactions connect each transcription factor with its direct targets to form a gene network scaffold. To map these protein-DNA interactions comprehensively across entire mammalian genomes, we developed a large-scale chromatin immunoprecipitation assay ( ChIPSeq) based on direct ultrahigh-throughput DNA sequencing. This sequence census method was then used to map in vivo binding of the neuron-restrictive silencer factor ( NRSF; also known as REST, for repressor element-1 silencing transcription factor) to 1946 locations in the human genome. The data display sharp resolution of binding position [ +/- 50 base pairs ( bp)], which facilitated our finding motifs and allowed us to identify noncanonical NRSF-binding motifs. These ChIPSeq data also have high sensitivity and specificity [ ROC ( receiver operator characteristic) area >= 0.96] and statistical confidence ( P < 10(-4)), properties that were important for inferring new candidate interactions. These include key transcription factors in the gene network that regulates pancreatic islet cell development.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology; California Institute of Technology	Wold, B (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	myers@shgc.stanford.edu; woldb@its.caltech.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG003162] Funding Source: Medline; NIGMS NIH HHS [5T32GM07616] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	7	1842	1949	8	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1497	1502		10.1126/science.1141319	http://dx.doi.org/10.1126/science.1141319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17540862				2022-12-24	WOS:000247066400049
J	Wang, B; Matsuoka, S; Ballif, BA; Zhang, D; Smogorzewska, A; Gygi, SP; Elledge, SJ				Wang, Bin; Matsuoka, Shuhei; Ballif, Bryan A.; Zhang, Dong; Smogorzewska, Agata; Gygi, Steven P.; Elledge, Stephen J.			Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response	SCIENCE			English	Article							LIGASE ACTIVITY; F-BOX; PHOSPHORYLATION; REPAIR; HETERODIMER; PROTEOMICS; INTERACTS; DOMAINS; BREAKS; CTIP	The BRCT repeats of the breast and ovarian cancer predisposition protein BRCA1 are essential for tumor suppression. Phosphopeptide affinity proteomic analysis identified a protein, Abraxas, that directly binds the BRCA1 BRCT repeats through a phospho- Ser-X-X-Phe motif. Abraxas binds BRCA1 to the mutual exclusion of BACH1 (BRCA1-associated C-terminal helicase) and CtIP (CtBP-interacting protein), forming a third type of BRCA1 complex. Abraxas recruits the ubiquitin-interacting motif (UIM)-containing protein RAP80 to BRCA1. Both Abraxas and RAP80 were required for DNA damage resistance, G(2)- M checkpoint control, and DNA repair. RAP80 was required for optimal accumulation of BRCA1 on damaged DNA ( foci) in response to ionizing radiation, and the UIM domains alone were capable of foci formation. The RAP80-Abraxas complex may help recruit BRCA1 to DNA damage sites in part through recognition of ubiquitinated proteins.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Zhang, Dong/0000-0002-4515-2070; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [K01CA116275, T32CA009216] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [K01 CA116275, 1KO1, CA116275-01, T32CA09216, T32 CA009216] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMANCHY R, 2005, SCI STKE, pPL2, DOI DOI 10.1126/STKE.2672005PL2; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	29	550	580	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1194	1198		10.1126/science.1139476	http://dx.doi.org/10.1126/science.1139476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525340	Green Accepted			2022-12-24	WOS:000246724300044
J	Gray, RH; Makumbi, F; Serwadda, D; Lutalo, T; Nalugoda, F; Opendi, P; Kigozi, G; Reynolds, SJ; Sewankambo, NK; Wawer, MJ				Gray, Ronald H.; Makumbi, Fredrick; Serwadda, David; Lutalo, Tom; Nalugoda, Fred; Opendi, Pius; Kigozi, Godfrey; Reynolds, Steven J.; Sewankambo, Nelson K.; Wawer, Maria J.			Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the limitations of rapid tests for HIV-1. Design Diagnostic test accuracy study. Setting Rural Rakai, Uganda. Participants 1517 mates aged 15-49 screened for trials of circumcision for HIV prevention. Main outcome measures Sensitivity, specificity, negative predictive values, and positive predictive values of an algorithm using three rapid tests for HIV, compared with the results of enzyme immunoassay and western blotting as the optimal methods. Results Rapid test results were evaluated by enzyme immunoassay and western blotting. Sensitivity was 97.7%. Among 639 samples where the strength of positive bands was coded if the sample showed positivity for HIV, the algorithm had low specificity (94.1%) and a low positive predictive value (74.0%). Exclusion of 37 samples (5.8%) with a weak positive band improved the specificity (99.6%) and positive predictive value (97.7%.). Conclusion Weak positive bands on rapid tests for HIV should be confirmed by enzyme immunoassay and western blotting before disclosing the diagnosis. Programmes using rapid tests routinely should use standard serological assays for quality control.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Uganda Virus Res Inst, Rakai Hlth Sci Program, Entebbe, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; NIH, NIAID, Entebbe, Uganda; Makerere Univ, Sch Med, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University	Gray, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	rgray@jhsph.edu		Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, Z01AI001040] Funding Source: NIH RePORTER; FIC NIH HHS [2D43TW00001019-AITRP] Funding Source: Medline; NIAID NIH HHS [UO1 AI11171-01-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Downing RG, 1998, J ACQ IMMUN DEF SYND, V18, P384, DOI 10.1097/00042560-199808010-00011; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; McKenna SL, 1997, AIDS, V11, pS103; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	5	89	92	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					188	190		10.1136/bmj.39210.582801.BE	http://dx.doi.org/10.1136/bmj.39210.582801.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17545184	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000248662200029
J	Easton, DF; Pooley, KA; Dunning, AM; Pharoah, PDP; Thompson, D; Ballinger, DG; Struewing, JP; Morrison, J; Field, H; Luben, R; Wareham, N; Ahmed, S; Healey, CS; Bowman, R; Meyer, KB; Haiman, CA; Kolonel, LK; Henderson, BE; Le Marchand, L; Brennan, P; Sangrajrang, S; Gaborieau, V; Odefrey, F; Shen, CY; Wu, PE; Wang, HC; Eccles, D; Evans, DG; Peto, J; Fletcher, O; Johnson, N; Seal, S; Stratton, MR; Rahman, N; Chenevix-Trench, G; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Garcia-Closas, M; Brinton, L; Chanock, S; Lissowska, J; Peplonska, B; Nevanlinna, H; Fagerholm, R; Eerola, H; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Hunter, DJ; Hankinson, SE; Cox, DG; Hall, P; Wedren, S; Liu, JJ; Low, YL; Bogdanova, N; Schurmann, P; Dork, T; Tollenaar, RAEM; Jacobi, CE; Devilee, P; Klijn, JGM; Sigurdson, AJ; Doody, MM; Alexander, BH; Zhang, JH; Cox, A; Brock, IW; MacPherson, G; Reed, MWR; Couch, FJ; Goode, EL; Olson, JE; Meijers-Heijboer, H; van den Ouweland, A; Uitterlinden, A; Rivadeneira, F; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Hopper, JL; McCredie, M; Southey, M; Giles, GG; Schroen, C; Justenhoven, C; Brauch, H; Hamann, U; Ko, YD; Spurdle, AB; Beesley, J; Chen, XQ; Mannermaa, A; Kosma, VM; Kataja, V; Hartikainen, J; Day, NE; Cox, DR; Ponder, BAJ				Easton, Douglas F.; Pooley, Karen A.; Dunning, Alison M.; Pharoah, Paul D. P.; Thompson, Deborah; Ballinger, Dennis G.; Struewing, Jeffery P.; Morrison, Jonathan; Field, Helen; Luben, Robert; Wareham, Nicholas; Ahmed, Shahana; Healey, Catherine S.; Bowman, Richard; Meyer, Kerstin B.; Haiman, Christopher A.; Kolonel, Laurence K.; Henderson, Brian E.; Le Marchand, Loic; Brennan, Paul; Sangrajrang, Suleeporn; Gaborieau, Valerie; Odefrey, Fabrice; Shen, Chen-Yang; Wu, Pei-Ei; Wang, Hui-Chun; Eccles, Diana; Evans, D. Gareth; Peto, Julian; Fletcher, Olivia; Johnson, Nichola; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Chenevix-Trench, Georgia; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Garcia-Closas, Montserrat; Brinton, Louise; Chanock, Stephen; Lissowska, Jolanta; Peplonska, Beata; Nevanlinna, Heli; Fagerholm, Rainer; Eerola, Hannaleena; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Hunter, David J.; Hankinson, Susan E.; Cox, David G.; Hall, Per; Wedren, Sara; Liu, Jianjun; Low, Yen-Ling; Bogdanova, Natalia; Schuermann, Peter; Doerk, Thilo; Tollenaar, Rob A. E. M.; Jacobi, Catharina E.; Devilee, Peter; Klijn, Jan G. M.; Sigurdson, Alice J.; Doody, Michele M.; Alexander, Bruce H.; Zhang, Jinghui; Cox, Angela; Brock, Ian W.; MacPherson, Gordon; Reed, Malcolm W. R.; Couch, Fergus J.; Goode, Ellen L.; Olson, Janet E.; Meijers-Heijboer, Hanne; van den Ouweland, Ans; Uitterlinden, Andre; Rivadeneira, Fernando; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Hopper, John L.; McCredie, Margaret; Southey, Melissa; Giles, Graham G.; Schroen, Chris; Justenhoven, Christina; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Hartikainen, Jaana; Day, Nicholas E.; Cox, David R.; Ponder, Bruce A. J.		SEARCH Collaborators; kConFab; AOCS Management Grp	Genome-wide association study identifies novel breast cancer susceptibility loci	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-2; OVARIAN-CANCER; BRCA2 MUTATIONS; PROSTATE-CANCER; GENE; DISEASE; CHEK2-ASTERISK-1100DELC; POPULATIONS; PATTERNS; DATABASE	Breast cancer exhibits familial aggregation, consistent with variation in genetic susceptibility to the disease. Known susceptibility genes account for less than 25% of the familial risk of breast cancer, and the residual genetic variance is likely to be due to variants conferring more moderate risks. To identify further susceptibility alleles, we conducted a two-stage genome-wide association study in 4,398 breast cancer cases and 4,316 controls, followed by a third stage in which 30 single nucleotide polymorphisms (SNPs) were tested for confirmation in 21,860 cases and 22,578 controls from 22 studies. We used 227,876 SNPs that were estimated to correlate with 77% of known common SNPs in Europeans at r(2) > 0.5. SNPs in five novel independent loci exhibited strong and consistent evidence of association with breast cancer (P < 10(-7)). Four of these contain plausible causative genes (FGFR2, TNRC9, MAP3K1 and LSP1). At the second stage, 1,792 SNPs were significant at the P < 0.05 level compared with an estimated 1,343 that would be expected by chance, indicating that many additional common susceptibility alleles may be identifiable by this approach.	Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin 9001, New Zealand; Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; Spanish Natl Canc Ctr CNIO, E-28029 Madrid, Spain; Erasmus Univ, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; Mayo Clin, Coll Med, Rochester, MN 55905 USA; Univ Sheffield, Sch Med, Acad Unit Surg Oncol, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Univ Minnesota, Minneapolis, MN 55455 USA; NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA; Dr Daniel Den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; Hannover Med Sch, Dept Obstet & Gynecol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Genome Inst Singapore, Singapore 138672, Singapore; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Univ Ulsan, Coll Med, Ulsan 680749, South Korea; Natl Canc Ctr, Goyang 411769, South Korea; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki 00029, Finland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Ctr Canc, PL-02781 Warsaw, Poland; NCI, Ctr Adv Technol, Gaithersburg, MD 20877 USA; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Univ Copenhagen, Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Bispebjerg Univ Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Breakthrought Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; NCI, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69008 Lyon, France; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Univ Calif Los Angeles, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; MRC, Dunn Clin Nutr Ctr, Cambridge CB2 0XY, England; Univ Cambridge, Dept Publ Hlth & Primary Care, EPIC, Cambridge CB1 8RN, England; NCI, Lab Populat Genet, Bethesda, MD 20892 USA; Perlegen Sci Inc, Mountain View, CA 94043 USA; Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; Vaasa Cent Hosp, Dept Oncol, Vaasa 65130, Finland; Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70210 Kuopio, Finland; Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; Evangel Kliniken Bonn GGmbh, Johanniter Krankenhaus, D-53113 Bonn, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Tubingen, D-72074 Tubingen, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany	University of Cambridge; University of Cambridge; Cancer Council Victoria; University of Otago; University of Melbourne; Centro Nacional de Investigaciones Oncologicas (CNIO); Erasmus University Rotterdam; Mayo Clinic; University of Sheffield; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; Hannover Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Ulsan; National Cancer Center - Korea (NCC); Seoul National University (SNU); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; QIMR Berghofer Medical Research Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Academia Sinica - Taiwan; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Melbourne; Vaasa Central Hospital; Kuopio University Hospital; Kuopio University Hospital; University of Eastern Finland; Peter Maccallum Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England.	d.easton@srl.cam.ac.uk	Evans, D Gareth/AAB-4308-2022; Bogdanova, Natalia V./Y-2205-2019; DEVILEE, PETER/ABR-2140-2022; Amor, David J/A-6478-2018; Peplonska, Beata/AAO-1265-2020; Liu, Jianjun/AAK-4989-2020; Peplonska, Beata/F-6004-2010; Taylor, Donna B/I-5714-2015; Noh, Dong-Young/G-5531-2011; Gonzalez-Neira, Anna/C-5791-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Devilee, Peter/GXV-8005-2022; Dörk, Thilo/J-8620-2012; Struewing, Jeffery P/I-7502-2013; Wang, Hui-Chun/C-5680-2009; Yoo, Keun-Young/J-5548-2012; Bowtell, David/H-1007-2016; Zhang, Jing/GWZ-7332-2022; Brinton, Louise A/G-7486-2015; Rahman, Nazneen/B-8890-2012; Reed, Malcolm Walter/AAG-9219-2020; Ward, Robyn L/I-2313-2013; Spurdle, Amanda B/A-4978-2011; Rivadeneira, Fernando/O-5385-2015; Ribas-Despuig, Gloria/M-6190-2017; Luben, Robert N/H-5519-2015; Shen, CY/F-6271-2010; Pharoah, Paul/V-6658-2019; Kang, Dae Hee/E-8631-2012; Garcia-Closas, Montserrat/F-3871-2015; Osborne, Richard H/A-9447-2010; Cox, David/ABA-7454-2020; xin, xp/C-7350-2009; Eccles, Diana/K-6327-2019; DeFazio, Anna/O-2385-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Lissowska, Jolanta/AAH-3252-2020; Zhang, Jing/HII-4294-2022; Brennan, Meagan E/P-8274-2019; Cox, David G/A-2023-2009; Chenevix-Trench, Georgia/AAV-2014-2020; Hartikainen, Jaana M/E-6256-2015; Jenkins, Mark/P-7803-2015; Scott, Rodney/B-2827-2013; Saunders, Christobel/H-5779-2014; Webb, Penelope/D-5736-2013; Mann, Graham/G-4758-2014; Ribas, Gloria/K-3379-2013; Marsh, Deborah/I-1491-2014; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Amor, David J/0000-0001-7191-8511; Peplonska, Beata/0000-0003-3915-2872; Liu, Jianjun/0000-0002-3255-3019; Taylor, Donna B/0000-0002-1481-1141; Gonzalez-Neira, Anna/0000-0002-5421-2020; Dörk, Thilo/0000-0002-9458-0282; Struewing, Jeffery P/0000-0002-4848-3334; Bowtell, David/0000-0001-9089-7525; Brinton, Louise A/0000-0003-3853-8562; Reed, Malcolm Walter/0000-0001-7442-2132; Ward, Robyn L/0000-0002-6877-8906; Spurdle, Amanda B/0000-0003-1337-7897; Rivadeneira, Fernando/0000-0001-9435-9441; Luben, Robert N/0000-0002-5088-6343; Pharoah, Paul/0000-0001-8494-732X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Osborne, Richard H/0000-0002-9081-2699; Eccles, Diana/0000-0002-9935-3169; DeFazio, Anna/0000-0003-0057-4744; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lissowska, Jolanta/0000-0003-2695-5799; Brennan, Meagan E/0000-0002-3281-7643; Cox, David G/0000-0002-2152-9259; Chenevix-Trench, Georgia/0000-0002-1878-2587; Hartikainen, Jaana M/0000-0001-8267-1905; Kang, Daehee/0000-0003-4031-5878; Kataja, Vesa/0000-0003-4846-4843; Brown, Melissa/0000-0002-2830-9259; Dunning, Alison Margaret/0000-0001-6651-7166; Callen, David/0000-0002-6189-9991; Beesley, Jonathan/0000-0003-1942-325X; Shelling, Andrew/0000-0002-5300-1934; Jenkins, Mark/0000-0002-8964-6160; Nevanlinna, Heli/0000-0002-0916-2976; Richards, Robert Ian/0000-0002-5978-6453; Cox, Angela/0000-0002-5138-1099; Southey, Melissa/0000-0002-6313-9005; Kefford, Richard/0000-0001-9251-9229; Gaff, Clara/0000-0003-0160-4159; Scott, Rodney/0000-0001-7724-3404; Saunders, Christobel/0000-0003-2281-9829; Bennett, Ian/0000-0002-3634-9680; Bowman, Richard/0000-0002-6348-2241; Thorne, Heather/0000-0003-3610-2511; Webb, Penelope/0000-0003-0733-5930; Wang, Hui-Chun/0000-0003-1414-1595; Fletcher, Olivia/0000-0001-9387-7116; Giles, Graham/0000-0003-4946-9099; Phillips, Kelly-Anne/0000-0002-0475-1771; Brauch, Hiltrud/0000-0001-7531-2736; Cox, David/0000-0003-2047-4687; Mann, Graham/0000-0003-1301-405X; Edsall, Lee Elizabeth/0000-0002-0326-2829; Winship, Ingrid/0000-0001-8535-6003; Ribas, Gloria/0000-0001-6883-4130; Bowcock, Anne/0000-0001-8691-9090; Marsh, Deborah/0000-0001-5899-4931; Rahman, Nazneen/0000-0003-4376-0440; Lindeman, Geoffrey/0000-0001-9386-2416; Robinson, Bridget/0000-0001-9483-9146; Clarke, Christine/0000-0001-7568-111X	Cancer Research UK [A3353] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE, 2004NOV49] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADNANE J, 1991, ONCOGENE, V6, P659; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P688, DOI 10.1038/ng0507-688b; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Day N, 1999, BRIT J CANCER, V80, P95; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; EASTON DF, 1999, BREAST CANCER RES, V1, P1; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jang JH, 2001, CANCER RES, V61, P3541; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moffa AB, 2004, MOL CANCER RES, V2, P643; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	40	1768	1840	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1087	U7		10.1038/nature05887	http://dx.doi.org/10.1038/nature05887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17529967	Green Published, Green Accepted			2022-12-24	WOS:000247564600032
J	Pandey, UB; Nie, ZP; Batlevi, Y; McCray, BA; Ritson, GP; Nedelsky, NB; Schwartz, SL; DiProspero, NA; Knight, MA; Schuldiner, O; Padmanabhan, R; Hild, M; Berry, DL; Garza, D; Hubbert, CC; Yao, TP; Baehrecke, EH; Taylor, JP				Pandey, Udai Bhan; Nie, Zhiping; Batlevi, Yakup; McCray, Brett A.; Ritson, Gillian P.; Nedelsky, Natalia B.; Schwartz, Stephanie L.; DiProspero, Nicholas A.; Knight, Melanie A.; Schuldiner, Oren; Padmanabhan, Ranjani; Hild, Marc; Berry, Deborah L.; Garza, Dan; Hubbert, Charlotte C.; Yao, Tso-Pang; Baehrecke, Eric H.; Taylor, J. Paul			HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ANDROGEN RECEPTOR; PROTEIN; DISEASE; DEGRADATION; DROSOPHILA; ACETYLATION; INCLUSIONS; TOXICITY; PATHWAYS	A prominent feature of late-onset neurodegenerative diseases is accumulation of misfolded protein in vulnerable neurons(1). When levels of misfolded protein overwhelm degradative pathways, the result is cellular toxicity and neurodegeneration(2). Cellular mechanisms for degrading misfolded protein include the ubiquitin-proteasome system ( UPS), the main non-lysosomal degradative pathway for ubiquitinated proteins, and autophagy, a lysosome-mediated degradative pathway(3). The UPS and autophagy have long been viewed as complementary degradation systems with no point of intersection(4,5). This view has been challenged by two observations suggesting an apparent interaction: impairment of the UPS induces autophagy in vitro, and conditional knockout of autophagy in the mouse brain leads to neurodegeneration with ubiquitin-positive pathology(6-9). It is not known whether autophagy is strictly a parallel degradation system, or whether it is a compensatory degradation system when the UPS is impaired; furthermore, if there is a compensatory interaction between these systems, the molecular link is not known. Here we show that autophagy acts as a compensatory degradation system when the UPS is impaired in Drosophila melanogaster, and that histone deacetylase 6 (HDAC6), a microtubule-associated deacetylase that interacts with polyubiquitinated proteins(10), is an essential mechanistic link in this compensatory interaction. We found that compensatory autophagy was induced in response to mutations affecting the proteasome and in response to UPS impairment in a fly model of the neurodegenerative disease spinobulbar muscular atrophy. Autophagy compensated for impaired UPS function in an HDAC6-dependent manner. Furthermore, expression of HDAC6 was sufficient to rescue degeneration associated with UPS dysfunction in vivo in an autophagy-dependent manner. This study suggests that impairment of autophagy ( for example, associated with ageing or genetic variation) might predispose to neurodegeneration. Morover, these findings suggest that it may be possible to intervene in neurodegeneration by augmenting HDAC6 to enhance autophagy.	Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; NINDS, Neurogenet Branch, NIH, Bethesda, MD 20817 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Stanford University; Novartis; Duke University	Taylor, JP (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	jpt@mail.med.upenn.edu	Schuldiner, Oren/K-1353-2012; Taylor, J. Paul/N-2482-2018	Schuldiner, Oren/0000-0002-7350-9380; Taylor, J. Paul/0000-0002-5794-0349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003038, R01NS054022] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054022, R01 NS054022-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Neefjes J, 2004, NAT REV DRUG DISCOV, V3, P58, DOI 10.1038/nrd1282; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Smyth KA, 1999, GENETICS, V151, P211; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62	25	948	983	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					859	863		10.1038/nature05853	http://dx.doi.org/10.1038/nature05853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568747				2022-12-24	WOS:000247207500045
J	Reynwar, BJ; Illya, G; Harmandaris, VA; Muller, MM; Kremer, K; Deserno, M				Reynwar, Benedict J.; Illya, Gregoria; Harmandaris, Vagelis A.; Mueller, Martin M.; Kremer, Kurt; Deserno, Markus			Aggregation and vesiculation of membrane proteins by curvature-mediated interactions	NATURE			English	Article							ENDOPLASMIC-RETICULUM; DYNAMICS; BAR; ATTRACTION; INCLUSIONS; GEOMETRY; BILAYERS; SURFACE; COATS	Membrane remodelling(1-5) plays an important role in cellular tasks such as endocytosis, vesiculation and protein sorting, and in the biogenesis of organelles such as the endoplasmic reticulum or the Golgi apparatus. It is well established that the remodelling process is aided by specialized proteins that can sense(4) as well as create(6) membrane curvature, and trigger tubulation(7-9) when added to synthetic liposomes. Because the energy needed for such large-scale changes in membrane geometry significantly exceeds the binding energy between individual proteins and between protein and membrane, cooperative action is essential. It has recently been suggested(10,11) that curvature-mediated attractive interactions could aid cooperation and complement the effects of specific binding events on membrane remodelling. But it is difficult to experimentally isolate curvature-mediated interactions from direct attractions between proteins. Moreover, approximate theories predict repulsion between isotropically curving proteins(12-15). Here we use coarse-grained membrane simulations to show that curvature-inducing model proteins adsorbed on lipid bilayer membranes can experience attractive interactions that arise purely as a result of membrane curvature. We find that once a minimal local bending is realized, the effect robustly drives protein cluster formation and subsequent transformation into vesicles with radii that correlate with the local curvature imprint. Owing to its universal nature, curvature-mediated attraction can operate even between proteins lacking any specific interactions, such as newly synthesized and still immature membrane proteins in the endoplasmic reticulum.	Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Deserno, M (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	kremer@mpip-mainz.mpg.de; deserno@mpip-mainz.mpg.de	Müller, Martin Michael/B-3677-2009; Kremer, Kurt/G-5652-2011; Harmandaris, Vagelis/B-2958-2009; Deserno, Markus/P-1699-2014	Müller, Martin Michael/0000-0002-6062-8073; Kremer, Kurt/0000-0003-1842-9369; Harmandaris, Vagelis/0000-0002-9613-7639; Deserno, Markus/0000-0001-5692-1595				Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Bartolo D, 2003, EUR PHYS J E, V11, P141, DOI 10.1140/epje/i2002-10154-5; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Brannigan G, 2006, EUR BIOPHYS J BIOPHY, V35, P104, DOI 10.1007/s00249-005-0013-y; Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9; Cooke IR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011506; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fournier JB, 2003, CR BIOL, V326, P467, DOI 10.1016/S1631-0691(03)00096-9; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Goulding D, 1999, EUROPHYS LETT, V46, P407, DOI 10.1209/epl/i1999-00276-4; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Harmandaris VA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372761; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Koltover I, 1999, PHYS REV LETT, V82, P1991, DOI 10.1103/PhysRevLett.82.1991; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Muller M, 2006, PHYS REP, V434, P113, DOI 10.1016/j.physrep.2006.08.003; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Muller MM, 2005, EUROPHYS LETT, V69, P482, DOI 10.1209/epl/i2004-10368-1; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Venturoli M, 2006, PHYS REP, V437, P1, DOI 10.1016/j.physrep.2006.07.006; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	29	583	589	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					461	464		10.1038/nature05840	http://dx.doi.org/10.1038/nature05840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522680				2022-12-24	WOS:000246693100044
J	Barski, A; Cuddapah, S; Cui, KR; Roh, TY; Schones, DE; Wang, ZB; Wei, G; Chepelev, I; Zhao, KJ				Barski, Artern; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Schones, Dustin E.; Wang, Zhibin; Wei, Gang; Chepelev, Iouri; Zhao, Keji			High-resolution profiling of histone methylations in the human genome	CELL			English	Article							EMBRYONIC STEM-CELLS; ACTIVE GENES; T-CELLS; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN CHROMATIN; CODING REGIONS; WIDE; H2A.Z; H3	Histone modifications are implicated in influencing gene expression. We have generated high-resolution maps for the genome-wide distribution of 20 histone lysine and arginine methylations as well as histone variant H2A.Z, RNA polymerase II, and the insulator binding protein CTCF across the human genome using the Solexa 1G sequencing technology. Typical patterns of histone methylations exhibited at promoters, insulators, enhancers, and transcribed regions are identified. The monomethylations of H3K27, H3K9, H4K20, H3K79, and H2BK5 are all linked to gene activation, whereas trimethylations of H3K27, H3K9, and H3K79 are linked to repression. H2A.Z associates with functional regulatory elements, and CTCF marks boundaries of histone methylation domains. Chromosome banding patterns are correlated with unique patterns of histone modifications. Chromosome breakpoints detected in T cell cancers frequently reside in chromatin regions associated with H3K4 methylations. Our data provide new insights into the function of histone methylation and chromatin organization in genome function.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Gonda Neurosci & Genet Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Cuddapah, Suresh/AAU-4288-2021; Wei, Gang/A-3291-2011	Cuddapah, Suresh/0000-0002-4556-2029; Barski, Artem/0000-0002-1861-5316; Roh, Tae-Young/0000-0001-5833-0844; Chepelev, Iouri/0000-0002-2121-8805	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005801, ZIAHL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abeysinghe SS, 2004, HUM MUTAT, V23, P219, DOI 10.1002/humu.20006; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; KENT TH, 2007, CELL, V128, P1231; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang JX, 2006, BIOINFORMATICS, V22, P385, DOI 10.1093/bioinformatics/bti796; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	54	4778	4958	15	588	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					823	837		10.1016/j.cell.2007.05.009	http://dx.doi.org/10.1016/j.cell.2007.05.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512414	Bronze			2022-12-24	WOS:000246788300025
J	Benitez-Nelson, CR; Bidigare, RR; Dickey, TD; Landry, MR; Leonard, CL; Brown, SL; Nencioli, F; Rii, YM; Maiti, K; Becker, JW; Bibby, TS; Black, W; Cai, WJ; Carlson, CA; Chen, FZ; Kuwahara, VS; Mahaffey, C; McAndrew, PM; Quay, PD; Rappe, MS; Selph, KE; Simmons, MP; Yang, EJ				Benitez-Nelson, Claudia R.; Bidigare, Robert R.; Dickey, Tommy D.; Landry, Michael R.; Leonard, Carrie L.; Brown, Susan L.; Nencioli, Francesco; Rii, Yoshimi M.; Maiti, Kanchan; Becker, Jamie W.; Bibby, Thomas S.; Black, Wil; Cai, Wei-Jun; Carlson, Craig A.; Chen, Feizhou; Kuwahara, Victor S.; Mahaffey, Claire; McAndrew, Patricia M.; Quay, Paul D.; Rappe, Michael S.; Selph, Karen E.; Simmons, Melinda P.; Yang, Eun Jin			Mesoscale eddies drive increased silica export in the subtropical Pacific Ocean	SCIENCE			English	Article							ORGANIC-CARBON FLUX; COMMUNITY STRUCTURE; IRON FERTILIZATION; CYCLONIC EDDY; SARGASSO SEA; WATERS; GYRE; GROWTH	Mesoscale eddies may play a critical role in ocean biogeochemistry by increasing nutrient supply, primary production, and efficiency of the biological pump, that is, the ratio of carbon export to primary production in otherwise nutrient-deficient waters. We examined a diatom bloom within a cold-core cyclonic eddy off Hawaii. Eddy primary production, community biomass, and size composition were markedly enhanced but had little effect on the carbon export ratio. Instead, the system functioned as a selective silica pump. Strong trophic coupling and inefficient organic export may be general characteristics of community perturbation responses in the warm waters of the Pacific Ocean.	Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA; Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Santa Barbara, Ocean Phys Lab, Goleta, CA 93117 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; BAE Syst, Honolulu, HI 96813 USA; Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Soka Univ, Fac Educ, Tokyo 1928577, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; Korea Ocean Res & Dev Inst, MArine Environm Res Dept, Seoul 425600, South Korea	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; Scripps Institution of Oceanography; Bae Systems; University of Hawaii System; NERC National Oceanography Centre; University of Southampton; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University of California System; University of California Santa Barbara; Soka University; University of Washington; University of Washington Seattle; Korea Institute of Ocean Science & Technology (KIOST)	Benitez-Nelson, CR (corresponding author), Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA.	cbnelson@geol.sc.edu	Bibby, Thomas/C-9159-2014; Landry, Michael/HGF-1043-2022; Rii, Yoshimi/HGD-6422-2022; Maiti, Kanchan/E-1936-2013; Cai, Wei-Jun/C-1361-2013	Cai, Wei-Jun/0000-0003-3606-8325; Yang, Eun Jin/0000-0002-8639-5968; Nencioli, Francesco/0000-0001-6107-2479; Selph, Karen/0000-0001-7281-4706; Becker, Jamie/0000-0001-5308-1818; Bibby, Thomas/0000-0003-1743-473X; Becker, Jamie/0000-0003-4564-3192; Kuwahara, Victor S./0000-0003-4171-3894; Benitez-Nelson, Claudia/0000-0002-1004-5048				Benitez-Nelson C, 2001, DEEP-SEA RES PT I, V48, P2595, DOI 10.1016/S0967-0637(01)00032-2; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; Chavanne C, 2002, CAN J REMOTE SENS, V28, P466, DOI 10.5589/m02-047; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; JURANEK IW, 2005, GLOBAL BIOGEOCHEM CY, V19; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MOREL A, 1988, J GEOPHYS RES-OCEANS, V93, P10749, DOI 10.1029/JC093iC09p10749; Nelson DM, 1997, LIMNOL OCEANOGR, V42, P473, DOI 10.4319/lo.1997.42.3.0473; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; Patzert W. C, 1969, HIG698 U HAW; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Reichenbach H., 1992, PROKARYOTES, P3631; SAKAMOTO C, 2004, J GEOPHYS RES, V109; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Seki MP, 2001, GEOPHYS RES LETT, V28, P1583, DOI 10.1029/2000GL012439; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1	27	201	210	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1017	1021		10.1126/science.1136221	http://dx.doi.org/10.1126/science.1136221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510362				2022-12-24	WOS:000246554000044
J	Nurieva, R; Yang, XXO; Martinez, G; Zhang, YL; Panopoulos, AD; Ma, L; Schluns, K; Tian, Q; Watowich, SS; Jetten, AM; Dong, C				Nurieva, Roza; Yang, Xuexian O.; Martinez, Gustavo; Zhang, Yongliang; Panopoulos, Athanasia D.; Ma, Li; Schluns, Kimberly; Tian, Qiang; Watowich, Stephanie S.; Jetten, Anton M.; Dong, Chen			Essential autocrine regulation by IL-21 in the generation of inflammatory T cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AUTOIMMUNE INFLAMMATION; ROR-GAMMA; TH1 CELLS; DIFFERENTIATION; CYTOKINE; EXPRESSION; LINEAGE; T(H)17; ENCEPHALOMYELITIS	After activation, CD4(+) helper T (T-H) cells differentiate into distinct effector subsets that are characterized by their unique cytokine expression and immunoregulatory function(1,2). During this differentiation, T(H)1 and T(H)2 cells produce interferon-gamma and interleukin (IL)-4, respectively, as autocrine factors necessary for selective lineage commitment. A distinct T-H subset, termed THIL-17, T(H)17 or inflammatory T-H (T(H)i), has been recently identified as a distinct T-H lineage mediating tissue inflammation(3,4). T(H)17 differentiation is initiated by transforming growth factor-beta and IL-6 (refs 5 - 7) and reinforced by IL-23 ( ref. 8), in which signal transduction and activators of transcription ( STAT) 3 and retinoic acid receptor-related orphan receptor (ROR)-gamma mediate the lineage specification(8-10). T(H)17 cells produce IL-17, IL-17F and IL-22, all of which regulate inflammatory responses by tissue cells but have no importance in T(H)17 differentiation(11-14). Here we show that IL-21 is another cytokine highly expressed by mouse T(H)17 cells. IL-21 is induced by IL-6 in activated T cells, a process that is dependent on STAT3 but not ROR-gamma. IL-21 potently induces T(H)17 differentiation and suppresses Foxp3 expression, which requires STAT3 and ROR-gamma, which is encoded by Rorc. IL-21 deficiency impairs the generation of T(H)17 cells and results in protection against experimental autoimmune encephalomyelitis. IL-21 is therefore an autocrine cytokine that is sufficient and necessary for T(H)17 differentiation, and serves as a target for treating inflammatory diseases.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Inst Syst Engn, Seattle, WA 98103 USA; NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Nurieva, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	dong, chen/B-3181-2009; Yang, Xuexian/Y-2472-2019; Jetten, Anton/C-3736-2019	dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Jetten, Anton/0000-0003-0954-4445; Panopoulos, Athanasia/0000-0002-9610-2604; Watowich, Stephanie/0000-0003-1969-659X; Martinez, Gustavo/0000-0003-0178-3329	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, Z01ES101586] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; ANGKASEKWINAI P, IN PRESS J EXP MED; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Glimcher LH, 2000, GENE DEV, V14, P1693; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laky K, 1997, J IMMUNOL, V158, P1417; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 2000, J NEUROIMMUNOL, V105, P120, DOI 10.1016/S0165-5728(00)00192-2; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	28	1170	1269	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					480	U8		10.1038/nature05969	http://dx.doi.org/10.1038/nature05969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17581589				2022-12-24	WOS:000248302700048
J	Maron, BJ; Spirito, P; Shen, WK; Haas, TS; Formisano, F; Link, MS; Epstein, AE; Almquist, AK; Daubert, JP; Lawrenz, T; Boriani, G; Estes, NAM; Favale, S; Piccininno, M; Winters, SL; Santini, M; Betocchi, S; Arribas, F; Sherrid, MV; Buja, G; Semsarian, C; Bruzzi, P				Maron, Barry J.; Spirito, Paolo; Shen, Win-Kuang; Haas, Tammy S.; Formisano, Francesco; Link, Mark S.; Epstein, Andrew E.; Almquist, Adrian K.; Daubert, James P.; Lawrenz, Thorsten; Boriani, Giuseppe; Estes, N. A. Mark, III; Favale, Stefano; Piccininno, Marco; Winters, Stephen L.; Santini, Massimo; Betocchi, Sandro; Arribas, Fernando; Sherrid, Mark V.; Buja, Gianfranco; Semsarian, Christopher; Bruzzi, Paolo			Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL PROFILE; ABLATION; THERAPY; HEART; RISK	Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness and appropriate selection of patients for this therapy is incompletely resolved. Objective To study the relationship between clinical risk profile and incidence and efficacy of ICD intervention in HCM. Design, Setting, and Patients Multicenter registry study of ICDs implanted between 1986 and 2003 in 506 unrelated patients with HCM. Patients were judged to be at high risk for sudden death; had received ICDs; underwent evaluation at 42 referral and nonreferral institutions in the United States, Europe, and Australia; and had a mean follow-up of 3.7 (SD, 2.8) years. Measured risk factors for sudden death included family history of sudden death, massive left ventricular hypertrophy, nonsustained ventricular tachycardia on Holter monitoring, and unexplained prior syncope. Main Outcome Measure Appropriate ICD intervention terminating ventricular tachycardia or fibrillation. Results The 506 patients were predominately young ( mean age, 42 [ SD, 17] years) at implantation, and most ( 439 [87%]) had no or only mildly limiting symptoms. ICD interventions appropriately terminated ventricular tachycardia/fibrillation in 103 patients (20%). Intervention rates were 10.6% per year for secondary prevention after cardiac arrest (5-year cumulative probability, 39% [ SD, 5%]), and 3.6% per year for primary prevention (5-year probability, 17% [ SD, 2%]). Time to first appropriate discharge was up to 10 years, with a 27% ( SD, 7%) probability 5 years or more after implantation. For primary prevention, 18 of the 51 patients with appropriate ICD interventions (35%) had undergone implantation for only a single risk factor; likelihood of appropriate discharge was similar in patients with 1, 2, or 3 or more risk markers (3.83, 2.65, and 4.82 per 100 person-years, respectively; P=.77). The single sudden death due to an arrhythmia ( in the absence of advanced heart failure) resulted from ICD malfunction. ICD complications included inappropriate shocks in 136 patients ( 27%). Conclusions In a high-risk HCM cohort, ICD interventions for life-threatening ventricular tachyarrhythmias were frequent and highly effective in restoring normal rhythm. An important proportion of ICD discharges occurred in primary prevention patients who had undergone implantation for a single risk factor. Therefore, a single marker of high risk for sudden death may be sufficient to justify consideration for prophylactic defibrillator implantation in selected patients with HCM.	Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; Ente Osped Osped Galliera, Genoa, Italy; Mayo Clin, Rochester, MN USA; Tufts Univ New England Med Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Rochester, Med Ctr, Rochester, MN USA; Univ Munster, Acad Teaching Hosp, Bielefeld, Germany; Univ Bologna, Bologna, Italy; Univ Bari, Bari, Italy; Morristown Mem Hosp, Morristown, NJ USA; Osped S Filippo Neri, Rome, Italy; Univ Naples Federico II, Naples, Italy; Hosp 12 Octubre, E-28041 Madrid, Spain; St Lukes Roosevelt Hosp, New York, NY USA; Univ Padua, Padua, Italy; Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; Centenary Inst, Sydney, NSW, Australia; Ist Nazl Ric Canc, I-16132 Genoa, Italy	Minneapolis Heart Institute Foundation; Ente Ospedaliero Ospedali Galliera; Mayo Clinic; Tufts Medical Center; Tufts University; University of Alabama System; University of Alabama Birmingham; University of Rochester; University of Munster; University of Bologna; Universita degli Studi di Bari Aldo Moro; Atlantic Health System; San Filippo Neri Hospital; University of Naples Federico II; Hospital Universitario 12 de Octubre; Mount Sinai St. Luke's; Mount Sinai West; University of Padua; University of Sydney; University of Sydney; Centenary Institute; University of Genoa; IRCCS AOU San Martino IST	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org	Boriani, Giuseppe/A-4852-2015; Bruzzi, Paolo/AAU-3363-2021; Boriani, Giuseppe/AAC-3406-2022; Betocchi, Sandro/N-9647-2013; Arribas, Fernando/Q-9536-2017; Daubert, James P./ABC-1476-2021	Boriani, Giuseppe/0000-0002-9820-4815; Boriani, Giuseppe/0000-0002-9820-4815; Arribas, Fernando/0000-0002-2574-7923; Bruzzi, Paolo/0000-0002-7874-2077; Betocchi, Sandro/0000-0002-8701-2463; Sherrid, Mark/0000-0003-4972-7780				Almquist AK, 2005, HEART RHYTHM, V2, P814, DOI 10.1016/j.hrthm.2005.05.008; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Boriani G, 2004, CIRCULATION, V110, pE438, DOI 10.1161/01.CIR.0000144463.65977.C9; BRAUNWALD E, 1964, CIRCULATION, V30, P1; Corrado D, 2003, CIRCULATION, V108, P3084, DOI 10.1161/01.CIR.0000103130.33451.D2; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Goldenberg I, 2005, ANN NONINVAS ELECTRO, V10, P67, DOI 10.1111/j.1542-474X.2005.00070.x; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Jayatilleke I, 2004, AM J CARDIOL, V93, P1192, DOI 10.1016/j.amjcard.2004.01.057; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Marin F, 2006, REV ESP CARDIOL, V59, P537, DOI 10.1016/S1885-5857(07)60004-8; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Maron BJ, 2003, CIRCULATION, V107, P2872, DOI 10.1161/01.CIR.0000072343.81530.75; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Primo J, 1998, J AM COLL CARDIOL, V31, P1081, DOI 10.1016/S0735-1097(98)00037-0; Seggewiss H, 2000, EUR HEART J, V21, P704, DOI 10.1053/euhj.1999.2019; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Steinbrook R, 2005, NEW ENGL J MED, V353, P221, DOI 10.1056/NEJMp058158; TEARE D, 1958, BRIT HEART J, V20, P1; Valeti US, 2007, J AM COLL CARDIOL, V49, P350, DOI 10.1016/j.jacc.2006.08.055; WOO A, IN PRESS HEART	35	542	568	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2007	298	4					405	412		10.1001/jama.298.4.405	http://dx.doi.org/10.1001/jama.298.4.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193JA	17652294	Bronze			2022-12-24	WOS:000248269100019
J	McHugh, TJ; Jones, MW; Quinn, JJ; Balthasar, N; Coppari, R; Elmquist, JK; Lowell, BB; Fanselow, MS; Wilson, MA; Tonegawa, S				McHugh, Thomas J.; Jones, Matthew W.; Quinn, Jennifer J.; Balthasar, Nina; Coppari, Roberto; Elmquist, Joel K.; Lowell, Bradford B.; Fanselow, Michael S.; Wilson, Matthew A.; Tonegawa, Susumu			Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network	SCIENCE			English	Article							SPATIAL EXPERIENCE; NEURONAL ENSEMBLES; EPISODIC MEMORY; KNOCKOUT MICE; PLACE CELLS; CA3; REPRESENTATION; RAT; SLEEP; PLASTICITY	Forming distinct representations of multiple contexts, places, and episodes is a crucial function of the hippocampus. The dentate gyrus subregion has been suggested to fulfill this role. We have tested this hypothesis by generating and analyzing a mouse strain that lacks the gene encoding the essential subunit of the N-methyl-D-aspartate (NMDA) receptor NR1, specifically in dentate gyrus granule cells. The mutant mice performed normally in contextual fear conditioning, but were impaired in the ability to distinguish two similar contexts. A significant reduction in the context-specific modulation of firing rate was observed in the CA3 pyramidal cells when the mutant mice were transferred from one context to another. These results provide evidence that NMDA receptors in the granule cells of the dentate gyrus play a crucial role in the process of pattern separation.	MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas/M-6159-2019; McHugh, Thomas J/A-6693-2010; Coppari, Roberto/B-4799-2014	McHugh, Thomas/0000-0002-1243-5189; McHugh, Thomas J/0000-0002-1243-5189; Jones, Matthew/0000-0001-5396-3108; COPPARI, Roberto/0000-0003-1288-6948	MRC [G0501146] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH062122] Funding Source: NIH RePORTER; Medical Research Council [G0501146] Funding Source: Medline; NIMH NIH HHS [MH62122, P50-MH58880] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; FANSELOW MS, 1981, LEARN MOTIV, V12, P398, DOI 10.1016/0023-9690(81)90002-3; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilbert PE, 2006, BEHAV BRAIN RES, V169, P142, DOI 10.1016/j.bbr.2006.01.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Leutgeb S, 2006, HIPPOCAMPUS, V16, P765, DOI 10.1002/hipo.20201; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; McNaughton BL, 1990, NEUROSCIENCE CONNECT, P1; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rondi-Reig L, 2001, P NATL ACAD SCI USA, V98, P3543, DOI 10.1073/pnas.041620798; SCOVILLE W, 1957, J NEUROPSYCHIATRY CL, V12, P103; Shen JM, 1998, J SLEEP RES, V7, P6, DOI 10.1046/j.1365-2869.7.s1.2.x; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	35	662	677	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					94	99		10.1126/science.1140263	http://dx.doi.org/10.1126/science.1140263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17556551				2022-12-24	WOS:000247776700057
J	Pursell, ZF; Isoz, I; Lundstrom, EB; Johansson, E; Kunkel, TA				Pursell, Zachary F.; Isoz, Isabelle; Lundstroem, Else-Britt; Johansson, Erik; Kunkel, Thomas A.			Yeast DNA polymerase epsilon participates in leading-strand DNA replication	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; S-PHASE; POL EPSILON; CHECKPOINT; REPAIR; ERRORS; FORK	Multiple DNA polymerases participate in replicating the leading and lagging strands of the eukaryotic nuclear genome. Although 50 years have passed since the first DNA polymerase was discovered, the identity of the major polymerase used for leading-strand replication is uncertain. We constructed a derivative of yeast DNA polymerase e that retains high replication activity but has strongly reduced replication fidelity, particularly for thymine-deoxythymidine 5'-monophosphate (T-dTMP) but not adenine-deoxyadenosine 5'-monophosphate (A-dAMP) mismatches. Yeast strains with this DNA polymerase e allele have elevated rates of T to A substitution mutations. The position and rate of these substitutions depend on the orientation of the mutational reporter and its location relative to origins of DNA replication and reveal a pattern indicating that DNA polymerase e participates in leading-strand DNA replication.	NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Umea University	Kunkel, TA (corresponding author), NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Johansson, Erik/0000-0002-8526-6224	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES065070-17] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Dua R, 2000, J BIOL CHEM, V275, P28816, DOI 10.1074/jbc.M002376200; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shcherbakova PV, 1996, GENETICS, V142, P717; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177	14	399	410	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					127	130		10.1126/science.1144067	http://dx.doi.org/10.1126/science.1144067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615360	Green Accepted			2022-12-24	WOS:000247776700068
J	Makary, MA; Al-Attar, A; Holzmueller, CG; Sexton, JB; Syin, D; Gilson, MM; Sulkowski, MS; Pronovost, PJ				Makary, Martin A.; Al-Attar, Ali; Holzmueller, Christine G.; Sexton, J. Bryan; Syin, Dora; Gilson, Marta M.; Sulkowski, Mark S.; Pronovost, Peter J.			Needlestick injuries among surgeons in training	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE WORKERS; POSTTRAUMATIC-STRESS-DISORDER; HUMAN-IMMUNODEFICIENCY-VIRUS; OCCUPATIONAL EXPOSURES; PERCUTANEOUS INJURY; SHARPS INJURIES; HIV; BLOOD; PREVALENCE; URBAN	BACKGROUND: Surgeons in training are at high risk for needlestick injuries. The reporting of such injuries is a critical step in initiating early prophylaxis or treatment. METHODS: We surveyed surgeons in training at 17 medical centers about previous needlestick injuries. Survey items inquired about whether the most recent injury was reported to an employee health service or involved a ``high-risk'' patient (i.e., one with a history of infection with human immunodeficiency virus, hepatitis B or hepatitis C, or injection-drug use); we also asked about the perceived cause of the injury and the surrounding circumstances. RESULTS: The overall response rate was 95%. Of 699 respondents, 582 (83%) had had a needlestick injury during training; the mean number of needlestick injuries during residency increased according to the postgraduate year (PGY): PGY-1, 1.5 injuries; PGY-2, 3.7; PGY-3, 4.1; PGY-4, 5.3; and PGY-5, 7.7. By their final year of training, 99% of residents had had a needlestick injury; for 53%, the injury had involved a high-risk patient. Of the most recent injuries, 297 of 578 (51%) were not reported to an employee health service, and 15 of 91 of those involving high-risk patients (16%) were not reported. Lack of time was the most common reason given for not reporting such injuries among 126 of 297 respondents (42%). If someone other than the respondent knew about an unreported injury, that person was most frequently the attending physician (51%) and least frequently a ``significant other'' (13%). CONCLUSIONS: Needlestick injuries are common among surgeons in training and are often not reported. Improved prevention and reporting strategies are needed to increase occupational safety for surgical providers.	Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Ctr Outcomes Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Georgetown Univ, Sch Med, Dept Plast Surg, Washington, DC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Makary, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, 1909 Thames St,2nd Fl, Baltimore, MD 21231 USA.	mmakary1@jhmi.edu						Babcock HM, 2003, INFECT CONT HOSP EP, V24, P731, DOI 10.1086/502121; Bakaeen Faisal, 2006, Am J Surg, V192, pe18, DOI 10.1016/j.amjsurg.2006.08.013; Berguer R, 2005, SURG CLIN N AM, V85, P1299, DOI 10.1016/j.suc.2005.09.012; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; *CDC, 2001, MMWR RECOMM REP, V50, P47; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P25; Do AN, 2003, INFECT CONT HOSP EP, V24, P86, DOI 10.1086/502178; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; GERBERDING JL, 1990, NEW ENGL J MED, V322, P1788, DOI 10.1056/NEJM199006213222506; HEALD AE, 1990, J GEN INTERN MED, V5, P389, DOI 10.1007/BF02599422; Howsepian AA, 1998, GEN HOSP PSYCHIAT, V20, P123; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jagger J, 1998, AORN J, V67, P979, DOI 10.1016/S0001-2092(06)62623-9; JAGGER J, 1995, ADV EXPOSURE PREV, V1, P1; Jagger J, 1998, ADV EXPOSURE PREVENT, V3, P1; Jagger J, 1998, AORN J, V67, P983; Jagger J, 1998, AORN J, V67, P986; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Makary MA, 2006, WORLD J SURG, V30, P1224, DOI 10.1007/s00268-005-0605-9; Makary MA, 2006, JT COMM J QUAL PATIE, V32, P351, DOI 10.1016/S1553-7250(06)32045-4; Mingoli A, 1999, ANN SURG, V230, P737, DOI 10.1097/00000658-199911000-00022; *NIOSH, 1999, PUBL NIOSH; ONEILL TM, 1992, ARCH INTERN MED, V152, P1451, DOI 10.1001/archinte.152.7.1451; Osborn EHS, 1999, ANN INTERN MED, V130, P45, DOI 10.7326/0003-4819-130-1-199901050-00009; Patterson JMM, 1998, ANN SURG, V228, P266, DOI 10.1097/00000658-199808000-00017; PERRY J, 2005, ADV EXPOSURE PREV, V7, P42; Perry Jane, 2002, Bull Am Coll Surg, V87, P8; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; QUEBBEMAN EJ, 1992, ARCH SURG-CHICAGO, V127, P213; Shiao JSC, 1999, AM J INFECT CONTROL, V27, P254, DOI 10.1053/ic.1999.v27.a97006; Sohn JW, 2006, J OCCUP HEALTH, V48, P474, DOI 10.1539/joh.48.474; Stringer B, 2002, OCCUP ENVIRON MED, V59, P703, DOI 10.1136/oem.59.10.703; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V287, P2406, DOI 10.1001/jama.287.18.2406; TANNER J, 2002, COCHRANE DB SYST REV, V3; Tereskerz PM, 1997, AM J PUBLIC HEALTH, V87, P1558, DOI 10.2105/AJPH.87.9.1558; TOKARS JI, 1992, JAMA-J AM MED ASSOC, V267, P2899, DOI 10.1001/jama.267.21.2899; Weiss ES, 2007, AM J SURG, V193, P55, DOI 10.1016/j.amjsurg.2006.07.008; Weiss ES, 2005, ANN SURG, V241, P803, DOI 10.1097/01.sla.0000161174.71460.1f; Worthington MG, 2006, INFECT CONT HOSP EP, V27, P215, DOI 10.1086/501155	39	195	206	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2007	356	26					2693	2699		10.1056/NEJMoa070378	http://dx.doi.org/10.1056/NEJMoa070378			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183HS	17596603				2022-12-24	WOS:000247564500006
J	Vartiainen, MK; Guettler, S; Larijani, B; Treisman, R				Vartiainen, Maria K.; Guettler, Sebastian; Larijani, Banafshe; Treisman, Richard			Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL	SCIENCE			English	Article							SERUM RESPONSE FACTOR; MUTANT ACTINS; COACTIVATOR; TRANSCRIPTION; GROWTH; CELLS	Actin, which is best known as a cytoskeletal component, also participates in the control of gene expression. We report a function of nuclear actin in the regulation of MAL, a coactivator of the transcription factor serum response factor (SRF). MAL, which binds monomeric actin, is cytoplasmic in many cells but accumulates in the nucleus upon serum-induced actin polymerization. MAL rapidly shuttles between cytoplasm and nucleus in unstimulated cells. Serum stimulation effectively blocks MAL nuclear export, which requires MAL-actin interaction. Nuclear MAL binds SRF target genes but remains inactive unless actin binding is disrupted. Fluorescence resonance energy transfer analysis demonstrates that the MAL-actin interaction responds to extracellular signals. Serum-induced signaling is thus communicated to nuclear actin to control a transcriptional regulator.	Canc Res UK, London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; Canc Res UK, London Res Inst, Cell Biophys Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Treisman, R (corresponding author), Canc Res UK, London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Richard.Treisman@cancer.org.uk	Vartiainen, Maria/P-7043-2019; Larijani, Banafshe/H-3909-2015; Vartiainen, Maria K/F-4767-2013	Vartiainen, Maria/0000-0002-2017-0475; Larijani, Banafshe/0000-0003-4735-1169; Vartiainen, Maria K/0000-0002-2017-0475; Treisman, Richard/0000-0002-9658-0067; Guettler, Sebastian/0000-0002-3135-1546				Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134	14	471	485	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1749	1752		10.1126/science.1141084	http://dx.doi.org/10.1126/science.1141084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588931				2022-12-24	WOS:000247400500048
J	Sugase, K; Dyson, HJ; Wright, PE				Sugase, Kenji; Dyson, H. Jane; Wright, Peter E.			Mechanism of coupled folding and binding of an intrinsically disordered protein	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHEMICAL-EXCHANGE; KIX DOMAIN; UNSTRUCTURED PROTEINS; MACROMOLECULAR INTERACTIONS; TRANSACTIVATION DOMAIN; NMR-SPECTROSCOPY; CREB; CBP; COACTIVATOR	Protein folding and binding are analogous processes, in which the protein 'searches' for favourable intramolecular or intermolecular interactions on a funnelled energy landscape(1,2). Many eukaryotic proteins are disordered under physiological conditions, and fold into ordered structures only on binding to their cellular targets(3-6). The mechanism by which folding is coupled to binding is poorly understood, but it has been hypothesized on theoretical grounds that the binding kinetics may be enhanced by a 'fly-casting' effect, where the disordered protein binds weakly and non-specifically to its target and folds as it approaches the cognate binding site(7). Here we show, using NMR titrations and N-15 relaxation dispersion, that the phosphorylated kinase inducible activation domain (pKID) of the transcription factor CREB forms an ensemble of transient encounter complexes on binding to the KIX domain of the CREB binding protein. The encounter complexes are stabilized primarily by non-specific hydrophobic contacts, and evolve by way of an intermediate to the fully bound state without dissociation from KIX. The carboxy-terminal helix of pKID is only partially folded in the intermediate, and becomes stabilized by intermolecular interactions formed in the final bound state. Future applications of our method will provide new understanding of the molecular mechanisms by which intrinsically disordered proteins perform their diverse biological functions.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan	Scripps Research Institute; Scripps Research Institute; Suntory Holdings Ltd	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011; Sugase, Kenji/AAF-4552-2021; Sugase, Kenji/S-3132-2016	Dyson, Jane/0000-0001-6855-3398; Sugase, Kenji/0000-0001-8623-7743; Sugase, Kenji/0000-0001-8623-7743; Wright, Peter/0000-0002-1368-0223				ALLERHAN.A, 1965, J CHEM PHYS, V42, P1587, DOI 10.1063/1.1696165; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Huth JR, 1997, PROTEIN SCI, V6, P2359; JOHNSON CS, 1973, J CHEM EDUC, V50, P477, DOI 10.1021/ed050p477; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shih HM, 1996, P NATL ACAD SCI USA, V93, P13896, DOI 10.1073/pnas.93.24.13896; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	33	806	822	5	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1021	U11		10.1038/nature05858	http://dx.doi.org/10.1038/nature05858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17522630				2022-12-24	WOS:000247373100051
J	Bendall, SC; Stewart, MH; Menendez, P; George, D; Vijayaragavan, K; Werbowetski-Ogilvie, T; Ramos-Mejia, V; Rouleau, A; Yang, JB; Bosse, M; Lajoie, G; Bhatia, M				Bendall, Sean C.; Stewart, Morag H.; Menendez, Pablo; George, Dustin; Vijayaragavan, Kausalia; Werbowetski-Ogilvie, Tamra; Ramos-Mejia, Veronica; Rouleau, Anne; Yang, Jiabi; Bosse, Marc; Lajoie, Gilles; Bhatia, Mickie			IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro	NATURE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; SELF-RENEWAL; GROWTH; RECEPTOR; EXPRESSION; DIFFERENTIATION; SB-431542; INHIBITOR; SUPPORT; CULTURE	Distinctive properties of stem cells are not autonomously achieved, and recent evidence points to a level of external control from the microenvironment. Here, we demonstrate that self-renewal and pluripotent properties of human embryonic stem (ES) cells depend on a dynamic interplay between human ES cells and autologously derived human ES cell fibroblast-like cells (hdFs). Human ES cells and hdFs are uniquely defined by insulin-like growth factor (IGF)- and fibroblast growth factor (FGF)-dependence. IGF 1 receptor (IGF1R) expression was exclusive to the human ES cells, whereas FGF receptor 1 (FGFR1) expression was restricted to surrounding hdFs. Blocking the IGF-II/IGF1R pathway reduced survival and clonogenicity of human ES cells, whereas inhibition of the FGF pathway indirectly caused differentiation. IGF-II is expressed by hdFs in response to FGF, and alone was sufficient in maintaining human ES cell cultures. Our study demonstrates a direct role of the IGF-II/IGF1R axis on human ES cell physiology and establishes that hdFs produced by human ES cells themselves define the stem cell niche of pluripotent human stem cells.	McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; Univ Western Ontario, Don Rix Prot Identificat Facil, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	McMaster University; Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Vijayaragavan, Kausalia/AAM-8590-2021; Bujan, Pablo Menendez/W-3736-2017; Bendall, Sean/AGG-0126-2022; Bosse, Marc/AAM-8593-2021; Ramos-Mejia, Veronica/C-4338-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; Ramos-Mejia, Veronica/0000-0002-8013-4273; Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559; Bendall, Sean/0000-0003-1341-2453				Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Chi MMY, 2000, ENDOCRINOLOGY, V141, P4784, DOI 10.1210/en.141.12.4784; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Heyner S, 1997, Early Pregnancy, V3, P153; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; HUANG S, 1992, NATURE, V360, P745, DOI 10.1038/360745a0; HUANG S, 1994, NATURE, V368, P664, DOI 10.1038/368664a0; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kauma SW, 2000, J REPROD FERTIL, P31; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lighten AD, 1997, MOL REPROD DEV, V47, P134, DOI 10.1002/(SICI)1098-2795(199706)47:2<134::AID-MRD2>3.0.CO;2-N; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; ORFAO A, 1995, SCAND J CLIN LAB INV, V55, P145, DOI 10.3109/00365519509090577; ORFAO A, 1995, HAEMATOLOGICA, V80, P69; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	31	475	537	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1015	U3		10.1038/nature06027	http://dx.doi.org/10.1038/nature06027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17625568				2022-12-24	WOS:000249097600030
J	Frederick, KK; Marlow, MS; Valentine, KG; Wand, AJ				Frederick, Kendra King; Marlow, Michael S.; Valentine, Kathleen G.; Wand, A. Joshua			Conformational entropy in molecular recognition by proteins	NATURE			English	Article							CALMODULIN-PEPTIDE COMPLEX; NMR RELAXATION; TEMPERATURE-DEPENDENCE; BACKBONE DYNAMICS; INTERNAL DYNAMICS; STRUCTURAL BASIS; HEAT-CAPACITY; SIDE-CHAINS; BINDING; KINASE	Molecular recognition by proteins is fundamental to almost every biological process, particularly the protein associations underlying cellular signal transduction. Understanding the basis for protein-protein interactions requires the full characterization of the thermodynamics of their association. Historically it has been virtually impossible to experimentally estimate changes in protein conformational entropy, a potentially important component of the free energy of protein association. However, nuclear magnetic resonance spectroscopy has emerged as a powerful tool for characterizing the dynamics of proteins. Here we employ changes in conformational dynamics as a proxy for corresponding changes in conformational entropy. We find that the change in internal dynamics of the protein calmodulin varies significantly on binding a variety of target domains. Surprisingly, the apparent change in the corresponding conformational entropy is linearly related to the change in the overall binding entropy. This indicates that changes in protein conformational entropy can contribute significantly to the free energy of protein-ligand association.	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu		Frederick, Kendra/0000-0002-1656-5167	NIDDK NIH HHS [R01 DK039806] Funding Source: Medline; NIGMS NIH HHS [T32 GM008275] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Best RB, 2005, J MOL BIOL, V349, P185, DOI 10.1016/j.jmb.2005.03.001; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHARBONNEAU H, 1991, BIOCHEMISTRY-US, V30, P7931, DOI 10.1021/bi00246a009; Chou JJ, 2003, J AM CHEM SOC, V125, P8959, DOI 10.1021/ja029972s; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DELLWO MJ, 1989, J AM CHEM SOC, V111, P4571, DOI 10.1021/ja00195a007; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lee AL, 2002, BIOCHEMISTRY-US, V41, P13814, DOI 10.1021/bi026380d; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; SCOTT D, 1979, BIOMETRIKA, V10, P605; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STEINBERG IZ, 1963, J BIOL CHEM, V238, P172; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wintrode PL, 1997, J MOL BIOL, V266, P1050, DOI 10.1006/jmbi.1996.0785; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZHANG MJ, 1994, J BIOL CHEM, V269, P981	34	515	520	5	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					325	U3		10.1038/nature05959	http://dx.doi.org/10.1038/nature05959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637663	Green Accepted			2022-12-24	WOS:000248118300051
J	Lee, H; Lee, BP; Messersmith, PB				Lee, Haeshin; Lee, Bruce P.; Messersmith, Phillip B.			A reversible wet/dry adhesive inspired by mussels and geckos	NATURE			English	Article							MYTILUS-EDULIS; FORCE; MICRO; DOPA	The adhesive strategy of the gecko relies on foot pads composed of specialized keratinous foot-hairs called setae, which are subdivided into terminal spatulae of approximately 200 nm (ref.1). Contact between the gecko foot and an opposing surface generates adhesive forces that are sufficient to allow the gecko to cling onto vertical and even inverted surfaces. Although strong, the adhesion is temporary, permitting rapid detachment and reattachment of the gecko foot during locomotion. Researchers have attempted to capture these properties of gecko adhesive in synthetic mimics with nanoscale surface features reminiscent of setae(2-7); however, maintenance of adhesive performance over many cycles has been elusive(2,8), and gecko adhesion is greatly diminished upon full immersion in water(9,10). Here we report a hybrid biologically inspired adhesive consisting of an array of nanofabricated polymer pillars coated with a thin layer of a synthetic polymer that mimics the wet adhesive proteins found in mussel holdfasts. Wet adhesion of the nanostructured polymer pillar arrays increased nearly 15-fold when coated with mussel-mimetic polymer. The system maintains its adhesive performance for over a thousand contact cycles in both dry and wet environments. This hybrid adhesive, which combines the salient design elements of both gecko and mussel adhesives, should be useful for reversible attachment to a variety of surfaces in any environment.	Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; Northwestern Univ, Inst Bionanotechnol Med, Evanston, IL 60208 USA; Nerites Corp, Madison, WI 53711 USA	Northwestern University; Northwestern University; Northwestern University	Messersmith, PB (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	philm@northwestern.edu	Lee, Haeshin/C-1720-2011; Messersmith, Phil/B-6695-2009; Lee, Bruce P/H-5233-2011	Lee, Haeshin/0000-0003-3961-9727; Lee, Bruce P/0000-0002-6529-0032; Messersmith, Phillip/0000-0002-1197-333X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE014193] Funding Source: NIH RePORTER; NIDCR NIH HHS [R37 DE014193] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Arzt E, 2006, MAT SCI ENG C-BIO S, V26, P1245, DOI 10.1016/j.msec.2005.08.033; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Crosby AJ, 2005, LANGMUIR, V21, P11738, DOI 10.1021/la051721k; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Frank BP, 2002, BIOTECHNOL PROGR, V18, P580, DOI 10.1021/bp010140s; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Northen MT, 2006, SENSOR ACTUAT A-PHYS, V130, P583, DOI 10.1016/j.sna.2005.10.032; Northen MT, 2005, NANOTECHNOLOGY, V16, P1159, DOI 10.1088/0957-4484/16/8/030; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Peressadko A, 2004, J ADHESION, V80, P247, DOI 10.1080/00218460490430199; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788; Spolenak R, 2005, ACTA BIOMATER, V1, P5, DOI 10.1016/j.actbio.2004.08.004; Sun WX, 2005, BIOPHYS J, V89, pL14, DOI 10.1529/biophysj.105.065268; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038; Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172; WAITE JH, 1987, CHEMTECH, V17, P692; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z; Yurdumakan B, 2005, CHEM COMMUN, P3799, DOI 10.1039/b506047h	30	1507	1579	83	1565	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					338	U4		10.1038/nature05968	http://dx.doi.org/10.1038/nature05968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17637666				2022-12-24	WOS:000248118300054
J	Chow, CY; Zhang, YL; Dowling, JJ; Jin, N; Adamska, M; Shiga, K; Szigeti, K; Shy, ME; Li, J; Zhang, XB; Lupski, JR; Weisman, LS; Meisler, MH				Chow, Clement Y.; Zhang, Yanling; Dowling, James J.; Jin, Natsuko; Adamska, Maja; Shiga, Kensuke; Szigeti, Kinga; Shy, Michael E.; Li, Jun; Zhang, Xuebao; Lupski, James R.; Weisman, Lois S.; Meisler, Miriam H.			Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J	NATURE			English	Article							CHARCOT-MARIE-TOOTH; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MYOTUBULARIN FAMILY; MEMBRANE DYNAMICS; SODIUM-CHANNEL; PHOSPHATASE; DISEASE; NEUROPATHY; PROTEIN; GENE	Membrane-bound phosphoinositides are signalling molecules that have a key role in vesicle trafficking in eukaryotic cells(1). Proteins that bind specific phosphoinositides mediate interactions between membrane-bounded compartments whose identity is partially encoded by cytoplasmic phospholipid tags. Little is known about the localization and regulation of mammalian phosphatidylinositol-3,5-bisphosphate ( PtdIns( 3,5)P-2), a phospholipid present in small quantities that regulates membrane trafficking in the endosome - lysosome axis in yeast(2). Here we describe a multi-organ disorder with neuronal degeneration in the central nervous system, peripheral neuronopathy and diluted pigmentation in the 'pale tremor' mouse. Positional cloning identified insertion of ETn2 beta ( early transposon 2 beta)(3) into intron 18 of Fig4 (A530089I17Rik), the homologue of a yeast SAC ( suppressor of actin) domain PtdIns(3,5) P-2 5-phosphatase located in the vacuolar membrane. The abnormal concentration of PtdIns( 3,5) P2 in cultured fibroblasts from pale tremor mice demonstrates the conserved biochemical function of mammalian Fig4. The cytoplasm of fibroblasts from pale tremor mice is filled with large vacuoles that are immunoreactive for LAMP-2 (lysosomal-associated membrane protein 2), consistent with dysfunction of the late endosome - lysosome axis. Neonatal neurodegeneration in sensory and autonomic ganglia is followed by loss of neurons from layers four and five of the cortex, deep cerebellar nuclei and other localized brain regions. The sciatic nerve exhibits reduced numbers of large-diameter myelinated axons, slowed nerve conduction velocity and reduced amplitude of compound muscle action potentials. We identified pathogenic mutations of human FIG4 (KIAA0274) on chromosome 6q21 in four unrelated patients with hereditary motor and sensory neuropathy. This novel form of autosomal recessive Charcot - Marie - Tooth disorder is designated CMT4J.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; John D Dingle VA Med Ctr, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Wayne State University	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Zhang, Yanling/E-8932-2013; Adamska, Maja/M-4128-2014; Adamska, Maja/L-3306-2015	Zhang, Yanling/0000-0002-1483-9021; Adamska, Maja/0000-0002-4223-8450; Shy, Michael/0000-0001-8460-6971	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024872, T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM024872-30, R01 GM024872, T32 GM007544] Funding Source: Medline; NINDS NIH HHS [R01 NS064015] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamska M, 2005, DEV DYNAM, V233, P368, DOI 10.1002/dvdy.20437; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bonneick S, 2005, HUM MOL GENET, V14, P3685, DOI 10.1093/hmg/ddi400; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Hughes WE, 2000, BIOCHEM J, V350, P337, DOI 10.1042/0264-6021:3500337; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; Li J, 2006, J COMP NEUROL, V498, P252, DOI 10.1002/cne.21051; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Schroder JM, 2006, NEUROMOL MED, V8, P23, DOI 10.1385/NMM:8:1-2:23; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; STENDEL C, IN PRESS AM J HUM GE; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	28	356	372	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					68	72		10.1038/nature05876	http://dx.doi.org/10.1038/nature05876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572665	Green Published, Green Accepted			2022-12-24	WOS:000247720900039
J	Sandrelli, F; Tauber, E; Pegoraro, M; Mazzotta, G; Cisotto, P; Landskron, J; Stanewsky, R; Piccin, A; Rosato, E; Zordan, M; Costa, R; Kyriacou, CP				Sandrelli, Federica; Tauber, Eran; Pegoraro, Mirko; Mazzotta, Gabriella; Cisotto, Paola; Landskron, Johannes; Stanewsky, Ralf; Piccin, Alberto; Rosato, Ezio; Zordan, Mauro; Costa, Rodolfo; Kyriacou, Charalambos P.			A molecular basis for natural selection at the timeless locus in Drosophila melanogaster	SCIENCE			English	Article							CIRCADIAN CLOCK; LATITUDINAL CLINES; CRYPTOCHROME; PHOTORECEPTOR; ENTRAINMENT; PACEMAKER; PROTEIN	Diapause is a protective response to unfavorable environments that results in a suspension of insect development and is most often associated with the onset of winter. The ls-tim mutation in the Drosophila melanogaster clock gene timeless has spread in Europe over the past 10,000 years, possibly because it enhances diapause. We show that the mutant allele attenuates the photosensitivity of the circadian clock and causes decreased dimerization of the mutant TIMELESS protein isoform to CRYPTOCHROME, the circadian photoreceptor. This interaction results in a more stable TIMELESS product. These findings reveal a molecular link between diapause and circadian photoreception.	Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Regensburg, Lehrstuhl Entwicklungsbiol, Inst Zool, D-93040 Regensburg, Germany; Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England	University of Padua; University of Leicester; University of Regensburg; University of London; Queen Mary University London	Costa, R (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	rodolfo.costa@unipd.it	Tauber, Eran/F-9826-2011; Stanewsky, Ralf/ABB-9193-2021; Tauber, Eran/AAA-1562-2022	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; SANDRELLI, FEDERICA/0000-0002-5631-7467; Rosato, Ezio/0000-0001-7297-4697; Pegoraro, Mirko/0000-0001-9381-5249; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837; Stanewsky, Ralf/0000-0001-8238-6864	Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish; NERC [NE/D012058/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ashmore LJ, 2003, J BIOL RHYTHM, V18, P206, DOI [10.1177/0748730403018003003, 10.1177/0748730403253385]; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Young MW, 1996, COLD SPRING HARB SYM, V61, P279; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	18	129	130	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1898	1900		10.1126/science.1138426	http://dx.doi.org/10.1126/science.1138426			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600216				2022-12-24	WOS:000247602700040
J	Molnar, A; Schwach, F; Studholme, DJ; Thuenemann, EC; Baulcombe, DC				Molnar, Attila; Schwach, Frank; Studholme, David J.; Thuenemann, Eva C.; Baulcombe, David C.			miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii	NATURE			English	Article							TRANS-ACTING SIRNAS; SMALL RNAS; MICRORNAS; METHYLATION; SEQUENCES; CLONING	MicroRNAs (miRNAs) in eukaryotes guide post-transcriptional regulation by means of targeted RNA degradation and translational arrest(1). They are released by a Dicer nuclease as a 21-24-nucleotide RNA duplex from a precursor in which an imperfectly matched inverted repeat forms a partly double-stranded region. One of the two strands is then recruited by an Argonaute nuclease that is the effector protein of the silencing mechanism. Short interfering RNAs (siRNAs), which are similar to miRNAs, are also produced by Dicer but the precursors are perfectly double-stranded RNA. These siRNAs guide post-transcriptional regulation, as with miRNAs, and epigenetic genome modification. Diverse eukaryotes including fungi, plants, protozoans and metazoans produce siRNAs(2-5) but, until now, miRNAs have not been described in unicellular organisms and it has been suggested that they evolved together with multicellularity in separate plant and animal lineages(6). Here we show that the unicellular alga Chlamydomonas reinhardtii contains miRNAs, putative evolutionary precursors of miRNAs and species of siRNAs resembling those in higher plants. The common features of miRNAs and siRNAs in an alga and in higher plants indicate that complex RNA-silencing systems evolved before multicellularity and were a feature of primitive eukaryotic cells.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@tsl.ac.uk	Molnar, Attila/F-5833-2011; Studholme, David/H-6790-2019	Molnar, Attila/0000-0002-1044-6327; Studholme, David/0000-0002-3010-6637; Schwach, Frank/0000-0001-5495-7535; Baulcombe, David/0000-0003-0780-6878				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHAPPELL L, 2005, CURRENT PROTOCOLS MI; Djikeng A, 2001, RNA, V7, P1522; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Han J, 2001, DRUG DELIV, V8, P125; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; WEGENER D, 1989, PLANT PHYSIOL, V90, P512, DOI 10.1104/pp.90.2.512; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	30	361	433	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1126	U15		10.1038/nature05903	http://dx.doi.org/10.1038/nature05903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17538623				2022-12-24	WOS:000247564600040
J	Griffiths, C; Foster, G; Ramsay, J; Eldridge, S; Taylor, S				Griffiths, Chris; Foster, Gill; Ramsay, Jean; Eldridge, Sandra; Taylor, Stephanie			How effective are expert patient (lay led) education programmes for chronic disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT PROGRAM; ARTHRITIS; CARE; REHABILITATION; INTERVENTIONS		Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England	University of London; Queen Mary University London	Griffiths, C (corresponding author), Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England.	c.j.griffiths@qmul.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0001-7454-6354	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665; Bethell HJN, 2007, J PUBLIC HEALTH, V29, P57, DOI 10.1093/pubmed/fdl091; *BRIT THOR SOC, 2003, PULM REH SURV; BURY M, 2005, RAPID REV CURRENT ST; Buszewicz M, 2006, BMJ-BRIT MED J, V333, P879, DOI 10.1136/bmj.38965.375718.80; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; *DEP HLTH, 1999, CMND4386; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Griffiths C, 2005, BRIT J GEN PRACT, V55, P831; GRIFFITHS C, 2005, COCHRANE DB SYST REV; Haas M, 2005, J MANIP PHYSIOL THER, V28, P228, DOI 10.1016/j.jmpt.2005.03.010; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, NURS RES, V52, P361, DOI 10.1097/00006199-200311000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; *NAT HLTH SERV, 2007, EXP PAT PROGR; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; *SECR STAT HLTH, 2001, EXP PAT NEW APPR CHR; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3; Wanless, 2002, SECURING OUR FUTURE; *WHO, 2007, CHRON DIS HLTH PROM	27	123	124	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1254	1256		10.1136/bmj.39227.698785.47	http://dx.doi.org/10.1136/bmj.39227.698785.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183AM	17569933	Green Published			2022-12-24	WOS:000247545100032
J	Forstemann, K; Horwich, MD; Wee, L; Tomari, Y; Zamore, PD				Foerstemann, Klaus; Horwich, Michael D.; Wee, LiangMeng; Tomari, Yukihide; Zamore, Phillip D.			Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by Dicer-1	CELL			English	Article							RNA-INTERFERENCE; CRYSTAL-STRUCTURE; PASSENGER-STRAND; STRUCTURAL BASIS; MESSENGER-RNAS; ENZYME DICER; SIRNA; RECOGNITION; CLEAVAGE; SLICER	Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide distinct classes of RNA-induced silencing complexes (RISCs) to repress mRNA expression in biological processes ranging from development to antiviral defense. In Drosophila, separate but conceptually similar endonucleolytic pathways produce siRNAs and miRNAs. Here, we show that despite their distinct biogenesis, double-stranded miRNAs and siRNAs participate in a common sorting step that partitions them into Ago1- or Ago2-containing effector complexes. These distinct complexes silence their target RNAs by different mechanisms. miRNA-loaded Ago2-RISC mediates RNAi, but only Ago1 is able to repress an mRNA with central mismatches in its miRNA-binding sites. Conversely, Ago1 cannot mediate RNAi, because it is an inefficient nuclease whose catalytic rate is limited by the dissociation of its reaction products. Thus, the two members of the Drosophila Ago subclade of Argonaute proteins are functionally specialized, but specific small RNA classes are not restricted to associate with Ago1 or Ago2.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, CiPS, D-81377 Munich, Germany; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawagoe, Saitama 3320012, Japan	University of Munich; University of Munich; University of Tokyo; Japan Science & Technology Agency (JST)	Zamore, PD (corresponding author), Univ Munich, Gene Ctr, Foedor Lynen Str 25, D-81377 Munich, Germany.	phillip.zamore@umassmed.edu	Tomari, Yukihide/A-8009-2009; Zamore, Phillip D/A-8941-2013; Wee, Liang Meng/U-2188-2017	Tomari, Yukihide/0000-0001-8442-0851; Wee, Liang Meng/0000-0003-3870-8568; Zamore, Phillip/0000-0002-4505-9618	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [P30 DK032520-259007, P30 DK032520, 5 P30 DK032520] Funding Source: Medline; NIGMS NIH HHS [R01 GM062862, R01 GM065236, R01 GM065236-07, R01 GM062862-08, GM62862, GM65236, R37 GM062862] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Davis AC, 2001, J HIGH ENERGY PHYS; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Preall JB, 2006, CURR BIOL, V16, P530, DOI 10.1016/j.cub.2006.01.061; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	83	298	316	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					287	297		10.1016/j.cell.2007.05.056	http://dx.doi.org/10.1016/j.cell.2007.05.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662943	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000248588000018
J	Rodrigo-Brenni, MC; Morgan, DO				Rodrigo-Brenni, Monica C.; Morgan, David O.			Sequential E2s drive polyubiquitin chain assembly on APC targets	CELL			English	Article							UBIQUITIN-CONJUGATING ENZYME; ANAPHASE-PROMOTING COMPLEX; MITOTIC CYCLIN; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; DEPENDENT PROTEOLYSIS; DEGRADATION; DESTRUCTION; SYSTEM; TRANSLOCATION	The anaphase- promoting complex ( APC), or cyclosome, is an E3 ubiquitin- protein ligase that collaborates with E2 ubiquitin- conjugating enzymes to assemble polyubiquitin chains on proteins important for cell- cycle progression. It remains unclear how the APC - or many other E3s - promotes the multiple distinct reactions necessary for chain assembly. We addressed this problem by analyzing APC interactions with different E2s. We screened all budding yeast E2s as APC coenzymes in vitro and found that two, Ubc4 and Ubc1, are the key E2 partners for the APC. These proteins display strikingly different but complementary enzymatic behaviors: Ubc4 supports the rapid monoubiquitination of multiple lysines on APC targets, while Ubc1 catalyzes K48- linked polyubiquitin chain assembly on preattached ubiquitins. Mitotic APC function is lost in yeast strains lacking both Ubc1 and Ubc4. E2- 25K, a human homolog of Ubc1, also promotes APC- dependent chain extension on preattached ubiquitins. We propose that sequential E2 proteins catalyze K48- linked polyubiquitination and thus proteasomal destruction of APC targets.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053270, R01GM053270] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53270, R01 GM053270] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kraft C, 2006, METHODS, V38, P39, DOI 10.1016/j.ymeth.2005.07.005; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mathe E, 2004, CURR BIOL, V14, P1723, DOI 10.1016/j.cub.2004.09.023; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Townsley FM, 1998, YEAST, V14, P747, DOI 10.1002/(SICI)1097-0061(19980615)14:8<747::AID-YEA271>3.0.CO;2-T; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	50	198	204	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					127	139		10.1016/j.cell.2007.05.027	http://dx.doi.org/10.1016/j.cell.2007.05.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632060	Bronze			2022-12-24	WOS:000248587000016
J	Nene, V; Wortman, JR; Lawson, D; Haas, B; Kodira, C; Tu, ZJ; Loftus, B; Xi, ZY; Megy, K; Grabherr, M; Ren, QH; Zdobnov, EM; Lobo, NF; Campbell, KS; Brown, SE; Bonaldo, MF; Zhu, JS; Sinkins, SP; Hogenkamp, DG; Amedeo, P; Arensburger, P; Atkinson, PW; Bidwell, S; Biedler, J; Birney, E; Bruggner, RV; Costas, J; Coy, MR; Crabtree, J; Crawford, M; deBruyn, B; DeCaprio, D; Eiglmeier, K; Eisenstadt, E; El-Dorry, H; Gelbart, WM; Gomes, SL; Hammond, M; Hannick, LI; Hogan, JR; Holmes, MH; Jaffe, D; Johnston, JS; Kennedy, RC; Koo, H; Kravitz, S; Kriventseva, EV; Kulp, D; LaButti, K; Lee, E; Li, S; Lovin, DD; Mao, CH; Mauceli, E; Menck, CFM; Miller, JR; Montgomery, P; Mori, A; Nascimento, AL; Naveira, HF; Nusbaum, C; O'Leary, S; Orvis, J; Pertea, M; Quesneville, H; Reidenbach, KR; Rogers, YH; Roth, CW; Schneider, JR; Schatz, M; Shumway, M; Stanke, M; Stinson, EO; Tubio, JMC; VanZee, JP; Verjovski-Almeida, S; Werner, D; White, O; Wyder, S; Zeng, QD; Zhao, Q; Zhao, YM; Hill, CA; Raikhel, AS; Soares, MB; Knudson, DL; Lee, NH; Galagan, J; Salzberg, SL; Paulsen, IT; Dimopoulos, G; Collins, FH; Birren, B; Fraser-Liggett, CM; Severson, DW				Nene, Vishvanath; Wortman, Jennifer R.; Lawson, Daniel; Haas, Brian; Kodira, Chinnappa; Tu, Zhijian (Jake); Loftus, Brendan; Xi, Zhiyong; Megy, Karyn; Grabherr, Manfred; Ren, Quinghu; Zdobnov, Evgeny M.; Lobo, Neil F.; Campbell, Kathryn S.; Brown, Susan E.; Bonaldo, Maria F.; Zhu, Jingsong; Sinkins, Steven P.; Hogenkamp, David G.; Amedeo, Paolo; Arensburger, Peter; Atkinson, Peter W.; Bidwell, Shelby; Biedler, Jim; Birney, Ewan; Bruggner, Robert V.; Costas, Javier; Coy, Monique R.; Crabtree, Jonathan; Crawford, Matt; deBruyn, Becky; DeCaprio, David; Eiglmeier, Karin; Eisenstadt, Eric; El-Dorry, Hamza; Gelbart, William M.; Gomes, Suely L.; Hammond, Martin; Hannick, Linda I.; Hogan, James R.; Holmes, Michael H.; Jaffe, David; Johnston, J. Spencer; Kennedy, Ryan C.; Koo, Hean; Kravitz, Saul; Kriventseva, Evgenia V.; Kulp, David; LaButti, Kurt; Lee, Eduardo; Li, Song; Lovin, Diane D.; Mao, Chunhong; Mauceli, Evan; Menck, Carlos F. M.; Miller, Jason R.; Montgomery, Philip; Mori, Akio; Nascimento, Ana L.; Naveira, Horacio F.; Nusbaum, Chad; O'Leary, Sinead; Orvis, Joshua; Pertea, Mihaela; Quesneville, Hadi; Reidenbach, Kyanne R.; Rogers, Yu-Hui; Roth, Charles W.; Schneider, Jennifer R.; Schatz, Michael; Shumway, Martin; Stanke, Mario; Stinson, Eric O.; Tubio, Jose M. C.; VanZee, Janice P.; Verjovski-Almeida, Sergio; Werner, Doreen; White, Owen; Wyder, Stefan; Zeng, Qiandong; Zhao, Qi; Zhao, Yongmei; Hill, Catherine A.; Raikhel, Alexander S.; Soares, Marcelo B.; Knudson, Dennis L.; Lee, Norman H.; Galagan, James; Salzberg, Steven L.; Paulsen, Ian T.; Dimopoulos, George; Collins, Frank H.; Birren, Bruce; Fraser-Liggett, Claire M.; Severson, David W.			Genome sequence of Aedes aegypti, a major arbovirus vector	SCIENCE			English	Article							YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER; EXPRESSION; EVOLUTION; ORGANIZATION; TRANSPOSONS; SUPERFAMILY; RECEPTORS; INSECTS	We present a draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at similar to 1376 million base pairs is about 5 times the size of the genome of the malaria vector Anopheles gambiae. Nearly 50% of the Ae. aegypti genome consists of transposable elements. These contribute to a factor of similar to 4 to 6 increase in average gene length and in sizes of intergenic regions relative to An. gambiae and Drosophila melanogaster. Nonetheless, chromosomal synteny is generally maintained among all three insects, although conservation of orthologous gene order is higher (by a factor of similar to 2) between the mosquito species than between either of them and the fruit fly. An increase in genes encoding odorant binding, cytochrome P450, and cuticle domains relative to An. gambiae suggests that members of these protein families underpin some of the biological differences between the two mosquito species.	Inst Genome Res, Rockville, MD 20850 USA; European Bioinformat Inst EMBL EBI, Hinxton CB10 1SD, Cambs, England; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; Univ Notre Dame, Notre Dame, IN 46556 USA; Harvard Univ, Cambridge, MA 02138 USA; Colorado State Univ, Coll Agr Sci, Ft Collins, CO 80523 USA; Northwestern Univ, Chicago, IL 60614 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Oxford, Oxford OX1 3PS, England; Purdue Univ, W Lafayette, IN 47907 USA; Hosp Clin Univ Santiago, Fdn Publ Galega Med Xenom, Ctr Nacl Genotipado, E-15706 Santiago, Spain; Inst Pasteur, F-75724 Paris, France; Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, Brazil; Texas A&M Univ, College Stn, TX 77843 USA; Joint Technol Ctr, Rockville, MD 20850 USA; Univ Massachusetts, Amherst, MA 01003 USA; Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; Inst Butantan, BR-05503900 Sao Paulo, Brazil; Univ A Coruna, La Coruna 15001, Spain; Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75252 Paris, France; Univ Paris 06, F-75252 Paris, France; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Gottingen, D-37077 Gottingen, Germany; Complexo Hosp Univ Santiago, Santiago De Compostela 15706, Spain	J. Craig Venter Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; University of Notre Dame; Harvard University; Colorado State University; Northwestern University; University of California System; University of California Riverside; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Complexo Hospitalario Universitario de Santiago de Compostela; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Amherst; Universidade de Sao Paulo; Instituto Butantan; Universidade da Coruna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; University of Gottingen; Complexo Hospitalario Universitario de Santiago de Compostela	Nene, V (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nene@tigr.org; severson.1@nd.edu	Salzberg, Steven L/F-6162-2011; Gomes, Suely Lopes/D-8938-2012; Tubio, Jose/AAG-7345-2019; Menck, Carlos FM/G-6321-2011; Verjovski-Almeida, Sergio/E-4082-2012; Naveira, Horacio/H-7249-2014; Stanke, Mario/P-7876-2019; Quesneville, Hadi/AAG-1048-2020; Salzberg, Steven/Q-6514-2019; Tubio, Jose M.C./H-5076-2015; Xi, Zhiyong/AAD-7936-2022; Naveira, Horacio/I-7802-2019; Zdobnov, Evgeny M/K-1133-2012; Costas, Javier/B-5016-2008; Schatz, Michael/L-2690-2019; Nascimento, Ana L. T. O./E-8488-2012; Pertea, Mihaela/AAT-2705-2021; Lopes Gomes, Suely/HGC-5280-2022; Paulsen, Ian T/K-3832-2012; Zdobnov, Evgeny/AAB-2745-2022; Zeng, Qiandong/AAF-3305-2019	Salzberg, Steven L/0000-0002-8859-7432; Gomes, Suely Lopes/0000-0002-3367-9676; Tubio, Jose/0000-0003-3540-2459; Menck, Carlos FM/0000-0003-1941-0694; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Naveira, Horacio/0000-0002-3840-1569; Stanke, Mario/0000-0001-8696-0384; Quesneville, Hadi/0000-0003-3001-4908; Salzberg, Steven/0000-0002-8859-7432; Tubio, Jose M.C./0000-0003-3540-2459; Xi, Zhiyong/0000-0001-7786-012X; Naveira, Horacio/0000-0002-3840-1569; Costas, Javier/0000-0003-0306-3990; Schatz, Michael/0000-0002-4118-4446; Nascimento, Ana L. T. O./0000-0003-4851-0870; Pertea, Mihaela/0000-0003-0762-8637; Paulsen, Ian T/0000-0001-9015-9418; Zdobnov, Evgeny/0000-0002-5178-1498; DeCaprio, Dave/0000-0001-8931-9461; Wyder, Stefan/0000-0002-3412-0292; Grabherr, Manfred/0000-0001-8792-6508; Wortman, Jennifer/0000-0002-8713-1227; Megy, Karyn/0000-0002-2826-3879; Galagan, James/0000-0003-0542-3291; Hannick, Linda/0000-0002-8018-8466; Kulp, David/0000-0001-6540-0222; Zhu, Jinsong/0000-0002-1587-753X; Birney, Ewan/0000-0001-8314-8497; Fraser, Claire/0000-0003-1462-2428; Nene, Vishvanath/0000-0001-7066-4169; Lawson, Daniel/0000-0001-7765-983X; Dimopoulos, George/0000-0001-6755-8111; loftus, brendan/0000-0001-8871-8356; Miller, Jason/0000-0002-6912-2925	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024716, R01AI061576, U01AI050936, R01AI059492] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NIAID NIH HHS [HHSN266200400001C, U01 AI050936, 5 R01 AI61576-2, UO1 AI50936, HHSN266200400039C, R01 AI059492, R37 AI024716] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845] Funding Source: Medline; Wellcome Trust [079059] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004; Beaty B.J., 1996, BIOL DIS VECTORS; Bosio CF, 2000, GENETICS, V156, P687; Christophers, 1960, AEDES AEGYPTI L YELL; Clements AN., 1992, BIOL MOSQUITOES DEV; Coy MR, 2005, INSECT MOL BIOL, V14, P537, DOI 10.1111/j.1365-2583.2005.00584.x; CRAIG NL, 2002, MOBILE DNA, V2; Feschotte C, 2004, MOL BIOL EVOL, V21, P1769, DOI 10.1093/molbev/msh188; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; HOIT RA, 2002, SCIENCE, V298, P129; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85; Pal GB, 1967, GENETICS INSECT VECT, P67; RANSON H, COMMUNICATION; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schutt C, 2000, DEVELOPMENT, V127, P667; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; WARREN AM, 1991, GENET RES, V58, P225, DOI 10.1017/S0016672300029979; WHO, 2021, DENGUE DENGUE HAEMOR; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	37	828	1132	1	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1718	1723		10.1126/science.1138878	http://dx.doi.org/10.1126/science.1138878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17510324	Green Accepted			2022-12-24	WOS:000247400500039
J	Trepat, X; Deng, LH; An, SS; Navajas, D; Tschumperlin, DJ; Gerthoffer, WT; Butler, JP; Fredberg, JJ				Trepat, Xavier; Deng, Linhong; An, Steven S.; Navajas, Daniel; Tschumperlin, Daniel J.; Gerthoffer, William T.; Butler, James P.; Fredberg, Jeffrey J.			Universal physical responses to stretch in the living cell	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; SLOW DYNAMICS; FORCE; VISCOELASTICITY; RHEOLOGY; BEHAVIOR	With every beat of the heart, inflation of the lung or peristalsis of the gut, cell types of diverse function are subjected to substantial stretch. Stretch is a potent stimulus for growth, differentiation, migration, remodelling and gene expression(1,2). Here, we report that in response to transient stretch the cytoskeleton fluidizes in such a way as to define a universal response class. This finding implicates mechanisms mediated not only by specific signalling intermediates, as is usually assumed, but also by non-specific actions of a slowly evolving network of physical forces. These results support the idea that the cell interior is at once a crowded chemical space(3) and a fragile soft material in which the effects of biochemistry, molecular crowding and physical forces are complex and inseparable, yet conspire nonetheless to yield remarkably simple phenomenological laws. These laws seem to be both universal and primitive, and thus comprise a striking intersection between the worlds of cell biology and soft matter physics.	Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; Chongqing Univ, Bioengn Coll, Project Lab Biomech & Tissue Repair 111, Chongqing 400044, Peoples R China; Johns Hopkins Bloomberg Sch Publ Hlth, Div Physiol, Baltimore, MD 21205 USA; Univ Barcelona, IDIBAPS, Unitat Biofis & Bioengn, E-08036 Barcelona, Spain; Inst Bioengn Catalunya, E-08036 Barcelona, Spain; Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA	Harvard University; Harvard T.H. Chan School of Public Health; Chongqing University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fredberg, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, 665 Huntington Ave, Boston, MA 02115 USA.	jeffrey_fredberg@harvard.edu	Trepat, Xavier/I-3912-2015; Fredberg, Jeffrey/M-9877-2019; Deng, Linhong/C-1485-2009; An, Steven/AAM-3848-2020; Deng, Linhong/O-3218-2019; Navajas, Daniel/E-4233-2010	Trepat, Xavier/0000-0002-7621-5214; Deng, Linhong/0000-0003-1970-8239; An, Steven/0000-0003-4723-1888; Navajas, Daniel/0000-0001-7150-9363; Gerthoffer, William/0000-0001-5154-4962	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960, P01HL033009, R01HL102373, R01HL084224] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065960, P01 HL033009-06, P01 HL033009, R01 HL065960-07, R01 HL084224, R01 HL084224-03, R01 HL102373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Brujic J, 2006, NAT PHYS, V2, P282, DOI 10.1038/nphys269; BULATOV VV, 1994, MODEL SIMUL MATER SC, V2, P185, DOI 10.1088/0965-0393/2/2/002; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Cloitre M, 2000, PHYS REV LETT, V85, P4819, DOI 10.1103/PhysRevLett.85.4819; Corwin EI, 2005, NATURE, V435, P1075, DOI 10.1038/nature03698; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Johnson PA, 2005, NATURE, V437, P871, DOI 10.1038/nature04015; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Miguel MC, 2006, SCIENCE, V312, P1151, DOI 10.1126/science.1127729; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Rosenblatt N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168101; Sollich P, 1997, PHYS REV LETT, V78, P2020, DOI 10.1103/PhysRevLett.78.2020; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Viasnoff V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.065701; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004	30	515	532	6	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					592	+		10.1038/nature05824	http://dx.doi.org/10.1038/nature05824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538621	Green Accepted			2022-12-24	WOS:000246842000049
J	Baena-Gonzalez, E; Rolland, F; Thevelein, JM; Sheen, J				Baena-Gonzalez, Elena; Rolland, Filip; Thevelein, Johan M.; Sheen, Jen			A central integrator of transcription networks in plant stress and energy signalling	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; NITRATE REDUCTASE; SUCROSE; TRANSDUCTION; IDENTIFICATION; PATHWAYS; LEAVES; METABOLISM	Photosynthetic plants are the principal solar energy converter sustaining life on Earth. Despite its fundamental importance, little is known about how plants sense and adapt to darkness in the daily light-dark cycle, or how they adapt to unpredictable environmental stresses that compromise photosynthesis and respiration and deplete energy supplies. Current models emphasize diverse stress perception and signalling mechanisms(1,2). Using a combination of cellular and systems screens, we show here that the evolutionarily conserved Arabidopsis thaliana protein kinases, KIN10 and KIN11 (also known as AKIN10/At3g01090 and AKIN11/At3g29160, respectively), control convergent reprogramming of transcription in response to seemingly unrelated darkness, sugar and stress conditions. Sensing and signalling deprivation of sugar and energy, KIN10 targets a remarkably broad array of genes that orchestrate transcription networks, promote catabolism and suppress anabolism. Specific bZIP transcription factors partially mediate primary KIN10 signalling. Transgenic KIN10 overexpression confers enhanced starvation tolerance and lifespan extension, and alters architecture and developmental transitions. Significantly, double kin10 kin11 deficiency abrogates the transcriptional switch in darkness and stress signalling, and impairs starch mobilization at night and growth. These studies uncover surprisingly pivotal roles of KIN10/11 in linking stress, sugar and developmental signals to globally regulate plant metabolism, energy balance, growth and survival. In contrast to the prevailing view that sucrose activates plant SnRK1s (Snf1-related protein kinases)(3-6), our functional analyses of Arabidopsis KIN10/11 provide compelling evidence that SnRK1s are inactivated by sugars and share central roles with the orthologous yeast Snf1 and mammalian AMPK in energy signalling.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven	Rolland, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	baena@molbio.mgh.harvard.edu; filip.rolland@bio.kuleuven.be	Baena-González, Elena/G-5811-2013; Baena-González, Elena/AAI-4051-2020; Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Baena-González, Elena/0000-0001-6598-3579; Baena-González, Elena/0000-0001-6598-3579; Thevelein, Johan M./0000-0002-2626-0180; Rolland, Filip/0000-0003-2601-0752				Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cheng SH, 2001, FEBS LETT, V503, P185, DOI 10.1016/S0014-5793(01)02732-6; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gonzali S, 2005, ANN BOT-LONDON, V96, P661, DOI 10.1093/aob/mci218; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huang JZ, 2001, PLANT CELL PHYSIOL, V42, P1079, DOI 10.1093/pcp/pce137; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Radchuk R, 2006, PLANT PHYSIOL, V140, P263, DOI 10.1104/pp.105.071167; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Thelander M, 2004, EMBO J, V23, P1900, DOI 10.1038/sj.emboj.7600182; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang YH, 2001, PLANT J, V28, P431, DOI 10.1046/j.1365-313X.2001.01167.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	45	982	1026	21	365	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2007	448	7156					938	U10		10.1038/nature06069	http://dx.doi.org/10.1038/nature06069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17671505				2022-12-24	WOS:000248912900049
J	Strom, L; Karlsson, C; Lindroos, HB; Wedahl, S; Katou, Y; Shirahige, K; Sjogren, C				Stroem, Lena; Karlsson, Charlotte; Betts Lindroos, Hanna; Wedahl, Sara; Katou, Yuki; Shirahige, Katsuhiko; Sjoegren, Camilla			Postreplicative formation of cohesion is required for repair and induced by a single DNA break	SCIENCE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; DAMAGE-RESPONSE; BUDDING YEAST; COMPLEX; PROTEIN; CHECKPOINT; ANAPHASE; RECOMBINATION; ESTABLISHMENT	Sister-chromatid cohesion, established during replication by the protein complex cohesin, is essential for both chromosome segregation and double-strand break (DSB) repair. Normally, cohesion formation is strictly limited to the S phase of the cell cycle, but DSBs can trigger cohesion also after DNA replication has been completed. The function of this damage-induced cohesion remains unknown. In this investigation, we show that damage-induced cohesion is essential for repair in postreplicative cells in yeast. Furthermore, it is established genome-wide after induction of a single DSB, and it is controlled by the DNA damage response and cohesin-regulating factors. We thus define a cohesion establishment pathway that is independent of DNA duplication and acts together with cohesion formed during replication in sister chromatid-based DSB repair.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Karolinska Institutet; Tokyo Institute of Technology	Sjogren, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	camilla.sjogren@ki.se	Ström, Lena/AAJ-9025-2020	Shirahige, Katsuhiko/0000-0002-7862-1144; Lindroos, Hanna/0000-0002-8455-8452; Bjorkegren, Camilla/0000-0001-7354-9270; Strom, Lena/0000-0002-8898-3675				Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Strom L, 2005, CELL CYCLE, V4, P536, DOI 10.4161/cc.4.4.1613; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679	28	234	238	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					242	245		10.1126/science.1140649	http://dx.doi.org/10.1126/science.1140649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626884				2022-12-24	WOS:000247968600042
J	van der Wel, N; Hava, D; Houben, D; Fluitsma, D; van Zon, M; Pierson, J; Brenner, M; Peters, PJ				van der Wel, Nicole; Hava, David; Houben, Diane; Fluitsma, Donna; van Zon, Maaike; Pierson, Jason; Brenner, Michael; Peters, Peter J.			M-tuberculosis and M-leprae translocate from the phagolysosome to the cytosol in myeloid cells	CELL			English	Article							CROSS-PRESENTATION; CALMETTE-GUERIN; BOVIS BCG; ALVEOLAR MACROPHAGES; PHAGOSOMAL MEMBRANES; DENDRITIC CELLS; II MOLECULES; HOST-CELLS; INFECTION; VIRULENCE	M. tuberculosis and M. leprae are considered to be prototypical intracellular pathogens that have evolved strategies to enable growth in the intracellular phagosomes. In contrast, we show that lysosomes rapidly fuse with the virulent M. tuberculosis- and M. leprae-containing phagosomes of human monocyte-derived dendritic cells and macrophages. After 2 days, M. tuberculosis progressively translocates from phagolysosomes into the cytosol in nonapoptotic cells. Cytosolic entry is also observed for M. leprae but not for vaccine strains such as M. bovis BCG or in heat-killed mycobacteria and is dependent upon secretion of the mycobacterial gene products CFP-10 and ESAT-6. The cytosolic bacterial localization and replication are pathogenic features of virulent mycobacteria, causing significant cell death within a week. This may also reveal a mechanism for MHC-based antigen presentation that is lacking in current vaccine strains.	Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; VU Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; VU Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Netherlands Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Peters, PJ (corresponding author), Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.peters@nki.nl	Van Der Wel, Nicole/AAE-7569-2020	van der Wel, Nicole/0000-0001-6392-3417				Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Adams LB, 2002, J INFECT DIS, V185, pS1, DOI 10.1086/338002; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; LEAKE ES, 1984, INFECT IMMUN, V45, P443, DOI 10.1128/IAI.45.2.443-446.1984; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Peters P. J., 2006, CURRENT PROTOCOLS CE; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Philipp WJ, 1996, MICROBIOL-UK, V142, P3135, DOI 10.1099/13500872-142-11-3135; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; van der Wel NN, 2005, CURR OPIN MICROBIOL, V8, P323, DOI 10.1016/j.mib.2005.04.014; van der Wel NN, 2003, MOL BIOL CELL, V14, P3378, DOI 10.1091/mbc.e02-11-0744; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015	53	686	697	0	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1287	1298		10.1016/j.cell.2007.05.059	http://dx.doi.org/10.1016/j.cell.2007.05.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604718	Bronze			2022-12-24	WOS:000247911400015
J	Tang, X; Orlicky, S; Lin, Z; Willems, A; Neculai, D; Ceccarelli, D; Mercurio, F; Shilton, BH; Sicheri, F; Tyers, M				Tang, Xiaojing; Orlicky, Stephen; Lin, Zhenyuan; Willems, Andrew; Neculai, Dante; Ceccarelli, Derek; Mercurio, Frank; Shilton, Brian H.; Sicheri, Frank; Tyers, Mike			Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination	CELL			English	Article							F-BOX PROTEINS; ANGLE SCATTERING DATA; CYCLIN-E; LIGASE COMPLEX; MULTISITE PHOSPHORYLATION; DEPENDENT UBIQUITINATION; STRUCTURAL-ANALYSIS; SCF; DEGRADATION; PROTEOLYSIS	SCF ubiquitin ligases recruit substrates for degradation via F box protein adaptor subunits. WD40 repeat F box proteins, such as Cdc4 and beta-TrCP, contain a conserved dimerization motif called the D domain. Here, we report that the D domain protomers of yeast Cdc4 and human beta-TrCP form a superhelical homotypic dimer. Disruption of the D domain compromises the activity of yeast SCFCdc4 toward the CDK inhibitor Sicl and other substrates. SCFCdc4 dimerization has little effect on the affinity for Sicl but markedly stimulates ubiquitin conjugation. A model of the dimeric holo-SCFCdc4 complex based on small-angle X-ray scatter measurements reveals a suprafacial configuration, in which substrate-binding sites and E2 catalytic sites lie in the same plane with a separation of 64 angstrom within and 102 angstrom between each SCIF monomer. This spatial variability may accommodate diverse acceptor lysine geometries in both substrates and the elongating ubiquitin chain and thereby increase catalytic efficiency.	Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; Cellgene Corp, Summit, NJ 07901 USA; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Western University (University of Western Ontario); University of Toronto	Tyers, M (corresponding author), Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca; tyers@mshri.on.ca	Shilton, Brian H/A-6667-2011; Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021; Neculai, Dante/A-9923-2011; Neculai, Dante/M-2884-2013	Neculai, Dante/0000-0001-8887-9168; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	NCRR NIH HHS [RR-08630] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	160	166	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1165	1176		10.1016/j.cell.2007.04.042	http://dx.doi.org/10.1016/j.cell.2007.04.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574027	Bronze			2022-12-24	WOS:000247390400019
J	Rossi, DJ; Bryder, D; Seita, J; Nussenzweig, A; Hoeijmakers, J; Weissman, IL				Rossi, Derrick J.; Bryder, David; Seita, Jun; Nussenzweig, Andre; Hoeijmakers, Jan; Weissman, Irving L.			Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age	NATURE			English	Article							LIFE-SPAN; SERIAL TRANSPLANTATION; SELF-RENEWAL; MOUSE MODEL; MICE; TELOMERASE; CANCER; TRANSCRIPTION; DEFECTS; STRESS	A diminished capacity to maintain tissue homeostasis is a central physiological characteristic of ageing. As stem cells regulate tissue homeostasis, depletion of stem cell reserves and/or diminished stem cell function have been postulated to contribute to ageing(1). It has further been suggested that accumulated DNA damage could be a principal mechanism underlying age-dependent stem cell decline(2). We have tested these hypotheses by examining haematopoietic stem cell reserves and function with age in mice deficient in several genomic maintenance pathways including nucleotide excision repair(3,4), telomere maintenance(5,6) and non-homologous end-joining(7,8). Here we show that although deficiencies in these pathways did not deplete stem cell reserves with age, stem cell functional capacity was severely affected under conditions of stress, leading to loss of reconstitution and proliferative potential, diminished self-renewal, increased apoptosis and, ultimately, functional exhaustion. Moreover, we provide evidence that endogenous DNA damage accumulates with age in wild-type stem cells. These data are consistent with DNA damage accrual being a physiological mechanism of stem cell ageing that may contribute to the diminished capacity of aged tissues to return to homeostasis after exposure to acute stress or injury.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Receptor Biol, NIH, Bethesda, MD 20892 USA; Erasmus MC, MGC CBG Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC	Rossi, DJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	drossi@stanford.edu	Seita, Jun/AAM-1478-2020; Hoeijmakers, Jan/AAX-6972-2021; Bryder, David/Q-6292-2019	Seita, Jun/0000-0002-3008-3615; Bryder, David/0000-0002-8761-4237	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Schlessinger D, 2001, MECH AGEING DEV, V122, P1537, DOI 10.1016/S0047-6374(01)00299-8; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236	35	816	847	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					725	U15		10.1038/nature05862	http://dx.doi.org/10.1038/nature05862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554309				2022-12-24	WOS:000247030700046
J	Bishop, NA; Guarente, L				Bishop, Nicholas A.; Guarente, Leonard			Two neurons mediate diet-restriction-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; CALORIC RESTRICTION; LARVAL DEVELOPMENT; OXIDATIVE STRESS; METABOLIC-RATE; GENETICS; INTERFERENCE; SPECIFY	Dietary restriction extends lifespan and retards age-related disease in many species and profoundly alters endocrine function in mammals. However, no causal role of any hormonal signal in diet-restricted longevity has been demonstrated. Here we show that increased longevity of diet-restricted Caenorhabditis elegans requires the transcription factor gene skn-1 acting in the ASIs, a pair of neurons in the head. Dietary restriction activates skn-1 in these two neurons, which signals peripheral tissues to increase metabolic activity. These findings demonstrate that increased lifespan in a diet-restricted metazoan depends on cell non-autonomous signalling from central neuronal cells to non-neuronal body tissues, and suggest that the ASI neurons mediate diet-restriction-induced longevity by an endocrine mechanism.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jin Y., 1999, C ELEGANS PRACTICAL, P69; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lawless J.F, 1982, STAT MODELS METHODS; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mobbs CV, 2001, J GERONTOL A-BIOL, V56, P34, DOI 10.1093/gerona/56.suppl_1.34; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	482	506	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					545	+		10.1038/nature05904	http://dx.doi.org/10.1038/nature05904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538612				2022-12-24	WOS:000246842000038
J	Elf, J; Li, GW; Xie, XS				Elf, Johan; Li, Gene-Wei; Xie, X. Sunney			Probing transcription factor dynamics at the single-molecule level in a living cell	SCIENCE			English	Article							COLI-LAC REPRESSOR; DIFFUSION-DRIVEN MECHANISMS; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; NUCLEIC-ACIDS; OPERATOR INTERACTION; GENE-EXPRESSION; DNA; BINDING; TIME	Transcription factors regulate gene expression through their binding to DNA. In a living Escherichia coli cell, we directly observed specific binding of a lac repressor, labeled with a fluorescent protein, to a chromosomal lac operator. Using single-molecule detection techniques, we measured the kinetics of binding and dissociation of the repressor in response to metabolic signals. Furthermore, we characterized the nonspecific binding to DNA, one-dimensional (1D) diffusion along DNA segments, and 3D translocation among segments through cytoplasm at the single-molecule level. In searching for the operator, a lac repressor spends similar to 90% of time nonspecifically bound to and diffusing along DNA with a residence time of < 5 milliseconds. The methods and findings can be generalized to other nucleic acid binding proteins.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Li, Gene-Wei/E-7657-2010	Li, Gene-Wei/0000-0001-7036-8511; elf, johan/0000-0001-5522-1810	NIH HHS [DP1 OD000277-02, DP1 OD000277] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1976, BIOPHYS CHEM, V4, P367, DOI 10.1016/0301-4622(76)80017-8; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Kepes A, 1969, Prog Biophys Mol Biol, V19, P199, DOI 10.1016/0079-6107(69)90006-6; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Mller-Hill B., 1996, LAC OPERON; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WANG AC, 1977, NUCLEIC ACIDS RES, V4, P1579, DOI 10.1093/nar/4.5.1579; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	29	779	792	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1191	1194		10.1126/science.1141967	http://dx.doi.org/10.1126/science.1141967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525339	Green Accepted			2022-12-24	WOS:000246724300043
J	Zoltowski, BD; Schwerdtfeger, C; Widom, J; Loros, JJ; Bilwes, AM; Dunlap, JC; Crane, BR				Zoltowski, Brian D.; Schwerdtfeger, Carsten; Widom, Joanne; Loros, Jennifer J.; Bilwes, Alexandrine M.; Dunlap, Jay C.; Crane, Brian R.			Conformational switching in the fungal light sensor vivid	SCIENCE			English	Article							PHOTOACTIVE YELLOW PROTEIN; PLANT PHOTORECEPTOR DOMAIN; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; WHITE COLLAR-1; LOV2 DOMAIN; BLUE; RECEPTOR; BINDING; SIGNAL	The Neurospora crassa photoreceptor Vivid tunes blue-light responses and modulates gating of the circadian clock. Crystal structures of dark-state and light-state Vivid reveal a light, oxygen, or voltage Per-Arnt-Sim domain with an unusual N-terminal cap region and a loop insertion that accommodates the flavin cofactor. Photoinduced formation of a cystein-flavin adduct drives flavin protonation to induce an N-terminal conformational change. A cysteine-to-serine substitution remote from the flavin adenine dinucleotide binding site decouples conformational switching from the flavin photocycle and prevents Vivid from sending signals in Neurospora. Key elements of this activation mechanism are conserved by other photosensors such as White Collar-1, ZEITLUPE, ENVOY, and flavin-binding, kelch repeat, F-BOX 1 ( FKF1).	Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Cornell University; Dartmouth College; Dartmouth College	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu	Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457; Bilwes Crane, Alexandrine/0000-0001-9922-0692	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, P01GM068087, R37GM034985, F31GM079879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM079879, R37 GM034985, P01 GM068087, GM079879-01, R01 GM034985-24, R37GM34985, R01 GM034985] Funding Source: Medline; NIMH NIH HHS [R01 MH044651, MH44651] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ballario P, 1997, TRENDS MICROBIOL, V5, P458, DOI 10.1016/S0966-842X(97)01144-X; Bernard C, 2005, STRUCTURE, V13, P953, DOI 10.1016/j.str.2005.04.017; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200	31	285	296	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1054	1057		10.1126/science.1137128	http://dx.doi.org/10.1126/science.1137128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510367	Green Accepted			2022-12-24	WOS:000246554000054
J	Thines, B; Katsir, L; Melotto, M; Niu, Y; Mandaokar, A; Liu, GH; Nomura, K; He, SY; Howe, GA; Browse, J				Thines, Bryan; Katsir, Leron; Melotto, Maeli; Niu, Yajie; Mandaokar, Ajin; Liu, Guanghui; Nomura, Kinya; He, Sheng Yang; Howe, Gregg A.; Browse, John			JAZ repressor proteins are targets of the SCFCO11 complex during jasmonate signalling	NATURE			English	Article							METHYL JASMONATE; DEFENSE RESPONSES; REGULATED DEFENSE; GENE-EXPRESSION; PLANT DEFENSE; MALE-STERILE; ACID; COI1; CORONATINE-INSENSITIVE1; BIOSYNTHESIS	Jasmonate and related signalling compounds have a crucial role in both host immunity and development in plants, but the molecular details of the signalling mechanism are poorly understood. Here we identify members of the jasmonate ZIM-domain (JAZ) protein family as key regulators of jasmonate signalling. JAZ1 protein acts to repress transcription of jasmonate-responsive genes. Jasmonate treatment causes JAZ1 degradation and this degradation is dependent on activities of the SCFCOI1 ubiquitin ligase and the 26S proteasome. Furthermore, the jasmonoyl-isoleucine (JA-Ile) conjugate, but not other jasmonate-derivatives such as jasmonate, 12-oxo-phytodienoic acid, or methyl-jasmonate, promotes physical interaction between COI1 and JAZ1 proteins in the absence of other plant proteins. Our results suggest a model in which jasmonate ligands promote the binding of the SCF COI1 ubiquitin ligase to and subsequent degradation of the JAZ1 repressor protein, and implicate the SCFCOI1-JAZ1 protein complex as a site of perception of the plant hormone JA-Ile.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Washington State University; Michigan State University; Michigan State University; Michigan State University	Browse, J (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jab@wsu.edu	Howe, Gregg A/N-1887-2014	Howe, Gregg A/0000-0002-9218-979X; Browse, John/0000-0002-2554-2821; He, Sheng Yang/0000-0003-1308-498X; Melotto, Maeli/0000-0001-6021-9803				Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; Conconi A, 1996, NATURE, V383, P826, DOI 10.1038/383826a0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Jensen AB, 2002, PLANT J, V29, P595, DOI 10.1046/j.0960-7412.2001.01241.x; KATAGIRI F, 2002, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0039; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kramell R, 1997, FEBS LETT, V414, P197, DOI 10.1016/S0014-5793(97)01005-3; Li CY, 2005, PLANT CELL, V17, P971, DOI 10.1105/tpc.104.029108; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	37	1610	1745	42	477	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					661	U2		10.1038/nature05960	http://dx.doi.org/10.1038/nature05960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17637677				2022-12-24	WOS:000248598000037
J	Miller-Jensen, K; Janes, KA; Brugge, JS; Lauffenburger, DA				Miller-Jensen, Kathryn; Janes, Kevin A.; Brugge, Joan S.; Lauffenburger, Douglas A.			Common effector processing mediates cell-specific responses to stimuli	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTORS; CANCER; TNF; NETWORKS; INFLAMMATION; INDUCTION; APOPTOSIS	The fundamental components of many signalling pathways are common to all cells(1-3). However, stimulating or perturbing the intracellular network often causes distinct phenotypes that are specific to a given cell type(4,5). This 'cell specificity' presents a challenge in understanding how intracellular networks regulate cell behaviour and an obstacle to developing drugs that treat signalling dysfunctions(6,7). Here we apply a systems-modelling approach(8) to investigate how cell-specific signalling events are integrated through effector proteins to cause cell-specific outcomes. We focus on the synergy between tumour necrosis factor and an adenoviral vector as a therapeutically relevant stimulus that induces cell-specific responses(9-11). By constructing models that estimate how kinase-signalling events are processed into phenotypes through effector substrates, we find that accurate predictions of cell specificity are possible when different cell types share a common 'effector-processing' mechanism. Partial-least-squares regression models based on common effector processing accurately predict cell-specific apoptosis, chemokine release, gene induction, and drug sensitivity across divergent epithelial cell lines. We conclude that cell specificity originates from the differential activation of kinases and other upstream transducers, which together enable different cell types to use common effectors to generate diverse outcomes. The common processing of network signals by downstream effectors points towards an important cell biological principle, which can be applied to the understanding of cell-specific responses to targeted drug therapies(6).	MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lauffenburger, DA (corresponding author), MIT, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lauffen@mit.edu		Miller-Jensen, Kathryn/0000-0002-7233-0100				Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bowen GP, 2002, HUM GENE THER, V13, P367, DOI 10.1089/10430340252792503; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Gerhart J, 1999, TERATOLOGY, V60, P226; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Janes KA, 2006, CURR OPIN CHEM BIOL, V10, P73, DOI 10.1016/j.cbpa.2005.12.016; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenakin T, 2003, NAT REV DRUG DISCOV, V2, P429, DOI 10.1038/nrd1110; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P118; Liu TC, 2005, GENE THER, V12, P1333, DOI 10.1038/sj.gt.3302555; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; NELSON PJ, 1993, J IMMUNOL, V151, P2601; OHMORI Y, 1994, BIOCHEM BIOPH RES CO, V198, P590, DOI 10.1006/bbrc.1994.1086; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schmitz EK, 2004, APOPTOSIS, V9, P369, DOI 10.1023/B:APPT.0000025814.46962.62; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	34	145	151	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					604	U11		10.1038/nature06001	http://dx.doi.org/10.1038/nature06001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17637676				2022-12-24	WOS:000248446700046
J	Laporte, NT; Stabach, JA; Grosch, R; Lin, TS; Goetz, SJ				Laporte, Nadine T.; Stabach, Jared A.; Grosch, Robert; Lin, Tiffany S.; Goetz, Scott J.			Expansion of industrial logging in Central Africa	SCIENCE			English	Article							FOREST STRUCTURE; CONSERVATION		Woods Hole Res Ctr, Falmouth, MA 02540 USA	Woods Hole Research Center	Laporte, NT (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	nlaporte@whrc.org	Goetz, Scott J/A-3393-2015; Stabach, Jared/AEX-9187-2022	Goetz, Scott J/0000-0002-6326-4308; Stabach, Jared/0000-0002-7896-1237				BUYS P, 2006, 4097 WPS WORLD BANK; Hall JS, 2003, FOREST ECOL MANAG, V183, P249, DOI 10.1016/S0378-1127(03)00107-5; Malcolm JR, 2000, CONSERV BIOL, V14, P1623, DOI [10.1046/j.1523-1739.2000.99070.x, 10.1111/j.1523-1739.2000.99070.x]; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; WHITE LIT, 1994, J TROP ECOL, V10, P309	5	223	228	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1451	1451		10.1126/science.1141057	http://dx.doi.org/10.1126/science.1141057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556578				2022-12-24	WOS:000247066400034
J	Dodd, IB; Micheelsen, MA; Sneppen, K; Thon, G				Dodd, Ian B.; Micheelsen, Mille A.; Sneppen, Kim; Thon, Genevive			Theoretical analysis of epigenetic cell memory by nucleosome modification	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; METHYLATION PATTERNS; HISTONE DEACETYLASE; IN-VIVO; HETEROCHROMATIN FORMATION; DROSOPHILA SU(VAR)3-9; CHROMODOMAIN PROTEIN; POSITIVE-FEEDBACK; RNA INTERFERENCE	Chromosomal regions can adopt stable and heritable alternative states resulting in bistable gene expression without changes to the DNA sequence. Such epigenetic control is often associated with alternative covalent modifications of histones. The stability and heritability of the states are thought to involve positive feedback where modified nucleosomes recruit enzymes that similarly modify nearby nucleosomes. We developed a simplified stochastic model for dynamic nucleosome modification based on the silent mating-type region of the yeast Schizosaccharomyces pombe. We show that the mechanism can give strong bistability that is resistant both to high noise due to random gain or loss of nucleosome modifications and to random partitioning upon DNA replication. However, robust bistability required: (1) cooperativity, the activity of more than one modified nucleosome, in the modification reactions and (2) that nucleosomes occasionally stimulate modification beyond their neighbor nucleosomes, arguing against a simple continuous spreading of nucleosome modification.	Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen O, Denmark; Univ Adelaide, Dept Mol & Biomed Sci Biochem, Adelaide, SA 5005, Australia; Univ Copenhagen, Bioctr, Dept Mol Biol, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Niels Bohr Institute; University of Adelaide; University of Copenhagen	Sneppen, K (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	sneppen@nbi.dk	; Thon, Genevieve/L-9497-2014	Dodd, Ian/0000-0003-2969-6841; Sneppen, Kim/0000-0001-9820-3567; Thon, Genevieve/0000-0001-8550-5945				Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Arney KL, 2001, INT J DEV BIOL, V45, P533; Ayoub N, 2000, GENETICS, V156, P983; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; LEWIS J, 1977, J THEOR BIOL, V65, P579, DOI 10.1016/0022-5193(77)90216-8; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Rusche LN, 2001, GENE DEV, V15, P955; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Thon G, 1999, GENETICS, V151, P945; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Thon G, 1997, GENETICS, V145, P685; Thon G, 2002, GENETICS, V161, P611; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; ZIMM BH, 1959, P NATL ACAD SCI USA, V45, P1601, DOI 10.1073/pnas.45.11.1601	55	303	306	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					813	822		10.1016/j.cell.2007.02.053	http://dx.doi.org/10.1016/j.cell.2007.02.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512413	Bronze			2022-12-24	WOS:000246788300024
J	Lartigue, C; Glass, JI; Alperovich, N; Pieper, R; Parmar, PP; Hutchison, CA; Smith, HO; Venter, JC				Lartigue, Carole; Glass, John I.; Alperovich, Nina; Pieper, Rembert; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig			Genome transplantation in bacteria: Changing one species to another	SCIENCE			English	Article							MYCOPLASMA-CAPRICOLUM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; COMPETENT CELLS; DNA; TRANSFORMATION; PLASMIDS; CLONING	As a step toward propagation of synthetic genomes, we completely replaced the genome of a bacterial cell with one from another species by transplanting a whole genome as naked DNA. Intact genomic DNA from Mycoplasma mycoides large colony (LC), virtually free of protein, was transplanted into Mycoplasma capricolum cells by polyethylene glycol-mediated transformation. Cells selected for tetracycline resistance, carried by the M. mycoides LC chromosome, contain the complete donor genome and are free of detectable recipient genomic sequences. These cells that result from genome transplantation are phenotypically identical to the M. mycoides LC donor strain as judged by several criteria.	J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Glass, JI (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	jglass@jcvi.org	Lartigue, Carole/GQP-4896-2022; lartigue, carole/I-1576-2013; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Glass, John/0000-0002-3784-5301				Akamatsu T, 2001, BIOSCI BIOTECH BIOCH, V65, P823, DOI 10.1271/bbb.65.823; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Garfinkel M. S., SYNTHETIC GENOMICS O; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; *GENBANK, NC007633 GENBANK; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holt RA, 2007, BIOESSAYS, V29, P580, DOI 10.1002/bies.20585; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Saito Y, 2006, J BIOSCI BIOENG, V101, P334, DOI 10.1263/jbb.101.334; Seto S, 1999, J BACTERIOL, V181, P6073, DOI 10.1128/JB.181.19.6073-6080.1999; Seto S, 1998, J BACTERIOL, V180, P256, DOI 10.1128/JB.180.2.256-264.1998; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TARSHIS M, 1993, BIOPHYS J, V64, P709, DOI 10.1016/S0006-3495(93)81430-9; Teachman AM, 2002, J BACTERIOL, V184, P947, DOI 10.1128/jb.184.4.947-951.2002; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	24	266	311	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					632	638		10.1126/science.1144622	http://dx.doi.org/10.1126/science.1144622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17600181				2022-12-24	WOS:000248494400037
J	Ousman, SS; Tomooka, BH; van Noort, JM; Wawrousek, EF; O'Connor, KC; Hafler, DA; Sobel, RA; Robinson, WH; Steinman, L				Ousman, Shalina S.; Tomooka, Beren H.; van Noort, Johannes M.; Wawrousek, Eric F.; O'Connor, Kevin C.; Hafler, David A.; Sobel, Raymond A.; Robinson, William H.; Steinman, Lawrence			Protective and therapeutic role for alpha B-crystallin in autoimmune demyelination	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; LENS EPITHELIAL-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; CANDIDATE AUTOANTIGEN; A-CRYSTALLIN; APOPTOSIS; EXPRESSION; DISEASE; ENCEPHALOMYELITIS	alpha B-crystallin (CRYAB) is the most abundant gene transcript present in early active multiple sclerosis lesions, whereas such transcripts are absent in normal brain tissue(1). This crystallin has anti-apoptotic(2-7) and neuroprotective(8) functions. CRYAB is the major target of CD4(+) T-cell immunity to the myelin sheath from multiple sclerosis brain(9,10). The pathophysiological implications of this immune response were investigated here. We demonstrate that CRYAB is a potent negative regulator acting as a brake on several inflammatory pathways in both the immune system and central nervous system (CNS). Cryab(-/-) mice showed worse experimental autoimmune encephalomyelitis (EAE) at the acute and progressive phases, with higher Th1 and Th17 cytokine secretion from T cells and macrophages, and more intense CNS inflammation, compared with their wild-type counterparts. Furthermore, Cryab(-/-) astrocytes showed more cleaved caspase-3 and more TUNEL staining, indicating an anti-apoptotic function of Cryab. Antibody to CRYAB was detected in cerebrospinal fluid from multiple sclerosis patients and in sera from mice with EAE. Administration of recombinant CRYAB ameliorated EAE. Thus, the immune response against a negative regulator of inflammation, CRYAB, in multiple sclerosis, would exacerbate inflammation and demyelination. This can be countered by giving CRYAB itself for therapy of ongoing disease.	Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Lab Serv, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; TNO Qual Life, Dept Biosci, NL-2301 CE Leiden, Netherlands; NEI, NIH, Bethesda, MD 20892 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Netherlands Organization Applied Science Research; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	steinman@stanford.edu	Wawrousek, Eric/A-4547-2008	van Noort, Johannes/0000-0002-9060-5921; Sobel, Raymond/0000-0002-0477-9002; Steinman, Lawrence/0000-0002-2437-2250; Robinson, William/0000-0003-4385-704X	NATIONAL EYE INSTITUTE [ZIAEY000286, Z01EY000286] Funding Source: NIH RePORTER; Multiple Sclerosis Society [835] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Multiple Sclerosis Society(National Multiple Sclerosis Society)		Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; Doerwald L, 2004, J MOL EVOL, V59, P674, DOI 10.1007/s00239-004-2659-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Korlimbinis A, 2006, BIOCHEMISTRY-US, V45, P1852, DOI 10.1021/bi051737+; Li DWC, 2001, EXP CELL RES, V266, P279, DOI 10.1006/excr.2001.5223; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Webster KA, 2003, CIRC RES, V92, P130, DOI 10.1161/01.RES.0000056967.51841.21; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901	30	399	413	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					474	U7		10.1038/nature05935	http://dx.doi.org/10.1038/nature05935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17568699				2022-12-24	WOS:000248302700047
J	Koster, DA; Palle, K; Bot, ESM; Bjornsti, MA; Dekker, NH				Koster, Daniel A.; Palle, Komaraiah; Bot, Elisa S. M.; Bjornsti, Mary-Ann; Dekker, Nynke H.			Antitumour drugs impede DNA uncoiling by topoisomerase I	NATURE			English	Article							CELL-DEATH; CAMPTOTHECIN; MECHANISM; RELAXATION; INHIBITORS; YEAST; REPLICATION; MUTATIONS; COMPLEXES; TOXICITY	Increasing the ability of chemotherapeutic drugs to kill cancer cells is often hampered by a limited understanding of their mechanism of action. Camptothecins, such as topotecan, induce cell death by poisoning DNA topoisomerase I, an enzyme capable of removing DNA supercoils(1-4). Topotecan is thought to stabilize a covalent topoisomerase-DNA complex(5-7), rendering it an obstacle to DNA replication forks(2,3,8,9). Here we use single-molecule nanomanipulation to monitor the dynamics of human topoisomerase I in the presence of topotecan. This allowed us to detect the binding and unbinding of an individual topotecan molecule in real time and to quantify the drug-induced trapping of topoisomerase on DNA. Unexpectedly, our findings also show that topotecan significantly hinders topoisomerase-mediated DNA uncoiling, with a more pronounced effect on the removal of positive (overwound) versus negative supercoils. In vivo experiments in the budding yeast verified the resulting prediction that positive supercoils would accumulate during transcription and replication as a consequence of camptothecin poisoning of topoisomerase I. Positive supercoils, however, were not induced by drug treatment of cells expressing a catalytically active, camptothecin-resistant topoisomerase I mutant. This combination of single-molecule and in vivo data suggests a cytotoxic mechanism for camptothecins, in which the accumulation of positive supercoils ahead of the replication machinery induces potentially lethal DNA lesions.	Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	Delft University of Technology; St Jude Children's Research Hospital	Dekker, NH (corresponding author), Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	n.h.dekker@tudelft.nl		Dekker, Nynke/0000-0003-4029-0973				Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHAMPOUX JJ, 1989, J BIOL CHEM, V264, P1010; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; Hann C, 1998, J BIOL CHEM, V273, P8425, DOI 10.1074/jbc.273.14.8425; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Minsky Bruce D, 2004, Oncology (Williston Park), V18, P49; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rodriguez-Galindo C, 2000, MED PEDIATR ONCOL, V35, P385, DOI 10.1002/1096-911X(20001001)35:4<385::AID-MPO1>3.0.CO;2-E; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart DJ, 2004, ONCOLOGIST, V9, P33, DOI 10.1634/theoncologist.9-90006-33; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stivers JT, 1997, BIOCHEMISTRY-US, V36, P5212, DOI 10.1021/bi962880t; Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	30	224	228	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					213	217		10.1038/nature05938	http://dx.doi.org/10.1038/nature05938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17589503				2022-12-24	WOS:000247934500047
J	Foster, SL; Hargreaves, DC; Medzhitov, R				Foster, Simmie L.; Hargreaves, Diana C.; Medzhitov, Ruslan			Gene-specific control of inflammation by TLR-induced chromatin modifications	NATURE			English	Article							KAPPA-B; MACROPHAGE ACTIVATION; MOLECULAR-MECHANISMS; MURINE MACROPHAGES; BACTERIAL PYROGENS; MESSENGER-RNA; TNF-ALPHA; IN-VITRO; RECEPTOR; LIPOPOLYSACCHARIDE	Toll-like receptors (TLRs) induce a multi-component inflammatory response that must be tightly regulated to avoid tissue damage. Most known regulatory mechanisms target TLR signalling pathways and thus broadly inhibit multiple aspects of the inflammatory response. Given the functional diversity of TLR-induced genes, we proposed that additional, gene-specific regulatory mechanisms exist to allow individual aspects of the TLR-induced response to be differentially regulated. Using an in vitro system of lipopolysaccharide tolerance in murine macrophages, we show that TLR-induced genes fall into two categories on the basis of their functions and regulatory requirements. We demonstrate that representatives from the two classes acquire distinct patterns of TLR-induced chromatin modifications. These gene-specific chromatin modifications are associated with transient silencing of one class of genes, which includes pro-inflammatory mediators, and priming of the second class, which includes antimicrobial effectors. These findings illustrate an adaptive response in macrophages and reveal component-specific regulation of inflammation.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06405 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA.	ruslan.medzhitov@yale.edu						BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEESON PB, 1947, J EXP MED, V86, P39, DOI 10.1084/jem.86.1.39; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Flohe S, 1999, CYTOKINE, V11, P796, DOI 10.1006/cyto.1998.0490; Fujihara M, 2000, J LEUKOCYTE BIOL, V68, P267; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shnyra A, 1998, J IMMUNOL, V160, P3729; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	37	874	914	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					972	U4		10.1038/nature05836	http://dx.doi.org/10.1038/nature05836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17538624				2022-12-24	WOS:000247373100040
J	Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; Snyder, M; Dermitzakis, ET; Stamatoyannopoulos, JA; Thurman, RE; Kuehn, MS; Taylor, CM; Neph, S; Koch, CM; Asthana, S; Malhotra, A; Adzhubei, I; Greenbaum, JA; Andrews, RM; Flicek, P; Boyle, PJ; Cao, H; Carter, NP; Clelland, GK; Davis, S; Day, N; Dhami, P; Dillon, SC; Dorschner, MO; Fiegler, H; Giresi, PG; Goldy, J; Hawrylycz, M; Haydock, A; Humbert, R; James, KD; Johnson, BE; Johnson, EM; Frum, TT; Rosenzweig, ER; Karnani, N; Lee, K; Lefebvre, GC; Navas, PA; Neri, F; Parker, SCJ; Sabo, PJ; Sandstrom, R; Shafer, A; Vetrie, D; Weaver, M; Wilcox, S; Yu, M; Collins, FS; Dekker, J; Lieb, JD; Tullius, TD; Crawford, GE; Sunyaev, S; Noble, WS; Dunham, I; Dutta, A; Guigo, R; Denoeud, F; Reymond, A; Kapranov, P; Rozowsky, J; Zheng, DY; Castelo, R; Frankish, A; Harrow, J; Ghosh, S; Sandelin, A; Hofacker, IL; Baertsch, R; Keefe, D; Flicek, P; Dike, S; Cheng, J; Hirsch, HA; Sekinger, EA; Lagarde, J; Abril, JF; Shahab, A; Flamm, C; Fried, C; Hackermuller, J; Hertel, J; Lindemeyer, M; Missal, K; Tanzer, A; Washietl, S; Korbel, J; Emanuelsson, O; Pedersen, JS; Holroyd, N; Taylor, R; Swarbreck, D; Matthews, N; Dickson, MC; Thomas, DJ; Weirauch, MT; Gilbert, J; Drenkow, J; Bell, I; Zhao, X; Srinivasan, KG; Sung, WK; Ooi, HS; Chiu, KP; Foissac, S; Alioto, T; Brent, M; Pachter, L; Tress, ML; Valencia, A; Choo, SW; Choo, CY; Ucla, C; Manzano, C; Wyss, C; Cheung, E; Clark, TG; Brown, JB; Ganesh, M; Patel, S; Tammana, H; Chrast, J; Henrichsen, CN; Kai, C; Kawai, J; Nagalakshmi, U; Wu, JQ; Lian, Z; Lian, J; Newburger, P; Zhang, XQ; Bickel, P; Mattick, JS; Carninci, P; Hayashizaki, Y; Weissman, S; Dermitzakis, ET; Margulies, EH; Hubbard, T; Myers, RM; Rogers, J; Stadler, PF; Lowe, TM; Wei, CL; Ruan, YJ; Snyder, M; Birney, E; Struhl, K; Gerstein, M; Antonarakis, SE; Gingeras, TR; Brown, JB; Flicek, P; Fu, YT; Keefe, D; Birney, E; Denoeud, F; Gerstein, M; Green, ED; Kapranov, P; Karaoz, U; Myers, RM; Noble, WS; Reymond, A; Rozowsky, J; Struhl, K; Siepel, A; Stamatoyannopoulos, JA; Taylor, CM; Taylor, J; Thurman, RE; Tullius, TD; Washietl, S; Zheng, DY; Liefer, LA; Wetterstrand, KA; Good, PJ; Feingold, EA; Guyer, MS; Collins, FS; Margulies, EH; Cooper, GM; Asimenos, G; Thomas, DJ; Dewey, CN; Siepel, A; Birney, E; Keefe, D; Hou, MM; Taylor, J; Nikolaev, S; Montoya-Burgos, JI; Loytynoja, A; Whelan, S; Pardi, F; Massingham, T; Brown, JB; Huang, HY; Zhang, NR; Bickel, P; Holmes, I; Mullikin, JC; Ureta-Vidal, A; Paten, B; Seringhaus, M; Church, D; Rosenbloom, K; Kent, WJ; Stone, EA; Gerstein, M; Antonarakis, SE; Batzoglou, S; Goldman, N; Hardison, RC; Haussler, D; Miller, W; Pachter, L; Green, ED; Sidow, A; Weng, ZP; Trinklein, ND; Fu, YT; Zhang, ZDD; Karaoz, U; Barrera, L; Stuart, R; Zheng, DY; Ghosh, S; Flicek, P; King, DC; Taylor, J; Ameur, A; Enroth, S; Bieda, MC; Koch, CM; Hirsch, HA; Wei, CL; Cheng, J; Kim, J; Bhinge, AA; Giresi, PG; Jiang, N; Liu, J; Yao, F; Sung, WK; Chiu, KP; Vega, VB; Lee, CWH; Ng, P; Shahab, A; Sekinger, EA; Yang, A; Moqtaderi, Z; Zhu, Z; Xu, XQ; Squazzo, S; Oberley, MJ; Inman, D; Singer, MA; Richmond, TA; Munn, KJ; Rada-Iglesias, A; Wallerman, O; Komorowski, J; Clelland, GK; Wilcox, S; Dillon, SC; Andrews, RM; Fowler, JC; Couttet, P; James, KD; Lefebvre, GC; Bruce, AW; Dovey, OM; Ellis, PD; Dhami, P; Langford, CF; Carter, NP; Vetrie, D; Kapranov, P; Nix, DA; Bell, I; Patel, S; Rozowsky, J; Euskirchen, G; Hartman, S; Lian, J; Wu, JQ; Urban, AE; Kraus, P; Van Calcar, S; Heintzman, N; Kim, TH; Wang, K; Qu, CX; Hon, G; Luna, R; Glass, CK; Rosenfeld, MG; Aldred, SF; Cooper, SJ; Halees, A; Lin, JM; Shulha, HP; Zhang, XL; Xu, MS; Haidar, JNS; Yu, Y; Birney, E; Weissman, S; Ruan, YJ; Lieb, JD; Iyer, VR; Green, RD; Gingeras, TR; Wadelius, C; Dunham, I; Struhl, K; Hardison, RC; Gerstein, M; Farnham, PJ; Myers, RM; Ren, B; Snyder, M; Thomas, DJ; Rosenbloom, K; Harte, RA; Hinrichs, AS; Trumbower, H; Clawson, H; Hillman-Jackson, J; Zweig, AS; Smith, K; Thakkapallayil, A; Barber, G; Kuhn, RM; Karolchik, D; Haussler, D; Kent, WJ; Dermitzakis, ET; Armengol, L; Bird, CP; Clark, TG; Cooper, GM; de Bakker, PIW; Kern, AD; Lopez-Bigas, N; Martin, JD; Stranger, BE; Thomas, DJ; Woodroffe, A; Batzoglou, S; Davydov, E; Dimas, A; Eyras, E; Hallgrimsdottir, IB; Hardison, RC; Huppert, J; Sidow, A; Taylor, J; Trumbower, H; Zody, MC; Guigo, R; Mullikin, JC; Abecasis, GR; Estivill, X; Birney, E; Bouffard, GG; Guan, XB; Hansen, NF; Idol, JR; Maduro, VVB; Maskeri, B; McDowell, JC; Park, M; Thomas, PJ; Young, AC; Blakesley, RW; Muzny, DM; Sodergren, E; Wheeler, DA; Worley, KC; Jiang, HY; Weinstock, GM; Gibbs, RA; Graves, T; Fulton, R; Mardis, ER; Wilson, RK; Clamp, M; Cuff, J; Gnerre, S; Jaffe, DB; Chang, JL; Lindblad-Toh, K; Lander, ES; Koriabine, M; Nefedov, M; Osoegawa, K; Yoshinaga, Y; Zhu, BL; de Jong, PJ				Birney, Ewan; Stamatoyannopoulos, John A.; Dutta, Anindya; Guigo, Roderic; Gingeras, Thomas R.; Margulies, Elliott H.; Weng, Zhiping; Snyder, Michael; Dermitzakis, Emmanouil T.; Stamatoyannopoulos, John A.; Thurman, Robert E.; Kuehn, Michael S.; Taylor, Christopher M.; Neph, Shane; Koch, Christoph M.; Asthana, Saurabh; Malhotra, Ankit; Adzhubei, Ivan; Greenbaum, Jason A.; Andrews, Robert M.; Flicek, Paul; Boyle, Patrick J.; Cao, Hua; Carter, Nigel P.; Clelland, Gayle K.; Davis, Sean; Day, Nathan; Dhami, Pawandeep; Dillon, Shane C.; Dorschner, Michael O.; Fiegler, Heike; Giresi, Paul G.; Goldy, Jeff; Hawrylycz, Michael; Haydock, Andrew; Humbert, Richard; James, Keith D.; Johnson, Brett E.; Johnson, Ericka M.; Frum, Tristan T.; Rosenzweig, Elizabeth R.; Karnani, Neerja; Lee, Kirsten; Lefebvre, Gregory C.; Navas, Patrick A.; Neri, Fidencio; Parker, Stephen C. J.; Sabo, Peter J.; Sandstrom, Richard; Shafer, Anthony; Vetrie, David; Weaver, Molly; Wilcox, Sarah; Yu, Man; Collins, Francis S.; Dekker, Job; Lieb, Jason D.; Tullius, Thomas D.; Crawford, Gregory E.; Sunyaev, Shamil; Noble, William S.; Dunham, Ian; Dutta, Anindya; Guigo, Roderic; Denoeud, France; Reymond, Alexandre; Kapranov, Philipp; Rozowsky, Joel; Zheng, Deyou; Castelo, Robert; Frankish, Adam; Harrow, Jennifer; Ghosh, Srinka; Sandelin, Albin; Hofacker, Ivo L.; Baertsch, Robert; Keefe, Damian; Flicek, Paul; Dike, Sujit; Cheng, Jill; Hirsch, Heather A.; Sekinger, Edward A.; Lagarde, Julien; Abril, Josep F.; Shahab, Atif; Flamm, Christoph; Fried, Claudia; Hackermueller, Joerg; Hertel, Jana; Lindemeyer, Manja; Missal, Kristin; Tanzer, Andrea; Washietl, Stefan; Korbel, Jan; Emanuelsson, Olof; Pedersen, Jakob S.; Holroyd, Nancy; Taylor, Ruth; Swarbreck, David; Matthews, Nicholas; Dickson, Mark C.; Thomas, Daryl J.; Weirauch, Matthew T.; Gilbert, James; Drenkow, Jorg; Bell, Ian; Zhao, XiaoDong; Srinivasan, K. G.; Sung, Wing-Kin; Ooi, Hong Sain; Chiu, Kuo Ping; Foissac, Sylvain; Alioto, Tyler; Brent, Michael; Pachter, Lior; Tress, Michael L.; Valencia, Alfonso; Choo, Siew Woh; Choo, Chiou Yu; Ucla, Catherine; Manzano, Caroline; Wyss, Carine; Cheung, Evelyn; Clark, Taane G.; Brown, James B.; Ganesh, Madhavan; Patel, Sandeep; Tammana, Hari; Chrast, Jacqueline; Henrichsen, Charlotte N.; Kai, Chikatoshi; Kawai, Jun; Nagalakshmi, Ugrappa; Wu, Jiaqian; Lian, Zheng; Lian, Jin; Newburger, Peter; Zhang, Xueqing; Bickel, Peter; Mattick, John S.; Carninci, Piero; Hayashizaki, Yoshihide; Weissman, Sherman; Dermitzakis, Emmanouil T.; Margulies, Elliott H.; Hubbard, Tim; Myers, Richard M.; Rogers, Jane; Stadler, Peter F.; Lowe, Todd M.; Wei, Chia-Lin; Ruan, Yijun; Snyder, Michael; Birney, Ewan; Struhl, Kevin; Gerstein, Mark; Antonarakis, Stylianos E.; Gingeras, Thomas R.; Brown, James B.; Flicek, Paul; Fu, Yutao; Keefe, Damian; Birney, Ewan; Denoeud, France; Gerstein, Mark; Green, Eric D.; Kapranov, Philipp; Karaoez, Ulas; Myers, Richard M.; Noble, William S.; Reymond, Alexandre; Rozowsky, Joel; Struhl, Kevin; Siepel, Adam; Stamatoyannopoulos, John A.; Taylor, Christopher M.; Taylor, James; Thurman, Robert E.; Tullius, Thomas D.; Washietl, Stefan; Zheng, Deyou; Liefer, Laura A.; Wetterstrand, Kris A.; Good, Peter J.; Feingold, Elise A.; Guyer, Mark S.; Collins, Francis S.; Margulies, Elliott H.; Cooper, Gregory M.; Asimenos, George; Thomas, Daryl J.; Dewey, Colin N.; Siepel, Adam; Birney, Ewan; Keefe, Damian; Hou, Minmei; Taylor, James; Nikolaev, Sergey; Montoya-Burgos, Juan I.; Loeytynoja, Ari; Whelan, Simon; Pardi, Fabio; Massingham, Tim; Brown, James B.; Huang, Haiyan; Zhang, Nancy R.; Bickel, Peter; Holmes, Ian; Mullikin, James C.; Ureta-Vidal, Abel; Paten, Benedict; Seringhaus, Michael; Church, Deanna; Rosenbloom, Kate; Kent, W. James; Stone, Eric A.; Gerstein, Mark; Antonarakis, Stylianos E.; Batzoglou, Serafim; Goldman, Nick; Hardison, Ross C.; Haussler, David; Miller, Webb; Pachter, Lior; Green, Eric D.; Sidow, Arend; Weng, Zhiping; Trinklein, Nathan D.; Fu, Yutao; Zhang, Zhengdong D.; Karaoez, Ulas; Barrera, Leah; Stuart, Rhona; Zheng, Deyou; Ghosh, Srinka; Flicek, Paul; King, David C.; Taylor, James; Ameur, Adam; Enroth, Stefan; Bieda, Mark C.; Koch, Christoph M.; Hirsch, Heather A.; Wei, Chia-Lin; Cheng, Jill; Kim, Jonghwan; Bhinge, Akshay A.; Giresi, Paul G.; Jiang, Nan; Liu, Jun; Yao, Fei; Sung, Wing-Kin; Chiu, Kuo Ping; Vega, Vinsensius B.; Lee, Charlie W. H.; Ng, Patrick; Shahab, Atif; Sekinger, Edward A.; Yang, Annie; Moqtaderi, Zarmik; Zhu, Zhou; Xu, Xiaoqin; Squazzo, Sharon; Oberley, Matthew J.; Inman, David; Singer, Michael A.; Richmond, Todd A.; Munn, Kyle J.; Rada-Iglesias, Alvaro; Wallerman, Ola; Komorowski, Jan; Clelland, Gayle K.; Wilcox, Sarah; Dillon, Shane C.; Andrews, Robert M.; Fowler, Joanna C.; Couttet, Phillippe; James, Keith D.; Lefebvre, Gregory C.; Bruce, Alexander W.; Dovey, Oliver M.; Ellis, Peter D.; Dhami, Pawandeep; Langford, Cordelia F.; Carter, Nigel P.; Vetrie, David; Kapranov, Philipp; Nix, David A.; Bell, Ian; Patel, Sandeep; Rozowsky, Joel; Euskirchen, Ghia; Hartman, Stephen; Lian, Jin; Wu, Jiaqian; Urban, Alexander E.; Kraus, Peter; Van Calcar, Sara; Heintzman, Nate; Kim, Tae Hoon; Wang, Kun; Qu, Chunxu; Hon, Gary; Luna, Rosa; Glass, Christopher K.; Rosenfeld, M. Geoff; Force Aldred, Shelley; Cooper, Sara J.; Halees, Anason; Lin, Jane M.; Shulha, Hennady P.; Zhang, Xiaoling; Xu, Mousheng; Haidar, Jaafar N. S.; Yu, Yong; Birney, Ewan; Weissman, Sherman; Ruan, Yijun; Lieb, Jason D.; Iyer, Vishwanath R.; Green, Roland D.; Gingeras, Thomas R.; Wadelius, Claes; Dunham, Ian; Struhl, Kevin; Hardison, Ross C.; Gerstein, Mark; Farnham, Peggy J.; Myers, Richard M.; Ren, Bing; Snyder, Michael; Thomas, Daryl J.; Rosenbloom, Kate; Harte, Rachel A.; Hinrichs, Angie S.; Trumbower, Heather; Clawson, Hiram; Hillman-Jackson, Jennifer; Zweig, Ann S.; Smith, Kayla; Thakkapallayil, Archana; Barber, Galt; Kuhn, Robert M.; Karolchik, Donna; Haussler, David; Kent, W. James; Dermitzakis, Emmanouil T.; Armengol, Lluis; Bird, Christine P.; Clark, Taane G.; Cooper, Gregory M.; de Bakker, Paul I. W.; Kern, Andrew D.; Lopez-Bigas, Nuria; Martin, Joel D.; Stranger, Barbara E.; Thomas, Daryl J.; Woodroffe, Abigail; Batzoglou, Serafim; Davydov, Eugene; Dimas, Antigone; Eyras, Eduardo; Hallgrimsdottir, Ingileif B.; Hardison, Ross C.; Huppert, Julian; Sidow, Arend; Taylor, James; Trumbower, Heather; Zody, Michael C.; Guigo, Roderic; Mullikin, James C.; Abecasis, Goncalo R.; Estivill, Xavier; Birney, Ewan; Bouffard, Gerard G.; Guan, Xiaobin; Hansen, Nancy F.; Idol, Jacquelyn R.; Maduro, Valerie V. B.; Maskeri, Baishali; McDowell, Jennifer C.; Park, Morgan; Thomas, Pamela J.; Young, Alice C.; Blakesley, Robert W.; Muzny, Donna M.; Sodergren, Erica; Wheeler, David A.; Worley, Kim C.; Jiang, Huaiyang; Weinstock, George M.; Gibbs, Richard A.; Graves, Tina; Fulton, Robert; Mardis, Elaine R.; Wilson, Richard K.; Clamp, Michele; Cuff, James; Gnerre, Sante; Jaffe, David B.; Chang, Jean L.; Lindblad-Toh, Kerstin; Lander, Eric S.; Koriabine, Maxim; Nefedov, Mikhail; Osoegawa, Kazutoyo; Yoshinaga, Yuko; Zhu, Baoli; de Jong, Pieter J.		ENCODE Project Consortium	Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project	NATURE			English	Review							FACTOR-BINDING-SITES; POLYCOMB TARGET GENES; SEQUENCE TAG ANALYSIS; HIGH-RESOLUTION; ANTISENSE TRANSCRIPTION; REGULATORY ELEMENTS; ADENINE TRACT; C-MYC; DNA; REPLICATION	We report the generation and analysis of functional data from multiple, diverse experiments performed on a targeted 1% of the human genomeas part of the pilot phase of the ENCODE Project. These data have been further integrated and augmented by a number of evolutionary and computational analyses. Together, our results advance the collective knowledge about human genome function in several major areas. First, our studies provide convincing evidence that the genome is pervasively transcribed, such that the majority of its bases can be found in primary transcripts, including non-protein-coding transcripts, and those that extensively overlap one another. Second, systematic examination of transcriptional regulation has yielded new understanding about transcription start sites, including their relationship to specific regulatory sequences and features of chromatin accessibility and histone modification. Third, a more sophisticated view of chromatin structure has emerged, including its inter-relationship with DNA replication and transcriptional regulation. Finally, integration of these new sources of information, in particular with respect to mammalian evolution based on inter-and intra-species sequence comparisons, has yielded new mechanistic and evolutionary insights concerning the functional landscape of the human genome. Together, these studies are defining a path for pursuit of a more comprehensive characterization of human genome function.	EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Res Grp Biomed Informat, Barcelona 08003, Spain; Univ Pompeu Fabra, Ctr Genom Regulat, Genom Bioinformat Program, Barcelona 08003, Spain; Affymetrix Inc, Santa Clara, CA 95051 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Dept Chem, Boston, MA 02215 USA; Boston Univ, Program Bioinformat, Boston, MA 02215 USA; NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Allen Inst Brain Sci, Seattle, WA 98103 USA; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Duke Univ, Dept Pediat, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; RIKEN, Yokohama Inst, RIKEN Genom Sci Ctr, Genome Explorat Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Barcelona, Fac Biol, Dept Genet, Barcelona 08028, Catalonia, Spain; Bioinformat Inst, Singapore 138671, Singapore; Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany; Fraunhofer Inst Zelltherapie & Immunol, D-04103 Leipzig, Germany; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Genome Inst Singapore, Singapore 138672, Singapore; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Univ Calif Berkeley, Dept Math & Comp Sci, Berkeley, CA 94720 USA; Spanish Natl Canc Res Ctr, CNIO, E-28029 Madrid, Spain; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Calif Berkeley, Dept Appl Sci & Technol, Berkeley, CA 94720 USA; RIKEN, Wako Inst, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Santa Fe Inst, Santa Fe, NM 87501 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, Huck Inst Life Sci, University Pk, PA 16802 USA; NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; NHGRI, Off Director, NIH, Bethesda, MD 20892 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; Univ Geneva, Fac Sci, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Penn State Univ, HUck Inst Life Sci, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, HUman Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Genom Sequencing Ctr, St Louis, MO 63108 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA; Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Spain; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	European Molecular Biology Laboratory (EMBL); University of Washington; University of Washington Seattle; University of Virginia; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; Boston University; Yale University; Yale University; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Allen Institute for Brain Science; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Duke University; University of Lausanne; University of Geneva; RIKEN; University of Vienna; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; University of Barcelona; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Leipzig University; Leipzig University; Fraunhofer Gesellschaft; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Washington University (WUSTL); University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Imperial College London; University of California System; University of California Berkeley; RIKEN; Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; University of Queensland; The Santa Fe Institute; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Ludwig Institute for Cancer Research; Uppsala University; University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Austin; Roche Holding; Roche NimbleGen; University of Wisconsin System; University of Wisconsin Madison; Uppsala University; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Oxford	Birney, E (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	birney@ebi.ac.uk; jstam@u.washington.edu; ad8q@virginia.edu; rguigo@imim.es; Tom_Gingeras@affymetrix.com; elliott@nhgri.nih.gov; zhiping@bu.edu; michael.snyder@yale.edu; md4@sanger.ac.uk	Gasull, Martina/J-4076-2019; Hubbard, Tim J/C-2567-2008; Kutalik, Zoltan/HHZ-5697-2022; Korbel, Jan O/G-6470-2012; Eyras, Eduardo/ABG-7144-2020; Dillon, Shane/A-2280-2011; Brent, Michael/AAK-3702-2020; Schor, Jana/F-8503-2017; Kim, Jonghwan/AAR-2815-2021; Parker, Stephen/ABF-1063-2021; Komorowski, Jan/AAP-1685-2020; Ferrando, Josep F Abril/B-3877-2014; Stone, Eric/Q-7840-2016; Weinstock, George M/C-6314-2013; Ameur, Adam/E-6207-2011; Karnani, Neerja/G-2539-2012; Dermitzakis, Emmanouil/B-7687-2013; Tanzer, Andrea/AAY-5431-2021; Hubbard, Tim J.P./AAT-4571-2020; Abecasis, Goncalo R/B-7840-2010; Hackermüller, Jörg/F-2494-2016; Wilson, Richard K./AAF-4139-2019; Stadler, Peter F. F/L-7857-2015; Taylor, James/F-1026-2011; Lagarde, Julien/AAI-1686-2020; Alioto, Tyler/AAF-6342-2020; Hor, Charlotte/AAB-4850-2020; Oberley, Matthew/I-8107-2019; Eyras, Eduardo/A-1560-2010; Califano, Andrea/F-7239-2012; Bruce, Alexander W/H-4235-2014; Carninci, Piero/K-1568-2014; Couttet, Philippe/AAH-5489-2019; Castelo, Robert/A-4679-2010; Oberley, Matthew/L-4326-2019; Chiu, Kuo-Ping/AAG-8855-2020; Whelan, Simon/A-6638-2011; Komorowski, Jan/A-9175-2010; Nikolaev, Sergey/F-3148-2012; Wheeler, David A/M-9740-2018; Antonarakis, Stylianos E/N-8866-2014; Weirauch, Matthew/M-5459-2019; Dutta, Anindya/P-3203-2016; Valencia, Alfonso/I-3127-2015; Hardison, Ross C/G-1142-2010; Peng, Bo/A-6920-2009; Kawai, Jun/A-6451-2016; Zhang, Xiaoling/A-7132-2013; Guigo, Roderic/D-1303-2010; Pedersen, Jakob/G-3382-2012; Hofacker, Ivo L/A-2378-2013; Cooper, Gregory/D-6914-2011; Huppert, Julian/C-6664-2008; Frankish, Adam/G-6545-2011; Glass, Christopher/AAI-3933-2021; Enroth, Stefan/C-7396-2009; Malhotra, Ankit/J-8130-2019; Komorowski, Jan/M-2667-2013; Mardis, Elaine/W-2202-2019; Lowe, Todd Michael/ABJ-5261-2022; Lopez-Bigas, Nuria/F-6193-2011; Taylor, Christopher M./AAF-5480-2020; Hinrichs, Angie S./H-9159-2019; Eduardo, Eyras/L-1053-2014; Hor, Charlotte/H-5908-2015; Alioto, Tyler/K-7267-2015; Tullius, Thomas D./A-9685-2008; Mattick, John/ABH-6130-2020; Tanzer, Andrea/L-3147-2015; Mattick, John S/I-7789-2012; Pedersen, Jakob/C-4985-2009; Estivill, Xavier/A-3125-2013; Malhotra, Ankit/I-3752-2012; Karaoz, Ulas/J-7093-2014; Choo, Siew Woh/E-3406-2010; Estivill, Xavier/E-2957-2012; Clark, Taane G./AAM-2570-2020; Clawson, Hiram/ABE-6101-2020; Brown, James/H-2971-2015; de Bakker, Paul IW/B-8730-2009; Sandelin, Albin/G-2881-2011; Davis, Sean/AAD-1801-2021	Hubbard, Tim J/0000-0002-1767-9318; Kutalik, Zoltan/0000-0001-8285-7523; Korbel, Jan O/0000-0002-2798-3794; Eyras, Eduardo/0000-0003-0793-6218; Brent, Michael/0000-0002-8689-0299; Schor, Jana/0000-0003-1200-6234; Komorowski, Jan/0000-0002-0766-8789; Ferrando, Josep F Abril/0000-0001-7793-589X; Weinstock, George M/0000-0002-2997-4592; Ameur, Adam/0000-0001-6085-6749; Tanzer, Andrea/0000-0003-2873-4236; Hubbard, Tim J.P./0000-0002-1767-9318; Hackermüller, Jörg/0000-0003-4920-7072; Wilson, Richard K./0000-0002-1992-1358; Stadler, Peter F. F/0000-0002-5016-5191; Taylor, James/0000-0001-5079-840X; Lagarde, Julien/0000-0002-0290-7445; Alioto, Tyler/0000-0002-2960-5420; Hor, Charlotte/0000-0002-5361-2372; Oberley, Matthew/0000-0001-6419-2513; Bruce, Alexander W/0000-0003-4297-4412; Carninci, Piero/0000-0001-7202-7243; Castelo, Robert/0000-0003-2229-4508; Chiu, Kuo-Ping/0000-0001-9144-0674; Wheeler, David A/0000-0002-9056-6299; Antonarakis, Stylianos E/0000-0001-8907-5823; Valencia, Alfonso/0000-0002-8937-6789; Hardison, Ross C/0000-0003-4084-7516; Peng, Bo/0000-0001-8225-2284; Guigo, Roderic/0000-0002-5738-4477; Pedersen, Jakob/0000-0002-7236-4001; Hofacker, Ivo L/0000-0001-7132-0800; Cooper, Gregory/0000-0001-5509-9923; Huppert, Julian/0000-0001-5207-4886; Glass, Christopher/0000-0003-4344-3592; Enroth, Stefan/0000-0002-5056-9137; Malhotra, Ankit/0000-0002-1905-0732; Komorowski, Jan/0000-0002-0766-8789; Lopez-Bigas, Nuria/0000-0003-4925-8988; Taylor, Christopher M./0000-0002-7983-5275; Hinrichs, Angie S./0000-0002-1697-1130; Eduardo, Eyras/0000-0003-0793-6218; Hor, Charlotte/0000-0002-5361-2372; Alioto, Tyler/0000-0002-2960-5420; Tullius, Thomas D./0000-0003-4425-796X; Mattick, John/0000-0002-7680-7527; Tanzer, Andrea/0000-0003-2873-4236; Mattick, John S/0000-0002-7680-7527; Estivill, Xavier/0000-0002-0723-2256; Karaoz, Ulas/0000-0002-8238-6757; Clark, Taane G./0000-0001-8985-9265; de Bakker, Paul IW/0000-0001-7735-7858; Sandelin, Albin/0000-0002-7109-7378; Davis, Sean/0000-0002-8991-6458; Newburger, Peter/0000-0002-8615-673X; Lefebvre, Greg/0000-0001-7519-2316; Reymond, Alexandre/0000-0003-1030-8327; FRUM, Tristan/0000-0003-3452-8762; Harrow, Jennifer/0000-0003-0338-3070; Montoya-Burgos, Juan I./0000-0001-9080-9820; Rada-Iglesias, Alvaro/0000-0001-7137-1341; Kapranov, Philipp/0000-0003-2647-4856; Dutta, Anindya/0000-0002-4319-0073; Lieb, Jason/0000-0001-7601-8061; Stuart, Rhona/0000-0001-5916-9693; Sung, Wing-Kin/0000-0001-7806-7086; Birney, Ewan/0000-0001-8314-8497; Karnani, Neerja/0000-0002-5301-409X; Stone, Eric/0000-0002-2725-4209; Swarbreck, David/0000-0002-5453-1013; Dunham, Ian/0000-0003-2525-5598; Kim, Tae Hoon/0000-0003-3950-7557; Reiche, Kristin/0000-0002-4452-4872; Denoeud, France/0000-0001-8819-7634; Siepel, Adam/0000-0002-3557-7219; Frankish, Adam/0000-0002-4333-628X; Foissac, Sylvain/0000-0002-2631-5356; Worley, Kim/0000-0002-0282-1000; Snyder, Michael/0000-0003-0784-7987; Adzhubey, Ivan/0000-0002-1483-9259; Sandstrom, Richard/0000-0002-3356-1547; Abecasis, Goncalo/0000-0003-1509-1825; Farnham, Peggy/0000-0003-4469-7914; Holmes, Ian/0000-0001-7639-5369; Flamm, Christoph/0000-0001-5500-2415; Fosker, Christine/0000-0002-3799-9474; Stranger, Barbara/0000-0001-9021-7331; /0000-0001-9150-3954; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502; Cuff, James/0000-0003-0570-4106; King, David/0000-0003-1601-1612; Tress, Michael/0000-0001-9046-6370; Halees, Anason/0000-0001-5880-7067; Kim, Jonghwan/0000-0002-9919-9843; Cooper, Sara/0000-0002-9627-0309; Vetrie, David/0000-0003-2075-4662; Koch, Christof/0000-0001-6482-8067; Clawson, Hiram/0000-0002-0480-0545; Gingeras, Thomas/0000-0001-9106-3573; Flicek, Paul/0000-0002-3897-7955; Loytynoja, Ari/0000-0001-5389-6611; Hallgrimsdottir, Ingileif/0000-0002-4710-0047; Bhinge, Akshay/0000-0003-2939-099X; Wallerman, Ola/0000-0003-1037-7904; Marz, Manja/0000-0003-4783-8823; Goldman, Nick/0000-0001-8486-2211; Pachter, Lior/0000-0002-9164-6231; Soriaga, Leah/0000-0001-5852-741X; Zheng, Deyou/0000-0003-4354-5337; Rozowsky, Joel/0000-0002-3565-0762	NATIONAL CANCER INSTITUTE [F32CA108313] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, Z01HG000196, U01HG003162, U01HG003161, U01HG003151, Z01HG000060, R01HG003532, R01HG003521, U54HG003273, U01HG003156, U01HG003168, U01HG003147, Z01HG200330, K22HG003169, U54HG003067, R01HG003541, U01HG003157, U01HG002523, R01HG002238, Z01HG200341, P41HG002371, U54HG003079, R01HG003110, R01HG003129, U01HG003150] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA108313] Funding Source: Medline; NHGRI NIH HHS [U01 HG003151, U54 HG003273-01, U54 HG003079, U01 HG003157, R01 HG003110, U01 HG003151-03, K22 HG003169-01A1, R01 HG003541-03, K22 HG003169, U01 HG003162, R01 HG002238-15, R01 HG003532, U01 HG003156, U01 HG003161-03, U54 HG003273, R01 HG003521, R01 HG003532-01, U01 HG003147-02, P41 HG002371, U01 HG003150-03, R01 HG003143-04, R01 HG003143, R01 HG003521-01, U01 HG003156-03, R01 HG003110-03, U54 HG003079-01, U54 HG003067, U01 HG003168-02, U01 HG002523-01, U01 HG003162-03, U01 HG003147, U01 HG003157-03, P41 HG002371-03S1, U54 HG003067-01, R01 HG003541, R01 HG002238, U01 HG003150, R01 HG003129-03, U01 HG003161, U01 HG002523] Funding Source: Medline; Wellcome Trust [062023, 077198] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASTHANA S, UNPUB PLOS COMP BIOL; Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLARK TG, 2007, UNPUB GENOME BIOL; Cohen SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-301; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Emanuelsson O, 2007, GENOME RES, V17, P886, DOI 10.1101/gr.5014606; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gartler SM, 1999, HUM MOL GENET, V8, P1085, DOI 10.1093/hmg/8.6.1085; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; GUIGO R, 2006, GENOME BIOL S1, V7, P1; Halees AS, 2004, NUCLEIC ACIDS RES, V32, pW191, DOI 10.1093/nar/gkh433; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; HUDSON RR, 1987, GENETICS, V116, P153; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McAuliffe JD, 2005, P NATL ACAD SCI USA, V102, P7900, DOI 10.1073/pnas.0502790102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; PRICE MA, 1993, BIOCHEMISTRY-US, V32, P127, DOI 10.1021/bi00052a018; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rozowsky JS, 2007, GENOME RES, V17, P732, DOI 10.1101/gr.5696007; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s13; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; [No title captured]	128	3798	3984	8	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					799	816		10.1038/nature05874	http://dx.doi.org/10.1038/nature05874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17571346	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-24	WOS:000247207500034
J	Kapranov, P; Cheng, J; Dike, S; Nix, DA; Duttagupta, R; Willingham, AT; Stadler, PF; Hertel, J; Hackermuller, J; Hofacker, IL; Bell, I; Cheung, E; Drenkow, J; Dumais, E; Patel, S; Helt, G; Ganesh, M; Ghosh, S; Piccolboni, A; Sementchenko, V; Tammana, H; Gingeras, TR				Kapranov, Philipp; Cheng, Jill; Dike, Sujit; Nix, David A.; Duttagupta, Radharani; Willingham, Aarron T.; Stadler, Peter F.; Hertel, Jana; Hackermueller, Joerg; Hofacker, Ivo L.; Bell, Ian; Cheung, Evelyn; Drenkow, Jorg; Dumais, Erica; Patel, Sandeep; Helt, Gregg; Ganesh, Madhavan; Ghosh, Srinka; Piccolboni, Antonio; Sementchenko, Victor; Tammana, Hari; Gingeras, Thomas R.			RNA maps reveal new RNA classes and a possible function for pervasive transcription	SCIENCE			English	Article							GENE; EVOLUTION	Significant fractions of eukaryotic genomes give rise to RNA, much of which is unannotated and has reduced protein-coding potential. The genomic origins and the associations of human nuclear and cytosolic polyadenylated RNAs longer than 200 nucleotides ( nt) and whole-cell RNAs less than 200 nt were investigated in this genome-wide study. Subcellular addresses for nucleotides present in detected RNAs were assigned, and their potential processing into short RNAs was investigated. Taken together, these observations suggest a novel role for some unannotated RNAs as primary transcripts for the production of short RNAs. Three potentially functional classes of RNAs have been identified, two of which are syntenically conserved and correlate with the expression state of protein-coding genes. These data support a highly interleaved organization of the human transcriptome.	Affymetrix Inc, Affymetrix Lab, Santa Clara, CA 95051 USA; Univ Leipzig, Dept Comp Sci, D-7010 Leipzig, Germany; Univ Vienna, Inst Theoret Chem, A-1010 Vienna, Austria; Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany	Affymetrix; Leipzig University; University of Vienna; Fraunhofer Gesellschaft	Gingeras, TR (corresponding author), Affymetrix Inc, Affymetrix Lab, 3420 Cent Expressway, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com	Hackermüller, Jörg/F-2494-2016; Stadler, Peter F. F/L-7857-2015; Hofacker, Ivo L/A-2378-2013; Schor, Jana/F-8503-2017	Hackermüller, Jörg/0000-0003-4920-7072; Stadler, Peter F. F/0000-0002-5016-5191; Hofacker, Ivo L/0000-0001-7132-0800; Schor, Jana/0000-0003-1200-6234; Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NHGRI NIH HHS [U01HG003147] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009	11	1824	1977	5	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1484	1488		10.1126/science.1138341	http://dx.doi.org/10.1126/science.1138341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17510325				2022-12-24	WOS:000247066400045
J	Lee, H; Cheng, YC; Fleming, GR				Lee, Hohjai; Cheng, Yuan-Chung; Fleming, Graham R.			Coherence dynamics in photosynthesis: Protein protection of excitonic coherence	SCIENCE			English	Article							ENERGY-TRANSFER DYNAMICS; RHODOBACTER-SPHAEROIDES; REACTION CENTERS; PHOTON-ECHO; ELECTRON-DONOR; SPECTROSCOPY	The role of quantum coherence in promoting the efficiency of the initial stages of photosynthesis is an open and intriguing question. We performed a two-color photon echo experiment on a bacterial reaction center that enabled direct visualization of the coherence dynamics in the reaction center. The data revealed long-lasting coherence between two electronic states that are formed by mixing of the bacteriopheophytin and accessory bacteriochlorophyll excited states. This coherence can only be explained by strong correlation between the protein-induced fluctuations in the transition energy of neighboring chromophores. Our results suggest that correlated protein environments preserve electronic coherence in photosynthetic complexes and allow the excitation to move coherently in space, enabling highly efficient energy harvesting and trapping in photosynthesis.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Cheng, Yuan-Chung/A-6566-2008	Cheng, Yuan-Chung/0000-0003-0125-4267				Agarwal R, 2002, J CHEM PHYS, V116, P6243, DOI 10.1063/1.1459414; [Anonymous], 2002, PHOTOSYNTHETICA; Arnett DC, 1999, J PHYS CHEM B, V103, P2014, DOI 10.1021/jp984464j; BREE PD, 1979, J CHEM PHYS, V70, P790, DOI 10.1063/1.437512; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; Jackson JA, 1997, J PHYS CHEM B, V101, P5747, DOI 10.1021/jp970380j; Jang SJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218301; JEAN JM, 1995, J CHEM PHYS, V103, P2092, DOI 10.1063/1.469684; Jordanides XJ, 2004, J PHYS CHEM B, V108, P1753, DOI 10.1021/jp036516x; Kuhn O, 2002, CHEM PHYS, V275, P15, DOI 10.1016/S0301-0104(01)00526-2; Meier T, 1997, J CHEM PHYS, V107, P8759, DOI 10.1063/1.475169; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; OHTSUKI Y, 1989, J CHEM PHYS, V91, P3903, DOI 10.1063/1.456822; Parkinson DY, 2007, J PHYS CHEM B, V111, P7449, DOI 10.1021/jp070029q; PISILAKOV AV, 2006, J CHEM PHYS, V124; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Rickard MA, 2006, J PHYS CHEM A, V110, P11384, DOI 10.1021/jp063917e; Rubtsov IV, 2003, P NATL ACAD SCI USA, V100, P5601, DOI 10.1073/pnas.0931292100; Souaille M, 1997, J AM CHEM SOC, V119, P3948, DOI 10.1021/ja943841c; Stanley RJ, 1996, J PHYS CHEM-US, V100, P12052, DOI 10.1021/jp9614916; TREUTLEIN H, 1992, P NATL ACAD SCI USA, V89, P75, DOI 10.1073/pnas.89.1.75; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; Vos MH, 1997, J PHYS CHEM B, V101, P9820, DOI 10.1021/jp971486h; WRAIGHT CA, 1974, BIOCHIM BIOPHYS ACTA, V333, P246, DOI 10.1016/0005-2728(74)90009-7; WYNNE K, 1993, CHEM PHYS, V171, P179, DOI 10.1016/0301-0104(93)85142-U	28	860	869	4	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1462	1465		10.1126/science.1142188	http://dx.doi.org/10.1126/science.1142188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556580	Green Submitted			2022-12-24	WOS:000247066400038
J	Kasahara, M; Naruse, K; Sasaki, S; Nakatani, Y; Qu, W; Ahsan, B; Yamada, T; Nagayasu, Y; Doi, K; Kasai, Y; Jindo, T; Kobayashi, D; Shimada, A; Toyoda, A; Kuroki, Y; Fujiyama, A; Sasaki, T; Shimizu, A; Asakawa, S; Shimizu, N; Hashimoto, SI; Yang, J; Lee, Y; Matsushima, K; Sugano, S; Sakaizumi, M; Narita, T; Ohishi, K; Haga, S; Ohta, F; Nomoto, H; Nogata, K; Morishita, T; Endo, T; Shin-I, T; Takeda, H; Morishita, S; Kohara, Y				Kasahara, Masahiro; Naruse, Kiyoshi; Sasaki, Shin; Nakatani, Yoichiro; Qu, Wei; Ahsan, Budrul; Yamada, Tomoyuki; Nagayasu, Yukinobu; Doi, Koichiro; Kasai, Yasuhiro; Jindo, Tomoko; Kobayashi, Daisuke; Shimada, Atsuko; Toyoda, Atsushi; Kuroki, Yoko; Fujiyama, Asao; Sasaki, Takashi; Shimizu, Atsushi; Asakawa, Shuichi; Shimizu, Nobuyoshi; Hashimoto, Shin-ichi; Yang, Jun; Lee, Yongjun; Matsushima, Kouji; Sugano, Sumio; Sakaizumi, Mitsuru; Narita, Takanori; Ohishi, Kazuko; Haga, Shinobu; Ohta, Fumiko; Nomoto, Hisayo; Nogata, Keiko; Morishita, Tomomi; Endo, Tomoko; Shin-, Tadasu, I; Takeda, Hiroyuki; Morishita, Shinichi; Kohara, Yuji			The medaka draft genome and insights into vertebrate genome evolution	NATURE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; RAY-FINNED FISHES; GENE MAP; DUPLICATION; CHROMOSOMES; PERSPECTIVE; PHYLOGENY; ZEBRAFISH; LATIPES; DMY	Teleosts comprise more than half of all vertebrate species and have adapted to a variety of marine and freshwater habitats(1). Their genome evolution and diversification are important subjects for the understanding of vertebrate evolution. Although draft genome sequences of two pufferfishes have been published(2,3), analysis of more fish genomes is desirable. Here we report a high-quality draft genome sequence of a small egg-laying freshwater teleost, medaka ( Oryzias latipes). Medaka is native to East Asia and an excellent model system for a wide range of biology, including ecotoxicology, carcinogenesis, sex determination(4-6) and developmental genetics(7). In the assembled medaka genome ( 700 megabases), which is less than half of the zebrafish genome, we predicted 20,141 genes, including 2,900 new genes, using 5'-end serial analysis of gene expression tag information. We found single nucleotide polymorphisms ( SNPs) at an average rate of 3.42% between the two inbred strains derived from two regional populations; this is the highest SNP rate seen in any vertebrate species. Analyses based on the dense SNP information show a strict genetic separation of 4 million years ( Myr) between the two populations, and suggest that differential selective pressures acted on specific gene categories. Four-way comparisons with the human, pufferfish ( Tetraodon), zebrafish and medaka genomes revealed that eight major interchromosomal rearrangements took place in a remarkably short period of similar to 50 Myr after the whole-genome duplication event in the teleost ancestor and afterwards, intriguingly, the medaka genome preserved its ancestral karyotype for more than 300 Myr.	Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Natl Inst Informat, Tokyo 1018430, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1088639, Japan; Niigata Univ, Dept Environm Sci, Fac Sci, Niigata 9502181, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 4118540, Japan	University of Tokyo; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Keio University; University of Tokyo; University of Tokyo; Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kohara, Y (corresponding author), Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan.	htakeda@biol.s.u-tokyo.ac.jp; ykohara@lab.nig.ac.jp	Narita, Takanori/F-1092-2011; Sasaki, Takashi/AAD-1461-2019; TAKEDA, HIROYUKI/G-4950-2014	Kobayashi, Daisuke/0000-0001-9755-6168; Nakatani, Yoichiro/0000-0001-7604-0242; Sasaki, Takashi/0000-0002-6275-046X; Morishita, Shinichi/0000-0002-6201-8885; Narita, Takanori/0000-0003-0295-5014; Naruse, Kiyoshi/0000-0001-9185-3495; Kasahara, Masahiro/0000-0001-8430-1414				Aida T, 1921, GENETICS, V6, P554; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Hedges SB, 2002, SCIENCE, V297, P1283; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Naruse K, 2004, MECH DEVELOP, V121, P619, DOI 10.1016/j.mod.2004.04.014; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Ohno S., 1970, EVOLUTION GENE DUPLI; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; YAMAMOTO TO, 1953, J EXP ZOOL, V123, P571, DOI 10.1002/jez.1401230309; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zhang JZ, 2004, GENETICS, V166, P1887, DOI 10.1534/genetics.166.4.1887	30	797	839	7	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					714	719		10.1038/nature05846	http://dx.doi.org/10.1038/nature05846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554307	hybrid			2022-12-24	WOS:000247030700044
J	Hafler, DA; Compston, A; Sawcer, S; Lander, ES; Daly, MJ; De Jager, PL; de Bakker, PIW; Gabriel, SB; Mirel, DB; Ivinson, AJ; Pericak-Vance, MA; Gregory, SG; Rioux, JD; McCauley, JL; Haines, JL; Barcellos, LF; Cree, B; Oksenberg, JR; Hauser, SL				Hafler, David A.; Compston, Alastair; Sawcer, Stephen; Lander, Eric S.; Daly, Mark J.; De Jager, Philip L.; de Bakker, Paul I. W.; Gabriel, Stacey B.; Mirel, Daniel B.; Ivinson, Adrian J.; Pericak-Vance, Margaret A.; Gregory, Simon G.; Rioux, John D.; McCauley, Jacob L.; Haines, Jonathan L.; Barcellos, Lisa F.; Cree, Bruce; Oksenberg, Jorge R.; Hauser, Stephen L.		Int Multiple Sclerosis Genetics Co	Risk alleles for multiple sclerosis identified by a genomewide study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; LYMPHOID TYROSINE PHOSPHATASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; INTERLEUKIN-7 RECEPTOR-ALPHA; TYPE-1 DIABETES LOCUS; WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; SUSCEPTIBILITY LOCI	Background: Multiple sclerosis has a clinically significant heritable component. We conducted a genomewide association study to identify alleles associated with the risk of multiple sclerosis. Methods: We used DNA microarray technology to identify common DNA sequence variants in 931 family trios (consisting of an affected child and both parents) and tested them for association. For replication, we genotyped another 609 family trios, 2322 case subjects, and 789 control subjects and used genotyping data from two external control data sets. A joint analysis of data from 12,360 subjects was performed to estimate the overall significance and effect size of associations between alleles and the risk of multiple sclerosis. Results: A transmission disequilibrium test of 334,923 single-nucleotide polymorphisms (SNPs) in 931 family trios revealed 49 SNPs having an association with multiple sclerosis (P<1 x 10(sup -4)); of these SNPs, 38 were selected for the second-stage analysis. A comparison between the 931 case subjects from the family trios and 2431 control subjects identified an additional nonoverlapping 32 SNPs (P<0.001). An additional 40 SNPs with less stringent P values (<0.01) were also selected, for a total of 110 SNPs for the second-stage analysis. Of these SNPs, two within the interleukin-2 receptor (alpha) gene (IL2RA) were strongly associated with multiple sclerosis (P=2.96 x 10(sup -8)), as were a nonsynonymous SNP in the interleukin-7 receptor (alpha) gene (IL7RA) (P=2.94 x 10(sup -7)) and multiple SNPs in the HLA-DRA locus (P=8.94 x 10(sup -81)). Conclusions: Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Broad Inst, Boston, MA USA; MIT, Cambridge, MA 02139 USA; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; Harvard Partners Ctr Genet & Genom, Boston, MA USA; Harvard Univ, Sch Med, Harvard Ctr Neurodgenerat & Repair, Boston, MA USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Miami, Sch Med, Miami, FL USA; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Duke University; University of Miami; Universite de Montreal; Vanderbilt University; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Ivinson, AJ (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, 75 Francis St, Boston, MA 02115 USA.		Haines, Jonathan/C-3374-2012; Hauser, Stephen L/J-2978-2016; Cree, Bruce C/AAV-6109-2020; de Bakker, Paul IW/B-8730-2009; Daly, Mark J/B-2453-2017; Rioux, John D/A-9599-2015	Haines, Jonathan/0000-0002-4351-4728; Cree, Bruce C/0000-0001-7689-2533; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Rioux, John D/0000-0001-7560-8326; Gregory, Simon/0000-0002-7805-1743	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477, R01NS032830] Funding Source: NIH RePORTER; NCRR NIH HHS [U54-RR020278-1] Funding Source: Medline; NIAID NIH HHS [U19 AI067152, AI067152, P01-AI039671] Funding Source: Medline; NINDS NIH HHS [NS26799, NS032830, NS2427, NS049477] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P17565, DOI 10.1073/pnas.0404694101; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 1999, J NEUROIMMUNOL, V100, P115, DOI 10.1016/S0165-5728(99)00200-3; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; COMPSTON A, 2005, MCALPINES MULTIPLE S, P113; Criswell LA, 2005, RHEUMATOLOGY, V44, P9, DOI 10.1093/rheumatology/kei054; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2006, EUR J HUM GENET, V14, P317, DOI 10.1038/sj.ejhg.5201548; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300; GREGORY SG, IN PRESS NAT GENET; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Kyogoku C, 2004, ARTHRITIS RHEUM, V50, P671, DOI 10.1002/art.20029; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PRINEAS JW, 1978, LAB INVEST, V38, P409; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	64	1278	1308	1	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					851	862		10.1056/NEJMoa073493	http://dx.doi.org/10.1056/NEJMoa073493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17660530				2022-12-24	WOS:000249065700004
J	Mikkelsen, TS; Ku, MC; Jaffe, DB; Issac, B; Lieberman, E; Giannoukos, G; Alvarez, P; Brockman, W; Kim, TK; Koche, RP; Lee, W; Mendenhall, E; O'Donovan, A; Presser, A; Russ, C; Xie, XH; Meissner, A; Wernig, M; Jaenisch, R; Nusbaum, C; Lander, ES; Bernstein, BE				Mikkelsen, Tarjei S.; Ku, Manching; Jaffe, David B.; Issac, Biju; Lieberman, Erez; Giannoukos, Georgia; Alvarez, Pablo; Brockman, William; Kim, Tae-Kyung; Koche, Richard P.; Lee, William; Mendenhall, Eric; O'Donovan, Aisling; Presser, Aviva; Russ, Carsten; Xie, Xiaohui; Meissner, Alexander; Wernig, Marius; Jaenisch, Rudolf; Nusbaum, Chad; Lander, Eric S.; Bernstein, Bradley E.			Genome-wide maps of chromatin state in pluripotent and lineage-committed cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; HISTONE LYSINE METHYLATION; DEVELOPMENTAL REGULATORS; DNA METHYLATION; GENE-EXPRESSION; NONCODING RNAS; MOUSE; POLYCOMB; TRANSCRIPTION; DIFFERENTIATION	We report the application of single-molecule-based sequencing technology for high-throughput profiling of histone modifications in mammalian cells. By obtaining over four billion bases of sequence from chromatin immunoprecipitated DNA, we generated genome-wide chromatin-state maps of mouse embryonic stem cells, neural progenitor cells and embryonic fibroblasts. We find that lysine 4 and lysine 27 trimethylation effectively discriminates genes that are expressed, poised for expression, or stably repressed, and therefore reflect cell state and lineage potential. Lysine 36 trimethylation marks primary coding and non-coding transcripts, facilitating gene annotation. Trimethylation of lysine 9 and lysine 20 is detected at satellite, telomeric and active long-terminal repeats, and can spread into proximal unique sequences. Lysine 4 and lysine 9 trimethylation marks imprinting control regions. Finally, we show that chromatin state can be read in an allele-specific manner by using single nucleotide polymorphisms. This study provides a framework for the application of comprehensive chromatin profiling towards characterization of diverse mammalian cell populations.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Lander, ES (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	lander@broad.mit.edu; bbernstein@partners.org	Mikkelsen, Tarjei S/A-1306-2007; Kim, Tae-Kyung/AAX-4230-2020; Aiden, Erez Lieberman/A-2908-2010	Mikkelsen, Tarjei S/0000-0002-8133-3135; Kim, Tae-Kyung/0000-0001-5161-9864; Xie, Xiaohui/0000-0002-5479-6345; Mendenhall, Eric/0000-0002-7395-6295; Koche, Richard/0000-0002-6820-5083; Issac, Biju/0000-0002-7311-678X	NCI NIH HHS [T32 CA009216] Funding Source: Medline; NIGMS NIH HHS [R01 GM078986, R01 GM078986-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander DL, 1998, J CELL SCI, V111, P3311; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Baust C, 2003, J VIROL, V77, P11448, DOI 10.1128/JVI.77.21.11448-11458.2003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	48	3057	3190	3	316	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					553	U2		10.1038/nature06008	http://dx.doi.org/10.1038/nature06008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17603471	Green Accepted			2022-12-24	WOS:000248446700035
J	Chinchilla, D; Zipfel, C; Robatzek, S; Kemmerling, B; Nurnberger, T; Jones, JDG; Felix, G; Boller, T				Chinchilla, Delphine; Zipfel, Cyril; Robatzek, Silke; Kemmerling, Birgit; Nuernberger, Thorsten; Jones, Jonathan D. G.; Felix, Georg; Boller, Thomas			A flagellin-induced complex of the receptor FLS2 and BAK1 initiates plant defence	NATURE			English	Article							INNATE IMMUNITY; ARABIDOPSIS-THALIANA; KINASE; PERCEPTION; BRASSINOSTEROIDS; PHOSPHORYLATION; ENDOCYTOSIS; DOMAIN; SIGNAL; GENE	Plants sense potential microbial invaders by using pattern-recognition receptors to recognize pathogen-associated molecular patterns (PAMPs)(1). In Arabidopsis thaliana, the leucine-rich repeat receptor kinases flagellin-sensitive 2 (FLS2) (ref. 2) and elongation factor Tu receptor (EFR) ( ref. 3) act as pattern-recognition receptors for the bacterial PAMPs flagellin(4) and elongation factor Tu (EF-Tu) ( ref. 5) and contribute to resistance against bacterial pathogens. Little is known about the molecular mechanisms that link receptor activation to intracellular signal transduction. Here we show that BAK1 (BRI1-associated receptor kinase 1), a leucine-rich repeat receptor-like kinase that has been reported to regulate the brassinosteroid receptor BRI1 (refs 6,7), is involved in signalling by FLS2 and EFR. Plants carrying bak1 mutations show normal flagellin binding but abnormal early and late flagellin-triggered responses, indicating that BAK1 acts as a positive regulator in signalling. The bak1-mutant plants also show a reduction in early, but not late, EF-Tu-triggered responses. The decrease in responses to PAMPs is not due to reduced sensitivity to brassino-steroids. We provide evidence that FLS2 and BAK1 form a complex in vivo, in a specific ligand-dependent manner, within the first minutes of stimulation with flagellin. Thus, BAK1 is not only associated with developmental regulation through the plant hormone receptor BRI1 ( refs 6,7), but also has a functional role in PRR-dependent signalling, which initiates innate immunity.	Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Univ Tubingen, Inst Plant Biochem, ZMBP, D-72076 Tubingen, Germany	University of Basel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; Eberhard Karls University of Tubingen	Chinchilla, D (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	delphine.chinchilla@unibas.ch; thomas.boller@unibas.ch	Jones, Jonathan DG/J-5129-2012; Boller, Thomas/G-3500-2012; Robatzek, Silke/B-6844-2013; ZIPFEL, CYRIL/ABD-5076-2021; ZIPFEL, CYRIL B/D-7103-2011	Jones, Jonathan DG/0000-0002-4953-261X; Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL/0000-0003-4935-8583; ZIPFEL, CYRIL B/0000-0003-4935-8583; Kemmerling, Birgit/0000-0003-1174-0189				Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	31	1199	1272	14	368	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					497	U12		10.1038/nature05999	http://dx.doi.org/10.1038/nature05999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17625569	Green Published			2022-12-24	WOS:000248302700052
J	Dominguez-Sola, D; Ying, CY; Grandori, C; Ruggiero, L; Chen, B; Li, MY; Galloway, DA; Gu, W; Gautier, J; Dalla-Favera, R				Dominguez-Sola, David; Ying, Carol Y.; Grandori, Carla; Ruggiero, Luca; Chen, Brenden; Li, Muyang; Galloway, Denise A.; Gu, Wei; Gautier, Jean; Dalla-Favera, Riccardo			Non-transcriptional control of DNA replication by c-Myc	NATURE			English	Article							LEUKEMIA-CELL-LINE; NEGATIVE AUTOREGULATION; GENOMIC INSTABILITY; BURKITT-LYMPHOMA; DAMAGE RESPONSE; ONC GENE; TUMORIGENESIS; PROTEIN; ACTIVATION; CHECKPOINT	The c-Myc proto-oncogene encodes a transcription factor that is essential for cell growth and proliferation and is broadly implicated in tumorigenesis. However, the biological functions required by c-Myc to induce oncogenesis remain elusive. Here we show that c-Myc has a direct role in the control of DNA replication. c-Myc interacts with the pre-replicative complex and localizes to early sites of DNA synthesis. Depletion of c-Myc from mammalian ( human and mouse) cells as well as from Xenopus cell-free extracts, which are devoid of RNA transcription, demonstrates a non-transcriptional role for c-Myc in the initiation of DNA replication. Overexpression of c-Myc causes increased replication origin activity with subsequent DNA damage and checkpoint activation. These findings identify a critical function of c-Myc in DNA replication and suggest a novel mechanism for its normal and oncogenic functions.	Columbia Univ, Med Ctr, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Med Ctr, Herbert Irving Ctr Comprehens Canc, New York, NY 10032 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Columbia University; Columbia University; Fred Hutchinson Cancer Center	Gautier, J (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA.	jg130@columbia.edu; rd10@columbia.edu	Gautier, jean/A-2774-2008	Dominguez-Sola, David/0000-0001-9569-8402				Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DALLAFAVERA R, 1982, NATURE, V299, P61; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; Jackson JR, 2000, CANCER RES, V60, P566; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mai Sabine, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P179; McCormack SJ, 1998, ONCOGENE, V16, P2755, DOI 10.1038/sj.onc.1201804; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Norio P, 2006, EMBO REP, V7, P779, DOI 10.1038/sj.embor.7400766; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	51	489	503	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					445	U3		10.1038/nature05953	http://dx.doi.org/10.1038/nature05953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17597761				2022-12-24	WOS:000248302700041
J	Unal, E; Heidinger-Pauli, JM; Koshland, D				Uenal, Elcin; Heidinger-Pauli, Jill M.; Koshland, Douglas			DNA double-strand breaks trigger genome-wide sister-chromatid cohesion through Eco1 (Ctf7)	SCIENCE			English	Article							ESTABLISHMENT; REPLICATION; PROTEINS; DAMAGE; RECRUITMENT; PATHWAY; COMPLEX; REPAIR	Faithful chromosome segregation and repair of DNA double-strand breaks (DSBs) require cohesin, the protein complex that mediates sister-chromatid cohesion. Cohesion between sister chromatids is thought to be generated only during ongoing DNA replication by an obligate coupling between cohesion establishment factors such as Eco1 (Ctf7) and the replisome. Using budding yeast, we challenge this model by showing that cohesion is generated by an Eco1-dependent but replication-independent mechanism in response to DSBs in G(2)/M. Furthermore, our studies reveal that Eco1 has two functions: a cohesive activity and a conserved acetyltransferase activity, which triggers the generation of cohesion in response to the DSB and the DNA damage checkpoint. Finally, the DSB-induced cohesion is not limited to broken chromosomes but occurs also on unbroken chromosomes, suggesting that the DNA damage checkpoint through Eco1 provides genome-wide protection of chromosome integrity.	Howard Hughes Med Inst, Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Koshland, D (corresponding author), Howard Hughes Med Inst, Carnegie Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	koshland@ciwemb.edu		Unal, Elcin/0000-0002-6768-609X				Brands A, 2005, CURR BIOL, V15, pR50, DOI 10.1016/j.cub.2004.12.052; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Meluh PB, 2002, EUR J BIOCHEM, V269, P2300, DOI 10.1046/j.1432-1033.2002.02886.x; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STROM L, 2007, CURR OPIN CELL BIOL; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024	19	244	247	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					245	248		10.1126/science.1140637	http://dx.doi.org/10.1126/science.1140637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626885				2022-12-24	WOS:000247968600043
J	Brons, IGM; Smithers, LE; Trotter, MWB; Rugg-Gunn, P; Sun, BW; Lopes, SMCD; Howlett, SK; Clarkson, A; Ahrlund-Richter, L; Pedersen, RA; Vallier, L				Brons, I. Gabrielle M.; Smithers, Lucy E.; Trotter, Matthew W. B.; Rugg-Gunn, Peter; Sun, Bowen; de Sousa Lopes, Susana M. Chuva; Howlett, Sarah K.; Clarkson, Amanda; Ahrlund-Richter, Lars; Pedersen, Roger A.; Vallier, Ludovic			Derivation of pluripotent epiblast stem cells from mammalian embryos	NATURE			English	Article							PRIMORDIAL GERM-CELLS; MOUSE EMBRYO; ES CELLS; DIFFERENTIATION; CULTURE; LINE; GASTRULATION; BLASTOCYSTS; EXPRESSION	Although the first mouse embryonic stem (ES) cell lines were derived 25 years ago(1,2) using feeder-layer-based blastocyst cultures, subsequent efforts to extend the approach to other mammals, including both laboratory and domestic species, have been relatively unsuccessful. The most notable exceptions were the derivation of non-human primate ES cell lines(3) followed shortly thereafter by their derivation of human ES cells(4). Despite the apparent common origin and the similar pluripotency of mouse and human embryonic stem cells, recent studies have revealed that they use different signalling pathways to maintain their pluripotent status. Mouse ES cells depend on leukaemia inhibitory factor and bone morphogenetic protein, whereas their human counterparts rely on activin (INHBA)/nodal (NODAL) and fibroblast growth factor (FGF). Here we show that pluripotent stem cells can be derived from the late epiblast layer of post-implantation mouse and rat embryos using chemically defined, activin-containing culture medium that is sufficient for long-term maintenance of human embryonic stem cells. Our results demonstrate that activin/Nodal signalling has an evolutionarily conserved role in the derivation and the maintenance of pluripotency in these novel stem cells. Epiblast stem cells provide a valuable experimental system for determining whether distinctions between mouse and human embryonic stem cells reflect species differences or diverse temporal origins.	Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 0XY, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; UCL, Wolfson Inst Biomed Res, CR UK Viral Oncol Grp, London WC1E 6BT, England; Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol, Cambridge CB2 1QR, England; Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 0XY, England; Univ Cambridge, Hosp NHS Fdn Trust, Dept Med Genet, Cambridge CB2 2FF, England; Karolinska Inst, Karolinska Univ Hosp, Clin Res Ctr, Dept Lab Med, S-14157 Stockholm, Sweden	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Cancer Research UK; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Karolinska Institutet; Karolinska University Hospital	Vallier, L (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 0XY, England.	lv225@cam.ac.uk	Ahrlund-Richter, Lars/C-6226-2012; vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602; Trotter, Matthew/0000-0003-3702-915X; Rugg-Gunn, Peter/0000-0002-9601-5949	MRC [G0300723, G0600275] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; Medical Research Council [G0300723, G0600275] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CONLON FL, 1994, DEVELOPMENT, V120, P1919; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gu ZY, 1999, DEVELOPMENT, V126, P2551; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pelton TA, 2002, J CELL SCI, V115, P329; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761	26	1429	1499	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					191	U7		10.1038/nature05950	http://dx.doi.org/10.1038/nature05950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17597762				2022-12-24	WOS:000247934500042
J	Rinn, JL; Kertesz, M; Wang, JK; Squazzo, SL; Xu, X; Brugmann, SA; Goodnough, LH; Helms, JA; Farnham, PJ; Segal, E; Chang, HY				Rinn, John L.; Kertesz, Michael; Wang, Jordon K.; Squazzo, Sharon L.; Xu, Xiao; Brugmann, Samantha A.; Goodnough, L. Henry; Helms, Jill A.; Farnham, Peggy J.; Segal, Eran; Chang, Howard Y.			Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs	CELL			English	Article							DEVELOPMENTAL REGULATORS; RESPONSE ELEMENTS; GENE-EXPRESSION; HISTONE H3; CELL FATE; POLYCOMB; TRANSCRIPTION; GENOME; ROLES; EVOLUTION	Noncoding RNAs (ncRNA) participate in epigenetic regulation but are poorly understood. Here we characterize the transcriptional landscape of the four human HOX loci at five base pair resolution in 11 anatomic sites and identify 231 HOX ncRNAs that extend known transcribed regions by more than 30 kilobases. HOX ncRNAs are spatially expressed along developmental axes and possess unique sequence motifs, and their expression demarcates broad chromosomal domains of differential histone methylation and RNA polymerase accessibility. We identified a 2.2 kilobase ncRNA residing in the HOXC locus, termed HOTAIR, which represses transcription in trans across 40 kilobases of the HOXD locus. HOTAIR interacts with Polycomb Repressive Complex 2 (PRC2) and is required for PRC2 occupancy and histone H3 lysine-27 trimethylation of HOXD locus. Thus, transcription of ncRNA may demarcate chromosomal domains of gene silencing at a distance; these results have broad implications for gene regulation in development and disease states.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; Univ Calif Davis, Dept Pharmacol, Genome Ctr, Livermore, CA 95616 USA	Weizmann Institute of Science; Stanford University; Stanford University; University of California System; University of California Davis	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; howchang@stanford.edu	Segal, Eran/AAF-4855-2019	Rinn, John/0000-0002-7231-7539; Wang, Jordon/0000-0003-1108-2534; Helms, Jill/0000-0002-0463-396X; Segal, Eran/0000-0002-6859-1164; Farnham, Peggy/0000-0003-4469-7914	NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050007] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA119176-02, R01 CA119176] Funding Source: Medline; NIAMS NIH HHS [K08 AR050007-03, K08 AR050007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albrecht U, 1997, MOL CELLULAR METHODS, P23; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chuong CM, 2003, J INVEST DERMATOL, V120, P9, DOI 10.1046/j.1523-1747.2003.00002.x; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Nelson CE, 1996, DEVELOPMENT, V122, P1449; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Sun Yinyan, 2005, RNA Biol, V2, P8, DOI 10.4161/rna.2.1.1465; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	45	3221	3462	15	325	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1311	1323		10.1016/j.cell.2007.05.022	http://dx.doi.org/10.1016/j.cell.2007.05.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604720	Green Accepted, Bronze			2022-12-24	WOS:000247911400017
J	Gregor, T; Tank, DW; Wieschaus, EF; Bialek, W				Gregor, Thomas; Tank, David W.; Wieschaus, Eric F.; Bialek, William			Probing the limits to positional information	CELL			English	Article							EARLY DROSOPHILA EMBRYO; GENE-EXPRESSION; BICOID PROTEIN; DNA-BINDING; FLUORESCENCE MICROSCOPY; MORPHOGEN GRADIENTS; PHYSICAL LIMITS; SINGLE-CELL; PATTERN; DOMAIN	The reproducibility and precision of biological patterning is limited by the accuracy with which concentration profiles of morphogen molecules can be established and read out by their targets. We consider four measures of precision for the Bicoid morphogen in the Drosophila embryo: the concentration differences that distinguish neighboring cells, the limits set by the random arrival of Bicoid molecules at their targets ( which depends on absolute concentration), the noise in readout of Bicoid by the activation of Hunchback, and the reproducibility of Bicoid concentration at corresponding positions in multiple embryos. We show, through a combination of different experiments, that all of these quantities are similar to 10%. This agreement among different measures of accuracy indicates that the embryo is not faced with noisy input signals and readout mechanisms; rather, the system exerts precise control over absolute concentrations and responds reliably to small concentration differences, approaching the limits set by basic physical principles.	Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X	NIGMS NIH HHS [R01 GM077599, R01 GM077599-01, P50 GM071508-01, R01 GM077599-02, P50 GM071508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM077599] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2006, COOPERATIVITY SENSIT; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gao Q, 1998, DEVELOPMENT, V125, P4185; Gergen J. P., 1986, S SOC DEV BIOL, V43, P195; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Ma XG, 1996, DEVELOPMENT, V122, P1195; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ptashne M., 1992, A GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHRODINGER E, 1944, WHAT LIFE; Slonim N, 2005, ESTIMATING MUTUAL IN; Spirov Alexander V., 2003, In Silico Biology, V3, P89; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Winston RL, 1999, BIOCHEMISTRY-US, V38, P5138, DOI 10.1021/bi982856a; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zhao C, 2002, DEVELOPMENT, V129, P1669	50	481	486	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					153	164		10.1016/j.cell.2007.05.025	http://dx.doi.org/10.1016/j.cell.2007.05.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632062	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000248587000018
J	Hector, A; Bagchi, R				Hector, Andy; Bagchi, Robert			Biodiversity and ecosystem multifunctionality	NATURE			English	Article							STATISTICAL INEVITABILITY; EUROPEAN GRASSLANDS; CURRENT KNOWLEDGE; DIVERSITY; STABILITY; PRODUCTIVITY; ECOLOGY; COMMUNITIES; SERVICES	Biodiversity loss can affect ecosystem functions and services(1-4). Individual ecosystem functions generally show a positive asymptotic relationship with increasing biodiversity, suggesting that some species are redundant(5-8). However, ecosystems are managed and conserved for multiple functions, which may require greater biodiversity. Here we present an analysis of published data from grassland biodiversity experiments(9-11), and show that ecosystem multifunctionality does require greater numbers of species. We analysed each ecosystem function alone to identify species with desirable effects. We then calculated the number of species with positive effects for all possible combinations of functions. Our results show appreciable differences in the sets of species influencing different ecosystem functions, with average proportional overlap of about 0.2 to 0.5. Consequently, as more ecosystem processes were included in our analysis, more species were found to affect overall functioning. Specifically, for all of the analysed experiments, there was a positive saturating relationship between the number of ecosystem processes considered and the number of species influencing overall functioning. We conclude that because different species often influence different functions, studies focusing on individual processes in isolation will underestimate levels of biodiversity required to maintain multifunctional ecosystems.	Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland	University of Zurich	Hector, A (corresponding author), Univ Zurich, Inst Environm Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ahector@uwinst.uzh.ch	Bagchi, Robert/F-1732-2011; Hector, Andrew/H-4199-2011	Bagchi, Robert/0000-0003-4035-4105; Hector, Andrew/0000-0002-1309-7716				Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CARLANDER KD, 1955, J FISH RES BOARD CAN, V12, P543, DOI 10.1139/f55-029; COMTET L, 1974, ADV COMBINATORICS AR, P176; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Darwin C., 1858, J LINNEAN SOC ZOOLOG, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, SCIENCE, V295, P639, DOI 10.1126/science.1064815; HECTOR A, 2005, ECOL ARCH, pS1; HECTOR A, IN PRESS FUNCT ECOL; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCullagh P, 1989, GEN LINEAR MODELS; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RIPLEY BD, 2004, METHODS MODELS STAT, P155; Sanderson MA, 2004, CROP SCI, V44, P1132, DOI 10.2135/cropsci2004.1132; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steiner CF, 2006, ECOLOGY, V87, P996, DOI 10.1890/0012-9658(2006)87[996:PACRIM]2.0.CO;2; TAPER ML, 2005, NATURE SCI EVIDENCE, P488; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	32	715	810	86	947	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					188	U6		10.1038/nature05947	http://dx.doi.org/10.1038/nature05947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625564				2022-12-24	WOS:000247934500041
J	Major, MB; Camp, ND; Berndt, JD; Yi, XH; Goldenberg, SJ; Hubbert, C; Biechele, TL; Gingras, AC; Zheng, N; MacCoss, MJ; Angers, S; Moon, RT				Major, Michael B.; Camp, Nathan D.; Berndt, Jason D.; Yi, XianHua; Goldenberg, Seth J.; Hubbert, Charlotte; Biechele, Travis L.; Gingras, Anne-Claude; Zheng, Ning; MacCoss, Michael J.; Angers, Stephane; Moon, Randall T.			Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling	SCIENCE			English	Article							PATHWAY	Aberrant WNT signal transduction is involved in many diseases. In colorectal cancer and melanoma, mutational disruption of proteins involved in the degradation of beta-catenin, the key effector of the WNT signaling pathway, results in stabilization of beta-catenin and, in turn, activation of transcription. We have used tandem-affinity protein purification and mass spectrometry to define the protein interaction network of the beta-catenin destruction complex. This assay revealed that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 (beta-transducin repeat-containing protein 2), and APC ( adenomatous polyposis coli). Functional analyses in cultured cells, Xenopus, and zebrafish demonstrate that WTX promotes beta-catenin ubiquitination and degradation, which antagonize WNT/beta-catenin signaling. These data provide a possible mechanistic explanation for the tumor suppressor activity of WTX.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Moon, RT (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Moon, Randall/M-5605-2019; 高, 雨莉/HGU-8187-2022; Moon, Randall T/B-1743-2014; Gingras, Anne-Claude/ABA-8341-2020; Angers, Stephane/E-1432-2014; Gingras, Anne-Claude/E-9982-2010	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Gingras, Anne-Claude/0000-0002-6090-4437; Angers, Stephane/0000-0001-7241-9044; Gingras, Anne-Claude/0000-0002-6090-4437; Major, Michael/0000-0002-6753-8513				Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Koesters R, 1999, CANCER RES, V59, P3880; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006	10	316	342	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1043	1046		10.1126/science/1141515	http://dx.doi.org/10.1126/science/1141515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510365				2022-12-24	WOS:000246554000051
J	Tomlins, SA; Laxman, B; Dhanasekaran, SM; Helgeson, BE; Cao, XH; Morris, DS; Menon, A; Jing, XJ; Cao, Q; Han, B; Yu, JD; Wang, L; Montie, JE; Rubin, MA; Pienta, KJ; Roulston, D; Shah, RB; Varambally, S; Mehra, R; Chinnaiyan, AM				Tomlins, Scott A.; Laxman, Bharathi; Dhanasekaran, Saravana M.; Helgeson, Beth E.; Cao, Xuhong; Morris, David S.; Menon, Anjana; Jing, Xiaojun; Cao, Qi; Han, Bo; Yu, Jindan; Wang, Lei; Montie, James E.; Rubin, Mark A.; Pienta, Kenneth J.; Roulston, Diane; Shah, Rajal B.; Varambally, Sooryanarayana; Mehra, Rohit; Chinnaiyan, Arul M.			Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer	NATURE			English	Article							HIGH-FREQUENCY; EXPRESSION; TMPRSS2-ERG; TRANSLOCATIONS; IDENTIFICATION; MECHANISMS; RELEVANT; PATHWAYS; 3Q21	Recently, we identified recurrent gene fusions involving the 59 untranslated region of the androgen-regulated gene TMPRSS2 and the ETS (E26 transformation-specific) family genes ERG, ETV1 or ETV4 in most prostate cancers(1,2). Whereas TMPRSS2 ERG fusions are predominant, fewer TMPRSS2-ETV1 cases have been identified than expected on the basis of the frequency of high (outlier) expression of ETV1 (refs 3-13). Here we explore the mechanism of ETV1 outlier expression in human prostate tumours and prostate cancer cell lines. We identified previously unknown 59 fusion partners in prostate tumours with ETV1 outlier expression, including untranslated regions from a prostate-specific androgen-induced gene (SLC45A3) and an endogenous retroviral element (HERV-K_22q11.23), a prostate-specific androgen-repressed gene (C15orf21), and a strongly expressed housekeeping gene (HNRPA2B1). To study aberrant activation of ETV1, we identified two prostate cancer cell lines, LNCaP and MDA-PCa 2B, that had ETV1 outlier expression. Through distinct mechanisms, the entire ETV1 locus (7p21) is rearranged to a 1.5-megabase prostate-specific region at 14q13.3-14q21.1 in both LNCaP cells (cryptic insertion) and MDA- PCa 2B cells (balanced translocation). Because the common factor of these rearrangements is aberrant ETV1 overexpression, we recapitulated this event in vitro and in vivo, demonstrating that ETV1 overexpression in benign prostate cells and in the mouse prostate confers neoplastic phenotypes. Identification of distinct classes of ETS gene rearrangements demonstrates that dormant oncogenes can be activated in prostate cancer by juxtaposition to tissue-specific or ubiquitously active genomic loci. Subversion of active genomic regulatory elements may serve as a more generalized mechanism for carcinoma development. Furthermore, the identification of androgen-repressed and insensitive 59 fusion partners may have implications for the anti-androgen treatment of advanced prostate cancer.	Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Pienta, Kenneth/E-7679-2015	Cao, Qi/0000-0002-5140-3681; Tomlins, Scott/0000-0001-8661-9821; Pienta, Kenneth/0000-0002-4138-2186; Varambally, Sooryanarayana/0000-0002-2277-1127; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Rubin, Mark/0000-0002-8321-9950				Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; DEMICHELIS F, 2007, ONCOGENE        0122, DOI DOI 10.1038/SJ.ONC.1210237; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Korenchuk S, 2001, IN VIVO, V15, P163; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; MEHRA R, 2007, MODERN PATHOL, V6, P1177; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Stauffer Yves, 2004, Cancer Immun, V4, P2; SUZUKAWA K, 1994, BLOOD, V84, P2681; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van Bokhoven A, 2003, PROSTATE, V57, P226, DOI 10.1002/pros.10291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiemels JL, 1999, CANCER RES, V59, P4075; Wieser R, 2002, LEUKEMIA LYMPHOMA, V43, P59, DOI 10.1080/10428190210196; Winnes M, 2007, ONCOL REP, V17, P1033; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	34	601	643	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					595	U9		10.1038/nature06024	http://dx.doi.org/10.1038/nature06024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671502	Green Published			2022-12-24	WOS:000248446700044
J	McGregor, AP; Orgogozo, V; Delon, I; Zanet, J; Srinivasan, DG; Payre, F; Stern, DL				McGregor, Alistair P.; Orgogozo, Virginie; Delon, Isabelle; Zanet, Jennifer; Srinivasan, Dayalan G.; Payre, Francois; Stern, David L.			Morphological evolution through multiple cis-regulatory mutations at a single	NATURE			English	Article							DROSOPHILA-MELANOGASTER; EPIDERMIS DIFFERENTIATION; EXPRESSION; GENE; WINGLESS; MAIZE; OVO/SHAVENBABY; PARALLELISM; GERMLINE; PROTEINS	One central, and yet unsolved, question in evolutionary biology is the relationship between the genetic variants segregating within species and the causes of morphological differences between species. The classic neo-darwinian view postulates that species differences result from the accumulation of small-effect changes at multiple loci. However, many examples support the possible role of larger abrupt changes in the expression of developmental genes in morphological evolution(1-3). Although this evidence might be considered a challenge to a neo-darwinian micromutationist view of evolution, there are currently few examples of the actual genes causing morphological differences between species(4-10). Here we examine the genetic basis of a trichome pattern difference between Drosophila species, previously shown to result from the evolution of a single gene, shavenbaby (svb), probably through cis-regulatory changes(6). We first identified three distinct svb enhancers from D. melanogaster driving reporter gene expression in partly overlapping patterns that together recapitulate endogenous svb expression. All three homologous enhancers from D. sechellia drive expression in modified patterns, in a direction consistent with the evolved svb expression pattern. To test the influence of these enhancers on the actual phenotypic difference, we conducted interspecific genetic mapping at a resolution sufficient to recover multiple intragenic recombinants. This functional analysis revealed that independent genetic regions upstream of svb that overlap the three identified enhancers are collectively required to generate the D. sechellia trichome pattern. Our results demonstrate that the accumulation of multiple small-effect changes at a single locus underlies the evolution of a morphological difference between species. These data support the view that alleles of large effect that distinguish species may sometimes reflect the accumulation of multiple mutations of small effect at select genes.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Ctr Dev Biol, F-31062 Toulouse 4, France	Princeton University	Stern, DL (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	dstern@princeton.edu		Stern, David/0000-0002-1847-6483; PAYRE, Francois/0000-0002-8144-6711; Courtier-Orgogozo, Virginie/0000-0002-9297-9230; McGregor, Alistair/0000-0002-2908-2420	NIGMS NIH HHS [R01 GM063622-01, R01 GM063622] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bokor P, 1996, DEVELOPMENT, V122, P1083; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; DOEBLEY J, 1995, GENETICS, V141, P333; GLEASON JM, 2004, DROSOPHILA INFO SERV, V87, P107; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Hatini V, 2005, GENE DEV, V19, P709, DOI 10.1101/gad.1268005; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Khila A, 2003, INSECT BIOCHEM MOLEC, V33, P691, DOI 10.1016/S0965-1748(03)00063-8; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Powell J. R., 1997, PROGR PROSPECTS EVOL; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; ROBERTSON HM, 1988, GENETICS, V118, P461; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Stam LF, 1996, GENETICS, V144, P1559; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Tao H, 2006, PLOS GENET, V2, P848, DOI 10.1371/journal.pgen.0020093; Thummel CS, 1992, DROS INF SERV, V71, P150; True JR, 1996, GENETICS, V142, P507; Walters JW, 2005, DEV BIOL, V286, P415, DOI 10.1016/j.ydbio.2005.06.031; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; Wiellette EL, 1999, DEVELOPMENT, V126, P1985; Yoon HS, 2004, P NATL ACAD SCI USA, V101, P6524, DOI 10.1073/pnas.0401824101	37	234	237	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					587	U6		10.1038/nature05988	http://dx.doi.org/10.1038/nature05988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632547				2022-12-24	WOS:000248446700042
J	Mucida, D; Park, Y; Kim, G; Turovskaya, O; Scott, I; Kronenberg, M; Cheroutre, H				Mucida, Daniel; Park, Yunji; Kim, Gisen; Turovskaya, Olga; Scott, Iain; Kronenberg, Mitchell; Cheroutre, Hilde			Reciprocal T(H)17 and regulatory T cell differentiation mediated by retinoic acid	SCIENCE			English	Article							TGF-BETA; INFLAMMATION; GENERATION; FOXP3	The cytokine transforming growth factor-beta (TGF-beta) converts naive T cells into regulatory T (Treg) cells that prevent autoimmunity. However, in the presence of interleukin-6 (IL-6), TGF-beta has also been found to promote the differentiation of naive T lymphocytes into proinflammatory IL-17 cytokine-producing T helper 17 (TH17) cells, which promote autoimmunity and inflammation. This raises the question of how TGF-beta can generate such distinct outcomes. We identified the vitamin A metabolite retinoic acid as a key regulator of TGF-beta-dependent immune responses, capable of inhibiting the IL-6-driven induction of proinflammatory TH17 cells and promoting anti-inflammatory Treg cell differentiation. These findings indicate that a common metabolite can regulate the balance between pro- and anti-inflammatory immunity.	La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hilde@liai.org	Kronenberg, Mitchell/AAT-6078-2021; Eckhardt, Erik/G-1567-2010	Mucida, Daniel/0000-0002-0000-0452; Park, Yunji/0000-0003-0042-202X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050265-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Hadley GA, 1997, J IMMUNOL, V159, P3748; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; SOMMER A, 1993, J INFECT DIS, V167, P1003, DOI 10.1093/infdis/167.5.1003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	17	1489	1595	1	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					256	260		10.1126/science.1145697	http://dx.doi.org/10.1126/science.1145697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569825				2022-12-24	WOS:000247968600046
J	Borg, NA; Wun, KS; Kjer-Nielsen, L; Wilce, MCJ; Pellicci, DG; Koh, R; Besra, GS; Bharadwaj, M; Godfrey, DI; McCluskey, J; Rossjohn, J				Borg, Natalie A.; Wun, Kwok S.; Kjer-Nielsen, Lars; Wilce, Matthew C. J.; Pellicci, Daniel G.; Koh, Ruide; Besra, Gurdyal S.; Bharadwaj, Mandvi; Godfrey, Dale I.; McCluskey, James; Rossjohn, Jamie			CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor	NATURE			English	Article							ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; STRUCTURAL BASIS; HIGH-AFFINITY; HUMAN CD1D; TCR; SELECTION; COMPLEX; BINDING; GLYCOSPHINGOLIPIDS	The CD1 family is a large cluster of non-polymorphic, major histocompatibility complex (MHC) class-I-like molecules that bind distinct lipid-based antigens that are recognized by T cells. The most studied group of T cells that interact with lipid antigens are natural killer T (NKT) cells, which characteristically express a semi-invariant T-cell receptor ( NKT TCR) that specifically recognizes the CD1 family member, CD1d. NKT-cell-mediated recognition of the CD1d - antigen complex has been implicated in microbial immunity, tumour immunity, autoimmunity and allergy. Here we describe the structure of a human NKT TCR in complex with CD1d bound to the potent NKT-cell agonist alpha-galactosylceramide, the archetypal CD1d-restricted glycolipid. In contrast to T-cell receptor - peptide- antigen - MHC complexes, the NKT TCR docked parallel to, and at the extreme end of the CD1d-binding cleft, which enables a lock-and-key type interaction with the lipid antigen. The structure provides a basis for the interaction between the highly conserved NKT TCR alpha-chain and the CD1d - antigen complex that is typified in innate immunity, and also indicates how variability of the NKT TCR beta-chain can impact on recognition of other CD1d - antigen complexes. These findings provide direct insight into how a T-cell receptor recognizes a lipid-antigen-presenting molecule of the immune system.	Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Monash University; University of Melbourne; University of Birmingham	Rossjohn, J (corresponding author), Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	McCluskey, James/A-1291-2007; Pellicci, Daniel/AAX-8539-2020; Rossjohn, Jamie/F-9032-2013; Bharadwaj, Mandvi/C-4446-2014	McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Godfrey, Dale/0000-0002-3009-5472; Borg, Natalie/0000-0002-8677-9056; Pellicci, Daniel/0000-0001-5305-2398; Besra, Gurdyal/0000-0002-5605-0395; Wun, Kwok/0000-0002-1908-4596	MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; FISCHER B, 1985, FERTILITAT, V1, P101; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Kamada N, 2001, INT IMMUNOL, V13, P853, DOI 10.1093/intimm/13.7.853; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2005, J IMMUNOL, V175, P7303, DOI 10.4049/jimmunol.175.11.7303; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	36	464	506	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					44	49		10.1038/nature05907	http://dx.doi.org/10.1038/nature05907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17581592				2022-12-24	WOS:000247720900033
J	Sarkar, I; Hauber, I; Hauber, J; Buchholz, F				Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank			HIV-1 proviral DNA excision using an evolved recombinase	SCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; LONG TERMINAL REPEAT; CRE RECOMBINASE; ANTIRETROVIRAL THERAPY; INFECTION; EVOLUTION; REPLICATION; SPECIFICITY; RESISTANCE; INHIBITOR	HIV-1 integrates into the host chromosome and persists as a provirus flanked by long terminal repeats (LTRs). To date, treatment regimens primarily target the virus enzymes or virus-cell fusion, but not the integrated provirus. We report here the substrate-linked protein evolution of a tailored recombinase that recognizes an asymmetric sequence within an HIV-1 LTR. This evolved recombinase efficiently excised integrated HIV proviral DNA from the genome of infected cells. Although a long way from use in the clinic, we speculate that this type of technology might be adapted in future antiretroviral therapies, among other possible uses.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Max Planck Society; Heinrich Pette Institute	Hauber, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	joachim.hauber@hpi.uni-hamburg.de; buchholz@mpi-cbg.de	Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344				Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Blackard JT, 1999, VIROLOGY, V254, P220, DOI 10.1006/viro.1998.9504; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Flowers CC, 1997, J VIROL, V71, P2685, DOI 10.1128/JVI.71.4.2685-2692.1997; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lee YS, 1998, BIOCHEM BIOPH RES CO, V253, P588, DOI 10.1006/bbrc.1998.9814; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Rufer AW, 2002, NUCLEIC ACIDS RES, V30, P2764, DOI 10.1093/nar/gkf399; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Saraf-Levy T, 2006, BIOORGAN MED CHEM, V14, P3081, DOI 10.1016/j.bmc.2005.12.016; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87	23	147	161	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1912	1915		10.1126/science.1141453	http://dx.doi.org/10.1126/science.1141453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600219				2022-12-24	WOS:000247602700044
J	Yang, T; Shadlen, MN				Yang, Tianming; Shadlen, Michael N.			Probabilistic reasoning by neurons	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; DEVELOPING OCULOMOTOR COMMANDS; PERCEPTUAL DECISION; VISUAL-CORTEX; SENSORY STIMULI; PREMOTOR CORTEX; MACAQUE MONKEY; REPRESENTATION; TASK	Our brains allow us to reason about alternatives and to make choices that are likely to pay off. Often there is no one correct answer, but instead one that is favoured simply because it is more likely to lead to reward. A variety of probabilistic classification tasks probe the covert strategies that humans use to decide among alternatives based on evidence that bears only probabilistically on outcome. Here we show that rhesus monkeys can also achieve such reasoning. We have trained two monkeys to choose between a pair of coloured targets after viewing four shapes, shown sequentially, that governed the probability that one of the targets would furnish reward. Monkeys learned to combine probabilistic information from the shape combinations. Moreover, neurons in the parietal cortex reveal the addition and subtraction of probabilistic quantities that underlie decision-making on this task.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Yang, T (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Box 357290, Seattle, WA 98195 USA.	tianming@u.washington.edu; shadlen@u.washington.edu	Yang, Tianming/D-3582-2014; Shadlen, Michael Neil/AAL-1870-2020	Yang, Tianming/0000-0001-6976-9246; Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [P51 RR000166] Funding Source: Medline; NEI NIH HHS [R01 EY011378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; GEISLER WS, 1997, VISUAL CORTEX NEURON, P897; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; GREEN DM, 1966, SIGNAL DETECTION THE; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Hayes A, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI [10.1093/ietfec/e88-a.10.2496, 10.1093/ietfec/e88.a.10.2496]; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wald A., 1947, SEQUENTIAL ANAL; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; ZOHARY E, 1994, NATURE, V370, P1405; ZOHARY E, 1994, NATURE, V371, P6495	57	338	345	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1075	U2		10.1038/nature05852	http://dx.doi.org/10.1038/nature05852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17546027				2022-12-24	WOS:000247564600030
J	Sitch, S; Cox, PM; Collins, WJ; Huntingford, C				Sitch, S.; Cox, P. M.; Collins, W. J.; Huntingford, C.			Indirect radiative forcing of climate change through ozone effects on the land-carbon sink	NATURE			English	Article							SURFACE OZONE; RESPONSES; TROPOSPHERE; EMISSIONS; EXPOSURE; IMPACT; TREES; CO2	The evolution of the Earth's climate over the twenty- first century depends on the rate at which anthropogenic carbon dioxide emissions are removed from the atmosphere by the ocean and land carbon cycles(1). Coupled climate - carbon cycle models suggest that global warming will act to limit the land- carbon sink(2), but these first generation models neglected the impacts of changing atmospheric chemistry. Emissions associated with fossil fuel and biomass burning have acted to approximately double the global mean tropospheric ozone concentration(3), and further increases are expected over the twenty- first century(4). Tropospheric ozone is known to damage plants, reducing plant primary productivity and crop yields(5), yet increasing atmospheric carbon dioxide concentrations are thought to stimulate plant primary productivity(6). Increased carbon dioxide and ozone levels can both lead to stomatal closure, which reduces the uptake of either gas, and in turn limits the damaging effect of ozone and the carbon dioxide fertilization of photosynthesis(6). Here we estimate the impact of projected changes in ozone levels on the land- carbon sink, using a global land carbon cycle model modified to include the effect of ozone deposition on photosynthesis and to account for interactions between ozone and carbon dioxide through stomatal closure(7). For a range of sensitivity parameters based on manipulative field experiments, we find a significant suppression of the global land- carbon sink as increases in ozone concentrations affect plant productivity. In consequence, more carbon dioxide accumulates in the atmosphere. We suggest that the resulting indirect radiative forcing by ozone effects on plants could contribute more to global warming than the direct radiative forcing due to tropospheric ozone increases.	Hadley Ctr Climate Predict & Res JCHMR, Met Off, Wallingford OX10 8BB, Oxon, England; Ctr Ecol & Hydrol Wallingford, Wallingford OX10 8BB, Oxon, England; Univ Exeter, Sch Engn Comp Sci & Math, Exeter ES4 4QF, Devon, England; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); University of Exeter; Met Office - UK; Hadley Centre	Sitch, S (corresponding author), Hadley Ctr Climate Predict & Res JCHMR, Met Off, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	stephen.sitch@metoffice.gov.uk	Cox, Peter Michae;/B-3299-2012; Sitch, Stephen A/F-8034-2015; Huntingford, Christopher/A-4307-2008; Collins, William/A-5895-2010	Cox, Peter Michae;/0000-0002-0679-2219; Sitch, Stephen A/0000-0003-1821-8561; Huntingford, Christopher/0000-0002-5941-7770; Collins, William/0000-0002-7419-0850	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Berntsen TK, 2000, J GEOPHYS RES-ATMOS, V105, P8915, DOI 10.1029/1999JD901139; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Essery RLH, 2003, J HYDROMETEOROL, V4, P530, DOI 10.1175/1525-7541(2003)004<0530:EROSHI>2.0.CO;2; Felzer B, 2005, CLIMATIC CHANGE, V73, P345, DOI 10.1007/s10584-005-6776-4; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gauss M, 2006, ATMOS CHEM PHYS, V6, P575, DOI 10.5194/acp-6-575-2006; Gauss M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002624; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Karlsson PE, 2004, ATMOS ENVIRON, V38, P2283, DOI 10.1016/j.atmosenv.2004.01.027; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nussbaum S, 2000, ENVIRON POLLUT, V109, P463, DOI 10.1016/S0269-7491(00)00049-X; Percy KE, 2007, ENVIRON POLLUT, V147, P554, DOI 10.1016/j.envpol.2006.10.009; Pleijel H, 2004, ATMOS ENVIRON, V38, P2259, DOI 10.1016/j.atmosenv.2003.09.076; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanderson MG, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017642; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; van der Werf GR, 2003, GLOBAL CHANGE BIOL, V9, P547, DOI 10.1046/j.1365-2486.2003.00604.x; Volk M, 2006, GLOBAL CHANGE BIOL, V12, P74, DOI 10.1111/j.1365-2486.2005.01083.x; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067	30	655	706	18	343	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					791	U4		10.1038/nature06059	http://dx.doi.org/10.1038/nature06059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653194				2022-12-24	WOS:000248754200036
J	Patra, S; Kumar, A; Trivedi, SS; Puri, M; Sarin, SK				Patra, Sharda; Kumar, Ashish; Trivedi, Shubha Sagar; Puri, Manju; Sarin, Shiv Kumar			Maternal and fetal outcomes in pregnant women with acute hepatitis e virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE VIRAL-HEPATITIS; ACUTE LIVER-FAILURE; CLINICAL-COURSE; ETIOLOGY; TRANSMISSION; INDIA	Background: Hepatitis E virus (HEV) infection is known to cause severe liver disease in pregnant women. It is unclear whether obstetric and fetal outcomes are worse in pregnant women with HEV infection than in women with other forms of viral hepatitis. Objective: To compare maternal, obstetric, and fetal outcomes in pregnant women with acute viral hepatitis caused by HEV and other hepatitis viruses. Design: Observational cohort. Setting: Tertiary care hospital, New Delhi, India. Patients: 220 consecutive pregnant women presenting with jaundice caused by acute viral hepatitis. Measurements: Maternal mortality and medical complications, obstetric complications, deliveries, and fetal outcomes. Results: Infection with HEV caused acute viral hepatitis in 60% of included women. Fulminant hepatic failure was more common (relative risk, 2.7 [95% Cl, 1.7 to 4.2]; P = 0.001) and maternal mortality was greater (relative risk, 6.0 [Cl, 2.7 to 13.3]; P < 0.001) in HEV-infected women than in non-HEV-infected women. Women with HEV infection were more likely than those with other forms of viral hepatitis to have obstetric complications (relative risk, 4.1 [Cl, 1.7 to 10.2] for antepartum hemorrhage and 1.9 [Cl, 1.3 to 2.7] for intrauterine fetal death; P < 0.001 for both) and poor fetal outcomes (relative risk, 1.2 [Cl, 1.0 to 1.4] for preterm delivery [P = 0.0051 and 1.8 [Cl, 1.2 to 2.51 for stillbirth [P = 0.026]). Limitations: The findings may not apply to community settings, to women who are asymptomatic or have only minor symptoms, or in the setting of an HEV epidemic. Conclusions: Pregnant women with jaundice and acute viral hepatitis caused by HEV infection had a higher maternal mortality rate and worse obstetric and fetal outcomes than did pregnant women with jaundice and acute viral hepatitis caused by other types of viral hepatitis.	GB Pant Hosp, Dept Gastroenterol, New Delhi 110002, India; Lady Hardinge Med Coll & Hosp, New Delhi, India	Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; Lady Hardinge Medical College & Hospital	Sarin, SK (corresponding author), GB Pant Hosp, Dept Gastroenterol, Room 201,Acad Block, New Delhi 110002, India.	sksarin@nda.vsnl.net.in	Kumar, Ashish/F-6737-2010; Kumar, Ashish/GRR-3470-2022	Kumar, Ashish/0000-0001-6680-7227; Kumar, Ashish/0000-0002-4476-3494				Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; Arankalle V A, 2000, Indian J Gastroenterol, V19, P24; Aziz Aliya B., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P198; Gelpi A P, 1978, Int J Gynaecol Obstet, V17, P73; Jaiswal SPB, 2001, INT J GYNECOL OBSTET, V72, P103, DOI 10.1016/S0020-7292(00)00264-2; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Khuroo MS, 1997, HEPATOLOGY, V26, P244; KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0; Krawczynski K, 2000, INFECT DIS CLIN N AM, V14, P669, DOI 10.1016/S0891-5520(05)70126-4; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; MEDHAT A, 1993, INT J GYNECOL OBSTET, V40, P25, DOI 10.1016/0020-7292(93)90768-R; Mishra D, 2003, Indian J Pediatr, V70, P273, DOI 10.1007/BF02725598; NAYAK NC, 1989, J GASTROEN HEPATOL, V4, P345, DOI 10.1111/j.1440-1746.1989.tb00846.x; Pal R, 2005, J GASTROEN HEPATOL, V20, P1094, DOI 10.1111/j.1440-1746.2005.03875.x; SARIN SK, 2006, TXB LIVER DIS, P693; Schwartz E, 1999, CLIN INFECT DIS, V29, P1312, DOI 10.1086/313430; Singh Sarman, 2003, Indian Journal of Pediatrics, V70, P37, DOI 10.1007/BF02722743; Strand RT, 2003, SCAND J INFECT DIS, V35, P401, DOI 10.1080/00365540310010930; Trey C, 1970, Prog Liver Dis, V3, P282; TSEGA E, 1993, ETHIOPIAN MED J, V31, P173	24	270	275	3	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					28	33		10.7326/0003-4819-147-1-200707030-00005	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	186MN	17606958				2022-12-24	WOS:000247782900004
J	Kyle, RA; Remstein, ED; Therneau, TM; Dispenzieri, A; Kurtin, PJ; Hodnefield, JM; Larson, DR; Plevak, MF; Jelinek, DF; Fonseca, R; Melton, LJI; Rajkumar, SV				Kyle, Robert A.; Remstein, Ellen D.; Therneau, Terry M.; Dispenzieri, Angela; Kurtin, Paul J.; Hodnefield, Janice M.; Larson, Dirk R.; Plevak, Matthew F.; Jelinek, Diane F.; Fonseca, Rafael; Melton, Lee Joseph, III; Rajkumar, S. Vincent			Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL GAMMOPATHY; NATURAL-HISTORY	Background: Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Prognostic factors for the progression and outcome of this disease are unclear. Methods: We searched a computerized database and reviewed the medical records of all patients at Mayo Clinic who fulfilled the criteria of the International Myeloma Working Group for the diagnosis of smoldering multiple myeloma between 1970 and 1995. Bone marrow aspirate and biopsy specimens were studied, and patients were followed throughout the course of disease. Results: During the 26-year period, 276 patients fulfilled the criteria for smoldering multiple myeloma. During 2131 cumulative person-years of follow-up, symptomatic multiple myeloma or amyloidosis developed in 163 persons (59%). The overall risk of progression was 10% per year for the first 5 years, approximately 3% per year for the next 5 years, and 1% per year for the last 10 years; the cumulative probability of progression was 73% at 15 years. At diagnosis, significant risk factors for progression included the serum level and type of monoclonal protein, the presence of urinary light chain, the extent and pattern of bone marrow involvement, and the reduction in uninvolved immunoglobulins. The proportion of plasma cells in the bone marrow and the serum monoclonal protein level were combined to create a risk-stratification model with three distinct prognostic groups. Conclusions: The risk of progression from smoldering multiple myeloma to symptomatic disease is related to the proportion of bone marrow plasma cells and the serum monoclonal protein level at diagnosis.	Mayo Clin, Div Hematol, Rochester, MN 55905 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; Mayo Clin, Div Biostat, Rochester, MN USA; Mayo Clin, Dept Immunol, Rochester, MN USA; Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	McPhail, Ellen D. Remstein/AAF-3474-2020; Rajkumar, S. Vincent/AAV-1834-2021	McPhail, Ellen D. Remstein/0000-0001-6918-3376; Rajkumar, S. Vincent/0000-0002-5862-1833; Fonseca, Rafael/0000-0002-5938-3769; Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [CA62242, CA107476] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA062242, R01CA107476] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANIAN R, 1988, ARCH INTERN MED, V148, P1963, DOI 10.1001/archinte.148.9.1963; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; Cesana C, 2002, J CLIN ONCOL, V20, P1625, DOI 10.1200/JCO.20.6.1625; COX DR, 1972, J R STAT SOC B, V34, P187; DIMOPOULOS MA, 1993, AM J MED, V94, P57, DOI 10.1016/0002-9343(93)90120-E; FACON T, 1995, AM J HEMATOL, V48, P71, DOI 10.1002/ajh.2830480201; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; KYLE RA, 1992, BLOOD, V79, P1817; KYLE RA, 1980, NEW ENGL J MED, V302, P1347, DOI 10.1056/NEJM198006123022405; KYLE RA, 2002, MANUAL CLIN LAB IMMU, P71; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Rajkumar SV, 2001, LEUKEMIA, V15, P1274, DOI 10.1038/sj.leu.2402183; Rosinol L, 2003, BRIT J HAEMATOL, V123, P631, DOI 10.1046/j.1365-2141.2003.04654.x; *SEER PROGR, 2005, SEER STAT DAT INC SE; SUKPANICHNANT S, 1994, HUM PATHOL, V25, P308, DOI 10.1016/0046-8177(94)90204-6; Weber DM, 1997, BRIT J HAEMATOL, V97, P810, DOI 10.1046/j.1365-2141.1997.1122939.x; WEBER DM, 2003, HEMATOL J, V4, pS31	23	548	573	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2582	2590		10.1056/NEJMoa070389	http://dx.doi.org/10.1056/NEJMoa070389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180GN	17582068				2022-12-24	WOS:000247351200005
J	Alsos, IG; Eidesen, PB; Ehrich, D; Skrede, I; Westergaard, K; Jacobsen, GH; Landvik, JY; Taberlet, P; Brochmann, C				Alsos, Inger Greve; Eidesen, Pernille Bronken; Ehrich, Dorothee; Skrede, Inger; Westergaard, Kristine; Jacobsen, Gro Hilde; Landvik, Jon Y.; Taberlet, Pierre; Brochmann, Christian			Frequent long-distance plant colonization in the changing Arctic	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; DISPERSAL; SVALBARD; DISTRIBUTIONS; MECHANISMS; MIGRATION; EUROPE; AREA	The ability of species to track their ecological niche after climate change is a major source of uncertainty in predicting their future distribution. By analyzing DNA fingerprinting ( amplified fragment-length polymorphism) of nine plant species, we show that long-distance colonization of a remote arctic archipelago, Svalbard, has occurred repeatedly and from several source regions. Propagules are likely carried by wind and drifting sea ice. The genetic effect of restricted colonization was strongly correlated with the temperature requirements of the species, indicating that establishment limits distribution more than dispersal. Thus, it may be appropriate to assume unlimited dispersal when predicting long-term range shifts in the Arctic.	Univ Oslo, Museum Nat Hist, Natl Ctr Biosystemat, NO-0318 Oslo, Norway; Univ Tromso, Tromso Univ Museum, NO-9037 Tromso, Norway; Norwegian Univ Life Sci, NO-1432 As, Norway; Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, F-38041 Grenoble 09, France	University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Alsos, IG (corresponding author), Univ Ctr Svalbard, POB 156, NO-9171 Svalbard, Norway.	ingera@unis.no	Taberlet, Pierre/D-1178-2010; Alsos, Inger Greve/O-8154-2019; Alsos, Inger G/A-9507-2016; Brochmann, Christian/A-4105-2009; Westergaard, Kristine Bakke/GYJ-6582-2022; Westergaard, Kristine/M-7084-2018; Ehrich, Dorothee/F-6492-2015	Taberlet, Pierre/0000-0002-3554-5954; Alsos, Inger Greve/0000-0002-8610-1085; Alsos, Inger G/0000-0002-8610-1085; Westergaard, Kristine/0000-0003-4609-8704; Ehrich, Dorothee/0000-0002-3028-9488; Skrede, Inger/0000-0002-1113-7403				Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; ACIA, 2006, ARCT CLIM IMP ASS SC; BIRKS HH, 1994, J QUATERNARY SCI, V9, P133, DOI 10.1002/jqs.3390090207; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Cooper EJ, 2004, J VEG SCI, V15, P115, DOI 10.1111/j.1654-1103.2004.tb02244.x; Elven R, 2005, CHECKLIST PANARCTIC; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Karlsen SR, 2003, J BIOGEOGR, V30, P1469, DOI 10.1046/j.1365-2699.2003.00942.x; Landvik JY, 1998, QUATERNARY SCI REV, V17, P43, DOI 10.1016/S0277-3791(97)00066-8; Landvik JY, 2003, GEOLOGY, V31, P905, DOI 10.1130/G19703.1; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Neilson RP, 2005, BIOSCIENCE, V55, P749, DOI 10.1641/0006-3568(2005)055[0749:FRTGPM]2.0.CO;2; Ronning O.I., 1963, N ATLANTIC BIOTA THE, P99; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102	23	265	286	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1606	1609		10.1126/science.1139178	http://dx.doi.org/10.1126/science.1139178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569861				2022-12-24	WOS:000247239900038
J	Samani, NJ; Erdmann, J; Hall, AS; Hengstenberg, C; Mangino, M; Mayer, B; Dixon, RJ; Meitinger, T; Braund, P; Wichmann, HE; Barrett, JH; Konig, IR; Stevens, SE; Szymczak, S; Tregouet, D; Iles, MM; Pahlke, F; Pollard, H; Lieb, W; Cambien, F; Fischer, M; Ouwehand, W; Blankenberg, S; Balmforth, AJ; Baessler, A; Ball, SG; Strom, TM; Braenne, I; Gieger, C; Deloukas, P; Tobin, MD; Ziegler, A; Thompson, JR; Schunkert, H				Samani, Nilesh J.; Erdmann, Jeanette; Hall, Alistair S.; Hengstenberg, Christian; Mangino, Massimo; Mayer, Bjoern; Dixon, Richard J.; Meitinger, Thomas; Braund, Peter; Wichmann, H.-Erich; Barrett, Jennifer H.; Koenig, Inke R.; Stevens, Suzanne E.; Szymczak, Silke; Tregouet, David-Alexandre; Iles, Mark M.; Pahlke, Friedrich; Pollard, Helen; Lieb, Wolfgang; Cambien, Francois; Fischer, Marcus; Ouwehand, Willem; Blankenberg, Stefan; Balmforth, Anthony J.; Baessler, Andrea; Ball, Stephen G.; Strom, Tim M.; Braenne, Ingrid; Gieger, Christian; Deloukas, Panos; Tobin, Martin D.; Ziegler, Andreas; Thompson, John R.; Schunkert, Heribert		WTCCC; Cardiogenics Consortium	Genomewide association analysis of coronary artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WIDE ASSOCIATION; RISK-FACTORS; MYOCARDIAL-INFARCTION; GENE; SUSCEPTIBILITY; EXPRESSION; FAMILIES; LINKAGE; LOCI	Background Modern genotyping platforms permit a systematic search for inherited components of complex diseases. We performed a joint analysis of two genomewide association studies of coronary artery disease. Methods We first identified chromosomal loci that were strongly associated with coronary artery disease in the Wellcome Trust Case Control Consortium (WTCCC) study (which involved 1926 case subjects with coronary artery disease and 2938 controls) and looked for replication in the German MI [Myocardial Infarction] Family Study (which involved 875 case subjects with myocardial infarction and 1644 controls). Data on other single-nucleotide polymorphisms (SNPs) that were significantly associated with coronary artery disease in either study (P<0.001) were then combined to identify additional loci with a high probability of true association. Genotyping in both studies was performed with the use of the GeneChip Human Mapping 500K Array Set (Affymetrix). Results Of thousands of chromosomal loci studied, the same locus had the strongest association with coronary artery disease in both the WTCCC and the German studies: chromosome 9p21.3 (SNP, rs1333049) (P=1.80x10(-14) and P=3.40x10(-6), respectively). Overall, the WTCCC study revealed nine loci that were strongly associated with coronary artery disease (P<1.2x10(-5) and less than a 50% chance of being falsely positive). In addition to chromosome 9p21.3, two of these loci were successfully replicated (adjusted P<0.05) in the German study: chromosome 6q25.1 (rs6922269) and chromosome 2q36.3 (rs2943634). The combined analysis of the two studies identified four additional loci significantly associated with coronary artery disease (P<1.3x10(-6)) and a high probability(>80%) of a true association: chromosomes 1p13.3 (rs599839), 1q41 (rs17465637), 10q11.21 (rs501120), and 15q22.33 (rs17228212). Conclusions We identified several genetic loci that, individually and in aggregate, substantially affect the risk of development of coronary artery disease.	Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; Univ Leeds, Leeds, W Yorkshire, England; Univ Cambridge, Cambridge, England; Wellcome Trust Sanger Inst, Hinxton, England; Wellcome Trust Sanger Inst, Hinxton, England; Univ Regensburg, D-8400 Regensburg, Germany; GSF Forschungszentrum Umwelt & Gesundheit GMBH, Neuherberg, Germany; Tech Univ Munich, D-8000 Munich, Germany; Univ Munich, Munich, Germany; Johannes Gutenberg Univ Mainz, D-6500 Mainz, Germany; Univ Paris 06, INSERM, UMR S525, Paris, France	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Leeds; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Samani, NJ (corresponding author), Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk; heribert.schunkert@innere2.uni-luebeck.de	Erdmann, Jeanette/P-7513-2014; Hall, Alistair/K-1953-2019; Szymczak, Silke/HGT-8202-2022; Hengstenberg, Christian/U-5485-2019; Mangino, Massimo/F-5134-2011; Deloukas, Panos/B-2922-2013; Cambien, Francois/AAP-9751-2020; Lieb, Wolfgang/AAC-7650-2022; Girelli, Domenico/B-1183-2008; Tregouet, David-Alexandre/E-3961-2016; Szymczak, Silke/C-6625-2013; Brown, Matthew A/E-5749-2010; Erdmann, Jeanette/A-4417-2009; Trégouët, David-Alexandre/P-9210-2019; Wichmann, Heinz Erich/AAA-5695-2022; Meitinger, Thomas/O-1318-2015; König, Inke R/A-4544-2009; Ziegler, Andreas/G-4246-2012	Erdmann, Jeanette/0000-0002-4486-6231; Mangino, Massimo/0000-0002-2167-7470; Deloukas, Panos/0000-0001-9251-070X; Girelli, Domenico/0000-0001-9684-1899; Brown, Matthew A/0000-0003-0538-8211; Trégouët, David-Alexandre/0000-0001-9084-7800; König, Inke R/0000-0003-0504-6465; Barrett, Jenny/0000-0002-1720-7724; Tobin, Martin/0000-0002-3596-7874; Gieger, Christian/0000-0001-6986-9554; Szymczak, Silke/0000-0002-8897-9035; Iles, Mark/0000-0002-2603-6509; Pahlke, Friedrich/0000-0003-2105-2582; Meitinger, Thomas/0000-0002-8838-8403; Ziegler, Andreas/0000-0002-8386-5397; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X	MRC [G9806740, G0501942] Funding Source: UKRI; Medical Research Council [G9806740, G0501942] Funding Source: Medline; Wellcome Trust [077011, 076113] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALFAKIH K, IN PRESS ATHEROSCLER; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bosserhoff AK, 2002, HISTOL HISTOPATHOL, V17, P289, DOI 10.14670/HH-17.289; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P1391, DOI 10.1161/01.ATV.0000133605.89421.79; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Randak C, 2000, J INHERIT METAB DIS, V23, P520, DOI 10.1023/A:1005667707355; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	32	1572	1646	1	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					443	453		10.1056/NEJMoa072366	http://dx.doi.org/10.1056/NEJMoa072366			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17634449	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000248436300005
J	Webster, M				Webster, Mark			A Cambrian peak in morphological variation within trilobite species	SCIENCE			English	Article							EVOLUTION; PATTERNS; LINES	Morphological variation within species is a raw material subject to natural selection. However, temporal change in morphological diversity has usually been studied in terms of variation among rather than within species. The distribution of polymorphic traits in cladistic character-taxon matrices reveals that the frequency and extent of morphological variation in 982 trilobite species are greatest early in the evolution of the group: Stratigraphically old and/or phylogenetically basal taxa are significantly more variable than younger and/or more derived taxa. Through its influence on evolutionary tempo, high intraspecific variation may have played a major role in the pronounced Cambrian diversification of trilobites.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Webster, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	mwebster@geosci.uchicago.edu						Adrain J.M, 2006, GEOL SOC AM ABSTR, V38, P207; Adrain JM, 1998, SCIENCE, V280, P1922, DOI 10.1126/science.280.5371.1922; [Anonymous], 1994, ACTA PALAEONTOL POL; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; Cotton TJ, 2005, CRUSTACEAN ISS, V16, P95, DOI 10.1201/9781420037548.ch5; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1991, PALAEONTOLOGY, V34, P461; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fortey R.A., 1990, P121; Fortey RA, 2001, J PALEONTOL, V75, P1141, DOI 10.1666/0022-3360(2001)075<1141:TSTLY>2.0.CO;2; Gould S. J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1987, SCIENCE, V236, P1437, DOI 10.1126/science.236.4807.1437; Hughes NC, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P139; Hughes NC, 1999, EVOL DEV, V1, P24, DOI 10.1046/j.1525-142x.1999.99005.x; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; JAANUSSON V, 1975, Fossils and Strata, V4, P209; Jablonski D, 2007, PALAEONTOLOGY, V50, P87, DOI 10.1111/j.1475-4983.2006.00615.x; MCNAMARA KJ, 1986, BIOL REV, V61, P121, DOI 10.1111/j.1469-185X.1986.tb00464.x; Naimark EB, 2006, PALEONTOL J+, V40, P541, DOI 10.1134/S003103010605008X; RAMSKOLD L, 1991, T ROY SOC EDIN-EARTH, V82, P143, DOI 10.1017/S0263593300007616; Renaud S, 2006, EVOLUTION, V60, P1701; Riedl R., 1978, ORDER LIVING ORGANIS; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; VALENTINE JW, 1995, PALAIOS, V10, P190, DOI 10.2307/3515182; Wagner GP, 2004, J EXP ZOOL PART B, V302B, P92, DOI 10.1002/jez.b.20005; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; West-Eberhard Mary Jane, 2003, pi	31	77	79	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					499	502		10.1126/science.1142964	http://dx.doi.org/10.1126/science.1142964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656721				2022-12-24	WOS:000248339800041
J	Teh, OK; Moore, I				Teh, Ooi-kock; Moore, Ian			An ARF-GEF acting at the Golgi and in selective endocytosis in polarized plant cells	NATURE			English	Article							REGULATES VESICLE TRAFFICKING; NUCLEOTIDE-EXCHANGE FACTORS; ENDOPLASMIC-RETICULUM; BREFELDIN-A; PLASMA-MEMBRANE; AUXIN TRANSPORT; H+-ATPASE; ARABIDOPSIS; PROTEIN; GTPASE	Circumstantial evidence suggests that intracellular membrane trafficking pathways diversified independently in the plant kingdom(1-10), but documented examples are rare(6,11,12). ARF-GEFs (guanine-nucleotide exchange factors for ADP-ribosylation factor GTPases) are essential for vesicular trafficking in all eukaryotic kingdoms, but of the eight ARF-GEF families, only the ancestral BIG and GBF types are found in plants(1,2). Whereas fungal and animal GBF proteins perform conserved functions at the Golgi, the Arabidopsis thaliana GBF protein GNOM is thought to act in only the process of recycling from endosomes(3-5). We now show that the related Arabidopsis GBF protein GNOM-LIKE1 (GNL1) has an ancestral function at the Golgi but is also required for selective internalization from the plasma membrane in the presence of brefeldin A (BFA). We identified gnl1 mutants that accumulated biosynthetic and recycling endoplasmic reticulum markers in enlarged internal compartments. Notably, in the absence of functional GNL1, Golgi stacks were rendered sensitive to the selective ARF-GEF inhibitor BFA, which caused them to fuse with the endoplasmic reticulum. Furthermore, in BFA-treated gnl1 roots, the internalization of a polar plasma-membrane marker, the auxin efflux carrier PIN2, was selectively inhibited. Thus, GNL1 is a BFA-resistant GBF protein that functions with a BFA-sensitive ARF-GEF both at the Golgi and in selective endocytosis, but not in recycling from endosomes. We propose that the evolution of endocytic trafficking in plants was accompanied by neo-functionalization within the GBF family, whereas in other kingdoms it occurred independently by elaboration of additional ARF-GEF families.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Moore, I (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	ian.moore@plants.ox.ac.uk	Teh, Ooi-kock/ABF-6401-2021	Teh, Ooi-kock/0000-0001-6800-2748	Biotechnology and Biological Sciences Research Council [REI20537, BBS/B/09562] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Geldner N, 2004, PLANTA, V219, P547, DOI 10.1007/s00425-004-1302-x; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Hawes C, 2005, NEW PHYTOL, V165, P29, DOI 10.1111/j.1469-8137.2004.01218.x; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Samalova M, 2006, TRAFFIC, V7, P1701, DOI 10.1111/j.1600-0854.2006.00502.x; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	35	198	204	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					493	496		10.1038/nature06023	http://dx.doi.org/10.1038/nature06023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653191				2022-12-24	WOS:000248302700051
J	Lunyak, VV; Prefontaine, GG; Nunez, E; Cramer, T; Ju, BG; Ohgi, KA; Hutt, K; Roy, R; Garcia-Diaz, A; Zhu, XY; Yung, Y; Montoliu, L; Glass, CK; Rosenfeld, MG				Lunyak, Victoria V.; Prefontaine, Gratien G.; Nunez, Esperanza; Cramer, Thorsten; Ju, Bong-Gun; Ohgi, Kenneth A.; Hutt, Kasey; Roy, Rosa; Garcia-Diaz, Angel; Zhu, Xiaoyan; Yung, Yun; Montoliu, Lluis; Glass, Christopher K.; Rosenfeld, Michael G.			Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis	SCIENCE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN INSULATOR; GROWTH-HORMONE GENE; RNA-POLYMERASE-II; NUCLEAR ARCHITECTURE; METHYLTRANSFERASES; HETEROCHROMATIN; ELEMENTS; CELLS; TRANSCRIPTION	The temporal and spatial regulation of gene expression in mammalian development is linked to the establishment of functional chromatin domains. Here, we report that tissue-specific transcription of a retrotransposon repeat in the murine growth hormone locus is required for gene activation. This repeat serves as a boundary to block the influence of repressive chromatin modifications. The repeat element is able to generate short, overlapping Pol II- and Pol III-driven transcripts, both of which are necessary and sufficient to enable a restructuring of the regulated locus into nuclear compartments. These data suggest that transcription of interspersed repetitive sequences may represent a developmental strategy for the establishment of functionally distinct domains within the mammalian genome to control gene activation.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Dept Med, Sch Med, La Jolla, CA 92093 USA; CSIC, CNB, Dept Mol & Cellular Biol, Madrid 28049, Spain; Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lunyak, VV (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	vlunyak@uscd.edu; mrosenfeld@ucsd.edu	Montoliu, Lluis/I-2039-2015; ROY, ROSA/AAA-9584-2019; Garcia-Diaz, Angel/AAT-9213-2020; Glass, Christopher/AAI-3933-2021; Cramer, Thorsten/S-2479-2016; lunyak, victoria/R-3765-2017	Montoliu, Lluis/0000-0003-3941-1176; Garcia-Diaz, Angel/0000-0001-6139-6764; Glass, Christopher/0000-0003-4344-3592; Cramer, Thorsten/0000-0002-6462-239X; Roy Barcelona, Rosa/0000-0003-0729-3849; lunyak, victoria/0000-0001-9093-2714				Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; BACHVAROVA R, 1988, DEV BIOL, V130, P513, DOI 10.1016/0012-1606(88)90346-6; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; Biron VL, 2004, DEV BIOL, V276, P337, DOI 10.1016/j.ydbio.2004.08.038; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CILIBERTO G, 1983, CELL, V32, P725, DOI 10.1016/0092-8674(83)90058-2; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Giraldo P, 2003, NUCLEIC ACIDS RES, V31, P6290, DOI 10.1093/nar/gkg793; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice JC, 2001, NATURE, V414, P258, DOI 10.1038/35104721; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shewchuk BM, 2001, NUCLEIC ACIDS RES, V29, P3356, DOI 10.1093/nar/29.16.3356; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301	27	196	209	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					248	251		10.1126/science.1140871	http://dx.doi.org/10.1126/science.1140871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626886				2022-12-24	WOS:000247968600044
J	Okamura, K; Hagen, JW; Duan, H; Tyler, DM; Lai, EC				Okamura, Katsutomo; Hagen, Joshua W.; Duan, Hong; Tyler, David M.; Lai, Eric C.			The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila	CELL			English	Article							UTR SEQUENCE MOTIF; NUCLEAR EXPORT; C-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; DISTINCT ROLES; K-BOX; GENES; IDENTIFICATION; INTERFERENCE; EXPRESSION	The canonical microRNA ( miRNA) pathway converts primary hairpin precursor transcripts into similar to 22 nucleotide regulatory RNAs via consecutive cleavages by two RNase III enzymes, Drosha and Dicer. In this study, we characterize Drosophila small RNAs that derive from short intronic hairpins termed `` mirtrons.'' Their nuclear biogenesis appears to bypass Drosha cleavage, which is essential for miRNA biogenesis. Instead, mirtron hairpins are defined by the action of the splicing machinery and lariat- debranching enzyme, which yield pre- miRNA- like hairpins. The mirtron pathway merges with the canonical miRNA pathway during hairpin export by Exportin- 5, and both types of hairpins are subsequently processed by Dicer- 1/ loqs. This generates small RNAs that can repress perfectly matched and seed- matched targets, and we provide evidence that they function, at least in part, via the RNA- induced silencing complex effector Ago1. These findings reveal that mirtrons are an alternate source of miRNA- type regulatory RNAs.	Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Lai, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Dev Biol, 1275 York Ave,Box 252, New York, NY 10021 USA.	laie@mskcc.org	Lai, Eric C/A-3412-2008; Lai, Eric/AAO-1143-2021	Lai, Eric/0000-0002-8432-5851	NIGMS NIH HHS [GM07739, R01 GM083300-01, R01 GM083300, T32 GM007739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300, T32GM007739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Conklin JF, 2005, METHODS, V37, P368, DOI 10.1016/j.ymeth.2005.08.002; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Ooi SL, 1998, RNA, V4, P1096, DOI 10.1017/S1355838298980785; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	50	688	735	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					89	100		10.1016/j.cell.2007.06.028	http://dx.doi.org/10.1016/j.cell.2007.06.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17599402	Green Accepted, Bronze			2022-12-24	WOS:000248587000013
J	Tauber, E; Zordan, M; Sandrelli, F; Pegoraro, M; Osterwalder, N; Breda, C; Daga, A; Selmin, A; Monger, K; Benna, C; Rosato, E; Kyriacou, CP; Costa, R				Tauber, Eran; Zordan, Mauro; Sandrelli, Federica; Pegoraro, Mirko; Osterwalder, Nicolo; Breda, Carlo; Daga, Andrea; Selmin, Alessandro; Monger, Karen; Benna, Clara; Rosato, Ezio; Kyriacou, Charalambos P.; Costa, Rodolfo			Natural selection favors a newly derived timeless allele in Drosophila melanogaster	SCIENCE			English	Article							CLOCK GENE; DIAPAUSE; MUTATIONS; REGION	Circadian and other natural clock-like endogenous rhythms may have evolved to anticipate regular temporal changes in the environment. We report that a mutation in the circadian clock gene timeless in Drosophila melanogaster has arisen and spread by natural selection relatively recently in Europe. We found that, when introduced into different genetic backgrounds, natural and artificial alleles of the timeless gene affect the incidence of diapause in response to changes in light and temperature. The natural mutant allele alters an important life history trait that may enhance the fly's adaptation to seasonal conditions.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Leicester; University of Padua	Kyriacou, CP (corresponding author), Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England.	cpk@leicester.ac.uk	Tauber, Eran/F-9826-2011; Tauber, Eran/AAA-1562-2022; benna, clara/K-1083-2018; daga, andrea/J-1865-2018	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; daga, andrea/0000-0001-8935-5489; BENNA, CLARA/0000-0002-9077-2471; Pegoraro, Mirko/0000-0001-9381-5249; Breda, Carlo/0000-0002-6365-9828; SANDRELLI, FEDERICA/0000-0002-5631-7467; Rosato, Ezio/0000-0001-7297-4697	Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish; NERC [NE/D012058/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bradshaw WE, 2003, AM NAT, V161, P735, DOI 10.1086/374344; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; FU YX, 1993, GENETICS, V133, P693; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; LACHAISE D, 1988, EVOL BIOL, V22, P159; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Ousley A, 1998, GENETICS, V148, P815; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schmidt PS, 2006, EVOLUTION, V60, P1602, DOI 10.1111/j.0014-3820.2006.tb00505.x; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; TAJIMA F, 1989, GENETICS, V123, P585; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141	23	210	213	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1895	1898		10.1126/science.1138412	http://dx.doi.org/10.1126/science.1138412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600215				2022-12-24	WOS:000247602700039
J	Saalmann, YB; Pigarev, IN; Vidyasagar, TR				Saalmann, Yuri B.; Pigarev, Ivan N.; Vidyasagar, Trichur R.			Neural mechanisms of visual attention: How top-down feedback highlights relevant locations	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; EXTRASTRIATE CORTEX; FEATURE-INTEGRATION; DIRECTED ATTENTION; FUNCTIONAL MRI; MODULATION; SPOTLIGHT; MACAQUE; MONKEY	Attention helps us process potentially important objects by selectively increasing the activity of sensory neurons that represent the relevant locations and features of our environment. This selection process requires top-down feedback about what is important in our environment. We investigated how parietal cortical output influences neural activity in early sensory areas. Neural recordings were made simultaneously from the posterior parietal cortex and an earlier area in the visual pathway, the medial temporal area, of macaques performing a visual matching task. When the monkey selectively attended to a location, the timing of activities in the two regions became synchronized, with the parietal cortex leading the medial temporal area. Parietal neurons may thus selectively increase activity in earlier sensory areas to enable focused spatial attention.	Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia; Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia	University of Melbourne; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Vidyasagar, TR (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	trv@unimelb.edu.au	Vidyasagar, Trichur/D-9665-2012; Saalmann, Yuri B/AAW-5814-2021; ivan, pigarev/AAP-5502-2021	Vidyasagar, Trichur/0000-0002-4148-2048; Saalmann, Yuri/0000-0001-8880-6698				Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BULLIER J, 1988, EXP BRAIN RES, V70, P90; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	29	299	302	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1612	1615		10.1126/science.1139140	http://dx.doi.org/10.1126/science.1139140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569863				2022-12-24	WOS:000247239900040
J	Nakatogawa, H; Ichimura, Y; Ohsumi, Y				Nakatogawa, Hitoshi; Ichimura, Yoshinobu; Ohsumi, Yoshinori			Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion	CELL			English	Article							MAMMALIAN HOMOLOG; FUSION; YEAST; RECONSTITUTION; BINDING; STATE	Autophagy involves de novo formation of double membrane- bound structures called autophagosomes, which engulf material to be degraded in lytic compartments. Atg8 is a ubiquitinlike protein required for this process in Saccharomyces cerevisiae that can be conjugated to the lipid phosphatidylethanolamine by a ubiquitin- like system. Here, we show using an in vitro system that Atg8 mediates the tethering and hemifusion of membranes, which are evoked by the lipidation of the protein and reversibly modulated by the deconjugation enzyme Atg4. Mutational analyses suggest that membrane tethering and hemifusion observed in vitro represent an authentic function of Atg8 in autophagosome formation in vivo. In addition, electron microscopic analyses indicate that these functions of Atg8 are involved in the expansion of autophagosomal membranes. Our results provide further insights into the mechanisms underlying the unique membrane dynamics of autophagy and also indicate the functional versatility of ubiquitin- like proteins.	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166				Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	28	844	881	4	102	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					165	178		10.1016/j.cell.2007.05.021	http://dx.doi.org/10.1016/j.cell.2007.05.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632063	Bronze			2022-12-24	WOS:000248587000019
J	Naugler, WE; Sakurai, T; Kim, S; Maeda, S; Kim, K; Elsharkawy, AM; Karin, M				Naugler, Willscott E.; Sakurai, Toshiharu; Kim, Sunhwa; Maeda, Shin; Kim, KyoungHyun; Elsharkawy, Ahmed M.; Karin, Michael			Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production	SCIENCE			English	Article							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CHEMICAL HEPATOCARCINOGENESIS; ESTROGEN-RECEPTOR; INNATE IMMUNITY; RISK-FACTORS; INFLAMMATION; MICE; REGENERATION; CIRRHOSIS	Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men. Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine ( DEN). DEN administration caused greater increases in serum interleukin-6 (IL-6) concentration in males than it did in females. Furthermore, ablation of IL-6 abolished the gender differences in hepatocarcinogenesis in mice. DEN exposure promoted production of IL-6 in Kupffer cells (KCs) in a manner dependent on the Toll-like receptor adaptor protein MyD88, ablation of which also protected male mice from DEN-induced hepatocarcinogenesis. Estrogen inhibited secretion of IL-6 from KCs exposed to necrotic hepatocytes and reduced circulating concentrations of IL-6 in DEN-treated male mice. We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk in females, and these findings may be used to prevent HCC in males.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 93093 USA; Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Chiyoda Ku, Tokyo 1000005, Japan; Univ Newcastle Upon Tyne, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Asahi Life Foundation; Newcastle University - UK	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Rd,Mail Code 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Elsharkawy, Ahmed Mohamed/0000-0001-5369-3734; Kim, Kyounghyun/0000-0002-7240-2768	NATIONAL CANCER INSTITUTE [R01CA118165, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R37ES004151, R01ES006376] Funding Source: NIH RePORTER; NCI NIH HHS [CA118165, R01 CA118165, T32 CA121938] Funding Source: Medline; NIDDK NIH HHS [T32 DK007202, DK007202] Funding Source: Medline; NIEHS NIH HHS [ES004151, R01 ES006376, ES006376] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Erikoglu M, 2005, SURG TODAY, V35, P467, DOI 10.1007/s00595-004-2958-3; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOVALSZKY I, 1992, CARCINOGENESIS, V13, P773, DOI 10.1093/carcin/13.5.773; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Suzuki T, 2007, J APPL PHYSIOL, V102, P163, DOI 10.1152/japplphysiol.00964.2006; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Velayudham A, 2006, J HEPATOL, V45, P813, DOI 10.1016/j.jhep.2006.06.017; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zheng R, 2006, MOL MED, V12, P65, DOI 10.2119/2006-00030.Zheng	27	1389	1472	9	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					121	124		10.1126/science.1140485	http://dx.doi.org/10.1126/science.1140485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615358				2022-12-24	WOS:000247776700066
J	Yazawa, M; Ferrante, C; Feng, J; Mio, K; Ogura, T; Zhang, M; Lin, PH; Pan, Z; Komazaki, S; Kato, K; Nishi, M; Zhao, XL; Weisleder, N; Sato, C; Ma, JJ; Takeshima, H				Yazawa, Masayuki; Ferrante, Christopher; Feng, Jue; Mio, Kazuhiro; Ogura, Toshihiko; Zhang, Miao; Lin, Pei-Hui; Pan, Zui; Komazaki, Shinji; Kato, Kazuhiro; Nishi, Miyuki; Zhao, Xiaoli; Weisleder, Noah; Sato, Chikara; Ma, Jianjie; Takeshima, Hiroshi			TRIC channels are essential for Ca2+ handling in intracellular stores	NATURE			English	Article							SARCOPLASMIC-RETICULUM VESICLES; AUTOMATIC PARTICLE PICKUP; CALCIUM-RELEASE; RECEPTOR; ION; EXPRESSION; TOPOLOGY; NETWORK; FAMILY; BLOCK	Cell signalling requires efficient Ca2+ mobilization from intracellular stores through Ca2+ release channels, as well as predicted counter-movement of ions across the sarcoplasmic/endoplasmic reticulum membrane to balance the transient negative potential generated by Ca2+ release(1-7). Ca2+ release channels were cloned more than 15 years ago(8,9), whereas the molecular identity of putative counter- ion channels remains unknown. Here we report two TRIC ( trimeric intracellular cation) channel subtypes that are differentially expressed on intracellular stores in animal cell types. TRIC subtypes contain three proposed transmembrane segments, and form homo-trimers with a bullet-like structure. Electrophysiological measurements with purified TRIC preparations identify a monovalent cation-selective channel. In TRIC-knockout mice suffering embryonic cardiac failure, mutant cardiac myocytes show severe dysfunction in intracellular Ca2+ handling. The TRIC-deficient skeletal muscle sarcoplasmic reticulum shows reduced K+ permeability, as well as altered Ca2+ 'spark' signalling and voltage-induced Ca2+ release. Therefore, TRIC channels are likely to act as counter- ion channels that function in synchronization with Ca2+ release from intracellular stores.	Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; Tohoku Univ, Dept Med Chem, Grad Sch Med, Miyagi 9808575, Japan; Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Ibaraki 3058568, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; Saitama Med Univ, Dept Anat, Saitama 3500495, Japan	Kyoto University; Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Saitama Medical University	Takeshima, H (corresponding author), Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan.	takeshim@pharm.kyoto-u.ac.jp	Sato, Chikara/M-7183-2016; Mio, Kazuhiro/L-7488-2018; Weisleder, Noah L/A-7098-2013; Lin, Pei-Hui/I-3011-2015	Sato, Chikara/0000-0001-5543-4496; Mio, Kazuhiro/0000-0002-1655-8231; Weisleder, Noah L/0000-0002-2619-8022; Lin, Pei-Hui/0000-0002-3894-5099; Takeshima, Hiroshi/0000-0003-4525-3725; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X				ANTOON FM, 2000, DEV BIOL, V223, P279; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Collet C, 1999, J PHYSIOL-LONDON, V520, P417, DOI 10.1111/j.1469-7793.1999.00417.x; CORONADO R, 1980, NATURE, V288, P495, DOI 10.1038/288495a0; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DANI JA, 1995, CURR OPIN NEUROBIOL, V5, P310, DOI 10.1016/0959-4388(95)80043-3; EBASHI S, 1976, ANNU REV PHYSIOL, V38, P293, DOI 10.1146/annurev.ph.38.030176.001453; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fink RHA, 1996, ACTA PHYSIOL SCAND, V156, P387, DOI 10.1046/j.1365-201X.1996.212000.x; Frank J, 2006, 3 DIMENSIONAL ELECT; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; HARAUZ G, 1986, OPTIK, V73, P146; Kourie JI, 1996, BIOPHYS J, V70, P202, DOI 10.1016/S0006-3495(96)79564-4; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU QY, 1991, FEBS LETT, V291, P13, DOI 10.1016/0014-5793(91)81092-M; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; MEISSNER G, 1980, J BIOL CHEM, V255, P6814; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SOMLYO AV, 1977, NATURE, V268, P556, DOI 10.1038/268556a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; ZHANG M, IN PRESS CELL CALCIU	40	115	125	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					78	82		10.1038/nature05928	http://dx.doi.org/10.1038/nature05928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611541				2022-12-24	WOS:000247720900041
J	Wernig, M; Meissner, A; Foreman, R; Brambrink, T; Ku, MC; Hochedlinger, K; Bernstein, BE; Jaenisch, R				Wernig, Marius; Meissner, Alexander; Foreman, Ruth; Brambrink, Tobias; Ku, Manching; Hochedlinger, Konrad; Bernstein, Bradley E.; Jaenisch, Rudolf			In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state	NATURE			English	Article							DE-NOVO METHYLATION; DEVELOPMENTAL REGULATORS; RETROVIRAL GENOMES; SOMATIC-CELLS; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; POLYCOMB; CLONING; GENES	Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells - derived from mouse fibroblasts - can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eads Cindy A, 2002, Methods Mol Biol, V200, P71; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; MAHERALI N, IN PRESS CELL STEM C; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	34	2027	2300	3	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					318	U2		10.1038/nature05944	http://dx.doi.org/10.1038/nature05944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554336				2022-12-24	WOS:000248118300050
J	Day, M				Day, Michael			Don't blame it all on the bogey	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Day, M (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	miday@f2s.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1250	1251		10.1136/bmj.39244.680880.59	http://dx.doi.org/10.1136/bmj.39244.680880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569929	Green Published			2022-12-24	WOS:000247545100029
J	Rucci, M; Iovin, R; Poletti, M; Santini, F				Rucci, Michele; Iovin, Ramon; Poletti, Martina; Santini, Fabrizio			Miniature eye movements enhance fine spatial detail	NATURE			English	Article							VISUAL-CORTEX; MOTION; MICROSACCADES; VISION; IMAGES; STATISTICS; FIXATION; STRIATE; CELLS	Our eyes are constantly in motion. Even during visual fixation, small eye movements continually jitter the location of gaze(1-4). It is known that visual percepts tend to fade when retinal image motion is eliminated in the laboratory(5-9). However, it has long been debated whether, during natural viewing, fixational eye movements have functions in addition to preventing the visual scene from fading(10-17). In this study, we analysed the influence in humans of fixational eye movements on the discrimination of gratings masked by noise that has a power spectrum similar to that of natural images. Using a new method of retinal image stabilization(18), we selectively eliminated the motion of the retinal image that normally occurs during the intersaccadic intervals of visual fixation. Here we show that fixational eye movements improve discrimination of high spatial frequency stimuli, but not of low spatial frequency stimuli. This improvement originates from the temporal modulations introduced by fixational eye movements in the visual input to the retina, which emphasize the high spatial frequency harmonics of the stimulus. In a natural visual world dominated by low spatial frequencies, fixational eye movements appear to constitute an effective sampling strategy by which the visual system enhances the processing of spatial detail.	Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA	Boston University	Rucci, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.	rucci@cns.bu.edu		Poletti, Martina/0000-0002-4773-8745; Rucci, Michele/0000-0002-3066-1964				Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; AREND LE, 1973, PSYCHOL REV, V80, P374, DOI 10.1037/h0020072; Averill HL, 1925, J COMP PSYCHOL, V5, P147, DOI 10.1037/h0072373; Ditchburn R. W., 1955, OPT ACTA, V1, P171; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HERING E, 1899, MATH PHYS KLASSE, V20, P16; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; KELLY DH, 1979, J OPT SOC AM, V69, P1266, DOI 10.1364/JOSA.69.001266; KOENDERINK JJ, 1972, J OPT SOC AM, V62, P685, DOI 10.1364/JOSA.62.000685; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Macmillan N. A., 2005, DETECTION THEORY USE; Marshall W. H., 1942, BIOL S VISUAL MECHAN, V7, P117; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; RIGGS LA, 1952, J OPT SOC AM, V42, P872; Rucci M, 2005, NETWORK-COMP NEURAL, V16, P121, DOI 10.1080/09548980500300507; SANTINI F, IN PRESS BEHAV RES M; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; TULUNAY-KEESEY U, 1976, Vision Research, V16, P481, DOI 10.1016/0042-6989(76)90026-2; TULUNAYKEESEY U, 1982, J OPT SOC AM, V72, P440, DOI 10.1364/JOSA.72.000440; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	30	230	231	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					851	854		10.1038/nature05866	http://dx.doi.org/10.1038/nature05866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568745				2022-12-24	WOS:000247207500043
J	Matsuoka, S; Ballif, BA; Smogorzewska, A; McDonald, ER; Hurov, KE; Luo, J; Bakalarski, CE; Zhao, ZM; Solimini, N; Lerenthal, Y; Shiloh, Y; Gygi, SP; Elledge, SJ				Matsuoka, Shuhei; Ballif, Bryan A.; Smogorzewska, Agata; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Bakalarski, Corey E.; Zhao, Zhenming; Solimini, Nicole; Lerenthal, Yaniv; Shiloh, Yosef; Gygi, Steven P.; Elledge, Stephen J.			ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; IDENTIFICATION; CHECKPOINTS; INVOLVEMENT; PROTEOMICS; PATHWAYS; FANCD2; SITES; SMC1	Cellular responses to DNA damage are mediated by a number of protein kinases, including ATM ( ataxia telangiectasia mutated) and ATR ( ATM and Rad3-related). The outlines of the signal transduction portion of this pathway are known, but little is known about the physiological scope of the DNA damage response (DDR). We performed a large-scale proteomic analysis of proteins phosphorylated in response to DNA damage on consensus sites recognized by ATM and ATR and identified more than 900 regulated phosphorylation sites encompassing over 700 proteins. Functional analysis of a subset of this data set indicated that this list is highly enriched for proteins involved in the DDR. This set of proteins is highly interconnected, and we identified a large number of protein modules and networks not previously linked to the DDR. This database paints a much broader landscape for the DDR than was previously appreciated and opens new avenues of investigation into the responses to DNA damage in mammals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tel Aviv University; Sackler Faculty of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Smogorzewska, Agata/0000-0001-6285-1562; Bakalarski, Corey/0000-0003-1085-7828	PHS HHS [1U19A1067751] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; THORNE KC, 2000, J BIOL CHEM, V275, P35233; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	31	2255	2781	9	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1160	1166		10.1126/science.1140321	http://dx.doi.org/10.1126/science.1140321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525332				2022-12-24	WOS:000246724300034
J	Maamar, H; Raj, A; Dubnau, D				Maamar, Hedia; Raj, Arjun; Dubnau, David			Noise in gene expression determines cell fate in Bacillus subtilis	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; POSITIVE FEEDBACK; ESCHERICHIA-COLI; K-STATE; COMK; DIFFERENTIATION; STOCHASTICITY; PROTEIN; SWITCH; VISUALIZATION	Random cell-to-cell variations in gene expression within an isogenic population can lead to transitions between alternative states of gene expression. Little is known about how these variations ( noise) in natural systems affect such transitions. In Bacillus subtilis, noise in ComK, the protein that regulates competence for DNA uptake, is thought to cause cells to transition to the competent state in which genes encoding DNA uptake proteins are expressed. We demonstrate that noise in comK expression selects cells for competence and that experimental reduction of this noise decreases the number of competent cells. We also show that transitions are limited temporally by a reduction in comK transcription. These results illustrate how such stochastic transitions are regulated in a natural system and suggest that noise characteristics are subject to evolutionary forces.	Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Dubnau, D (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, 225 Warren St, Newark, NJ 07103 USA.	dubnauda@umdnj.edu		Raj, Arjun/0000-0002-2915-6960	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070357, R01GM057720] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057720, GM 070357, R01 GM070357, GM 57720] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	30	481	536	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					526	529		10.1126/science.1140818	http://dx.doi.org/10.1126/science.1140818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17569828	Green Accepted			2022-12-24	WOS:000248339800049
J	Park, CB; Asin-Cayuela, J; Camara, Y; Shi, YH; Pellegrini, M; Gaspari, M; Wibom, R; Hultenby, K; Erdjument-Bromage, H; Tempst, P; Falkenberg, M; Gustafsson, CM; Larsson, NG				Park, Chan Bae; Asin-Cayuela, Jorge; Camara, Yolanda; Shi, Yonghong; Pellegrini, Mina; Gaspari, Martina; Wibom, Rolf; Hultenby, Kjell; Erdjument-Bromage, Hediye; Tempst, Paul; Falkenberg, Maria; Gustafsson, Claes M.; Larsson, Nils-Goran			MTERF3 is a negative regulator of mammalian mtDNA transcription	CELL			English	Article							MITOCHONDRIAL-DNA POLYMERASE; TERMINATION FACTOR MTERF; GENE-EXPRESSION; ATP PRODUCTION; RIBOSOMAL-RNA; IN-VITRO; MICE; PROTEIN; FAMILY; CELLS	Regulation of mammalian mtDNA gene expression is critical for altering oxidative phosphorylation capacity in response to physiological demands and disease processes. The basal machinery for initiation of mtDNA transcription has been molecularly defined, but the mechanisms regulating its activity are poorly understood. In this study, we show that MTERF3 is a negative regulator of mtDNA transcription initiation. The MTERF3 gene is essential because homozygous knockout mouse embryos die in midgestation. Tissue-specific inactivation of MTERF3 in the heart causes aberrant mtDNA transcription and severe respiratory chain deficiency. MTERF3 binds the mtDNA promoter region and depletion of MTERF3 increases transcription initiation on both mtDNA strands. This increased transcription initiation leads to decreased expression of critical promoter-distal tRNA genes, which is possibly explained by transcriptional collision on the circular mtDNA molecule. To our knowledge, MTERF3 is the first example of a mitochondrial protein that acts as a specific repressor of mammalian mtDNA transcription initiation in vivo.	Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Karolinska Institutet; Memorial Sloan Kettering Cancer Center	Gustafsson, CM (corresponding author), Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden.	claes.gustafsson@ki.se; nils-goran.larsson@ki.se	Cámara, Yolanda/P-2540-2019; Larsson, Nils-Göran/GVS-5578-2022; shi, yonghong/E-8254-2017; Cámara, Yolanda/K-4597-2014	Larsson, Nils-Göran/0000-0001-5100-996X; shi, yonghong/0000-0002-5265-7982; Cámara, Yolanda/0000-0003-2458-6942; Gustafsson, Claes/0000-0003-3531-8468; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Asin-Cayuela J, 2005, J BIOL CHEM, V280, P25499, DOI 10.1074/jbc.M501145200; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; CAREY J, 1991, METHOD ENZYMOL, V208, P103; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Enriquez J A, 1996, Methods Enzymol, V264, P50, DOI 10.1016/S0076-6879(96)64008-7; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HEDDI A, 1993, J BIOL CHEM, V268, P12156; Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Micol V, 1996, Methods Enzymol, V264, P158, DOI 10.1016/S0076-6879(96)64017-8; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHANG J, 1994, J BIOL CHEM, V269, P29112; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	40	176	191	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					273	285		10.1016/j.cell.2007.05.046	http://dx.doi.org/10.1016/j.cell.2007.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662942	Bronze			2022-12-24	WOS:000248588000017
J	Merkle, FT; Mirzadeh, Z; Alvarez-Buylla, A				Merkle, Florian T.; Mirzadeh, Zaman; Alvarez-Buylla, Arturo			Mosaic organization of neural stem cells in the adult brain	SCIENCE			English	Article							OLFACTORY-BULB INTERNEURONS; RADIAL GLIA; NEURONS; GENERATION; FOREBRAIN; ZONE; SUBPOPULATIONS; NEUROGENESIS; PROGENITORS; ASTROCYTES	The in vivo potential of neural stem cells in the postnatal mouse brain is not known, but because they produce many different types of neurons, they must be either very versatile or very diverse. By specifically targeting stem cells and following their progeny in vivo, we showed that postnatal stem cells in different regions produce different types of neurons, even when heterotopically grafted or grown in culture. This suggests that rather than being plastic and homogeneous, neural stem cells are a restricted and diverse population of progenitors.	Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Merkle, Florian/A-2639-2011	Merkle, Florian/0000-0002-8513-2998; Alvarez-Buylla, Arturo/0000-0003-4426-8925				Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Fukushima N, 2002, NEUROSCI RES, V44, P467, DOI 10.1016/S0168-0102(02)00173-6; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; HACK MA, 2005, NAT NEUROSCI; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Imura T, 2003, J NEUROSCI, V23, P2824; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PRICE JL, 1970, J CELL SCI, V7, P125; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; SHEPHERD GM, 1998, SYNOPATIC ORG BRAIN; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018	29	612	630	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					381	384		10.1126/science.1144914	http://dx.doi.org/10.1126/science.1144914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17615304				2022-12-24	WOS:000248150200049
J	Tesar, PJ; Chenoweth, JG; Brook, FA; Davies, TJ; Evans, EP; Mack, DL; Gardner, RL; McKay, RDG				Tesar, Paul J.; Chenoweth, Josh G.; Brook, Frances A.; Davies, Timothy J.; Evans, Edward P.; Mack, David L.; Gardner, Richard L.; McKay, Ronald D. G.			New cell lines from mouse epiblast share defining features with human embryonic stem cells	NATURE			English	Article							IN-VITRO; CLONAL ANALYSIS; SELF-RENEWAL; GERM-LINE; DIFFERENTIATION; PLURIPOTENCY; ORIGIN; GENOME; DERIVATION; NETWORK	The application of human embryonic stem (ES) cells in medicine and biology has an inherent reliance on understanding the starting cell population. Human ES cells differ from mouse ES cells and the specific embryonic origin of both cell types is unclear. Previous work suggested that mouse ES cells could only be obtained from the embryo before implantation in the uterus(1-5). Here we show that cell lines can be derived from the epiblast, a tissue of the post-implantation embryo that generates the embryo proper. These cells, which we refer to as EpiSCs (post-implantation epiblast-derived stem cells), express transcription factors known to regulate pluripotency, maintain their genomic integrity, and robustly differentiate into the major somatic cell types as well as primordial germ cells. The EpiSC lines are distinct from mouse ES cells in their epigenetic state and the signals controlling their differentiation. Furthermore, EpiSC and human ES cells share patterns of gene expression and signalling responses that normally function in the epiblast. These results show that epiblast cells can be maintained as stable cell lines and interrogated to understand how pluripotent cells generate distinct fates during early development.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Oxford, Dept Zool, Mammalian Dev Lab, Oxford OX1 3PS, England; NCI, Stem Cell Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McKay, RDG (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	paultesar@ninds.nih.gov; mckayr@ninds.nih.gov	Mack, David/AAE-5437-2022; Tesar, Paul/GPK-5942-2022	Tesar, Paul/0000-0003-1532-3155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002881, Z01NS002881] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RS, 1987, ISOLATION CULTURE MA; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; DEOME KB, 1959, CANCER RES, V19, P515; Downs KM, 2006, METH MOLEC MED, V121, P241; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pelton TA, 2002, J CELL SCI, V115, P329; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	1566	1652	1	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					196	U10		10.1038/nature05972	http://dx.doi.org/10.1038/nature05972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17597760				2022-12-24	WOS:000247934500043
J	Griffin, BM; Schott, J; Schink, B				Griffin, Benjamin M.; Schott, Joachim; Schink, Bernhard			Nitrite, an electron donor for anoxygenic photosynthesis	SCIENCE			English	Article									Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Griffin, BM (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	griff113@uiuc.edu						CUSANOVI.MA, 1968, BIOCHIM BIOPHYS ACTA, V153, P397, DOI 10.1016/0005-2728(68)90083-2; Imhoff J.F., 1995, ANOXYGENIC PHOTOSYNT, P1, DOI DOI 10.1007/0-306-47954-0_1; IMHOFF JF, 2006, PROKARYOTES, V6, P846; OLSON JM, 1970, SCIENCE, V168, P438, DOI 10.1126/science.168.3930.438; Visscher P.T., 2003, BIOGEOCHEMISTRY, V8, P317, DOI DOI 10.1016/B0-08-043751-6/08132-9	5	62	71	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1870	1870		10.1126/science.1139478	http://dx.doi.org/10.1126/science.1139478			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600210				2022-12-24	WOS:000247602700030
J	Maherali, H; Klironomos, JN				Maherali, Hafiz; Klironomos, John N.			Influence of Phylogeny on fungal community assembly and ecosystem functioning	SCIENCE			English	Article							PLANT-COMMUNITIES; CURRENT KNOWLEDGE; BIODIVERSITY; NICHE; EVOLUTION; ECOLOGY; PRODUCTIVITY; CONSERVATISM; CONVERGENCE	Ecology seeks to explain species coexistence and its functional consequences, but experimental tests of mechanisms that simultaneously account for both processes are difficult. We used an experimental mycorrhizal plant system to test whether functional similarity among closely related species (phylogenetic conservatism) can drive community assembly and ecosystem functioning. Communities were constructed with the same number of fungal species, but after 1 year of growth, realized species richness was highest where the starting species were more distantly related to each other. Communities with high realized species richness also stimulated plant productivity more than those with low realized species richness. Our findings suggest that phylogenetic trait conservatism can promote coexistence because of reduced competition between distinct evolutionary lineages and enhance ecosystem function because of functional complementarity among those same lineages.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Maherali, H (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	maherali@uoguelph.ca; jklirono@uoguelph.ca						Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Ackerly DD, 2004, AM NAT, V163, P654, DOI 10.1086/383062; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Darwin C., 1859, ORIGIN SPECIES MEANS; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell Stephen P., 2001, V32, pi; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Schmid B, 2002, MG POP BIOL, V33, P120; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tofts R, 2000, P ROY SOC B-BIOL SCI, V267, P363, DOI 10.1098/rspb.2000.1010; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956; Weiher E., 1999, ECOLOGICAL ASSEMBLY; WINSTON MR, 1995, AM NAT, V145, P527, DOI 10.1086/285754; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	36	642	672	18	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1746	1748		10.1126/science.1143082	http://dx.doi.org/10.1126/science.1143082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588930				2022-12-24	WOS:000247400500047
J	Waterhouse, RM; Kriventseva, EV; Meister, S; Xi, ZY; Alvarez, KS; Bartholomay, LC; Barillas-Mury, C; Bian, GW; Blandin, S; Christensen, BM; Dong, YM; Jiang, HB; Kanost, MR; Koutsos, AC; Levashina, EA; Li, JY; Ligoxygakis, P; MacCallum, RM; Mayhew, GF; Mendes, A; Michel, K; Osta, MA; Paskewitz, S; Shin, SW; Vlachou, D; Wang, LH; Wei, WQ; Zheng, LB; Zou, Z; Severson, DW; Raikhel, AS; Kafatos, FC; Dimopoulos, G; Zdobnov, EM; Christophides, GK				Waterhouse, Robert M.; Kriventseva, Evgenia V.; Meister, Stephan; Xi, Zhiyong; Alvarez, Kanwal S.; Bartholomay, Lyric C.; Barillas-Mury, Carolina; Bian, Guowu; Blandin, Stephanie; Christensen, Bruce M.; Dong, Yuemei; Jiang, Haobo; Kanost, Michael R.; Koutsos, Anastasios C.; Levashina, Elena A.; Li, Jianyong; Ligoxygakis, Petros; MacCallum, Robert M.; Mayhew, George F.; Mendes, Antonio; Michel, Kristin; Osta, Mike A.; Paskewitz, Susan; Shin, Sang Woon; Vlachou, Dina; Wang, Lihui; Wei, Weiqi; Zheng, Liangbiao; Zou, Zhen; Severson, David W.; Raikhel, Alexander S.; Kafatos, Fotis C.; Dimopoulos, George; Zdobnov, Evgeny M.; Christophides, George K.			Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER; SERINE PROTEASES; ANTIVIRAL RESPONSE; SEPHADEX BEADS; AEDES-AEGYPTI; PLASMODIUM; MELANIZATION; PHAGOCYTOSIS; RECOGNITION	Mosquitoes are vectors of parasitic and viral diseases of immense importance for public health. The acquisition of the genome sequence of the yellow fever and Dengue vector, Aedes aegypti (Aa), has enabled a comparative phylogenomic analysis of the insect immune repertoire: in Aa, the malaria vector Anopheles gambiae (Ag), and the fruit fly Drosophila melanogaster (Dm). Analysis of immune signaling pathways and response modules reveals both conservative and rapidly evolving features associated with different functional gene categories and particular aspects of immune reactions. These dynamics reflect in part continuous readjustment between accommodation and rejection of pathogens and suggest how innate immunity may have evolved.	Univ Geneva, Sch Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London SW7 2AZ, England; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; NIAID, Lab Malaria & Vector Res, Twinbrook II Facil, NIH, Bethesda, MD 20892 USA; CNRS, Unite Propre Rech 9022, Avnir INSERM, Inst Mol & Cellulaire, Strasbourg, France; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; Yale Univ, Sch Med Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Fujian Ctr Prevent & Control Occupat Dis & Chem P, Fuzhou, Fujian, Peoples R China; Inst Plant Physiol & Ecol, Shanghai, Peoples R China; Univ Notre Dame, Ctr Global Hlth & Infect Dis, Dept Biol Sci, Notre Dame, IN 46556 USA; Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland	University of Geneva; Imperial College London; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Riverside; University of California System; University of California Riverside; Iowa State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Wisconsin System; University of Wisconsin Madison; Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University; Virginia Polytechnic Institute & State University; University of Oxford; University of Wisconsin System; University of Wisconsin Madison; Yale University; Chinese Academy of Sciences; University of Notre Dame; Swiss Institute of Bioinformatics	Kafatos, FC (corresponding author), Univ Geneva, Sch Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva, Switzerland.	f.kafatos@imperial.ac.uk; zdobnov@medecine.unige.ch; g.christophides@imperial.ac.uk	Michel, Kristin/F-3400-2011; Jiang, Haobo/A-6519-2008; Waterhouse, Robert M/A-1858-2010; Bian, Guowu/B-1572-2010; Meister, Stephan/M-6608-2014; Blandin, Stephanie/ABH-2267-2021; Alvarez, Kanwal/AAQ-6451-2020; Mayhew, George F/B-4042-2016; Blandin, Stephanie/I-2786-2016; zou, zhen/C-6134-2016; Zdobnov, Evgeny M/K-1133-2012; Zdobnov, Evgeny/AAB-2745-2022; Xi, Zhiyong/AAD-7936-2022	Waterhouse, Robert M/0000-0003-4199-9052; Meister, Stephan/0000-0003-2436-7037; Blandin, Stephanie/0000-0003-4566-1200; Mayhew, George F/0000-0003-0609-6018; Blandin, Stephanie/0000-0003-4566-1200; zou, zhen/0000-0003-3550-7656; Zdobnov, Evgeny/0000-0002-5178-1498; Xi, Zhiyong/0000-0001-7786-012X; Kanost, Michael/0000-0002-6827-0061; Dimopoulos, George/0000-0001-6755-8111; Jiang, Haobo/0000-0003-1357-1315; Levashina, Elena/0000-0003-4605-906X; Christophides, George/0000-0002-3323-1687; Shin, Sang Woon/0000-0001-9467-0803; Vlachou, Dina/0000-0002-8305-3014; Dong, Yuemei/0000-0002-7902-2899; MacCallum, Robert/0000-0001-5070-4493; M. Mendes, Antonio/0000-0001-6562-5325	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000947, R01AI037083, R01AI059492, R01AI061576, P01AI044220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041247, R37GM041247, R01GM058634, R01GM041247] Funding Source: NIH RePORTER; MRC [G0300170] Funding Source: UKRI; Medical Research Council [G0300170] Funding Source: Medline; NIAID NIH HHS [1 R01 AI059492-01A1, 5 R01 AI61576-2, R01 AI037083, P01 AI044220-06A1] Funding Source: Medline; NIGMS NIH HHS [GM41247, R01 GM058634-09] Funding Source: Medline; Wellcome Trust [GR077229MA] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust)		Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; IMIER JL, 2004, J LEUKOCYTE BIOL, V75, P18; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Li JS, 2005, INSECT BIOCHEM MOLEC, V35, P1269, DOI 10.1016/j.ibmb.2005.07.001; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	42	471	490	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1738	1743		10.1126/science.1139862	http://dx.doi.org/10.1126/science.1139862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588928	Green Accepted, Green Submitted			2022-12-24	WOS:000247400500045
J	Osei-Atweneboano, MY; Eng, JKL; Boakye, DA; Gyapong, JO; Prichard, RK				Osei-Atweneboano, Mike Y.; Eng, Jeffrey K. L.; Boakye, Daniel A.; Gyapong, John O.; Prichard, Roger K.			Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study	LANCET			English	Article							MULTIPLE TREATMENTS; CONTROL-PROGRAM; P-GLYCOPROTEIN; WEST-AFRICA; SELECTION; CHEMOTHERAPY; VACCINE; FOCI	Background Ivermectin has been used for onchocerciasis control since 1987. Because of the long-term use of this drug and the development of resistance in other nematodes, we have assessed Onchocerca volvulus burdens, effectiveness of ivermectin as a microfilaricide, and its effect on adult female worm reproduction. Methods For the first phase of the study, 2501 individuals in Ghana, from 19 endemic communities who had received six to 18 annual rounds of ivermectin and one ivermectin naive community, were assessed for microfilarial loads 7 days before the 2004 yearly ivermectin treatment, by means of skin snips, and 30 days after treatment to assess the ivermectin microfilaricidal action. For the second phase, skin snips were taken from 342 individuals from ten communities, who were microfilaria positive at pretreatment assessment, on days 90 and 180 after treatment, to identify the effects of ivermectin on female worm fertility, assessed by microfilaria repopulation. Findings 487 (19%) of the 2501 participants were microfilaria positive. The microfilaria prevalence and community microfilarial load in treated communities ranged from 2.2% to 51.8%, and 0.06 microfilariae per snip to 2.85 microfilariae per snip, respectively. Despite treatment, the prevalence rate doubled between 2000 and 2005 in two communities. Microfilaria assessment 30 days after ivermectin treatment showed 100% clearance of microfilaria in more than 99% of people. At day 90 after treatment, four of ten communities had significant microfilaria repopulation, from 7.1% to 21.1% of pretreatment counts, rising to 53.9% by day 180. Interpretation Ivermectin remains a potent microfilaricide. However, our results suggest that resistant adult parasite populations, which are not responding as expected to ivermectin, are emerging. A high rate of repopulation of skin with microfilariae will allow parasite transmission, possibly with ivermectin-resistant 0 volvulus, which could eventually lead to recrudescence of the disease.	McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana	McGill University; University of Ghana; Ghana Health Service	Prichard, RK (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	roger.prichard@mcgill.ca		Gyapong, John/0000-0002-8415-1468				Ali MMM, 2002, ACTA TROP, V84, P49, DOI 10.1016/S0001-706X(02)00117-1; ALLEY ES, 1994, T ROY SOC TROP MED H, V88, P581, DOI 10.1016/0035-9203(94)90172-4; [Anonymous], 1995, WHO TECHN REP SER; Ardelli BF, 2006, PARASITOLOGY, V132, P375, DOI 10.1017/S0031182005008991; Ardelli BF, 2006, MOL BIOCHEM PARASIT, V145, P94, DOI 10.1016/j.molbiopara.2005.09.011; Ardelli BF, 2005, MOL BIOCHEM PARASIT, V143, P58, DOI 10.1016/j.molbiopara.2005.05.006; Ardelli BF, 2004, ANN TROP MED PARASIT, V98, P371, DOI 10.1179/000349804225003415; AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; AWADZI K, 1995, TROP MED PARASITOL, V46, P131; AWADZI K, 1989, TROP MED PARASITOL, V40, P361; Basanez MG, 2006, PLOS MED, V3, P1454, DOI 10.1371/journal.pmed.0030371; BOATIN BA, 1998, ANN TROP MED PARASIT, V92, P46; Borsboom GJJM, 2003, FILARIA J, V2, P1; CHAVASSE DC, 1992, TROP MED PARASITOL, V43, P256; DUKE BOL, 1992, AM J TROP MED HYG, V46, P189, DOI 10.4269/ajtmh.1992.46.189; Eng JKL, 2006, MOL BIOCHEM PARASIT, V150, P229, DOI 10.1016/j.molbiopara.2006.08.007; Eng JKL, 2005, MOL BIOCHEM PARASIT, V142, P193, DOI 10.1016/j.molbiopara.2005.01.021; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; *MIN SAL PUBL, 2000, ORG DES CONTR PROC D, P1; Nutman TB, 2002, TRENDS PARASITOL, V18, P237, DOI 10.1016/S1471-4922(02)02310-3; PETER J, 2006, VACCINE, V24, P5787; PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; REMME J, 1990, ACT LEIDENS, V59, P177; SCHULZ-KEY H, 1986, Parasitology Today, V2, P284, DOI 10.1016/0169-4758(86)90138-9; Whitworth JAG, 1996, TROP MED INT HEALTH, V1, P786; *WHO, 2001, OCP TDR M IMP IV ONC; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	32	279	284	0	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2021	2029		10.1016/S0140-6736(07)60942-8	http://dx.doi.org/10.1016/S0140-6736(07)60942-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574093				2022-12-24	WOS:000247354400026
J	Hoskins, RA; Carlson, JW; Kennedy, C; Acevedo, D; Evans-Holm, M; Frise, E; Wan, KH; Park, S; Mendez-Lago, M; Rossi, F; Villasante, A; Dimitri, P; Karpen, GH; Celniker, SE				Hoskins, Roger A.; Carlson, Joseph W.; Kennedy, Cameron; Acevedo, David; Evans-Holm, Martha; Frise, Erwin; Wan, Kenneth H.; Park, Soo; Mendez-Lago, Maria; Rossi, Fabrizio; Villasante, Alfredo; Dimitri, Patrizio; Karpen, Gary H.; Celniker, Susan E.			Sequence finishing and mapping of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							CENTRIC HETEROCHROMATIN; INSERTIONS; ELEMENTS	Genome sequences for most metazoans and plants are incomplete because of the presence of repeated DNA in the heterochromatin. The heterochromatic regions of Drosophila melanogaster contain 20 million bases (Mb) of sequence amenable to mapping, sequence assembly, and finishing. We describe the generation of 15 Mb of finished or improved heterochromatic sequence with the use of available clone resources and assembly methods. We also constructed a bacterial artificial chromosome-based physical map that spans 13 Mb of the pericentromeric heterochromatin and a cytogenetic map that positions 11 Mb in specific chromosomal locations. We have approached a complete assembly and mapping of the nonsatellite component of Drosophila heterochromatin. The strategy we describe is also applicable to generating substantially more information about heterochromatin in other species, including humans.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Sapienza University Rome; University of California System; University of California Berkeley	Celniker, SE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA.	celniker@fruitfly.org			NHGRI NIH HHS [R01 HG000747, R01 HG00747, R01 HG000747-16, P50-HG00750] Funding Source: Medline; NIGMS NIH HHS [R01 GM066272] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747, P50HG000750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; CELNIKER SE, 2002, GENOME BIOL, V0003; CELNIKER SE, 2006, BDGP RELEASE 5 GENOM; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; JOHN B, 1988, EUKARYOTE GENOME DEV, P416; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Konev AY, 2003, GENETICS, V165, P2039; LOHE AR, 1986, P NATL ACAD SCI USA, V83, P696, DOI 10.1073/pnas.83.3.696; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Yan CM, 2002, GENETICS, V161, P217	21	213	238	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1625	1628		10.1126/science.1139816	http://dx.doi.org/10.1126/science.1139816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569867	Green Accepted, Green Submitted			2022-12-24	WOS:000247239900044
J	Womelsdorf, T; Schoffelen, JM; Oostenveld, R; Singer, W; Desimone, R; Engel, AK; Fries, P				Womelsdorf, Thilo; Schoffelen, Jan-Mathijs; Oostenveld, Robert; Singer, Wolf; Desimone, Robert; Engel, Andreas K.; Fries, Pascal			Modulation of neuronal interactions through neuronal synchronization	SCIENCE			English	Article							VISUAL-CORTEX; GAMMA-OSCILLATIONS; SYNAPTIC MODIFICATIONS; INTERNEURON NETWORKS; CORTICAL NEURON; BEHAVING RAT; COINCIDENCE; HIPPOCAMPUS; RESPONSES; MEMORY	Brain processing depends on the interactions between neuronal groups. Those interactions are governed by the pattern of anatomical connections and by yet unknown mechanisms that modulate the effective strength of a given connection. We found that the mutual influence among neuronal groups depends on the phase relation between rhythmic activities within the groups. Phase relations supporting interactions between the groups preceded those interactions by a few milliseconds, consistent with a mechanistic role. These effects were specific in time, frequency, and space, and we therefore propose that the pattern of synchronization flexibly determines the pattern of neuronal interactions.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT); University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	thilo.womelsdorf@tcdonders.ru.nl; jan.schoffelen@tcdonders.ru.nl	Engel, Andreas K./AAH-6384-2019; Desimone, Robert/G-1121-2018; Singer, Wolf/D-6874-2012; Engel, Andreas K/C-7781-2012; Oostenveld, Robert/D-3259-2009; Schoffelen, Jan-Mathijs/D-3716-2009; Womelsdorf, Thilo/C-3096-2015; Fries, Pascal/E-3196-2010	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; Oostenveld, Robert/0000-0002-1974-1293; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Womelsdorf, Thilo/0000-0001-6921-4187; Fries, Pascal/0000-0002-4270-1468	NEI NIH HHS [R01EY017292] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY017292] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; BUZSEKI G, 2006, RHYTHMS BRAIN; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONIG P, 1995, NEURAL COMPUT, V7, P469, DOI 10.1162/neco.1995.7.3.469; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	28	899	914	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1609	1612		10.1126/science.1139597	http://dx.doi.org/10.1126/science.1139597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569862	Green Published			2022-12-24	WOS:000247239900039
J	Wollert, T; Pasche, B; Rochon, M; Deppenmeier, S; van den Heuvel, J; Gruber, AD; Heinz, DW; Lengeling, A; Schubert, WD				Wollert, Thomas; Pasche, Bastian; Rochon, Maike; Deppenmeier, Stefanie; van den Heuvel, Joop; Gruber, Achim D.; Heinz, Dirk W.; Lengeling, Andreas; Schubert, Wolf-Dieter			Extending the host range of Listeria monocytogenes by rational protein design	CELL			English	Article							GUINEA-PIG; E-CADHERIN; INTERNALIN; RECEPTOR; INVASION; CELLS; ENTRY; SPECIFICITY; MODEL; PLACENTA	In causing disease, pathogens outmaneuver host defenses through a dedicated arsenal of virulence determinants that specifically bind or modify individual host molecules. This dedication limits the intruder to a defined range of hosts. Newly emerging diseases mostly involve existing pathogens whose arsenal has been altered to allow them to infect previously inaccessible hosts. We have emulated this chance occurrence by extending the host range accessible to the human pathogen Listeria monocytogenes by the intestinal route to include the mouse. Analyzing the recognition complex of the listerial invasion protein InIA and its human receptor E-cadherin, we postulated and verified amino acid substitutions in InIA to increase its affinity for E-cadherin. Two single substitutions increase binding affinity by four orders of magnitude and extend binding specificity to include formerly incompatible murine E-cadherin. By rationally adapting a single protein, we thus create a versatile murine model of human listeriosis.	Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Free University of Berlin	Lengeling, A (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, Inhoffenstr 7, D-38124 Braunschweig, Germany.	wolf-dieter.schubert@helmholtz-hzi.de; andreas.lengeling@helmholtz-hzi.de	Gruber, Achim D./ABA-4514-2021; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Wollert, Thomas/0000-0001-9732-4789				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; CLARK MA, 2002, CELL BIOL, V118, P137; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; Dramsi S, 1997, INFECT IMMUN, V65, P1615, DOI 10.1128/IAI.65.5.1615-1625.1997; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Le Monnier A, 2006, INFECT IMMUN, V74, P663, DOI 10.1128/IAI.74.1.663-672.2006; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Marco AJ, 1997, MICROB PATHOGENESIS, V23, P255, DOI 10.1006/mpat.1997.0144; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sleator RD, 2006, CURR OPIN BIOTECH, V17, P211, DOI 10.1016/j.copbio.2006.01.006; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Weiss RA, 2003, CURR TOP MICROBIOL, V278, P47; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yap GS, 2002, CELL MICROBIOL, V4, P627, DOI 10.1046/j.1462-5822.2002.00224.x	52	156	157	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					891	902		10.1016/j.cell.2007.03.049	http://dx.doi.org/10.1016/j.cell.2007.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540170	Bronze, Green Published			2022-12-24	WOS:000247084600010
J	Bird, A				Bird, Adrian			Perceptions of epigenetics	NATURE			English	Editorial Material							DNA METHYLATION	Geneticists study the gene; however, for epigeneticists, there is no obvious `epigene'. Nevertheless, during the past year, more than 2,500 articles, numerous scientific meetings and a new journal were devoted to the subject of epigenetics. It encompasses some of the most exciting contemporary biology and is portrayed by the popular press as a revolutionary new science - an antidote to the idea that we are hard-wired by our genes. So what is epigenetics?	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	apbird@staffmail.ed.ac.uk		Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; JEGGO PA, 1986, MOL CELL BIOL, V6, P2944, DOI 10.1128/MCB.6.8.2944; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SILVA AJ, 1993, DEV BIOL, V156, P391, DOI 10.1006/dbio.1993.1086; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Waddington C., 1957, STRATEGY GENES; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116	18	1813	1935	18	639	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					396	398		10.1038/nature05913	http://dx.doi.org/10.1038/nature05913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522671	Bronze			2022-12-24	WOS:000246693100033
